<SEC-DOCUMENT>0000721371-19-000127.txt : 20191107
<SEC-HEADER>0000721371-19-000127.hdr.sgml : 20191107
<ACCEPTANCE-DATETIME>20191107162042
ACCESSION NUMBER:		0000721371-19-000127
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		89
CONFORMED PERIOD OF REPORT:	20190930
FILED AS OF DATE:		20191107
DATE AS OF CHANGE:		20191107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		191200639

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>a20q110q093019form10-q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:4ecf6c83c9364ffaa5e09f8b27c3d5a7,x:f11f97c60a78470f82972ecb332c2f61-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2019 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:cah="http://www.cardinal.com/20190930" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="FD2020Q1YTD" name="dei:AmendmentFlag" id="Fact-03851B3F47D6B214760693192986D604-wk-Fact-03851B3F47D6B214760693192986D604" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q1YTD" name="dei:CurrentFiscalYearEndDate" id="Fact-66D653005BACA5530824931926EBCC16-wk-Fact-66D653005BACA5530824931926EBCC16">--06-30</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q1YTD" name="dei:DocumentFiscalPeriodFocus" id="Fact-E5F679FA624C68C1CD18931928B4956A-wk-Fact-E5F679FA624C68C1CD18931928B4956A">Q1</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q1YTD" name="dei:DocumentFiscalYearFocus" id="Fact-F9E6C55E8F4229D4699E931927C94862-wk-Fact-F9E6C55E8F4229D4699E931927C94862">2020</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q1YTD" name="dei:EntityCentralIndexKey" id="Fact-DBBEF5F96FE2F1EBE22393192631E974-wk-Fact-DBBEF5F96FE2F1EBE22393192631E974">0000721371</ix:nonNumeric><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-BF7BA5939DBD23296D9874189FB72F03-wk-Fact-BF7BA5939DBD23296D9874189FB72F03">755000000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q1" name="us-gaap:CommonStockSharesAuthorized" id="Fact-B0C8BC96263F2C9EE91D74189FA7DFF4-wk-Fact-B0C8BC96263F2C9EE91D74189FA7DFF4">755000000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-C9C1D3565F006568F66E74189FB7F8A1-wk-Fact-C9C1D3565F006568F66E74189FB7F8A1">327000000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q1" name="us-gaap:CommonStockSharesIssued" id="Fact-7961B8F1C9301A4E89AC74189FB73511-wk-Fact-7961B8F1C9301A4E89AC74189FB73511">327000000</ix:nonFraction><ix:nonFraction decimals="-8" unitRef="usd" contextRef="FI2019Q4" name="us-gaap:DebtAndCapitalLeaseObligations" id="Fact-CC971F9D740B2F025CB3126E9B603DCD-wk-Fact-CC971F9D740B2F025CB3126E9B603DCD">8000000000</ix:nonFraction><ix:nonFraction decimals="INF" unitRef="Number_of_Reportable_Segments" contextRef="FD2020Q1YTD" name="us-gaap:NumberOfReportableSegments" id="Fact-CA070B4FA21B18EE514D1CFCC3BB9BD0-wk-Fact-CA070B4FA21B18EE514D1CFCC3BB9BD0">2</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-3D9379467961DD3497E874189FB72DE9-wk-Fact-3D9379467961DD3497E874189FB72DE9">500000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q1" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-353001115F5F8BAD85D574189FA76840-wk-Fact-353001115F5F8BAD85D574189FA76840">500000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-93CA4D17D50927846EDE74189FA70D73-wk-Fact-93CA4D17D50927846EDE74189FA70D73">0</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q1" name="us-gaap:PreferredStockSharesIssued" id="Fact-8203F7A161711566F30574189FB7BCF5-wk-Fact-8203F7A161711566F30574189FB7BCF5">0</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:TreasuryStockShares" id="Fact-124727C0A519C25933E874189FB7AFDF-wk-Fact-124727C0A519C25933E874189FB7AFDF">28000000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q1" name="us-gaap:TreasuryStockShares" id="Fact-F618A0412A91D0D7663674189FA78817-wk-Fact-F618A0412A91D0D7663674189FA78817">34000000</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:href="cah-20190930.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="FD2020Q1YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1Oct31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1ASC842">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cah:EnterpriseWideCostSavingMeasuresMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cah:EnterpriseWideCostSavingMeasuresMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-08-01</xbrli:startDate>
			<xbrli:endDate>2018-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1SD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-11-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1lawsuits_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-11-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1lawsuits_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-11-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-11-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_MajorCustomersAxis_cah_CVSHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-11-01</xbrli:startDate>
			<xbrli:endDate>2019-11-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-11-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationnetoftaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1opioid_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-10-21</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-11-01</xbrli:startDate>
			<xbrli:endDate>2019-11-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_cah_TaxMatterAxis_cah_CareFusionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2019Q1ASR">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-25</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit><xbrli:unit id="StateAG">
		<xbrli:measure>cah:StateAG</xbrli:measure>
	</xbrli:unit><xbrli:unit id="segment">
		<xbrli:measure>cah:segment</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="Number_of_Reportable_Segments">
		<xbrli:measure>cah:Reportable_Segments</xbrli:measure>
	</xbrli:unit><xbrli:unit id="jpy">
		<xbrli:measure>iso4217:JPY</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit><xbrli:unit id="plaintiff">
		<xbrli:measure>cah:plaintiff</xbrli:measure>
	</xbrli:unit><xbrli:unit id="eur">
		<xbrli:measure>iso4217:EUR</xbrli:measure>
	</xbrli:unit><xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit><xbrli:unit id="lawsuit">
		<xbrli:measure>cah:lawsuit</xbrli:measure>
	</xbrli:unit></ix:resources></ix:header></div><div><a id="s6B835A401B7D56DC8F276F941D9FEACA"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;" href="#s8648FE3C2B625FBB82EF18D8C04C058E"><span style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;">Table of Contents</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:100%;padding-bottom:4px;padding-top:8px;text-align:center;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Washington,&#160;D.C. 20549</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Form </span><span><ix:nonNumeric id="d113070679e2744-wk-Fact-1D1B7C2164515E709578A38E11AD66B4" name="dei:DocumentType" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">10-Q</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;"><span><ix:nonNumeric id="d113070679e2762-wk-Fact-CCCC036B50F42C3EBCE292C2DCF2436D" name="dei:DocumentQuarterlyReport" contextRef="FD2020Q1YTD" format="ixt-sec:boolballotbox">&#9745;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For the quarterly period ended </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d113070679e2772-wk-Fact-808AE6486E405B709EACACA22950E5F0" name="dei:DocumentPeriodEndDate" contextRef="FD2020Q1YTD" format="ixt:datemonthdayyearen">September 30, 2019</ix:nonNumeric></span></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">or</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;"><span><ix:nonNumeric id="d113070679e2792-wk-Fact-30DDD43F776BEDFE503B92C3499AC80C" name="dei:DocumentTransitionReport" contextRef="FD2020Q1YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For the transition period from ________ to ________</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Commission File Number:&#160;</span><span><ix:nonNumeric id="d113070679e2805-wk-Fact-77F0B507F87532B0F19092C423D3E39C" name="dei:EntityFileNumber" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;">1-11373</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:24pt;"><span><ix:nonNumeric id="d113070679e2812-wk-Fact-EA306DE4D52F3A5652E592C48788F861" name="dei:EntityRegistrantName" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;font-size:24pt;font-weight:bold;">Cardinal Health, Inc.</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:24pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Exact name of registrant as specified in its charter)</span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:755px;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:196px;"></td><td style="width:8px;"></td><td style="width:45px;"></td><td style="width:8px;"></td><td style="width:116px;"></td><td style="width:9px;"></td><td style="width:373px;"></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e2838-wk-Fact-2C0A3CC8A2CDFB3028F192C948D79BB1" name="dei:EntityIncorporationStateCountryCode" contextRef="FD2020Q1YTD" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e2868-wk-Fact-388B10B98E730D2AC58A92CCFFA3276C" name="dei:EntityTaxIdentificationNumber" contextRef="FD2020Q1YTD">31-0958666</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:middle;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">(State or other jurisdiction of</span></div><div style="text-align:center;vertical-align:middle;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">incorporation or organization)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:middle;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">(IRS Employer</span></div><div style="text-align:center;vertical-align:middle;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">Identification No.)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e2952-wk-Fact-5E7C98E3D3635AF41E7792CD237CC7C0" name="dei:EntityAddressAddressLine1" contextRef="FD2020Q1YTD">7000 Cardinal Place</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">,</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e2962-wk-Fact-EE8D27460BE52439C4E192CD4989B32D" name="dei:EntityAddressCityOrTown" contextRef="FD2020Q1YTD">Dublin</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">,</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e2972-wk-Fact-EB50E24701CEE249262C92CD742A1238" name="dei:EntityAddressStateOrProvince" contextRef="FD2020Q1YTD" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e2982-wk-Fact-74D6BB81F7B4D875939792CD9D10E2DB" name="dei:EntityAddressPostalZipCode" contextRef="FD2020Q1YTD">43017</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Address of principal executive offices)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Zip Code)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(</span><span><ix:nonNumeric id="d113070679e3023-wk-Fact-8371BAFDD4A6F71AAA9C92CF16C97A94" name="dei:CityAreaCode" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;font-weight:bold;">614</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">)&#160;</span><span><ix:nonNumeric id="d113070679e3028-wk-Fact-6FC9DF892B7EBC23BCEA92CF3FC08FB3" name="dei:LocalPhoneNumber" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;font-weight:bold;">757-5000</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:721px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:266px;"></td><td style="width:186px;"></td><td style="width:266px;"></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Title of each class</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Trading Symbol(s)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e3081-wk-Fact-4E3AB3224F3C893755C792D222C3035D" name="dei:Security12bTitle" contextRef="FD2020Q1YTD">Common shares (without par value)</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e3086-wk-Fact-5CA866ACCC37B77E982292D223770DF3" name="dei:TradingSymbol" contextRef="FD2020Q1YTD">CAH</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d113070679e3091-wk-Fact-3E2392A0AA607612B07A92D223F16B70" name="dei:SecurityExchangeName" contextRef="FD2020Q1YTD" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d113070679e3096-wk-Fact-7A88D5CC7AE5B743FC2992CF8BB85906" name="dei:EntityCurrentReportingStatus" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9745;</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d113070679e3110-wk-Fact-768A8AB834F000EE0F2E92D00BADAF3D" name="dei:EntityInteractiveDataCurrent" contextRef="FD2020Q1YTD"><span style="font-family:Arial Narrow;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:inherit;font-size:10pt;">&#160;</span><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9745;</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:17%;"></td><td style="width:4%;"></td><td style="width:28%;"></td><td style="width:19%;"></td><td style="width:4%;"></td><td style="width:28%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d113070679e3143-wk-Fact-084C0A803CEB800CF27A92D0A5FEFF19" name="dei:EntityFilerCategory" contextRef="FD2020Q1YTD" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9745;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Accelerated filer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Non-accelerated filer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Smaller&#160;reporting&#160;company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;"><span><ix:nonNumeric id="d113070679e3194-wk-Fact-2BC1A2F7C0A844824D1392D0D8665D36" name="dei:EntitySmallBusiness" contextRef="FD2020Q1YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Emerging growth&#160;company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;"><span><ix:nonNumeric id="d113070679e3225-wk-Fact-467FDDD8970EA3AD8BEF92D0D929442A" name="dei:EntityEmergingGrowthCompany" contextRef="FD2020Q1YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act   </span><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). &#160;&#160;&#160;Yes&#160;&#160;</span><span><ix:nonNumeric id="d113070679e3240-wk-Fact-64C2B25BA9E62D09E22D92D185DA7E57" name="dei:EntityShellCompany" contextRef="FD2020Q1YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;No&#160;</span><span style="font-family:inherit;font-size:10pt;">&#160;</span><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9745;</span></div><div style="line-height:120%;padding-bottom:1px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The number of the registrant&#8217;s common shares, without par value, outstanding as of </span><span style="font-family:Arial Narrow;font-size:10pt;">October&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, was the following: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113070679e3259-wk-Fact-EE0BCB3884065ACEA80A216FCDA1DFB3" name="dei:EntityCommonStockSharesOutstanding" contextRef="I2020Q1Oct31" unitRef="shares" decimals="0" scale="0" format="ixt:numdotdecimal">292,488,354</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div><br/></div><hr style="page-break-after:always"></hr><div><a id="s8648FE3C2B625FBB82EF18D8C04C058E"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:22pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:22pt;"><span style="font-family:Arial Narrow;font-size:22pt;font-weight:bold;color:#ee2724;">Cardinal Health</span><span style="font-family:Arial Narrow;font-size:20pt;font-weight:bold;color:#ee2724;">&#160;</span><span style="font-family:Arial Narrow;font-size:18pt;font-weight:bold;color:#ee2724;">&#160;</span></div><div style="text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Q1 Fiscal 2020 Form 10-Q                                                                                                                                   </span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Table of Contents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:92%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s492296C284645086995797A96171E14B"><span style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s492296C284645086995797A96171E14B">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s504393E2A748551E84082BA736845A61"><span style="font-family:Arial Narrow;font-size:10pt;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s504393E2A748551E84082BA736845A61">14</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s8E3FD63AE9965CA9940DC3B7559763AF"><span style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s8E3FD63AE9965CA9940DC3B7559763AF">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s6B40C01A6B4F5FD5A866333DF1E5C3B7"><span style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s6B40C01A6B4F5FD5A866333DF1E5C3B7">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sCE5D482753A65320B6D303408E3252CD"><span style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sCE5D482753A65320B6D303408E3252CD">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s7A2F75BABE8D50558DAEA11B9415396B"><span style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7A2F75BABE8D50558DAEA11B9415396B">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sC229A9502CD557929C9EDDF384EFB929"><span style="font-family:Arial Narrow;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sC229A9502CD557929C9EDDF384EFB929">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD1B7CCA5193854DB9EEEA979E0247169"><span style="font-family:Arial Narrow;font-size:10pt;">Financial Statements and Supplementary Data</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sD1B7CCA5193854DB9EEEA979E0247169">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s6E5639170A9F5236A35D521D5C0BC23B"><span style="font-family:Arial Narrow;font-size:10pt;">Exhibits</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s6E5639170A9F5236A35D521D5C0BC23B">36</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sA73FAAF0701F5D9F83D5E99E739D1576"><span style="font-family:Arial Narrow;font-size:10pt;">Form 10-Q Cross Reference Index</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sA73FAAF0701F5D9F83D5E99E739D1576">37</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s0903B431604E5A26B93243DC1C8D5119"><span style="font-family:Arial Narrow;font-size:10pt;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s0903B431604E5A26B93243DC1C8D5119">38</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">About Cardinal Health</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is an Ohio corporation formed in 1979 and is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. We manage our business and report our financial results in two segments: Pharmaceutical and Medical. As used in this report, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our fiscal year ends on June 30. References to fiscal 2020 and fiscal 2019 and to FY20 and FY19 are to the fiscal years ending or ended June 30, 2020 and June 30, 2019, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Forward-Looking Statements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">This Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 (this "Form 10-Q") (including information incorporated by reference) includes "forward-looking statements" addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Many forward-looking statements appear in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), but there are others in this Form 10-Q, which may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results, trends or guidance, statements of outlook and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those made, projected or implied. The most significant of these risks and uncertainties are described in this Form 10-Q, including Exhibit 99.1, and in "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2019 (our &#8220;2019 Form 10-K&#8221;). Forward-looking statements in this Form 10-Q speak only as of the date of this document. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In the "Overview of Consolidated Results" section of MD&amp;A, we use financial measures that are derived from our consolidated financial data but are not presented in our condensed consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). These measures are considered "non-GAAP financial measures" under the Securities and Exchange Commission ("SEC") rules. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in the &#8220;Explanation and Reconciliation of Non-GAAP Financial Measures&#8221; section following MD&amp;A in this Form 10-Q. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s492296C284645086995797A96171E14B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><a id="s32BB6046029D5B48A1055F93AEF3A14C"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The discussion and analysis presented below is concerned with material changes in financial condition and results of operations between the periods specified in our condensed consolidated balance sheets at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and in our condensed consolidated statements of earnings/(loss) for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and 2018. All comparisons presented are with respect to the prior-year period, unless stated otherwise. This discussion and analysis should be read in conjunction with the MD&amp;A included in our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K. </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s20C1CF6F61CE57B29838C48FCCFD2342"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Overview of Consolidated Results</span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="chart-986746bac297519d8c3.jpg" alt="chart-986746bac297519d8c3.jpg" style="height:200px;width:213px;"></img></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">6 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$37.3 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> due to sales growth from pharmaceutical distribution and specialty pharmaceutical customers.</span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">GAAP and Non-GAAP Operating Earnings/(Loss)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5,264</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">816</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">29</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">156</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(511</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,673</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">19</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">577</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">542</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had a GAAP operating loss of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.3 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> due to a $5.63 billion pre-tax charge we recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications. As described further in the Significant Developments in Fiscal 2020 section in this MD&amp;A and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements", in October 2019, we agreed in principle to a global settlement framework with a leadership group of four state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions. GAAP operating earnings during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were favorably impacted by a $508 million pre-tax gain from the divestiture of our naviHealth Holdings, LLC ("naviHealth") business. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">6 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> increase in non-GAAP operating earnings to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$577 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to the beneficial impact of enterprise-wide cost-savings measures, higher contribution from our Medical </span><span style="font-family:Arial Narrow;font-size:10pt;">distribution and products businesses</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and growth from our specialty pharmaceutical products distribution and services business, partially offset by the adverse impact of pharmaceutical customer contract renewals.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">GAAP and Non-GAAP Diluted EPS </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">($ per share)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019 </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) (2) (3) </sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1) (2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(16.65</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.94</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.07</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.08</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.08</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.33</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.39</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.23</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17.51</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.05</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.27</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.29</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(2</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1) The sum of the components may not equal the total due to rounding.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(2) The reconciling items are presented within this table net of tax. See quantification of tax effect of each reconciling item in our GAAP to Non-GAAP Reconciliations in the "Explanation and Reconciliation of Non-GAAP Financial Measures". </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)  </span><span style="font-family:Arial Narrow;font-size:8pt;">First quarter fiscal 2020 GAAP diluted loss per share attributable to Cardinal Health, Inc. ("GAAP diluted EPS") and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 296 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the quarter. First quarter fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 297 million common shares, which includes potentially dilutive shares.</span><span style="font-family:Arial Narrow;font-size:9pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had a $(16.65) GAAP diluted loss per share attributable to Cardinal Health, Inc. ("GAAP diluted EPS") during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> due to the charge we recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications. The charge had a $(17.40) after tax impact on GAAP diluted EPS. GAAP diluted EPS during the three months ended September&#160;30, 2018 was favorably impacted by a $1.24 gain from the divestiture of naviHealth.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, non-GAAP diluted EPS decreased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.27</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> per share. This decrease was primarily due to the prior-year benefit from discrete tax items, largely related to international legal entity changes. The unfavorable year-over-year impact of the discrete tax items was largely offset by the&#160;factors discussed above impacting non-GAAP operating earnings and a lower share count as a result of share repurchases.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cash and Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our cash and equivalents balance was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.2 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.5 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The decrease in cash and equivalents during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was due to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$653 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of net cash used in operating activities, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> paid for share repurchases and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$146 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> paid in dividends. Cash used in operating activities for the quarter was primarily driven by changes in working capital associated with the timing of payments to vendors. We expect our operating cash flow to be higher in the quarter ended December 31, 2019 due to expected working capital improvement.</span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">4</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Significant Developments in Fiscal 2020</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Opioid Lawsuits Development</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of four state attorneys general from the multi-state task force that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation. The Settlement Framework includes (1) a cash component, pursuant to which we would pay up to $5.56 billion over eighteen years, (2) development and participation in a program for free or rebated distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. In order to continue working on the Settlement Framework, we also agreed, with two other national distributors, to a $215 million settlement with two plaintiffs counties in a trial that had been scheduled for October 2019; our portion of that settlement is $66 million, which will be payable upon execution of a final settlement agreement. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with these matters, we recorded a total pre-tax charge of $5.63 billion ($5.14 billion after tax) during the three months ended September 30, 2019 for the cash component. We accrue for contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. Moreover, the global Settlement Framework is in its early phases, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. We are unable to reasonably estimate the liability associated with any potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to under the Settlement Framework. The amount of ultimate loss may differ materially from this accrual. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Also in connection with these matters, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$487 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$468 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, during the three months ended September 30, 2019, reflecting our current assessment of the estimated future deductibility of the amount that may be paid under the $5.63 billion accrual taken in connection with the opioid litigation. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. Our assumptions and estimates around this benefit and uncertain tax position require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act (&#8220;Tax Act&#8221;). We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act which is subject to further interpretation by the U.S. Internal Revenue Service ("IRS"). Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sBC12EA8303315D5191F2DE7B26F26E1E"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the &#8220;Notes to the Condensed Consolidated Financial Statements&#8221; for additional information.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cost-savings Initiatives</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are implementing certain cost-savings initiatives intended to optimize and simplify our operating model and cost structure. As a result of these initiatives, we recognized </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$20 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in restructuring and employee severance expense during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We expect these cost-savings initiatives, which will affect various functional and commercial areas across the Company, to be substantially implemented during fiscal year 2020.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s341B5030E3945CEEA603BB01AB1DDC43"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Results of Operations</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="chart-0e7efb26c0365e6cb47.jpg" alt="chart-0e7efb26c0365e6cb47.jpg" style="height:200px;width:213px;"></img><img src="chart-5f32bf9b0ca256e99b2.jpg" alt="chart-5f32bf9b0ca256e99b2.jpg" style="height:200px;width:213px;"></img></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">33,428</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31,416</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,917</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3,801</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">37,345</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">35,217</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">37,341</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">35,213</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pharmaceutical Segment </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pharmaceutical segment revenue increased during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> due to sales growth from pharmaceutical distribution and specialty pharmaceutical customers, which together increased revenue by $2.0 billion.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Segment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Medical segment revenue increased during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> primarily due to sales growth from our distribution and products businesses and Cardinal Health at-Home Solutions. The increase was partially offset by the divestiture of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">naviHealth in the prior year.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cost of Products Sold</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cost of products sold increased </span><span style="font-family:Arial Narrow;font-size:10pt;">6 percent</span><span style="font-family:Arial Narrow;font-size:10pt;"> to $</span><span style="font-family:Arial Narrow;font-size:10pt;">35.7 billion</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">due to the factors affecting the changes in revenue and gross margin.</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">6</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Gross Margin</span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><img src="chart-ff3385a010ad5ef68c1.jpg" alt="chart-ff3385a010ad5ef68c1.jpg" style="height:200px;width:213px;"></img><img src="chart-f4d60677c0e25c84939.jpg" alt="chart-f4d60677c0e25c84939.jpg" style="height:200px;width:213px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,679</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,667</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was essentially flat versus the prior-year period. </span></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin rate declined 23 basis points during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> mainly due to the adverse impact of pharmaceutical customer contract renewals and pharmaceutical distribution product mix.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Distribution, Selling, General, and Administrative ("SG&amp;A") Expenses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:74%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">SG&amp;A expenses</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,107</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,155</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, SG&amp;A expenses decreased due to the beneficial impact of enterprise-wide cost-savings measures and lower state assessments on sales of prescription opioid medications. In the three months ended September 30, 2018, we accrued $34 million for an assessment on prescription opioid medications that were sold or distributed in New York state, which was reversed in the three months ended December 31, 2018 when the New York state assessment was declared unconstitutional. </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sEAB52936A26D5BC69805C98E00A1DD63"><span style="font-family:Arial Narrow;font-size:10pt;">Note 13</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information on segment profit.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">398</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">409</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">170</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">135</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">26</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">568</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">544</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5,832</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">272</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total consolidated operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5,264</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">816</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">&#160;</span></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pharmaceutical Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The decrease in Pharmaceutical segment profit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to the adverse impact of customer contract renewals. This decrease was partially offset by the beneficial impact of cost-savings measures and growth from our specialty pharmaceutical products and services business.</span></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in Medical segment profit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to the beneficial impact of cost-savings measures and higher contribution from the segment's </span><span style="font-family:Arial Narrow;font-size:10pt;">distribution and products businesses</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Corporate</span></div><div style="line-height:120%;padding-bottom:6px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The changes in Corporate during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> are due to the factors discussed in the Other Components of Consolidated Operating Earnings/(Loss) section that follows.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">8</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Other Components of Consolidated Operating Earnings/(Loss)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to revenue, gross margin, and SG&amp;A expenses discussed previously, consolidated operating earnings/(loss) were impacted by the following:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">156</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(511</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,673</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">19</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Restructuring and Employee Severance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$20 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$26 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, of expenses in connection with our implementation of certain enterprise-wide cost-saving measures.</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Amortization and Other Acquisition-Related Costs</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Amortization of acquisition-related intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$129 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$133 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Transaction and integration costs associated with the Patient Recovery Business acquisition were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$22 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Impairments and (Gain)/Loss on Disposal of Assets, Net</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$508 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to the divestiture of our naviHealth business.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Litigation (Recoveries)/Charges, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of $5.63 billion ($5.14 billion after tax) associated with the opioid litigation. See Significant Developments in Fiscal 2020 section in this MD&amp;A for additional information.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition to the items discussed above, earnings/(loss) before income taxes was impacted by the following:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">14</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">66</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">77</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(14</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other (Income)/Expense, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in other (income)/expense, net during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to fluctuations in foreign exchange rates.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Interest Expense, Net</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The decrease in interest expense during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to less debt outstanding.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Provision for/(Benefit From) Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">7.9</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">19.4</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent, respectively. The decrease in the effective tax rate from fiscal 2019 to fiscal 2020 is primarily due to the net tax benefit of $487 million related to the opioid litigation pre-tax charge of $5.63 billion, as described further in the Significant Developments in Fiscal 2020 section in this MD&amp;A, partially offset by the prior-year benefit of discrete tax items.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">9</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sFC762615C02A508980FDF0D1F6FC71EC"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Liquidity and Capital Resources</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We currently believe that, based on available capital resources (cash on hand and committed credit facilities) and projected operating cash flow, we have adequate capital resources to fund working capital needs; currently anticipated capital expenditures; currently anticipated business growth and expansion; contractual obligations; tax payments; and current and projected debt service requirements, dividends and share repurchases as well as potential opioid litigation settlement payments associated with the Settlement Framework. If we were to decide to engage in one or more additional acquisitions, depending on the size and timing of such transactions, we might need to access capital markets for additional financing.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cash and Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our cash and equivalents balance was </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.2 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> compared to </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.5 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. At </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, our cash and equivalents were held in cash depository accounts with major banks or invested in high quality, short-term liquid investments. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, net cash used in operating activities was </span><span style="font-family:Arial Narrow;font-size:10pt;">$653 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, primarily driven by increases in working capital associated with the timing of payments to vendors. We also deployed </span><span style="font-family:Arial Narrow;font-size:10pt;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for share repurchases and </span><span style="font-family:Arial Narrow;font-size:10pt;">$146 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for cash dividends. We expect our operating cash flow to be </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">higher in the quarter ended December 31, 2019 due to expected working capital improvement.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Changes in working capital, which impact operating cash flow, can vary significantly depending on factors such as the timing of customer payments, inventory purchases and payments to vendors in the regular course of business, as well as fluctuating working capital needs driven by customer and product mix.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The cash and equivalents balance at </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> included </span><span style="font-family:Arial Narrow;font-size:10pt;">$710 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of cash held by subsidiaries outside of the United States. </span></div></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Other Financing Arrangements and Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Credit Facilities and Commercial Paper</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity at </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> include a $2.0 billion commercial paper program, backed by a&#160;$2.0 billion&#160;revolving credit facility. We also have a&#160;$1.0 billion&#160;committed receivables sales facility. At&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had no amounts outstanding under our commercial paper program, revolving credit facility or our committed receivables sales facility. Under our commercial paper program, we had maximum amounts outstanding of&#160;$190 million&#160;and an average daily amount outstanding of&#160;$6 million&#160;during three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. Our revolving credit facility and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter from </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> through December 2020, a consolidated net leverage ratio of&#160;no more than 4.00-to-1. The maximum quarter-end permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every fiscal quarter thereafter. </span><span style="font-family:Arial Narrow;">As of September 30, 2019, we were in compliance with our financial covenants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Long-Term Debt</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had total long-term obligations</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, including the current portion and other short-term borrowings,</span><span style="font-family:Arial Narrow;font-size:10pt;"> of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$8.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at both</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we repurchased a total of $74 million of notes due in 2022 and 2047 with available cash. We plan to repay our outstanding 2.40% notes at maturity in November 2019 with $450 million of available cash.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">10</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Capital Deployment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a Settlement Framework which includes a cash component, pursuant to which we would pay up to $5.56 billion over eighteen years. We currently expect payment amounts under the Settlement Framework to be spread through the 18-year period subject to participation by states and political subdivisions. See </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Significant Developments in Fiscal 2020 section in this MD&amp;A </span><span style="font-family:Arial Narrow;font-size:10pt;">for additional information.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Capital Expenditures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Capital expenditures during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$72 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$58 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Dividends</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On each of May 8, 2019 and August 7, 2019, our Board of Directors approved a quarterly dividend of $0.4811 per share, or $1.92 per share on an annualized basis, which were paid on July 15, 2019  and October 15, 2019 to shareholders of record on July 1, 2019 and October 1, 2019, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On November 6, 2019, our Board of Directors approved a quarterly dividend of </span><span style="font-family:Arial Narrow;font-size:10pt;">$0.4811</span><span style="font-family:Arial Narrow;font-size:10pt;"> per share, or </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.92</span><span style="font-family:Arial Narrow;font-size:10pt;"> per share on an annualized basis, payable on January 15, 2020 to shareholders of record on January 2, 2020.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Share Repurchases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we d</span><span style="font-family:Arial Narrow;font-size:10pt;">eployed </span><span style="font-family:Arial Narrow;font-size:10pt;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> to purchase our common shares under an accelerated share repurchase ("ASR") program</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We funded the ASR program with available cash and short-term borrowings. At </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> remaining under our existing share repurchase authorization. The ASR program is expected to conclude in the second quarter of fiscal 2020, which will reduce the amount remaining under our existing share repurchase authorization to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$943 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s36CD3C46065E5AF893E312A064188DBE"><span style="font-family:Arial Narrow;font-size:10pt;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information on our ASR program.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">11</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s71DE2089C5325D0F8F7C599D44DF9D69"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Items</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Other Items</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The MD&amp;A in our 2019 Form 10-K addresses our contractual obligations and off-balance sheet arrangements, as of and for the fiscal year ended June 30, 2019. There have been no subsequent material changes outside of the ordinary course of business to those items except for the agreement in principle on a global settlement framework designed to resolve all pending and future opioid lawsuits and claims brought by states and political subdivisions described in the Significant Developments in Fiscal 2020 section in this MD&amp;A and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements".</span></div><div><a id="sA84FDFAA27775D74A9968A64BE9C4E86"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The discussion and analysis presented below are supplemental disclosures to the critical accounting policies and sensitive accounting estimates specified in our consolidated balance sheets at June 30, 2019. This discussion and analysis should be read in conjunction with the Critical Accounting Policies and Sensitive Accounting Estimates included in our 2019 Form 10-K.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Critical accounting policies are those accounting policies that (i) can have a significant impact on our financial condition and results of operations and (ii) require the use of complex and subjective estimates based upon past experience and management&#8217;s judgment. Other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Because estimates are inherently uncertain, actual results may differ.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Purchased goodwill is tested for impairment annually or when indicators of impairment exist. Goodwill impairment testing involves a comparison of the estimated fair value of reporting units to the respective carrying amount, which may be performed utilizing either a qualitative or quantitative assessment.&#160;Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If it is determined that it is more likely than not that the fair value does not exceed the carrying amount, then a quantitative test is performed. The quantitative goodwill impairment test involves a comparison of the estimated fair value of the reporting unit to the respective carrying amount.&#160;A reporting unit is defined as an operating segment or&#160;one level below an operating segment (also known as a component).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary,&#160;the estimation of the fair value of the applicable reporting&#160;unit. Our qualitative evaluation considers </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Unit Goodwill</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">For our annual impairment test in fiscal 2019, the fair value of our Medical Unit exceeded its carrying value of $10.8 billion by approximately 4 percent. Although we believe the assumptions used to arrive at the estimate of fair value during the fourth quarter of fiscal 2019 continue to be reasonable and appropriate, changes in key assumptions during fiscal 2020, including a failure to meet expected earnings or other financial plans, or other unanticipated events and circumstances, such as an increase in interest rates or a significant change in industry or economic trends, may affect future estimates. Adverse changes in key assumptions may result in a decline in fair value below the carrying value in the future resulting in an impairment in our Medical segment in future periods, which could adversely affect our results of operations.</span></div></div></div><div style="line-height:120%;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Loss Contingencies</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as described further in the Significant Developments in Fiscal 2020 section in this MD&amp;A, we recorded a pre-tax charge of $5.63 billion ($5.14 billion after tax) during the three months ended September 30, 2019. We accrue for contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur the assessment is highly subjective and requires judgments about future events. Moreover, the global Settlement Framework is in its early phases, and there is no assurance that the necessary parties will agree to a </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">12</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Items</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Provision for Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the $5.63 billion pre-tax charge for the opioid litigation, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$487 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$468 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sBC12EA8303315D5191F2DE7B26F26E1E"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the Notes to the "Condensed Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2008</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">13</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s504393E2A748551E84082BA736845A61"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ff0000;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The "Overview of Consolidated Results" section within MD&amp;A in this Form 10-Q contains financial measures that are not calculated in accordance with GAAP.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">In addition to analyzing our business based on financial information prepared in accordance with GAAP, we use these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning, and determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business. We provide these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results on a year-over-year basis and in comparing our performance to that of our competitors. However, the non-GAAP financial measures that we use may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth below should be carefully evaluated.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Exclusions from Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">Management believes it is useful to exclude the following items from the non-GAAP measures presented in this report for its own and for investors&#8217; assessment of the business for the reasons identified below:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">LIFO charges and credits</span><span style="font-family:Arial Narrow;"> are excluded because the factors that drive last-in first-out ("LIFO") inventory charges or credits, such as pharmaceutical manufacturer price appreciation or deflation and year-end inventory levels (which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end), are largely out of our control and cannot be accurately predicted. The exclusion of LIFO charges and credits from non-GAAP metrics facilitates comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">State opioid assessments related to prior fiscal years</span><span style="font-family:Arial Narrow;"> is the portion of state assessments for prescription opioid medications that were sold or distributed in periods prior to the fiscal year of the initial assessment. This portion is excluded from non-GAAP financial measures because it is retrospectively applied to sales in prior fiscal years and inclusion would obscure analysis of the current fiscal year results of our underlying, ongoing business. Additionally, while states' laws may require us to make payments on an ongoing basis, the portion of the assessment related to sales in prior periods are contemplated to be one-time, nonrecurring items. Reversals of these accruals have occurred when certain assessments were declared unconstitutional.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Restructuring and employee severance costs</span><span style="font-family:Arial Narrow;"> are excluded because they are not part of the ongoing operations of our underlying business.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Amortization and other acquisition-related costs</span><span style="font-family:Arial Narrow;">, which include transaction costs, integration costs, and changes in the fair value of contingent consideration obligations, are excluded because they are not part of the ongoing operations of our underlying business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies' financial results. Additionally, costs for amortization of acquisition-related intangible assets are non-cash amounts, which are variable in amount and frequency and are significantly impacted by the timing and size of acquisitions, so their exclusion facilitates comparison of historical, current and forecasted financial results. We also exclude other acquisition-related costs, which are directly related to an acquisition but do not meet the criteria to be recognized on the acquired entity&#8217;s initial balance sheet as part of the purchase price allocation. These costs are also significantly impacted by the timing, complexity and size of acquisitions.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Impairments and gain or loss on disposal of assets</span><span style="font-family:Arial Narrow;">&#160;are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and are inherently unpredictable in timing and amount, and in the case of impairments, are non-cash amounts, so their exclusion facilitates comparison of historical, current and forecasted financial results.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Litigation recoveries or charges, net</span><span style="font-family:Arial Narrow;"> are excluded because they often relate to events that may have occurred in prior or multiple periods, do not occur in or reflect the ordinary course of our business and are inherently unpredictable in timing and amount.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Loss on extinguishment of debt</span><span style="font-family:Arial Narrow;"> is excluded because it does not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of this type of charge is not consistent and is significantly impacted by the timing and size of debt extinguishment transactions.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Transitional tax benefit, net</span><span style="font-family:Arial Narrow;"> related to the Tax Cuts and Jobs Act is excluded because it results from the one-time impact of a very significant change in the U.S. federal corporate tax rate and, due to the significant size of the benefit, obscures analysis of trends and financial performance. The transitional tax benefit includes the initial estimate and subsequent adjustments for the re-</span></div></td></tr></table><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">14</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-left:48px;padding-bottom:4px;text-align:justify;"><span style="font-family:Arial Narrow;">measurement of deferred tax assets and liabilities due to the reduction of the U.S. federal corporate income tax rate and the repatriation tax on undistributed foreign earnings. </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">The tax effect for each of the items listed above, other than the transitional tax benefit item, is determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded. The gross, tax and net impact of each item are presented with our GAAP to non-GAAP reconciliations.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:12px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Definitions</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Growth rate calculation</span><span style="font-family:Arial Narrow;font-size:10pt;">: growth rates in this report are determined by dividing the difference between current-period results and prior-period results by prior-period results.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP distribution, selling, general and administrative expenses or Non-GAAP SG&amp;A:</span><span style="font-family:Arial Narrow;font-size:10pt;"> distribution, selling, general and administrative expenses, excluding state opioid assessments related to prior fiscal years.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP operating earnings</span><span style="font-family:Arial Narrow;">: operating earnings excluding (1) LIFO charges/(credits), (2) state opioid assessment related to prior fiscal years, (3) restructuring and employee severance, (4) amortization and other acquisition-related costs, (5) impairments and (gain)/loss on disposal of assets, and (6) litigation (recoveries)/charges, net.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP earnings before income taxes</span><span style="font-family:Arial Narrow;">: earnings before income taxes excluding (1) LIFO charges/(credits), (2) state opioid assessment related to prior fiscal years, (3) restructuring and employee severance, (4) amortization and other acquisition-related costs, (5) impairments and (gain)/loss on disposal of assets, (6) litigation (recoveries)/charges, net, and (7) loss on extinguishment of debt.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP Net Earnings attributable to Cardinal Health, Inc.:</span><span style="font-family:Arial Narrow;"> net earnings attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) state opioid assessment related to prior fiscal years, (3) restructuring and employee severance, (4) amortization and other acquisition-related costs, (5) impairments and (gain)/loss on disposal of assets, (6) litigation (recoveries)/charges, net, (7) loss on extinguishment of debt, each net of tax, and (8) transitional tax benefit, net.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP effective tax rate</span><span style="font-family:Arial Narrow;">: provision for/(benefit from) income taxes adjusted for (1) LIFO charges/(credits), (2) state opioid assessment related to prior fiscal years, (3) restructuring and employee severance, (4) amortization and other acquisition-related costs, (5) impairments and (gain)/loss on disposal of assets, (6)  litigation (recoveries)/charges, net, (7) loss on extinguishment of debt, and (8) transitional tax benefit, (net) divided by (earnings before income taxes adjusted for the first seven items).</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP diluted earnings/(loss) per share attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;">: non-GAAP net earnings/(loss) attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">15</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s379B86E52E385AD2869FC3C59E041EAD"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">GAAP to Non-GAAP Reconciliations</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="27"></td></tr><tr><td style="width:27%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">SG&amp;A</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">SG&amp;A</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings/(Loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings Growth Rate</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for/ (Benefit from) Income Taxes</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup></span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2,3</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">2</sup></span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="26" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30, 2019</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,107</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5,264</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5,344</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(423</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,922</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(16.65</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.08</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">34</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">98</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.33</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">4</sup></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,673</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,673</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">498</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,175</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17.51</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,102</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(2</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">577</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">496</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">117</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">378</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.27</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(2</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="26" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Three Months Ended September 30, 2018</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,155</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">9</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">816</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">211</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">736</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">142</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">593</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">416</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.94</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">439</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(29</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">29</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">29</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">8</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">21</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.07</span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">8</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">24</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.08</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">156</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">156</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">36</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">120</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.39</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(511</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(511</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(134</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(377</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.23</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">19</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">19</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">14</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.05</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,126</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">542</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(11</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">461</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">65</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">396</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">14</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.29</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">18</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Distribution, selling, general and administrative expenses. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">2</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Attributable to Cardinal Health, Inc.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">3</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:8pt;"> </span><span style="font-family:Arial Narrow;font-size:9pt;">First quarter fiscal 2020 GAAP diluted loss per share attributable to Cardinal Health, Inc. ("GAAP diluted EPS") and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 296 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the quarter. First quarter fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 297 million common shares, which includes potentially dilutive shares.</span><span style="font-family:Arial Narrow;font-size:9pt;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">4</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Litigation (recoveries)/charges, net includes a pre-tax charge of</span><span style="font-family:Arial Narrow;font-size:9pt;"> $5.63 billion </span><span style="font-family:Arial Narrow;font-size:9pt;">($5.14 billion after tax) recorded in the first quarter of fiscal 2020 related to the opioid litigation. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The sum of the components may not equal the total due to rounding.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">16</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s4F4A05BD6733573D9F7A24E39C167F41"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><a id="s8E3FD63AE9965CA9940DC3B7559763AF"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">There have been no material changes in the quantitative and qualitative market risk disclosures included in our&#160;2019&#160;Form 10-K since the end of fiscal&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;through&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div><a id="s6B40C01A6B4F5FD5A866333DF1E5C3B7"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Based on this evaluation, our principal executive officer and principal financial officer have concluded that as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Changes in Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">There were no changes in our internal control over financial reporting during the quarter ended&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><a id="sCE5D482753A65320B6D303408E3252CD"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to the proceeding described below, the legal proceedings described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Condensed Consolidated Financial Statements" are incorporated in this "Legal Proceedings" section by reference.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2019, Melissa Cohen, a purported shareholder, filed an action on behalf of Cardinal Health, Inc. in the U.S. District Court for the Southern District of Ohio against certain current and former members of our Board of Directors alleging that the defendants breached their fiduciary duties by failing to effectively monitor Cardinal Health's distribution of controlled substances. The derivative complaint seeks, among other things, unspecified money damages against the defendants and an award of attorneys' fees. </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">17</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s7A2F75BABE8D50558DAEA11B9415396B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Risk Factors</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">You should carefully consider the information in this Form 10-Q, including the risk factors below, and the risk factors discussed in "Risk Factors" and other risks discussed in our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K and our filings with the SEC since June&#160;30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These risks could materially and adversely affect our results of operations, financial condition, liquidity, and cash flows. Our business also could be affected by risks that we are not presently aware of or that we currently consider immaterial to our operations.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes prescription opioid pain medications. In recent years, the abuse of prescription opioid pain medication has become a public health crisis.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">A significant number of counties, municipalities and other plaintiffs, including a number of state attorneys general, have filed lawsuits against pharmaceutical manufacturers, pharmaceutical wholesale distributors (including us), retail chains and others relating to the manufacturing, marketing or distribution of prescription opioid pain medications. In addition, we are currently being investigated or sued by most other states for the same activities and expect to be named as a defendant in additional lawsuits. The defense and resolution of current and future lawsuits and events relating to these lawsuits are subject to uncertainty and could have a material adverse effect on our results of operations, financial condition, cash flows, liquidity, our ability to pay dividends or repurchase our shares, or have adverse reputational or operational effects on our business. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2019, we agreed in principle to Settlement Framework and in connection with this development we recorded a pre-tax accrual of $5.56 billion in the quarter ended September 30, 2019. This Settlement Framework is subject to contingencies but is the basis for our negotiation of definitive terms and documentation. Moreover, the Settlement Framework is in its early phases, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. See&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the "Notes to Condensed Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Other legislative, regulatory or industry measures related to the public health crisis involving the abuse of prescription opioid pain medication and the distribution of these medications could affect our business in ways that we may not be able to predict. For example, several states have now adopted taxes or other fees on the sale of opioids, and several other states have proposed similar legislative initiatives. These laws and proposals vary in the tax amounts imposed and the means of calculation. Liabilities for taxes or assessments under any such laws could have an adverse impact on our results of operations unless we are able to mitigate them through operational changes or commercial arrangements where permitted.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Ongoing unfavorable publicity regarding the abuse or misuse of prescription opioid pain medications and the role of wholesale </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">distributors in the supply chain of such prescription medications, as well as the continued proliferation of the opioid lawsuits, investigations, regulations and legislative actions, and unfavorable publicity in relation to those lawsuits could have a material adverse effect on our reputation or results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">We could be subject to adverse changes in the tax laws or challenges to our tax positions. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a large multinational corporation with operations in the United States and many foreign countries. As a result, we are subject to the tax laws of many jurisdictions. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">From time to time, initiatives are proposed in the United States and other jurisdictions in which we operate that could adversely affect our tax positions, effective tax rate or tax payments. Specific initiatives that may impact us include the repeal of the LIFO (last-in, first-out) method of inventory accounting for income tax purposes, the establishment or increase in taxation at the U.S. state level on the basis of gross revenues, recommendations of the recently completed base erosion and profit shifting project undertaken by the Organization for Economic Cooperation and Development and the European Commission&#8217;s investigation into illegal state aid. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Additionally, in connection with the $5.63 billion pre-tax charge for the opioid litigation, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$487 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$468 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act.  Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sBC12EA8303315D5191F2DE7B26F26E1E"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">18</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div></div></div><div><a id="sC229A9502CD557929C9EDDF384EFB929"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Issuer Purchases of Equity Securities</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:15%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number<br/>of Shares<br/>Purchased&#160;(1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Average Price Paid&#160;per Share (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number of Shares<br/>Purchased<br/>as Part of Publicly Announced Programs&#160;(2, 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Approximate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Dollar Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shares That May</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Yet be Purchased</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Under the Program&#160;(3)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">July 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,203</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">47.26</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,293</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">August 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,400,332</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">43.76</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6,398,537</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,013</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">September 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">285</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">47.36</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,013</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,401,820</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">43.76</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,398,537</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,013</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reflects </span><span style="font-family:Arial Narrow;font-size:8pt;">1,203</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">1,795</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">285</span><span style="font-family:Arial Narrow;font-size:8pt;"> common shares purchased in July, August and September 2019, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">On </span><span style="font-family:Arial Narrow;font-size:8pt;">August 20, 2019</span><span style="font-family:Arial Narrow;font-size:8pt;">, we entered into an accelerated share repurchase ("ASR") program to purchase common shares for an aggregate purchase price of </span><span style="font-family:Arial Narrow;font-size:8pt;">$350 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> and received an initial delivery of </span><span style="font-family:Arial Narrow;font-size:8pt;">6.4 million</span><span style="font-family:Arial Narrow;font-size:8pt;"> common shares using a reference price of $</span><span style="font-family:Arial Narrow;font-size:8pt;">43.76</span><span style="font-family:Arial Narrow;font-size:8pt;">. The program is expected to conclude in the second quarter of fiscal 2020. See </span><a style="font-family:Arial Narrow;font-size:8pt;" href="#s36CD3C46065E5AF893E312A064188DBE"><span style="font-family:Arial Narrow;font-size:8pt;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:8pt;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">On February 7, 2018, our Board of Directors approved a $1.0 billion share repurchase program that expires on December 31, 2020. On November 7, 2018, our Board of Directors approved a new $1.0 billion share repurchase program that expires on December 31, 2021. As of September 30, 2019, we have $1.0 billion authorized for share repurchases remaining under these programs. The approximate dollar value of shares that may yet be purchased under these programs has been reduced by the initial delivery of 6.4 million shares under the ASR program. </span></div></td></tr></table><div><a id="s6ED1CBF67DF75346833CEEBB7D84E88E"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">19</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sD1B7CCA5193854DB9EEEA979E0247169"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Earnings</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e2835-wk-Fact-2EB2517D9B7C56CF8B4E3EA80588EA22" name="us-gaap:Revenues" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,341</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e2854-wk-Fact-0A6172E3579B0878A1BA74189FE5023E" name="us-gaap:Revenues" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,213</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cost of products sold</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e2869-wk-Fact-4EDDEE0C6D378D155DF174189FE5D1A9" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,662</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e2888-wk-Fact-F423499D4BB3CE30FDB574189FE55EA8" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33,546</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e2908-wk-Fact-0629FA7509FB597CAFF79BD1A7BFFC67" name="us-gaap:GrossProfit" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,679</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e2927-wk-Fact-5709F3B2E27A9618E5C474189FE548C5" name="us-gaap:GrossProfit" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,667</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating expenses:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3029-wk-Fact-C4D0FDF407C45245B9023ED2CCC6D99A" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,107</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3048-wk-Fact-9E016B61E89C362C33FA74189FD6D792" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,155</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3068-wk-Fact-FC6357DD0856F8E6785674189FD65150" name="us-gaap:RestructuringCharges" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3087-wk-Fact-76D8C8D0F3F3A19A1A7E74189FD61527" name="us-gaap:RestructuringCharges" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">32</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3107-wk-Fact-341B2F11B418954B6E4474189FE56D5A" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">132</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3126-wk-Fact-003ECA458AD9D3DA508574189FE5D00A" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">156</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3146-wk-Fact-26E35CF3BB3A12B0A6CB74189FD68C16" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113118214e3165-wk-Fact-E50D33B0DE70FEF2421474189FE54D37" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">511</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3187-wk-Fact-339651A9460C4BA8E66274189FD67937" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,673</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3206-wk-Fact-B8AD5079716E08F8615B74189FE5726D" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3226-wk-Fact-C69CC6A1EB30AC79AEA374189FE51E22" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,264</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3246-wk-Fact-9E7250608ACD7C0949BA74189FE59C2A" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">816</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3307-wk-Fact-EB895B0DBC7B5642900E74189FD6FF92" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3326-wk-Fact-A4EAD856191F08E67F7574189FC6FDD9" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3346-wk-Fact-F700C2D94B2C80AA1EA574189FE56260" name="us-gaap:InterestExpense" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">66</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3365-wk-Fact-F01596FBD407DC00E70874189FE595D8" name="us-gaap:InterestExpense" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">77</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Earnings/(loss) before income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3385-wk-Fact-8672D8BC1DB49E74979F74189FE5D37D" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,344</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3405-wk-Fact-B42BF90E4B0662E8F0B874189FE56096" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">736</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for (benefit from) income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3466-wk-Fact-9083B5C4BBFBE29B5DBD74189FE549A7" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">423</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3486-wk-Fact-CC66B2605549CED11BB974189FD685EB" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">142</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3506-wk-Fact-20615342158EE0B1641174189FE583ED" name="us-gaap:ProfitLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,921</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3526-wk-Fact-D5D3196327F48E77BF2FB5FE576F0E7B" name="us-gaap:ProfitLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3587-wk-Fact-11DFE9E87DC05B519D59C53959BFE356" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113118214e3607-wk-Fact-A205E9BD1D73BE967F5474189FE51F51" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3634-wk-Fact-1A54C3173FDE51E0A09F56C9BE18161A" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3654-wk-Fact-B9E1AF545110BC886F6D74189FE5100D" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">593</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3756-wk-Fact-D24DE77832DDB090C67174189FD6E9F0" name="us-gaap:EarningsPerShareBasic" contextRef="FD2020Q1YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">16.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3776-wk-Fact-4377CD3164F70A0F3C4274189FE5B2E3" name="us-gaap:EarningsPerShareBasic" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113118214e3791-wk-Fact-4C4398D2C5F97F558F0374189FC65D14" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2020Q1YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">16.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3811-wk-Fact-EC923336F5FA80B9DE9974189FE5E98F" name="us-gaap:EarningsPerShareDiluted" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.94</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average number of common shares outstanding:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3913-wk-Fact-D6C8D60818B189B0168C74189FD6136D" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3932-wk-Fact-6E64E45E52945A2BB3CD74189FA7EE57" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q1QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">305</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e3952-wk-Fact-46FD7D10EEDAFA15016374189FE5F0CD" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e3971-wk-Fact-DD255080D24812C9B08874189FE5673E" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q1QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">306</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash dividends declared per common share</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113118214e4037-wk-Fact-1B8A5101527F59160CFC74189FD674FD" name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="FD2020Q1YTD" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.4811</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#c4c4c4;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113118214e4056-wk-Fact-E666A9A9123E8BDB616074189FF522F8" name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="FD2019Q1QTD" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.4763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#c4c4c4;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">20</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sEDB400C257CC56528541EBDEB7D03664"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Comprehensive Income/(Loss)</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e2834-wk-Fact-20615342158EE0B1641174189FE583ED" name="us-gaap:ProfitLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,921</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113117897e2854-wk-Fact-D5D3196327F48E77BF2FB5FE576F0E7B" name="us-gaap:ProfitLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Other comprehensive income/(loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e2951-wk-Fact-37C681EAB28FEEDEF0CF74189FD6F059" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113117897e2971-wk-Fact-8BCB1610D232C4492CE474189FD6780E" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net unrealized gain/(loss) on derivative instruments, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e2992-wk-Fact-15CECAF243773555C29A74189FD6AD24" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113117897e3012-wk-Fact-F8D25D4616385DFCAFA774189FD66324" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e3033-wk-Fact-787E9E0F660FBFCE017774189FD66FFA" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113117897e3053-wk-Fact-8922AB9156A1C19E7B0D74189FD61069" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e3115-wk-Fact-62A95E0557DCAF3D8F3974189FD6749B" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,943</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113117897e3135-wk-Fact-95BDD1AFDAB59DBDC30F74189FD686DB" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">590</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e3197-wk-Fact-11DFE9E87DC05B519D59C53959BFE356" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113117897e3217-wk-Fact-A205E9BD1D73BE967F5474189FE51F51" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total comprehensive income/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113117897e3243-wk-Fact-66366E2BA43EFF11212374189FD6A429" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,944</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113117897e3263-wk-Fact-7C90F9C4E6DD3D075F3074189FE5FB14" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">589</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">21</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sF9F88FD85AC15068AA8C014BF727814C"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Balance Sheets</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e2876-wk-Fact-2FAE2CD18834556198580AC0692371F4" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,212</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e2895-wk-Fact-6CF1D02DC3B55A08BB6BE141ECBEE440" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trade receivables, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e2910-wk-Fact-50D813EE310A57DBAB0464FFD2AD4917" name="us-gaap:ReceivablesNetCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,190</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e2929-wk-Fact-B49E767CA381519A99B2571252D502BF" name="us-gaap:ReceivablesNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,448</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inventories, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e2949-wk-Fact-EBBB20710F9C5449965D4B8AAC671A48" name="us-gaap:InventoryNet" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12,458</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e2968-wk-Fact-52DAACAC7ECB53829D44FDACC65BA65B" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12,822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e2988-wk-Fact-70D9FE9B77A55C30998BF1B5D99878ED" name="us-gaap:OtherAssetsCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,855</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3007-wk-Fact-CA131BBFA77F5A2782C3BA57E94E1E1B" name="us-gaap:OtherAssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,946</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3027-wk-Fact-419A09CFAF525F92B9410AA3CCB94A59" name="us-gaap:AssetsCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23,715</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3046-wk-Fact-34B2C3B4D2045C3D9F87DCC07AA2D606" name="us-gaap:AssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25,747</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3107-wk-Fact-030D573DA6B15E6A89DBFD8DE41D74E0" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,324</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3126-wk-Fact-581ECCE4735E5EE99061BA80A524CA20" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,356</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3146-wk-Fact-03E8EC4195F952E09A81AEE6E9F7A83C" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,658</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3165-wk-Fact-52787ACB841D50CD8B12FD538222F4BE" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,808</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3186-wk-Fact-19C1A935103752C7AA1CE506BCAE9E06" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,482</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3205-wk-Fact-AB25ED817A745D77B00B9A8F51D789F7" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,052</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3230-wk-Fact-1B6A9B277CF557F2B4AF8989D169AA36" name="us-gaap:Assets" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,179</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3249-wk-Fact-25A8ADCBD95A5ECFAAB5838D8DCE774C" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities and Shareholders&#8217; Equity</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3392-wk-Fact-059736ACDBC4561598B0463A8587761E" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19,724</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3411-wk-Fact-06C661D6E83951658C5017B3E75F99BF" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,535</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3426-wk-Fact-9D197DD01EA65B8BACC8728F3F416321" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">631</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3445-wk-Fact-2A03227CB44B5EFA88C15C50924C451E" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">452</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3465-wk-Fact-149E758871B95AB39078D701D0EA286A" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,194</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3484-wk-Fact-B5731062608B522683EC117D51DEED16" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,122</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3504-wk-Fact-F510E29A95DA5EF7BFE9A859413E2CC8" name="us-gaap:LiabilitiesCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22,549</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3523-wk-Fact-90FBB01E2FEF5D0186C1A61F0A87F768" name="us-gaap:LiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24,109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3584-wk-Fact-76A797952E225384BAC3F840B1B60AA0" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,360</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3603-wk-Fact-8BECC219FEB35575BF2390A3AD6E683A" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3624-wk-Fact-54A0262E6A035D4C92E6DF2EAB0FB8C6" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,367</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3643-wk-Fact-A68C3ECA11B3536CBD950A939258EC4D" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,945</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shareholders&#8217; equity:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Preferred shares, without par value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">500&#160;thousand</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">none</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3792-wk-Fact-C39D37D4B17C52598B80035C5241ED90" name="us-gaap:PreferredStockValue" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3811-wk-Fact-794183FF51A85C0AA028F78C56690B81" name="us-gaap:PreferredStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common shares, without par value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">755&#160;million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">327 million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares at</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;September 30, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;">and June 30, 2019, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3884-wk-Fact-33E5132C4AA5539B8F579FC21C26DF5D" name="us-gaap:CommonStockValue" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,669</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3903-wk-Fact-281BDEB7DBF957E4B36578656309849C" name="us-gaap:CommonStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Retained earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e3923-wk-Fact-7C67F838B9C65A089AFBF5136F8072D8" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">371</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e3942-wk-Fact-FE6C51E8BC0F582FB769EB10F9DBCD94" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,434</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common shares in treasury, at cost:</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;34 million </span><span style="font-family:Arial Narrow;font-size:8pt;">shares and 28&#160;million shares at</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;September 30, 2019</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;and June 30, 2019, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113123061e3970-wk-Fact-7D76E032ACF15352B83B3AD9653BF739" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,039</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113123061e3990-wk-Fact-925D7327DA9F5B608CADD3D8CA88BCCE" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,790</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113123061e4011-wk-Fact-342B257EA09C565EABB78E213A2500B6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">101</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113123061e4031-wk-Fact-2447D06E11965163A0E019E15F78C658" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Cardinal Health, Inc. shareholders' equity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e4052-wk-Fact-2944B823E8D35CD08E719A9A0E22C9E9" name="us-gaap:StockholdersEquity" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">900</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e4071-wk-Fact-6B319AB31643582CB6DEE82BEB949299" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,328</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e4092-wk-Fact-05197C5E29B558C69B2036BD1779DEB6" name="us-gaap:MinorityInterest" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e4111-wk-Fact-5C84B37A23435AE28F8B03F2BD63FF2A" name="us-gaap:MinorityInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total shareholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e4131-wk-Fact-B6C4A36010E956AF9BB5F5160629B01E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">903</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e4150-wk-Fact-4A7519D276995847851ABD77F30E521C" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,330</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities and shareholders&#8217; equity</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113123061e4175-wk-Fact-9623F1FC8A345D7AAD0CD6D008A95464" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,179</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113123061e4194-wk-Fact-8139A144E4215B56B551F13EDC30D701" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">22</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s9cd9e50a98624073b6b9dced3ab9044b"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Shareholders' Equity</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(Unaudited)</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:32%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated Other<br/>Comprehensive<br/>Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total<br/>Shareholders&#8217;<br/>Equity</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Retained<br/>Earnings/(Deficit)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="29" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e3230-wk-Fact-BFCB88004E1122D268B5FA0C3CFB7A10" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e3249-wk-Fact-4DC1D2C6DB57E62312D5FA0C41BAE946" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e3268-wk-Fact-3944F89BE4C010D29ECAFA0C44F9C283" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,434</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3283-wk-Fact-3EABC0CD34A748C07D94FA0C48005196" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3303-wk-Fact-348D10A02C50743EEF9FFA0C4AF50DD5" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,790</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3323-wk-Fact-071601D8D69897438770FA0C4E1F18C9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e3344-wk-Fact-151B8FBD5F0A4DCA5B43FA0C4FC90DB1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e3363-wk-Fact-4A7519D276995847851ABD77F30E521C" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,330</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net loss</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3413-wk-Fact-1A54C3173FDE51E0A09F56C9BE18161A" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,922</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e3490-wk-Fact-23C9265606CA7B930FE846F120F78FA6" name="us-gaap:ProfitLoss" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e3509-wk-Fact-20615342158EE0B1641174189FE583ED" name="us-gaap:ProfitLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,921</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3621-wk-Fact-8406AAE597DB0C4AC93FFA16BC55D48F" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e3662-wk-Fact-2AA592A00B66DD1C572DFA16C13F5FF2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3696-wk-Fact-B64B7FF6977EC37FAD82FA17B91780EF" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e3750-wk-Fact-A269E5FBD3B3AB81BAF6FA17BF1EC2C1" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e3810-wk-Fact-B3327C1C8C0BA4167D32FA17C349CE61" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3845-wk-Fact-8EBEC36E75DCE61F9F58136D3D8B4FDB" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3884-wk-Fact-3351D8DA1A9D2AC1C3F9FA187C43B99A" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e3899-wk-Fact-937860E42DB2830910A8FA19E0799EE4" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">280</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e3960-wk-Fact-EC09646B09BD5464E583FA1A70E1E761" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4016-wk-Fact-052A555F8C753111AF71FA1ACD031A74" name="us-gaap:Dividends" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e4113-wk-Fact-D9F457536EDB23EA7068FA1A72E5F522" name="us-gaap:Dividends" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e4134-wk-Fact-56F9B47CDEF9772FC270FA1B6FC3EFD2" name="us-gaap:CommonStockSharesIssued" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e4153-wk-Fact-C08440E7E6A897150863FA1B71B6EFF2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,669</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e4172-wk-Fact-BDF4D1FCABC66EBE61FFFA1B73AAB5F9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">371</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e4187-wk-Fact-209D89320781DA949CFBFA1B75A065AA" name="us-gaap:TreasuryStockShares" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e4207-wk-Fact-9A49F47ED60EC247A8C9FA1B77950ED4" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,039</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113132713e4227-wk-Fact-E34511C10C32EDD553A3FA1B79871F1E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">101</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e4248-wk-Fact-3028A39BFFADE8E166F1FA1B7BA00308" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113132713e4267-wk-Fact-B6C4A36010E956AF9BB5F5160629B01E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">903</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:32%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="29" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Three Months Ended September 30, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4475-wk-Fact-C6709446863CFD9FB5CEFA20DC2E243B" name="us-gaap:CommonStockSharesIssued" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4494-wk-Fact-AC44E26B84EFA8A8AEA1FA20DEC83A6E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,730</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4513-wk-Fact-B2E351A726A27368F778FA20E163A401" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,645</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4528-wk-Fact-BFBDF3AB260697F28ED3FA20E41FB559" name="us-gaap:TreasuryStockShares" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4548-wk-Fact-ACBEAB4305D5645D6D0EFA20E6EC0461" name="us-gaap:TreasuryStockValue" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,224</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4568-wk-Fact-F0FC2671DB2AEA78A1F5FA20E9DAF16A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4589-wk-Fact-0DA31E4C31E063DBA100FA20ECEE4DB0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4608-wk-Fact-1E9B49341796FA83C340FA20EF8BAFED" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,059</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4658-wk-Fact-DDBB3102BE6323DA2AC3FA21F8576512" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">593</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4754-wk-Fact-B9E1AF545110BC886F6D74189FE5100D" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">593</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4865-wk-Fact-BA9945E841400C48BC35FA220594CB52" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4906-wk-Fact-F81D2D52F39BCAD840FFFA220ACAF793" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e4940-wk-Fact-4AAC038CD2492E49B4AFFA22143D5356" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e4994-wk-Fact-CFAA6B6BA2664C46E50EFA221B965798" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">26</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5054-wk-Fact-00E38CAF69231A238822FA22223A5927" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5089-wk-Fact-85FFA6C83B393F9128C2136CBEEF88C5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">120</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5130-wk-Fact-D6F75E692A0EB1BE55BDFA2225CD3303" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5145-wk-Fact-F6B407ACB2D57F8A4B6CFA2228561F54" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">480</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5206-wk-Fact-67722AE26562B60A14DBFA2230E25D8B" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5262-wk-Fact-ACB39F35E28E1CB9B568FA2235F7B0E3" name="us-gaap:Dividends" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">143</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5359-wk-Fact-9EF486632D7F387EEFE0FA224593A285" name="us-gaap:Dividends" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">143</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5415-wk-Fact-59E515CC2734A8DD81D5FA224A27FDA9" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5511-wk-Fact-0F876415DDCAAB46DA50FA225A157F2C" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5531-wk-Fact-761FACB4F38E6F630971FA214DDC7AD0" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5550-wk-Fact-3795A419A6B903EF3318FA21511A089A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,590</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5569-wk-Fact-CFD3FAE7EC7459E922C6FA215463EE01" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,097</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5584-wk-Fact-DBDFA9A68CB5AAF4AE05FA21576C3E81" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5604-wk-Fact-F8362EF85A05A4EED475FA2159E9EFD4" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,678</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113132713e5624-wk-Fact-7FD60141CC612AE36F65FA215CF9F794" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5645-wk-Fact-4A36FB68F5C2CB88CBCDFA215F8FFD1B" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113132713e5664-wk-Fact-CA6679447FA78401D251FA21625DEC3D" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,913</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">23</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="sAC1599DA0A055BE2828B86440C8FD9A7"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Cash Flows</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(Unaudited)</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e2874-wk-Fact-20615342158EE0B1641174189FE583ED" name="us-gaap:ProfitLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,921</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e2894-wk-Fact-D5D3196327F48E77BF2FB5FE576F0E7B" name="us-gaap:ProfitLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments to reconcile net earnings/(loss) to net cash provided by/(used in) operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e2991-wk-Fact-795E6807B52763EFA3FD74189FD69B01" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">234</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3010-wk-Fact-B76E84F3D1630CD8DD8A74189FD6A00D" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">245</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on sale of investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3030-wk-Fact-4C3E96593FFC54DD050B74189FC6C897" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3049-wk-Fact-72003EB7EE52294C028874189FC6CEFB" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3069-wk-Fact-26E35CF3BB3A12B0A6CB74189FD68C16" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3088-wk-Fact-E50D33B0DE70FEF2421474189FE54D37" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">511</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3109-wk-Fact-BF2D43D3FCC2502D97E374189FD688F6" name="us-gaap:ShareBasedCompensation" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3128-wk-Fact-FC8D0668E0CCB0A419BB74189FD626CC" name="us-gaap:ShareBasedCompensation" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for bad debts</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3148-wk-Fact-FFD5904F32EFE6D6CDEE74189FC6D7B3" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3167-wk-Fact-0DB3FB57D01D911004AB74189FD68CE3" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(Increase)/decrease in trade receivables</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3229-wk-Fact-61346CE076B40CA0031A74189FC6C6D2" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">229</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3248-wk-Fact-CF2A59C421A79AD0BFE474189FD6A5F4" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">302</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(Increase)/decrease in inventories</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3269-wk-Fact-71CACDFCFDCF760C6B8F74189FD6A2B0" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">356</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3288-wk-Fact-27804DCFA6F15E82662774189FC6C7B8" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">178</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Increase/(decrease) in accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3309-wk-Fact-1F8F92DF618F95F4A95B74189FC6B2FC" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,812</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3329-wk-Fact-6273CDA26BC4E758B45C74189FD6A3FF" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">559</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities and operating items, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3349-wk-Fact-E6D11EF678D4B017A43174189FD67DC5" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,211</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3368-wk-Fact-B22640171ED41FB87DD774189FD64789" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by/(used in) operating activities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3389-wk-Fact-5709DFB42A034681EF0F74189FD68A3C" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">653</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3409-wk-Fact-19981D5E1F8567F9899574189FC676B5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">365</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from investing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions to property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3511-wk-Fact-D8AD73904D0CD5B23F1974189FD6F81B" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">72</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3531-wk-Fact-81ADF8B28F1562A9C00F74189FD6010F" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of available-for-sale securities and other investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3552-wk-Fact-FC2E7CD6EB9337EFD94974189FD696E6" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3572-wk-Fact-AB7117E6D84FAC4E4FF374189FD68021" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from sale of available-for-sale securities and other investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3593-wk-Fact-B036D5DD257FBC65AA7D74189FD67F57" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3612-wk-Fact-8F0D4B2144FE48E7FDDB74189FD67A3C" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e3633-wk-Fact-F7F2DE1C4FFFE6BA84F074189FD60A59" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3652-wk-Fact-DEDE4FBC41F15576E51374189FC6BA0A" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">740</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by/(used in) investing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3672-wk-Fact-D8CD4A06DEB42291EA3D74189FD66E25" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">73</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3692-wk-Fact-34BA50F7A75BD28A79E074189FD67E70" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">679</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from financing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net change in short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3794-wk-Fact-7C076D5A7E7F985981C0F9FBD4D1B11E" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e3814-wk-Fact-7158B6C76244C918F1C5F9FBD4D132ED" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reduction of long-term obligations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3834-wk-Fact-84266507C37F7D0D7FBB74189FD682C8" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3854-wk-Fact-174646EFB17FB2E816B274189FD63A3B" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net tax proceeds/(withholdings) from share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3875-wk-Fact-AB14BA91ABC6628EDFA774189FD69EE2" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3895-wk-Fact-FE76F6582218E7AD586474189FD6D3BD" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends on common shares</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3916-wk-Fact-CBF425A2EEEA821C4A5E74189FE5B72A" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">146</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3936-wk-Fact-65DBD271AE0265EB451A74189FD6140A" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">150</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of treasury shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3957-wk-Fact-EC09646B09BD5464E583FA1A70E1E761" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e3977-wk-Fact-67722AE26562B60A14DBFA2230E25D8B" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash used in financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e3998-wk-Fact-390E6013804C373E5C0974189FD6459F" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">585</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113137623e4018-wk-Fact-3D0E8AD2FA4F2D35F82674189FD61E01" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">764</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Effect of exchange rate changes on cash and equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e4081-wk-Fact-444EF4868703817C983E74189FD68D52" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e4101-wk-Fact-D5D2831A64B17AE5D06774189FC628DB" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net increase/(decrease) in cash and equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113137623e4162-wk-Fact-F09C05CC0288F3092B2074189FD6FFDF" name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,319</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e4182-wk-Fact-CA4233AA332ADF0B93C174189FD63D05" name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">282</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents at beginning of period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e4202-wk-Fact-6CF1D02DC3B55A08BB6BE141ECBEE440" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e4221-wk-Fact-609B85E7AD9052962BC974189FC62CFD" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash and equivalents at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113137623e4246-wk-Fact-2FAE2CD18834556198580AC0692371F4" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,212</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113137623e4265-wk-Fact-96D972D046548AF93F8574189FD6A572" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,045</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">24</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sA4342C40DF1A563BADBA05608AC66196"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Notes to Condensed Consolidated Financial Statements </span></div><div style="line-height:120%;padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div><a id="sED8CBB329B995720B65D66744B44FDD7"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="TextSelection-04C33DC208A221B4B6D77418A0058754-0-wk-Fact-CCC48DD14087CAA4E21474189FB7FCDF" continuedAt="TextSelection-04C33DC208A221B4B6D77418A0058754-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="TextSelection-AEA6674A9F146FABF9757418A005FA86-0-wk-Fact-FA3B5F79C171AC78D79674189FC6742F" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. Refer to </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sF26386BC522F5F17861BDCB6DADF5D65"><span style="font-family:Arial Narrow;font-size:10pt;">Note 4</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for further information on our equity method investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="TextSelection-60B296B6B2C10CEDC6627418A0057F98-0-wk-Fact-6AF5367D58A86600805974189FE5ABB2" continuedAt="TextSelection-60B296B6B2C10CEDC6627418A0057F98-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Derivatives and Hedging</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a Benchmark </span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-60B296B6B2C10CEDC6627418A0057F98-1"><ix:continuation id="TextSelection-04C33DC208A221B4B6D77418A0058754-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Interest Rate for Hedge Accounting Purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113143499e2820-wk-Fact-5A723703A1031B5BE55728F1290E7CC6" name="cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" contextRef="I2020Q1ASC842" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">422</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. </span><span style="font-family:Arial Narrow;font-size:10pt;">S</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">ee&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s1b4f19725b5347a89ea3b6d3c65e17fb"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of adoption on our consolidated financial statements.</span></div></ix:continuation></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">25</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s2888EA3867DF545CB412DC5063FBF9A8"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="TextSelection-500D7889F1E75F73158A7418A00555EB-0-wk-Fact-E9CE402CAC19FF34F69574189FB75A1E" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Restructuring and Employee Severance</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="TextSelection-5C164C39B02F20E9E7CD74189FF5FA65-0-wk-Fact-8EE9EAB035E72B2E0DB574189FB77425" continuedAt="TextSelection-5C164C39B02F20E9E7CD74189FF5FA65-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance costs:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e2884-wk-Fact-966D2BF5DB025D303C0174189FC6533E" name="us-gaap:SeveranceCosts1" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e2903-wk-Fact-0D6306C6E12DAD6D57FE74189FC62533" name="us-gaap:SeveranceCosts1" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e2918-wk-Fact-B003EEA4667288CC473474189FC6A85E" name="cah:FacilityExitAndOtherCosts" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e2937-wk-Fact-E99D833FB4C191549E3174189FC6BAA8" name="cah:FacilityExitAndOtherCosts" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e2962-wk-Fact-FC6357DD0856F8E6785674189FD65150" name="us-gaap:RestructuringCharges" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e2981-wk-Fact-76D8C8D0F3F3A19A1A7E74189FD61527" name="us-gaap:RestructuringCharges" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">32</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.</span></div></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-5C164C39B02F20E9E7CD74189FF5FA65-1" continuedAt="TextSelection-5C164C39B02F20E9E7CD74189FF5FA65-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-5C164C39B02F20E9E7CD74189FF5FA65-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal 2020 and 2019, we implemented certain enterprise-wide cost-saving initiatives affecting various functional and commercial areas intended to optimize and simplify our operating model and cost structure. We incurred </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113151149e3043-wk-Fact-F8FE406895A64FD94D6EA7B533DD8805" name="us-gaap:RestructuringCosts" contextRef="FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113151149e3047-wk-Fact-179F2B2AD55BB5EB6EFFA7B4371470E7" name="us-gaap:RestructuringCosts" contextRef="FD2019Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">26</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, in expenses related to these cost savings initiatives, which are reflected in restructuring and employee severance in the condensed consolidated statements of earnings.</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="TextSelection-F3C4E3BC5FE590F1013C74189FF548CD-0-wk-Fact-A3309D2521691953F63674189FB77E94" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e3175-wk-Fact-FDA4F247F9C857BBAF82C1F81AEDC56E" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">64</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e3194-wk-Fact-C88E416445C7559BB8A01C7712F6679F" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e3213-wk-Fact-B78BE175D46C5924A4D7F229B7B8CC4B" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">72</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e3229-wk-Fact-F9A36EF9A02555269B8AA6FA5702226C" name="us-gaap:RestructuringCosts" contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113151149e3248-wk-Fact-EC7DA0A9C6AB5AAF98194750FC3DC10B" name="us-gaap:RestructuringCosts" contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e3267-wk-Fact-54E791A337AF5DC398A650DDB0451B88" name="us-gaap:RestructuringCosts" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113151149e3288-wk-Fact-40336673F13355D495CEFA980929019A" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113151149e3308-wk-Fact-B41A098CBB5255BD94F27564E3085911" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113151149e3328-wk-Fact-5AD776B51F8A53CCA82A2FAB1AC86209" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e3355-wk-Fact-02A01DBA7EE35D2CB8371BE6ED5F00E1" name="us-gaap:RestructuringReserve" contextRef="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">73</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e3374-wk-Fact-FC60B0C0E3CC52A8B11C897A8B3F85E1" name="us-gaap:RestructuringReserve" contextRef="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113151149e3393-wk-Fact-13C7D7C846115E939A0059692AB6366E" name="us-gaap:RestructuringReserve" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric><div><a id="sE8B4004248D2519294ACDD66DF13C72E"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="TextSelection-7B102BFA2515469A6A1A7418A0051D00-0-wk-Fact-2FD6889C03328C2FF74C74189FC6AC1D" continuedAt="TextSelection-7B102BFA2515469A6A1A7418A0051D00-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Goodwill and Other Intangible Assets</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfGoodwillTextBlock" id="TextSelection-325FE466B5D46D7F69A27418A0051D02-0-wk-Fact-87B4564CA1E7C930492474189FC6C82A" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e2848-wk-Fact-6C6BD431632551CBB618CAB1485E3438" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,663</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e2867-wk-Fact-6412ABB0FAA55EEFAF07C2C0C62C0CD3" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,715</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e2886-wk-Fact-7D554EE9405958328C0F245EFE162DBF" name="us-gaap:Goodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,378</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113172190e2902-wk-Fact-5C416E9498ED5A70A7DF8B57E8DCCD9D" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e2922-wk-Fact-F230856634C953E8A5F777D301CBCB7B" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113172190e2941-wk-Fact-DEFB2BBB956D566FA07F7A7CA02E99AC" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e2963-wk-Fact-1C8E0CF9B7B154009C69DF7AEE8F761C" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113172190e2982-wk-Fact-DE1CB6801D57557FB2FB1DD692FDA51C" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113172190e3002-wk-Fact-41BCF94B321B588A8A1908B208FDF79F" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3029-wk-Fact-B3ECBF6B3FBE508BA820BB94B732207A" name="us-gaap:Goodwill" contextRef="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,658</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3048-wk-Fact-22049C37AC1F5DBBACAC430A48F38F4E" name="us-gaap:Goodwill" contextRef="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,702</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3067-wk-Fact-209E5B2652B95EB69D4622AB1BE59262" name="us-gaap:Goodwill" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,360</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-7B102BFA2515469A6A1A7418A0051D00-1"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="cah:ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock" id="TextSelection-6148D2052A6C5B9EE9087418A00564AD-0-wk-Fact-C389B90C3A3D5C220AA374189FD6D28A" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3370-wk-Fact-16D413E79DD75E7F916DFE5BC244DA53" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3408-wk-Fact-16D413E79DD75E7F916DFE5BC244DA53" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3434-wk-Fact-2359C9C3F3765D96A11B474A22992278" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3472-wk-Fact-2359C9C3F3765D96A11B474A22992278" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3647-wk-Fact-156C2596C0315ECE8DBD1441269446A9" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,555</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3666-wk-Fact-D00338625A06532E8171FFA615637414" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,592</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3685-wk-Fact-E57357C306C65D13B080FC5713B57F09" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d113172190e3705-wk-Fact-737A88EAE5805BE686892E1728EFCAA9" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear">13</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3716-wk-Fact-DAE688AF8FC2551BAF7E026FF9B9E8FE" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">673</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3735-wk-Fact-95C64061BB865A4C935228BF36A5A3FD" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">307</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3754-wk-Fact-D9B07CF65EFA57DABAA05176FC257D89" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">366</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d113172190e3774-wk-Fact-936DE9E2EA165E47B24EC8EE8BEFD062" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" format="ixt-sec:duryear">13</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3785-wk-Fact-5516F54F85EB5E309EEC507FC80441E8" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,603</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3804-wk-Fact-877968D977FE5D0C8C4901761FDA57E7" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">656</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3823-wk-Fact-AA452D6D1C2F5D0A80D03066A536788D" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">947</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d113172190e3843-wk-Fact-CDE853B63CB256C590487FEF5C9BC739" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" format="ixt-sec:duryear">11</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3854-wk-Fact-B4AFD79CF13E5D4E910A55BD6F34B259" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,831</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3873-wk-Fact-C3598D28424B57ADB11A14FE3B76705A" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,555</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3892-wk-Fact-BECA546C78CF5B1498F4A6F7DBE5F212" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,276</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d113172190e3912-wk-Fact-3340978409705A179D45BD8AC7340D5B" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q1YTD" format="ixt-sec:duryear">12</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3929-wk-Fact-5874C2CDD69D5F64ABDF3D304CD0D909" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,853</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3948-wk-Fact-C3598D28424B57ADB11A14FE3B76705A" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,555</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113172190e3967-wk-Fact-29A516CC38325059A67D4CF9E61BB3D8" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,298</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4212-wk-Fact-CD737963CE5F53F19BDF66AACB22E1DF" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4250-wk-Fact-CD737963CE5F53F19BDF66AACB22E1DF" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4266-wk-Fact-1296F6644DFB52BAA144453F964872B7" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4304-wk-Fact-1296F6644DFB52BAA144453F964872B7" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4449-wk-Fact-E53CB576AF67509DA8ED2B9DA79116F0" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,562</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4468-wk-Fact-30EFC104B10558838B8E8EDE0A874191" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,517</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4487-wk-Fact-9B3CC7BC21A858C6813A2FF8BC952EEB" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,045</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4508-wk-Fact-31BCBAD6DA9E50EAB68D88639E74F588" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">672</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4527-wk-Fact-647667D06E965580931F8774EA99518E" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">295</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4546-wk-Fact-FF9B8D99B31355EEA2F77352B5BECBCB" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">377</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4567-wk-Fact-851B5392424E551EB3CD7993988833D9" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,602</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4586-wk-Fact-1BA88DCA6E7C53ADB878CD90E4145E0F" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">616</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4605-wk-Fact-800027ABA6135BCD90059E78A59A3395" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">986</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4626-wk-Fact-CBD6B020708451E3B93ACE9F3C6CA20D" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,836</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4645-wk-Fact-F850A66737FB55138C14CDD0E72F0537" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4664-wk-Fact-6EEA529E17D159DD935C7C67DC86B8BA" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,408</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4691-wk-Fact-FEDEBF2E866452218405ED2DDEADB998" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,858</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4710-wk-Fact-F850A66737FB55138C14CDD0E72F0537" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113172190e4729-wk-Fact-24BBBD95FB5B523E950EE9F428DC3559" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,430</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Total amortization of intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4758-wk-Fact-9B9293F2F10881ED393E74189FC6F41C" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4762-wk-Fact-F6176CF0D7010A68527EB6148FE0759D" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">133</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> 2024</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4783-wk-Fact-327E95A019CA5B109BC6BBA0F8DA1149" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">382</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4787-wk-Fact-DD1F19B131FD589684317A35382C38AC" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">442</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4791-wk-Fact-A2932E075D2A5798ACB44D19796A4FBB" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">408</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4795-wk-Fact-4DE89FFA0681585B927AAEA8999AD39E" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">358</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113172190e4799-wk-Fact-A0BF2D2A14B450B38C203A6B30E4531C" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">328</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">26</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sF26386BC522F5F17861BDCB6DADF5D65"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock" id="TextSelection-8AF7D3B98273AD4F457E7418A005613E-0-wk-Fact-3008154C028C58C5942674189FC6C403" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Investments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2018, we sold our&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113144993e2733-wk-Fact-A20EAE36D96A862C5A8E13EAB5181928" name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">98</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;ownership interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp; Rice in exchange for cash proceeds of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113144993e2737-wk-Fact-70EC407B4705C19D8F9713EF4C1D522C" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">737</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;(after adjusting for certain fees and expenses) and a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113144993e2741-wk-Fact-24DB21BF78396AD6E78974189FC65153" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">44</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;equity interest in a partnership that owns&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113144993e2745-wk-Fact-E74D0F76A79C8460476174189FC6E1CA" name="cah:PartnershipIndirectOwnership" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We are accounting for this investment using the equity method of accounting and on a one-month reporting lag. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended September 30, 2018, we recognized a pre-tax gain of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113144993e2752-wk-Fact-0C8C2A8C8E5611F0A18E13F1EC18BA9B" name="cah:PreTaxGainonDivestiture" contextRef="FD2019Q1YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;related to this divestiture in impairments and (gain)/loss on disposal of assets in our condensed consolidated statement of earnings.&#160;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying value of this investment was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113144993e2759-wk-Fact-0F68A432F6A81D396448FA6AA6A1F670" name="us-gaap:EquityMethodInvestments" contextRef="FI2020Q1_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">329</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113144993e2763-wk-Fact-AF6839DA4CA85B6D8CADC5287332BF7E" name="us-gaap:EquityMethodInvestments" contextRef="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">334</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. For the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our proportionate share of naviHealth&#8217;s net loss, which was recorded in Other (income)/expense, net in the condensed consolidated statement of earnings, was immaterial.</span></div></ix:nonNumeric><div><a id="s1b4f19725b5347a89ea3b6d3c65e17fb"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="cah:LeasesTextBlock" id="TextSelection-612CC902D3975E99DA7CFA3BD7FCDBE2-0-wk-Fact-6CA02D878A89031D01ABFA3FA7516187" continuedAt="TextSelection-612CC902D3975E99DA7CFA3BD7FCDBE2-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We primarily have operating leases for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Beginning July 1, 2019, operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our condensed consolidated balance sheet. Operating lease right-of-use assets and corresponding operating lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our condensed consolidated balance sheet. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our lease agreements include leases that contain lease components and non-lease components. For all asset classes, we have elected to account for both of these provisions as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the condensed </span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-612CC902D3975E99DA7CFA3BD7FCDBE2-1" continuedAt="TextSelection-612CC902D3975E99DA7CFA3BD7FCDBE2-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">consolidated financial statements at or for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was not material. In addition, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our leases have remaining lease terms from less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113162555e2751-wk-Fact-9B6D9CBA0CA3039B9E6246CB01154BF0" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2020Q1_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:duryear">1</ix:nonNumeric> year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> up to approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113162555e2755-wk-Fact-AB14E6DBDE68CE46FD2F46C778DB3A06" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2020Q1_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">23</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:LeaseCostTableTextBlock" id="TextSelection-9395663871308CACA136030B42C4085F-0-wk-Fact-527D47454A07DB07B8E0030E8CEF423E" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e2830-wk-Fact-F1401BC500C997BD109003189B27E727" name="us-gaap:OperatingLeaseCost" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization of right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e2864-wk-Fact-447D052FE2F57A19A1DB0319B25CFD0A" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e2884-wk-Fact-664F455CB49FD59FB8D7031CE6E21047" name="cah:TotalFinanceLeaseCost" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e2904-wk-Fact-E979870FE8A9FEE30433031D83988925" name="us-gaap:VariableLeaseCost" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e2929-wk-Fact-2FB661CA4180333ECC8E031DD2AD60CB" name="us-gaap:LeaseCost" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">36</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental balance sheet information related to leases:</span><ix:nonNumeric contextRef="FD2020Q1YTD" name="cah:LeasesSupplementalBalanceSheetInformationTableTextBlock" id="TextSelection-C54CC1D910216496BB821CCC5ABA6174-0-wk-Fact-F1535FC490A3832CA0F81CCDAE491FB1" continuedAt="TextSelection-C54CC1D910216496BB821CCC5ABA6174-1" escape="true"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3008-wk-Fact-101AD897D97F4C82D11C1CD2F8C1D31E" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">394</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3044-wk-Fact-8E6F5F09C8189AAE4D631CD53D8379D0" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">103</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3064-wk-Fact-80CDE59581B55E0A64D91CD484D837F1" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">312</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3084-wk-Fact-258395C256D6D9410DD41CD4E974AC1B" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">415</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3146-wk-Fact-084DD41474120257E91A1CD6157FA5A5" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3188-wk-Fact-3BFBAF9A14BCA7460AD91CD6700E2037" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3208-wk-Fact-6010939FA46A1F82AAFB1CD6C70260A1" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3233-wk-Fact-93062B0775ABF09271EF1CD703CC401C" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></ix:nonNumeric></div><ix:continuation id="TextSelection-C54CC1D910216496BB821CCC5ABA6174-1"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:continuation></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">27</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-612CC902D3975E99DA7CFA3BD7FCDBE2-2"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes s<ix:nonNumeric contextRef="FD2020Q1YTD" name="cah:LeasePaymentsTableTextBlock" id="TextSelection-DBBA12EDEE00EA04C1F3030A238D688F-0-wk-Fact-AD47960169CF94378FAC034570EE773E" continuedAt="TextSelection-DBBA12EDEE00EA04C1F3030A238D688F-1" escape="true">upplemental cash flow information related to leases:</ix:nonNumeric></span><ix:continuation id="TextSelection-DBBA12EDEE00EA04C1F3030A238D688F-1"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3334-wk-Fact-9C3D27EAD0AD7145181F035D8BDCEE1E" name="us-gaap:OperatingLeasePayments" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance lease</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3349-wk-Fact-EF1E8953E77D8F8CB312035F4A212D2A" name="us-gaap:FinanceLeasePrincipalPayments" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3389-wk-Fact-3A8193C1BF75B7CED68E03608029EB79" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3409-wk-Fact-CBECA57F3FF0F8269AF70360DB99C38D" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3433-wk-Fact-8791C640818C4E4303A503616B760111" name="us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" contextRef="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">400</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></ix:continuation></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d113162555e3453-wk-Fact-18B21A4E222B11C42F601D09F674A3F8" name="cah:ReclassificationofdeferredrentinaccordancewithASC842" contextRef="D2020Q1SD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> from reclassifying deferred rent as an offset in accordance with the transition guidance. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113162555e3460-wk-Fact-B64648B31DB2233F232C02FB2BDB6889" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2020Q1" format="ixt-sec:duryear">6.2</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> years and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113162555e3464-wk-Fact-368D6D7685F6182E1BF502FBE7EB1124" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2020Q1" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">3.0</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="TextSelection-B3422A66DA2DF9771A3A03C1C47A4E20-0-wk-Fact-3080828176D9C1B035B503C31D0FC377" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:51%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Years Ending September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3633-wk-Fact-14D41F7BC2EB127654A103C9D3290BEB" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">91</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3652-wk-Fact-36FEC0A8DEAD8058464003C9D32F86BC" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3671-wk-Fact-EA5DCD1E73623D8CA4E503C9D337E936" name="cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3687-wk-Fact-4CAB1E2436E84F9816CF03CB0595EA58" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">101</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3706-wk-Fact-3F82311EDF71F78C72E203CB058FE441" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3725-wk-Fact-99382DA1B1789261E4AF03CB059BD5E8" name="cah:LesseeLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">107</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3746-wk-Fact-14DA99460860D9F841FD03CB47BC5FE9" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3765-wk-Fact-445BCB7075AA399F9E1B03CB47E34AF2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3784-wk-Fact-B88C6CEED60328EC3D5303CB47AE8094" name="cah:LesseeLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">83</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3805-wk-Fact-D1882104D40F3946A55103CB89C7D761" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3824-wk-Fact-93F4A2B170EE5D3E0EAB03CB89CDFF1D" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3843-wk-Fact-3A180DFEB1C1273D2D5B03CB89D59E07" name="cah:LesseeLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">62</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3864-wk-Fact-BF436B500077F0F9348103CBC4316666" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">41</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3883-wk-Fact-ED546F052DA272C46BC803CBC4667BFB" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3902-wk-Fact-6A70321980822327879E03CBC43EA9D1" name="cah:LesseeLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">42</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3923-wk-Fact-33B2017B6B09C973E99103CC33B52D8A" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">149</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3942-wk-Fact-4E3BD4FA92D065A130CA03CC33B03002" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e3961-wk-Fact-CD798A78C8373E0E738F03CC33AB3AF5" name="cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">149</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e3982-wk-Fact-B4A59316EFC2C2B0698C03CCBB6FB1B7" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">519</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4001-wk-Fact-82737FBEF43079DA969403CCBB69AFE9" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e4020-wk-Fact-449F8D27FE5DB32772DC03CCBC70CB65" name="cah:TotalLeaseLiabilityPaymentsDue" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">538</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4045-wk-Fact-51ED23BB9D0018CB22C603CFDC877756" name="cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">61</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4064-wk-Fact-272872E17B1AB814FC1C03CFDC6C0B83" name="cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e4083-wk-Fact-0C3648968D2159B2F8DC03CFDCB29AF7" name="cah:TotalLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">61</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4104-wk-Fact-A865FBFB5EDFEBA0D6DD03CD43B60A50" name="cah:OperatingLeaseImputedInterest" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">43</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4123-wk-Fact-E0DD8908B6C6F46A1E3603CD43C5E1D8" name="cah:FinanceLeaseImputedInterest" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e4142-wk-Fact-68D9DDFA87393E628D4A03CD43EAAA8E" name="cah:TotalLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4169-wk-Fact-541F8E78F6BE57CE9F9403D021338652" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">415</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113162555e4188-wk-Fact-1F1C519B660A0C2790C403D021382C49" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113162555e4207-wk-Fact-149F1349903E1FBAD4B203D0213EF50A" name="cah:TotalLeaseLiability" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">432</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of September 30, 2019, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As previously disclosed in our fiscal 2019 Form 10-K under the prior accounting guidance, the future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113162555e4236-wk-Fact-A14DC9C7AC1493E538FB3F4B00CB69F0" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">126</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113162555e4240-wk-Fact-54B7D7CF5AC192F9ECF63F4B00CB2403" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113162555e4245-wk-Fact-AD422F245C87DED908283F4B00CBB76C" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">76</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113162555e4249-wk-Fact-5C3EEB444A0E7A7ED8203F4B00CB2321" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">54</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113162555e4253-wk-Fact-28E7D49D7E1D195BE26A3F4B00BC2396" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113162555e4257-wk-Fact-1071D27B5AC1D20991703F4B00CB57A6" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">94</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div></ix:nonNumeric></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s6C038A34E2BF5F0FBA9A57B3449704A1"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:DebtDisclosureTextBlock" id="TextSelection-A61F28039C602432AF2A7418A005F57B-0-wk-Fact-56BB80D4E0251C78095574189FB7F87B" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;">6. Long-Term Obligations and Other Short-Term Borrowings</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had total long-term obligations, including the current portion and other short-term borrowings, of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113151154e2733-wk-Fact-2F18C7B499CBFF2E8F4674189FE5732B" name="us-gaap:DebtAndCapitalLeaseObligations" contextRef="FI2020Q1" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">8.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at both </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113151154e2747-wk-Fact-3F7132AB85A7403B103512A919493FF2" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q1" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">19.7</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113151154e2751-wk-Fact-186042CE13C61A97F8F612FD0D40C27A" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">21.5</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we repurchased a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113151154e2771-wk-Fact-E44D3ED299C567440432FA87DB0C7F13" name="cah:NotesPayableRepurchased" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of notes due in 2022 and 2047 with available cash.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113151154e2781-wk-Fact-2841F996BBEF5DD8A27851A6BFF29356" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;commercial paper program backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113151154e2785-wk-Fact-7A2479D365CD5D5F9B2FA032AC0814AC" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113151154e2789-wk-Fact-79327C1227FA5FC4B072457F82C2F0C7" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> committed receivables sales facility.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our revolving credit facility and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter from  </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> through December 2020, a consolidated net leverage ratio of&#160;no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every fiscal quarter thereafter. </span><span style="font-family:Arial Narrow;">As of September 30, 2019, we were in compliance with our financial covenants.</span></div></ix:nonNumeric><div><a id="s3E77F52A990B55D8984E21DCB5CC440C"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-0-wk-Fact-2EA8B0B18151C780AE1B74189FE5900B" continuedAt="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Commitments, Contingent Liabilities and Litigation</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113156494e2745-wk-Fact-955E82571B1C382AEBA33C72C8825BFB" name="us-gaap:LongtermPurchaseCommitmentPeriod" contextRef="FD2020Q1QTD_srt_MajorCustomersAxis_cah_CVSHealthMember" format="ixt-sec:duryear">10</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113156494e2749-wk-Fact-13E89AE26351F5888D9474189FD6C188" name="cah:MaximumQuarterlyPayment" contextRef="FD2020Q1QTD_srt_MajorCustomersAxis_cah_CVSHealthMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the remainder of the initial term.</span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">28</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-1" continuedAt="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-2"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are named from time to time in </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information have led, and may in the future lead, to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-2" continuedAt="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our condensed consolidated statements of earnings.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Opioid Lawsuits </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical wholesale distributors, including us, have been named as defendants in approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2797-wk-Fact-CC310D8A0ED8E87B86883BFAEAED921E" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="number" decimals="0" scale="0" format="ixt:numdotdecimal">2,400</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits relating to the distribution of prescription opioid pain medications. These lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as negligence, public nuisance and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2807-wk-Fact-33AC43B6921B23E94BBC3BFD2B7FC38D" name="cah:NumberofStateAttorneysGeneralfilinglawsuits" contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="StateAG" decimals="0" scale="0" format="ixt:numdotdecimal">21</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have filed lawsuits against distributors, including us, in various state courts. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2814-wk-Fact-EF149905CA93A22E38C83BFD81A77DCB" name="cah:InvestigationbyMultitateTaskForce" contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="StateAG" decimals="0" scale="0" format="ixt:numdotdecimal">43</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have formed a multi-state task force to investigate the manufacturing, distribution, dispensing and prescribing practices of opioid medications. We have received requests related to the multi-state investigation, as well as separate civil investigative demands, subpoenas or requests for information from these and other state attorneys general offices. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of four state attorneys general from the multi-state task force that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework includes (1) a cash component, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2824-wk-Fact-A13CDA568F748FE405853C4F19A8D598" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.56</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d113156494e2828-wk-Fact-D1034B4348C61FD6A3C446E025361324" name="cah:CashComponentForSettlementFrameworkTerm" contextRef="FD2020Q1YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" format="ixt-sec:durwordsen">eighteen years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;">, (2) development and participation in a program for free or rebated distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. The Settlement Framework is in its early phases, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We have included a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2832-wk-Fact-A13CDA568F748FE405853C4F19A8D598" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.56</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrual related to the Settlement Framework in deferred income taxes and other liabilities in the condensed consolidated balance sheets and litigation (recoveries)/charges, net, in the condensed consolidated statements of earnings.  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On October 21, 2019, we and two other national distributors agreed to a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2839-wk-Fact-D1F7A855E0AFBC74FA073C52050132AE" name="cah:OpioidTotalSettlementCuyahogaandSummitCounties" contextRef="I2020Q1opioid_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">215</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> settlement with two Ohio counties, Cuyahoga and </span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">29</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-3" continuedAt="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Summit, to resolve all claims in the first bellwether trial in the MDL that had been scheduled for trial in October 2019. In connection with this settlement, we have accrued </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2846-wk-Fact-225F3F55569943BABA8B3C5BFCACC04B" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">66</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, which is included in other accrued liabilities in the condensed consolidated balance sheets and litigation (recoveries)/charges, net, in the condensed consolidated statements of earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these matters, we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113156494e2853-wk-Fact-B506B163336CA2A537D23C2E6E5AC74F" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2857-wk-Fact-44379A8082792262DF663C56556A2302" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.14</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> after tax) during the three-months ended September 30, 2019 for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. Moreover, the global Settlement Framework is in early stages and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. We are unable to reasonably estimate the liability associated with any potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to under the Settlement Framework. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.    </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals. Private parties had brought approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2865-wk-Fact-49EE1DEAA7E1E8918D243C60B4076F69" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q1lawsuits_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">325</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits as of November 1, 2019. Of these, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2869-wk-Fact-B9F441FF943F8ABFF1FE3C64787C95CE" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q1lawsuits_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">97</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. We will continue to vigorously defend ourselves in these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Product Liability Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As of November 1, 2019, we are named as a defendant in </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2879-wk-Fact-43C92510F2F23F189DE63BFEDE4815D7" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">280</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2883-wk-Fact-3C08D5E119447B7DE0B83BFF2805F9BB" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextRef="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="INF" scale="0" format="ixt:numdotdecimal">3,463</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2887-wk-Fact-F3F476F70FB25E8E14F73BFFFFA1A1ED" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="0" scale="0" format="ixt:numdotdecimal">24</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits involving similar claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d113156494e2891-wk-Fact-20DEAEBEC0427631015F3C0047E0FEDB" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextRef="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="INF" scale="0" format="ixt:numdotdecimal">28</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At September 30, 2019, we had a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2898-wk-Fact-EF269163684A80383ACF3C0121F0FCAE" name="cah:LossContingencyAccrualNetofInsuranceRecoveries" contextRef="FI2020Q1_srt_RangeAxis_srt_MinimumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">414</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, net of estimated insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits which are presented on a gross basis in the condensed consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-4" continuedAt="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-5"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d113156494e2905-wk-Fact-913E310B1B2A2BE6A38A3C01719635A4" name="cah:LossContingencyAccrualNetofInsuranceRecoveries" contextRef="FI2020Q1_srt_RangeAxis_srt_MaximumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">836</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, net of estimated insurance recoveries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Shareholder Securities Litigation</span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-5">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. Due to the early stage of this proceeding, it is not possible to reasonably estimate the amount of any possible loss or range of loss in this matter.</ix:continuation> </span></div><div><a id="sBC12EA8303315D5191F2DE7B26F26E1E"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:IncomeTaxDisclosureTextBlock" id="TextSelection-F314BED7E6BE01B007AB7418A00555B1-0-wk-Fact-F9C9792EE55091E6839874189FA72D4C" continuedAt="TextSelection-F314BED7E6BE01B007AB7418A00555B1-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Income Taxes</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fluctuations in our provision for income taxes as a percentage of pre-tax earnings (&#8220;effective tax rate&#8221;) are due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items.</span></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2737-wk-Fact-B506B163336CA2A537D23C2E6E5AC74F" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2741-wk-Fact-C9CD6B08A7031FD26DD0277587D815EF" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">487</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2745-wk-Fact-0923D5404A13C6277704277F1B2B5A9D" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">468</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Effective Tax Rate</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113161720e2768-wk-Fact-1DE819693BC927BB339374189FB790E7" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q1YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">7.9</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113161720e2772-wk-Fact-66171FF81F70CC79485374189FA758B6" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q1QTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">19.4</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent, respectively. The change in the effective tax rate from fiscal 2019 to fiscal 2020 is primarily due to the net effects of </span><span style="font-family:Arial Narrow;font-size:10pt;">the Settlement Framework, partially offset by the prior-year benefit of discrete tax items</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">30</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-F314BED7E6BE01B007AB7418A00555B1-1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Unrecognized Tax Benefits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2786-wk-Fact-8D65B2A0A4A4A27E073213F812267D05" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">943</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2790-wk-Fact-A143F72D6DA157EEADC0BAC1A6DA1431" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">456</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> balances include </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2811-wk-Fact-858485D87A6C2A3DDDE713F8940A70EC" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">795</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2815-wk-Fact-E998AA6838165229AAB4072F6DE9915A" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">303</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2830-wk-Fact-BB7F588F375A507F89EBE18E9A576D83" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">126</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2834-wk-Fact-BA004D72295B52C1B0C856FF6530A700" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">122</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for/(benefit from) income taxes in the condensed consolidated statements of earnings. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113161720e2841-wk-Fact-3936A8FA1F7F57848E2E45CEE8802D16" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" contextRef="FI2020Q1_srt_RangeAxis_srt_MinimumMember" unitRef="usd" decimals="-6" scale="6" format="ixt-sec:numwordsen">zero</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a net decrease of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2845-wk-Fact-A53029DBA34F503EAC8DD49ECBC6E98F" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" contextRef="FI2020Q1_srt_RangeAxis_srt_MaximumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, exclusive of penalties and interest.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Tax Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113161720e2856-wk-Fact-E3A4CAC8D2383422A9A992FD3604BB1C" name="us-gaap:OpenTaxYear" contextRef="FD2020Q1QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">2008</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2863-wk-Fact-6379AB05FF925289B1F968A18B73849F" name="cah:IndemnificationReceivable" contextRef="FI2020Q1_cah_TaxMatterAxis_cah_CareFusionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">168</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2867-wk-Fact-70004961458358BF8DD33C121E16444F" name="cah:IndemnificationReceivable" contextRef="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">165</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition. The indemnification receivable was&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2882-wk-Fact-3815843869A45388B082BE8FB895877A" name="cah:IndemnificationReceivable" contextRef="FI2020Q1_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113161720e2886-wk-Fact-265955F65B015870B68DD112C9BF40EA" name="cah:IndemnificationReceivable" contextRef="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheet.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Future adjustments to the financial statements may be necessary as final tax regulations related to U.S. Tax Reform are issued. We will assess any impact as additional guidance is issued.</span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s29D95D29503C5F7B8F63E0FE3ADBA73E"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="TextSelection-061CAC08006F27343D647418A005D3E9-0-wk-Fact-F05A7A31B8FF69A2316D74189FB726C9" continuedAt="TextSelection-061CAC08006F27343D647418A005D3E9-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="TextSelection-B50C28896AD44EDBEFAA7418A005F93F-0-wk-Fact-821DE10FFE69B2E6D05474189FB731F6" continuedAt="TextSelection-B50C28896AD44EDBEFAA7418A005F93F-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3031-wk-Fact-3A266D0C483C5F069F82CE57DCC13E47" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3050-wk-Fact-17CEF2CD47D35B9C9D2EB7C372D2FA2F" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3069-wk-Fact-7D4387CB8FB7576DAAD4FDE8FE2D2066" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3089-wk-Fact-8DC2356E39E856C0B7A41CE12D46F5BE" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3104-wk-Fact-B56668CF1D2C58091A3174189FC63402" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3123-wk-Fact-B93B0DC0D202594CABB36C1C0C6800E6" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3142-wk-Fact-B9EA90193CA74A39E2C074189FD60F46" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175573e3162-wk-Fact-49BF938C03CB5BBBB519A5C4233973CA" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3456-wk-Fact-E60F2E9A330258028EF28F301B5EDE8B" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3475-wk-Fact-C75FA6BE84DE5EF88F4328F64FF2C59F" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3494-wk-Fact-D95FDA1C90395F42A14F88125FC84DA4" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3514-wk-Fact-64E48318DBA9503C9DC3BEE135AD0834" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3529-wk-Fact-639547B086125E6BAA90BD889B173266" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3548-wk-Fact-FC2991C23DA55E8985AFFC229A09627A" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3567-wk-Fact-19DBFC31CF135B5B903A50123475A587" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175573e3587-wk-Fact-2CC33737A18F5363963036CE1A52CE25" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:continuation id="TextSelection-B50C28896AD44EDBEFAA7418A005F93F-1"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><ix:continuation id="TextSelection-061CAC08006F27343D647418A005D3E9-1">(2)    The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.</ix:continuation> </span></div></ix:continuation><div><a id="s95AB9D9192C553B29C5223D32983C97C"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="TextSelection-4D239D8E4356A16EF7AA7418A005167D-0-wk-Fact-B7D4A0C237C9334FA8B974189FC63FB2" continuedAt="TextSelection-4D239D8E4356A16EF7AA7418A005167D-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes </span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-4D239D8E4356A16EF7AA7418A005167D-1" continuedAt="TextSelection-4D239D8E4356A16EF7AA7418A005167D-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Currency Exchange Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce volatility in earnings, cash flow and net investments in certain subsidiaries to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the condensed consolidated statements of earnings. For the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113175563e2767-wk-Fact-1E4A04B8A97D7CED3E8F74189FC65DA2" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Flow Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into a forward interest rate swap with a total notional amount of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113175563e2785-wk-Fact-175D87DF859D77410CDD1CE850154095" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">50</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;to hedge probable, but not firmly committed, future transactions associated with our debt.</span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-4D239D8E4356A16EF7AA7418A005167D-2" continuedAt="TextSelection-4D239D8E4356A16EF7AA7418A005167D-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gains and losses recognized in accumulated other comprehensive loss and reclassified into earnings were immaterial for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. All gains and losses currently included within accumulated other comprehensive loss associated with our foreign exchange forward contracts to be reclassified into net earnings within the next 12 months are immaterial. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Net Investment Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#165;<ix:nonFraction id="d113175563e2813-wk-Fact-B27A36CFDDB2CE1ABF4BFF6CC35510AE" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="jpy" decimals="-6" scale="9" format="ixt:numdotdecimal">64.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> cross-currency swap maturing in 2022.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During three months ended September&#160;30, 2018, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#8364;<ix:nonFraction id="d113175563e2820-wk-Fact-D52D656C3D6C567CBF685661AA68CFA2" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="eur" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> cross-currency swap maturing in 2023.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cross-currency swaps designated as net investment hedges are marked to market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive income/(loss) until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in our net investment hedges during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Economic (Non-Designated) Hedges</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The gain and losses recognized in the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were immaterial. The principal currencies managed through foreign currency contracts are the euro, Canadian dollar, British pound, Japanese yen, and Chinese renminbi.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, accounts payable, and other accrued liabilities at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">32</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-4D239D8E4356A16EF7AA7418A005167D-3"><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="TextSelection-CB6C795BD80C52C50A517418A00507B8-0-wk-Fact-9FF961D7A25CBF0717FD74189FC6C13D" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:26%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175563e2938-wk-Fact-2B8AC88CD1AC537FB80130D609C18B3B" name="us-gaap:DebtInstrumentFairValue" contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,001</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175563e2957-wk-Fact-BDDCA688E57E5E8398C556AB1D295E3B" name="us-gaap:DebtInstrumentFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,065</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113175563e2972-wk-Fact-E11E3F8B9488DEE2DBD374189FD60998" name="us-gaap:DebtAndCapitalLeaseObligations" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,991</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113175563e2991-wk-Fact-2413CA5A499E549187148F86D7E18BA1" name="us-gaap:DebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,031</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div></ix:continuation><div><a id="s36CD3C46065E5AF893E312A064188DBE"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="TextSelection-D6AF146B3664B947C07F7418A0055005-0-wk-Fact-251EAC5711D1C4AC71F074189FC69592" continuedAt="TextSelection-D6AF146B3664B947C07F7418A0055005-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Shareholders' Equity</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered in an accelerated share repurchase ("ASR") program to purchase common shares for an aggregate purchase price of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113179283e2746-wk-Fact-EC09646B09BD5464E583FA1A70E1E761" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and received an initial delivery of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113179283e2750-wk-Fact-B1F4212AA19353809BFAA920A9BF9713" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">6.4</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113179283e2754-wk-Fact-0BEF0FDC145C175897D774189FC69BBD" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">280</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113179283e2758-wk-Fact-DACE87CF131E58799A0B8CC8D7566010" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">43.76</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The ASR program began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;20, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and is expected to conclude in the second quarter of fiscal 2020. We funded the repurchases with available cash and short-term borrowings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered in an ASR program to purchase common shares for an aggregate purchase price of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113179283e2774-wk-Fact-67722AE26562B60A14DBFA2230E25D8B" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and received an initial delivery of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113179283e2778-wk-Fact-CD4E24E70A0554468C2596F8DAF82F83" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">9.5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113179283e2782-wk-Fact-D66144D7A52552FCB96CBD2A33C36946" name="us-gaap:TreasuryStockValueAcquiredCostMethod" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">480</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113179283e2786-wk-Fact-4C3A6BDF41E05266B947C85900182087" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.45</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The ASR program began on August 16, 2018 and was completed on October 25, 2018 when we received the final delivery of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113179283e2791-wk-Fact-C9EF386A862C5EBB0274272157B948FE" name="cah:FinalSharesReceivedfromASRProgram" contextRef="I2019Q1ASR" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares. We funded the repurchases with available cash and short-term borrowings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-AE48D64FD4F988DB97377418A005C018-0-wk-Fact-4205D718CE895E94079E74189FC6BF81" continuedAt="TextSelection-AE48D64FD4F988DB97377418A005C018-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113179283e2930-wk-Fact-8D96C37DC9B950F996CA01E91A5A3D19" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113179283e2950-wk-Fact-FAD122199E3A55E192DCAD8BBBDEF534" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113179283e2969-wk-Fact-96A3B6F01252589BA0D9D0F1A616B0BE" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113179283e2986-wk-Fact-3349BF97A5A657DFAE532DFEB6834C48" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113179283e3006-wk-Fact-07EE5CE4B4745CA48E6CB983281F1B3D" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113179283e3025-wk-Fact-B7F54CF26E995C1CACEEC48937E12358" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113179283e3047-wk-Fact-603D029C90795BD5A3C7CF49A3FE3725" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113179283e3066-wk-Fact-DD397E0DEB245C2B91268430938CD503" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113179283e3086-wk-Fact-5EC81D68C0275594A064669E0C2A81B6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113179283e3108-wk-Fact-8CDBEEB3339A1F0605D574189FB748CE" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113179283e3128-wk-Fact-0D28DD3FF2EC43B154FF74189FB707FA" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113179283e3148-wk-Fact-89EA8B078D7F467D306374189FC624E5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113179283e3175-wk-Fact-82BFA8437E115682A3A11DFE9009A1E3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">112</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113179283e3195-wk-Fact-710CDB9CF7A05D918CCA52BB02E68FDD" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113179283e3214-wk-Fact-DAE58CA1ECA75C63B0F57F47D704B2E2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">101</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><ix:continuation id="TextSelection-AE48D64FD4F988DB97377418A005C018-1"><ix:continuation id="TextSelection-D6AF146B3664B947C07F7418A0055005-1">The sum of components may not equal the total due to rounding.</ix:continuation></ix:continuation> </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s983C95C353DA520CBE8644DE7126D61E"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:EarningsPerShareTextBlock" id="TextSelection-E4145B6DBEC45BF408167418A00519B7-0-wk-Fact-791EFD8CB2DFE02326FB74189FB7E370" continuedAt="TextSelection-E4145B6DBEC45BF408167418A00519B7-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Earnings Per Share Attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="TextSelection-6F49B8D1C4C6F93177717418A005CCA5-0-wk-Fact-F50D8FD1DF65D7339DC674189FB78F9E" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:70%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113182751e2820-wk-Fact-D6C8D60818B189B0168C74189FD6136D" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113182751e2834-wk-Fact-6E64E45E52945A2BB3CD74189FA7EE57" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q1QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">305</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113182751e2880-wk-Fact-BD26C7762CF58010A02B74189FB7F8FE" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113182751e2894-wk-Fact-14BF7E222BDC99D7DEB6FF6FC9C0499E" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2019Q1QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113182751e2909-wk-Fact-46FD7D10EEDAFA15016374189FE5F0CD" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113182751e2923-wk-Fact-DD255080D24812C9B08874189FE5673E" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q1QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">306</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">For the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113182751e2942-wk-Fact-2078264059D7BFAC99241405983B9CF9" name="cah:Numberofsharesexcludedfromcalculationofdilutedshares" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> employee stock options, restricted share units and performance share units were excluded from the calculation of diluted shares outstanding, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113182751e2946-wk-Fact-2816668B82065370EBBC14080A884F40" name="cah:Sharesthatwouldbeantidilutiveasaresultofnetloss" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of which would be anti-dilutive as a result of the net loss for the period. </span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-E4145B6DBEC45BF408167418A00519B7-1" continuedAt="TextSelection-E4145B6DBEC45BF408167418A00519B7-2"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for the three months ended September 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113182751e2957-wk-Fact-2F73427B9D18400BDE8374189FB72FCB" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q1QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span></ix:continuation><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-E4145B6DBEC45BF408167418A00519B7-2">.</ix:continuation> </span></div><div><a id="sEAB52936A26D5BC69805C98E00A1DD63"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:SegmentReportingDisclosureTextBlock" id="TextSelection-D5EB916ACEF74B4A02217418A0059F5C-0-wk-Fact-01509553240AC9483BA074189FF5DDBB" continuedAt="TextSelection-D5EB916ACEF74B4A02217418A0059F5C-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Segment Information</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113200062e2731-wk-Fact-2C5AB69C8E09576C8B2672107B337B38" name="us-gaap:NumberOfOperatingSegments" contextRef="FD2020Q1YTD" unitRef="segment" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment </span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">33</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-D5EB916ACEF74B4A02217418A0059F5C-1" continuedAt="TextSelection-D5EB916ACEF74B4A02217418A0059F5C-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="TextSelection-57E629E0F1ACF36757417418A0052FB1-0-wk-Fact-9E68A53EA695D57ADF3474189FE560E0" escape="true"></ix:nonNumeric>Revenue</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="TextSelection-54C7A415717EA0BC0E237418A005427D-0-wk-Fact-D61815FED296CFCC0BC874189FE5CF0C" continuedAt="TextSelection-54C7A415717EA0BC0E237418A005427D-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:60%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e2873-wk-Fact-75FDAFF094B04FFB1E5774189FB7002D" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33,212</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e2892-wk-Fact-5FEB709CCE0D5B4C3F51FF7640C9E51C" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31,209</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e2907-wk-Fact-D365D56F6B32B633066574189FA70B58" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">216</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e2926-wk-Fact-7BC0EDE7EB35EEEEB3A7FF764439A6D7" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">207</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e2946-wk-Fact-9322960E35296FF7D7F674189FE57A1B" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e2965-wk-Fact-94F07C1C2F0CC190213774189FE50D2F" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31,416</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e2985-wk-Fact-9F21207EA9E0E1B6F67674189FB75D32" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,446</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3004-wk-Fact-669367ADA2E4542C9E14FF76486F7804" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,380</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3024-wk-Fact-479A3B1717A0429191AB74189FB7AF26" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">471</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3043-wk-Fact-0E65F4EC6D2AD3010A61FF764C0B2ABF" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">421</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3063-wk-Fact-A065FAB12FD6E82CF19974189FE527D8" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,917</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3082-wk-Fact-CAD7425759D4623AF43174189FE52902" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,801</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3102-wk-Fact-BCA91130B4F39530B77074189FB7C48D" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,345</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3121-wk-Fact-7AFA75CD4358E29E425BFF7599AB94EF" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,217</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113200062e3141-wk-Fact-338EAA0C70B476F7739C74189FC6B624" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113200062e3161-wk-Fact-B3E8683DA707418FA0C1FF759B900A48" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3187-wk-Fact-2EB2517D9B7C56CF8B4E3EA80588EA22" name="us-gaap:Revenues" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,341</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3206-wk-Fact-0A6172E3579B0878A1BA74189FE5023E" name="us-gaap:Revenues" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,213</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-54C7A415717EA0BC0E237418A005427D-1" continuedAt="TextSelection-54C7A415717EA0BC0E237418A005427D-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-54C7A415717EA0BC0E237418A005427D-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></td></tr></table><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="TextSelection-EAC1B5CA9BD5B60D9CCC7418A0054105-0-wk-Fact-AE802BF7FC901646BAD574189FE58FD5" continuedAt="TextSelection-EAC1B5CA9BD5B60D9CCC7418A0054105-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:60%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3355-wk-Fact-8786B7C52D2C2F0FA85774189FC6D1DA" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">36,310</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3374-wk-Fact-265570CA61F1A09C006AFF7595EBC9C1" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34,245</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3389-wk-Fact-83CD6193BA6DD56857A374189FC6E0A4" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,035</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3408-wk-Fact-50978C0BD74341B189ACFF7597DBC9FE" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">972</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3428-wk-Fact-BCA91130B4F39530B77074189FB7C48D" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,345</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3447-wk-Fact-7AFA75CD4358E29E425BFF7599AB94EF" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,217</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113200062e3467-wk-Fact-338EAA0C70B476F7739C74189FC6B624" name="us-gaap:Revenues" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113200062e3487-wk-Fact-B3E8683DA707418FA0C1FF759B900A48" name="us-gaap:Revenues" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3513-wk-Fact-2EB2517D9B7C56CF8B4E3EA80588EA22" name="us-gaap:Revenues" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,341</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3532-wk-Fact-0A6172E3579B0878A1BA74189FE5023E" name="us-gaap:Revenues" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,213</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-EAC1B5CA9BD5B60D9CCC7418A0054105-1" continuedAt="TextSelection-EAC1B5CA9BD5B60D9CCC7418A0054105-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-EAC1B5CA9BD5B60D9CCC7418A0054105-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-D5EB916ACEF74B4A02217418A0059F5C-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; state opioid assessment related to prior fiscal years; other (income)/expense, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113200062e3562-wk-Fact-3B1AC78018485D7EAF62AC566422A1FB" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113200062e3566-wk-Fact-52F39D2D1D9C5D9F9671F64FC84B7E14" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s3E77F52A990B55D8984E21DCB5CC440C"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113200062e3586-wk-Fact-B506B163336CA2A537D23C2E6E5AC74F" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the naviHealth divestiture, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113200062e3597-wk-Fact-0C8C2A8C8E5611F0A18E13F1EC18BA9B" name="cah:PreTaxGainonDivestiture" contextRef="FD2019Q1YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three months ended September 30, 2018, which was retained at Corporate.</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="TextSelection-0216633A22A564BF7B327418A0056D5B-0-wk-Fact-C6155509D66E4250D14B74189FE51FFE" escape="true"><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3719-wk-Fact-996C21E56BB37654870674189FC6CBD0" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">398</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3738-wk-Fact-D4244625ADDFDF9A1FF374189FE50F74" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">409</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3753-wk-Fact-88AE264E40BA5BDEE89A74189FE5091A" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3772-wk-Fact-964881E02799EAF0874D74189FB79DF3" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">135</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3792-wk-Fact-8DAF8C6B204EC904BBA174189FA7F95E" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">568</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3811-wk-Fact-8B0105944ACF05AFD4F274189FF5E468" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">544</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113200062e3831-wk-Fact-97167790AD19ABCB886A74189FC67807" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,832</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3851-wk-Fact-82FC50683B80D8DBB86E74189FC6A82D" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">272</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d113200062e3876-wk-Fact-C69CC6A1EB30AC79AEA374189FE51E22" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,264</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e3896-wk-Fact-9E7250608ACD7C0949BA74189FE59C2A" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">816</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="TextSelection-698C2AB6DE2F324ADC257418A005B778-0-wk-Fact-413949A6C5D4756AF09574189FE55D26" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e3987-wk-Fact-62245C0C3BC0518DBC1B03CED7CC47DA" name="us-gaap:Assets" contextRef="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,755</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e4006-wk-Fact-D6DA3EDBFE0E59978CCC85FED7013410" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22,446</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e4021-wk-Fact-745BE35D38F558AB8E670C55EBEAB51F" name="us-gaap:Assets" contextRef="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,462</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e4040-wk-Fact-2A6DCB6AD27D535DB17BAFDFE9C85D0E" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,284</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e4060-wk-Fact-DDC1D5A12ADF5E1CAB78869146632E78" name="us-gaap:Assets" contextRef="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,962</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e4079-wk-Fact-F0FF2A69CB115530B166E4DC9050D6BB" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113200062e4104-wk-Fact-1B6A9B277CF557F2B4AF8989D169AA36" name="us-gaap:Assets" contextRef="FI2020Q1" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,179</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113200062e4123-wk-Fact-25A8ADCBD95A5ECFAAB5838D8DCE774C" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:13pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><a id="sE05088315CCF59BFAC25BE01132043D1"></a></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="TextSelection-6897547C5483FFC308047418A00574E6-0-wk-Fact-40972DED5A3250EA9B5A74189FE5A485" continuedAt="TextSelection-6897547C5483FFC308047418A00574E6-1" escape="true"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Share-Based Compensation</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. </span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="TextSelection-F9E9329767B3B84477147418A005738E-0-wk-Fact-5B121AE9FC189C202E9174189FA7DCA4" continuedAt="TextSelection-F9E9329767B3B84477147418A005738E-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div></ix:nonNumeric></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">34</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-6897547C5483FFC308047418A00574E6-1" continuedAt="TextSelection-6897547C5483FFC308047418A00574E6-2"><ix:continuation id="TextSelection-F9E9329767B3B84477147418A005738E-1" continuedAt="TextSelection-F9E9329767B3B84477147418A005738E-2"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e2868-wk-Fact-9DDA14637177026D846B74189FE586FC" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e2887-wk-Fact-6908026753640B700C9274189FA7EDC4" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e2902-wk-Fact-7F52047F11E2FFB756B774189FA75662" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e2921-wk-Fact-92F819503C7BE737B11674189FE59911" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e2941-wk-Fact-4B0310D3854F4C890FA074189FE53BAB" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e2960-wk-Fact-F56E4B03ABF8D7B178BF74189FA76F24" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e2985-wk-Fact-BA532CF6F2F6046F290A74189FF5D3FC" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3004-wk-Fact-6BB99FBF2C0B954C4B5F74189FA784F8" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-F9E9329767B3B84477147418A005738E-2"></ix:continuation>The total tax benefit related to share-based compensation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113202395e3023-wk-Fact-26FDD1C095EA6DA1F22974189FD63671" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2020Q1YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113202395e3027-wk-Fact-EBB92A0380D10E60297E74189FB74E8A" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2019Q1QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113202395e3045-wk-Fact-415D254A1B8B52EBBDFBD74574CB6126" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="TextSelection-E92FDF24D4D0CB0A79B37418A005B067-0-wk-Fact-E4FDF479B56CB24B20DB74189FD6EE41" continuedAt="TextSelection-E92FDF24D4D0CB0A79B37418A005B067-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:52%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3122-wk-Fact-462E373A3DBB58889D5242B83058C48C" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3141-wk-Fact-9FAE0F44DE915733BC71E56C41C3B7D0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3156-wk-Fact-9E9AB16CE74E5A8E87E5A723CF4DE4D9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3170-wk-Fact-76461793B1A65D30910FF63024174F4F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">42.09</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113202395e3190-wk-Fact-F9524487C2175BA6B1CCB98BF161B5FE" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3205-wk-Fact-C13EADD24716502291A9104210080787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">60.92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3225-wk-Fact-2ED1746C07955DE3A4D00AB547F0396B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3239-wk-Fact-4E7A2AD7D6B8519BAE3FFF08677BCB8A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3259-wk-Fact-A5B2F66416A55617B30EA9AC55E5F8E5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3278-wk-Fact-9181E4715B9554FCB7C3BD1F0039C6A4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">45.29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-E92FDF24D4D0CB0A79B37418A005B067-1"></ix:continuation>At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113202395e3296-wk-Fact-41C68FA021B65DEB85B12A200688B7BB" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113202395e3300-wk-Fact-904D6522612E5E2E96091CD4B0FE5278" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">two years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113202395e3311-wk-Fact-A3C869F4161F5DFD8E3E7923A4F7DCFB" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113202395e3315-wk-Fact-7C10990F94EA5CA3BF5AD4511F9B5A8D" name="cah:ExercisablePeriodOfPlansInYears" contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="TextSelection-EB47921C32E8E651AF327418A005C1D3-0-wk-Fact-D7298DBE7854B7603E7074189FD63900" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.58847736625515%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:53%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3402-wk-Fact-66E39B0166385B97868AD2BB04B60AD9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2019Q4" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3421-wk-Fact-8EA4ED3AF55B5BFE9F82982EFC6AE284" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2019Q4" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">63.78</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3436-wk-Fact-CF2AE0871FDF514CA0621A36B7358430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3450-wk-Fact-67AE6A16D2975F3185F96A0467AC7504" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q1YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3470-wk-Fact-FCF145B002895C16A883EF4B53955559" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3484-wk-Fact-7B75DF87C6F95BC592A2460265FF1C2B" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q1YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3504-wk-Fact-F4259C7E30A85B168A412A7C03CC4E4A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="FD2020Q1YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3518-wk-Fact-931312956AC355EFB50671052BD8222A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q1YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3538-wk-Fact-CD300B70E53654FF92354352CD0016DD" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2020Q1" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3557-wk-Fact-32C5559BC6A35EE5879B6FFD304D4F55" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2020Q1" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">63.75</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3572-wk-Fact-C70164520D7C5BBDBCB3BFC0BA325B2C" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="FI2020Q1" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3591-wk-Fact-371860AB68215579B9041C5C2B3B3A6B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="FI2020Q1" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">63.67</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113202395e3618-wk-Fact-F6E3F80ADD925B7E843B6131C7BC22CC" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113202395e3622-wk-Fact-1F537310A9E85C3694ED952BCEBEDFDB" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">one year</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-6897547C5483FFC308047418A00574E6-2"><ix:nonNumeric contextRef="FD2020Q1YTD" name="cah:AdditionalStockOptionPlanDataTableTextBlock" id="TextSelection-3E3EFC245CC9E98060027418A00535DA-0-wk-Fact-2536857381CF749E1AAA74189FA740B4" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3705-wk-Fact-BF93CE481E635800AF5D9AAD72986E60" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3724-wk-Fact-070CF01F30D2528B9F2C73F2D93B37A1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e3739-wk-Fact-761880AE3DB95FFDB0A136065685CB43" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e3758-wk-Fact-B168BF8EB088534AA43FB110A0709594" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:58%;"></td><td style="width:21%;"></td><td style="width:2%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d113202395e3810-wk-Fact-A7AF48BACE955350A614F66AEF402233" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d113202395e3820-wk-Fact-7466038374AD523C9939A0C287A1CAFE" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d113202395e3831-wk-Fact-E1B957F2CB2E5EA8842209F096B7847D" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d113202395e3841-wk-Fact-BD784B81F6F158498165D903AA48B860" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units vest over a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113202395e3914-wk-Fact-1A88A95399165914B95EA36880B94D8B" name="cah:VestingPeriodinyearsforShares" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113202395e3918-wk-Fact-10FA6F24C98455C7B0E119424524B632" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="FD2020Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="2" scale="-2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d113202395e3922-wk-Fact-54F2F948FC025604BB0D1742EF4FD46B" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="FD2020Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">240</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="FD2020Q1YTD" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="TextSelection-669A6F411C9A84E61E5A7418A005E071-0-wk-Fact-05A9C0AA18B24BDCF0E174189FD68D43" continuedAt="TextSelection-669A6F411C9A84E61E5A7418A005E071-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:51%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e4030-wk-Fact-210D8645A43E5D299E5346E97C01C98B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e4049-wk-Fact-D5BA21AE8D8F5DBFB98B9263AFB34152" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e4064-wk-Fact-B2BEA4FEF3685620912E9FB092B76EA6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e4078-wk-Fact-2571FBB6784059B69C3021A5C765644A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">43.68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113202395e4098-wk-Fact-193C646341585048AD0A35B2B98F8363" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e4113-wk-Fact-DF0E6B82F4F3553D9E4E44D41B1A578F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">48.40</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d113202395e4133-wk-Fact-09571AD138775C8BA6C874CCD09A611E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d113202395e4148-wk-Fact-4B14B44359AF5EEDB2009F1A0A44258E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.59</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e4168-wk-Fact-115B1BBB51E85F95B5706004CB3BA709" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d113202395e4187-wk-Fact-63A682CC66D05D4DBADF13630172414F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-669A6F411C9A84E61E5A7418A005E071-1"></ix:continuation>At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d113202395e4227-wk-Fact-8EDC7E7D9FCF50A0B44013BD15AB007F" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d113202395e4231-wk-Fact-57CA0B42B4325FB3A9A4CF133B1D8FD1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> if the performance goals are achieved.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">35</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s6E5639170A9F5236A35D521D5C0BC23B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;-sec-extract:summary;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;-sec-extract:summary;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-weight:bold;">Exhibits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Exhibit</span></div><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Exhibit Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex31.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137116000243/exhibit32-restatedcodeofre.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 30, 2016, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex101_4thamendmentjoindert.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Fourth Amendment and Joinder, dated September 30, 2019, to the Fourth Amended and Restated Receivables Purchase Agreement (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on October 2, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000109/ex102_3rdamendmentto7tharp.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 3 to Seventh Amended and Restated Performance Guaranty (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed on October 2, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000062/exhibit101evansofferletter.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Offer Letter to David C. Evans (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on August 8, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q110q93019exhibit311.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31.2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q110q93019exhibit312.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q110q93019exhibit321.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">99.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q110q93019exhibit991.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Statement Regarding Forward-Looking Information</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.SCH</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Schema Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.CAL</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.DEF</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Definition Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.LAB</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.PRE</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">104</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">Cardinal Health Website</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cardinal Health&#160;uses its website as a channel of distribution for material company information. Important information, including news releases, financial information, earnings and analyst presentations, and information about upcoming presentations and events is routinely posted and accessible at ir.cardinalhealth.com. In addition, the website allows investors and other interested persons to sign up automatically to receive e-mail alerts when we post news releases,&#160;SEC filings and certain other information on its website.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">36</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sA73FAAF0701F5D9F83D5E99E739D1576"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:29%;"></td><td style="width:47%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Form 10-Q Cross Reference Index</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Form 10-Q Cross Reference Index</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:85%;"></td><td style="width:7%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part I. Financial Information</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD1B7CCA5193854DB9EEEA979E0247169"><span style="font-family:Arial Narrow;font-size:10pt;">Financial Statements </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sD1B7CCA5193854DB9EEEA979E0247169">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s492296C284645086995797A96171E14B"><span style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s492296C284645086995797A96171E14B">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s8E3FD63AE9965CA9940DC3B7559763AF"><span style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s8E3FD63AE9965CA9940DC3B7559763AF">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s6B40C01A6B4F5FD5A866333DF1E5C3B7"><span style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s6B40C01A6B4F5FD5A866333DF1E5C3B7">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part II. Other Information</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sCE5D482753A65320B6D303408E3252CD"><span style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sCE5D482753A65320B6D303408E3252CD">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 1A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s7A2F75BABE8D50558DAEA11B9415396B"><span style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s7A2F75BABE8D50558DAEA11B9415396B">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sC229A9502CD557929C9EDDF384EFB929"><span style="font-family:Arial Narrow;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sC229A9502CD557929C9EDDF384EFB929">19</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Defaults Upon Senior Securities </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mine Safety Disclosures </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other Information</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 6</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s6E5639170A9F5236A35D521D5C0BC23B"><span style="font-family:Arial Narrow;font-size:10pt;">Exhibits</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s6E5639170A9F5236A35D521D5C0BC23B">36</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s0903B431604E5A26B93243DC1C8D5119"><span style="font-family:Arial Narrow;font-size:10pt;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s0903B431604E5A26B93243DC1C8D5119">38</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:48%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Not applicable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">37</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"></hr><div><a id="s0903B431604E5A26B93243DC1C8D5119"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Additional Information</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Signatures</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:50%;"></td><td style="width:44%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Date:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;MICHAEL C. KAUFMANN</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Michael C. Kaufmann</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chief Executive Officer</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/ DAVID C. EVANS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">David C. Evans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chief Financial Officer</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">38</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a20q110q93019exhibit311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s0521A8D5DF0B56E5B23964E876007551"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, </font><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font><font style="font-family:Arial Narrow;font-size:10pt;">, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-Q of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2019</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:627px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:198px;"></td><td style="width:428px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ M</font><font style="font-family:Arial Narrow;font-size:8pt;">ICHAEL</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;C. K</font><font style="font-family:Arial Narrow;font-size:8pt;">AUFMANN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a20q110q93019exhibit312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA501DA84FACB596A93CB19470ACA9BFC"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, David C. Evans, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-Q of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2019</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:184px;"></td><td style="width:498px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/</font><font style="font-family:Arial Narrow;font-size:9pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">D</font><font style="font-family:Arial Narrow;font-size:9pt;">AVID </font><font style="font-family:Arial Narrow;font-size:10pt;">C</font><font style="font-family:Arial Narrow;font-size:9pt;">. </font><font style="font-family:Arial Narrow;font-size:10pt;">E</font><font style="font-family:Arial Narrow;font-size:9pt;">VANS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">David C. Evans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a20q110q93019exhibit321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1D2F5F0759D7560496810AB9F0B31A35"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann, Chief Executive Officer of Cardinal Health, Inc. (the &#8220;Company&#8221;) and David C. Evans, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the Periodic Report on Form 10-Q for the quarter ended September 30, 2019 containing the financial statements of the Company (the &#8220;Periodic Report&#8221;), which this statement accompanies, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Dated: </font><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2019</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ M</font><font style="font-family:Arial Narrow;font-size:8pt;">ICHAEL</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;C. K</font><font style="font-family:Arial Narrow;font-size:8pt;">AUFMANN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Executive Officer </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ D</font><font style="font-family:Arial Narrow;font-size:9pt;">AVID</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;C. E</font><font style="font-family:Arial Narrow;font-size:9pt;">VANS</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">David C. Evans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>a20q110q93019exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s370DFB3369F05842B46E6B2885D296B0"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Statement Regarding Forward-Looking Information </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As used in this exhibit, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our filings with the Securities and Exchange Commission, including this Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2019 (the &#8220;2019 Form 10-K&#8221;), our quarterly reports on Form 10-Q and our current reports on Form 8-K (along with any exhibits and amendments to such reports), as well as our news releases or any other written or oral statements made by or on behalf of us, including materials posted on our website, may include, directly or by incorporation by reference, forward-looking statements that reflect our current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance. The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements. These risks and uncertainties include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">competitive pressures in the markets in which we operate, including pricing pressures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the pricing of generic pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">with respect to our distribution services agreements with branded pharmaceutical manufacturers, changes in the amount of service fees we receive or, in cases where part of our compensation under these agreements is based on branded pharmaceutical price appreciation, changes in the frequency or magnitude of such price appreciation; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturer approaches to pricing branded pharmaceutical products and risks related to our compensation under contractual arrangements with manufacturers being set as a percentage of the wholesale acquisition cost of branded pharmaceuticals; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in the timing or frequency of the introduction of branded pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the resolution and defense of the lawsuits and investigations in which we have been or will be named relating to the distribution of prescription opioid pain medication, including the risk that the outcome of these lawsuits and investigations could have a material adverse effect on our results of operations, financial condition, cash flows or liquidity;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">potential damage to our reputation, adverse operational impacts or other effects that may result from the national opioid epidemic, the allegations that have been made about our role in such epidemic and the ongoing unfavorable publicity surrounding the lawsuits and investigations against us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the ongoing discussions regarding a potential global settlement of certain opioid lawsuits and investigations against us, including the risk that we could fail to reach a final settlement, that any final settlement reached could require us to pay more than we currently anticipate or could have a negative effect on our liquidity or ability to return money to shareholders, and the risk that any injunctive or non-monetary remedies we may agree to could have unintended consequences;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">potential adverse impact to our financial results resulting from enacted and proposed state taxes or other assessments on the sale or distribution of opioid medications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our high sales concentration with certain key customers, including CVS Health Corporation and OptumRx;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance authorities, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any compromise of our information systems or of those of a third-party service provider, including unauthorized access to or use or disclosure of company or customer information, disruption of access and ancillary risks associated with our ability to effectively manage any issues arising from any such compromise or disruption;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties related to our Medical segment's Cardinal Health Brand products, including our ability to manage infrastructure and cost challenges, and to improve its performance;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the realignment of our Medical segment's supply chain and other businesses, including our ability to achieve the expected benefits from such realignment; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties with respect to our cost-savings initiatives or other restructuring activities, including the ability to achieve the expected benefits from such initiatives, the risk that we could incur unexpected charges, and the risk that we may fail to retain key personnel; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory consents or approvals associated with those activities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">manufacturing disruptions, whether due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product is manufactured at a single manufacturing facility with limited alternate facilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of healthcare fraud and abuse laws;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">costs or claims resulting from potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from remediation efforts or recalls and related product liability claims and lawsuits, including class action lawsuits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses being Medicare-certified suppliers or participating in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs and other applicable standards and regulations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">material reductions in purchases, pricing changes, non-renewal, early termination, or delinquencies or defaults under contracts with key customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unfavorable changes to the terms of key customer or supplier relationships, or changes in customer mix;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from changes in U.S. or foreign tax laws and unfavorable challenges to our tax positions and payments to settle these challenges;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties due to possible government healthcare reform, including proposals related to Medicare drug rebate arrangements, possible repeal or replacement of major parts of the Patient Protection and Affordable Care Act, proposals related to prescription drug pricing transparency and the possible adoption of Medicare-For-All;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reductions or limitations on governmental funding at the state or federal level or efforts by healthcare insurance companies to limit payments for products and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in legislation or regulations governing prescription drug pricing, healthcare services or mandated benefits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in hospital buying groups or hospital buying practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">continuing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">disruption, damage or lack of access to, or failure of, our or our third-party service providers' information systems, our critical facilities, including our national logistics center, or our distribution networks;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks to our business and information and controls systems in the event that business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, patent infringement claims, </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;actions, government investigations, shareholder lawsuits or other legal proceedings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">possible losses relating to product liability lawsuits and claims regarding products for which we cannot obtain product liability insurance or for which such insurance may not be adequate to cover our losses, including the product liability lawsuits we are currently defending relating to alleged personal injuries associated with the use of Cordis inferior vena cava filter products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain adequate intellectual property protections;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to manage and complete divestitures or other strategic business combination transactions, including our ability to find buyers or other strategic exit opportunities and risks associated with the possibility that we could experience greater dis-synergies than anticipated or otherwise fail to achieve our strategic objectives;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increased costs for commodities and other materials used in the Medical segment manufacturing, including various components, compounds, raw materials or energy such as oil-based resins, pulp, cotton, latex and other commodities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes;</font></div></td></tr></table><div><br></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties with respect to U.S. or international trade policies, tariffs, excise or border taxes and their impact on our ability to source products or materials that we need to conduct our business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with our use of and reliance on the global capital and credit markets, including our ability to access credit and our cost of credit, which may adversely affect our ability to efficiently fund our operations or undertake certain expenditures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to introduce and market new products and our ability to keep pace with advances in technology;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">significant charges to earnings if goodwill or intangible assets become impaired; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to general political, business, industry, regulatory and market conditions; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">other factors described in the &#8220;Risk Factors&#8221; section of the 2019 Form 10-K.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals. We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cah-20190930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20190930" xmlns:cah="http://www.cardinal.com/20190930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20190930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20190930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20190930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20190930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigation" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation">
        <link:definition>2109100 - Disclosure - Commitments, Contingent Liabilities and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails">
        <link:definition>2409401 - Disclosure - Commitments, Contingent Liabilities and Litigation Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1003000 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementOfShareholdersEquity" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity">
        <link:definition>1014000 - Statement - Condensed Consolidated Statement of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>1015000 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfEarnings" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings">
        <link:definition>1001000 - Statement - Condensed Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthInc" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc">
        <link:definition>2114100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails">
        <link:definition>2414403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails">
        <link:definition>2414402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncTables" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables">
        <link:definition>2314301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cardinal.com/role/FairValueMeasurements">
        <link:definition>2111100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2411402 - Disclosure - Fair Value Measurements Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables">
        <link:definition>2311301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cardinal.com/role/FinancialInstruments">
        <link:definition>2112100 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>2412402 - Disclosure - Financial Instruments Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails">
        <link:definition>2412403 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables">
        <link:definition>2312301 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssets" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets">
        <link:definition>2105100 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2405404 - Disclosure - Goodwill and Other Intangible Assets Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails">
        <link:definition>2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails">
        <link:definition>2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables">
        <link:definition>2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cardinal.com/role/IncomeTaxes">
        <link:definition>2110100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2410401 - Disclosure - Income Taxes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cardinal.com/role/Investments">
        <link:definition>2106100 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.cardinal.com/role/InvestmentsNarrativeDetails">
        <link:definition>2406401 - Disclosure - Investments Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cardinal.com/role/Leases">
        <link:definition>2107100 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarativeDetails" roleURI="http://www.cardinal.com/role/LeasesNarativeDetails">
        <link:definition>2407402 - Disclosure - Leases Narative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryOfLeaseCostsDetails" roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails">
        <link:definition>2407403 - Disclosure - Leases Summary of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryOfLeasePaymentsDetails" roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails">
        <link:definition>2407404 - Disclosure - Leases Summary of Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryOfMinimumLeaseCommittmentsDetails" roleURI="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails">
        <link:definition>2407405 - Disclosure - Leases Summary of Minimum Lease Committments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2407406 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cardinal.com/role/LeasesTables">
        <link:definition>2307301 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowings" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings">
        <link:definition>2108100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails">
        <link:definition>2408401 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeverance" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance">
        <link:definition>2103100 - Disclosure - Restructuring and Employee Severance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails">
        <link:definition>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails">
        <link:definition>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceNarrativeDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails">
        <link:definition>2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceTables" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables">
        <link:definition>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cardinal.com/role/SegmentInformation">
        <link:definition>2115100 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails">
        <link:definition>2415405 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" roleURI="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails">
        <link:definition>2415406 - Disclosure - Segment Information Disaggregated Revenue Within Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2415402 - Disclosure - Segment Information Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenueByGeographicalSegmentsDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails">
        <link:definition>2415407 - Disclosure - Segment Information Revenue by Geographical Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenueByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails">
        <link:definition>2415403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentProfitByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails">
        <link:definition>2415404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cardinal.com/role/SegmentInformationTables">
        <link:definition>2315301 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.cardinal.com/role/ShareBasedCompensation">
        <link:definition>2116100 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2416402 - Disclosure - Share-Based Compensation Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails">
        <link:definition>2416405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails">
        <link:definition>2416404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails">
        <link:definition>2416407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails">
        <link:definition>2416406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails">
        <link:definition>2416403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables">
        <link:definition>2316301 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cardinal.com/role/ShareholdersEquity">
        <link:definition>2113100 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2413403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2413402 - Disclosure - Shareholders' Equity Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cardinal.com/role/ShareholdersEquityTables">
        <link:definition>2313301 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="cah_ASC842Member" name="ASC842Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AdditionalStockOptionPlanDataTableTextBlock" name="AdditionalStockOptionPlanDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_AlamedaCountyMember" name="AlamedaCountyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Amortizationandotheracquisitionrelatedcosts" name="Amortizationandotheracquisitionrelatedcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract" name="BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CVSHealthMember" name="CVSHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CardinalHealthAtHomeMember" name="CardinalHealthAtHomeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CareFusionMember" name="CareFusionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CashComponentForSettlementFrameworkTerm" name="CashComponentForSettlementFrameworkTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ClassActionLawsuitsMember" name="ClassActionLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CommittedReceivablesSalesFacilityProgramMember" name="CommittedReceivablesSalesFacilityProgramMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_EnterpriseWideCostSavingMeasuresMember" name="EnterpriseWideCostSavingMeasuresMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ExercisablePeriodOfPlansInYears" name="ExercisablePeriodOfPlansInYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_FacilityExitAndOtherCosts" name="FacilityExitAndOtherCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_FinalSharesReceivedfromASRProgram" name="FinalSharesReceivedfromASRProgram" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_FinanceLeaseImputedInterest" name="FinanceLeaseImputedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_FinanceLeaseMember" name="FinanceLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_IPRDTrademarksandOtherMember" name="IPRDTrademarksandOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_IndemnificationReceivable" name="IndemnificationReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_InvestigationbyMultitateTaskForce" name="InvestigationbyMultitateTaskForce" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_LawsuitTypeAxis" name="LawsuitTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" name="LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LeasePaymentsTableTextBlock" name="LeasePaymentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" name="LeasesSupplementalBalanceSheetInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeasesTextBlock" name="LeasesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" name="LesseeFinanceLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" name="LesseeLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFive" name="LesseeLeaseLiabilityPaymentsDueYearFive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFour" name="LesseeLeaseLiabilityPaymentsDueYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearThree" name="LesseeLeaseLiabilityPaymentsDueYearThree" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearTwo" name="LesseeLeaseLiabilityPaymentsDueYearTwo" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" name="LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" name="LesseeOperatingLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_LitigationTypeDomain" name="LitigationTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LossContingencyAccrualNetofInsuranceRecoveries" name="LossContingencyAccrualNetofInsuranceRecoveries" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LossContingencyLawsuitsNumber" name="LossContingencyLawsuitsNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_MaximumQuarterlyPayment" name="MaximumQuarterlyPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalMember" name="MedicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalSegmentAxis" name="MedicalSegmentAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalSegmentDomain" name="MedicalSegmentDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicaldistributionandproductsMember" name="MedicaldistributionandproductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NaviHealthMember" name="NaviHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Netproceedstaxwithholdingsfromsharebasedcompensation" name="Netproceedstaxwithholdingsfromsharebasedcompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_NotesPayableRepurchased" name="NotesPayableRepurchased" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NuclearPrecisionHealthServicesMember" name="NuclearPrecisionHealthServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_NumberofStateAttorneysGeneralfilinglawsuits" name="NumberofStateAttorneysGeneralfilinglawsuits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_Numberofsharesexcludedfromcalculationofdilutedshares" name="Numberofsharesexcludedfromcalculationofdilutedshares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_OperatingLeaseImputedInterest" name="OperatingLeaseImputedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OperatingLeaseMember" name="OperatingLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLawsuitsMember" name="OpioidLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationAxis" name="OpioidLitigationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationCuyahogaandSummitCountiesMember" name="OpioidLitigationCuyahogaandSummitCountiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" name="OpioidLitigationlessCuyahogaandSummitCountiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidSettlementFrameworkMember" name="OpioidSettlementFrameworkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_OpioidTotalSettlementCuyahogaandSummitCounties" name="OpioidTotalSettlementCuyahogaandSummitCounties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OtherJurisdictionsMember" name="OtherJurisdictionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PartnershipIndirectOwnership" name="PartnershipIndirectOwnership" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_PatientRecoveryBusinessMember" name="PatientRecoveryBusinessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalDistributionandSpecialtyMember" name="PharmaceuticalDistributionandSpecialtyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalMember" name="PharmaceuticalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalSegmentAxis" name="PharmaceuticalSegmentAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalSegmentDomain" name="PharmaceuticalSegmentDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PlaintiffTypeAxis" name="PlaintiffTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PlaintiffTypeDomain" name="PlaintiffTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PreTaxGainonDivestiture" name="PreTaxGainonDivestiture" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PrivatePartiesMember" name="PrivatePartiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" name="Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ProductLiabilityLawsuitsMember" name="ProductLiabilityLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ProjectCostsOnInvestmentAndOtherSpending" name="ProjectCostsOnInvestmentAndOtherSpending" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Purchaseofavailableforsalesecuritiesandotherinvestments" name="Purchaseofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cah_ReclassificationofdeferredrentinaccordancewithASC842" name="ReclassificationofdeferredrentinaccordancewithASC842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock" name="ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SegmentRevenuebyGeographicLineItems" name="SegmentRevenuebyGeographicLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SegmentRevenuebyGeographicTable" name="SegmentRevenuebyGeographicTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" name="Sharesthatwouldbeantidilutiveasaresultofnetloss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ShortTermCreditFacilitiesMember" name="ShortTermCreditFacilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SummaryofMinimumLeasePaymentsAbstract" name="SummaryofMinimumLeasePaymentsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMatterAxis" name="TaxMatterAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMatterDomain" name="TaxMatterDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMattersAgreementDomain" name="TaxMattersAgreementDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TotalFinanceLeaseCost" name="TotalFinanceLeaseCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_TotalLeaseLiability" name="TotalLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityNotYetCommencedAmount" name="TotalLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityPaymentsDue" name="TotalLeaseLiabilityPaymentsDue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityUndiscountedExcessAmount" name="TotalLeaseLiabilityUndiscountedExcessAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_TotalOpioidLitigationMember" name="TotalOpioidLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TotalOpioidLitigationnetoftaxMember" name="TotalOpioidLitigationnetoftaxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TrademarksAndPatentsMember" name="TrademarksAndPatentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_VestingPeriodinyearsforShares" name="VestingPeriodinyearsforShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cah-20190930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20190930.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:href="cah-20190930.xsd#CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cah-20190930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20190930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:href="cah-20190930.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20190930.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="cah-20190930.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20190930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20190930.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20190930.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20190930.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20190930.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20190930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20190930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20190930.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsNarrativeDetails" xlink:href="cah-20190930.xsd#InvestmentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20190930.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesNarativeDetails" xlink:href="cah-20190930.xsd#LeasesNarativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20190930.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20190930.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20190930.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:href="cah-20190930.xsd#LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20190930.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:href="cah-20190930.xsd#SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20190930.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:href="cah-20190930.xsd#SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20190930.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20190930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20190930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20190930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20190930.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20190930.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20190930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_9c889623-7b4f-c89a-bbb3-2bc9fb9ad9f5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_AccountsPayableCurrent_9c889623-7b4f-c89a-bbb3-2bc9fb9ad9f5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9b76c483-9f0b-f620-cc71-e72e11c0cf50" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9b76c483-9f0b-f620-cc71-e72e11c0cf50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fa7787c9-a33c-d084-bb97-5e2455f77a4c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30dca50d-a7bd-cff0-949a-3d7ae869c50d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_fa7787c9-a33c-d084-bb97-5e2455f77a4c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c04a9f43-7296-9f06-8aab-f3b0c03decfa" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_c04a9f43-7296-9f06-8aab-f3b0c03decfa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_df1d20df-a1b2-edc3-bafe-324fb8573ea9" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_df1d20df-a1b2-edc3-bafe-324fb8573ea9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d7f1ad03-6ed4-706a-15fc-eae794dee33a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_928e20af-e738-4a2d-05b8-cf88fed11953" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:to="loc_us-gaap_PreferredStockValue_928e20af-e738-4a2d-05b8-cf88fed11953" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_f05ab245-2bd1-7865-e7ed-1461a5a6155f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:to="loc_us-gaap_CommonStockValue_f05ab245-2bd1-7865-e7ed-1461a5a6155f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62305d8f-d807-0fe8-d0ab-f2c2b3d03011" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_62305d8f-d807-0fe8-d0ab-f2c2b3d03011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_e6069c8d-dfec-45ff-4b3f-643d125d5b29" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:to="loc_us-gaap_TreasuryStockValue_e6069c8d-dfec-45ff-4b3f-643d125d5b29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_988c1346-b444-a867-fe80-f3aec1443d54" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b9904d8-8624-0dbb-a949-29ff2cf808a8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_988c1346-b444-a867-fe80-f3aec1443d54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_3070eb63-b0f5-1f18-a22f-cc54a94922d9" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2605fa18-bbd8-c7d7-35fc-aace43a8c019" xlink:to="loc_us-gaap_MinorityInterest_3070eb63-b0f5-1f18-a22f-cc54a94922d9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1de780cc-9607-daa3-0bed-03c88ae94769" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1de780cc-9607-daa3-0bed-03c88ae94769" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_c4de65c9-dd27-7a0a-0b7a-4158d1967739" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_ReceivablesNetCurrent_c4de65c9-dd27-7a0a-0b7a-4158d1967739" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_InventoryNet_cc720f44-4c90-5acc-2e7e-b88e80f2af28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_7832082e-fa39-48cc-a655-249c101debf9" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b3bd361-d592-2906-279e-2682647fdd27" xlink:to="loc_us-gaap_OtherAssetsCurrent_7832082e-fa39-48cc-a655-249c101debf9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4246ec24-1a4c-19dd-57c9-32d4a8e0cbaa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_0572c4a5-7251-883f-b3a9-f968acd71b9b" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_0572c4a5-7251-883f-b3a9-f968acd71b9b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bd8545de-cfc2-6f31-bff6-ed0d4012c357" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_17ef3f41-42f7-52c0-cba1-93e7e0e1116a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bd8545de-cfc2-6f31-bff6-ed0d4012c357" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_b2425514-ebf2-89bc-8a6a-e6b6edfea6c3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_b2425514-ebf2-89bc-8a6a-e6b6edfea6c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ebef248a-da21-637d-9d28-3d42ff90e8e2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ebef248a-da21-637d-9d28-3d42ff90e8e2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_7d7d39ac-9507-af5c-a46f-65dbaaa2c625" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_7d7d39ac-9507-af5c-a46f-65dbaaa2c625" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0398271c-2d82-5820-21ec-070cd381174c" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0398271c-2d82-5820-21ec-070cd381174c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_f0b9d825-b0b9-37fd-4d25-9294a8598890" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_ShareBasedCompensation_f0b9d825-b0b9-37fd-4d25-9294a8598890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5ae19a9f-6de6-075a-2c5a-a587d82ebad5" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5ae19a9f-6de6-075a-2c5a-a587d82ebad5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_a6b55487-86c4-3218-b33b-75029447f45e" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_a6b55487-86c4-3218-b33b-75029447f45e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f2b34f8d-2445-12ee-2c68-fa0c5409d5e0" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f2b34f8d-2445-12ee-2c68-fa0c5409d5e0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_792166b2-b561-55ef-12fd-ca8b50f64a38" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_792166b2-b561-55ef-12fd-ca8b50f64a38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2d3aea93-0685-7648-d025-abd4b91cbb46" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce0d7b63-a366-bc9b-79e1-780981e428fe" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_2d3aea93-0685-7648-d025-abd4b91cbb46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_b2425514-ebf2-89bc-8a6a-e6b6edfea6c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f8df60b-841f-6df5-83c3-e4049d366459" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0f8df60b-841f-6df5-83c3-e4049d366459" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_5b1200e5-574f-f571-8d02-3f4b1cbc7e2e" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_5b1200e5-574f-f571-8d02-3f4b1cbc7e2e" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_3594fd25-5f79-1eec-29aa-3f4b1cb8bac5" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_3594fd25-5f79-1eec-29aa-3f4b1cb8bac5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6d7a72cc-b15d-447c-3b26-c3564dc5b0b1" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0f07a806-a2da-6d18-a7a9-d734fad1f3b0" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6d7a72cc-b15d-447c-3b26-c3564dc5b0b1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_b2425514-ebf2-89bc-8a6a-e6b6edfea6c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_12c0685e-44b3-8fd2-2b79-15793d0fdbbe" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_12c0685e-44b3-8fd2-2b79-15793d0fdbbe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_50c96d39-6558-6bd8-b3d6-7ed1c558807e" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_50c96d39-6558-6bd8-b3d6-7ed1c558807e" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_703dae2e-a5b4-4bf1-cb7b-3f4b1d22510b" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_703dae2e-a5b4-4bf1-cb7b-3f4b1d22510b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_41d72ed0-9a2b-31fb-9f8e-ad33f5eca26a" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_41d72ed0-9a2b-31fb-9f8e-ad33f5eca26a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f804297-91a1-3939-541d-a39b6288c9f9" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1efd93c0-bb90-2a64-a997-3a70afaa3faa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3f804297-91a1-3939-541d-a39b6288c9f9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_32f0c8eb-accb-9ab7-5d53-b9d2845af404" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_b2425514-ebf2-89bc-8a6a-e6b6edfea6c3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_32f0c8eb-accb-9ab7-5d53-b9d2845af404" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c4761fa8-dc2a-e270-4b5c-921deca83ad0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c4761fa8-dc2a-e270-4b5c-921deca83ad0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c4761fa8-dc2a-e270-4b5c-921deca83ad0" xlink:to="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c4761fa8-dc2a-e270-4b5c-921deca83ad0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_68a2669c-01f8-c962-bf95-0b4231cd45da" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_68a2669c-01f8-c962-bf95-0b4231cd45da" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2efcb6ae-5d3a-652c-5e64-2f0332c3d5a3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2efcb6ae-5d3a-652c-5e64-2f0332c3d5a3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a3a6becb-cb5c-3f3c-51b9-6edd8011ed69" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5c8b3520-1ca2-0a91-0912-70d62831826c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a3a6becb-cb5c-3f3c-51b9-6edd8011ed69" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:to="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:to="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_425ada39-f194-a279-47ac-dd09cf899fb1" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:to="loc_us-gaap_Revenues_425ada39-f194-a279-47ac-dd09cf899fb1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3549c1c0-2f2a-e44b-026b-b4042153e489" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_98c25af7-47ba-69a3-12c4-e52bd51b359e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3549c1c0-2f2a-e44b-026b-b4042153e489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89fcc343-1933-1e77-588e-68d1c2f1a04f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89fcc343-1933-1e77-588e-68d1c2f1a04f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_d445215a-3b87-2f11-ac68-3256f2f2966f" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_RestructuringCharges_d445215a-3b87-2f11-ac68-3256f2f2966f" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_f9c30fd2-d9c2-7553-5ed6-3f4b1d0c0b92" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_f9c30fd2-d9c2-7553-5ed6-3f4b1d0c0b92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0398271c-2d82-5820-21ec-070cd381174c" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0398271c-2d82-5820-21ec-070cd381174c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_de4daba6-07da-9e14-df22-fdf11128e44e" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8db01d6d-ae17-523f-94b9-8ab4add4a22e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_de4daba6-07da-9e14-df22-fdf11128e44e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7a3a9730-2927-590e-4e76-6aeb4157256e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7a3a9730-2927-590e-4e76-6aeb4157256e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_16e9f6a6-5524-a7b1-7e7c-73ee97610ec6" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d71649eb-5769-933d-7982-2a2ada9ea257" xlink:to="loc_us-gaap_InterestExpense_16e9f6a6-5524-a7b1-7e7c-73ee97610ec6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8b582348-a62e-cdfb-bc53-d5894b42e091" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_666ca9f0-28f1-b21a-025e-36222808a6c3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a3a6becb-cb5c-3f3c-51b9-6edd8011ed69" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e170ce1e-c3a8-e8ee-88b0-37e8dd7b1d11" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a3a6becb-cb5c-3f3c-51b9-6edd8011ed69" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c9389ea-1fbb-7e45-ce1f-5a1d89572c0d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fbdbb03d-8583-701f-d6e2-69f8229c6051" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c9389ea-1fbb-7e45-ce1f-5a1d89572c0d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fbdbb03d-8583-701f-d6e2-69f8229c6051" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_72ad9ebf-e829-cc37-8382-628e47c585ab" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c9389ea-1fbb-7e45-ce1f-5a1d89572c0d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_72ad9ebf-e829-cc37-8382-628e47c585ab" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/InvestmentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesNarativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:type="locator" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalFinanceLeaseCost" xlink:label="loc_cah_TotalFinanceLeaseCost_8B30312AC680D885B870031CCD9C8ED4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_cah_TotalFinanceLeaseCost_8B30312AC680D885B870031CCD9C8ED4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e6bc46d1-fec7-6b3b-527e-4ad756896790" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cah_TotalFinanceLeaseCost_8B30312AC680D885B870031CCD9C8ED4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e6bc46d1-fec7-6b3b-527e-4ad756896790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_3df88f41-850d-02ae-dd0b-ab0215935a95" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_VariableLeaseCost_3df88f41-850d-02ae-dd0b-ab0215935a95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_88d5ba82-39dd-36ed-37fe-92977ff632df" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ac3b1889-9651-365f-e4fc-e6474385db69" xlink:to="loc_us-gaap_OperatingLeaseCost_88d5ba82-39dd-36ed-37fe-92977ff632df" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_d445215a-3b87-2f11-ac68-3256f2f2966f" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_602cce24-5ce6-992d-b143-c1204a3e69cf" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_d445215a-3b87-2f11-ac68-3256f2f2966f" xlink:to="loc_us-gaap_SeveranceCosts1_602cce24-5ce6-992d-b143-c1204a3e69cf" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_8f17a104-1c8c-3b25-0e44-3f4b1a9377d7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_d445215a-3b87-2f11-ac68-3256f2f2966f" xlink:to="loc_cah_FacilityExitAndOtherCosts_8f17a104-1c8c-3b25-0e44-3f4b1a9377d7" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78f9a384-d8cc-c622-a09d-cab78e8426f5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_78f9a384-d8cc-c622-a09d-cab78e8426f5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_33fd7cc6-9d16-3ba3-ad10-286b2340fef5" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ed26a82-dd4b-490f-d61a-b04c5d44793e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_33fd7cc6-9d16-3ba3-ad10-286b2340fef5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cah-20190930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20190930.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:href="cah-20190930.xsd#CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cah-20190930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20190930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:href="cah-20190930.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20190930.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="cah-20190930.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20190930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20190930.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20190930.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20190930.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20190930.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20190930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20190930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20190930.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsNarrativeDetails" xlink:href="cah-20190930.xsd#InvestmentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20190930.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesNarativeDetails" xlink:href="cah-20190930.xsd#LeasesNarativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20190930.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20190930.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20190930.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:href="cah-20190930.xsd#LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20190930.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:href="cah-20190930.xsd#SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20190930.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:href="cah-20190930.xsd#SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20190930.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20190930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20190930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20190930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20190930.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20190930.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20190930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:to="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:to="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:to="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:to="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:to="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:to="loc_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:to="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:to="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:to="loc_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:to="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:to="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:to="loc_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:to="loc_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:to="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:to="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:to="loc_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:to="loc_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:to="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:to="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:to="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:to="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:to="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:to="loc_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:to="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:to="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_27F547F5BCE85A84AFF946B114A41521" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_OpioidLawsuitsMember_27F547F5BCE85A84AFF946B114A41521" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_FB4EF6EF34F78762480046B114A41837" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_ClassActionLawsuitsMember_FB4EF6EF34F78762480046B114A41837" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_2033B52FFC44A47D1B9646B114A42CD9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_2033B52FFC44A47D1B9646B114A42CD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_7A3C806E45A77731586246B114A55732" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544" xlink:to="loc_us-gaap_SubsequentEventMember_7A3C806E45A77731586246B114A55732" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LossContingencyAccrualNetofInsuranceRecoveries" xlink:label="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_InvestigationbyMultitateTaskForce" xlink:label="loc_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:to="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:to="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_5B618790E1086E18049346B818E0ABE8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_TreasuryStockMember_5B618790E1086E18049346B818E0ABE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_B2B82BCE630C235E9BC646B818E086EB" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_B2B82BCE630C235E9BC646B818E086EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_306857E9C11105B7F05D28CDBCC82E46" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_306857E9C11105B7F05D28CDBCC82E46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:to="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:to="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:to="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:to="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:to="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:to="loc_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:to="loc_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:to="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:to="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B21CE1B0F75B35A207C0130C8589DDE6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:to="loc_cah_PharmaceuticalMember_B21CE1B0F75B35A207C0130C8589DDE6" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_D239EC104B3A8081BB3A130C85890EE1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:to="loc_cah_MedicalMember_D239EC104B3A8081BB3A130C85890EE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:to="loc_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:to="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:to="loc_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:to="loc_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="loc_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="loc_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:to="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:to="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:to="loc_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:to="loc_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_A8C70807379894AD93DF47707E865FFE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:to="loc_cah_PatientRecoveryBusinessMember_A8C70807379894AD93DF47707E865FFE" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:to="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:to="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_E680EBD6AB092458403B47707E865062" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:to="loc_cah_TotalOpioidLitigationMember_E680EBD6AB092458403B47707E865062" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_B7AA8C1D13682645FA7647707E863E53" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:to="loc_cah_CareFusionMember_B7AA8C1D13682645FA7647707E863E53" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_EEF48B41CF7138FF7A1A47707E865540" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:to="loc_cah_PatientRecoveryBusinessMember_EEF48B41CF7138FF7A1A47707E865540" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08C66BE85988659E71E047707E86D311_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08C66BE85988659E71E047707E86D311_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08C66BE85988659E71E047707E86D311" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08C66BE85988659E71E047707E86D311" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:to="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:to="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_5DC47FCCFC4F32AFD8B047707E9655E5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:to="loc_srt_MinimumMember_5DC47FCCFC4F32AFD8B047707E9655E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_24991B74A6BB055225CB47707E962889" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:to="loc_srt_MaximumMember_24991B74A6BB055225CB47707E962889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_EF0003731461DD0F1B9C47707E96BDD9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_LitigationReserve_EF0003731461DD0F1B9C47707E96BDD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentLineItems" xlink:label="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentTable" xlink:label="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:to="loc_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PartnershipIndirectOwnership" xlink:label="loc_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesNarativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:to="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:to="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:to="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:to="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_92C0278DDFCF2BDD626046CB56F24DE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:to="loc_srt_MinimumMember_92C0278DDFCF2BDD626046CB56F24DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_4399A4061D537FC57DC246C8C31A57D5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:to="loc_srt_MaximumMember_4399A4061D537FC57DC246C8C31A57D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_BC843F2EDDB867F517C5284DBC31960F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_BC843F2EDDB867F517C5284DBC31960F" xlink:to="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:to="loc_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" xlink:label="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_BC843F2EDDB867F517C5284DBC31960F" xlink:to="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:to="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:to="loc_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:to="loc_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:to="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:to="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:to="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="loc_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_866974ED853BC5FBB34612D39E74167D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_866974ED853BC5FBB34612D39E74167D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:to="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:to="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_679E376231F519C1E26412D39E74041E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:to="loc_srt_RangeMember_679E376231F519C1E26412D39E74041E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_679E376231F519C1E26412D39E74041E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:to="loc_srt_RangeMember_679E376231F519C1E26412D39E74041E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:to="loc_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:to="loc_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:to="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:to="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:to="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:to="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_EnterpriseWideCostSavingMeasuresMember" xlink:label="loc_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:to="loc_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_0C24532787BC7AC6D6D3FF700D358B3E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_cah_FacilityExitAndOtherCosts_0C24532787BC7AC6D6D3FF700D358B3E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:to="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:to="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:to="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_EA50923C8C57669EBAA07418D888E6B4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:to="loc_us-gaap_OperatingSegmentsMember_EA50923C8C57669EBAA07418D888E6B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_823306ABC99BFEE633E17418D8882DF9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:to="loc_us-gaap_CorporateNonSegmentMember_823306ABC99BFEE633E17418D8882DF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:to="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:to="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_87750A3E7CE5E453ABF07418D8884A7C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:to="loc_cah_PharmaceuticalMember_87750A3E7CE5E453ABF07418D8884A7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_7C3D00841747236F061C7418D888040F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:to="loc_cah_MedicalMember_7C3D00841747236F061C7418D888040F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:to="loc_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentAxis" xlink:label="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentDomain" xlink:label="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:to="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentDomain" xlink:label="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:to="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:to="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:to="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentAxis" xlink:label="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentDomain" xlink:label="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:to="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentDomain" xlink:label="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:to="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:to="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:to="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_9C02D59552F03A37650FFF7646607084" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:to="loc_us-gaap_OperatingSegmentsMember_9C02D59552F03A37650FFF7646607084" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8A4D95FB566910EE1871FF76466177F7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8A4D95FB566910EE1871FF76466177F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:to="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:to="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_7300EC7081F65BF4D4EBFF764662D9C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:to="loc_cah_PharmaceuticalMember_7300EC7081F65BF4D4EBFF764662D9C9" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_9E22A48366D9D25250C0FF76466259B4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:to="loc_cah_MedicalMember_9E22A48366D9D25250C0FF76466259B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:to="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:to="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_5EF768F2D673FDBABE06FF764663BEC2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_CardinalHealthAtHomeMember_5EF768F2D673FDBABE06FF764663BEC2" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_F819F330CED4D6743311FF7646635691" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_MedicaldistributionandproductsMember_F819F330CED4D6743311FF7646635691" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_3719F3E2759DC80119B2FF76466451EE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_3719F3E2759DC80119B2FF76466451EE" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_983D3427463EAC23A6A9FF764664B592" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_983D3427463EAC23A6A9FF764664B592" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:to="loc_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:to="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:to="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:to="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_DE36531505980DCD47AD47471E7ADF40" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:to="loc_cah_TotalOpioidLitigationMember_DE36531505980DCD47AD47471E7ADF40" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidSettlementFrameworkMember" xlink:label="loc_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:to="loc_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_73554DB13C66D3319AFA46B8177E2C94" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA" xlink:to="loc_cah_NaviHealthMember_73554DB13C66D3319AFA46B8177E2C94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_7606A70D2DCE3C738DEA46B8177ECDCA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_cah_PreTaxGainonDivestiture_7606A70D2DCE3C738DEA46B8177ECDCA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20190930.xsd#cah_SegmentRevenuebyGeographicLineItems" xlink:label="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:type="locator" />
    <link:loc xlink:href="cah-20190930.xsd#cah_SegmentRevenuebyGeographicTable" xlink:label="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:to="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:to="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:to="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:to="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_3D124DA4F0C66A87787EFF759AE43054" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9" xlink:to="loc_us-gaap_OperatingSegmentsMember_3D124DA4F0C66A87787EFF759AE43054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingSegmentsMember_3D124DA4F0C66A87787EFF759AE43054" xlink:to="loc_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:to="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:to="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:to="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:to="loc_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:to="loc_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_E09FE931380416178D90FF759AE6DB3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:to="loc_us-gaap_Revenues_E09FE931380416178D90FF759AE6DB3C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_25B51FBD3BD6DAD588371272537DF454" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_25B51FBD3BD6DAD588371272537DF454" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:to="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:to="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_E9F105BDF12837F771E21272537DAF03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_E9F105BDF12837F771E21272537DAF03" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_BE4D12D1E836C4B815751272537D6BFC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_BE4D12D1E836C4B815751272537D6BFC" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_ABAA95976DAA7D2467201272537D4EE7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_MedicaldistributionandproductsMember_ABAA95976DAA7D2467201272537D4EE7" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_2227889CB9E01E6141FE1272537DA1F3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_CardinalHealthAtHomeMember_2227889CB9E01E6141FE1272537DA1F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:to="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:to="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_B8F6FA4152E58EB54D3D1272537DC7C3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:to="loc_us-gaap_OperatingSegmentsMember_B8F6FA4152E58EB54D3D1272537DC7C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_280B29706E4BB73482E01272537D0563" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:to="loc_us-gaap_CorporateNonSegmentMember_280B29706E4BB73482E01272537D0563" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:to="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:to="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_A7955B2C76267424838E1272537D0248" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:to="loc_cah_PharmaceuticalMember_A7955B2C76267424838E1272537D0248" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FA195D20A16E10DF54A81272537DECE2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:to="loc_cah_MedicalMember_FA195D20A16E10DF54A81272537DECE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_25B51FBD3BD6DAD588371272537DF454" xlink:to="loc_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:to="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:to="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:to="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:to="loc_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:to="loc_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:to="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:to="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:to="loc_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:to="loc_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:to="loc_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_684CC18580B41B16FDD21355F8317603" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_684CC18580B41B16FDD21355F8317603" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_69569FCFA0012CC997091355F82FB85E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:to="loc_srt_ConsolidationItemsDomain_69569FCFA0012CC997091355F82FB85E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_69569FCFA0012CC997091355F82FB85E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:to="loc_srt_ConsolidationItemsDomain_69569FCFA0012CC997091355F82FB85E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_58B79D4527F83DD42A7C1355F830C71E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:to="loc_us-gaap_SegmentDomain_58B79D4527F83DD42A7C1355F830C71E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_58B79D4527F83DD42A7C1355F830C71E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:to="loc_us-gaap_SegmentDomain_58B79D4527F83DD42A7C1355F830C71E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_07DA49D50C78F6315C6F1355F830E689_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:to="loc_us-gaap_SubsegmentsDomain_07DA49D50C78F6315C6F1355F830E689_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_07DA49D50C78F6315C6F1355F830E689" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:to="loc_us-gaap_SubsegmentsDomain_07DA49D50C78F6315C6F1355F830E689" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_5B97C6DBD25C476D14141355F8315BD1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_5B97C6DBD25C476D14141355F8315BD1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_5B97C6DBD25C476D14141355F8315BD1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_5B97C6DBD25C476D14141355F8315BD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_684CC18580B41B16FDD21355F8317603" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:to="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_B921F6247EB26F66B8621E8DEFA72B20" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_B921F6247EB26F66B8621E8DEFA72B20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:to="loc_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:to="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:to="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:to="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_C32064526215DDFFDF661E8DEFA7EE17" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:to="loc_srt_MinimumMember_C32064526215DDFFDF661E8DEFA7EE17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CF7598891FA7C9F1C2571E8DEFA77A04" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:to="loc_srt_MaximumMember_CF7598891FA7C9F1C2571E8DEFA77A04" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_BEA559D551823541D5201E8DEFA741C2" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_BEA559D551823541D5201E8DEFA741C2" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:to="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0110F76EDED8743E38027418D8E6BFB9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0110F76EDED8743E38027418D8E6BFB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5F06CCCB81A541EEB7DC7418D8E6A8AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5F06CCCB81A541EEB7DC7418D8E6A8AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0E5DAE26BA3B2C0A17D37418D8F58513" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0E5DAE26BA3B2C0A17D37418D8F58513" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:to="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_1B5368CE09A86129A25D7418D859B432" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E" xlink:to="loc_us-gaap_PerformanceSharesMember_1B5368CE09A86129A25D7418D859B432" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_45FAFCF08A64AF72F1337418D8594BFD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_45FAFCF08A64AF72F1337418D8594BFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9EBAA1B34397DDFEB8637418D8597506" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9EBAA1B34397DDFEB8637418D8597506" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_E0D1F01EBBB0C8CA1C367418D859C674" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_E0D1F01EBBB0C8CA1C367418D859C674" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_617FD502705AD1401CB97418D8590DA9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_617FD502705AD1401CB97418D8590DA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8DEBAF744346D7FB00C97418D859BB11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8DEBAF744346D7FB00C97418D859BB11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_721430AA7F20B5D361E87418D869EFED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_721430AA7F20B5D361E87418D869EFED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F1048FB15410152E2E917418D8698552" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F1048FB15410152E2E917418D8698552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_E0CB3E34A261E7585DFD7418D869378F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_E0CB3E34A261E7585DFD7418D869378F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_84D51B336FC0F7B54D557418D869FE8A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_84D51B336FC0F7B54D557418D869FE8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082635DF0A6E62725E7A7418D869D02F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082635DF0A6E62725E7A7418D869D02F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:to="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23D1BEAD1AA994C68E227418D95339EA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23D1BEAD1AA994C68E227418D95339EA" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:to="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:to="loc_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23D1BEAD1AA994C68E227418D95339EA" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:to="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:to="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EE0A9DF4715C50B0DD5338067C2BE6FD" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EE0A9DF4715C50B0DD5338067C2BE6FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:to="loc_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:to="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:to="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:to="loc_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FinalSharesReceivedfromASRProgram" xlink:label="loc_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cah-20190930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:to="lab_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:type="arc" />
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B_terseLabel_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPR&amp;D, trademarks and other</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B_label_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPR&amp;D,TrademarksandOther [Member]</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B_documentation_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:to="lab_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:to="lab_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:type="arc" />
    <link:label id="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C_terseLabel_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names and patents</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C_label_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks And Patents Member</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C_documentation_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:to="lab_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technology and other</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08" xlink:to="lab_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:to="lab_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:to="lab_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:to="lab_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:to="lab_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="lab_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired (using cost method), shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired, average price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:type="arc" />
    <link:label id="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9_terseLabel_en-US" xlink:label="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Final Shares Received from ASR Program</link:label>
    <link:label id="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9_label_en-US" xlink:label="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Final Shares Received from ASR Program</link:label>
    <link:label id="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9_documentation_en-US" xlink:label="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Final Shares Received from ASR Program</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_FinalSharesReceivedfromASRProgram" xlink:label="loc_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:to="lab_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="lab_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:type="arc" />
    <link:label id="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D_label_en-US" xlink:label="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D_documentation_en-US" xlink:label="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:to="lab_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:type="arc" />
    <link:label id="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8_terseLabel_en-US" xlink:label="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8_label_en-US" xlink:label="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Type [Domain]</link:label>
    <link:label id="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8_documentation_en-US" xlink:label="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Litigation Type [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:to="lab_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:type="arc" />
    <link:label id="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4_terseLabel_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4_label_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4_documentation_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:to="lab_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="arc" />
    <link:label id="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17_label_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:to="lab_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:type="arc" />
    <link:label id="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528_label_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Plaintiff Type [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:to="lab_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:type="arc" />
    <link:label id="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9_terseLabel_en-US" xlink:label="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9_label_en-US" xlink:label="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9_documentation_en-US" xlink:label="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:to="lab_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1_label_en-US" xlink:label="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1_documentation_en-US" xlink:label="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:to="lab_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:type="arc" />
    <link:label id="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237_terseLabel_en-US" xlink:label="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Domain]</link:label>
    <link:label id="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237_label_en-US" xlink:label="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Domain]</link:label>
    <link:label id="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237_documentation_en-US" xlink:label="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Tax Matters Agreement [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:to="lab_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:type="arc" />
    <link:label id="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:to="lab_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:type="arc" />
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Settlement Framework [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:to="lab_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:to="lab_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:to="lab_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:type="arc" />
    <link:label id="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0_terseLabel_en-US" xlink:label="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0_label_en-US" xlink:label="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0_documentation_en-US" xlink:label="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:to="lab_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:type="arc" />
    <link:label id="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901_terseLabel_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901_label_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901_documentation_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:to="lab_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90_label_en-US" xlink:label="lab_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:to="lab_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD_terseLabel_en-US" xlink:label="lab_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD_label_en-US" xlink:label="lab_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:to="lab_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76_label_en-US" xlink:label="lab_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:to="lab_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_988010067837E20F537E46B1149AD586_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_988010067837E20F537E46B1149AD586_label_en-US" xlink:label="lab_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:to="lab_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E_label_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:to="lab_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="arc" />
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D_terseLabel_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D_label_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D_documentation_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:to="lab_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="arc" />
    <link:label id="lab_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154_label_en-US" xlink:label="lab_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:to="lab_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:type="arc" />
    <link:label id="lab_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:to="lab_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:type="arc" />
    <link:label id="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F_terseLabel_en-US" xlink:label="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F_label_en-US" xlink:label="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:label id="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F_documentation_en-US" xlink:label="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:to="lab_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809_label_en-US" xlink:label="lab_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:to="lab_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="lab_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868_label_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868_documentation_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:to="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cuyahoga and Summit County [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2_label_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2_documentation_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:to="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="lab_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0_label_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:to="lab_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:type="arc" />
    <link:label id="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF_terseLabel_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum quarterly payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF_label_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF_documentation_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:to="lab_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:type="arc" />
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB_terseLabel_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB_label_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB_documentation_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:to="lab_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:type="arc" />
    <link:label id="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9_terseLabel_en-US" xlink:label="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Net of Insurance Recoveries</link:label>
    <link:label id="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9_label_en-US" xlink:label="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Net of Insurance Recoveries</link:label>
    <link:label id="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9_documentation_en-US" xlink:label="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Net of Insurance Recoveries</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LossContingencyAccrualNetofInsuranceRecoveries" xlink:label="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:to="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:type="arc" />
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD_terseLabel_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lawsuits Against Distributors</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD_label_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD_documentation_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:to="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:type="arc" />
    <link:label id="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72_terseLabel_en-US" xlink:label="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">InvestigationbyMultitateTaskForce</link:label>
    <link:label id="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72_label_en-US" xlink:label="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">InvestigationbyMultitateTaskForce</link:label>
    <link:label id="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72_documentation_en-US" xlink:label="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investigation by Multitate Task Force</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_InvestigationbyMultitateTaskForce" xlink:label="loc_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:to="lab_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C_verboseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">litigation settlement liability recorded</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C_label_en-US" xlink:label="lab_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:to="lab_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:type="arc" />
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723_terseLabel_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723_label_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723_documentation_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:to="lab_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:type="arc" />
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55_terseLabel_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55_label_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55_documentation_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:to="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D" xlink:to="lab_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53_label_en-US" xlink:label="lab_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="lab_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:to="lab_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:to="lab_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:to="lab_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:to="lab_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:to="lab_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:to="lab_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:type="arc" />
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:to="lab_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:to="lab_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:to="lab_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:to="lab_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98_label_en-US" xlink:label="lab_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:to="lab_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:to="lab_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:to="lab_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C_label_en-US" xlink:label="lab_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:to="lab_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:to="lab_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:to="lab_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="lab_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, without par value:</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;500 thousand shares, Issued&#8212;none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:to="lab_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, without par value:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;755 million shares, Issued&#8212;327 million shares at September 30, 2019 and June 30, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:to="lab_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury, at cost: 34 million shares and 28 million shares at September 30, 2019 and June 30, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:to="lab_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cardinal Health, Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:to="lab_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:to="lab_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:type="arc" />
    <link:label id="lab_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02_label_en-US" xlink:label="lab_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="lab_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD_terseLabel_en-US" xlink:label="lab_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD_label_en-US" xlink:label="lab_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:to="lab_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:type="arc" />
    <link:label id="lab_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:to="lab_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:to="lab_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:type="arc" />
    <link:label id="lab_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10_label_en-US" xlink:label="lab_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:to="lab_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32_label_en-US" xlink:label="lab_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:to="lab_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4_label_en-US" xlink:label="lab_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:to="lab_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:to="lab_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:to="lab_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:to="lab_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:to="lab_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B_label_en-US" xlink:label="lab_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:to="lab_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:to="lab_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:to="lab_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:to="lab_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:to="lab_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:to="lab_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:to="lab_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B_label_en-US" xlink:label="lab_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:to="lab_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:to="lab_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:to="lab_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:type="arc" />
    <link:label id="lab_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:to="lab_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B_label_en-US" xlink:label="lab_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:to="lab_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:to="lab_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:to="lab_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A_label_en-US" xlink:label="lab_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:to="lab_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7_label_en-US" xlink:label="lab_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:to="lab_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1_label_en-US" xlink:label="lab_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:to="lab_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32_label_en-US" xlink:label="lab_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:to="lab_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A" xlink:to="lab_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:to="lab_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:to="lab_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:to="lab_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:to="lab_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:to="lab_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08_label_en-US" xlink:label="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Member</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08_documentation_en-US" xlink:label="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:to="lab_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:type="arc" />
    <link:label id="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63_terseLabel_en-US" xlink:label="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63_label_en-US" xlink:label="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Member</link:label>
    <link:label id="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63_documentation_en-US" xlink:label="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:to="lab_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating earnings</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:to="lab_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Share-based Compensation Expense by Type of Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Transactions Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:type="arc" />
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810_terseLabel_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Additional Data Related to Stock Option Activity</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810_label_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810_documentation_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A disclosure of additional data related to all stock option activity</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:to="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Restricted Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Performance Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="lab_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:to="lab_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:to="lab_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B" xlink:to="lab_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B" xlink:type="arc" />
    <link:label id="lab_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5_terseLabel_en-US" xlink:label="lab_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment [Table]</link:label>
    <link:label id="lab_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5_label_en-US" xlink:label="lab_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentTable" xlink:label="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:to="lab_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:type="arc" />
    <link:label id="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2_terseLabel_en-US" xlink:label="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2_label_en-US" xlink:label="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2_documentation_en-US" xlink:label="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:to="lab_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:type="arc" />
    <link:label id="lab_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C_terseLabel_en-US" xlink:label="lab_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment [Line Items]</link:label>
    <link:label id="lab_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C_label_en-US" xlink:label="lab_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentLineItems" xlink:label="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="lab_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:type="arc" />
    <link:label id="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602_terseLabel_en-US" xlink:label="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:label id="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602_label_en-US" xlink:label="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:label id="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602_documentation_en-US" xlink:label="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PartnershipIndirectOwnership" xlink:label="loc_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:to="lab_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:type="arc" />
    <link:label id="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B_terseLabel_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B_label_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B_documentation_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:to="lab_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:to="lab_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:type="arc" />
    <link:label id="lab_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E_label_en-US" xlink:label="lab_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E_documentation_en-US" xlink:label="lab_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract" xlink:label="loc_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:to="lab_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:type="arc" />
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61_terseLabel_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61_label_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61_documentation_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:to="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee- Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:to="lab_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:type="arc" />
    <link:label id="lab_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:to="lab_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="lab_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:to="lab_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:to="lab_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:to="lab_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6" xlink:to="lab_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:to="lab_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net earnings/(loss) to net cash provided by/(used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairments and (gain)/loss on sale of investments</link:label>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149_label_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:to="lab_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairments and (gain)/loss on disposal of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:to="lab_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for bad debts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Increase)/decrease in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(Increase)/decrease in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities and operating items, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:type="arc" />
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C_negatedLabel_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C_label_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C_documentation_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow from purchases of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:to="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:type="arc" />
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6_label_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6_documentation_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash inflow from sales of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:to="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction of long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:type="arc" />
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A_terseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net tax proceeds/(withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A_label_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A_documentation_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividends on common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase/(decrease) in cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:type="arc" />
    <link:label id="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD_terseLabel_en-US" xlink:label="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD_label_en-US" xlink:label="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares excluded from calculation of diluted shares</link:label>
    <link:label id="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD_documentation_en-US" xlink:label="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of shares excluded from calculation of diluted shares</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_Numberofsharesexcludedfromcalculationofdilutedshares" xlink:label="loc_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:to="lab_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:type="arc" />
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD_terseLabel_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD_label_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD_documentation_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:to="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:type="arc" />
    <link:label id="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56_terseLabel_en-US" xlink:label="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Segment [Axis]</link:label>
    <link:label id="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56_label_en-US" xlink:label="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Segment [Axis]</link:label>
    <link:label id="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56_documentation_en-US" xlink:label="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Segment [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentAxis" xlink:label="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:to="lab_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:type="arc" />
    <link:label id="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10_terseLabel_en-US" xlink:label="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Segment [Domain]</link:label>
    <link:label id="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10_label_en-US" xlink:label="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Segment [Domain]</link:label>
    <link:label id="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10_documentation_en-US" xlink:label="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Medical Segment [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentDomain" xlink:label="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:to="lab_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:type="arc" />
    <link:label id="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201_terseLabel_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201_label_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201_documentation_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:to="lab_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="arc" />
    <link:label id="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB_terseLabel_en-US" xlink:label="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB_label_en-US" xlink:label="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB_documentation_en-US" xlink:label="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:to="lab_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical Segment [Axis]</link:label>
    <link:label id="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5_label_en-US" xlink:label="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Segment [Axis]</link:label>
    <link:label id="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5_documentation_en-US" xlink:label="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical Segment [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentAxis" xlink:label="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:to="lab_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical Segment [Domain]</link:label>
    <link:label id="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340_label_en-US" xlink:label="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Segment [Domain]</link:label>
    <link:label id="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340_documentation_en-US" xlink:label="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Pharmaceutical Segment [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentDomain" xlink:label="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:to="lab_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC_label_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC_documentation_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:to="lab_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="arc" />
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729_terseLabel_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729_label_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729_documentation_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:to="lab_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:to="lab_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="lab_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1_label_en-US" xlink:label="lab_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:to="lab_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Consolidated Statement of Shareholders' Equity</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:to="lab_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:to="lab_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:to="lab_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:type="arc" />
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:to="lab_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:to="lab_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:to="lab_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Earnings/(Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:to="lab_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:to="lab_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Employee stock plans activity, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D_label_en-US" xlink:label="lab_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:to="lab_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:to="lab_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A" xlink:to="lab_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694" xlink:to="lab_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E" xlink:to="lab_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:to="lab_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:type="arc" />
    <link:label id="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30_totalLabel_en-US" xlink:label="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Finance Lease Cost</link:label>
    <link:label id="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30_label_en-US" xlink:label="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Finance Lease Cost</link:label>
    <link:label id="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30_documentation_en-US" xlink:label="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Finance Lease Cost</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalFinanceLeaseCost" xlink:label="loc_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:to="lab_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:to="lab_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C_label_en-US" xlink:label="lab_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:to="lab_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484_label_en-US" xlink:label="lab_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:to="lab_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:to="lab_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:type="arc" />
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E_terseLabel_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E_label_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E_documentation_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:to="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:to="lab_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Shares, issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF" xlink:to="lab_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Shares in Treasury</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1" xlink:to="lab_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:type="arc" />
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711_terseLabel_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711_label_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LeasesSupplementalBalanceSheetInformation [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711_documentation_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:to="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:type="arc" />
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622_terseLabel_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Payments</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622_label_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Payments [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622_documentation_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for Lease Payments [Table]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LeasePaymentsTableTextBlock" xlink:label="loc_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:to="lab_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Lease Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="lab_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A_label_en-US" xlink:label="lab_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:to="lab_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:to="lab_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution, selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:to="lab_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:type="arc" />
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6_terseLabel_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6_label_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6_documentation_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:to="lab_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Litigation (recoveries)/charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating earnings/(loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF" xlink:to="lab_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5_label_en-US" xlink:label="lab_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:to="lab_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings/(loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1" xlink:to="lab_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss) attributable to Cardinal Health, Inc.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61" xlink:to="lab_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings/(loss) per common share attributable to Cardinal Health, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:to="lab_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:to="lab_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends declared per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:to="lab_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:type="arc" />
    <link:label id="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF_terseLabel_en-US" xlink:label="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF_label_en-US" xlink:label="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF_documentation_en-US" xlink:label="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Amount of Notes Payable Repurchased during the year</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:to="lab_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="lab_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:to="lab_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="lab_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:to="lab_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:type="arc" />
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F_terseLabel_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F_label_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F_documentation_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other short-term credit facilities and an unsecured line of credit</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:to="lab_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:type="arc" />
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1_terseLabel_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1_label_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1_documentation_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:to="lab_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:to="lab_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:to="lab_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:to="lab_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:to="lab_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:type="arc" />
    <link:label id="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9_terseLabel_en-US" xlink:label="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Definite and Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9_label_en-US" xlink:label="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Definite and Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9_documentation_en-US" xlink:label="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Definite and Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:to="lab_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:to="lab_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:to="lab_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:type="arc" />
    <link:label id="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A_terseLabel_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A_label_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A_documentation_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:to="lab_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:type="arc" />
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5_terseLabel_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable period of plans (in years)</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5_label_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable period of plans, in years</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5_documentation_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The instrument's contractual term.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:to="lab_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Target performance goal (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Holdings, Schedule of Investments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:type="arc" />
    <link:label id="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6_terseLabel_en-US" xlink:label="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6_label_en-US" xlink:label="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:label id="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6_documentation_en-US" xlink:label="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LeasesTextBlock" xlink:label="loc_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:to="lab_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF_terseLabel_en-US" xlink:label="lab_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:to="lab_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating and Reportable Segment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:to="lab_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:to="lab_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:to="lab_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E_label_en-US" xlink:label="lab_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:to="lab_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4" xlink:to="lab_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments, Contingent Liabilities and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:type="arc" />
    <link:label id="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283_terseLabel_en-US" xlink:label="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Revenue by Geographic [Table]</link:label>
    <link:label id="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283_label_en-US" xlink:label="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Revenue by Geographic [Table]</link:label>
    <link:label id="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283_documentation_en-US" xlink:label="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Revenue by Geographic [Table]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_SegmentRevenuebyGeographicTable" xlink:label="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:to="lab_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:to="lab_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:type="arc" />
    <link:label id="lab_country_US_AD2BE283CC9F4C229A72FF759AE5433B_terseLabel_en-US" xlink:label="lab_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_AD2BE283CC9F4C229A72FF759AE5433B_label_en-US" xlink:label="lab_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:to="lab_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC_label_en-US" xlink:label="lab_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:to="lab_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:type="arc" />
    <link:label id="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB_terseLabel_en-US" xlink:label="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Revenue by Geographic [Line Items]</link:label>
    <link:label id="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB_label_en-US" xlink:label="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Revenue by Geographic [Line Items]</link:label>
    <link:label id="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB_documentation_en-US" xlink:label="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Line Items] for Segment Revenue by Geographic [Table]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_SegmentRevenuebyGeographicLineItems" xlink:label="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:to="lab_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:type="arc" />
    <link:label id="lab_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35_label_en-US" xlink:label="lab_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Minimum Lease Payments [Abstract]</link:label>
    <link:label id="lab_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35_documentation_en-US" xlink:label="lab_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of Minimum Lease Payments [Abstract]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_SummaryofMinimumLeasePaymentsAbstract" xlink:label="loc_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:to="lab_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033_label_en-US" xlink:label="lab_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Arrangement, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:to="lab_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA_label_en-US" xlink:label="lab_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Arrangement, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:to="lab_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:type="arc" />
    <link:label id="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD_label_en-US" xlink:label="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD_documentation_en-US" xlink:label="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:to="lab_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:type="arc" />
    <link:label id="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F_label_en-US" xlink:label="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F_documentation_en-US" xlink:label="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:to="lab_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total undiscounted Lease Liability Payments Due for both operating and financing leases</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:to="lab_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:type="arc" />
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C_terseLabel_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C_label_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C_documentation_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:to="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:type="arc" />
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58_terseLabel_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58_label_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58_documentation_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:to="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:to="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:type="arc" />
    <link:label id="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E_label_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E_documentation_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:to="lab_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:type="arc" />
    <link:label id="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F_label_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F_documentation_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:to="lab_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:to="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:to="lab_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:to="lab_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315_label_en-US" xlink:label="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:to="lab_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee-related costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:to="lab_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:type="arc" />
    <link:label id="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4_terseLabel_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4_label_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4_documentation_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:to="lab_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total restructuring and employee severance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC" xlink:to="lab_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Profit by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A_verboseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:to="lab_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Unit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:to="lab_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Unit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:to="lab_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:to="lab_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain/(Loss) on Derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Loss [Rollforward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(loss), before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income/(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:type="arc" />
    <link:label id="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55_terseLabel_en-US" xlink:label="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Settlement Framework [Member]</link:label>
    <link:label id="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55_label_en-US" xlink:label="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Settlement Framework [Member]</link:label>
    <link:label id="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55_documentation_en-US" xlink:label="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Settlement Framework [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidSettlementFrameworkMember" xlink:label="loc_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:to="lab_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:to="lab_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:to="lab_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:to="lab_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:type="arc" />
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C_terseLabel_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C_label_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C_documentation_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:to="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:to="lab_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:to="lab_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:type="arc" />
    <link:label id="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3_terseLabel_en-US" xlink:label="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Enterprise Wide Cost Saving Measures [Member]</link:label>
    <link:label id="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3_label_en-US" xlink:label="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Enterprise Wide Cost Saving Measures [Member]</link:label>
    <link:label id="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3_documentation_en-US" xlink:label="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Enterprise Wide Cost Saving Measures</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_EnterpriseWideCostSavingMeasuresMember" xlink:label="loc_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:to="lab_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:to="lab_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:to="lab_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized gain/(loss) on derivative instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: comprehensive income attributable to noncontrolling interests</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:type="arc" />
    <link:label id="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598_terseLabel_en-US" xlink:label="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598_label_en-US" xlink:label="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598_documentation_en-US" xlink:label="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:to="lab_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:type="arc" />
    <link:label id="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7_terseLabel_en-US" xlink:label="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7_label_en-US" xlink:label="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7_documentation_en-US" xlink:label="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Tax Matter [Axis]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:to="lab_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:type="arc" />
    <link:label id="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD_terseLabel_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD_label_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD_documentation_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:to="lab_cah_PatientRecoveryBusinessMember_51DEEBBC58FA371091EE4775441421DD" xlink:type="arc" />
    <link:label id="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC_terseLabel_en-US" xlink:label="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC_label_en-US" xlink:label="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC_documentation_en-US" xlink:label="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:to="lab_cah_CareFusionMember_1C07E8FA14FD49522C5D4774CA5688BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:type="arc" />
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated range of decrease in unrecognized tax benefits within the next 12 months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90_terseLabel_en-US" xlink:label="lab_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:label id="lab_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90_label_en-US" xlink:label="lab_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:to="lab_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:type="arc" />
    <link:label id="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548_terseLabel_en-US" xlink:label="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnification receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548_label_en-US" xlink:label="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548_documentation_en-US" xlink:label="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:to="lab_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:to="lab_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:type="arc" />
    <link:label id="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB_terseLabel_en-US" xlink:label="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASC 842</link:label>
    <link:label id="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB_label_en-US" xlink:label="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ASC 842 [Member]</link:label>
    <link:label id="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB_documentation_en-US" xlink:label="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ASC 842</link:label>
    <link:loc xlink:href="cah-20190930.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:to="lab_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amended lease standard adoption impact as of July 1, 2019</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" xlink:label="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:to="lab_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows paid for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:to="lab_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows paid for finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Operating Leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New financing leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share Attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of outstanding options at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of exercisable options at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cah-20190930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20190930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20190930.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:href="cah-20190930.xsd#CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cah-20190930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20190930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:href="cah-20190930.xsd#CondensedConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:href="cah-20190930.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20190930.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20190930.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="cah-20190930.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20190930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20190930.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20190930.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20190930.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20190930.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20190930.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20190930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20190930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20190930.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsNarrativeDetails" xlink:href="cah-20190930.xsd#InvestmentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20190930.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesNarativeDetails" xlink:href="cah-20190930.xsd#LeasesNarativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:href="cah-20190930.xsd#LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20190930.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20190930.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20190930.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:href="cah-20190930.xsd#LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20190930.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20190930.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:href="cah-20190930.xsd#SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20190930.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:href="cah-20190930.xsd#SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20190930.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20190930.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20190930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20190930.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20190930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20190930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20190930.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20190930.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20190930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_A6E681A6DA18C4737A217418D80B62DD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_A6E681A6DA18C4737A217418D80B62DD" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_956E588D33EE754253727418D80BDEB8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20190930.xsd#cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract" xlink:label="loc_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:type="locator" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract_0050853E8F317EFD9CC928EBF6346C7E" xlink:to="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_2DFBD8CB8C96E253C6BE28F128FA1E61" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_321792697B19234532FC7418D9721695" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B1239E528CC8CF2A5E457418D972499E" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6FD2A38100B463EEAA3C7418D97211BC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_EF678C628AAEE3FC9FFB7418D8F5200A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_EF678C628AAEE3FC9FFB7418D8F5200A" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2779D157D40F8C1DCCF17418D8F56913" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9484EB83834236046AED46B1148E4440" xlink:to="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LitigationTypeDomain" xlink:label="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeAxis_88C4D96279C7E2C3210A46B11494D81D" xlink:to="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LitigationTypeDomain_A5B0128AD78F55D8753F46B11494E8C8" xlink:to="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeAxis_FC9C28C5BE8BA504A41646B11495EC17" xlink:to="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeDomain_E83F688CBC5B5A36E2CF46B114957528" xlink:to="loc_cah_PrivatePartiesMember_C52D0EEBD0A24EE84ADB46B114966BA9" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_B025C8E2E1419BBA8B1546B1149771D1" xlink:to="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:to="loc_cah_TotalOpioidLitigationMember_AD2873355D1E1A54110346B114976481" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_D03DDC102DE09A1E715A46B11497D237" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_930D1A5C8E9CDD44443B46B11497799D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5DD2AE7A4397B7D45BAD46B114989133" xlink:to="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:to="loc_cah_AlamedaCountyMember_FE664D706D1EB34A943146B11499E8F0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_453D2EFD4681C003B69646B114981932" xlink:to="loc_cah_OtherJurisdictionsMember_4835A21B8D0AC51045DD46B114996901" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2DDDFB4E60C757B56CCD46B11499CA90" xlink:to="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:to="loc_srt_MinimumMember_0DD788826802F04932EB46B1149A9E76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_B6785CC906EE416F7F9C46B1149995DD" xlink:to="loc_srt_MaximumMember_988010067837E20F537E46B1149AD586" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_37BA1E7229168F8861A846B1149A9138" xlink:to="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:to="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_E1240B541FE57EBFD5D946B1149BB1C5" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_0B98D356FC4FAC8D4BF546B114A14154" xlink:to="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_21E4ACE6FC29E9775C2546B114A132B0" xlink:to="loc_cah_CVSHealthMember_2FC31F7ADAAC73D729F546B114A13C9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_F9210500CE51CA11F12446B114A2D809" xlink:to="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_6F131F2AF685C10D19D046B114A3C868" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_6F7F408E9FB53EE8B35D46B114A339D2" xlink:type="arc" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_OpioidLawsuitsMember_4843B6D10531AA4D9E8E46B1149BB83E" xlink:type="arc" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_ClassActionLawsuitsMember_65ECFCCE46226A39027F46B1149565E4" xlink:type="arc" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_1D6C2E805E66AB621AC246B114A3D0DE" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_3131CA6EC645F9CD538E46B1149CA45D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_21470A4E13B5254E24FE46B114A4C253" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_7A3C806E45A77731586246B114A55732" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_835FC4B8F442C634E0C446B114A5B544" xlink:to="loc_us-gaap_SubsequentEventMember_7A3C806E45A77731586246B114A55732" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_A42CDD23A40EAC05B7A746B1148E2E9D" xlink:to="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_043548FE5551B2F0EA8C46B114A5D9F0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_MaximumQuarterlyPayment_2209AD7D7AD356E202AA46B114A69CEF" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_LossContingencyLawsuitsNumber_40BAC269F3595CAAFC7946B1191B9DEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_95602F9309A8B2DABFC246B114A6DB65" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LossContingencyAccrualNetofInsuranceRecoveries" xlink:label="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_87533B91ED24336AAF4246B114A68EF9" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_BFA8B83904D534ABBFFD46BCE523C1AD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_InvestigationbyMultitateTaskForce" xlink:label="loc_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_InvestigationbyMultitateTaskForce_022B41A76B132694DDE946B114A7CC72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_us-gaap_LitigationReserve_5DBE98FD6FC070AEDAE846B114A72D5C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_CashComponentForSettlementFrameworkTerm_1AC8A06AD3D52283F41846E024E79723" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5D6C623D267493DB396146B114A5F53F" xlink:to="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_6AF5802FCB10AB5B784046B6BC392D55" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:to="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:to="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6CA44C5E7C3F085E61FC3CEE0AEE54C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:to="loc_us-gaap_ReceivablesNetCurrent_9A28CBCEEDAD74E36FA83CEE0AEFFEC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:to="loc_us-gaap_InventoryNet_CF248E226A2A1A6288653CEE0AEF6A98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:to="loc_us-gaap_OtherAssetsCurrent_FB7230738098E82880193CEE0AEF6BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_AF358123D8779EDE7D4C3CEE0AEE0DFF" xlink:to="loc_us-gaap_AssetsCurrent_1FF6AEF253670237136F3CEE0AEF065D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_282AB718BED2FED994B13CEE0AEF652F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_DD0AA2A909E44B65837F3CEE0AF0AA1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_14BDF6BC694E1B9729C63CEE0AF14BBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04B950B0D92E3BAEB9B13CEE0AEDAF50" xlink:to="loc_us-gaap_Assets_10BD6D2B73E77391C4D23CEE0AF1BE2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:to="loc_us-gaap_AccountsPayableCurrent_BBDB821B3DCEF1BFCD9E3CEE0AF11932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8B9C4AB077CB220F23513CEE0AEDAC95" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_A8AD3AF7D33D92A9EA523CEE0AF230E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_81CD293F7A386AA1DE963CEE0AF2A5EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4961D9560778BB0A47743CEE0AF1EAD6" xlink:to="loc_us-gaap_LiabilitiesCurrent_0CCD0250F7B96F8494FF3CEE0AF36C62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_DE69A04178CF7CDF45C83CEE0AF372FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_CE53FBEE38924EDF77A73CEE0AF423BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:to="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_2CDFD74EBE49CE95957E3CEE0AF4C313" xlink:to="loc_us-gaap_PreferredStockValue_BBA91733AE052A29F44C3CEE0AF4C10B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_667A61114D197A2AE1063CEE0AF5BFEE" xlink:to="loc_us-gaap_CommonStockValue_3F3517C236E0D80DB6043CEE0AF61147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_281F727EE5627E93A22D3CEE0AF6F42B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_TreasuryStockValue_D9B115173AD4AA25BFB83CEE0AF6D7C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_A9A4CDC018BA50E91CE53CEE0AF69800" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_StockholdersEquity_07DA9265C369FB63CDD53CEE0AF7B776" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_MinorityInterest_090B6E573D5FA95952BE3CEE0AF7D345" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_F7250B67E80CE69DBC3B3CEE0AF40862" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_B9B9D1BF9D357F1C4EE43CEE0AF7E97B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_CF25810A6F04022AE8413CEE0AF17E93" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9528F4A28E264D3209463CEE0AF85081" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_58D7200EB01F5C38BBBB7418D89872B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_DD2538C841440615E0647418D8982FD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:to="loc_us-gaap_PreferredStockSharesIssued_972716CA041235C317727418D8986450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_605B3FAF2C4A398933067418D89846E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:to="loc_us-gaap_CommonStockSharesIssued_62F2914802E06C2A96827418D8983DFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_C2A93ACF18B12D998F277418D898BF3B" xlink:to="loc_us-gaap_TreasuryStockShares_F36C0E29EF40A548E5487418D898F5A1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfCondensedFinancialStatementsTable" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_613E8CD61ECCEFD870AD46B818E020C9" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0CA8F7854D8B785435A546B818E08BEB" xlink:to="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_CommonStockMember_DF150674D6F401FEFAE146B818E0F679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_RetainedEarningsMember_6574564F05F7EDE6E9F546B818E0A036" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_5B618790E1086E18049346B818E0ABE8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_TreasuryStockMember_5B618790E1086E18049346B818E0ABE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_D2BE4F989293EB1E8EFD46B818E0EEE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_89EBA27BDD01924F549046B818E0C1C9" xlink:to="loc_us-gaap_NoncontrollingInterestMember_BFD7EDC7477303EC8E4B46B818E0EFFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CondensedFinancialStatementsCaptionsLineItems" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_66B20EC7E6A447CCAECB46B818E05AFD" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_CommonStockSharesIssued_B72E89DCB63ACC108F6546B818E058F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46FDFF047F7DB279F1CC46B818E06F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockShares_69F78D6AD077B314C79846B818E0685F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockValue_DFED3E7C4B91CD5F0F9346B818E0F635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_NetIncomeLoss_81DAAD37A978892908C346B818E0502C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_ProfitLoss_81D21CD7A3B7C6BEC65F4709067D0B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_A717217A7396696B84A746B818E0845F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_AC852CDD01CF5F4D4C2046B818E0EC6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_85011F9896A733FC8A5B46B818E0B45B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_B2B82BCE630C235E9BC646B818E086EB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_B2B82BCE630C235E9BC646B818E086EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_Dividends_B592434900DC652C2C5846F38698B43D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockholdersEquityOther_AE70922BBAE9E53B015046B818E040A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_CommonStockSharesIssued_61D25A025655162B801646B818E0BB2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8A22C75938B9CADC66E846B818E0F5A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockShares_5C8912320E8655351C4646B818E0B694" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_FE2C6AD0E8ECD5C05B3F46B818E0E64D" xlink:to="loc_us-gaap_TreasuryStockValue_51D689E60152B930D9CE46B818E01E8E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:to="loc_us-gaap_ProfitLoss_14BB8F5615A797473C1038050D27CA3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_36ABF6B8A6A117E69F9E38050D2845FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_92FAE35C5B63502CDF4238050D2D4149" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9F1427946EF1DB08889638050D2E0DEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="loc_us-gaap_ShareBasedCompensation_831418FDE87C9751326738050D2E3B7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5C905FED236CE15566F038050D2E5340" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_746B47A15211501082FC38050D28F075" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_9C571512D0553173A28E38050D2F876F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_F28598346170247E8C3938050D2F99D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_F845B75082D93CB1B99A38050D2F7A42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FBF2ABE4EA21FBCC60C738050D2F4CF4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_DE94931A3673B4C9B2EC38050D2F9374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_C4D082D2B05FF71E5DD938050D27C29E" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_C6778B7467825EFB92D138050D2F045A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_096D2FF7A935190CEDD738050D308EBB" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_96D9004681A4620BE8ED38050D312A7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_7D11E22573C2ACFC582938050D3108D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1BBBDFA9034109D9722638050D310A1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5D7F032AF9D42FC5E3A438050D30C79B" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_AEFCB1BDE37F09319F7E38050D31E026" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_576789982E0105B31EF638050D316DAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1D916091510E62FEE87138050D32DBA6" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_93659F14CC4DE6734C1238050D32629A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6AAC56D2AD91830EF54A38050D33EA17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1A96BE8102389B2B98D838050D3307B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8220C43FF2584FC0AF6538050D315843" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_87C3DF436BBF6A9EF12938050D3347EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_4C04A4BFD7BC90CF029838050D332B30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_637CE3591DDCA6E872FA38050D330C76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_300689E4782866B61A4438050D34F0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_17F9A0C0E1F4978BA70538050D260F25" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3D5F9B8816754CDFA97C38050D34B55A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_D782609D575F4C30C39E37FD92ED3DDE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:to="loc_us-gaap_ProfitLoss_D782609D575F4C30C39E37FD92ED3DDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_C45A066C29D754D4194C37FD92F13004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_C0FCA7CAD58A4C154E1D37FD92F1E065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5124FBE9A9A600485EA137FD92F19E73" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2BBE725B7D0EEC3E2CF637FD92ED8D89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5124FBE9A9A600485EA137FD92F19E73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_AE062449D5D22FCE48D637FD92F2CC89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_FD93F4742755F029227537FD92F205F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C248A47825DD8F8F9A337FD92DFA295" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_626C15D7EF389604CF3137FD92F22589" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F70D893FDEB04862D1C446B8191E7667" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_Revenues_F70D893FDEB04862D1C446B8191E7667" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6B5B256656381404F45746B8191EC4AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_GrossProfit_5DE20C51250DA4821C1246B8191EEA6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4CF6C647815288C0477F46B8191E0ACF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:to="loc_us-gaap_RestructuringCharges_63ACF54650B00E94EFE846B8191E912A" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_D815E6F6FB48AB7311C446B8191E4DB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0B34F67FE7C326A9C3B246B8191E3449" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0B34F67FE7C326A9C3B246B8191E3449" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_C94C1149F1B39943E23F46B8191E7792" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_28201E625ABAC22F07FA46B8191E7A38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_OperatingIncomeLoss_0F347C326DAE3D5838C246B8191E73AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2A3CC86FCAD8229C89BB46B8191EADD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_InterestExpense_CDDD2B5B3D516407837946B8191EFCF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_54B1FCF77C27D0279AD646B8191E0E93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5E3EB218DEBAFE73720046B8191E3A25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_ProfitLoss_453230924BA46D49E71746B8191ED4F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_C12606D7F320E289C04F46B8191EC0B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_NetIncomeLoss_586B71AFB10B85C3AC7446B8191E1C61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:to="loc_us-gaap_EarningsPerShareBasic_09D3ACB3B57F26D52B0646B8191EBD13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_30F41029660A1337674546B8191E9B73" xlink:to="loc_us-gaap_EarningsPerShareDiluted_16A8E6635B188CC07BDB46B8191E3636" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_F7C67D4A3B051B4F866346B8191E980D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_ED378DD58D66FD8BB7D646B8191E4EE2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F026D0AA5DA9F383FB5746B8191E1F4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_677CB3A2A4E4BEA9267A46B8191E0DB9" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_DAD82B02E4D89B5EEBD446B8191E390C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_DocumentType_6D8FAACB9FA8F98D516A46BDEC6BFAFD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_DocumentQuarterlyReport_A2044E4BC046C261CA2546BDEC6B5967" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_DocumentPeriodEndDate_2BEF3CC67DD6FD67E02346BDEC6CB7FD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_DocumentTransitionReport_93FB2CEE0BA8DB0A3BF446BDEC6C5B10" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityFileNumber_0A83464FE97393269EEA46BDEC6C9D32" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityRegistrantName_1D731C6D173CF988419146BDEC6C22E4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityCentralIndexKey_D167163F6E3F199C2A2146BDEC6CE505" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_CurrentFiscalYearEndDate_8634A4E88ED53006063B46BDEC6D677A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_DocumentFiscalYearFocus_062886C0B09B72CFB44D46BDEC6DF2C1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_DocumentFiscalPeriodFocus_76BA51F3D916515325CA46BDEC6DC87E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_AmendmentFlag_238BE12EA192425CC62B46BDEC6D048B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityIncorporationStateCountryCode_16B6ACB335177C92298A46BDEC6DC427" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityTaxIdentificationNumber_C91111BCB1BFE6B947CF46BDEC6D27F9" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityAddressAddressLine1_185766494D92FB66B9DD46BDEC6E31BF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityAddressCityOrTown_2B0E05E051CCA2FF2AC746BDEC6EE9FC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityAddressStateOrProvince_01D7AF3BBEA19788346046BDEC6E7ECD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityAddressPostalZipCode_1CADC1CDE6EED7D3486F46BDEC6E0268" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_CityAreaCode_8F26969E9F11F779F0B446BDEC6EF65B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_LocalPhoneNumber_E37F6DC190C6187FAE5746BDEC6ECE42" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityCurrentReportingStatus_125A54E31FD1B3E685DA46BDEC6ED073" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityInteractiveDataCurrent_B37383BAECE781D0DBBC46BDEC6F75CB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityFilerCategory_3B722B18F4C1BCB9231F46BDEC6FFC4B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntitySmallBusiness_6AC78C4FEA4B743FF08F46BDEC6FB6B0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityEmergingGrowthCompany_79490D2ED7FC515D13E546BDEC6FB63D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityShellCompany_6552706A29790AA19BD746BDEC6F515A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_Security12bTitle_B2FF8568B5BD88753E2E46BDEC7085D7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_TradingSymbol_98CEE6D34EA250A51FEA46BDEC70DAD1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_SecurityExchangeName_56219416ABCC25518C2F46BDEC70AE32" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7D8C26580086B6FF99D146BDEC682A02" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_46BDC384B36737A3988946BDEC75C3AB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_A7B1C528358A8F840ECC7418D9246DC4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_A7B1C528358A8F840ECC7418D9246DC4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_EBD0B021626C8CCEA9877418D92475E1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_72033BFDD9981DCE75F21DD5F24E9133" xlink:type="locator" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Numberofsharesexcludedfromcalculationofdilutedshares" xlink:label="loc_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_72033BFDD9981DCE75F21DD5F24E9133" xlink:to="loc_cah_Numberofsharesexcludedfromcalculationofdilutedshares_D2FCCBC0212DF5FC32911DD5F556D1CD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_72033BFDD9981DCE75F21DD5F24E9133" xlink:to="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_076A6A55A7F963538A041DD5F24F01FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_72033BFDD9981DCE75F21DD5F24E9133" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7841D2C68A171FE435301DD5F2502A4C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CBC30492BAA78859A19438067C1AE5DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_995DC12C9102F6428EF038067C1A97C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_EF9BEDF73B9EF2464B3938067C1A7A7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5729CD1D430C97B426D238067C19F6EF" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2005B2A6CAD7A774E76D38067C1A4DC8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3FFB98459FC2B65452DA7418D8B748CB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3FFB98459FC2B65452DA7418D8B748CB" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_76E91D6E34346E22DF637418D8B78772" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_128E3A962581880AC9247418D7FB42AD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_128E3A962581880AC9247418D7FB42AD" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_74CD886EBF89B8D7994C7418D7FBDFF3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_65DD10FCE34DE879D08128CDBCC48AA2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C709D166C65039ED0B6728CDBCC52427" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_CE63010FCEB8B45A975028CDBCC5A413" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_82ECCC9258E398C00AE628CDBCC6E103" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_984477ADD4BE9821F7FC28CDBCC7D185" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_DBC3118FFC7B782985C328CDBCC8F3DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_306857E9C11105B7F05D28CDBCC82E46" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_306857E9C11105B7F05D28CDBCC82E46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BC65970051E8D886B32A28CDBCC82658" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_36071BD5AAD67182E6CE28CDBCC9F519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6124194049F6342FB9FE28CDBCC58DAD" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_D44F225FA96CE85BE15D28CDBCC9F12E" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_2BD807F9FB44EFB9EA0F28CDBCC90274" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91BEB345EB0CDC98F0F628CDBCC9568E" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_39F6695A6B47F0FEA4FF28CDBCCABA86" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_0583B9A5834A92597CC028CDBCCA52E2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1DED7909281B466855B87418D8E69483" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1DED7909281B466855B87418D8E69483" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_51B6AE147AE9E086EBFE7418D8E6E7F4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5C9CBD9E87BB11C9003F7418D91571AE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5C9CBD9E87BB11C9003F7418D91571AE" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_B58B2D14B210F3A17D957418D9151E6B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70478E96D11CCD3FAC0E1CCEB312DD0E" xlink:to="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17A6006B69A8288604471CCEB312B463" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8E018718FF412F1461DC1CCEB31389F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_E59A6D37288E07CBF3271CCEB31304AD" xlink:to="loc_us-gaap_HedgingDesignationDomain_BF8E7CAB4EA36DB30DA41CCEB3137957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_C7E11A4F813BBFC143421CCEB314C696" xlink:to="loc_us-gaap_HedgingRelationshipDomain_903921C6CADA134B6E6E1CCEB3142185" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4B4BA90AD4C583504F211CCEB314F0A1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:to="loc_us-gaap_CashFlowHedgingMember_09548C258CE662B2BF921CEE181AD930" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6FB650C1D4B5473836321CCEB3140614" xlink:to="loc_us-gaap_CurrencySwapMember_2D4E750F8D6664362AFF1CCEB3159B72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_F25F4962B9AB05E7CEDA1CCEB3129D53" xlink:to="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_A57C40CCE1208A47C8C51CCEB315BDB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_B9BA5E92CB0F1B5C0D311CCEB3158209" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_6833002B72AA1A557F9E1CCEB3164C80" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_931EFD7B8741761328F27418D7FB8943" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_931EFD7B8741761328F27418D7FB8943" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BF51DE4A611D334AD0ED7418D7FBCB12" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DBC514665ED66CAE80D47418D7FB8DA6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D817730D453CC26B7BAB7418D7FB4125" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_C90EF038411715E280307418D7FBA952" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_81BE5AD57728CDF8CC9D7418D80B9540" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_727CF8CB67D1A67F32137418D80BB28E" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_2C95B550B093D006FA057418D80B7063" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_E6C5BA8CBC9B095055CF7418D9155333" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_E6C5BA8CBC9B095055CF7418D9155333" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_B0E2C57CBD322A1653607418D91593A4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_81CF4BE82CF1386B5C937418D83A4210" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_81CF4BE82CF1386B5C937418D83A4210" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5DB8275576521D2DA84C7418D83ADB2D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_66A0F8BAEE0FCF8D3E5AB60B09003600" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86D8EECDA3E560E57577B60B09019A76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_FDFB5C3B5439B4408C23B60B09016949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50DBCBC90AC6F25E10D0B60B0902A153" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2D70B1AB89541ACAA150B60B090223C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C50216A10F6274BC1509B60B09003F88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_FFFFC75BF802FC2A8235B60B09024677" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_285D18B9C00F690C9756130C8582D9B3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_285D18B9C00F690C9756130C8582D9B3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B559CD481E68C100E39130C8587450B" xlink:to="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B21CE1B0F75B35A207C0130C8589DDE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:to="loc_cah_PharmaceuticalMember_B21CE1B0F75B35A207C0130C8589DDE6" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_D239EC104B3A8081BB3A130C85890EE1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_B79060E355AF25932761130C85882ED4" xlink:to="loc_cah_MedicalMember_D239EC104B3A8081BB3A130C85890EE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_AB473042DBC72603D54D130C8587D81E" xlink:to="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:to="loc_us-gaap_GoodwillTransfers_A9AA8A3BD00A41BA0349130C89277DFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_C2A518D291CB694D83FB130C8589554D" xlink:to="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:to="loc_us-gaap_Goodwill_B527EF0995FA1ACC9C9F130C858A899E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_D76BA92FB0C871936B2B130C858AC7F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_B66CE8AE5661E944B1A9130C85891981" xlink:to="loc_us-gaap_Goodwill_44AD763CEAA8A6673E31130C858BE2A4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_51FAAB2FEA3E43F2A229135898BED5BB" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1A35F73A91BCD22BFFB9135898BE1E0D" xlink:to="loc_cah_IPRDTrademarksandOtherMember_D6ED9AE8DB7B7D7AE1AE135898BE980B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_E3F1BC82A69705618755135898BE5B11" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_A28CB5D12F87CC7CD0DA135898BE41E3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_F7646089282B744F70E4135898BE9F47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_867FEB4E4E6777CC981B135898BE981A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="loc_us-gaap_CustomerRelationshipsMember_A9C382E2E3BBD43339EE135898C9E0A8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="loc_cah_TrademarksAndPatentsMember_ED5B6BC244F71ED5FE2A135898C9AA9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_70C6C5183B2DA6D30613135898C9F209" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_97A965E4509FB6BBF332135898C93B0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B35AC5860D6C993637A8135898BE0312" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1757FF08A0E523D93D2A135898C905E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_DE6F8804985BE7366C1C135898C9D91C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6F5F2B0D6ADF7D18E868135898C9FF0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_DE463C835954E8DFFD4A135898C9ADDD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_24C4AB9FBEEE8EEEBC5F135898C90756" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79AD2B86D7D5085DF165135898C9F965" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F7A30D4BD994070F0ABB135898BE4388" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_F4E696E4757643B20E9F135898C9F59C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_378C507190411B288A1E3C1C106E7A11" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_378C507190411B288A1E3C1C106E7A11" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9C537189C4B2FD1BA0D43C1C106E9558" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_378C507190411B288A1E3C1C106E7A11" xlink:to="loc_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock_97414893AD25D48FE3EE3C229260F6B9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31762EADDADE4012D1237418D9921333" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_EF4C9D91B32D42182C9D7418D992CC28" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_88D6144A42B947C3107247707E86A92E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_88D6144A42B947C3107247707E86A92E" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterAxis_2118BFF22686FBDBFB2B4774A7F9F598" xlink:to="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_A8C70807379894AD93DF47707E865FFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:to="loc_cah_PatientRecoveryBusinessMember_A8C70807379894AD93DF47707E865FFE" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_B7AA8C1D13682645FA7647707E863E53" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_3F8CC85D68DB672612494774ABE6ECA7" xlink:to="loc_cah_CareFusionMember_B7AA8C1D13682645FA7647707E863E53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4DA0ADFF0495C15B439847707E86A796" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A31C7D00684041769E8347707E86F6DC" xlink:to="loc_cah_PatientRecoveryBusinessMember_A8C70807379894AD93DF47707E865FFE" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_307191004FDD69CCF1BB47707E861E52" xlink:to="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_E680EBD6AB092458403B47707E865062" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:to="loc_cah_TotalOpioidLitigationMember_E680EBD6AB092458403B47707E865062" xlink:type="arc" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:to="loc_cah_CareFusionMember_B7AA8C1D13682645FA7647707E863E53" xlink:type="arc" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_88333983844AC207A31B47707E869728" xlink:to="loc_cah_PatientRecoveryBusinessMember_A8C70807379894AD93DF47707E865FFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08C66BE85988659E71E047707E86D311" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7AA5D4D1527D2CF7AA5E47707E867DC3" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08C66BE85988659E71E047707E86D311" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_8E7C6392C0BE2D47B98047707E865A63" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_C3F8665F717A51F8988347707E86EA96" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_B8417EB5F5F2DE77806347707E86BFF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_58C414A929A6BF0ABC2A47707E869D8E" xlink:to="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_5DC47FCCFC4F32AFD8B047707E9655E5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:to="loc_srt_MinimumMember_5DC47FCCFC4F32AFD8B047707E9655E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_24991B74A6BB055225CB47707E962889" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_DBBF6155A2AAFEA4DDBA47707E96B44F" xlink:to="loc_srt_MaximumMember_24991B74A6BB055225CB47707E962889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_C4F8B3E1863B53C60DAC47707E862A70" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_EF0003731461DD0F1B9C47707E96BDD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_LitigationReserve_EF0003731461DD0F1B9C47707E96BDD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_96096A809EBD6E10EE9447707E967A4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_D116BFCDBCDF6DC7BDD047707E962790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4AB4A0ABC9A68F1FAC2A47707E96F7EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2523A2F86A25676AE48D47707E96A381" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8DE3625897E26B7BAFA147707E9687C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_DF84D0246760526071AC47707E966AB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_us-gaap_OpenTaxYear_0FCD9C3DABC412E7E47347707E964A90" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_A18D5159AB6535E893D847707E96F2DC" xlink:to="loc_cah_IndemnificationReceivable_506492E07831639A854447707E966548" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_9D4C619C777D8CF4F6697418D9247712" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_9D4C619C777D8CF4F6697418D9247712" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_2C2C1A681F0972F8903D7418D92478B0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentTable" xlink:label="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5EB64BE3C498941D44D61E7AF35F7D0B" xlink:to="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_165EC1A9825FDE94F3621E7AF3621128" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_21B464398F184BD14E631E7AF363360C" xlink:to="loc_cah_NaviHealthMember_6D99B84468B16477CD111E7AF3637DB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentLineItems" xlink:label="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentTable_0DD1A73380A615AC15701E7AF3606CC5" xlink:to="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_811CD907188A7DE06D601E7AF3642112" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7239E106D0FD7FC1546D1E7AF3649C2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_1D89C5EE71D9AC3E61561E7AF364D3A8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PartnershipIndirectOwnership" xlink:label="loc_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_cah_PartnershipIndirectOwnership_918086CF145BA13E44851E7AF3656602" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_cah_PreTaxGainonDivestiture_BDCCE0E53490701B44851E7AF365D20B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_invest_InvestmentLineItems_B4FD61DAD4D50260F1101E7AF363849C" xlink:to="loc_us-gaap_EquityMethodInvestments_2031D1EB1384427FF7391E7AF365A1D8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_7474ADBED02517CFFF0E46B81856E1A3" xlink:type="locator" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LeasesTextBlock" xlink:label="loc_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7474ADBED02517CFFF0E46B81856E1A3" xlink:to="loc_cah_LeasesTextBlock_52D3E84C6FD490D4FB6346D76FA6E9A6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesNarativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:to="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1DD53D14AE080B8432EE46C89E88C7C4" xlink:to="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_92C0278DDFCF2BDD626046CB56F24DE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:to="loc_srt_MinimumMember_92C0278DDFCF2BDD626046CB56F24DE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_4399A4061D537FC57DC246C8C31A57D5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_E90AA6F57FF01D16D5FA46C89E9869F9" xlink:to="loc_srt_MaximumMember_4399A4061D537FC57DC246C8C31A57D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CEA6F31D9F52B3F5B6C346C80C2F4484" xlink:to="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_953FAFF1305F5B1111D246C80C31EF93" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_091EA5C16B44F479674546C778B4F6B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_A1013166CD8115C0448D46B818560201" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_80B96948B3CA396F27D146B81856F81E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2361F2EF71636524071346B818562BC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2204699B03CA9BCBDAC946B81856CE1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_30F437E88C247DEF38FC46B818562B47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_4F63D58D9664022A0E7946B81856FA7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_8FFE74E774C9079AC0C246B818566BF6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_C5DBF723668DBAABCF5446B818569AFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6AB9641813B8AEAE324D46B818564045" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_E6E063A1291E9D4B2B5A46B818566F73" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_757534D7CDC02335DE521CCC6D3D2943" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_757534D7CDC02335DE521CCC6D3D2943" xlink:to="loc_us-gaap_OperatingLeaseCost_9B1A9ED00D0D36ED15951CCC6D3E3C34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_757534D7CDC02335DE521CCC6D3D2943" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_DCBB36B8842E2A380B5F1CCC6D3E3762" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalFinanceLeaseCost" xlink:label="loc_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_757534D7CDC02335DE521CCC6D3D2943" xlink:to="loc_cah_TotalFinanceLeaseCost_B7981629AF8E673BC8D61CCC6D3F3F30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_757534D7CDC02335DE521CCC6D3D2943" xlink:to="loc_us-gaap_VariableLeaseCost_511F7AB06F0F352ECA6B1CCC6D3FA633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_757534D7CDC02335DE521CCC6D3D2943" xlink:to="loc_us-gaap_LeaseCost_D602D0FBF4CDF06DBF041CCC6D405B9C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_EB3B68CCB540664DBB26284DBC214774" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EB3B68CCB540664DBB26284DBC214774" xlink:to="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1B0968F38310270D7C11284DBC21B3A1" xlink:to="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_D79B85E584C2125538BE284DBC21ABE0" xlink:to="loc_cah_ASC842Member_79D0E7472DC4091F147A284DBC218DFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_BC843F2EDDB867F517C5284DBC31960F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_27B29E766FED1515E54E284DBC215277" xlink:to="loc_us-gaap_StatementLineItems_BC843F2EDDB867F517C5284DBC31960F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification" xlink:label="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_BC843F2EDDB867F517C5284DBC31960F" xlink:to="loc_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification_9CD0226A7BF299BFDD5C284DBC31A665" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EB3B68CCB540664DBB26284DBC214774" xlink:to="loc_us-gaap_OperatingLeasePayments_606E48AABA3F14B88508284DBC310B84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EB3B68CCB540664DBB26284DBC214774" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_029C79994AFD46037BF2284DBC31649E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EB3B68CCB540664DBB26284DBC214774" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_C129359A1A7F54BA6316284DBC31929B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EB3B68CCB540664DBB26284DBC214774" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6CF8592B5EA2D51CCC46284DBC31FAE2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20190930.xsd#cah_SummaryofMinimumLeasePaymentsAbstract" xlink:label="loc_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SummaryofMinimumLeasePaymentsAbstract_75A0D80C6C3D7220441303C80B94DB35" xlink:to="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:to="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_15DBC2DC3F363576D7EC03D0BABEA033" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:to="loc_cah_OperatingLeaseMember_04E99F43EB01C7BBFF120424FD73C5CD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_D1FB700273C26D3DBA7B03D0BAC29BDA" xlink:to="loc_cah_FinanceLeaseMember_56BAAAD95FFC03BE75FA042568283F3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_19CEF1EC7ADB243C8A1203C8148361B3" xlink:to="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8F781E8E83511642248603C9D31B5067" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_D43F7AD965541AFFCEEF03E705AC3579" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_5FE03847082DB04B8C5703EFB05E6367" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3C982D87B91465F15F0F03CB057DEFF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_F733CCE71C8B871086A503E80232350A" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_1A958B7BBAD0F976451E03F1104C852D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_07C1A47818E2C313631703CB4784AE9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_006ADAD954CFD9AB615B03E866574369" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_34D4785D3EB336D1363C03F1A8A476B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_E66D7D03E33660074AD803CB89B70575" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_E43416AB99A50CC4785803E8CF36925C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_0D7AF08841EAC2FF2F9803F244300B58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_D865F4A9F5D1EC3048C103CBC40C9B27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1469DF3BD70FA6E9672D03E910026C70" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_6A0A483BC7B71235BD5803F2D6441278" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3615BC0A870B831DE5AB03CC3392468F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_B1D05820D9E1631D6B6503E9A02AC240" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_C90D0074C3562807E29003F362A26B05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_585A05FC5747ABB6A7D803CCBB50B43D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_40E6F0467EDDA9194E1503F5DCEF5774" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_61EA76006A3D0DC3983D03F50CA4499F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_5BDD33C5D7153614410103CFDC1D6A4C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_AA16991114215301ACA603EC28D4CB58" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_8F5040F3763FC8E907D803F6B825DEF0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_OperatingLeaseImputedInterest_09411639467CE8D73C7804014B58C48E" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_FinanceLeaseImputedInterest_F17D01E7EE089170D2600401F0684C4F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_0412425393030F54B7A003F84D254236" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_OperatingLeaseLiability_1F0C074917F4ACE8E8D403EB5CA9CAAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_us-gaap_FinanceLeaseLiability_0CCBE59491B4E306DF1203EB1430CF26" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1976344C228BF9202DC803C814844A03" xlink:to="loc_cah_TotalLeaseLiability_B6E9CAD99D0275DE2BFC03D4F4C82315" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_913895F819C15F6EC34B4114859475F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_E3CA15D54627F61CB7F341148595E69C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ADE161D9710DAFE3CCCA411485952A27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_OperatingLeaseLiability_E7C865A4A7F07F7105CE411485954234" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_AD71105027CD32829D9141148595EC7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1569BE5E47CBF494AD0E41148595EC08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_FF83A591E0F8FEC36BA1411485950DFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2CB4B39E1AFFA1434AC6411485948D55" xlink:to="loc_us-gaap_FinanceLeaseLiability_0206970AD4C6D25F66C941148596B355" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_F7FCD95C519B934BDDE91CCC6C49C1D5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F7FCD95C519B934BDDE91CCC6C49C1D5" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_D3C60AC208B7167BF5471CCC6C49C971" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F7FCD95C519B934BDDE91CCC6C49C1D5" xlink:to="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_97CBE34DBB1CF5C9BC0E1CCDAE350711" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_LeasePaymentsTableTextBlock" xlink:label="loc_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F7FCD95C519B934BDDE91CCC6C49C1D5" xlink:to="loc_cah_LeasePaymentsTableTextBlock_BE4CC97917557F3CB98B1CCC6C492622" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F7FCD95C519B934BDDE91CCC6C49C1D5" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_7B8FCE1FB6351DF2C7CD1CCC6C4A58D0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_C985973EBF2440C0436C7418D89851CB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_C985973EBF2440C0436C7418D89851CB" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_056EFD3CD86D84746CAD7418D8987E8D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_C9F2341328955054529412D39E748115" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_DD25813B8B43B3886EED12E348D0521C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:to="loc_us-gaap_AccountsPayableCurrent_DD25813B8B43B3886EED12E348D0521C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:to="loc_cah_NotesPayableRepurchased_D57D00AD0F080EB2E83312D39E7404BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6137320BD5D28B06ECFA12D39E7472A5" xlink:to="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_667CB9F193BC4AA1AEED12D39E748697" xlink:to="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="loc_us-gaap_CommercialPaperMember_BF150CFE2D3ED199B71512D39E743AB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_C7771A807296F4014DB012D39E74B3C4" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_B0F4368BC007520095C312D39E7499DC" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_92D436C03DF736C6417B12D39E74200F" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_A2FD69D0E69C7464D10F12D39E7411DE" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1FA39A751BBC90179CDB12D39E745547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4D1E2265167F95506C0A12D39E74FF8C" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2F842A3049E6098B530712D39E741D47" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_77F351971ED19CA459CF12D39E7471F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_953262FC37D605BA4E4D12D39E74F9D6" xlink:to="loc_us-gaap_VariableRateDomain_E25CD52A66B46D95AD6D12D39E747A98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1A0BF632887F408F63A812D39E7467EC" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_AB64B6AF63CD71D764F812D39E7480DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_679E376231F519C1E26412D39E74041E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_E198414BEEABE103D03112D39E743AD3" xlink:to="loc_srt_RangeMember_679E376231F519C1E26412D39E74041E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_353887BFCD8E1FD760AC12D39E74DF9B" xlink:to="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_DAAD74646F6107FAD8C012D39E74B74E" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_B35099C13B0649C1289912D39E83F19A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_CCC0492387333606732C7418D8D6993D" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_2CF2EC2FCB7DD48D27547418D8D67ADE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_07AAF5B7C4B3715F994C7418D7EC5824" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_07AAF5B7C4B3715F994C7418D7EC5824" xlink:to="loc_us-gaap_SeveranceCosts1_852323DBE8DDD29593EA7418D7EC3232" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_07AAF5B7C4B3715F994C7418D7EC5824" xlink:to="loc_cah_FacilityExitAndOtherCosts_16ADC159FD57DC239A317418D7EC07D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_07AAF5B7C4B3715F994C7418D7EC5824" xlink:to="loc_us-gaap_RestructuringCharges_1F4D97771C42D4E377B37418D7ECFDEC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_D3DA97589A7A4F12621C7418D83AFD36" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_D3DA97589A7A4F12621C7418D83AFD36" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_07FDE14C0C0D9B9A2EA37418D83A608A" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:to="loc_us-gaap_EmployeeSeveranceMember_DA380A8C994979E745887418D83A7899" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_F697728DBC032CDAA8DC7418D83A9A87" xlink:to="loc_us-gaap_FacilityClosingMember_6504F2FE684C86F646927418D83AC329" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_913C74BCA6A138FEF32F7418D83A6F1A" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E67ED21DCFE6314313A67418D83A4E8F" xlink:to="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_RestructuringReserve_C573EFBB786E15B981947418D83ABB6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_RestructuringCosts_08B0ADC8C507EA46AF307418D83A168F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_PaymentsForRestructuring_D30709D41A344547D7567418D83A0D8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_E5EC46E2F3EA65E7E0807418D83A93E1" xlink:to="loc_us-gaap_RestructuringReserve_EDD5C698DE755CF2D9917418D83A72C6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_196564D3200057D42E5EFF700D33F600" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:to="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_B64687E8C39F79611F56FF700D335A43" xlink:to="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_EnterpriseWideCostSavingMeasuresMember" xlink:label="loc_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_27F36151DA04A3D1758FFF700D347726" xlink:to="loc_cah_EnterpriseWideCostSavingMeasuresMember_C66ED6FE1D4792149699FF700D34CED3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_00DA8DC9DEB5DC0E170DFF700D333304" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_us-gaap_RestructuringCosts_F9C9BF6637B4BF102B32FF700D358DF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_us-gaap_SeveranceCosts1_0E93AF308C30E1ADD29AFF700D3508F3" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_0C24532787BC7AC6D6D3FF700D358B3E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_C6DEC9B0946408208138FF700D34B5F3" xlink:to="loc_cah_FacilityExitAndOtherCosts_0C24532787BC7AC6D6D3FF700D358B3E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_FB91A87E74B3C51BE5BD7418D9240DB6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_FB91A87E74B3C51BE5BD7418D9240DB6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2838D17A88EC62EACEEF7418D924E150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_FB91A87E74B3C51BE5BD7418D9240DB6" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_CC84836DB8A5AB68173D7418D92471CA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_FD3723FE41E34DC5792C7418D7EC6A23" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_FD3723FE41E34DC5792C7418D7EC6A23" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_45CDDC5409F66C2DDA557418D7EC5D97" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_1C71C1CE35FC3D587EE87418D8884B28" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1C71C1CE35FC3D587EE87418D8884B28" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:to="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4F6B54F9DDE075457F1A7418D888AA51" xlink:to="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_EA50923C8C57669EBAA07418D888E6B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:to="loc_us-gaap_OperatingSegmentsMember_EA50923C8C57669EBAA07418D888E6B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_823306ABC99BFEE633E17418D8882DF9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_CB249A8F62F6D5D961C77418D888CB71" xlink:to="loc_us-gaap_CorporateNonSegmentMember_823306ABC99BFEE633E17418D8882DF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4F2820019403F209A5617418D8889F40" xlink:to="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_87750A3E7CE5E453ABF07418D8884A7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:to="loc_cah_PharmaceuticalMember_87750A3E7CE5E453ABF07418D8884A7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_7C3D00841747236F061C7418D888040F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7BBE87734D96046077027418D888CB8A" xlink:to="loc_cah_MedicalMember_7C3D00841747236F061C7418D888040F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_514F3958C2418FE3C0637418D8884BC5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_DC498D5972C6659EE1027418D888369A" xlink:to="loc_us-gaap_Assets_456DCED8D1D83231A64C7418D888C2CF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_4CB26AA3B532BA5D8C96FF7646580BDF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4CB26AA3B532BA5D8C96FF7646580BDF" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentAxis" xlink:label="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalSegmentDomain" xlink:label="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_MedicalSegmentAxis_D1F7AD9C996003DCAC06FF764658FF56" xlink:to="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:to="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_MedicalSegmentDomain_6B56C83E9DE6095ADDC6FF7646594E10" xlink:to="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentAxis" xlink:label="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalSegmentDomain" xlink:label="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PharmaceuticalSegmentAxis_EF96842F02BBD8C82F9BFF76465AF4E5" xlink:to="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PharmaceuticalSegmentDomain_BBD7ACE1EC718D10EC0BFF76465A1340" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5DB2354E2D07E81D30FAFF76465BEA30" xlink:to="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_9C02D59552F03A37650FFF7646607084" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:to="loc_us-gaap_OperatingSegmentsMember_9C02D59552F03A37650FFF7646607084" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_8A4D95FB566910EE1871FF76466177F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_B0A0E0577D14E30BF2E3FF76465B8C0B" xlink:to="loc_us-gaap_CorporateNonSegmentMember_8A4D95FB566910EE1871FF76466177F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8CDE4B08277FAC7C0D7FFF764662D20F" xlink:to="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_7300EC7081F65BF4D4EBFF764662D9C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:to="loc_cah_PharmaceuticalMember_7300EC7081F65BF4D4EBFF764662D9C9" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_9E22A48366D9D25250C0FF76466259B4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_62C5D1BA64F69D204E40FF764662724F" xlink:to="loc_cah_MedicalMember_9E22A48366D9D25250C0FF76466259B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_2131C01520FB2791E6ADFF76466285F7" xlink:to="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_CardinalHealthAtHomeMember_FA886EBFC9D1179C24DFFF764659A6EB" xlink:type="arc" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_MedicaldistributionandproductsMember_09ED3252CAFB1D8C73DCFF764659F201" xlink:type="arc" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_751EDDEAC18FBAD3532EFF76465BF729" xlink:type="arc" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_421485EDBDA6C043CC7FFF76466231B0" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_7BEC2AD6D2326CCF0E79FF76465AACFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_A5AEC22ABC96E19BC303FF7646649D3B" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_9D889267F7FB68C76791FF764664D943" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_DAF865761ED8E5DB27CAFF7646581BBA" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_721164343A8D512C83CCFF764664133B" xlink:to="loc_us-gaap_Revenues_F7692AA225E59D36CA45FF76466541C1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_C1365F5463B0898D1D7E46B8177E1457" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C1365F5463B0898D1D7E46B8177E1457" xlink:to="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:to="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_FB29EB253D64E5EE626146B8177E9EA0" xlink:to="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_DE36531505980DCD47AD47471E7ADF40" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:to="loc_cah_TotalOpioidLitigationMember_DE36531505980DCD47AD47471E7ADF40" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_OpioidSettlementFrameworkMember" xlink:label="loc_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_F383354158F63DD79C8046B8177E9583" xlink:to="loc_cah_OpioidSettlementFrameworkMember_7165630B02D75CEF3E9E46B8177E7A55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_BACA7161365BB75D978746B8177E89E1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_73554DB13C66D3319AFA46B8177E2C94" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2D38D0D73B04E040207D46B8177E6DCA" xlink:to="loc_cah_NaviHealthMember_73554DB13C66D3319AFA46B8177E2C94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_EE853C1A9FB8A424751846B8177E6134" xlink:to="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_us-gaap_NumberOfReportableSegments_0957DD51C7AB057B5EE346B8177E4516" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_us-gaap_LitigationReserve_2707F4B07A6173AA909B47471E37FD2B" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_7606A70D2DCE3C738DEA46B8177ECDCA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_E30AE5F08F6C85A7ADF646B8177ED7F4" xlink:to="loc_cah_PreTaxGainonDivestiture_7606A70D2DCE3C738DEA46B8177ECDCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C1365F5463B0898D1D7E46B8177E1457" xlink:to="loc_us-gaap_NumberOfOperatingSegments_321B6063FBC92C9BB42E46B8177E9F54" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C1365F5463B0898D1D7E46B8177E1457" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3E2193B928E588B2D0D146B8177E492C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_739D35CB26E219BE77BBFF759AE31EA3" xlink:type="locator" />
    <link:loc xlink:href="cah-20190930.xsd#cah_SegmentRevenuebyGeographicTable" xlink:label="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_739D35CB26E219BE77BBFF759AE31EA3" xlink:to="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:to="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9416A899936D7C2BA3A7FF759AE36EAC" xlink:to="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_3D124DA4F0C66A87787EFF759AE43054" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_FD15E92E1CED2D362112FF759AE452D9" xlink:to="loc_us-gaap_OperatingSegmentsMember_3D124DA4F0C66A87787EFF759AE43054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingSegmentsMember_3D124DA4F0C66A87787EFF759AE43054" xlink:to="loc_us-gaap_CorporateNonSegmentMember_817C39D596AD7FB257ABFF759AE5C819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:to="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2632EF1B8DB8096E139BFF759AE5F143" xlink:to="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:to="loc_country_US_AD2BE283CC9F4C229A72FF759AE5433B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_94C431893737E404C015FF759AE5803A" xlink:to="loc_us-gaap_NonUsMember_DB7240B912F234018393FF759AE62DBC" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_SegmentRevenuebyGeographicLineItems" xlink:label="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuebyGeographicTable_F62D91FA47CFCD798307FF759AE38283" xlink:to="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_E09FE931380416178D90FF759AE6DB3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuebyGeographicLineItems_4D16E0975A14AD001D86FF759AE60BEB" xlink:to="loc_us-gaap_Revenues_E09FE931380416178D90FF759AE6DB3C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_A41BED958BA76B9487091272537D52E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_A41BED958BA76B9487091272537D52E9" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_7147FAF7B0E39324BC551272537D5F7E" xlink:to="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_E9F105BDF12837F771E21272537DAF03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_E9F105BDF12837F771E21272537DAF03" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_BE4D12D1E836C4B815751272537D6BFC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_BE4D12D1E836C4B815751272537D6BFC" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_ABAA95976DAA7D2467201272537D4EE7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_MedicaldistributionandproductsMember_ABAA95976DAA7D2467201272537D4EE7" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_2227889CB9E01E6141FE1272537DA1F3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_E07DD9653A5B4129A0851272537DA451" xlink:to="loc_cah_CardinalHealthAtHomeMember_2227889CB9E01E6141FE1272537DA1F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_278C10E8C0734D377B681272537DB402" xlink:to="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_B8F6FA4152E58EB54D3D1272537DC7C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:to="loc_us-gaap_OperatingSegmentsMember_B8F6FA4152E58EB54D3D1272537DC7C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_280B29706E4BB73482E01272537D0563" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2E3B4B410E14802BDFF71272537D89D0" xlink:to="loc_us-gaap_CorporateNonSegmentMember_280B29706E4BB73482E01272537D0563" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_80A86A52A258970EA7111272537D8B2C" xlink:to="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_A7955B2C76267424838E1272537D0248" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:to="loc_cah_PharmaceuticalMember_A7955B2C76267424838E1272537D0248" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FA195D20A16E10DF54A81272537DECE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9C631109DDE940F852D71272537DD4FD" xlink:to="loc_cah_MedicalMember_FA195D20A16E10DF54A81272537DECE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_25B51FBD3BD6DAD588371272537DF454" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_3E62E0A7AA38A76524C31272537D0E7A" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_25B51FBD3BD6DAD588371272537DF454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_25B51FBD3BD6DAD588371272537DF454" xlink:to="loc_us-gaap_Revenues_53346AD6275988E6D4C41272537D0253" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6BB2AE105AF0C0FE41051355F13FE26A" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:to="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5CCFA81BDCC1EA5C500C1355F14569F5" xlink:to="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:to="loc_us-gaap_OperatingSegmentsMember_A3D86A91CADDD5906BF61355F1469416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_E6E78E65DACBA4414F161355F1467437" xlink:to="loc_us-gaap_CorporateNonSegmentMember_AABE64C108D0D188D6B91355F1465D76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7DD49405A87B2295AC481355F147D7A6" xlink:to="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:to="loc_cah_PharmaceuticalMember_B26C4555C96EC3534A9B1355F1479F08" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5FE7D0A76BB36776461F1355F14798C8" xlink:to="loc_cah_MedicalMember_AEDE6547F6ACC622A1151355F1478E63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_01D816E9482E9B51B2D31355F1457F15" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_D3047DA601B5D3748DD81355F148AF86" xlink:to="loc_us-gaap_OperatingIncomeLoss_FF2AEF16FB9800980DE11355F1494790" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_8226762A83A3CF51BB8A1355F82F5AF0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8226762A83A3CF51BB8A1355F82F5AF0" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_69569FCFA0012CC997091355F82FB85E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_E27D5F4BE601A6922B661355F82F351C" xlink:to="loc_srt_ConsolidationItemsDomain_69569FCFA0012CC997091355F82FB85E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_58B79D4527F83DD42A7C1355F830C71E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_53EDE1C00DAC7413BE301355F8307796" xlink:to="loc_us-gaap_SegmentDomain_58B79D4527F83DD42A7C1355F830C71E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_07DA49D50C78F6315C6F1355F830E689" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_91BAE968CE9249BDFA4A1355F830ECCD" xlink:to="loc_us-gaap_SubsegmentsDomain_07DA49D50C78F6315C6F1355F830E689" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsAxis" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsConsolidationItemsDomain" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_5B97C6DBD25C476D14141355F8315BD1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_1B8951656F229553F5331355F831840F" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_5B97C6DBD25C476D14141355F8315BD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_684CC18580B41B16FDD21355F8317603" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_2D63E4283F4DF055A9881355F82F6C40" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_684CC18580B41B16FDD21355F8317603" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_684CC18580B41B16FDD21355F8317603" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_26192EF0020AB969A60B1355F8327E17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8226762A83A3CF51BB8A1355F82F5AF0" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_8A2D18655230C4DBD26D1355F832C9EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8226762A83A3CF51BB8A1355F82F5AF0" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_70720ED218338C014B5E1355F837EB2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8226762A83A3CF51BB8A1355F82F5AF0" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_BA3508D5CFDA2BA6407C1355F8381273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8226762A83A3CF51BB8A1355F82F5AF0" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_55D345FE922D6E658FEF1355F8381D0A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7A4544090BC118A2D1ED7418D8D611A2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7A4544090BC118A2D1ED7418D8D611A2" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3CE8A1350D5F6CB1DA4D7418D8D681C1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_445D95324ADDAC2DFA5C1E8DEFA7538D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_445D95324ADDAC2DFA5C1E8DEFA7538D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:to="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_35B38EDD8043FF1D14FF1E8DEFA7ABCA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6DB384AA11D9DA9A3E1A1E8DEFA74704" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_B921F6247EB26F66B8621E8DEFA72B20" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_B921F6247EB26F66B8621E8DEFA72B20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E0523FA80C20D23E723D1E8DEFA7D63B" xlink:to="loc_us-gaap_PerformanceSharesMember_CF4AABF6E33DECADB1BF1E8DEFA71AB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:to="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_45E33A2712C16C6415F21E8DEFA77006" xlink:to="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_C32064526215DDFFDF661E8DEFA7EE17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:to="loc_srt_MinimumMember_C32064526215DDFFDF661E8DEFA7EE17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CF7598891FA7C9F1C2571E8DEFA77A04" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9843E982E13A755036C01E8DEFA7DAAC" xlink:to="loc_srt_MaximumMember_CF7598891FA7C9F1C2571E8DEFA77A04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_13947677F5B662242B4B1E8DEFA795CF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_cah_VestingPeriodinyearsforShares_B1146FF7817FE0B929641E8DF316440A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_CBBFEEB100D11B4485D51E8DEFA77DDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_486DFA8971344FFEAE9A1E8DEFA7E4CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_C25CA4B7BAB1571CF5241E8DEFA7B023" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_BEA559D551823541D5201E8DEFA741C2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_BEA559D551823541D5201E8DEFA741C2" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_2D89B112CB67A7C0253B1E8DEFA703E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4448FDA289D9AFDBA08A1E8DEFA7B41D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_B65E15CBD3D24AB3A7401E8DEFA7DC95" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5DA537F601C7F851831E7418D8E6480C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5DA537F601C7F851831E7418D8E6480C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:to="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_39B334E6DEE1394316677418D8E6B305" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0110F76EDED8743E38027418D8E6BFB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2C70C857EEABC3254A627418D8E6A013" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0110F76EDED8743E38027418D8E6BFB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D3A5E586FA5618601DF07418D8E60FDA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5F06CCCB81A541EEB7DC7418D8E6A8AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5F06CCCB81A541EEB7DC7418D8E6A8AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0E5DAE26BA3B2C0A17D37418D8F58513" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0E5DAE26BA3B2C0A17D37418D8F58513" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_D97901595AEC3E2D2AFA7418D8F5C3D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_E95099D690D482831EDD7418D8F5FA5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7BAF0ABE925B57F8E82D7418D8F5F642" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C025A66511B0B741EFC7418D8E63A44" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_062C059FB7C5149A60E77418D8F5C0E4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B4CEAB3AA43C21188BF87418D8E641E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B4CEAB3AA43C21188BF87418D8E641E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_EC516A4056B7DE8F19397418D8E6D6F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_AAF1DF0A5AFD30163E0F7418D8E68565" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_132CCFD25CC7FFA55BA97418D8E6680F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3E5B143C49E37AEE65A17418D8E6AF1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7C97CFD5FA746A0CE6577418D8E6D4D4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0EA6CCA6D6F750918B667418D8E65EFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B4CEAB3AA43C21188BF87418D8E641E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_B849C8CAF94090D354217418D8E69610" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B4CEAB3AA43C21188BF87418D8E641E7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7E2053E081F73DE914E27418D8E6722D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_B34CA2C006D623B4C4577418D8E67A9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_E7C82B52FD83958D16657418D8E666A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_86A430351CBBDA1374C97418D8E681BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_F4AFCC053904C072810C7418D8E67CEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_FB1CC4085B49DD8DA6F17418D8E6D9AC" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_F96407DC66D1DF62423C7418D8E6AEA0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1E9D07765BE4D8A17D237418D859D633" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1E9D07765BE4D8A17D237418D859D633" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:to="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2247930CA91A66B94F907418D859CB24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_1B5368CE09A86129A25D7418D859B432" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3288E55475DDF6E559887418D8593B7E" xlink:to="loc_us-gaap_PerformanceSharesMember_1B5368CE09A86129A25D7418D859B432" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8CC5A848633CF5C41497418D8599DAA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_475D9F0B6DF961B33E587418D8594ACB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_45FAFCF08A64AF72F1337418D8594BFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_45FAFCF08A64AF72F1337418D8594BFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9EBAA1B34397DDFEB8637418D8597506" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9EBAA1B34397DDFEB8637418D8597506" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_E0D1F01EBBB0C8CA1C367418D859C674" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_E0D1F01EBBB0C8CA1C367418D859C674" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_617FD502705AD1401CB97418D8590DA9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_617FD502705AD1401CB97418D8590DA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_E8A3BFA900BE3F9F3DF27418D859A382" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F9518758258745BE15E57418D8597635" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_E8A3BFA900BE3F9F3DF27418D859A382" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8DEBAF744346D7FB00C97418D859BB11" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8DEBAF744346D7FB00C97418D859BB11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_721430AA7F20B5D361E87418D869EFED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_721430AA7F20B5D361E87418D869EFED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F1048FB15410152E2E917418D8698552" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F1048FB15410152E2E917418D8698552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_E0CB3E34A261E7585DFD7418D869378F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_E0CB3E34A261E7585DFD7418D869378F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A1AAB0642EC2515BD11F7418D869309B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0B4B124E1016ACF4BF6D7418D8592E7B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_A1AAB0642EC2515BD11F7418D869309B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_84D51B336FC0F7B54D557418D869FE8A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_84D51B336FC0F7B54D557418D869FE8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082635DF0A6E62725E7A7418D869D02F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0C26DC4154842E68812D7418D8597098" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082635DF0A6E62725E7A7418D869D02F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50B4E749A5EF73A4D9F67418D9A11D13" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:to="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9EEC31BE154C216E87EC7418D9A198E4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8331F8BE84B645367A6E7418D9A1E452" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_86D85E0A5C67BE8653F97418D9A15FC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C1B4A47AAFD3250C88677418D9A1053E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4BED8D95CA289FD5CFD87418D9A17EE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_837DB02B617DCA815A247418D9A13B95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_D26048CC22C717C44B447418D9A1CBE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2EF55DD5112E672747D07418D9A150DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D43AEAD26E369B1A210E7418D9A1F165" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ABBD823E54A43BC712F27418D9A1933A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_188130DF93E0BE4621667418D9A1F428" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C26D63D454D53B8E59DA7418D9A162F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_251BABA652DD803C8F7B7418D9A11160" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8FDCF516322FB584963A7418D9A17A02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_21F201E6D0D131B1DDB47418D9A103F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9CDE3EBB713ACC6460D67418D9A1234A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_337C392A254608158C357418D9A16056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9634AE829719B0DD60297418D9A11F82" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FA75FAE105694E571B0A7418D943C813" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_FA75FAE105694E571B0A7418D943C813" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:to="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_31C719B57EB75F44742D7418D9436B37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_C3708F6350F733B356847418D9431EFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0B371E34C541BCE8100D7418D9430512" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_A4DEB29A35421ECCA94B7418D943977B" xlink:to="loc_us-gaap_PerformanceSharesMember_DD7B2ECABD0F7F5CFBC07418D95337CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23D1BEAD1AA994C68E227418D95339EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65DCDA539C45968011007418D943D5D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23D1BEAD1AA994C68E227418D95339EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_23D1BEAD1AA994C68E227418D95339EA" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_DC3545F7F256EF8934947418D953CAE9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8B36319DC8DEE955FE8D7418D869B81D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8B36319DC8DEE955FE8D7418D869B81D" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_AFF38A089102243CFD097418D86994B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8B36319DC8DEE955FE8D7418D869B81D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B653606160E38064A1297418D86967AA" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8B36319DC8DEE955FE8D7418D869B81D" xlink:to="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_B65BCAC6DC288ACF56267418D869A810" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8B36319DC8DEE955FE8D7418D869B81D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_370CF8BA1DE9946E3DF77418D869823B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8B36319DC8DEE955FE8D7418D869B81D" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_8F9FD049CE2349B7B0DF7418D8698D6D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_43FB357189C92728086C7418D943D66E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_43FB357189C92728086C7418D943D66E" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8947393E19722E0219BB7418D9435C7D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_96F8E8FC3AF49D6430AA38067C29FA52" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_96F8E8FC3AF49D6430AA38067C29FA52" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2A153D907033FC557B9638067C291366" xlink:to="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_61C6AFA92A8041A42D1538067C2A2378" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_49812597A71A25BDCE8538067C2A0CC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_70315B0255DE122D1F3138067C2AD446" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EE0A9DF4715C50B0DD5338067C2BE6FD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8581442175D7A637936438067C29487E" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_EE0A9DF4715C50B0DD5338067C2BE6FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82D77373BBCFC331939638067C29773F" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_61DD57E510354770567438067C2B8421" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_251AC4EB02D4EDC7113638067C2BF2B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_F2D9B27840E7DBAACD8A38067C2BD94B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_93F18C82141A0C642BB138067C2CFCF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_DF33B60FFB7933AB469038067C2C164F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_15FA92C868440A11B65C38067C2BD181" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_E788E69F0992380A3B8C38067C2C0CF4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_DF0C753CC9DD59F93E9A46B817B3AF08" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_F2A3431758910DDA98A046B817B3A1BD" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5A61C0F394FBD9FDBD8346B817B31A4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_A9EE180F1904FD118AFC46B817B3CF18" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_E62A457698FFDED504EF46B817B33D36" xlink:to="loc_us-gaap_SubsequentEventMember_5E4EA18DAACA0E159BB546B817B3D973" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8BC6CD5CAFB3EA686BAC46B817B3505E" xlink:to="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1316C46372F42F5924D946B817B3C9C8" xlink:to="loc_us-gaap_TreasuryStockMember_8C6D3F66268AAC5CBAC046B817B3A36F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_BECBE5AD5E9D87C4E1D546B817B3F014" xlink:to="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0794135BA78B7C07037346B817B3D96A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_89FF676BACB5202F97EA46B817C3B042" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_DBB2337650D1895C78F846B817C3C578" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_3D9F26FDA64F9CFA973B46B817C3EFD8" xlink:type="arc" />
    <link:loc xlink:href="cah-20190930.xsd#cah_FinalSharesReceivedfromASRProgram" xlink:label="loc_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6EEDCDFD158CB481A23A46B817B31136" xlink:to="loc_cah_FinalSharesReceivedfromASRProgram_08CA8AB59489710AF10346B817C3E5D9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_19C77FC0B83DDB73256E7418D8B7FE82" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19C77FC0B83DDB73256E7418D8B7FE82" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7CB48EF5337441C5C1E67418D8B7E502" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>11
<FILENAME>a20q110q93019form10q.pdf
<DESCRIPTION>10-Q FY 20 Q1 (PRINT READY)
<TEXT>
<PDF>
begin 644 a20q110q93019form10q.pdf
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M7BP_3V^"OD!OT:_P_#:]!/H.O0SZ)_IM^3EZEWZ'Y_?H%3R_3[\'_3/M!_U
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M>X,>'U2&C>@+*G *_-@!&,(!6# ?GJ#?$61L*DX;MC[<%ESD@4UQ[66]0?&
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M\GTY4!5U1:(1*TO,IR&+:'Y6J"\0J I9 SX7:Q(NJ <F![<$W-O@OH587Z%
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M62J %8[,1,\W-TBY@'6[*GPRI\QG0Z826QL*>)]I&SXH5]7:P!'E3*;$3D0
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MS>6J:C*J3VT;GDMD<FFMX[A&H3!>C IL+E@2(& U4BR.;U;"X7@]?T@I]H5
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M57BG-=)(P\"]L57H:VRU#/6OG/W>0/]B;OQ@;-'LQ^O\\_%F]+WC_-C8=L-
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M]6[]L?H;]+\QG7=XVN';#S]=W@SN6<)N"M,0> S,[U0Z0? \'S)9#)Z7T1G
MV85T$5T,&6VCR\'S+>#U-OH!W2>^O3Q+OX>$WZ>O(#7^'7DYJ0FQ';Q.DHZ5
MCI>F@]]3(<NM\-F^ [W]6GI%>E_Z'/$?LB1;Y'#/=Y^\/%INESOD2?*)\AQY
MI;Q:/D^^2KY&WBU_)'\J?Z9SZ8*ZI*ZH:]6-0YRK.U6W&?%QO:+WZ1?H%^JW
MZ+OUOS&0H<TPU= )A_HO1JO1;E2- XW3C)<;/S:G@(K=X/[KWS272O=(U].G
MD/7[](3\(^ SCQ6=2 MH"W;45[K%M%S:*9UQ>#L<YK+\ #VKJ\>^D/4SJ:"[
M2GH+4IBFJ]*9#._JYAK^(H<,FNXJ_<O2*?(O]6;(XS%IHI@FV1.7XE)QOKQ"
M-U1OUP_1GZ-_Q## L,)PI^$9PX?&L/$LXV.F@:8_FB>;W[9<:OFI]2);P3;7
M]@/;Y_9J^W+[>T[->9MKBNM/RBG*O<IA=9?ZICOJOM!C\[1Z:[R;O9_YYON^
M]-\0.#/P6+ F>+?V:&AVZ"?A<'A*>&/X\2I_5:EJ4L0;V1,M17\6&QV[/WY9
M_,^)?&)+TI$<FOQ#JB6UJWI0]9/II@QE3LN\6+.\=D+M5]D7<U-R;];IZZZM
M^RSOR*?S@_/'YA?D-^1WYN_./Y;_3?[#@KY051A0:"^<5%A5N+AP4^'>PL\+
M;Q:^*"K%3'%8\?CBTN*FXM7%[Q5_.D _8$G]P/J_-[Q5LI0Z2N7&]P;>.FC0
MH),&;1WT1=.*YJ'-KP\N#;YZ\!=#;AKJ&?J#EJJ6Z2W;6\K#+AOV]O"=(QX<
MN;-5:YW3>F'K:Z/.'QT:O6+T2V.&C%D]YN(Q-X^YOVU:^YCVD]O/:G]G[.2Q
MEXS]V3CSN,RX$>-.&'?Q^,'CEXZ_:T)VPK43OCI&.V;J,3_N.-#Q\43SQ.C$
MIHD3)\Z;N&[BCHEW3'QDXJ\F_FGBX4G>2;E)ITRZ9M+'QSJ/G77LNF-_/=D[
M>=+DC9._/\4_Y<PIETZY=<J^*<\>YSSN>U./G[ITZJ:IGT_;.>W^XP/'SSG^
MD>FUTT=.GS%]Q?3GIK\Y_8L3E!-2)PPZH>.$N2><><*E,X;/.&G&JAD7SKAQ
M1O>,G\QX9<9?9_Q]IGUF;.:@F1TSY\X\<^;VF3?/W#OS)S-?F?E1IZ$SW-G8
MV=$YMW-MYR6=MW0^V/E,YVN=?SW1=&+XQ,83.TZ<?^+9)UYQXATG/G+BBR<>
M/NGB631K\:QW9I\\^\$Y>IR NT[6G3RIZ[BN55U7=.WI>J&K/+<X=^'<,^;>
M-?>=>?*\Z+PQ\Q;/6SMOR[R=\VZ?=]^\G\[[[;SWYGTU7YE?.W_8_"GS%\X_
M:_[.^7?-?W3^[^=_N$"_(+J@<<'X!?,6K%]PY8+[%CRSX.V%IH6)A4,7GK3P
MC(67+OS!PA<6?K(HL6C HN&+CEDT8]&"4\*+5RZY<\G]2YY8\OR2/RQY?\G?
ME]8L;5NZ;NF;IS:=>NNI;RS++)N][#O+7EKVR?+D\FG+%R_?O/S*Y=<OO^VT
MY:>]<=JA%885X17-*V:O6+WBXA4WK[A_Q2]7O+[BT$K'RM3*(2LGKURX\NR5
M5ZS\SLH?K7QAY3LKOUKE6;5JU=.K7EOUZ>G6TV.G#SK]F--GG7[:Z5M._W"U
MM-J[>OGJ3:NO7'W'ZH?6Q-9L67/=FNXU3ZXYL.:C,Z0S F<4SMARQKMGE-?Z
MUM:M';5VQMKE:S>MO7+M76L?7?ORVO?/3)XY^<RU9UYRYJUG[COSN3/?./-O
MZYSKJM<-73=UW=)UF]9=O>YGZUY9OV/]J^L/GQ4]:\19<\XZ[ZS[S]I_MGIV
M]NQQ9R\Z^X*SKSO[OK.?/?OMLS\\^_,-QVXX8<.<#8LVG+9A[8:?;WAAP^_.
M4<_1SCGFG*GGW';.=\^Y]YP?;O1N7+OQLHUW;'QDXXL;W]GXY;G^<R\[]\--
M8S?MW/359L/F.9L?.D\^SWK>QO,N.._M\\><?\[Y'VR9O.6-+7_?JFZMV3I\
MZ[2MIVX]L/7C"]9<L.&"+1?<<,'M%[HO/.?"ER]\_R+IHI:+QEQT_46W7?3=
MBSZ_Z/#%;VV[9-M+V][=OFC[7=OW;']H^^/;G][^XO97MK]^R<A+GKCD%Y?J
M+AU_Z067OG!9ZK)!EVV^W'CY!9=?=_FM.Q([KMGQX!6F*UQ7_/5;V[[UTK?>
MO7+AE7?O#.V<O7/ASJMVWKCSVSO_N//]JW9>=<-5SUX=NGKVU;NO_M,U=$WK
M-?=?&[_VHFMW[_+LRN[:M>N677?M>FS7SZ_+7K?YNM>O^_QZ^_7CKS_M^JNO
MO_V&T3>LN.'1&_,W'G?C*S>=?]/5-]UUTR,W/7?3ZSB5\O!W]ACXSY),%&ZU
MF22]1 :=14]FY3?/XH<&-#X[X-F&^D8UH:83:B(O;3U\MU1[^'?\1S:#]+OY
M,PXLO=0!C\L 'V->JW6E33(O,+H,DF&?=&;K0)F,5@/I[Y5T]\JR=+K1?)[)
M<IZ)C(KQ4>-CQA>,!XU_,9HN-^XV=J.HWV&4C#=:E<]/7S5[V ?*!\JGPT ^
M&#*$1H[\8+;R04.]--NC4QM5FS2HT?=XX<'<!7=)RW06J?WP#[\\='CGL\^"
MGXF8R2#XL=&Z5I?U_^'K.P"CJ/+_WWO39W9G9WM+V93=) 220 @A&,@H" 2E
MB00I(4$($ 1)Z+T(&$ ED8 445!$L2 ( @$+J(AGQWX>=^+=H5XQ)^>AYRD[
M^7_?S":$\_\[<6=G=U]VW_O6S[>\&7HU(4P!!+TLK=*"9^@]Z95?&88@A9<%
MF!R6I],L#Q$VL]-U0##5X$_.8:X*S\8KP>WOAA<\/H'SD4W[L;XR_F-EJ]-5
M4D(?J*Q4H__BYA.\DV^>="]P,S!!IM \SL_9'SV:M3^;.8+]ERX9?[6.,"%'
MVS=,(_<1H()4'-+O#'+!%/#47B2QC =)'.]$DBAH2%($+2S;!"U@=PB:7W7Q
M3K_J9CQ^U4>\?C5(O %[B'C#<A+C"<O)C"=@3^&= 7LJ[PS3C9A3D>0! *CZ
M_5,#=D\@8'?R6S2A!6NZ5U7M=EF6L(?9XD4$2_ 0"?W$$0X' GX_4M)><7IY
MHKY ' "][,3Q? #5A:46XCB*O"_XZP(M6'X^7$?.H!:<?R0R8V4@5_OQ8OS'
M^$7M(K".'H$>%]OI='EBY<3*TGAI^TLX;>#R<I=K9QKR O3IOZ_Q13GN=V<4
M%9J/0B8-'H7>#/.1X4YCW&GNM%L&;=S;]\N?!B\=C)E!RP8W/M'W8GS0LD&&
M,:@:D[Z&$<1/;<5W;,4'C%'TL=78NM6HP$\9%:0,WT%EOZ2M&S.:OQYP91XJ
MPMWU]*G=Y@E+<S<E-:3?D_MPTL.YHB\YI2@_*]N=DP?$0GDI*2TDHJ<6R9ZB
M(EE6;"EY7&/1DT4GBLX4L45%.5(X[@CA4 M6#_N\GA:\X8@[^8.<%LSJDL_-
M\'%D*D?-88RR6_##AW&^1#_S9'V [5B2\W+<6?E%*<D^F]<+GV_4(QZSH:-K
M^&0HU&-U:F9^9G7FH<QSF5]F\B@SDDDR6TBZGLZ=Y/FNJW4 +G6.58XF!W?:
M<<[QI>.2@]4<NQT7'(SC!$E#O4S=:BW)C\=!DDOR6YTE^90A+C_(\N4X98D6
MK[Q85@H,O&*>4J&N])<TF%QB5*VT5"V%_S3K"40=57)%>22K. 7[G;&L/%S4
MLQ\N!KE/(7XAEN7T^5.(U\,+7D;%7H_?W0\&Q++P[D4;)XA;W7-ONKU:'W+K
M^KK;*E=6J-N#C37)-TPJ>6O+;;?6G+AMU-S1]1\][Y[TXMWICVZ52%_?P+Q]
M=]:?J%8K*I1;=]0GO9D9_T^JFCIU1_5KWTO'^&QM[;3#-\9]]FU+)R_H"OH_
ML>TM;@;HEP*B&T99J!#]H#NFBR%0B4 0%"'HF@"4=^F*;0(3"@89G#TAE;[V
MYTV(1D$!E$#8ZPB&NN<6#1HT)'UR=Y#UP[F3D^@3/]D+3\<=DU%YS_%K KG#
MM,M#0>KIOV$WU@SX^AH#,51KC;>:(@_/"7GO7A#HOUB_!1>Z16\%=LJ."N1G
MX0Q4K +E9W:OP-UBN16H, )G.2EPYA%<%4A3X.#C;!58Q7 HR,BK0%VSX- C
M+;L"=TF& _I5GF6UNV>OPAX@B7Q&>@RG\UZ/K[!'+^ "@PLE_']\-G'SC#NW
M;Y\Y8PO&Q>7E?8K*AQ23S8OB]7C3YMK9VW?<03_H73ZD3\_R<G;<\5=??>6E
M-U['9^<W-\^;OWGS@I_G\M)__HTW'7_UE5=>?N,L?IU^L&#SYOF@;>5M7[!]
M@"M)H&\],-;OX .^ "D2A2XY"(G)+G<@.SL0> Z)(/9BB/C<@1S$%71)=@EB
M-N_U%F3,M.."F40)*Z+0+=G5)9N-N5$.HZU=&6F,D$@D%O"&?:&0+W96EKMQ
MWK-E/KS;AQV^5!_QM9 <7>JVMHS#YT 'J4DOI":]-5Y9;QIUT(?"?%>)LP1.
MZ^/^$E +I^5]RN*@*8DW&M2\7)7:+/7,&3AHI6<2[(SEY:=%%0?#YC/='D?I
M:J0"9]IB%2B/+7@<I3DR*G!4R;!81+FS&O[#E5$@/2G2HE1S+%X([E[%?E[P
M@?Y@4UTR*&/\$J8:1/G#I&X^>^1MG#*\]\&E"Q[]\V\S?#NR^H^<,7FL,7]"
MZ8C>):/Z8*?Q_9QQRZ;HFPZ<Q;9'L>/QV8T#[GGQN?4?;#&>JUB0_?**M96-
M@YBU_:?V'S9AW. ;;XD7X1VCFH=-.78[-3:#F"/H.].'EAQ+.$_J.#W4:7*(
M80D[G;I(@K' FP:B%:3;DO:XY0;;7>"LV/XL<'RN'WXP_D&_N<88B;\'[MO0
MS;K+I\04PG-.&P3V=3:NCK>=!#_#$X<>DM=&F$;&*J1P9<Q*AE3!*\)LMIL6
M+'Z1NI<X_&!9*?41.$:<&B[D9>S5W'C]G4=QQHRZT=U_-$8^@W_"J?AK_/G?
MC;CQUD-&Q$BE\^@+\WC+G,< W1<D.?0V'$Z$W6*=@.I@6?):!IR<;C\MG!,(
M/7PI,,()G(/@]ROK+[=J)C+I^'UWALO94\99A<BID2=F_-#]UKH9..-9^)$_
MXB\?@CB=^;N1982,OQH2_?4>S&0R GX]@.[3G2*#O6ZGP^=2_?: 3=$\+^-#
M8+-HEY^,,-ZF]^>P77/(K,)[O'[,(LXE,LIOQ0_YR<R'XD+NMPAI*((*D(Y6
MH2:(O4^C<^A+I%A/EVB&,!0TN03S_BK^%37I3BK(IM'_$:S_Y5*0[)(2X%FQ
MSQ_+*N2%#@',XH6L7L6Q'K&[KG/@A<0YZLY8[>0>XV_/Z]\WKWI<WAWL@4V]
M<UJNK]Y>V&U3%[5H_>B;[[EOR.B-A4%8Y034RBQ@C\%:ANL*?UYD9DGDO(+$
M%CSI>5[9Q0%FF*0G(Z*1*C*;U)%5Y!P1"N  [V!2;DL85F#W4(H4+J+\4O.Y
M>T'4F5:4!C@PS9OFQ'N-$WC0O7B0<:(5;]Z/&XWZ_<:=E,J;C"^PCMX%*@YZ
M3N!;L*)'5Y$I.I(%_BRS2EY("#,=GP8*D3T(UP'Q""I7YJ]K_]'2H> /6T-:
MO <J"[6&K@!]"D&DP9=E@8?;OG]@_YQN>>3==Q<V9 X-5$VDOUB$6_#/9!98
MN7P]B>!9#"(_6-P9@>J -[S%$P9126*I)+7"HN)46XK2O$7X==QR]"A\SX/P
M9?UAY@SJIH?)%"3_?V;*7CM35-9JS>_!_0"#*6!H^P9_!#+&H+YZ"%Y.90C5
M7]!9!CC"8)8,X7 YVX+'/;<LD!L<!E#-=%LH0(6Z@1N:\%->7(CQA(7&WB#W
M[<\>BOC[ VX=Q9T&W0F@J;J_C^A;SG#:<MGN7BT,"=E7H_+@@NV63VP=IOTX
M%-2DE<X.+&17'."B3LE=@QV*O09Y63CS$SASB5H-4FUP\/"^&AS <+CJQ5:[
M-5=A#[\/E N,I5NC1M"I4;O8_XU7GYF\Z.QKSYS?MN&.FO4;9DUI(!_A>KQL
MYTECFG&_L0;P_"[CP7_]B&_'4[__$>CR/"QA-LQ>1E5'-@B8O(2?@<B%QP\!
M+'M55V2)0]@FR6"76O 3A[$,4EJF:P3A JSC.LR>PQB7*R?Q=+P<F8M,2,J/
MU/"9!B'>:H4J:1E.%0M%("R%9/:6PF<&+WDA5LTN+5T>>7;@6]641_D /X?"
M7,)@!T*BABOX&?:E]@W^9H'SB4$_Q[-*6(T[ "SJ=F6YBT/A5DQLXFH 'RMU
M'QJ2K)YT'&\*[PD?"C/5X;KPJC 3;B'R45*>U,&!RLK+)A<N4VL%T+LU?I%J
MOLD.U>V19-DMUF#)HP#!,?@D5 D^R9L6<Q5W^!Z0=],Q$0'6PPR]\A6S[KGW
M5ZVIGK9VN_;^DRTO;7E_[=# @0.UF'WNO3].JKMO^R;W1Y_\]/"]1MNG#;=W
MAW4.:/N:&0/KS$%_TI.G>.>3>=[CA!U(QI IA!DB1C3;<DG*"OGB?@#-Q]S+
M0QR. ]V/Z27,\BR[[;BB9")M]?O)%Y*_2VY+9AW)PY-)<C*_^E3F^YD7,IG4
MS"J P4-R?2?]Q_%)5-ZE8_'FTN?4#P7$F_#P$(L !2PJ  S&3HL21>&8ZF+%
M]*@:=86U&LS&^!HLIL'!G@HOG4D@J%R4J4%"AE2#TQPIMAJ4&D%::6[I5:QE
M^O-*=['+PE 9Z4*Q/W%F&@T+:0D4$(,<QP9LR7NA9LOZR5WZ.?VSUL^Y9?1\
MK3GIS#V;WQDS;/#$/O]X?.>G>$W ^/+I]:MV>1XF=]=-6[YF7>3%T[]];,K.
MKIX).ZO>,MJ^I/KH!BD:!=Y:1G;TL"[)+&\CK,UN;\$E>IAA0>M9&\L(]E:1
M$([E9&2S$Q8)X@M8 &\NX[(C-L1 V'=:+Y12$2YI1*=0&V)203S+4!6:C5:B
M1K0;'422 ]$WJ^#%*?0^NH!$A%2@(I@@".P@=#!]"<5/IAZ44--&\1) WH;E
M9TR5 ,.-"YT0OCD9)R9)\7^3Z**]>[<8ZW'5/N;8E2'[C$<(2[;&[P"IH7:F
MFGL<):/W="]-4S<D,<7N@:0"I(;-$%UN=PONIX=5AP?D6'6X9;O*RLN]WK#3
MU:HY6/P!%:'C['(];'=]#&,'Z7XUXM0^%E:G!JH"Y%3@_<"% !,8D@H*=K]N
MLY]43>E)Z20]%T%\ZN? 66DHJ,4O@FT,4>FA$1. 1;"6KI(&,2^7ZT#T 5^(
MDR2? -(2@H/HEVLP'V1K$#*EA H( @E)P857!<,-;HP!Z.>RQ*+_@ZZ5M]9N
M;Y[=?W[Z/?/):"/M^CL6;;MPX<5=G^%5VKT;7GGBH0,W]?>1?SYC+)A@M/WN
M,^/=ST$*2H%:%:8MR4+OZZFUS&+F7F87PT9T6[2_**7:ED>C[B#^@/*0 &54
MW<LM#W*IR]UV*<D'"S^>OMHQ) ?"FX%'?>79UUKPRZVF<0,SG@@)8>VFWO1(
MSK0'>%&(.F-\0*I!$5=Z#4[Q)-6@3'LZ73\'VJ*EUJ!D+QPRU&AGLTX5!I7?
MNOA8+$M6LN1H"[[E"!=38 JW'$80:8-V(<LB 1"AZL0S5(F 3BH&/^"D3L&'
MVT,6H"5S?;,WY[I1JX?UQX4[*QH_N6-_S;%OOW]IPXGXB0<FC]FP_O;J1G:4
M6E\P<,]&X_OJR4;\\^;OYN#!>"5^$M>^<.73W:\<V[WKF:=!]H:"3HWAG@!/
M6:++"FHEF.4%FP)"=!R<Z! [OUIHP<)15&YK)Y1I:FBL9_F A$_G$9/1*X2+
MAS+RL\9/GNW,[%?KV)\/W/NG>*ZQJP7_#;^X"SST#<"[<< [/\H _;JB5\P5
M;2C<#=E2 N'EW;JYTI;S7-9RESUEM4/"[TL7I.^D-HF5/G9(4I?5!QVG:'R?
MZJAR$,>0[H'5X-Q/,^>8+YE+#,M\[&68S-7>\H(.AI;D:Y<!>'081O.5R5O*
M5VQB *<)!X&_M^'\;&>7&AQS9P)SA90:G,X%:E (!VI(GC^SAB0I*35,5WN7
M&B9'RZI!40\<4L6T&IS!PB%(PC4(Y_NZ@9M'R3*\4')5>&&WF98S83X[!ZOX
M:AP$EA);D2F\X^[,YD[G.#9V_.M;'WCCMK&SYO]Y_U-_7CQ\SJB1<^:/&#&W
M^_TU4S=MGEIS'Q/.WCK[B0\_?7)&<T[NZ4UG_OWO-YM/X5$S5ZV8,FW-JBN_
M-.S;<W?#OL<2R&9<0H?>T=.GD'E@=383T*&H,E 44Q70H6#J<B<'M@5@G:E&
M1YGE0;M(U49W>(?D6(JD=E(@R_W&J?K0U$IK)^WIF9QI"["\/\9%W=%,6WH-
M8@-@-5)<234XHL'+#'NT!O$^\#O)GE3J=U*OT9]."B3)69*I0&Q,-A4(2^)5
M!0)@#Q1S]<6FXA3UI(KC C1EAOV) )..&+LI_?$ABV_-VS6R^9,_/%SWZHPY
MKRW>T$)NNG=\U=9-DV]?CT=I?ZG!Y)G,L=,QOO UEK887QK_-#XT#N]\@>G]
MT/.G]S0]_0SU22:"96-F9KF_GL5/89DIF&=EB"7I[;6F<RS[7WA6[(1G-8JH
MS!PAC;TIFG+38-)$M_OW,V/????*$Q3E$@OCF[^CHMMU26%E9HJ.>9FB_:ZK
M^"DZ*ROR66$51NI"X?_Z:<?_[Z<AQ.O _M_"P4EYUCZ-CB!@?R(,:)]3>S"
MT3CT)XA^7D,\JM5[8Y9AMA+L ?B-6([;R@/,Y1'^"GW%1I@W=/(%^T6$>X/>
M/XU:%Y&]"Z-R(1'_E)HVV*)&_M#64# >#P7@26MMI5E3\*R))SH][)6P=QR3
M%-] %I+5^_'.(\89XY4CL,H)^!&8#V]RI/!Y!J(4"%9NU=T"/XNE&4D!#9%X
M7"ZV_RK\),HWH>V/IC7#-.2"![/@RM=,B#Z8B?OC#^Y'UZQUFMX;L 392AL2
M,>(9EMW*\1Z.X]%7_%=,A'U#Y[Y@OHB0-S!S%X^&B!R]*1^^NE8S+PQF%.*B
M_[E2"1?!_Q@F<Y$LC&]@DLAJ8](17(9+CQA38;6#P'X/LW+KJ%E/FV=?%U@7
MW,EO=VX+\J(VCAMCGV*?&EC,+8(P5U0; 0$</ZK,=.$PJ/0VO4ORE-0D.?FN
MU)0Y:&WX!7'M*B_V;E//-IHY508Y\' '=I1'QMW9$:&";H.F7RXU4?:/)LR^
M!F(_3B'VXQ;$!I"(LWH6]^I V)W (478(&!X->F>/FM(WKWC*U>[M_O>W_O8
M^<$S)W1CMNW'M;WNOWW _.&3^]RY<].#OH\_^N/!ZCT+)L_=9&PSZQ]CC9'\
M#.X3I*-A^ Y]0*D^2U^NWZMOLS^D[QAT0']FX$OZB8$*G^7+&I0U)HN]1W2Z
M-/>@P>4JZT":VST/.2#(<ZAHT&"GRRW<Y,N;&:/*5)"3,K,7<]-,1= <?([L
MF]EOP$SFJ7[RH,'6]D* @J'K<\YV^2@TN:[/JCZD3PO)U)-[7+]6^$WZY$B/
M@AYZC^H>[*$>7_:XU(/I43Y\_(9$\#0T_F.K9A*/X@HS#PT:7P9.%#R21M_U
MFQDWBK&PE;>@OHF"K6XW#[NA?WY??Y25N6CO:%(L$NT9RXP51$MC@>C0J!3K
MSUX/\+$X] Y.+4IOP;./H&@^?=8#R-\W]#B^68;/;^ '/([")2GOX+3"%#H(
M9W2/T4$*"E[G>QP-$V]ZO#VM^NOF-9K$LV(F:EJSP%6YJ/?R%Q<R"9OJ*NI)
M,C/26>+TN-C"'IG%A2IF,R*9%+]D%O9@75Y-,.TP'=TN$80YUF==R:);)F]Z
MM7+ 7?GA+0L#Z?ZNC]ZYT_CG[I>,]TX]@\O.OXYSAVWI_D?CTG-&W'C@@Z]Q
MU=_.X)*7GFT^<,N-QLQ9 _K<.Z5N>-^E4_;><NNLM>?VX[)M$R8\&)]TCY8<
MO1<K6P_CR*/O&+.,^&7CJ</[-BS^P\QS>"M.QOGXVV].&\U_,#[^\^F1N&;C
MMOD_;;AWRW3C,MC;-@,A=C+$&@+8VP_T2=DHBZG6&M0GU./J.4U </J1G:DE
M@#[)8H:E-R\%.,QRDHV5;)QH,V_W((A8D%CRF V3"+8)0A7"M,1!;"Q;924I
M;"+!A./'2F(+?DO7!%V@]U)"\'>(L!KS,CZ#;/"(P(S"R*'] );" N-F]H+:
M$##=9IW)U1Y])"Q'KIG\*FG0SIP12AO.-,"35BK0DAT&+<[ A3B#H64EAF:^
M"'[O:?SML7L->>UAO&UYG["_"W?RYX'X16, &8<?>&'^???0^M$RH(D(--',
MG/9YO<]H49)<62[GV.SL@UFGLDA6%@HGC84EI22/U9 H)?.+_3LS%B.;9B,1
MFVZKMJVR[;&=MO&V%M)-]^4D)5=C*VUD9N_H"4T9;48Y-%M=2LLTE97QRZUF
MOB%>F@A'*FGRU4ST6=JA,S&OS^,C/!L-QM186GHDG?#1F%OTKP#;[5^!4QT9
M*W!,SEC!^ 37"B0&N/ *G&Y/68$RE:P56*;0K#0A\EWH8W6A,ZV'B<E,9 8"
MC]-ZF$8L#PR;L^,\(VT9?FW#GJFWC:A=/.O8;N,3S$[-[=>_;\V:?^+<R?D#
M!@V8N]3X&W=R]/.S:A[M'CM^][HWQS.WJ-[)HX?79O^RQQ5:.&[4W"+P*R/:
MOF$7FE;\G#X@&"I+'DP&JT.<-X5O4\<[USL?)#N=.T*[PD^3)T,'PEH6R5:[
M.J/A8M);+746A9]V2KFBHTW[@VNIC<%M&GQA"WY%CP:7LI)VT+$7';2JO75X
M%=Z#3V.A#%=AHH'?PAA\8T"W^Q:?$W&!.$*L$QGQ!%%0$@7-8.II$8TF5"Q$
MES#U*>X I_!13U2.!3C?).16X. 7@I.05W)-PAW)+--<8#_/@M)3+)9)[85
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M^#GY7/PK^8OX'_(?426B+"^R*HG8+HL\.<TU@R;83\O-*J*;L&5>;-* +'5
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MSUO.V$^[ST?K2C6!0*N,C&F9 7MF9B E)2>[,B\_7P#M.U3ZXLXC#IA@VW.
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M%%R;'20?+R#]%@AX#:?CN1\9]A/8TRAH?M1I/P&EA@M_5D6(8OJ0D#L^!3S
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M5%VFZ#I.IW=?C)\WZ)-BDQ.2A.0X7?0H&*])' 5B#+Y1T,_[6A"S\22>A/N
M NWK<SE%.S'_2<)S%1X^^"JBC+9HM[KP)7AK<F'%B+TP\#HL.[U\<D5>-9P<
M?*4LHT=-SI@W-UR8L/GLON"%?9U+JB&S^W58>EP^+]\[+ >KVI7PATZD)K<_
M_(?:)Z!K\Z-'Y)]NR&_V.'T8RRQYS=]SZ]D.)#XPZ SG23,X(V?BS,Q6WZZV
M1[C#,0=]S[5]@7NAK>8)[@G7"M_C;7=QNUS\1#2NXWQNOFNF[]&V?)JN4%=J
M*BTL-W*<43!I"Q@=E]6U7]?%73=TK>_*EW2%N1HQOW.G3E8^)3TNVF$2VY8
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MSQ(/+]AS"^PEGR%O^1"<OA]=VP_GR(_O#Z;OE]=C2IY"DV!GIBW1:)[&:PU
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MT:(I60<^4#4E5/LA_KM\U\/H$/]F(/R;P08?\.%]V/>_,[2HOO]&4@Y#1#G
M-ISB=9HV0RE'\U=J6M;WD!]V\_<XQ8^T'$K:CYL_4NGC?0_[5^MPBH\CTJYO
MOAXJ,TO*+&B4U*$R$^2!L1'EZ-S\O5H.SO>0E[>J#<H/:X/6P8%JW5%M4%Q8
M&_0K> 4?P_EJ^\7AM'$)OTS;DF]GN%S--Y:DC8E,J^ :Y(=Q#=;!)+6\=EQ>
MNU,''T[;@H'P,>RBUIL3IW5Z?IFV)=_.L).:KX.DM8?3XA7B$$Y12'>(1DM]
M0K8";(BQ8D/L%PMY!4@VTI!I7WB]UU=3+%RRXG-E2E1:5ME<" /+DHU! BU[
M: OE/3!][%$4Q;T*>% D^<R,$BN4Q<LKE@]N,,0RB5_&G61W,R?A,D1</P42
MGOB.BI$>K"HNI. B@M^68_-#3^61$WL:GN4&*6X'Q#>.?0VE<T>!$TR2\AW(
M:T*1T!_E:)AI+!IO). ?<TVKT&K3=K3#]"PZ;#J'&DP.@_XH6VDC_JM&3:7Y
MJ-,)#&O?UT-] _S]2>=:0(KC(HKC*JHVOMW8%+Q-@^94V9(+0D9 !3F*[HWL
M=_*P35:WW(JLF*@H?A(SO$MV>8$G*I%];5+[XOQ8?^Z,:6T3 UFDU&[V;>3F
M1OY"2Q+6MH>T)+:\>(<; ?;MK5O)?4GL&:3C&H !4YND01K>C=P\FXI2^;:H
M+=\#]>"'H"'\S^AG7D=^10"+HULDO:Z2!6L5OXX&%"=%:=8J*(#50IU (A0H
MV(DZ03 96ZQA @JQTZJJ8(ZR=9%#Z(4'QQJ7U=0L-8YU39>Z<0U+ERU;NHI8
M&;W$'H4SN"<(]W("/P=J3V&JB-W9*0C>8"VJMT?(V>.E<^S1K[ZB^[CL8O@\
MUTC]W*><+- P%V!KX("_ V;\J04\;'W2^@:6SEJ?49Q(5-_V*LK]!^_\'US;
M?\NM?>70HG9#AQ05#2W)34C(RTWPYW+M>HT?WZ^L=OR -ATZ! (=.F!ZA\C#
MX8NXS#;0X1P#& 2UE2:RJ6P 5V N/T;\&.BGXV('SI$=C _!2<Q&WFZTR%@.
M4'RS"/L("+OB*L@)N;"&/0U/I#\2W:5TX>3N.=J\Z,[M"W:=F*0;T*[O%,,L
MME5\G)_46Q8>6=.I]XZ I>]4Q-_ XTJ)>HP[S '^E)F+XY#6S$$-MUEQY=$,
M>4VUPPL2>*BJ1JJ*IF@^JA\.\>O)L>4P66,N'CLT_@]'%?\>.M@@V"97P"!P
M8]ZHM631 +Y2_QG0P3H)O&+2:!N@\<P29JUIMP4/8*+7N>VET ,$D;$@1['T
M4#!R\G(;QL9UR>[0JWI@O['NH;V[#F@]IWCFI'*"K(5I2J6S1:$42_SF+(R%
MS!;H!I906#Q#G&1VLR?9DWC.4$/H--X,31:!H#I7%.0P)')-\O!G&_:<.,*Y
MCQ("B$XS"  SGCL/C.!IJ?U>^"]X!S$ :E@CPQJ1P".!TVEQ9>D$A*9!#9:.
M-!K,XY&@P;JA!J,&&:&@J::;,B]"XLNG@4^=X7351B/; (LD;SB\DG(BX5/.
M LOPH"/ANTQ4+KI-JOFFI;%*5,VFL3#A4@W@%6<B4&43\@KP%%K@$(CT,'/.
MG+W//(/*@P:4-__9!>CSX!N'GCT4_".)^H17 0 G48ST+9($C%E&5&8\;D3C
MF&?QV,>4Z1E6'TD9I@<=BR0-Z'5(#S5&,X5-R#O'Z:KT=#L#YDE6ELW2E^GW
MZ9F->DAVIY!>P3\/4@3ZFU68E-LA0A0J5BT,43&-@+ZW$.*?,''BUD<>V8HZ
M/++G$?1%\/R,W3.":;C\-&HG7?'RZ2KV)?A97?&R\2J6DV5):5GQ*%HM1?L8
M3)%8OIRF8'UD)D#0.MWL;$E)HW?17-NKN=Y1<Q5QKE8S'[$^4S0WFFN5DNLL
M)5<;SM4N\A'[12V(7@(8\C*>F6Q @">P9&.3LLD,@"N.Y9X6>)["<?K01705
M?85N(0Y0GX[CZ@6!N'3LUJB!H2W%%,:?",F8UR<"I%^T$8_LF*5+EW(?-OV5
M<=Y_LND'AM@_-M_#"V8UC>_N!V])6E\2+-$P\0C+'9R4GI  8N.&\ARRVX9:
M@28AP>:9FT71$'\TL,! 3JL-)*8<CZ<EUQD09ZOF$.FYSHA@PL26F?&%C983
MP](\M383:6#8L)]88RB09;808S*:C18CP[O<3C?B"5RK1L_P4=YH+^(=HF<4
MC!'PP6VTCP)>?:RZ@=4*OVA86 (H2^,-DX"[Q$ ^*3Y;<;0F'KQD'"Q:L0+N
M?:K?A%V#)^V>VF&^W(CEY7VMVLT;*3W1!'O+I]%3*]!34?[S\E]>^U!^?:_?
M=FSLU&WO?2.G1\O6%62^+,2]9R2N.V(Q_YZ4I.46IZ%L#8L+[.88KX=C/9YC
M;LZ.OSGB7%Z>88'5<Q[F #=<?CJNPLIS#3!'\N$ATX\$2DBJT.LY3@.@EW'Q
M#H];FQ!="ZC?NN=D0JV9H&&GMD0J5N#2B)D%EM=D:G1B#9MA6930?!1PF$AO
MB;X4K6A,2B8QE!(-">7 )^)#BC:I'/A-^!!OB:.V6"T[@+8<IZO 1?P^$$6U
M52($48>R9,463S$XNG>B.+T^>3WDOWM^QKD)GSP5*,T/=/USXJ4R../)R1/7
M;IHX80MW/C]KW+B!\D9YGGQ?_GK!MR]"/72Y_3-'+:Z=,JSI=Q???O/#2Z^\
M%]85YX=UQ>O ]Q&R@]&L:(J5,:;HH5\-ZZ'7$4RG,*:/VZMHH9511J)BNW$[
MF?!*LTM*;:4QNVTF@W&HQ?PYYA:'NMR?0\S7V.9*VFKM$NT^[8]:+HO8.]'0
MV,CT[T)C>QX*C5T25 "WPS'O2#ACSJG$5'$DBWK;(NCD\,&JLRP"=HUK4<B#
MC\3'_JT(V7MA\GX2(OON R&RY8]CDM][\M)]^6/XR<K'*N8'PLCU:ARFSZ2T
M!Y'K'7@T8?F'H-<3['KQ(?#Z%(#$*OB_@:Y70K,K%H%$_49MN\7_O\#KQ7\#
M7K^EPZ1N!+Q^1\?Q[17P^M'#-I.8@\&F?H4$O?Z_Y$_;]HU$KX>@$BUF9C,I
M!%]1LC-H"E2=C$%/#I:R82LS$%!\&VC OWAF=M.WC!<MIK9ERZ"/Z<.NQJOG
M4BE)$#0ZO4ZKYUE6P:;E6)832&!; F&KPQ,:XO%LF7^&Z\1H.@&R_^/T:3LQ
M>BUW0-/)QT->WXDY #KQ*)!STW/;_6V@"G\4 S?^ZO4$\?>;GF"QH"G6%"O!
M0"*/F"?6P@*RLP,%+5P&&5FN(8$5Q\C-$-7(^ 5WPB+8;IY\&1;.E:_(E^?!
M=O(E3,-@]#E<R;V#&>71DA9HW;!&8+_#7/=1*5\C1&'9F67> !H\/L8H4AP3
M\DX)=9:O%!\517N+V0'57*Q1L2A1F12Z1T[6)E[(ZX 9+!&:!M7D+$P>BCY'
MK?K[YMLG%0=%(NWA[S9<&B^HD1)N.'YP((^[T@O<A@U$NQ?0E^A_U#?K>>4+
MHR=F65%8\HK2UQD,@!MCG7[! ST]H]VG0&E42!6F@,=0U [J/$J\$I3MDRH;
M,9S,BS0VIG@PO!#OL!O>>#10G)>7;UW@>73"['G924N[Q,#VZ//E)R9V2\XM
M:MW%,F/LU!&#>A5,;Y\XE_0&+WH;B;CLR;CL>I_/^)W!X$T"&X@D(Z6QE4D>
MUQ5;I3?*9[08# G ,B;F%6',A028T#/56>>:#NM :4JXR"KBC6J=K5C;-9)@
M;V(8,3.,*I_L-\,"9_Y#9/""(IAX'Q4[! I*.W2.LEK;=\[+S,RSS?+7CGYD
M>G'>^M53/V/VFSMD]VJ75XC@([!M(+5->I%K2O^QY46#K.E;QZP@>X"#FZ]P
MPRG.TX]XSBT +R)%;W*+Z1'$;,$99-("@<%S+YVI2>KJ!U)+)#5:1U.;SC(1
MR4EZ+TY?2=/_]%#Z+FKZ="WP,J!#GH*JAE_,&3KC+9%R]":+$6TUP6VB5C-%
MK]^@J]==T#$Z'>YF4S@6B#J3R6KSZ:#N]?>Y'SET@48@GBXY1,$RGH4?$S\V
M9!%_%-&7(A3)!&^U!"/8E9M5"E!IV*N=QE909WL25S.O14=/WOXGGGB"20_.
M1+G!=Z!?_GPO-"QGTX_)[8[)_[U<OHVIK6K^CCTC).!UK!6MPQMP/IQ(U[$4
MO.:U2M1%Z.)H=#&N :?MJ:0%3T7@4^:VMGA:TI*PH[WYYK!.Z]/F&RJ_2G5K
M0J1.J[<\G,2Y1\F48R:HGH**\Q@(<<N$5Y:'D\@..!7AE7GP69V2IE6Z.3&4
MI@Q3,X>NX,FJ9BJ@KN#1^*G1L9H(;1.-F4A7\&[J"KY.7<&]> 7W1@L1:95\
M"\+Y?@E[J=3X<+[Q_S;?+\$)-=]8G&]<2[YJ/+X#N.]X0!+XAQ2S. 7V2X%1
M4HPY2G+Z4S6&&(_3[]$3VSL!S]3K)?P@Z&2!O\(IQ%28]9H9*0@EI_AFZ&>P
M51Q'%U&SM[:?]4<K,EOW6K^T,E;"MR4KH0P)X"T=KQ;%$;)$\6TMH;TGPF,F
M.C$I*MKBL"='6[SE(-&!#U%B3#E(LOE_$=PP/L'ECG?[)W )+M\$Z/8\&-LD
M-LYHBC/&3&!C3?A7HR$RM@GQD\UQD+TQ_X-Q#A\(<K)+_@N,VCI[]A,1P0[E
M@E"L0_:-\4\\,?Y^V\B8A_*X4+Q#V'R;'\@:>!)?*OX$L2A>)^E# 645%*!(
MLQ\24)9UW_^>/U]+9L_7T4(XF>F)[[5+6K2,7$(U  0:8:!*W;!Z_3!:&&'[
MYP]KM&] +9Q$1X;-AX#3$JG15A!3&\(HJ#?">*5Y>!2US8Y 3&V6Y0K.SIT/
MX^-^080FW.L1YD08-HR *E>PR71D=%%2H30U59ML7WPHU2(B:=$^G*+V89^J
M#:8:WFBH:2EC0?/WK(%[$8_'[B0M;$2'^5S@P+47!U#<DH2$HCC,";V7GDNZ
M,2ZG*L4A)_@.4 1>7"*>ECM5*1$\HXYH@Q'H(\I-HE'B5#V45."F6N[H&!5=
M]5=V +Z$R>K8L^"Q)YHB9Y*',5N_)'IB2J,/UVW\ UBPC^)YNY;.%0%U_/]=
MG2N(1A\S26Q+VO$XQ0Z:MI^Z4W#ZMW8*E'RY*Z%\82.<R4O = 8*B/Q;WLMM
MR?-[[@I0\X2-8(62C@.0BTBGY$?JDN0G8-;MEEJ7@J:E#Y#<?L8S23+-C:0B
M&*.:DVI68:3C_##2\3J8K]) D8X-D4C'"M+KJV&DUW7@M0?032.17I5\"\+Y
M?@G;1.S\F/]MOE^"4VJ^43C?Z ?R?7A'XG,X\]^B+3^,#/LY>/[?HKUB>8T]
M2///4^LC2MWQB,?C(=X?N5-$HR;1O,L5O-XN2JFMN-16>^3(47(M".?Z)6Y9
M990EX5R3'\B50&M41N3Z9:Z2JY/4\0.Y*CJE_+!.:1WX46V[UKB.6V=97+^M
M4UHW5<DU#>>:]H!.J15>4;_!/2L?<SDDU\_ /;5G:77J?@_1)LG#X;^XG3A5
M!<WOLV(EC<=CM8;28-Z!^8927:"VZU_4/D 0MXVZR+$4W_Q?:";M]Q7J^+ H
M_=X#8*RYI=\KNT'KPKM!?X(2W*?LHL50]&ROLA\4:D\%#?>G,!KNG\!)S/_3
M]#Z*AAL3@8;[*[M-G\/>#Z%S_UK^+<B\GX/ZWT;;#6OL\L,:NW58!HO4)OP[
MC=VZ&J7-S+C-S&)D2IHK'PSG^BEDX(R67"V_S/6)<*Z?+H[(U=JB!X1@!4Y9
MA>=[#A1)&9R&&4K\*=AJXH>;I82F)^[59)/M8HN'[BV.X0(D]',.U04ISOVB
M?P6Z$;R\EWOQ]_?^B=?. <W7V07<E\ (W" :') 6M$/M^'QSOJV=HYV;]UB<
M5J?=XV*341J?IDTV=D<]^![:[L8*5&N=P^P0MAF-WJ$;HNNC+T0ST=$:TWS
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ML+^Y0WOYKSDP=M"!B5TG[AT$XPKE;[NUUY2N^!>Y?37.Y%_4U^>V7,KIN6^
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M D0O,+VRX6L9:$Y8;F8NH/3HDDP.V7RX:$FFM1=OZENX?. FHI*QZ\\W#7P
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ML6[2/![_D<IZ%YH:SG#U,HQL N8W]\KR6@&3K?#=MB.V-X0/H97,$5DVV>I
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M&<'R8@=;KF;J>/CF<H:7;1%ELT)+5FC)AK1DI9:<P,,)/%P(#R?QN'CI"K?
MZA98W2&L;HG5+; &!-: P!H(80U(K%;&9F.]"BM+[J!EQ$M5Q/,<N M*'VLA
M7J H(H^A_,1/2?<]=@UNX<1>7.3P:;RLC2,-6*N:W(KS0ZZ6GB?*>0M4HC:5
M"WL]\31(35?D\EZAXES%G(OS5ZB)HSLY5\"G)A[)LX4''9+/H K6A9P!G1;;
MX><8AY4K+E;[ D[A9EOI\;JM 8L?>3@=ENDGP^W0NKW68NSHQ._#,>W$OA#
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M9$2%O"_>B3-XG^ LLC+0/P Y 1C**8,Z80"'\NQN>3Z_E YB LJ@?I1FY]
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MLZFN;T(+$@#BKL9@TH.'"R>7?N(I()Q O'0\Y#%>RO%@+^94EH#7BS?Q%<J
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MU@3L4918[V"&-PI63"Z7A2-X$M/:#R? 'MDF894VJTO&?BUV*^^>[1'JA?;
MD6W!)NWM"";FK=$LA,Q[FN,4>YGCVFZ!5K %V*,=]FCGB#(4RRL+"=D<9KO#
M#LG"J.R0A@N;M[,Q<8>#]F@QSJN&3:AMCW9AVV:GDX>@@.AD]=I<HLB5=FP-
M]FASV<10(6*+L$,8H=4F@ ]\8S_"7F$(=KM8R.1B>Y3=#K9'#' Z8(]6MD?3
M(?9H8MO@,\P<'V*/*-ADNSAQ.)^,$18>S/8HU,XE.V.*P6+EXV1OK[I@YL+0
MYP(XXQ'H=] >46MW\E&$G0A[A#FY' Y(E_]UYJ ]H@GVZ'98':^S1_.\.9IM
M1IQBLX&%-V>/#@?$!?1KVYC5Y+ X+&R/O E8'Y1IY<CV:&6KM(@2&X@=BS!4
M8:^R;.5HE856;(=MCS('@(GLQJX@2T ,9C*:G6R/-C9+BT!>"V,01V;B4'N$
ML-M\,J?,YWQ)9OMS6%B,)MG.D>W1"MAR.$Q"HDZSW>DP.EYOC^#%C@Y\31BQ
MJ-G*F;5M23!FKK,#!C$IVR,^( RV"A=4:[//VZ-#V*/=:<6R/(L )3YL;3VS
M24#-5MB"HVWLPAX%W)AEE]5*BNHB$]^55MEE9 -F51XT%2-?@%:WT^' D7 X
MS=BFC-/!_#B=;E0R*MK: W@+1JO1*;[9'IUL1T:K#>S;V[?3PK2OLT<K_W.>
MF?LIL!_,;Q/H[X1UFG 4A&_ YT'!)++3I@BX1[N1<PC(;%$8!@0 BWO0:6S[
M#^Q'V(T,(D:7#3)J.PUHQP$&:+(1V_B"0\166)M0M-W4ON4<9@?Z0&$6+@GL
MP4"V8LQC5A0K1_!D8W4Z#R? 'NT*!RA14=V8E6\:" A:EZ$R,R_)S+4-S"$B
M,V$VMB-?Q.C<YI,YM2UP[82RG%849(?39G([.3J%G'AE%HK3X;(X74X3= J^
MS2Q2!U2*;V2 558G;Q,GMGV&+>)F%)> T^[@>U860U! E%F]#KE=Q*?3H2A.
MV>Y0'.U9'.)?=1USFF94$^*WL#FTD8DM PN9%;?-1JIGSAYMPAYQ8"SS3EC;
M$6/#5]H<@UW<3VY(T\5;<<(^V!Z%+0G$8?.%E%CM!^U12 *8\)_LT=8V.S!C
M$2X=#I8*7<@N%@XF=,K@RP43,-O;-XH*5;J=-I6O$W1P&OEJL[(]J@OV"%W/
MVZ-YSA[9E(S0.9]N>[L+"N:VG?T;>[2X<.AQY\ >[18'<&?!'EWL,=O;]JA:
M.8(GUHKCL.U1Y0#$4CT*LP.P<K$]6F5<LY8V:\XY>W0NQ 5[-+F 149XH>"3
M.;4?8H_*G#TZ73:3XN0H[-'!#D+[Q,KP$ESS]NAR :&%R)DQX8F;VKZ@J7TI
MLFH=3K8):!%BACVZW2QD88!VMXT_W;!P]@U@EVR/;KM39=E:VO<YP-DN[@#>
M#]LC;,'5=LIP-\-O8;BQJ KLT>.5A3W:[6X9/H+= 7LT'[Q:S.)V8V"""8)=
MW)F0G^#?Y51=3H>9;;CM+%MLXJJ!1(7'VG[OV-KVR-(XY/_X8!;#A+?!]P1?
M_G!(9=D#1MC>18/+S4<1=F)VL+1L-@^X4%QV#^,C PI[4;CLX%ZH?"X=<_;(
M<F^[/L(M-C/"&&5, #^;^^"BM,.[@:)M +>V[EW\KG"P#>) LXXA>3Q7,)0]
M%-8Y@Y2+?3'4V6UFU6/G:/>X^!YTN XS.#P<,-#C565 &78HN^ P6]TV7&1.
MYLDF&$9T+<1Y]]MJ=N%J-+?Y9$[9(9[OA%/+9PP68C>K3H[ /"B6'006"LZT
MU>66^9H WQ"8@LT+5\@EHY:G8MO!'MF&^).QF^N<#IEO1+-546#M+I8YS(&A
M!G-@"MBKC(+'XU(<3@_?1VQ]0N-\B[ U0(M0,W1AE6WM=S&K3-B$Q:/:[>3S
M*P2UPX!5A9\43O8R#]JC2=QN'AFLXA#(%AP[5<8=(#/S7E3R.]?!P_'P97_9
M;G(#+M@KAX09UXQ"$D[9+;<15U@@FXM=*)(7<;#?@=O [?;#B?2ZW=R DP>T
MM"@ROZ@Q/23FDV6WQ^WPM;TMN]RV1P<X\,E\,GE6M]LMY#[G]^#!86+-&MT.
M65Q(T(A;<3O<,$,;^U9@5;8A,O BFA@ZN1[]+3+Z0&&BGVAESF @F,?B]8$/
MG]WN<PO(DP\GL$'Z. !4?'X/9L4%Y(!,@4(JK L +1]<U.:V<^3RG/=M8L<0
MD-7FDSEE/MN^HFR'5NP !2]>!F:OS)$'.L"\F__O3+AL%9M;=9O9=)S8I%O%
MYK$V%(H.LCB4@&N'W<S7L:V]8QEUN)3=$#.DZO&PD&$#*'J$H<,HH (7J.SR
M>F6/4_;+#(H.R):5+$ZM\#.Q4=8%=B5, ?#G=L,$8  ^K\-!@: J[-'I]*JX
M8G%@X/L=O%HL##@.'[:BR"Y%L=@4EU=17 I.GZ+XW(H+F OM"$\"CBJ[J2I#
ME96-2 $C\)M9$G+;6YH/XM>;@ZN 9=RF#E4-6JPNG\*'#7BE>.  P[T"8*$(
MB07 A4]Q!OCN!EPK)H9]'%VK/>!F2?"LPB]3+&W7AUT7H2R[474J=C[4Z(*+
MTJG X1>*QF7&F8+]09<N&*?+JH!SW#E6-T!*AH?"=Q[C$+;,GC!N5J?5'[!S
MM <4%Q]6Y7 "MB<'.$"1@: /]S8@RJEB)I/=Z\ ](EL/VJ!L%^R(./\<M%D
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M-H?XD<QO]SI];K.F:CB_;+,V7)0H.+U.UAX6#L+7T; _H5D_'"(-G&MJP!E
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M=48@TA!4&F05Q9Q1G^IS>'TJG@C0H)_?.+A7M) #N@II,1Q;@%8J%0U'HN$
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M*VFZGDS"*/1(,JYG=3U1JZ6*D41G,J#A/O>EO'C]:/%P, R/*H@SI_%^X:C
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MYG:\XY'<4"+A=AMY'2BY 7'NAWK>S ]%R[NV9R[V\$KT42/1)[Y*KNQY@ Q
MWHWIN;GG#C*MY]&>J9BICNW9@O9W2<\N4D4ZA<ET@E#,9]#&O@HOHC_Z".Y
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MCKIV#]X_YBW7'P?_W?7.8%6UT,=08ZQS]8E55E<-3H]1%7C%D%A?T%C0OV!
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M:Q%+_'^AY1ZMPJV@,@G1?I1XHFJSU^/S4(4IJH]%U6&T$*)[!@D:L!;1Q&:
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M769$LKO>+=4J]$JW@GG98"CI=R>"H?K&ONYZ@>?=@E'VNGZ_.QX,]\G4N?L
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MX_.FSVR;G6VS?5;;M572KJ25A7>$>\,"5]D(*V ZB651@@''NE",0RY6 BE
M+G(*-9?8&&/+$()(#"&7.#BYA"/Y'8'D[R-PH(N3G\.?'&C]?]\WN[;(W?T_
M)WOFO7E3=LJWMS?==ZK/?8'8&Z2VT<']Z&5$HUVHZ1DV;-4'.D+!\+9H,!)Y
M.@PC%?\#;DP\^JUVM]5JSUG;[6Q*(@T?1[-8 \IT,/$,>(R1$6FK( 15+*90
MW%!*SN><].M.I#OW.U]W,LXI>O>1Z#]&<@KD..(#HI-%]%SQC\4SF+492ZI&
M\66\P5!%O5C&#(\M?@\MIFIH,0DT )(YG-N.B>78:4A-')L=JY5RINQ!^%8S
MVA#4?;NIY[>L^:0WC)3M,TW2VITH"ZY,RI*7NJBL YB:"Z^$,MZ4"]8NRF+-
MY](*9G$.>[8]J6(V)Y9X@/G<1TKF-(,6J;%AL!=<9KG"=J5R60[L!0CS6&J[
MF9!DM6B.&EMVU+K*#B(>#B'BX&D66(G0S:P!,RW2V16A6ZE)B50K[A&< ,RW
MD^KP/UY\U=VY^6]__YX5?_S>O$KTAP%_6$@F QN?NF[GYWOZTHUOW;ORC>]<
MMZ/7%XC)6"+*[=YWR:X+YW>MV'G%Q^^[\('7):X>*:&??^'S(W=LZKPB'_GA
M#9]=^X5_KOJC)8#\^5@V.D!DHS\9?9O0)GI3>%/D6G0M?6WXVHA8BM5CJV-?
MX;X<?)1[."C0*!SQ@D[?)@'UC M:G(K2BD.,3='3ADM".<KPV>NJ U]ND-H/
MB31TQ@B($J%S$B%I$J%S4IO/&\U%@#[:X0PJHD2V1/9%V,C3=(;RGGG7L  5
M]!+ZY\57?U+?.FPZ4$\/ \&+8 )KJ<(%#EH<%?R"<R>5_J9##KX,95BJ>&GM
M>I.(.F"&1\J/S6(GU+#IETF9;K<Y=(@88H2XB_VZ(V5Q1:]<^QR6R$NSSX-X
M_LTMF<IR(:5P*QL_6)OHZ_G@=$L49ZUVUW47H_GP5BUGWN">P&^UB&X_2I6Q
MVM%>JI1)5%N"M,9:;ZB2X?OXE?P.!YN,)].=\<[THOBB]$-I(9NNI>G!\@V6
M6QT/I)]+OY_B^^VFJ3@:#?IC;>W$8.P"(V <J^:83]')C$UJQSK:GP[!6\.=
M-XD"1SKP!K.@J2F2)!K6FFA@(44LB[0(5F2GVPV\A_ AGMB*0>DSC>[D3A?6
MJTH9C9;WE0^4WRBSY:A./J9./J9./J;>IJJ[7&B;"[D([W+989\K OM<_M+I
M<_K?<,MN UEJ1 /,#9\SYI",M58D9T=YQ84[GN@1,>JF8AG9"=FM-.](II,)
MNUZ@%&?*FBT@BQQ3D@4J8TF"5H%,X8?$_J!AC(O4=D!9]#?6Z70*\YJ/F/L)
M_C4Y$/-S]$;78,YSX<Q/?_MF65\$(3Z5M0E_>.7>J^[\Q2K,<<!<O2"Z??8W
M/_W=UQ_X]-!?:'7G!<ED-3$V^\3JGXXMO^&I5^GD+CV/X4#%6MEW ;MH]9#L
MX*.TZ6T[Y$41Q3;%_/Z(/4I[!3L6),#W55=F3YR81B4(GK2J2@QY14OM,2\B
MTH1FAD5V5<VPR'R)M,;M>KSR?]4/HJ=BS-.^H]HS@0.QOPK<8_Y_#'R/.\P?
M%;C'N4?XQX3'/8]XN0>%"<>$^H!W(L9=[=GJNX'=(8_'N$W>#;[!V.7\U0*W
M61@2-\N7V(<\G!$;I-8R&[@U/*?'*FRO9S&US,XE^:R0$3.>C)?#$F2L'!N)
MG8AQ3<-VB++'=-D;\+9[&:]@@T<,VC$?%\2H'6S:]6%E]H477@!3K1GG;[@I
M#@4IAT<).NPB/CCJBP2C4V=V&TZOP.NB(&!IR(VE 8[G 8"K7A\4 (@ZL)A%
MT0(O?>!#OC^4O89WPGO*RWK?*GL,SZ#G@.>4A],](YY1S[B']4S1[QS68U^*
M030E)A[#_M/#)X<IK6EQ()EZP#MPJY'._QQ :::<GOLC$@W6;,: Y$NRIM8<
MAEICP8J@U$315<-BXZN'734YXX+15Y]PU%I:[Q!DJ7J@R N*0X685+H*)9<P
M=T"HF:-:Y;Z[-%G--M+)!IM6_,OFT^V7]!;1$#)*?8LX*[<R:8MU7/[!I]C/
M;W)'XUPR*143G==\^&^,\X9"N&K!1 $H4?#,[X2=& )K3,2$O<,2ZLVFW$X,
M?6#@H--T2"H'68M*6T0*7+"^6IT XEE0]$N\3;"*LB3(<IFO":I=<]6L> D"
M((I2)0@QB;@-X=9X"W>ZI6IIN33$;I0>D?@4GQ/SEHPUX\H$LL'V3+JCFZ\%
M*N4E_$)AA65I<"V_4=@H#LD;K1L#&\MK.Z[FMPK76:X*7!6\MNLF]B;^)N$F
M^6;+K=9; S<'=X9NUF\LW<E^5OQ,Z.[2W>4]'5\0[K?<Z[I7NS_PE>!]F2^6
M[BL_*CXN/6YY//!H\+'0X^%'2D\*3XI'Y*G H?*/RG\5_VKY,/Q7??E5I<O+
M5W7LD=C>X'61;=%/%-C+A<O%JR1FA;0RNC2SHL0.!3>4+BPS@\*@N,G"L (E
M8S$KY"VUA[+1#J%F:;ESPI0ZKR]8ED*LQ6F^V: J"A9D$6MI%< >PWT_ ?P7
M7CB;XQ8T\E(H)$J2',)R5R0B4CQ&!%? '71E2ME@1K7BJZ0CJ6"ZUM$;K$V=
M&7TR:)'UJ3/;#'=9%'2KQ=(6Q$<' Z%01))E8H@+AO! J!06Q3:PU)9+';P@
MP)Y0N0-O=KC4=":#E7R*MLBR* K2O*_Q#W7@;W;0J':80:8D:#15*%?*'>,=
M$QW,ZHXM'2,=HV3CC8Y3'6+'6^(?I(LLP:<"EJ=IG0J@_S0LAG70>L+*6!_I
MFS=%7_.DB6B0%.M73FK*[&FBI.1FWSRKE\RI2@DYL@3SSG7$G7-P\7]&QKEK
M0;'WB_B?H/23/)OF'Z;_8*K . <(ZLYDO+9Z!%9Z&:^BFFJI4TU7S? 0\K0U
MT;&)D29[("CI2J=3YK\Y@TT\C5>%G=7S(^Y<XZY,XR>-XXG&QPM6]Z)YZ#VM
MVIM'EM]E=*S%N?Q^5Y96$KV5 F(1G0][4^=A#$Y5XG=\\ QSV8?_P%[Q*5\J
MF4R6V^*?FA7HW6.;.U,NFRKR>"C;M6LV2K]S6]F7$>T$JQU8G]Z/L;K.Y)L<
MQ<D*6A#C]"&^KR>3!.164LX85613_EXZ1?M%7J3J^(^$[ .;43X\B^#*#B>R
M^:54'[J9^F2,4Z.0<&1WU$J*NZ8,&#EC@!D P-@;C5=NHFYVWM(VFKNE\$#;
M_?&'T</*8[''VAZ+/UQXK/1,_)GD,ZFG>P_77U)>"+Z@OU2;'OB5^BO]KY93
M R&UI.AJFY[(98JETGE*62WK\V+=Z7)N"875] %]H#QP8H!]L8!N*-Q6NC.W
MI\0NR U9AV*,%/?'O?/K RL""]*\ZBZB1/'RV$.QAXIL$P/;V," D76FBK23
MBA798!)>13# !T1X%<%4;ZKI47WAA68#+Z'%@U84]1(JQ/22TN94VM0ZA0IJ
MG5>$(!_0\572A0Q&PGI?L,8A-LCY52WH3[7!54L]P=Y"FZ*TH8(;H0*FG"KQ
MDN@EMZZ7BC$GQ9(5:JOU]D(L6L#OYWE.O*J.ZCD*,M!T5$87HQ$TB@Z@:?0&
M.H5D-$7_I^%8J*_1M^J,WDFU[6NCVZ;H'QXV!K[40JS3PU@5PBQL;I!),]<9
M%"&"2?8F2OVOT&?N&@K"0O+A,):B#^(W ^44\!_:OF#CX1+*MI7F,UC7 0G[
MZMC6W+;2R #QE2*L^Q L<UR1OKJ7;@>O:5RQ@97\+<-EK<4U2ZV(E_A2;RU5
M]L+X]&%OK2WC!<[XQD%O#69W/&PASAH:O <6M580U5J;KM9ZP3SOJ*7-!DSS
MN-'-)F<V\S_*7L]-6&8:YH>)EV>HY8LUD\TP/C.(GY/VT-V#T!Q.['*91YDC
MH!(P"U%\QXV;9I_N"WF"DE!^LW&RH':O;$2[DO-'ER*C\9>/?^4R^OK!>>43
M?VIW61W%I>AWM43WIHOH/S8N.+0%\VADD9(NG\^Y!%W<N*\O[=';F6224P(;
M-Z/[T.[)R_ 64PPEES1^C#JZ,QZ/XG$B/.3P77 UX+T+X_UC1*_XU2&.0BJ1
MT!^M5XWR)=HE_L$RF_?=ZMN1VI&^Q[<GS?LY/T]398_@R>CEP3+'<?@I,AZ:
M)*PEA$PZD4D6R^7%R"A?B#8*FR(;,X/EZ_GKA>LSU[>/EL?1.'^'<$=FO'V\
M/-G^3?1->E_Y6/A7X3?*^IW\;F%WAD$"'42F0AA-Z<$HE2D&*5,UC&CA8"21
MTGP^K.:Z,?@+H@CHT9;.X*V,EO*5,D)9S CIE,9%%411T6@$5$F?MQ7NXFWY
MH:!C.(@FV&:($DW42#QVA&B2_ZBGX2VHMJJ>+J>-]&!Z-#V>GD@+Z2GZ*T^6
M &G\4& J@'6,_H!V+A#H+-Z<K=C*-D5!MLE^D%IKA0[,C1P@ZV8IC;Y47]HL
MI4'\D&  0&,H1^QB')!1C @H YP&5AJ L!7D0F@ H)^PUEH)[" 2$NZ"N=#?
M^AM3_PWOP:K*"?3K0&#K1?V-HZ'41?G9:=!0&Y\]O[3<G:(71DJKST-!)/>'
MN[LQKRFN_]CL;.,?6^HJ&J![MW;&Y60RGT]<TEB!OG%),93W4Z3F#<6"%]*)
MZ$.J 3FD^/U>Z@I4>AV]RD)NN>,N=H_MB 295%(274 M0A?(6]E+A1'7#>R8
M,.JZB[U=&'<]1CTF/V1[CII"S\E3-K=#P=#',0SOY'@(MFF39#>6?R1%E!&%
M1TD)+,/H$F5+W.FD(*97@ P8LR3E),_R@9*K[EKM8ES.3EU!RN=$O^K:$;MV
MF'@[5F&I'BN5;PZ3$F*K2!SU;+_R9K/TGEF"QW0LFB-SS  Y$. /48H5@CC
MABE/G7G_"=-+C&E&#%(/F%@5Q=I,L\ #']Y)Y\?W5&/&!P>8*QH77/>Q+D\J
MQ*W\@!_]-M^X/\F^4AJZ!:W!;_+1QC7T"'<M)5!_9V@&% ^4&)9+,;0B\"F,
MOY+/%V! ]#*JC"F!,2!#QWNJX)L;9<89=IR98.A]#&)V<_P!A ;I$9K&[%R:
M0AU/QGYA%H$UW:H0?(CO^ *S2*GY#LP <K/R8(R4/8S1(XVE:*KQ6]36N$9
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M;&LD0%4#*P_@A ;V.*+A:78 4BT%W#(* ZE8I9HNH!AKM=+K8N0:L8(&URB
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M+>8U]'+3__D#\QIZ._&-3IWYC6&!0W6ZN?]##*/@+_7Z2YV+EH) I2]9N\Z
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M'INYOUAWV[WSF(:4&2SF_J79$-)/C>6PDD;HOOW,"4/"5)XIXQ4)8+'ACL.
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MNP":)*1D$9%2E[<C!7S^'O?T9AJE>AVT8;(RR,S7@1J6K$!%/@A?.4,K\*T
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M[4X.!N9'!G-K ZNC:W/;#".)D?H[XK)^<6(,=_#R^F7UF^IWU^/ZQE3K&%[
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MZE\&?@1O+RT\@!J+C_UDX,>EF^!3]Q6_CY/(4/S/I:5[AXKC2$>S)P%TZ?<
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M'R%#VJM,D\I@-XP:L('J62I+HGZJ8DR5+"(X#&T9IQ A%\C_*C1(XX2[H$Z
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M_6#$8:ED#<\S=6@3NQ9P8!'OW,F\SJ!M1"Z_GJ'3QZ_AUYF?,;]C) ASZ!W
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M$9R3Z:66N/83-_^4!3W!5E8PJM=68+B$;B,G3NK77A-7B]75R7 4;L%S'/-
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M:.*7+N@+4EQJ!C04_<D<W$]G 3>2&@=N10[&\T&)5 JZ6I+).58BGJ7$[2F
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M5O)5SV(W2. JT(C=HA84"\6H^,HIFBK?*O;2:KMH<67LU\JN;/93US"$9H$
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M>6:2A%E-R;@P(]P4'N,F'9%HY<1GGR=&%#*5X)0YE(MDBY3[Y1_)/I(K#]3
MAQP'(JA>>-B*$I21(I21JDF_1B@CU3!&$F(">CGQ;@+)DCM-NUP[(YS<*7-9
MG1%GQ.5+ROB(V6EQ43#L(;Q*5,IE9KE<-IFI] EGA/.5,J:R9"W(0IDJ0YG*
M-\94NF>(::8E#/.5:.:4296HZB;NCDI0(94**"#3@B4<SVY575$<M]N+RN)&
M8T4<!(7@:! '@]5QNK8'%17545[;+:IT.@5CF;K:/,L,I[^?4\[D&64D<>9[
MF81"87T/KTBLXK? ($/<CL+_:\669XUO/X8OY,YV??9><Z<GS'4OCU^[:MW&
M?9*,F?*")&-:6QM:\QSA')F&+@YG-.?N86RPHC*OTA@7M'4SF=*^.#.O/L:J
M(+R82\+#HP> &=2*7B3(9"H]:()D(.G)KP+TP23DB W&74D,LH1$#\FDSPMP
M6%.1-#&12I/2\\*6OM:+4U=9Y4:'85Y+)#-[>RY9,K_:K]0M2";GSEIS$6WY
MF=P6^/GH+XFWLD#4 E$E9%1J+4 6DV((;1'56GI$KX5:K8EB9B'B^QB([X/4
M@ YSP%\F"!:0:!A_I!B-1L2&I=J\U!*,V<8=FLIQ"-QO8OXY"Z]?'BJU&^M;
MDT&EKIF?GYVS7!'C6DM]I8AX8)]R%E1)/# KRVS HW\G^R?Y=6REOPL\)<9O
M C=AM /\ .P'.(0">!/  @Z!$,0<$H !X6WD_?08XK>0ZAGBH]%<["?$"OE:
MK2"89/.T6N18:P)'<=;49>HU8=,]:/L^#+LP].($7H^WXM.8Q[C(S53?P(:S
M_^AA1E0Z$6.3:_F0L%+8QL$^#G+6AC\2QG0]!P0\"UA)>QR>-9P=7B2<ZVG(
M8Y;W@ '"AR;^_["N')7EW@^LAK*RK!@O$\5<@GR4Q4617Y<[ !=MH]O9LC(Q
M6UZ6I=^%: SS4D-LKF#WTP"8B#<,@D&=CGA_/IP//)">(WXLW\/H5P[^*4Z]
M'4 EO!7>@/$LV(E0P.MR^P-!FO875/OU>J_&I5;Y93*OTJ4BXQX03_(MC&5\
M4"\([G)N?W$,E JEJ'0(_4XTE)04(XMYO]OYB<OE5J#M> B.B'5!.M-VBG@B
MHE:? :#897!J'E>KE8]G55!0=1%IL3GV>$G,6YH@][G$T>%T\H+ &0+!0$("
MHR1<=;;GS,B7/0SXE#H7A/8] R-T!:/P*35M&X1<CX162R_)?MK#I@B&/P7"
M%_FO/+IXCXG2W>"G:P,8A+,T:Y"BH*AX\BRGB?Z\/_=>8#6Z#99N/)\/A[5+
M5^?>CG9\M&G=VKKB3=]^FBR?YJI=E.3,0M2U8I?4/9>,?#+GTESQ]O9<\T7)
MX.:!W./A4.-J/'!U9SCWSBUS\ST@F\5Z( L.'U-#F*<4&8@U)J]+ZP_XO2Z7
M/U#A=<7\@:R7)E_*O"Z-/VCVNIQ^XB&[2OW!E)<F7X[W"<]-"P2#,:U&0],O
MG2Y7:6E,P0<"?H[XU"9S0.;W9T.!%*B %<Q32Q<P>_)8G^/Y!!.I6$BEA(3F
M+)^?41#Z#11YO9 &:?G_2)J<=&Z>I&B3:7JZ K55$!J:R=;(,Q7E':Z1FTW3
M,S1[DA[MS-"D2K(E479D-=S>*](IX\:+S_V@,'E,TR7')I+7%'Z7J(SMC,H>
MT'M,,T9E,@A,3J_+[ ]HO"Z9/^#RNGA_4.MUF2914Z8PFP@5 \3_VDM,<$8R
M-A,U3I?OT.3[7Y?R%WME/'?DV>+::7;GM&8/:O5D.UU-*Z47^^:I<+A87(8O
MN: ]% Z'VBX\=^>6.:.CH\?I_"<;U=+\Y^[<JS3V)%I1EW>/%P&O0#_<2B49
MX6Y<2 HK<-C%[-UCX&]BL=:VT(94 ;A9L5FY.8KK2EJ#<P+=04X%E79EN"K(
MD2][GCPEY-)8S.MUIXID/*_D8K&HU^,)NXN*[%:OR^ /J+TNP1^,1B)#Z!4Q
MHU*:59&P2AF.1 (VN]D6B=KLD2+#1+;D/)XB)!@4$94Z8#MMA=8$]5UK&3$9
MTS&"4M1VA92V0K[MA?P56'!FQYS:_+H@2&E?7@[*RZ5T!IH\1<<V);L<3IH+
MI"F^4G<0A0XAU8ZL1[C7X/O.:_;DGF[M*ALYF9C7D+NY*;JR!+5XDK.:H LJ
M&VZ4.B@0_NO(2.[Q_.Q@,ZKIC=>$P_%X:&EN.GQ@:=F%@/3642)7C]/>0II\
M;[TD]1;LBN^)(Q 7Z$<)6SE1,MY;Y,K#HV?0+G:E@\TD?T8N#(D63.1V(ID0
M$Q@DBN0&$2*,XQ/F-"HKQR3_&J(=B>2G65X <!_Q,\A^&-#H#^$<[E_\&L()
M,O"IV-+!7\'?Q/^0YW@[L1,1_<!QM2'#Q96&3!AOD=T@^TK&:9 +(15TPBO@
M3?#?D%?S+GXACRDZ$@"TVZTRWBPC[,'Q,BZ D9DB/\JPC/QT!"CX(<2+%HK<
M" 'QP[A^;AN']9S(<$Z/B'H>[/7*$K+ULJVR/3(*,?>I:/'RL(L_R)_F/^.Y
M;60#\;Q"[BAHW![[L(/F?]N'#2QL1]0IX0!JZ5&T4_)MC^U27/W+?%X+'9J@
M)PW3, IA"O4%4--GN36Y3G[--S^8A\^<<X/""@M&IV)&-R?9?Y3M-[+]?%8]
MV8^Q?9;1R?;C!3JS;#HKS:8C)H6;[ \1.CNA1MSRE.PUTQ],>*JL4]ZE[M)T
M:3N,;_'OF+^4*W_-OZS_M0VOD)V0/27'E^/-LIU6K) KC/-E6"Z'*JW6X8 N
MH$JJ1352J^7:I(:H<4'C(R)(8W3HG5XG<CK-L!>L)YT+.)/19#8&) .>C#3:
M-Q52M,K$JS4:IQ,H9#R6F>1)HVA$1B-OXI)F:#;WFN >$US/$NY<!3JG[8D>
M8JVEV>?8\"3C4E<>XRFA=7E\63(H[?E@ ?O(;X)Q%(*!?'Y1FL*-DYZPLI@2
M2SN#D-K4-HM[YIPR^%X8_CO=V3/R3F]U>>Y [F19S;RP9L8EW'7?7KZY#8?#
MBF0D<3%VG?ML;;JT0A;.4U[V+T;Y).V)T;^._IV7>JZ"VH<T7XQ[FY\!5$3N
MEX&<&%$16=X:G!7EWE? 5[E7%>_SF)"'PEA8K-:B(H]'V*>'^B'2<0;'>B<D
M-"LC(XT"<LB(JQQ@F-JQTE*?S^N-A.F!Z?$RA2EEMJ;,O19HL<0T*;6Z*-7M
M@1Z/%Z>(HGD\IDP!U>/>DM)4+-85WQI'G\?AMOA@''7'^^,H'B_S^U)>KU@&
MRQ+,;F%$9.X,*Z!"TQZ8(3V<_Z8I?FR%8"J1U]-CF_DU#ST-^;ALJH#S2).[
M!DQ^R<H)R(.V-)&)Q/"AT^,9>DC&ZL5234V/DL/^+5PZ(NM;-?+$\XK(4&3A
M!9!?-C\<GM:?^W9C6^3/X73W0G3[V@LCWV[A9^2.S9E^[S5+JJJ6Y++=+>TS
MV^PS9CDZ5]MSUX]E"3&IE&*C@\@B_@'2)UYPO[C<YX>G_!_X4;]_T(^L?K9(
MA>Y;F'KQ,M.'*!FY/V!EY@ZB:CJH86H'P*!!H'AM+I=38;$&@.B%/N]I+QKT
MGO)^X,4^;]+;[\5>NIY$ZX<HH.E6]Y&1=)\OGQHWDD]"&#-X"JM%"NM!!J _
M'P&55+F4)FD9/\9Y1FYNVSHR=$U[^S7\U?1SY,35[3SZ]HN='5PXS'7LQ$L+
M6^<>D+:F[BK(YACCU#2CBH_L7TJH8@;'Q,0.+;R<OT*+$M;S-6LT-% <(./8
MI%29S$J54J$*TI%N).-=:>: @; K=U2G4ZN&X .BP6 0%,0GAQC+%?L)MZJ>
M'OTU,!%.=2B5!EU*CU,(Z?5&8"9W$ QPFP$:$@,;"F'\=(*Y,XZ$?;B&,1EE
MN"SEQ53B3"%6K"CH93Z/+TT&-\VL(:K5#R&UIVW$?H;$T_C:%9%7+5V9JR"6
M62G"M]P9CM1]^S%2C7Q)N.:Q%6N2(_\8>6OQ'F5N90A=A'Y"Z-)$Z'"(T:4:
MC,W4L?T&MD^<7Z(2Z'X]HYN=[)_BEX :\(IXXP*TH'1!W0JTHG03VE2Z ^TH
M56IDLDBQ+!+A7-4NJS]04^U*^P-"M<OB#Y95TPQ+BU4!XOIXT.U.614I.0JF
M0BB=0G*] BH4ZH"/>'&<$ )!& SZ HEB6%Q< X!>+Y3%XVZW$,BZNEQ;77M<
MIUV\CVQ\YL(N5UVM)$2')^2K$#I2+YB-;K8A)?Q)JY<9\Q48#_3 %*NNDJ:\
M9I;)QA9I-*%*0SFB<:Q*#[)Y4)I:EY0G=<B"S[MA=T(NOWE?;<GLLV^Y%IP_
M\O"B!47O_&->I&'%5=-Y>=G>7:[Y2]#B)?-=:.^2[3]Z[$"$FWW]R3>OXW,O
M;FHK#8=A>.IEL)'?]L:OKIDKBZ"&>Z[ZX?8>^.2FMF)(?HRV;Z+4;F!VS1I0
M#,O%MOW:?WO1]=H?JV_7XJO4 ]H;U;A#/<V+9LIG&B[RXDBX0=YHP%%52!=Q
M8U=DKE$FL]MLD*&($WU%U1+/49X-%SN<SFBT&/N*-=CD,CKYB"QJW.R4;8Z*
M3MCG['=N<V+G$+Y(U!1U1>'ZZ-;HGBB.T@-S@[:4PSY7#U/%8*ZRJ$$OBF)F
MKQXF]%E]KQYWZ_OT>_48Z'WZI!Y_KH?TP!OT@*#OTF.]/MB@5R:42%2.*I%>
MZ5,FE5A)$RJ&)2%,4S:'\U)X6#C3T\/^LVF3PKSA<';B"G7:L_2[D(4EQ22)
MJYFFHC4:H?->?A^PF)%<+CF>?E.(Y=?2*G,VD[\AS,V8"PUH7^X;N!9&8!&\
M^,.3*FCM;43AD5-.B$8>/39\\5VFD5.P=FI-BP\&_O@%7)P[,?I&[G1-2T=U
M[B58/AO> C$TY_YP9G_NG]6Y_QJS662/HT*]CEM'1\=FUA,E!B.=)8]\9V:=
MC3UV38-T#7R 7&,C2A"AFFAI1Y1\C^?)T"L6C)[A@M1ZA67YS(>G0&'5:<1F
M([Y)=-)\_]31,[B.G9_(GW]+(3^@IC)=1JSCZN_D&77B%YAU;,N?_V+A?)_'
MR)/S?9/.#Q-K.CEN38/=+^7/MML4"G*V?>+9H]^0IWF$G1U@N9Z?@8?9J@@=
MM5X;2@V8F=T3,GTJZ9K+=>297N=O 3;B3>N.W1B[,8%40Z.?'/7Z,X:AT=^+
M=IV0X556%=)JBWW%OLB_ @%36:4"VH>@XHC%XAR"+E%G4D.@\Q67AD)%5FTI
M2R<HC6>Z2_M*T=Y26$H-$DV7&JK5>@7-/RZB"^YH5E#1TS@%]*/_%D,L/U"_
M1X\2A,&)A+=;+!561%.(K!H-^<T:XO#0Z!=/:LD13-.7/33/:"\^A=$A#$_A
MSS%*XI,8T8"9#V/,^+^0L"P)L &:8T0M$;+%1!RQ#_/)1D2244%66\OL1Z8_
MB=T-@RS#J!!3E0K/1"UF0R$>S\*2TJ2XE'T$3?M#C8=WW/?.8Z.[#E]YR\)9
MM^RZ9FYS0W+%O,JNJ>L735T1R77^]$:N^=&'MQ[XT9.77IX;O>6/2U<_?1+^
M_MI?[;[DPWI]9=)^^>YK=G:OOX95DLVUX\OP \ *'A8;:ZQKP=7@5K +'@ '
M5'*]W6NO0=@JJ) 5FV00R 26I)4P9&FFEDYGDLGT2% 0*B% >U2L4%ED\U0&
M*W=[4D$KURBL0L)@L'IA F;)@(-ZL >PBC![B)]'2RI:'8F! 69))S88\O%0
M*CIBY ]D689'3T]^S4D-4Z34/+8(E"K5$41CHD$AG3*:T$]?SZW7KY[1;^V:
M._,:9>B7 ^OJ\)WGGMJU(O?QYA]]LA?>=>A9V)G[(M=,W[J=O+7([P*UX)Q8
M,E>Y7(G2RE8E>DKU:Q5:JKQ2N5N)L\HNY7HE=M3"1)G%QCDJ*@6:PIE1*$"%
M6DU&(U%WT=5>?:4@4W!:OS]=.FN/&V;=?>Z];NQVIX$/DG]8C"5HU8DBT5U3
M8]1KLUK"Y&FCF=),*@YB["6^%WW_GAA]>1HDB1$9R:9\!BC+&&RUA:4X7D>J
MMM*1"H0RCI1.GW$$M)4S'3T.I'&X'<A1H<[^5EK1XSH!'%!WF!P87D1Y+YN?
MBAS)K]V!&_++&?(!>U;AAL[W (.T6X@]3YP:8C%RGT%@DP#P0F'9M 2OZOA-
M0_FS!W+_NN+'AL8VQZ95@S=?WVZN+@\U3>M>8ID=MN=^"$/3E_&[0B4S*FO@
MC)O"4ZYUYOXG=]./?LCA>RZY[ZF%;0;]!8VM33($GX2WPTK4V7XIZ1\FQ?!!
M4 1>$Z<#J,#%&$.[Q9Y10846 <%H=SBL5I=<%T=R@U$E5^B (%?P*F*5B29[
M1F_?8T=V.L%CMQLYXI KM(3>?(CPZ#=BB(H'E5.KD\W+JJ">3;P93 9VBB%D
M--&?C4.C?Q(M])131@B,L,NXUXB 42#]E9BP*(&->&F3!EG)Z"=43@GYR-<P
M8U^Z5E6J%C< Z?("@]D6C!06(02E[R E.+SJWKL_C?PT('9??NG^<'RJ$#(]
M,?-"]/=?Y?:/.'^^<NDWZ.55RW:,S$8'>]IO^1N-4<PFTG@'D:MJ8BY8P;O'
M+*)&GS%1R4J^]52R*LF&-DX^Y'3/0C9X>@ZDA[KLOS:^8L'6IXD'+4#7DU:#
M0:8CHO8(P&::C"U3:ZR"P3HT^F\F$:U4CN+1S\4J*D>QV)C-8+&N+B/@)$9O
MX-,8K<=[\$'\/.8&,02X&_?A;9C#V*"AEQN&<$HDECF]^!3-V1N0UIU1"X*E
M9DIQ54E*-K *(CV%8&K**.E_@V"$9.0;+((QG3+!LS_]Y)N'[O_B?^&N/YVY
M8M5IQ-^2VY1[,?=H;C/<"CO@-'C/R"QT^<@-3;D3N5<0DW9,VQ&^LH#CHD:P
MB;91&U:K=1!0?5*DUF9HPC=6:Q->'=3I!+U<^SS=D)/A3L]0$HTU" [1%3!D
MSZ:DYPL&A8&]E0%356*@&:I_9DM@Y)3;#$SKR*%/WBWODY^2<RQ+56TT9VAV
M:C_+3HU)#"4M<XFQ>2 B$ @346'(F"A&%T"SK-2T5'9Q;,D*&[!(0WBE<4&1
M/>FF"QOC@;+6E_[2,F\UG#Y(ES..E"]B&3(6&@(A;^^'C>+1Z_37"G<8?JI_
M1#A@E&U$&_0#PB8#MTR_3$!M APTOVQXV?JR[1LK+P;[@EN,5UJY8E0L=!KQ
MY>A&]-\(VWFV^MW,5K\+=*B8$Q:OS^<P6RP&HS%DM1&;W.:QVT,.I]EA@T8#
MY]!Q*A4G]R:\OH0/^7S +[=8K7:[0^5W^.10+_<2@FPC))(#"&TVN]/."&MG
M"<#D/D.C?WDRO_CT<Y;Z2S;^+=KI.0E'EP-M=0PZ$' (CCV.O0[.D4_['2XL
M)V+#U5 [YLOFJ6NL)1(6$Z<-ZPI1&[H!B59B_AX0AMEJ>[KNE,9-B=@TP$GI
MAG(YI.XN+ SG:!C.@]R/;ZAL3ON+DDEG)GL0=LZ_-?=L;N?#SG+61?A@;CHT
M/9 JCI8[G:W/Y2Z\A O#_\E94'+_/-)CM+<<H__"_\/?##S@?=%9H[Y(_;(:
MK\"KM9LPUONZ?/.(^ZIV.B@MQ$:%F1 CJ9";%0JY0JF0*P5*%&5(I3:K5&H#
MH#EINH,6.'%>M*B(4ZI4( &'T+]$I3,A_U!A2(C&I^%!H"8&EU+A4]XL)HEX
M'$+/B'H?H I]G^)SJM5]WGP0S#G2X[0/.VF!S+-.&G6TLWI@#6R.E>AMZB2P
MR*/D$5/:,N*.Q:%A6DH-Q# (Z<IZ&9&%;"F^B2ZT3.&70JMF9C>6S\^]_1Q\
M/- WM99(<=Q_7M4%4Z=/C?5.Z8>^^_;VO@&WCRS!/SKZ^(+S[SB\Z)W<SW(O
M_FH'H>#&7#LW#=])3-%_B*9K%= -S!S2Z#U%11;2=^$0'8E&,NA#H4 @JG;&
MD1JXPPEV6$M&^M;08.A0Z&2(8T=,2GJBE^.M)@I/:O)XB]R$_8Y30KM#7C+H
MQ1"K^Q"A1WQ>J/?V>_=YW_!R7J_%:K8JM<S$).+Y'&-BLO%/T4Q%8[<)#II.
MFA P"::])FR2^':"@AF)%4(/S*E*,QDA24M)..0YVE!KD-((PY(1:1N;)*TF
M5F::.<FI:H,D,ZJ9)$'O'MLYO]/MJXO%,T[/?F]7:M&M#X=BK68B4*8O>_B%
M*95+>E;YRQO:*T)++[H0WSQR</%YE5>@IT>F+6S9\9<5%'?T=T0+74FDBAT<
M%L6L$^I]&D/&9K<+"B.M-"BQ(.&\$)W\4"E5:AOD3("3)1)R*)<K3'+"KW:@
M5MNT6&5@I2G(]88O?);UEJT6;+'8E0H 93*5G%:KD,N51+< U4'5\RJL4A'^
M9XQH2Y/1&B.V#;&<AF,LY8%J8&9-UA:",KI"])MMT3'=PV.IG$-U&II8P3EJ
M\!!#',)[_VCMR'I"NJ_C4/Y@F4&[IG=[[L]NM+?Y&FUPY;E1.'-QNJ2SRK5L
M\:)O1_Z2MRBWDM$Z#:;%RADN.%>V3+9!AHG!+K-JMJNW:W9Z9%>U7#,-R42E
M.:-QZIL=S=@YQ8!-=KO)!!K;M=2Z=/ \:%0HJ'692*17E^BG. WM6EZFTE,?
M:(FO-=G:WXI;6W%'/"Y6S1J,D$$C CJ@16I>XTK0(72@C@ZZ(FF]:JMJ#R'4
M&RJY2B4*ECY+OV70<M+"6RRB6S) W5YW@AJK7A&*B0T%$Y02-#4A&,.,4);(
M9APW11U!8GP&4X%@)DA-T5G!I4&D#<)@8\$()39HD-B@C=^U08>97\2RFFCD
M.T8-T0%HH9--!2N4;;--6J7<,MDDC4Q.B6.)&Y%*(4RYG!JFEUS8+_ZL-?WR
MS7/Z]@ZNV[CV_/FYK[??Z8Q?6KQEW9,##;-*G$9_4[AU5D.KI_3JTB._A\Z5
M\_?P-T=T';.L;:O+&S>CN3T79KNJPQGM(V\MO0HK?[+IH<<J2CTAM7GIU-1,
M)#_U( 1/S+[HP@M"ZZX$A364^""RTC64Q#181&S7(3(>#$1R?R/6KW7 !L<,
MQU('5CM><Z!_*> CCH.^(0?>*=NAN%N!UV@NMO8KB$A?K%EHQ9S"K)BBP7HM
M@#H+-<:T:A<9$T\14];EDLOMU"W54>-"L,,^.]QKITZRYKA*3D6*BJ[?35/%
MV$<<>)57A0253R6J3JNX;E6?:AL=,8)>[S%R1IZ>9511F60,$6?W:]'$%N?)
MV6HZ+&(6("4M'R5B#R<F6"AYJ;2!BBAJ"=,T_)A4DV5\)H-\29YMB'4;D'Q:
M\UBG$3>6>RP,=0\>?C=W]O&-J[<MVW3OV]<O:LEU7OHWE/GLH__]U3NY7W9>
M_R9JV++UE?UOGEU_=<%KT]$5S^ 5<5F"J;@ZV*#OA-/UW-/H:=VKZ%4=M\OX
M*'I,AV]$L"NU-87V$EN3B%XL]_O#JXOT7B\HKO0ZX1[G:2?RT>D+KPSZ9$2^
M"&Q("'1YM"!T@5[2D]0KBU%G;$.*OC$=!P7V]]G\VDI;<6U=QE9<EB ?@7#&
M1@>"QN:V(5LY'06QO"MF(\.@?&P8,,U(A32U)GIB)IKE/6%YD>7_Z(#E6;T=
MQGY[P?(R=[A]3M6>AZZ^)Y8LT?2O.+!CAVB=$; F>]>9W>=%][T,5WX)Y[94
M>(J=GG\>N.(:!/?T__CDHF:+:O[\*Y'\32*W62R'4#, CIT /'$/W#HAHP\E
M0@=#6.@UK*<NOBF0 '+BY\O=5/Z89&HAL=X #085T >\ 10(> MA%J_D'GPF
MIJ5%GE2Q>:E7X,/[,-I&XR:4K?HQIC7-);LNI%:9\WS[.?,Q5 D636E(YYTL
MY@E+*6V2LLM*\SO2[(.5(AY,L(:#8S5\"L$3U'[LB7,'+QBL"I2W6$+:XTVS
MO:[>VK[-"Y?@@];<-X__+G=J]5TWP.F+I^S\BSAW7>[0YLMFG/[PE><]+&Y.
MN.U5_ "QEHUBS17"C0)2"7 !N@BM=E_DOQQ=X;[<?S.^05#&^&*AQ)0-<@IO
M%)7A&,=-,T%'PNDT*A+*H=$OQ5+J60XJ8;>R3]FOQ$HE1 @+!D%O@'Z_C\Y)
M4HHR]W,(+Q-;C<!L- +!;T(<%)#)SP&CTD=C[;(^C<Z9<$"'P]971,,Q!J,.
MZD$6H#T K@=; <J"+AHX-AAINUIZRU'JO/93OW6@)Y:68K;2;"5; 9?_9! #
M5$T22XWH1JDLAH)LY"<O)9]D.#_ R?"&1&%:Q]>1,OLMRG1I4"JB;$.O'\S=
M.<6_H.EV51CU]\Z],#(E]\5!>'V-MVG*)G?X@KZY<R,9?.=()O>WFSL?_<%C
M%]\+K2,?8_CIM><?N>78%8/OLGGB7"?W5]('91"=  +AT6DZ0\85)Q\W.VYQ
M[RD:3/Q-QE^KNU9_O1%W<%.C8@*K!;7!8< RG:*H$W=R[<(T5WNTO5@!S):8
MS>HNQGHN9-,H543=/BF7>P-^LG$L) <Q<XQJX"Z;NBQ.W!*='BLMQ>Z 5>55
MPM-*:%*VT(1PBU\(P%,!Z [,H.QO+=/3.<UXKQ7JK5DK$J4EO\ J6)-6;+4F
MRJ6B:@,;&@JSOZRZE?0U%B%GT0*6E5E;2_^SVB0Z:?EN0:C&8N&JJNHF1.2!
MA1G*.DSC!^58(GLE8WZ;T6HSI-%3%Y_OM/HO[$Y4JQ6Q!JLE/7!#S]H+;EF=
MMEH:2I7JZD37A6'!M:IOK<][>/3-W?-T$7C1J1/WWCW#E.N%]YOG_.#'OWYA
M)8SHYNT^GGO[(3>^CO;%]-$SW+^)O"B'!K%TE^]!<!3@G6"7;I<1K]6L#:)$
MLB]YIQG+XT+RQVZ\+0F!V8V1G5IT2;TQ8[<KD2=<IA;"2!U.1.2JA%(>.1A^
M/OQ9&(?I*O9PN%0YJ#JD^H"H*7J1@1Q3J7BWV0K H/.0$SEI"$'IM4ZW(JN5
M]Q<DCY\>MGE+>TL1*#U=B@Z5GBI%?:7;2O>68A8G-FCU&8&ERY&12*_0LAL)
M?#>/NGC($_DNE<"A_42LQ]K$P'"/@]@\U-8F9B7KMUB/%)THS$C%#+:\OJ,S
M&.$">%#:4JAU6E5=,"8+0$W1R@+.$'IPP=&KW[SZU4?N?&C-M,2B4#A[_OE3
M.G9.7SOUEA6/O'K5*SN''OWUQ^\=^?#R\-D/_O)(7?.*[7><?OW6'WUP[_O'
M?[&6"U_QIT/__?'HZ.B7-)K!_6,L=G_K<\> 5S0@.!C^@!;Z\;(T&%0\,0L&
M%*+X[+J M!X0W#YZ#+@/(S@T>DQ4IN)VKRA-7(R%\<=J1:Q#$58K0@YV@_N(
MO5,DZE&7'V[U0S\0.F((>B>6.07_.6>0OX[-,82#*EJG-#QI1H+Q&3L_G%\1
M.;-P?D6"+Y7JG_U']4\Z!U.<GX/QCLW;M#2"-'V5NHGS-A118?1S?HB? 1+@
M+^*,&]&-YD?0P_)'S/QR;C.W78&A$[KF<]A?3;,[K=4NES^H4>OF*J$%NT^;
MH$FT%66(T8X%/$C4F;PT%HM$0%2(HBA-[)Q:G  @$ @&2XJ1RZW0)-1;U0?5
M6*T6&OJII>$OB:62I;"TU%H<246C !()8@T$DG[XN1_V^0_YD<^?]"._E.0P
MD@]=#-?FO9E\@G<Z7^B!A39RTIQ:EAHL ZQ:^G!M:JS@ S00X2 IRR@%81HO
M;&?+SYDRQSL_08WN?>YW0[][Z<[9,VUUB;MV7';B>G_3HI%?GC_3O?S *F-
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M>B9Z+LI[H\GH4)2/(F,FMV:S,7_MS!I2<]^D,<:,?@+&C"T(T-W2Y6RZZK+
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MIHF,F Z;F#,1"7,F0DUC+G"@?3!:% S&K>@*LD"Q^[<DN*(0,  +E+1CH@A
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M!$1&=F?58TI=-4^X1%,BUL2A.R?(:U72!(UBDGR8/'_[[1PGX?3YW\D721?
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M&D/$\"%(9RIP[5[ 9D363J9"*1C=#3F9"CF\#7 ZTC-@OIL*^61QYN<W @Y
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MW6JL\]60GU< 67E78VJKD8^KH;PLSA#D9'4AA=T0<RW6TEHLRUI,82VD\#O
M]4AO0&0UL!9K>!W6[3H<8]?AU]?AG+L.8Z[#NEV'=;L.:V =?FL]\'05H($A
MIK >O[L>V^IZ_/IZ;'OKL6^NIVLQ9!WB!@QA7U^/+60#CML;<-S> ",A"Q$0
MV7RT 5OF!N3I!OC*,.!BI)<@KH"Y> .VH@W(Y0U8SQNP+6W$EKP1<[(16\M&
M>/H>X%#^.4#V]4V8_B9(_U% QL=-R,=-D!H+60=\V83M?!/6_":4!C=!"O<"
M;D.:<7,SEGH'SO4[X.D*NA.^?A?@$I"$=T(>7@5<"9+V3LS#3JC5XX L#[L@
MYMV C.^[,+>[L$2[D&N[,/XNC+\+^]?-6&,W8XW=#+7DH+= 2 V@ =$-*=P"
M=<B0S2:WP&SR*"#,)AS'3>8%/-_+_JQ#Y%'S*. O'JW(M-R^ LUSU=Q=!5HR
M(8Z4<W+/%V@9T.<+M)S[3RY7H!5<&?EI@59R>\E[!5K#_XU>QW2=^*=&MJ%
M$TXG^W*!IIQ<=KQ \YQ3]GB!EDR((^4TLI\5:!G0ORW0<FZU[,T"K>#,\ED%
M6LD%Y:L*M(I^37Z@0)=PI:K* JWF*E7=!5I#?Z[:7:"U7$#3 SDA$IY9/F@V
M(2T%6J^Y#FD9AA] 6H[A=R&M0/H!I)6%.A=IL<Y%6JQSD1;K7*0E$^*(=2[2
M8IV+M%CG(BW6N4@KN4Z:*M J::?FNP6ZA*LS%N.KN46FV@*MD3YJNJ- :[D.
M1QO2J@GE+6%E<8AE5$\(US+:<2_2>E86AUA>$]!&QPFDS1/B6S"='R-MG1#N
MP'=?1MJ%<<0RNB?$\4R@@QC_/:3+&>VD2%<@K6>T8D+^%1.^I9X0KBZ6Y2'.
MRZ6X)/Q7"]0<;@VW$OZ=SFWF-L'?[=RUW!"&3(%?6X%FN!3"UV*,2G87-+<!
M_O-RLR!L-;R_G=N&OU;"ORLA]D[ %1!S#CS?B*%>;@;\NPMC;8:PI9 2B[^:
MVP$I+85W)D&LY1"R"=YD:7BY"LS=OTIA+L;<5LB9EZN!;R:Y*G@V_I[XUO@[
M_SI%+SQE3Y;"W^U8;I:;C9C#]1"VF5OU?Z@SENHF3%%\KP]^K85?K):\W&R@
MEN(O\<NL!A*8@A?37E.HC^7P:P<\9?E:B[$KKU)K5\_!QW,Z9XQJPYB[,(^K
MX7<OE'$5_%J.3RO&<K@).+42WA++O15KBJ4:AY"Y&'][(=?3L+Y68+ZVP^\J
MKIY+0YMC]2;6[RI\DSW;AG6Z';[/WEDYQH%B7>V$\ U0[J7<,OR^%W*]%=X9
MPO)NQ_R(7/FD=7%E':\MM-]M_Z^]+X&.HMC^KNJ93'8"A'VS#3LDH6?+PB(D
M(82PDX5-63HSG9DV/=-#=T\6]D0)NPH""D\Q"/H$%5$6!5ED\2'\145$0613
MGB H" @(*'Q5U37)!)#']\[WSOG^Y[SD9&YW577];MVM[NTI%*'XT*]$I*L$
M::-FC)]8.(MXP;AE1",!CK%^BLF3NE[]09P$5J.1>P\9KW.-+4VBTO;2V7FD
M!SR+0"P5RRF16MW#2J_VC$Z"+ =QK//_\!(KI++2GU>(%G09X7Z>1 -]1 &1
M$;8E;*'!,M-GPC(.<(.MK)CJ].[9',0G?6B\1ONP#$92_K%'XA7H-EV#H3V4
MC'1./(3CP%,\7>?_#4>ZCJ7JE0:DBV<KID@%Q'=T>3C_0M^%Q*(]]]6(+BDG
M^<3<8"ED@E(RRD?6QU/KQ1P[T,RZ[_(D1I=5K\1#;#@0<W3]!ZRR-C_Q02NY
M6\X.XGEE#RGIQ%6LA>.2V#RWP Z4O;)6YA/8#%GQR0JOB;(WD4V3)#9'=+DU
ME<T15$$I%IR)>:)'4-E!0@F;(WMX;X[@\DN\DJ8Z!*]34-@$]JX!PP1%19.Q
M]D3.S),^U$5Z[AK(BBK+LYK".P4/KQ2Q<N%?<L:*7E9#??E>41.<;*[&:V@F
MWNOL(BNLC'H4UB'[O9HB"FIB-6M!$Z GO))0AB971%7VQK/#1(>&GAW *T[!
MJ['F5*LESXT84@@O?($DL)B)0MXAL(6BHFHL[_,)O(+0$2]X.*:87WU5B/D!
MLM>)6/4*):J/]PE*/%N($$K<HL/-BAI;PJNL4U!%EQ<)E66S-=:-6E1_@2J,
M]R,>I#*V0'#('H&5O0*>#R^X1%8DI\IZ9,2 ZG<X!%4M]$N$-=:A"&1M*IH-
M,X*6YA*]O,0Z%;Y$]+I4MD10!-:#Y,OZB4#NDD)[Q)"H" XBX8*RNV7":S7K
MTQE&''G1I%Y\I<A^EQNI@!5*-<&KBL4"6J2 I8VN?(J,644B*I:E8L0+6^A7
MB)K0@HH"VLS#J^BM,\L.+BP4'0+"2>=5)&093XR$B,"]R!HIQTAD3J1IK]/O
MP';@5_&30P3%)VA^'ML#.T3BO9J(%"SJ\D5V5L;*DI-5M3*D4X>;5WCT+)I-
M$QTJ6^#7%<,[>1^>49-9%UZ 4.H0) FO5!)<8H$HB5H9-C&?A :5B)J;=<FR
MDT7Z\LJ>,L3U<-$I( WZ5=U "F2YB!@H8L#%3Q"]@JJ;@R(@D]30C4S6RSIE
MAU]?(A[,2ZI,ACE%U2?Q97JCLUA0-!&O-=&M:;ZN7;J4E)0D\M3,'<C*$Y'=
M='E0'S88:GR*BF;Q2,3:"V6T0E4NU$J096-_Q&HIYB4_<0"D1:0!M'!DC/=S
MJH #BAJV8Y]/$M'DA&7<@D2!C:I,]N.)'3):!%89F03#("5XB-_PK(0DX47#
M>9<B"%@:B>S]V:,#B9[PQ&C^^S*&18CZ%1;QC\P&^01J*,#F@JT2<X8&^7UX
M&CO;H1!IO&/-4"0OGU_#<F)'(@P/4@.*2.0I[5ZNT$0>6<%=R!<>,!E:N83!
M,=MN'IF87*#QB!]GT/H+%=E3LR#$G%-&0(EL)K)&'W)()&:?X!"1X? 2,C8$
MXA$U;+9(#EBD=)YX A+@VR'[RN[#>&)T='9A#3?835 84DE B6>1G2,W1-9:
M+*)P'31WC8[(LRAZ"&C!U"?N18D/V AR% TYWGW5A5C)H-W97J0Z#VGM&GV_
ML=$/L'+:=8_Q"VC#,G/$ZE&-(9/=%^_'.!LH@]%H9WP2[9@_D5TUT!?(L9UZ
M[FQ8:GC7L-6P'?UM,FPVO!64_2E!%4E-5AS([ M1FX-F%2+)4O0<P4=Z^>KL
M5*]( IEYX#Y0V01727J>.H#L\DZ:.WE)Y81S#I[F%_%!66()X=6!/O7,F249
M@4KR&(%DARZ:#^%LA@799(R[.I/QHU7A3&0\NM+S7SV3*2 9CDPXT[,XH9J_
M0"Y30GB0T-PJS?%4FIOXT;,.FJL5DKJ3#:J''$0R-3FO2GD+2$2O>%Q$3GH^
MZ*Q5-ZD$6Z 9I8=6CK6K@ ?74>VIA$0RAR,H^]:SM0?76#SYO%=_P1+69>2E
MG'JKVQ22[;F(OO0\6$ 9ID8SPD!&+-*\5Y=1<5 MYJC.@+$LBE&+A#X#]60A
MJ1AJZEA=0T7W5,4/5Y'JZTDGMJ);LES-L6Z)8G75I-XC8]W*G#23Q9KQ$YD&
M*C:U&G,(F0O/J)'JLZ86'$+>6'B)%/3J5ZQEO_J;!+TNE<@3*K$SB=J9FVB.
MI[@Z;QI9G4KKIV"/X4E$\%7SJ-<#KFH-"+06D,C\NDXE\F9%1'.))+?7JV3]
M_8&/]#H)@DADCV>3T:^3S.:@;PH\Z!E=UL/1."=!**NNM&HB2 %YMJA6M>PA
M%2P/)E37@<'102&5BTQL0N^1:[UQ<!*+\M?28F!F['DJK1WUV9Q$?CZBD[):
M(YVT&M?("%VOB>1ME8;&=T7U?Q<D _R;2&0=7'<Y:!V<2.--EW_[N4"$J1WY
M]'H6S^E!G/_WO<A_WXL$OQ>QH[\.U>\B.OY_]'[DW^/LO^])_L5[$A -(LA?
M-K']>^43V%'TC$@-RE+B"><2R5UT*>$9BXFOEOPE[_?SI1I</?\0J)9K[Q4/
MLY[X>V*)@X[5=[V'][ :R63<-4,VNBNLSI\#X[N2L0\[.Q[[[\7UVD_]ZUU
MH-]SF $7%/=K:@.>Z"=P?PK4KAN$6M6!GO<%]R/;,+8RFHW]C5G&'N@SM=9,
MV*,&$4O">Z)NH6ZX%BXW +(GIJ&1"OUF@<?_/!G_W'D4C;W/#S,/,M  C<
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M8S[9]WSL&6-.],6L]EU RMK3>Y\?M/2KN(*&UWLF/SK89YYV:4[*C'5GS[X
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M>V O/ ?/PPNP#_;# 7@1#L*?X"5X&5Z!5^$U. 0N. RU< 2.PC$X#J]#'9Q
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MC(11,!K&P%@H@'$P'B; 1"B$25 $Q3 9Y\\T<"-JWW;4LV=0JYY#O=J/FG4
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M3QWYCF;3.YP6<>4N;C=7SQ.^B-^*_!)0LOWQ678F-@/FX(I7PD/XNPU>@-?
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M&1P 8<#0>PA@K9KF1M\@ETQ/^CJI)XE)2H))-:Q@R87]?+7Q015>]X9I)PE
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MWSS*/-7,>AS S3@=P&6UV2$VM.S0S>B-HN!RN(5E1H.['1Z1<_"^8]]$$(2
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MVB;P8%)+&K,^L"X-^0#$6HG7'4@SFTP>$/"Y66>BUT.05_K+ :/7@?_3:/:
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M@>QY'18A5$=1T_9Z:RVCX<+-QXX=0Z\RKBO_^/$1QGWE[VK,$NN*S!WX-_+
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ME!=?A"G;(AG%]][[EW?>_^S?Z1O6;7YX@[IF Z@3#</CE8I7[0XY8:8PT[M
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MCO$]@_3@]7SK8WRK8:$VCW^NO?^,\:T&^_%8_TQ[E7'DC* 8WYM0HF9#&$W
M$&=#8/DPB\J'$9I\,&GR(1!MYT_%)?"Z2-/D@XVT4_JE^Q\#3FGWGT;:&8IO
M)SU[A\J';$T^K-/D0S+FFYRJC^-+L;(HWU&:?+A\E2UO]5[+=WB,;Q6\5VMO
M&N:;F?)+?*MBNJ4J=Z_G.RO&MQK>!3?_8GO_&>-;#3[1QNLGVJO4D3.(HGS!
M4KA1&Z^^^1I/.@Z4)W^SQM."-C/%+'^JUTN1&XYQC8U;.>W?'*U_*[7^U>97
MG-RAF%K""$Q[8RQ&M"C./^@2>W4&%O,]A&6-';C!(T>Q8$$F!R3'CQ0)8AF$
MK'.JU6K78177KM.Y++,-8C4%_F9^ 0@\8.><MMF0!7;)'K3GVK47#'E=;6?L
MQ*OG4<&$_A0I5T\-HJ_46N.R<,1:%LXI+_^3FL:N2IODJ,3!6G/(CM_>O7CQ
MM_#<-XL7?Z.$OL6OV $GW\1_3O[X6W*0$#O@-[^)8@<SF_#]^<%<.5'PGV-)
M11["4E8O>?4Z GJ"$,][I%H+R9!)2!08C]^?X*F%N5X8\.9Z41!?9&^UE_42
M!2A!;7>7M8#DDDC=I*F@HB*27Q$+/!) V2): T JU*Z!$0JAQ?0<^P4[IF_O
MTQFNOZ6V<S%7N7#A%N4?N^\Z]"P!%]NW:6=;Y"NVC<Z3GO=Q4T4A,18[&]]S
M#LZ-Q>1X:WSL[#U,JZ/VDFH[C_^LUR:/HZ1\L88*OZ?R5>4[MN?/FGR]/B:'
M-53X _=XC._83XR]]OO5MGX/IH#?4/FJ\JW"[57EJP[S-7#7\NV,L_6K/E#;
MJTNYBI+._YN5<? =*@?[4-J;_J*N*I8##*7#-',QS4>49K1*<TF5@#J1%:(T
M]&RIN%AD]<_%(J-8630/8JC<%T'^>JPLDAG#_?_#RR*(;=0.Z&3_374#-<[9
M%WZ(!]PMF^%!4X\)F6@F)@(P7%>$_ZDR8RF6&6'ZG='T.V/H=S)D7SBQ(A$Q
M2/:U^%# U^@[Z&-\!! <LN3[F$%345&=RH.<>_4"E2-]-=FP0I,C1/[;G #&
M9 /!E*.Y;!9L?4XZ#FRP6W:[VAS6%)U.7\-9++SC:><!UP%)>MI*)(;>'2C#
M'&NM@AF_/6JPE)G-'C=9%CD%!5WA<$Z75U)QB?%Z"5>4=Y/TH6N@XDI"]@)[
M* /6QB'&99XX<'9_^PS<<?&8<6M@AO+)H_2>EF.9>YR.>S^J9VV!-9K,]43]
M"92N2:DC&'.8;JQ*!_[XDW2+L,S8P:;9>+B.OJ?G4-$]**SIR;_3]B">K$$=
M9'ME[RP\9_XLY&+:*BTN_@ZL^^FX.%B%VW.:^U64+VYW=&^WN@$7:T]/CU('
M7Z/M)CQYM.6"2B4Y>^>^>E;6VS%>FQ'#RVH;L95D-C'L53HLVD[G496JET)2
M#^N7)<@BR+98+&5LBRB6X3?2NSDYA70)]OY&K+UXSSP;N9NVA!<U_NH\Q?Q?
MZ.6/Z8*83G<(<H@JO1IF!W.6GO'S@)QL,')0SQLY)# F%@G Q$(]:S+]WL@Y
MC$:.?8]KAX=EM^D]HU&/(,4_U^NP5F3422(43Z)BH <<'-&&A-G0V ZWT"/:
MJO6,GNPT9KP,_X57X5=2I*D\[E1'DK/EB7Q'3C)>+FF!5Y*W5^(4:,!=*%K[
M[?[]:-J50RO19^ASQ=_V[T.*_7OXKU5=&HX+/$/Q]E?( 5%/SI70D_8;2/L-
M!+K%8.C6<PZ]GF-?@0FX??N! 2;(+KT>"CI\&Z#!!%F#GGN+P$(2C5RVQ,!H
M<G50]Y:1Q'UHRZU1%,A?:G,(MWAI9V-C9R,Z@_ZA< M?6WBE!]D6OJ:.B1KS
M'QZ-^6.[L%2;PWH\+_7&^)B_ZB?\(.HGQ/-=N<KW$>\G)&NOA,[-/&T.#];F
ML,NOV4+T]Q?CN;Z9ZJ?CM+77%?6%9QKC[-QKVHGUTVAN M'/]>9?:"?63S5]
M#R:2=OKCVUF&^7Z#YV0&& ?KZ2K2X=U1. 3<2)W?>$Q7]EQD&["\\X-;C@.N
MY_)1BU2&G(O8]IX?Y*#%6L8R )E,ED5ZH]5>IA?].J/19ULA"(G0-]M/1)[7
M7U;MA^3E88.QS!_.J<N)E$N?2YJ6D$/$7D4.J=T'.?8"9W'45Z+&Y^BY612*
M;^6WSW]^\'>'GUM[VXA193<,6G[[Q'4#L$'XWC^4%Y7Q2H;RS\J_9.R!";#Y
MU\T//W_E/&G[(F4T\R [$"2!.;(XU $3)8.IS-G><UE.PB_L>FP6XAT1,C6)
M9DD/@(6OE;SPE!=ZB>0V>WQE7F_0-MA26XWM4MI^<YD4SFF.=&!-)Z>I.:;G
MX!OH*LO)H8YL]01[>S282'#1B"?;"ZE,AYU9_7RI61 -'C-TAJ?SXSL/-[R<
M=>^MLM+PO531A+R_6U5_[S-*@,W8V;9;^2[RU#^?G!'+W[#$<CW&8KU\U<_D
MA:@^W\=C_N&QX)_ ^#.^9)7ODAC?*K@8/J/:7)AO2L+U?-^)\:T"D9X?*&T2
MB<?\1,[+C3&^$VAN2ER^23#.[QSC_7&,]P0:O_DY/S4" WHZ^5H\)WT@"SPK
M5P_736*1)\V35:)C7%Z?E4$>[U2WRV4#OJE8,H86\:+#.=5N0_Y%9L;*!#*V
M(J?OC*TQ"G7'( 0#'O<VNV,KJ"*%!O!^6<H)Y(1SY!PF0 \T1?0LTVQ:'"DI
MO<EV=30(W1%U#$3*U:MV?IHY6G8*Z^K2G"I,5A1(VN4NBN;;P12!M])33DO(
M?.=KKUS)W=GP_I*M6^[^_<P#):@K<A'^2[$IKB6#JZL'W;.\O'KS?__[XLR9
M^\[ 57#E.R_,G/P43<I;Q'P^<XGR@_)IR\Q;6F F%#_18JU?T;,!,D$A^%KN
M(_*"Z$"Z[6BK!RW.>0"M]C"S/+-S%GF89) I939FMF2RU9D7,B]G,IDDAMK@
ML_@W^5&]O]&/_/ZDU!J7*W^95?@_0JE)-2S;9YG>D.D0_#.JPXWA,^'+8388
MS@VC<+B%7+)(N#3Y-*E*):<,U/LXB1PVX&N'WQPM;BV&63-,Q ]31"*F%%F1
MQDN;",Q'63ZX.D1*WUEC85(MSX4@PZK9L#1 BJ*GJ-.0J(KB7:S!> M<7(B)
M@Q>R?K^^9G?Y#=LFG^Q9]ML5M=L&-AY>>'(VBKRANVU4T>@,8>;(JKP4,7+_
MG?43%BV:,&41G-AGQS,WCAPU"H:O/ ?9E:-&/;)&^=>E^U8.@_-7+QM;NG3^
MPM>>?F[[[KTQN_4PE>=%VKZCT_QE*63=I<;;K13?D<KSB6J<<)HJS:U8FEOM
M2+S*'L;[SF&Z[Q1I^\ZMFK^C7T'\OM.@U!',R"A/M&6\NNLDIFC\KF\CWG,<
M6ALS21O3X]LXX>HVPC$W]>Z,5N?5;:1GLE&^Q=J]EVM[61;>R[+ZF./B A0G
MDO*=I.VY3VE[62;FG)EM3NFE5?D.C?+%.KQ9T^'_3[YP-'@VGF].?&QN(.Y3
M,Z4MUGP7'FV/+NQO3NWMTTR\ET^B?3I)BVNW:W0%95H[X^Z_,M;.,="CV5IA
MTLZ^&L^?;.>86#O[D7;VB6]G*O[]\W3L2[1VLMKO.QP@3I?PXK%/Y9[$=#5T
M/BVM5*E\:59K=.SI66MTC$JTW^W4QLB,VZ@SQNO-7MS&=.YM2>6'=6SX+-:Q
MS4>@%T$OT/RYY P4[?PV"QCWLA&+6*^<8T#(HN.F\O@J6Z'1J#LKFF=;(.3.
M8GT;RI9JRP7+90MKL5@E+0>BNRPL1<BUCNR[%$"*GA^=7!0]TDW%&%BO*! I
MCS.O*#OPL_(MRCH!+WS_O1(\$?D8MX7MZ41F;B?6"^J/^-!T>LRU5\Z%=KLQ
MT=6>X'/SHDA0(%V#;8F#$=J$]4$_T+.U'H<-2-%($">%ZPK*RR/YY>7X1;@C
MW &H*E 0E?]UY6%R]K$SI.7ETZ/<!E)'L8KVB/\+WKQEBS<K>8"MZM:;Y_@7
M+;K]]HL[=Z*;?^794.[_-*=VS<&R7WWY5X+X^-?>W+G$6([;>'B#YO>@N7.I
M\3EN:DRM+19_&P^^N2JN'1]_4_E:8GS'0EGS>UR?.Z?R?3S&-Z9?_$1<3^4K
MQ_A6P4K-[^''?),\U_/MC1=6Q>+P_A1">SW?DS&^XW![CZOQ+Q_)WTMT7Y6_
MI_*F^4F3M?RDSFB\S)="Z:^.+ZK\;XSQGP#MJOX2RP]4LQ3C^;=1_66RIK^\
M_XOQRR7*.,T^*-7\TBNUM>J.]@E=JPLPG<2FQ_C>A(*]=*Y>.GK>'95]_55Y
MA@1-]I&\>I.$XG0SB@M)XU!3-3FY3(M#F5*NH=7R'H=&\QXQ;9+&E^8]&E'<
M'J#&)$]'8Y)8IA[7^-*8K NPU_*MC.53QN7@BZ1_14GE'.TO>OX7E4<#M3W#
M>I6=QL;9/Q3GCLZC.FW/N!_$[YBZN/PYE>^,*%]8#;K@0[U\3=?S_6>4+Z9]
M3/5WJWP=U_.MC/'%-I@FXU5[[1?:BVG7Q]F55F.,+Y9;"_$^>P,]]WC8L0S3
M;!.!"2;'Y 1,4&<A"#22\+,PKA8U,0%;+G4@3 05P=428DCN)$:-;@B4%N;E
M7.J[:MJMW,$WI0%5/VYB[VIY8#SQ&5_&X_L\_NT4\+H\/\<]P(V8%&!GDAW
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M^4^/O;G;'+#I^B'.4,Z=\\T[^?.H*#>[E^3\Y068 QLYRV>.T *&?U=O?4"
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M.\_^]E&D]^0)<^=.F'CS/#[[QWN?.FF^ Y$S,2AT_'WCXRM??F75BI>YQ'Q
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MPSSS/O>*V=-7Z+_4FC>0V7D4>G%M.P!U^U?YV_-6X[%GWGCGZ94U9C?8#)?
MM;#ZVWT#3NWJB'-@=KABCON]O?3_55?.8K33V?T]&:T,M)T1:3Q!B-#*:XPD
M>Y6L)%6YW5IR%2>C*@VYD^LYSA5>Z*? $2"<A=^?Y5+53%S/N6A/X1-,WT09
M'PLTZ Y-G!ZW)9=;@!$/Q;8J3-"*'U1=BC*![%#:E(E.FYMZW5G7_>IA>M=4
MW!O&[CCTYF'S.> FC[OTW_R[,?&OK]\@GW:4UO!]8Z__NN>OYCDTWUR0-'G
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M0PCEH-S0<G->;!8M=Q";A9::6\TW+)O0Q3Y#383>KF'\2Z7AQEB!*L:^\#,
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MHL.++LA5?_&SI\'LA-^MH\OOKX_'^ ]MC_$?"#WCWTUSC-H4+%R<0[6CKN-
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M_H?DW,R,B-^5'5U"S[(\W"/P*S"$R:PJDS/&XU?0;G8LL#G1GQL"I_&7Y*C
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M-^U%V6M&)U.*#*VH6<5Z&9IKV8'@>9"7F8&&+>+;Z1F&/;)YJS5#L_IHO$>
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M<G_@Y@H5$[0.7V6OMO^9\9=GXQM36F0_#K\8HTV<?VAKZ)J[=IXU;VGJ,8N
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M05^GIT!WT].%/],>>@;T#?H3Z%YZ%O1-0??1\Z!O"?HVO5!X@?Y*?RX\3^^
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M)CHSAH8XQ,<15B 4R=]V>,.:L5%[1A7;H^> $U8+8UBM#MQ['58[VQ6+R>Z
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MGZJM&#VX7:'>"V=![W%P1![ PK*=_!U(=;E-+H]+AQ5#BSB8G"HK%.;#[G3
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M$C=>'J "*G!Y_,A%(D%H*@;9PBX[X+!@2"^;64<(T>W$'2?H=.#'91-0")?
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MG\5@# 9?"QG<H9!!J[.KDNQVV3?8_Q=A;P(?59&U#]>INGMOMY=TI[-O9"%
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M<A45%N531ITZK-FP[-;: 8]O.S%Q>F@,W YU1^"%S^XZ''HW="K4%'HX=)+
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M.FEERB8'JXZN3EH8?=!VQ/:CBJ30KV0I+%E;FFLS;(=MIVQ".8Z7VFQN ;F
MQ; F>J]Z*:+<0QSHTK_L<"^-%0D7'-"_&.G"TDPD&\EI<J-U@W6K]1WK9_Q
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MI;EA],4()VT2?DT3C-FNP%89L7\KDBR2$VSSMP9QW02C6U9TCC(BEX$"<*K
MEE_Y@/5N>X?V?P%V_@>VA[X/M89^0BD.@?G(L/+,.1QF\,M-"IQ:H,9F;I/V
MFZS*:Z!SX6X8IQ;G=H0JE"IA-M6LG^8_'PB.:KO0:=[<G#?A;0@KO;*;E;)<
MH*%0:#"P4!O*8A39Q)8+5U$6]<8($9G%2D'T"#@P"K"22!X.G>=6,N#VHHPQ
M]GXEA1P:H&6("MZ'#EF$&2R11BBD5/Y==W*P._^7.(I0%DZ(&D6-M@.L>!/$
M@@=?^T.CSJ$L_H<0P8:<QT_BR;V&2Q)*K1.M+#8NGL!G,7/C-<2\-B,J@(CX
M?>UI)\3&Q<3+-66>&@_U--'G=]CCOHE'@#_4T"L!N(,J P9;<N,!+>@8PY*$
M?U=3B\CYZP0S:-G*.XC*SW%>6-/:6H/-@;8+)6'E#T(JZI89731=;X?A0ZU#
M]:/]CKAF/KVXH&+TC0MBOLC^[PN;/YNRZ[;>OZ$FPBTK__[\\F#.@++;5O7X
MZ,2AO]VTI>F.JE?-59,7&B-5BD=(?YR'KXT!NVP[4VA*ES[#7_:RU&%IOB[I
MZ;?XTCP^7UJOZ588,9V@<9*[D#1(D[*?]G@&3O=KR(1*I@L.W^C,-)_>A0<T
MTK])XX&5&&+BEEK?+I]8Z!OJNP&?(-#S@>)KHH%=N=/U662Z&5>/*W.4@8HW
M)5"S.FY]'(T[VGNZLF&TS^<;'8GJMJ&(./;2+[0@8S=16'-;<WM$MZT5:42)
MWA((E@2"Z"-6V'MDBPA:(&(X$+%UR9>$Y*0TZM1=:?EY M)"TUED1"PC=_ ^
MY$V1*!>GB13E+- HCTO(STN#W[-'\?77QH<:0^=#YT(K/CL-"UH^AKX[5ZV_
M.'"HK6K)LJ:'#]24SDWU?'FGU6U+[W_][$=^>>FCT.=[7H,>7QV$F"NGQAF]
M<_I-G!"8'IC@_N+G8_ ,I$ 6?/7SFZ%GO@]=/GJQL*3^U-MOP8A'!P^N:<L?
M$N7S]QX!]/[-X%RU/[0P=#RTXX7[:-(]"[L6@K"L[O;Z#81>;4%MG8T(7$8,
MWF0,Z":6B"/%R>)<\2[Q0?%I\17Q0^$3\6O1JO!COC6@E%^$<Z(J>U15%AB;
M2%4$VNBF%.U= ):I-M%;C511H,AA*5,4(C()-(&I5/Z57P25SC#6J^=4JKY)
MER*F93 4!I'H[)P8?TLP)MKD*>$\DB^2! F4M'  WH9/(WQU11AL\RC["KWD
MH*GCR6C<D]VI"'C8A%!J8XAN!M???QHV)'01!H?>$/=>&DI[T]%MVWB<=A".
M>#..V(D\-IWL-B;.B =7>GQ<7'S\^+ 1U;JXNZ2[79,"Z9"37IF^/OU0NI">
M3C)CXR:A&Z*9"?&3,IU$T6SH$(NA%";"+!#C(8ZA>2-ZR@*;S;>@3 9DL\L,
MM98TD /XLVANG=LS4)';V3EZWQ8<;3LW#YI(Q<32[9B:#SQ8AT_T$OPP,GR9
MYQ4@F.].SO-Q\!*&,'9 3Y+'EWD/R(;(T_34Y$&7X>GGA\Y;6%\_<<X]A]YZ
MZ<V[YO;O,73^_A?_]\&90R=/#7TI[HU*>JWAGM>Z)SP]\^'3T]GLS)L#^<.B
MKV1DSAE4-HESX?573PO-9EYN@Y$SD4YD,RD;08>SX1[6A_9FO3W,HD:KF92I
M-A64 L\,L<IWFUCK$^T_.IH@VXAR+;0P^!&_BAO=!M)(SA$1I?&EX? OQ)6]
M0'4 *)M-ZO'R3L>+?<RP@&Q8O OVHQ!+XY:_85):9+3G@RU7< U/:3&M7!V:
MN=9F$W&;*SO(0]-":DIDL7I]811.S;59R%[Y[;K0B;>_;&N"^$W[?O.V1-7?
M&'SEC@>G53Y+]>Y70U""_SG@F0\O_"ONOEN6A]Y]\_4W'^/XI!3UY6W4%P?:
M\S-&HZSUEH9+,_0O]#.ZI%HT*U5E#52+:J5*O*Y'5,BI3W(0)2Y^$M>7/C "
M)L%,N!U6P&.P"3Z&X_ 3_ 96GF8NQ ]OA-FP'-;!1M@![^"'5A6\T 7MOA[/
M]UGKJ$Y*C;):.:D(JY4MRB'E%^6J(A(E4:$*5S)7.:DB844[3"2=[_G@VI;0
M2=OJ@VV<NIC:Y@LGDQ'DFTC_6AQH"G*7*9S A+4+)4?134BI&6C$^@.W8AGI
MV5!Z&0:_6#)]W81)S[U6V7_ERKM7%0U?//FZ0/?:U>)>NW_MQ5=WA3X^,\MM
M.^N.?@S4UQHWQGO,*"P1]J$<+>0_QH.BHO)KID6D)2N3)"+J8I*8*QIBE2CQ
MI_S).=%\9X.X53PLGN+7LE*98,I44R=9B#(95]X)8.G0!ZY#$<]"$7\"7\$/
M\"MH*@B,$HLLX;U/>_24!-);N;2<;J 'J-!H/K!<OH.QB=YGQ*I_%F&I%>57
M^0"O'U\T6C]G"C%[T:C?S"=U/'$;1IQ\\=:9DC1EZN2+MOZ:7,T%BP+EP2GS
M-N0RN[-KV]W%]):N;6N&T.U9XM[SH>WG0_7G>8P6I;0<I:22UXR;_RPEQ"H1
M :B$7Q/7B_IS'4S&<8MA6Q36LW6H9;M-47 ]LX$JF'HDO8X#YABHDC;2<U3D
M8U^^4RUO5QBMLWG*7L1'&JP[RW7&'&-^>_R0I_=S_L\1#KC,1G1M>ZT?'=JU
M;>\</K@-Y]L:\3<>NWI&S$1+DD2^-ZX;'C5!IIK%;^D=Q:]#J411P0K*1XYW
MXX\[/HO_9[P(\4"32$),0F+B1* > )J8- E6\[ZZ8_0?OW+^Y+SD9!IB1&YE
M\MP+;2QFH:@F)O#@<G(FU9^!%V$/'(0CT RM((L0!1S'#@ 10'6^J#?1>PW-
M]^)^<P,20\]US\YD\$%R&#N$D.>W9)< CP!QN "F2T*NU%H7-"-GP8@ >)B#
MN(HAWPSUD+J@N8J"W"EQ:Y21'L$./CF]PQH5%08@F7Y/_7.GA7Y:];]W//(^
MI.YX#X3LT_T^JS]P]X/+1@RM')0>^@=SM#U0/O7AEZ [2+#[H^:?DBX]$/K@
M\+[7O/%=OT))#"?H8,TU=="HD(G%HDBHT**J:>,MB@=?XA2/9X*'7[%=(M*D
MS'* <VAI@:D*.NE,S<*=M$5@>HUEM>5-"\NQ!"R5^'2_Y9#EI$6V6)J@S?"K
MY:R*\3S-"VP/.\ .,T7'EY3GUIP[K:K%QWS9UPQ-]J)3X< 9KVO@7IRK3(D9
M= [69[?\/STYOZ%;0S_NSF?)/(O [@GEU%V\_.O-\-E-%R]?I*O;ZL2];1_1
MPDM#N5?JBZ:Y.XZ<D4>-FUZ@(-,,OA>91=8*Y2D&);-6A&330<^$!7 ?&M_-
M\ 6T@<: BJ#S4#1?[@(A.N'.";T1(ID<$B!EI)*\2/:30^0D47C _9'M0F1Q
M\*A@T'0X9FE.<7&0V]+ -3,*=4%>>M'W\L7+''GPWO9$OG\.>^LA3QHE$QCJ
M,AWO(1X/MXM4^S%@ <M%?6&FJ+I=%INF>*(RB9[KV>+9[V$!SWK/20]S>'*0
M('B:X$<C6LU%$O#B >4P3VIL0'=P3F$Y"J K>&1GE,?GB8J@7V[P([-1WZ'%
MW&0AZ<]&:-R,G8Y 7A-%Y3,:QK4!: >T1;3MOW\)'-J_:8?P+W'(@&!& EJK
M*RM##_VP9TMJMX3LN.N&#<IKQ5$,1$T<R#41AAD?WPY/"Z\(; 7JRXO"'N%#
MX;CPHR#/4M=*;ZA,0NWT23':=.D^MDK;R8YK/_++^,GFI0]%U%3-HHD6RB]U
M/UY5//P2\/SBMU08+VH>4=2HQ1*99/PN;(UO9"(7YC:17WZ=*-P73$0#^(GI
M9G\%I8OI?V?!'?@2UX>%7TE>$50TB+),U&*Q5)P@[A4_$+\4?Q!_Y=>-G2G>
M(:X4_\(O?]9$5QAVM)#MKD$,6TKK[RWEC[^+%/N*S20%K^H)E'#TQ@/".01M
M:"?%-P/'"F>4XMT'944O44K"]Z8-B>@0)*NHP#(;>/GB;-H-1K9]#P^&?@Q]
M\>,H7 N/T)JVMZ_<1_?^%@K@#(Q$</NIF0%O,,I^MQ(R!38)T8*8%O$07!+/
MPT?H'7X$C1O%?!00=Z7/PTZTEU^!QE-U*!Y!D*\Y!^EW0W9>&VI^N^_K6 &\
MZ\GRR,N_?D:G=17W7N[+/=M@U)"_8_^L\+9QM2M-D[+D%+4/+98*U5)QF'HC
MG2A^8/W!:IO 9M$96CU905=:UY!GR6;ZLK1)_@?]AW1</*K^2SVO.B4JRX(:
M"W[J4;,ADV9:>DN]K<.ER3"!WBC-H7.E1?1.:3DTJ"NLC\-+-'JSU"3MDC^6
M/K >@Q/2:70'J@"*Y)<FT@G6)^G3T@FJ&'*#?%AFZ58HEQOY,XE:9&IEHJ!8
M";E'5CPR/\-&FVBQHF6U(BZ2[J& [(<+:V(X^D!E*^.7 )9$;ELM! VMH.A6
MV(:NS:HQ>U^Q6)XI?BP:>9_(/XF71-DK3A1GH0EG%"29R(+5(@IZI64)FN -
ME@.6<Q:I%FWQ20M#2TQ7&E%JN5G&U" <$ X+$A%T@0H"M\(VM,+"_VF%N?^N
M"_*[^K!BAG43[R-**;2G,2)ACHB2XBLS9@4F(28(>Z"^KBX83$ZU0*H[V6T:
M;/KKS]G[3UZ&F[K DS#M\G<MPH>7BW#6VP1V:2BOL@1R'<X]<%0#/8S-^^E6
MF09HKEQ)>3' :MH@'Z('9-2%OM('TH>R@**@5!8%+N*)81&C89X8G@&>U6D7
M=T3283&KI<I$99;RM2*DX9-%RDI%4(BE#ZYN+N+=XB?B3Z*<AR\.FO+F=8VR
MELDO!:W7R OEU?(&>;\L!N0MYH9C04;ZMLIP_U[@N@"FN U^[564MZR9IK:S
MU'^\)O4(:J@+.GE=9EZ'28AXP,ZIHVO"+BZ^%GZH0T$#=XG@SA>D,Z%]F\]<
M/@-#-I]AQZ]DH!W.9D<Y0WGTZFFQ"^(J!TD@LXRB"1IXM=[QP^.9QB0MFC&5
M6=!66@5)8XI[H56-72@RWX)S"AC*>F4KNA%AB>D][C5L^H+]IIEC&\S4P#TD
MT:QJ,;E#>Y8</1]G6^Y>12Z2GT><.C5A3CAZCB0AP\0YCQICH/^GQ\'_8>C8
M]F-+UIU?7S]YQWUCAR^8TG0/#;SU(1HF2VA7Z/M0*#3R\..O0_2S;S="Z4O;
MJB>M";W)1\7YPM.H,W;B)]N,*>.T&=K[(G/@2S\AX\.(T&:?I.<Z# =U."#:
M/XE1K@Q*!NU#KZ,3Z2SZ.-U$=]%_T!/T+#U/K?ET$CV."D3\" ! ]RP(;RUG
M?*[O1S-?!;70  ?@,(>(W.;%J/ G0-S.H4P;WPZ&@W] PX SAQPJ3,UE*1N*
MPI2<\R<HN7@9?ERY9N*<]?/Z;EG?=>3N^\;U3[MWF[AW] MWK#F_,,KRW[S[
M)E2F17$IK+W:3TS'N?62'F2[,6AX(O2V]4X<;F.:%JWYG B=-2LZRR'.(:X*
M9X5+>,SW&U"5\R'7$-]TG^B"--8MT^<1HKIW3XM?:&513?"6D9.VD*G=?9G$
M%25YNG5+]GAB%IQSP'K'5L=A!UOB ,?WR<B^#W SN,&,9-RS/6?Y3+/VA:>6
M37TP:R7-,IV6LV82+!+<CCBP,"?OPJO$$ .W*XN'FL5C+!(3Z\##7#0915ZV
MH/C.@4<;'@^,#2O/NMM&3EIPZ\BAE4\NF+)KZ5\7%OG5M)S\237QL7'K7H>H
M/5R-K%R-O@K=?OOD_OL&PW?C('7E]@.K0V^]OO4=!<64D>?;/ 0E.0+UZ1O4
M)Q])P07<.SIVA4+]SF)KL;O8(V3$%:OT(Q6LT3Y"4C2KR^$8;[=Z['9K2H>R
M:1JO FZ"CXR)_NAH2$XQ]<WN<*#*W4C!2POI"'HC:MWM= <]2+^B:A=4Q!&H
M<[>C&GZ,FO<352E)<;BL:.! [VKO8Z=V.ZCQ"W+D,C0_IAX^P&T.7--$20<(
M*V-J)V6LOZ:-7/LB*AEL-^^=.!KQ<_#1V<[8S1!G/H?<)F-!HQZLZU!7LX3/
MG9S.TC-X**E#;U.38<#%R]2W=LV-^[?GY997A2[HDW,SXTN&5:<OW;MT?%'2
MW!!"W-&OW??WG^.*IK\4^J(_N!_JDY7P=<[BD=>G1Z,]F7'UC%"#NMR57#'2
MLU.F6^=$+4QZ3'XQ>E?"1TF?)'^4<L;U4Z)U2 +<Z5QF><#)$I.3F^A\HX?%
MA@[7MLFRRW+"PGR6#,O]%O:T!6R)EF3!+WK/\#3@*1];[X/59E7$!X9VQ@_^
MA6Y&S@ GAWW%A1FJS9*8+/A 6?!XVIDTNBKM5!I-2_.]Z(U[\8!^6*>_Z*#K
M\&*.]Q?OKU[F\)9Y5^)3P<L!H$UO+UQ),HO>=Q#.#^M:S$7 *XC:S(=PS5I;
M:W.@+=A:;])$,]3"0;8] K)Q:;B+$JB96T2-[T'#I9-A<HC@W6N&77BN+7WV
MSV*WZ@GUMR8GW[_EUL#I]S_\M[7%]<'48+?LI:_6]PM=^N+9?UT/)QP+)Q=,
M&U.<E5D:G/%XU<&??OC<=OSZX0.SN@Z]<?JCP<.AW^X_S3WP1ZC]+YAQWNW&
M>(2]W(U*E6*-2$51[E!Q"8&B0%&?N]#A= *M1LU=1_?0#^D/]#>JR:9NLQA$
M/$3FVR!0B0^QJXPVLBUA-EB/RIMK*N_^L/*>-)67/KA=Z:2\O"SI7+N;A/R(
ME @G41U6%/)0N?-I!!%S[2Q*EI-I^<7/0NN[LNU=0\\+[YX_ST?VQ-4SHL#W
M'(/->&RZ=X&7XI(<;[5YK%8;( SV$P]Z#+O-AE0K4UGH48?ZQOFHSV^?:)MI
MN\.VTO:8;9-MM^T#VP\V=81MMNUK&U-MDVW488OM32:0F60="N]+\@/YE2B]
M2"F9A&\=)Z)")O+C$!FS^JTQF38K\>LUUM76#=;]5B''&L"G^ZV'K"?Y)6<Y
MAW:KM?X&_P'_8;_@\.?X*_W,[V^"EPTM1K7Z_#ZK/R:R.P!E=.[/ "Z\/<"4
MD\O<"Y+GS*]#PQM!$Q$6AX_1$3I'>':Q(U-;A("<IWQ,=E<$QL65R<*\*=?/
M'YRVZN*JKCF#?WCUPS.I""B:#\1Y@W-'//$92[GR[?E;-SWW[\.#/D89[T?\
M5H RELC+QO3! J21-"@@O:",CF0CA'&D JK)=*38*\A]\ YY%XX1YW2RG%!!
ME!"XA<$:"#@9830GB0C *!"E3 &12.B,!:%,JI4:I .2D"3E\LI0'CNOI#64
M)J*Z[8&_$]E$(G5!/SJ:XF*^U85$<Y6)H*EK^3FSX@;U*9C%-SQ /ET?NOC%
MQ2?@W^<1E+XL5.!XWB5$!I.+3#:>YB"T%L%_@[9#.R>?TQ2>#"FCAFQH')LV
M:"?I8?FP9DFD_/*>'+26:^MIH]P8^0"YH(R?::QX(V*G ^R0(@A$8 [%8AE,
M!K/KE,'6!M+ 5BNK+8?)8792.6G1=:*S1"71TD@:V7IE?<<'5K7]$Z'88N6!
MA^V&IO'+D%L8LEO^,B-2VR1K3.#7L3<Q,,H64)Z9%F+5%/S,:H=]=!O1"*7;
M#%UMNJK!:NV41@VM5J/:/KH*QRC2;=ND)J&);MMU2(8<=/-[H)G8=)Y0;.4)
MQ;I@:SBM'LG)HK+I9DHF3"#:"6WGS"B/Q/.U''Y(3F4\+X$T :=!>.-2;&C$
MU>[_T> 9L,7"@[\(N9</XY2$!'I%91=Q+5_]']2S-)P7-SENW'&]"\H54!59
MUF191(HO\PO:VEUN0O@E[AR"DU].'CF9).-3"[-;B46PR: )-@I(MNPV01C/
M[![&[)J%FS@-31R_EIW $#C:N;CL @(I C9N*&HM#2;G$I!IK=Y]"'Z!J\
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MX[TNH1I4@T?2MU]XZY@\^N2E&;Q_2Z^>@>_,:O)\PTW0@U0!0>F:;M@"P-Z
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MEUM%&.?N#.=Q, CB<5%$*HI;.D9%N %I7PPX@?Q<B/!#I_&96TPSBK@C=L.
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M'WW9M\]'?3Y<G(;JQ]6)__P=E7R7_A](Q31")>:";2ON2+>':VJNF2)WQT[
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M0HF;;AVS:=.86S>A#Y?NW;MTZ1-/$-U-4:;CA_GCP :6A=N:K#:$H,TX538
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M'3B  )E,7CN$Z<39 !,.\O@,C:V@!FYH5&V!1'\],OHCO_*;7V9/[T,;^-/
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MU%D_D]_ HQ,TD$P#VG/0JJ-S6\(!'0V_T_&@36=E4YSJX_9EBZ)"33W+@EJ
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M;7;#DC-H>J]+L"0LUYRAGF(.K4WY!_/II+Z_],[;'GS65_GC%.L+RR_K.7Z
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M93TPUFT41'MK&^M;.J*L8GIQC?#%@B9_;P\@$>O*IJ6]M*Z]C;3S_<V 31&
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M L.4NU1P88A"67X[$OQVS4B6I96T4!?8W7AC\=-?F@WASH##+WH<E9%8GB]
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MI\7NDEM_FLJ\?<'D!KKKWU1^?^5@EV_JW]EVK6[T3\G;?WK]XL1*Z^;A?LV
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MC]?E<*@*==A,DLXHFR6V&R1BT*E[E.;\6(BNK4#'L,2\-3E94I93LFA1AAN
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MUQ55@AYKQ,\19: &TPZQ0KS!L"T8#O+1!E9$$O*S0;&U>4,!L]?%AQD7WRX
M1Q]2-H\_R/8*>L/LH,QR/!IV0V%L)F\1[.;V 14PLL<3A*V+BH)%7E_,Q^=
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M*5SQ:ZL3";"(I3*Q6'TJ55[?+U;//\=,%2LI2\SM5I28;',/375[A?+R<MA
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MP\J,SIQ?P[%FWNBJQJK&QE%#1AU)&-,X_SB$QL;&A4O:QH[M/[RAMF9L4\E
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M?Q *A<+'1 5OX7TZE>@PMOI_;$6ZA$%XN/QP]G#F<-F/WW\\ZZ.O-& >./?
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MY8'8,=.?C V+"KNH#1.("0]3F_U43,<O/$1K#",$";G)U"%\B).E7YC4DYN
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MFZ>C'R0,"3;!UPS&3:03F0'#X3<41.MR<#6#'GS FP?=B91B>['#E&Y0&!S
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M[^FM4#F.'R"R51CU%VHWFY=7.KCY;NT',Z>+"@8#L8Q$?%Z37S;3H!N/O7"
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M%KR(K$>+F*W<DD]I]46$3KJW+R#'80Y\#A[U^IS7XQ7DN.51Z'..V><%1IF
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MD)33P5^84JXW<R@Q)!Q[;K=NU!XREYB:J;GX]+(Y=Q,O.J)P.$MP"NVR3KS
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MYHR?_.:FYW#O'5^]<_>PE(2=^Q;A11F;-AVD:]] 7+3&T8.>-";4LI/MA -
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MJ""O.9:D,/,_Y@X[\<0D-<)PNSTO:$6PI[5R(+9]6E%KT;I9,Q KX:":9>S
M#1.K[@NFUC]T3_Z3&_:=81]F9E3W&^/WSWPBO_RYH\=>Q-,L#RVKZEN<DW-'
M[_Y3>ZY\\ND#RL3I0[OD!U-#H[O<,W_%BY=.(3-7]C?BYXZC!/2A(65:>UFO
MR>9"!+>1Z)3L.VWR3LGF<#JMB@3ZH]H<5B><21#LGC0\5I1M=5I5YPA!!12I
MVN5=FH6'O]UE%'OQ8F\-8Q%\U"B% 4*U,%U8*FP67A;^(%P3OA?D/*&KT%]8
M)YP7N( PCJ[[@+!XSB<)NN!K/\G1CH5>T[ZBBQFIQ"BT>"#/6^:]EF>/4PA@
M3O$-Z3#=NRC^YU2L&7$&6D+9O;.$;O40GX_'VWQ=BNX9[YDZUSNWXXF[MGJW
M3G*F!#MMVVX?-2!M"9FZ 7.+HTLV1,[6N])2J+2F@LX>9S/!X_[)&-C5\ZR'
M( ?=A='C=H]PZ2Z72Y< /L?GCUUN%_!XD=<]<K8-G!3OS7;I(J_UU5?KN_1_
MZJQ?'Z@3KXYUG6*';I*7QR7\0'XFOX3?Q#_*'^7/\2_S[T!@_#NOL+R#+^)[
M\ROXQWA^"]VQ (!^(T]"/ ^",R2OI.N\SGMCLKM5Y3;;K"2*52R$6TL68AXL
M3D5O$9*V+3+B]IS1*K?6^H58J7H:6;?_L7$/)D[=WF"[L]N0_?W]0[:?6WOI
MPS73>A\FDR*C1^27]5QZ\1!^@_(U##$*,2= 9C*:U-0RT"B*URF,:*M3&!&K
M4X!3LU*!EZ$IP8Q%A,^4669)PGUF24)\BEPW)UEB5_\?RP8[%;:O17!NWC)0
M<>3UPJG[HU8V,_+LQ/=F;R5+X<(P>@A0MY?NN8_W&BU 212;FU&11UI#UO*[
MR>O\JUXA"1F^&A_C%P*BIFEVCZYY>2D!^3F_XG(_@4YR)Y7'W&*H]9W1J(JK
M4H:[]Z%]W#YEN_L3[A/E7?N[[G>]=G!@@DWD]-Y:7WNY_B'^A/M(D?LR [G^
MPD"EC[NW9PU>SZUP2Q_QGPA7Q2O:%?N[7KY*'&$?[F4&BGWL?;S,'6(7>V<O
MDR=FV-.]S!X>VS5MA$UQV6R*Y'8XIL=*&;R<*$YW>UUNM_>6D-VO:39:O, K
MB[G7O X[DFUVS2$IHI?N^LDD<(9+\REC6+?+34ZY+[J_=3/OF&YVJA'4.%S'
M'>0:N=>X*]P7W'><('$:5\AMX:YR\$1')Q4EQ!AOA!:7PB#%BG5CM0RQ3-RU
M6"E#\W_6,=PJ9VC=(:"^WJQ5G0V1M+XX/IC.UD-KV?2G59NRK7QVZ*W#23S)
MJ7YN1[1R;PJ+4_._8C.C:4]]>& /R8TTU[^SNAE_>>-C,JOGH>GW1W;2F<D(
MZ.-J&'<;^LH(R_@.3$;A45*=G<&8KM!!K529%C%8+58;4&5)!M@A8EZRLD00
M 8$@ 8*KP%"N+#,N66; .4+TY6T6BPSJ:[9$0A.I/BWNE!EZ)$\C"QP-J5!N
ME,E5&<L72"]D@W=4#2#>=X@I!$Y)]TN:@33M^_C>(O]/I0NQRH7+<1Y\.?Y,
MWXF)- TSQ;3JCW)BB"R8P?=_]%C_W)0;YZ(/?_)895):-$+\Q/+"M!J\)O)U
MY)\?]I\076S>*S8ZE/D52,J%UAL=))L'BR*X?JM5$,&K22-D%7JNVD +!2OX
M?ZOZFBC;K++$XPN8[C @&3K3:#AM5AL6P)8U'B&WS3-+Q1 ]/GS:G4)7S],B
M(WNH0#<3UK[F[YO-LI?F]A[)I)%LC.%3[F,OB><93=4 *Z<3*%)^7D=_9F[!
MUH?O<EGQRGV1]^Y9.JASM/:$YDVMFL+F1+X^M)\9>6/PN>G0KR!H0#7TRXZV
M&OI]S%K@UH"Z99N35OD(*J[4L$8Y4(:DAC2G)+.RJHZ(%1M(<H*<*X?DT?)"
MF<=JK/) .BOL HD G)0,F[H+S$ME,>.0G<UOTAW78L/7KJ@ A^,CB*E#RPN;
MBX3BQ*Y]C0%O%AD$O?C=HCOO*XB^X".'G-&L["'WY^.1_@UD>>_^ZJ[9D84E
M-=(!Z%4]C!;+_0'EH\5&7\[N=(YB.!?#<!X/>BD_/ZB^I-A37@HZ/8R3LX.W
MFZ*JA;9";&X;&YR2<BEQ<N8R[^3<0VB*EH]1?DI^83Z33S=?+ !($[YVO?EZ
MY#J=D*&E?=<<^JV]4.@29&LKRP=^ZKR3E,1V[;H#"R:1MQ(!@(L90\RWZ+Q#
M20SF;.I6U3T8M"<694R^.S_1U^N.],2,.T<-;BA2._5)\.</O[LP(RDKN0>9
MB'NO/'^N=+Q1F+,_8_BC[YV8E-/S2%7T?_IWZ)2S/Z>ZU\"/'NM^=Z<,>D_D
M?=&A.-&L9D@]CQB\T0#42Y@_X(,F6&/0$18Z5$JWNFZ&BX41V/=@=*CPT(]+
MP#<T1(<2NC:R "TP^KM8GA_E<+D<#I>NHY<P5E-?2K-;7U*=.NMR\!SHW934
M2\F3LY?Y)G<XA*?8$*;S;@7H*F)M@ X)0IVL4]0=A5J$EIE0IA^3HOV_B<\4
M%V]NQ)"'2\R8"P)M%5FF^1XM0A=,3$B$I&[5H6#0 1*L!0DF]"I-]V>6U?0N
MZY+NZ]3;EP@B+,A(S$HB$X\0$.&9LO%& 17A@?>>G):2,V7XZ+<>S@,19E?W
M'OS!X3N&=$H'"?8C'9G-S%SD03.,<AY[,)'4!)6PQ&)U$;^5S2"YUBZDN[4/
M&6"M)*.MM62J=3Y937:18^198E..,^)E&W/9]0_;<:2:!8I*$Y%HYO6@3C?O
MH'FD4I10<-U+MVZ P&YN7QL..[N8B#>V/XR;@H\LRB3ZC=R8/Z.VJKA3?L_.
MM8L+1XV>WK-H+.GXYH+4+@6).;W?G>WK=$=7U-(2V_] L)"NB"X$T]$F/ +/
M01Y#88@MA2$(/!@IQGE=NJ"R+EW:V@\EF69[ 7UBMM<-%=IZO=!68X@WA3;.
MHW_4TH)V1X?2=>[P%YGF7_P1%[7\C"SG,$I,HMLHYIFMS-7.0D>XCFSS.C;B
M2OA>AR%C)04CQ1J["OA>:&NNX1%\T+:3V?8#O PWF&U=T-85P)9;;<U5)V;_
MBN+].]O:OR3:OZ1TF]"N?[$Z6K-]MWC[I;'V!'M3"$;> %;:MS<K0K@+T+YW
M[+K1D_2F=(9,.J42U*G8[;MU+?_>MA=H_:VV19W_6]OWT7/MO_<7VNYN:[L)
MG82V9A\[I4(?.W6+M6Y_S1NXHVWM/Z!5=;>^N]3U']_]65O;3]!O6K^[N_G=
M);=_]]CH2%I' *-=;MY;_8_W(7.LDY)OC;4Y)VSVK5]<9GOBOY\&OY^6(6FW
M?O_?V]Z2&6V;GOG?VK[?UB_S>S/]_]%V=UO;3>:XF?U*H_U*RW5K[?LU&2&2
M:W[W>]#>@S9>,+\9LZD8"5Q[[:0MI78M>Z%;+3GVWUO6MVOY_E>W6LK2O[>\
MW[S:6,M-OT,QG61302<%\38;-;.U2\SQ'1H?WV?CU^"%;_:F8>G6-YO93/,:
MAL7'XI&XS/P@,W\2XO_OMKW01^W:)B:K_Z7M^^A$^^_]A;:[V]IN0OM:Q\)/
MQ\*?&FO=VK]8^Z-M[3] A]I_=V;[[S;9IWD=H^+]>Z6]+'R2^_]NVPN]UJYM
M@E]R_=]MWT?GVG^O7_R/[]W=UG831-7X^'E339\2:VWVC^X,$CW"_($[BBSH
M82.;;H+ L8"R:+F?A9>)9.$)@Q0@?BIOL8R*%0%0H)QI)'+9$EDM,A&>YU V
M41A&D501*=F<1O,3M>?H:F.DM.8**,-MK8>,[1$0VP<2 GW>K6T23,!%TP7Q
MNPO050CFXMT@@VUO1YM\N%__[?UQGX3HA2O1(^S+._')Z(B=-^X$E<5VYCA3
M"MC  C];>-8V#DE8:B(UANP>QV#'.%J["2^?4<:A\S@9>;4?:.VQN>T2+<!K
MW>&[+3L=WP[.?F1VP^$C<V8?F7%O>9][[^U3?B_[XIS#A^?,.7*XH?S>>\OA
M 4!B:70J\P#W>T 7V9@QPMT<H90NZ7NU[>DGM!.>XPG',L[CYS6+Q>Y(2DZ6
MQ6 *"@2 PP0"OTJ67?".S$L!?W**PXN27'Y[4+6(J;QH"=I3'"A)M"8'L@#]
MJA*V+K8!.+^ TU J=C[+"_KB0B_VTJ1:DFN.WY)LU<=X3UK'(!5K=,8#&DOP
M$%5: F7+FHC(9O(=86(WD3A/QM -X<R=\_X_VMX$/HHB_1NOJKZFI^>^CQPS
MN2^8D)"$D$":^R;< 7(A D'N@!! (@C*C8 0.50.4<$SR!E0%SSPQF-51'==
MW)6%W=\NJ[O+L@J9SEM5W3.9(.YO_Y_W_1-FIH_JZJJGGJIZGJKG^3YTU8LB
M4((R#1..?$%K-*( B#K:1GZ(S096 M:8&M5-\?9@ W1E(LVJF?BX&6HTE0[I
MUBDUIDIGTNV0VI Y'="UXZ$/EGF\ZRL>/( >"28I/]HM Q],;>KVR0/I:0]-
M:,%"W?#&C$+_3"@1<RH6;N^DW%=QU=!G1&+K=7;U.OL[K^N5AA"*0_^Z9\F3
M3Q)KV8*VJTP8\T%7<%JVBT:8!%/R=/%BW([X>&"V[;&WP'/'7-?-,+L%/B&+
MF2G7S7F)>2BO!0Z0,S.O=^X,I"28X$_T"GH#9G:8/3UGO[WI6QN4;9-L*VS[
M;*S%!FTM\"$Y 28V<=.]=66&<D,M15P]8_C8(!B^#$$(]Q9@*?:ZBE!([7XN
M>ZW4BEFC(5DBL=!P*I?+J,BIXD!$3/#<Z<3O*SVY*%_%X(M99\P7DMT.HGIH
MHIB;; H07NUO'7-O(7/"][#Y+P=6OV5;:UPX]JY'+'_S?03'C<]Q]!Y2-K!S
MU?A.C34])\X<W7>>]^7>NYX<8$G<L;;R \B</6==M?+DP7Z-.W(6O#-2,/OB
MRPX,[E28B7D['^LM3U&9NP=HDKV\&XH9N?H>AI+\U(+DPJ1N%FO0"CUQWA8X
M_43<*B?LM JK7.?D L!"J3 I@Q&"284%N2*?*-1E9>5;N@6L;&*=S=;=[#%[
M47Y=:JJWTN,I TT0=J\S$H6F)S&,#5W#(CGYJ<:#Q36B?X8HSCN1S&W%UPF\
MB)5P)B56%'!7=><J2KMM;=:E@2UI'1Q2I#"LW=!;^6N=]X\8-JO/ES/'U*V4
M#V]=][A[.[R[?.#D?O-?&[F@?M3IA]>_!6^.'IEQU_IN>[O</3'KOL:YY<4S
M/KUG2\V,IT=,NJ?I^&,MSAFSIPTO:JP_O7'T74=[SUVX_I4C\$)H<7%N_\D;
MA\Y9T[F:0'. "? 3^"/S 1ZA'$3SN7Q<Y"^"#08"DA8BND[,&#2A<?3H98VC
M1C>BCV9OV3)[SI:M^'D.CS*;J15J^1&#T7(:60&$#\@FK-;/%75 OU\R?&8R
M$E VT8Q5Y,\LU/1JVG%VD/5#%8!N&&8XS&4W*&@[19X+7Z8,9R6$ZPGS@\YD
M*_F#([>W3'KV/L0OW'A"N8=UBA>//_1&[8L_5?%/_51%ZM(#][)3M)=]+>=P
MC)M!W5"AT%^HL*U-YN*\J4*JBX'Y7;MJ^QR=%\@<[ KT&;[3L _PH@FRN")^
MDIL8N_I:X""YRQGOQU[D]8*T*8DF:#*!["GS="MT6W3?Z]ITG$X7F$+ JS]V
M,),<D :N=K2@!^1@)N;)H: ZNMQ/%OOUY #K=L\7:':P%#2@FO;"XE ]9IO0
M_&OXJUZSB/6%5=LIW[6($9IJ;$;W<'LB#3S4!*-LA+O;[0P7V=WE!:;'RXEU
M)Z?6[\[IW3/1V[LV=&[%2_<NRR[/DNL3ATS(RA\U=$ W>47 [GJ)%8^_.'US
M5=[BZ7<-#21V';5H1J]-'_]EU.0!]Y>G])@P<T*H\_+&>WMUZ5,YM//R5CP4
ML0"U_8V]B&E.M-A"((-79;=@T[ET/B&![>P)I77)SF1*"C,S"[JVP"$GBKIU
M8PUE,CE,$D$0ZH(M2);U<;4LTSD4*BP,M*#28XY:@UC2 I\[+@)J-@Y398.G
MME8'=8-[RX7!0GK+'( ZG+K7,4LM&-2K!0HO+]?0[HFF2!AJ.![LM#-0%E:Q
M)LOHN6I40ZP<BT-J(!MU+:7:WE5#\*-.[2FHR&&+(/[1;4VL^>=IO=;M2H1D
M90PKUUZ5[L0Y%IV"Y@-/0LNI4\H/3QY0_GYJ^NX_K%GSA]WJ]S^O+)K2>]:H
M5%=FT8B5I7VS$HKE5>,'I90,68J^_036'SFB;/[D8V7SD2.P_N,7E0^;FF#7
M%U^"79N:E _#+S,Y.;/[5:T0[/ZN,_:NV):1H!R$[Y659G3W *9#*Q2#:;)%
M;0,^@>VTI_-/76JS6J#O!*8R#.X)M,"I1XIJ4_ 56<*DECK7=JH.U 9;8.U)
M3ZWNKR5=:]-Q=R5TW=J=.FY8_H6_*(CH#6*,3+__&VI%S90[CGO$2/D_D@F]
M-]5[8,[&4R<?F;$];K+WKK*J98LJ!M?_KS12+J:LW'+IHT]^<U]]_-!A3SZQ
MZ[&I@*Z.;N!.4*\2!_A&#IHEL]5L8Z#>9."L>AM+W.;72;LEMKLT2!HO,=:6
MMG_*:3:CR8P<>KO--I-X3TEZ@\5JG2D9\*'!9K5(K,/.<J@%6HXQ#"LX6O"0
M9Q$->KTHLD!O<QBLDM&$[YZPF+^4OK0[R*&HV\=]R0OX\"@$7S*8QD>=.[^)
MQ*NX3L8_[_7KI1Z"K!UQH*1@A^H7G5E^YH!67 R[=8MBSEF3"\A@&;3F^V$^
M'C&99,8*'_D*)7T-4Y]Z]L"^J2]..88VH!-+EH0',Z'P0K2A]5/T0G@,.A$>
MC(=M/WL0S:.63?FR;QJSB%G#[& .,J\P_&KF40915Q$&HE<0"<J0 #HXB]17
M4_L[_^Y7OHYZB[S)?H":N9W4@G"(G-K"7X07>>(L@T@<#148,H,3$+$=Y(5*
M]@!3B>5@+] 1MM-"I6&9/!1#!XKO0R!K232+-Y,?2]Z6LCN9_>#\>1K5 @QO
MN\RZN#> '3PJ]WX7C^2L'1H8UHXDGK,A2="9D:0734@RBB9HL.C,T&#E;-"
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MW^0N@2RP7_:):5!,X)-\@E/OE#A7NCW0(,*LCP"PG\9<8(,G9(LCPZFW.>-
M1DJBLYS@%:"Y,I;Z<XR6##D#9>#38YF97'9<"ZPZN=?8;/S8R!A/HX4@!5;)
MMA!7QM5RR[EF[A+W/2=P?Z2!V\)JQ+9KU=%OXN%;1NS=2BV7B1.'%B<H-2T]
MC41^2LD/N%UJ_-!4/  54B!^1.5?J\/FQI?@#[.**VKVPM!;<,2Q5;,J"B;!
M6>'71^0,G))_]WN;S]SSR(E]X3/[^I1-@LP3;\%!AY73RLU#2KBZ>QG_S,L9
M:3T._:IN/70_LOA9Y>]?*>\-/'8(-\: MJO<"VP9EO:[@P&P2$Y/M6$VS0)Y
M()_1N;#(,[9'B:-'CY*\G)RQ)2Y'28G+W".Q!^I!0!ZR' O*2VI+-I?L+6DN
M.5/"EY3H$Y.2\KR"T#<_;T=F5A;;;4&*OS$Q#L81JVR3=T%B8XH &@&T4"_G
M9#F+[;M 'YK$-N)1WU62EY4/DBQ)@20F*<DE"#DE8")\/G^B"-*A+KT%_OMD
MWK8<U_,Y$TN(^VK0Z)\8]VDO/#.>-?Y@9,BN$PG-]:V1 \: <0MN(.(:,E##
M@R"F<B18C]K7M.V04+6Z)0(\-$Z(A6P\7:>AK37G:))*^U1?NU;= <(KLEA+
M?*8CGOKID?Y)\"*B'52=57_F2ZTAO@E1!(FB0O;*HT,_6S;YJ:YES37W/]H]
M9]>!]27V44..R]MRSF^;L#8T_X4G3AG":YC9HP:M4QZ&OX,%506CGOIX_+)I
MHSJ-'SBY;P6LL[[Y_,*&Q0N?>F111:]"B\DUH.OP,>^:]STS:-#6']_H/C4Q
M?F?3 OA 3L6*LN=N>4U25GG/$;5C9Y/(6HO;=C,?LVN  \2#--A%KDW59=D*
M=-UM_72#;.-T$VQ3F5FFZ4D+F?M,2Y+6FE9[UP=WFIJ\CP6?\CP?/.9Y)>A9
MF_8HV)G&,&D)DL& @#/>9(0$+O8E%2XV(3[-R;H#DHD!K%W$[=_G*'(O0"UP
MQPF[$%@@2G@:Z2,7&B6C)1UE</$)SC0VQ6\P28"!O"5E2H@;08U-/^%^X'@"
M+OXMQV Y7$SD8#%'O((Z^:>46VHM<S5?CF;+&<O'EDN6[RU2Y(#-M?Q@0:+%
M HLM9!<R_6<A'C3).=)=<4<MNW+-HBE/[IA]QPZZ.Q&@(5'7(X@5Z45I!18\
MFKDUI3TQHK2G,QG5@R<-6_-EP^S*ZL&U8]I^>R]7,&C8UKO]/0K[#'KX'@]S
M<]/ ;0TGWU;>WUVVJ=^6A2>@'6X]VW6^\N.C4WI/[+P 2MM&]R-S5ZTRFBFB
M,:0"X%[9XHF/T;[H5F.&G&.>Y JPWR$X&6LD&;9*^PH0J&.GTY"V3"6XF@22
MH*%NLQ=Z!P6GG8(/@TBDH&K+C6LTR"WM.#1.$(FJ="U\.38FJ9!<9#=!0=N@
MB.ZQJA,4[@+H7\F'4FIT1<7^NH9!\T=4-SK58$%RB 0+8M/.GU>VUFP;DCIM
MX:9>8Q=N?I9$"WI\0=W@IKHE4P#=_9L%/Z,U%,'LEXDGKZB#NF.0XWEP#.D$
MAC\FF#)8\=AW$$UFCN$JBMN/A5C(GCX"*K'4]>XQ_H8@##JF%S=M]F!Q?S@5
M\8<1.[MJ6BF :X5_<6-R6'S'U>*TX(:T:A),]D/X6?*AY,&5^<>ZO4@+_'#K
M9>5SV ^K>!!3X!"-2L6!+L>Q,,J24-@_R!8L_K$;> 0_X\!@+4+4C=)A6.J[
M B@<IX7&I4I6HU)M#,]G?/ 0/$$C4HUI.\).$89AB7*ZW!DK_C,%X!"P:$F"
M4]40?UR$R8T%7H$EJW8$)HIC=,1EB,>B1MT)2&# =*(ZO.5C;48%0J):=*B,
MK"OK;H/CP@7)%Z&0G@I9WV#E7<7R=A+L!)N$83].9<*5\H[6]W"ITI21S%+N
M<\QGS7*U).@EB??XX^+<4,?8'*+79V.P)!87-Y:7'#S^'#9#GVZ'Z/5X] 0\
M_G"BV>>UV:S6)#Z8(5ETN(P0[+;P,)>?RR_G?^!9GD\*BKR;USS5Z'!;#:\7
MDU7%*(Y5L19C+[)(7!8%[2&X#:J9  5SP%>BL UVS6N:0#>0[;18Y ;*JG&C
MLW)RC5N?LC_M<!15]^\Q)WY,9JBSV7+0<>AQU]3*8<K,QUS=)K&VC0^MF5F4
MMLO3;7K=QENO/CJ7<"=<S.:Q65BK#6'=)5.TB5E>FS=K/.",DPUP<D +F:=Z
M'QVR& XQ;SG_(;YE:4$5LM,OITX.I!SRO]7I'\&WY(Q#WLD!#U9FQQT!(*4%
MC3WNV9N[^@FB+5S!P@+PAGS7KOL\F'&]UWW7?!Z+0@XO4V/):A^>NM15FT)5
M>R,U=JKS$:DM\PO7\V>\4+KJOG[]DGMM*)17C2J=U=!0+M>/N>-5] =B49E@
M'5[R>6FA'\LF2C]R(=Y&+\05%!21_NH#@'V?FXF/.% KQR/B'OZFNG2%(.;6
MF>KB%6)Y!O>4_;(=]Q0][LT, IBC65YX]J GFS*OZB1 [11P2^='-34NBFJ8
MB4<P]OU;(]"]<(12KPSD9MZ\RKS36DS*\2 8R*QF/B?60N!1V9_!9NC?9=_5
MLSI6I_>P'CWNLH*DU^.BO IG Q&6X@FF7NZ)!)T.SU?ZI=(7PE+=5KY2/ #8
MI=P7<"G:"BHI[-A<9CFSF=G+-#-GF#9&B)RV,1Q#I%H#";-1';X1QL/F#?H#
MM$V-&U=N:,OD*LH1<4&'^7Y(OF'BRGDOPD$+@RL6/PE[+D=FI1A^ YN5$OQ[
M";Y(:M0/UVBD5J/5LDM@!;V;=>O9=#9=_P[[CIXEZX$ML/2$B <-0="=AO6X
M7K/E/#WNK'A<PG6Z0.HD5O)D\V4K6@HOL$O/XJF4SJ$6+D!G5H[;9U #-8;)
MAF"'"JCEMUR)UH" AB5KW_.7+'I".;,:S5XZ[UGER"(DP@^4>*4"GH*?*7YE
M A[!_PX GT!CEPNX#@-DHYY'DX&.98%>JM2UP)E'A$H6_\AVIG($.$O=YEC2
MA?;1,**U*FW#&L <'0%*U5CG0>WS=SQ0PW4I!]6O\_1?N^5OIZCE;Q]JR4NL
MZ,P!!"RV&/M#FC:>6MRF:!:WXU2+6YK6[(NU550M;GU1B]LOX0DM;3Q.&Y^A
MVMOBM+C]UK1=X;_&NI,79,# *:!K^U8VFRW%!!?>I9\FG@AP!N)4<+]D*"Z,
MZQ;H'S<@?1P<SXT7QR?>DS@]97'BPXD;4K:GDP!7EN)QTM,2HF@Y1J,A*0B\
M5I=KG-?D\'I-QE20P-AM54ZGP^$UI39(C,5:E6$VH0RWJRK#X]5E)#3@$<F9
M9#1Q'I/7XG&['5Z+V6XWF[-(U.\5LE?TU5\2OA?:!,8L6 3UD".+F2WP^2.9
M7G<'Q]>?15."*J#W[6"#%-X[@D4==5\G"V9OZ=2@F4"-!IN-?U/5S0 M-$]1
MS&X1C,6)X1$SL.S!T:?G+S\";8^\?F\">BX^_.]R9(H+_Z,"]8\/^\(_]%D[
M8OYK=8_5S?[UO%D#>VX[@#N; 3[WT3LO'52Z'%3$9U#=V5?N_A0ES]UR[%UE
M*Y&"[VG[$\^S/4$Z*  ]H%.N","0+@^6Z'K#0;I1<(+NGD[3NTSKNKC3XBX-
M75=GK>[:E/58SO;\%W*>RG\UYVB^>X5II?D1TR/F)TU/FH^8CI@I-&,ATAF-
MA9A-W-G!QGU)AY-0$L%X&N4J*MSA<KN9O 7ZD@56JU[(7L#$3TI-9:1"-QY1
M0T:C-Q2<>"8))CU?--'L"#G*'<L=FQW-#CX7_QQV,+7X?*_CDN-[!R<F.F"Q
MXU74!WCA2R $_RT;,J8D\G S#T,44;8_,6Y23>VHL$N JZNCJI!5&VZO43#?
M:Y88>*B("A31=:+ >*H+<V0+AZHVFH&^*@?"#J[VJ5CCH?.1J_S@I)UG5GVZ
M9,K>3J.*)TQ_O,447L>4Y8_LVZ,\<U?9MPW3MH=/UH_OMW5:W=WC'AN,]L)O
MT-RQ(Q\[.:_V#U^=@SUV39]T3VKWZZ^/'9$2V#"V;V'_>=;#9Z;#JB<?701M
MC\U_KDGY?G*7M1N>(/Y<\'WF *I4L1,17(.EMK^R3!0[\8\:=B)3$'0RS#/P
M_:U;Z>H6?)_?3)]*E$T LHCAZ+/D*?H$ED?RZ3AHQ0_RF]7G$'B!>0N]S)T&
M.F %OY.;*D =: !KF#6Z';H=5D''_)OYM^[?AG];.8,D5>A%!Q:/K*+4'G=4
M!Y"D-R\QZ2>+-TTF_$Y^"0<G@YL<,%6;5XBBOM(L)4I(-$M0)VV 7#6_ H_R
ME66H'-6BN6@YVH>^1VT(9V-!>]%9Q)I1(KZS%UU"G&IY><"FH3G5A[%XWWI9
M7852CT'9#:($T\&>'I"MNC7MFY81L G23>N)@&PKPJ)_,'( %R<_FYC_HO&N
M()RL!I:M36*WGC\&,[WE@=.17TREPYA*O]*H=%5N*D(#4 6JD.I0G=2 E@@-
MTA++&K1.6".MM>Q NX1'I5T6&P&;,2*=U2").BPM8/6R0ET91@Q3H>Y^6T5,
MN<?%R9(>YXP)]SB)HDL(-UV4*O5ZLYA(EO9(:.<-2,2DFPZH&M2,SI!%*;+M
M0IR 6#.%X2 3CDU##(,TO*X*@U6MG9'E9"W.+OGY&;9WU"9 52>H)0,-O)L?
M.?A.I=&DX)'DYQ+I 7OM_#'EHJ\\>"KR2WCQ<^8MK$@0:DV6BZXR5W6$B=@.
M/!/#)Q&6F(M9 4U"4+.WQ;41U?*K[7X]TM8Q34QW+J*-N0\W9MY+N#%I$V9$
M2O,9+LVO:6FFR"6X4:!.QX#V-M (C\!D"-I)+$=\GU0O*QY<%<E<GAVEY34U
M:'$[>%B$;M%XQ9"GY>E )3):#X=EK(NMTZ2*@4>P&M@";<=H6&!\("?J)TLZ
M1L)RQBVI0G>++^-&<).X+5C8^8'CJ;!377H]?%D-3UP:5LA>([%R*<AWT@U;
M\OO!>7@_V4T,'S_/[,8:X!\/*1XUDFT(%^$=[F$LE6$A7T3)(G2+"*42*X6Y
MRA*XIEAY 8Z!==S#X:)P"3J'WKLKO#.\"]41WQ#J/TEMY:L GA? PV C(-<I
M[C/URRE5KU-I!2J#VMYD1E+/M5YRO!L1-%JF1@.?(7(V;$*#.:8)#&)/HU'P
M?X!F)$=VX,.86T.E,6C%')X&E4'LDLVW&GOPEI]^("W;M^TJ6X+S3P5ORE8\
MTQH1M$B6XA2LL14;/2WPZ#&]/YX+X -9KXN/3[8[&RRRC0 HQ.M-Q38+DYK<
M@&1 \!, $H6 .Y >8"3D(:"060YGL<<?8.)M1HO17JPS>HQ(CSB+S5%LU&,%
MUI;@M:6F2WQ\O2YT[9M2RX6W+[Q-<1%@;4UU-HP>X@GJ7#; ZL^P\-OM1]I$
M]3LZDH/L;(!3$N]TQ&"MKVL1_K*!B.9'MC/IEXO,4TR/JGF__MXQWM5;/]E5
M-QP6O/O:_'XCMVW\32_$></7)1Z)?L5F/[2N<;H[%_JA<TW)P#58@$AL>&[Y
M>V?7].ZUYJWW[\:T&P$&(@N5SOO*%AWK85$&>Q*\R^+9AF-/8Q6#J!<.B-BF
MB#)QEOF$0<P^'O-?1$W  K9JG%BM:@575LU]#O:[#YF4[D0;(&WD!P/A=_0]
MDV0+ >1!Z6P+>(>\!R(B\C-8Y.^$Q?VHB-]$!/P?(B(^X?U]-"S?)YQHX2"W
ME]>61XE4C<6SZ]$R:')]W_L:#B@M*Y $WU."RFC,?968Y[=1238>!*%??E T
M)T.=BN#H]'B]#E]B0H(_/A ,QKE=+B,62C7XQKA@<&R"WX%O&ET&\V&S'NIA
MO.]=O]\<!^- AAOM8 *)B2Z7TTG@E8,)"5XO :=R :,K0.,&[S,<-G"Y!F@@
M&\?0Z2'K+GY+* $F)+3 =-DNY@*9^$JKH\RW1'L@B"U)6 !+</\\1@,!52*8
M4_D4P)P$BXS [T6!J["XFDU0Z8@.6GVM^&>P2Y"X)T=A(CO 1>+!*P(8299_
M->[35AXB*':5>U9[5OOL9O_D$</&^$?D^3(,HME^R'-P#_Q+RO84I>G$]A/,
M[HV/SD_M51:_)S$NSCEQQL;6:>R5SS^_Y:.0=RBV/2"4%XGFQ ZMX0Z1H!6Q
MS1 ?/];G=_A\?JT-(O3W># 3[6 T^L?[?"K]#6ZW\3_2WP=]/D+_>)%0'VT!
M$?IS $QT8.+[W'<1[+OL*"#S'1J@6'/*B6V L(8CAAL 4_].I*\N_N]I'OQ%
M>C_M>6H/=-S:?NL.I(Z@L.F5 \PWW#/ #KZ1AS*\(""CQ6HU0&0%(LM8@,CQ
M1B#J! ,0)<%@UYMXHUUO9BQVO0U9[7IJY0$<^!G&8'#J[?;Q:DP#8"?>3%EZ
M$608^;D&@;<P<ZU("V?K0,AA!4:#Q8*? 8X,4?-M(C0%CCOY-H5438Q*\R'5
M^HS&SR9L7-K!STE=S(X8+,:$_*1.3^V.3]3ZPR8K+7XXL)%^RTV]8%^_\FHC
M_9:5 W#A$^BW3\#%RMHGPBE/*,0+Y@TT$VYBNN'1PG$<*_F:M2<;]37 [/\&
M5M;13#R-PK;KRD7P3W >RQ3WR*4Z%NYDX"]+%EC,T6>TBQ8A+*V=(5T>@KT=
MA(KLLC#Q\+JC5$'1^C7!(ET5P^X*G#^J?.DM#[;06.G*1?AG6B(K^*.\V<4Z
MC8@*H/^]&"IA&5Z?T:'4_ZLHJ@I)91HHHNI4\#V05%A$+*%",,CV[!9/%#43
M#KN#9-I>\9^3X)?$T^IV>D0/;!'"--].H79*"6!NVWM\$QY]C&0VH(4?!JJQ
M5+^_ 37P#2D-&0V]&_JO06OX-2EK,M;T7M/?4&$?[Z\H&-^C8O3X2BSR\W4I
M=1EUO>OZ&XKLW?Q%!=UZ%(WN5CG /M _H&!@CP&C!U8:\%12HT86MM9*O_'4
MLGB:8&'WVK3?=!I?V_<W(VN'Y-=VZC3D4#"8("6 H-.4.#PP8&SM@ &#,^<4
M7<V=D[1WP)RQ5X?/D;<*<YQ737/ H)I-FC4"64[2_H;WF]KWBC7&;K-TF.4Z
M583#URQA==D9'\9L?U17V[O&H)2KKGM%49-%G@8F_8\IN C"\AWOSJU9-KQV
M7NW]@VOK&W*S!F5UZY*6FI 5E]J+D9:U_I-97GM?>0VY73.__79F7%IX''ZN
M9E[-\L$U]8NZ9 [.ZI:72IY+8_[X<-M=ZQ[:I-R:NGY]1=\YVS;T[QV?7K7T
MUCI>_.G?T*W=O3EUP_J*?G.V;^C7.RZ]ZK[*31#$7)^[3;M^IY6U"QU6UISV
MV-6RV_W>HVE5OW?S[:MPL?E&?>3553CKS_.5HOE&_?H1SAC+Q09[1Y_AV\O1
MIT,YC+'E(#&-T0,T;8[F4VO5TK(X+2?<GO;QF+07.J35ZVY/>Y:6.4?SD[5&
MRLP&[N#G3-+[8O+NTR%OEO_YJF2GZ*KD)GA"HQU=E0Q$5R7OD/8"Q0SX[]+V
MZ9 VH4-:%5N@4Q1;8!-<H977$R"^R-#XRVDO4!R":%J_BD)PY[1].J3UMJ?%
M0R4)9_XRW3N<*P^-!6[E5>!6$@<3#,&B^S2P&(^TCX"GL=!R ]\"1(RL!7/
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M,*]C15&O'V=D'48CJQ/PW,.Q*$/25V48C+H,P+"<R LZG<$($6-BC19IGL%
MHJ([Q9"QF[&7\:#QI)$K-'Y"K*^,1A*DU"0:.P1_B<1%CX9<C@F0#CJ&>2>;
MNIKO5'VU72@CZG&1&1(%Y,5=\;L:]D_^*/ZC26AV7.L_T,3ISTY')\-O;3ZX
M)?S),[CVB;@Y+E&,\RQYLE$PZ$88FXTL%LM)?"VHPT,L@U563 91K^<8($D=
M[Y%;.DX0. @E@T W@6<A 8_#" F80F,EUD$>T3&\3N!9@%J@71Z)TW(LP93'
ME,)J@82,Y&F=41",K&29*RV7-DM[I1>E7TF\6?))(:FO-$8Z(+TB799T?JE2
M.B8Q8J)4)E%8<(DKQESZ^!&#A$?/*]'()M'P7:H1AXJP2JP)BZT=J;=&UT@T
M8M4_P%8LZ$IUI2K\.;504K_4<_I-O3K;B9S\>*-_V:*F*2O]#]R_'<T=^?@(
M=#C\ZIC'QH13\:Q+H[;26;>0SKJ7HA)35SSK%N39_>TS-,%M'4C10L:I:;%L
MHZ*%=$J"H'.V.08MA$9OH_GVT/+-U/*U$W0CJRX&O86BLM%\JRDNS*5%:JX.
MG*O3%DV)QZ1VA"\!E+R&A]]<(,!/\3"=2P9)W$U9[C/21P6!6,H0BVQU9U+;
M4B;+#U@;(+X[R58[<4:/>^"!![C/6O^'<=UJ:OTSX\;O(%XD+V!^LX%D\+$\
M7C1[S9A9D@A\21!P 29H3TQ&2?9$K"*F) 6]@>1$.PLYD$AB&=)%F"049/Z)
ML-B46)7!<RC#8:_*L %=!@<LP: 7WTCQUI/.-E]V=P@*3+#8HV'1CZ;<(=;2
M-6T[CX;AZ[@'JZ$\W.ZU&..\2+0:NH)B#^;1(+2(&)*G$S-<&P4MR*8=<LB]
M*]TK[X735G2?^.BH5:^OO&O]/W^UYM5MLVI'EMS_ZW%PB%LYAG:O1KNMWJ8;
M![Y0GOY#I^1GBI^!6:\=/)?D58RK-6QQ$OT[#F2#/\A-.YBCS <>)DW*LA9*
MW:W]I4'6"=:ZI+JTZ9D-20UIJY,>2MN8T934E+8[XZFDYS-:]"=,QY*.I9W.
M:,GR\1ZOE_,S/L[K?<G'.GP^UF4/^CR\G^%XKQ=@RH/  CN?/LD@N1@/!'Z/
MSRNF$*DK?DI('$$C77TB_B#RA\6SXK<B0Z!;$D58+%*<\102&@7_-Y/]TYQ8
MG/&PNSUX-74S=T=P2<CZE.4M&B*R-!+DU46=^6Q."XK9.4VC=H)VU<)9LZ K
M1&AW0L+6M!4#RI1O]K^SYOUI/>>5N.17TU_L_GY#]9 -=]];7;$S.XD[G9PQ
M9'+_AY6_'%8N*8.O?'P2EC[:M=?FS5.FU%:VWGCHD=D_/;)]Z[9M#>U["IW4
M/84.F&-&JO,P,3U-W9<XK>Y+4)WG$:T'.TE?<^E-[7V-Q'"_"[>B"7C!IW*F
MBT_CBVV#;&/U$VSK;,_:3ME$QFLVFA RF30758/18JXRMJ#QQX''6\5BH?=N
MW#5+Y&R(3&IL2D=]F6Z23L5?V*<[K#NKTP%=KFX$/CVL^T3'ZW1J5/=,K /T
MQAWC+BR^K\6R>@ON&OHS ':(ZNZ[<U1W-:@[C>=^.4S=,6(ZAJ!Y8U;G0S?S
M"S'=(=B7#T>N7#[AX3\]J7S1=23DMVZ91,*Z?\*=ALI%+;*[<@%^,N!0W9#*
MM AJ/*8508U_2Z[&PX_.J4LQI <*F:Z&86PE.QU-]RR&B]%BSUJX%FWR[(0[
MT4YVI\5Y)Z1X$G>#H,43I/C_7R'B53#]#H$VH I\PL#V(&UWQH:'O;=7]FWH
M>1LX_-19*CB\,#)\;73?GZ'#QSVBHL-#4(V6,PU,.A[)$V0S@ZI(N+H-F&4X
M8E)IN1RQIB0!HXDA9>L5QH>64RO*E3# #&/78HG\I)R*52T!S]LZ MFJ%_42
MB62CTTMZ42)"&0U R\WM)<&18#G^;,:?O?C3C#]GX,@C/(^G^Y''N=Z,KC<@
M1P&Q-R--HNGGX<\*_-F"/_OPYS <*9MY3CS-]]8QO:73J+<.A/(O>Z][KH3P
M=^D"X,&G/F^8GH=+%\1.R1VG9[L(B\AN(A1$N!(RBC*%A!RY6VF#:(J"_\%=
ML 1V7ZJ\#8N7*.\H;R^%W95SN.:7T3=H%/<AT(.G97>,AP86?+3-0CVN1>.Q
M##A9QY[&96;@5+F?J/-G,( $^)8(&BLK&H"$562<>J V];P-/@>7P76@8[&Z
MD4+GHD\ 3S!>P)<2X2 I=CV:XDIK:]+$D"]430&WPB1\5*PFA0=&.R]09Y9\
M!E94CEGJZCVF9V;E"EP+Q\"$Y9Z>G7N&K:1%&_&5)W&]_*!>SHC 25YEN#J&
M')Q [Z +Z"H2O#Y@W&,R67S428GXI/CTM1:_W^>+%^;8[?'&)M.*><05):)C
MQ!'\TNO7&K'8Y"$6+\4J)A?1^Z#F%5=OCS'FY]O=;:CM0Z/_@?4C;8&B4'$O
M:V/>%S,7YZ7<5Q^ 14[TS>P7:KNYTW,RNA;T,/]VP:21?;I,')6W!+]W/?H
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M<FKOL28'*375=]U2:#'A,D)5]7VW-JKDU$:9*'6T<2DRTM!Q21MLF'.M)63
M47F0/B/%\J"5/D')27J$QH>X2S#1=W 4^U][!D;?A(<(3,IF9G1X*7XT^CI2
M1O65&F5P#O;8_A%ES^CHH8VC="S56"#"K1WSB.&"#E36BA\E=:02S5I=V&@N
MI"Y6.M/2OJWV+)7VZ@C((MK1PYC>$49!.7@X9'"NN%ZTQ]&6(&4D0R.AZVR:
M-YUQK=I8CV:SOXGRQNR.]W 9OXZI&4/':RNYWC[FH[^VWT%__5_O)(!IBH[.
M4ZHT1>*BN*D\F0S2038(@7Q0!$I &>@#!H A6%H>C66:2JR1WPWJP$PP%RP
M#7C<RW<FIVH?+N98^"^NN_\OTD]K;(3_P)]_-C:&'>1WV3)R_E-CHV+$'U-C
M(_L[\KML&3G_J3WU3W>\^@MY_-1^51C82/XMB_EN7$;^-?X7UT%IV__\/Z#V
M?6 Y6 76@ U@,]@&=H#'P%YP !P$SX-F<!2<!*^ ,^!-\ [X 'P,/@-?@M^
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ME:P"J<^2TH#_P]Z;.$919'_@5=5W]TQ/SWWFOH@1!C*$.!#,*(<<2L*1R)%
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MDCKL7UK_F/:[R\RM_L;L-P?WFY,;Y!(T 4/,*/@-19?6FL!XR",$PI2#F?C
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MSP(0Q-)70TBSG;(A&]%A)$O4%LZKI P74\^]F(_/P_<4@D[@#]1.^Z$-:X?
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ME\+<_=_?VY?-TCO##_0!K750GZ\OQ-(?&X_HGU1_7A*[@X?P,H1XM"PV_1B
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MED'[]H,G&O4W];&F5?X@/<$VK/)U[\>M\EWD4\,J!^M(Q&<BDLVL"$!M^V=
M>_N$%8\_?YE^3N>:?IYM? Z7@_9*%!8C[X%Z&C9#@KG4T/8-WH;',<=?&!LL
M.QV*0U'*#:#08T$H.\4*M]N&*H*2,M<B.JP5-A3S5P4:?0T!-BG)9]&XF@)?
MS%?E6^)C?9I/5:P.E9UE@19*BD3#NT1/>C'_PA,.+U&$RG!K?GYE>\QF$9[\
M1'(8(3@CIJQ'/'<L!WTZZ;9Y^Y;6U)U>],37^KQDYL44?7YI\^9W7_CEC;LG
MG^[YEUUSUXUO'4;<P7K1Z/\^\Z7^6N?X6489.?NG<0UD+L;#.7C,,]J^8QNH
M5^O^V'"WU-,VR#;(,4&<(QY2A*S@*FUYD/',<SIE5C,+DJT'NP%_D(37!^>Q
MBJJ.UJ V3V96"=#E$JR@!D*UQFI-=GIZ^*"O1@@3'Q1)F3.SN2J-+#J*RUE)
M,3<K"<N&7AYDF,#J'J^ 2!P.'CBEN53FC<?ZZ)\?_5AOA9.A>OB?ONV1[W=\
MVQ,VI^FEJ'D31+ E^"_]%]@/IL/EL/6GSQSPEBL_/I\:?>O_XI&(U!/>XU=/
M-XB?ZJ.K_%2=_J>?JK#M&U)/$-_?F6I [[5]PS=3KT &>#!VQ^\\T!8,J6HH
M5.X/N/S^ $"H7+%B26 -5MAL5K]4P4JA"K\(*JRHT=7@04TN& JHS#Y_DQ_Y
M_9;4&I<KB^<1L+)4"M@-C8#X.BI-Q&0Z;]?P,,%(((!4W,6C6=/,.HHJS$@+
M8HF02@D+6=86K9L1Z9M4X(O>EODL^GDZY(]L&5K_^4%]R%\+1C; 6[;.VL6Y
M6OZD[W_1W^!=_0YSH75#:>.T;5?*.%?K!AV=O6?\70"1TR*>1+>[\(XY&)M^
M@]13NEV:*K%6;/Q9$+$UG*K-AC4G3[D%X%T$'#9;N69W:9I=M;HKG%@MM'LJ
M+!;-)F)R<MA1 ]<HH!["0,L!2Y/ >K %N0_;R BW"-1D"]C@2K'9'4Q/3'%D
M.H@SOL/,$)\/>2$?_4K623Q<D[B*Z41%.LP-/8# 'WCC4\2,:)@"^>:ZH5L^
M/Z0/FZ?7SMG=@C]9]V#Y3GCKEIJ=W/'6#2/V3*EO*4=[6BO(52.9EKL)<9'H
M*"Z"Y\4''HH-<7,LZ[%8K>6JS:6J-A9/AM>';2Z?FW-6"%AQM*JB9ZY79'T5
M$ %DM5F8J'J+>I?ZH/J4VJ3R#ZM0]0 ?JW*SO-!+64D->0DGN A-+\%LY-KL
M$@.HUEGX*^DDY$U#,O,"X1W']NX[[.O;4&KY<M>+"W=^0SG'K17'GNNW6E\*
MC_<=\'95:RGG(CL%KS=;*G3!_+2O&<L4-NHDT5I<22DAJ6,\Y"7V/2$9M[W#
MC(<,P0V)&"F[#[;'=($\K'M\04]U[HO=!A%::'@'%0#*)=DE2;(@BN9Y%6)4
M2:P D.5$11;P)I$5!AL(D&%$K(XQW#@.7N1^X! 7KL3Z(MX^]@Y^ 2+FKC$E
MXV=0N33KB- $)H.+^K3^JP;HDR&[XRM4^^5NX@G$%O;W=!:N/B4V=@$;H3D>
M7C YUC?74F2).<=8IEGV.GD;QY)@(;,&JZV"XZ!6 42V HK;7$^[FF3&5>.1
ML^68S,A(1GX-WP Y0)Z;!MQ>JHP[?2ZU%TFEQ8(A+3H7)V %FG2;!P$CAEJW
M#(D3[_:1NV'?NMD-W/%&O4><8G7T[K3Q=UU[PAV7$N2:2@G4-E__E#U$8[OL
M8&=L,"\("T7))6+]5U$6&GN:','9K2Z[W2J(BL7"V358(6,]I8)ET$1MJ[97
M.Z*Q$E:>/A>AR%E9D3UEAW9L)'\?<ZHUQ0RT82-/8Z B SOD+&%#5-947KHI
MKL&9)^%X1U.(UM]:PIR( V_CB)$]!M,0DU8P_L)FQO?U/</6%K3L+US#+M3S
M-AQ&(QIA*O/3+]_K!3!+_Y2/MIS2W[_NE!S; /LP=YO'O0ZBH"6V>8+UB.M(
M%N/(N_%&>Q>;IG6V6BP+C<1UK"LO3$ESI:2D=<K)*<_.<F5G9]EOO+&\L^;J
MW%G+CT3*NQ>XNG<O*,COE,5V[D)*9[G24MRBEG%37I=YF"5VMFLH:9[/Q\P3
MF.Z1[)S.-XHYG;*8;'>**RV;NQB @<"-FIT9V!EV)C>S7*0@G^O,=0]3 B<S
M1%_")J5C6K^$N6"Q&;@>C9HA9U=Y2SOPB4121.)- O":\DD:159( :Z]#@]1
MA3T]:"XU-3IM!%?$X\5F1A=(CAA41!)+;H:%V7">S3;&5I@4SKEY1+HE>\CR
MFATU"S<]EKIL6$XX*=]5TK.P;$&?1<,W'*PMGC)U7L/\T@7W%_^M&?KGSIPZ
ME^T\;[&X2PKWJ] O[F71BM;Y\!CLW[=4VB4NFG=PL>.65KT4EK^\C6L=@@ZQ
MP_>/T??#QY^?G^?'W"07:X,7L4:3@;EOV01FFF\.L]#W<.J65'XW<R#I$$.
M ;!&D\REBEUIO0M6%/O+4)['2>%@<7!Q<'UP9_ D02;W8_7*;A> M08A3TU:
M6E:P)A02L4Y#TOZ)6%X4#?M:\^TD4X#H,U2S,90:?S1,K'1Z^ (R4IE"AZG4
M"8E*GTR.PT"\05\>:0.OZSL&K$EK6;IGQN$AN;&&YV8-^WSHXW/AG8^]L1S]
M7/7M[_4V>+2;?ORY!T;5HX-HU?RQB_6S.?#Y\_N6GB0<%-/N>WB?2F!C;.P<
M9H&(1HE3Q3G,(I'E>+Y<$+%-BL<I2>4&:\7F+.5)#*EDR&#+#$@BL5,1CV]@
M"X4-PFZ!$2!B)(&+@IW@ &!.@HO@!\  K+8E#*NXNS4:+X!BVJ6)/4G.GR(D
M3"5"7/!Y$&U_G8EN;0/;7V\YPQV_LIV=^$M_=NR5W7'I8DB,6TV)<:\I,4@]
M,]E^E<0@D@COS1 X&5O0TSO1-E=E8O8J^RQ[@YWU8V4B0$YDRO'L>CQN%BLA
MID@!@4!Y,.0*!D.,C559P>Z?!V'(B=NY@P'1@C<@"&'%Q6EG9[H6NPZX&!>K
M,C875RR-DY 4" 'HE_@HI8^+0388YU ).Y,F>T8B1!Y'KT&=7Z$N,M]PBUXS
M\D:H\_*JW<1C*],3A.9F@O LV3$IRTJT04E%CHS^NY<4+ZA<13?,_-T08;6#
M[HL^0_&^&* W+M5ZZ=_IU>;&P.2 N=A[;3^26 +@ !-B-Y-E9SD7BXE"$,H=
MT.5P0,&A52@2PXI\!5Y_AD-,$5O.+F=_8-D4%K)6 ?*8Y:0ZH"-<0]2.&F.L
MQ#][*1*Y1@DE)_!ID'!@OET-O?@LX];UW5_K>6NYX4NFIPQ.BKD*!\ OF LD
MRJ/E3RGZUGE:H_K8K\3A7!N9=%542\>_(SXAOQ+Q(O$\?]H^FUY?%5F!Z8AJ
M*7AV-% 9B_#M83$ V!BLMAL,'C \ ]4*2:([A.4 SS&,@A2&(?%:83]^\87-
M[7#)7/45XB*#T9)E)X>-$?P_3"2:%<)_Z0=W0P\\N[_UX=ZU([(>#L[R]QT(
M*]BQ+7<Q.Z]DW;? N<_[*-YN,_",^&G%7!](!H_$O%+ CQ^-G,0!B&2YW*@%
MY3\!>P$G; (,E%_$(PN<P.\=^$>"<BS#8H&R(N"'7^Y9E81DO,R*8DNJ:>!A
M"@]Y/M538Z,,;3;5IPV)2^7'UY?(!U^W?AVO ?4:_D<TZ"*S!A36/S1: ZH+
M+-! $)*J(!ZC"!3ZR+'=]?NO]+?TEX,-::]^!&^^;\M;7VZ%!S>_]S>NU^)5
MG/ZAWJ+?*>W>;_OE7>B&]2TI3#^+_NJ?EF]CBEM^)\+>?X&>7XEVR<,ZR46J
M+2Z-#<,4O="@: "A&?Q#V)Q9Y86%LE3!BT 1!<0QB&G"% T5P+(#,<.72,7M
M&_DB?@#/[.1/\G_B?^!9/L'?VGE<*U$\?D/K@(;&035']N*7-:6K>[2,QX3U
M5S3G"Z(S$BW#U!WQLV\UX\C<8%'L]EH>VK >I5+C0,'&@4+VI^%@M<EBA=T.
ML6U <_2MBH6)J'U4I.*U4UF_.]<]W\UL<Q]SHQ+W3C=RDP+R5[%E:A)<NSU-
MDZ"CAQ3+<[Q?#0_IH0$-(^P+IC<<7K2S#>R<>.CHMN-L%MRB=Q_59^2,<>B=
M7_JC_J./;>\+# [,Y])5(+X212DW]$+"5XSUB(L8+& $EL%*KRSQ'!Z*(LDD
MR R+(Q:/A66+J7BY"-@4, YKTY@&#;6F79MI_6V=+V)J[/@'2Q=V]]_@IB\;
MOH1KO][1!HQ9IS_]3;JA3VP#3\;NOIIN#-.,K,.U%(0?$$'5BJF(XT4%V"PF
M(>&'MP%6Q>NBL@8A%?,[^0.8BB[R7 H_#K._#B/I,!ABF!J*[*\.Z5?IBOSP
MN5_.PGKLE92.H[R:P"B1(6I]8M$ K, #IL5N*[%/%)&*H UBX]OPXZL5" %;
MA2):L,GIK-'XKCR)L]S-'^+Q/]]%ZP]69+5 FY6-* .5D<K;"JL8.X*:W+]J
MDL!*XFQ(]<3MZ82SX02RSX \E#<]^N<#>NF7^@:X9R2QH6?N(E;SYP]NOS*B
M@U/!T -X4N6F!RJGGJH;V?X).PM06\0-RF,]!FEE\@29L3)X<*IJDIJU@B&L
M&I!XLOV.)A$Y:D2R9:PBWQ-K+YB\R# N4?[V*T.(='0*=+2I&F9<;T^U.P ,
M<XK06.>V[]B)U)LV+U;:U='=/YB_U='7S^T)P:Q0=W59B E+Q5*)M%A:+RT/
M-%H;O">E@UX9X@6Q.KW>P#RG)$G"/"L#H8R5LYHE&M2T9*E&EKTU'L.'%B$N
MW(3.27[:O6@DVB>M,,U4+WMD1FB1PK1TE%-(P/T<3)-^:QI\_NCZ?\W:, 1:
MG_P80GV[_N/+/]D?59]XJ/XRVO%\QOL_ZF<ZG_U,/Z)_HB_612A\%CE^FB3S
MXQ5H^YI?@4?G!"G@[EC/ A_,<V<&$9_0*E"%(' L-L4Y;-#8)>\\A1$#-21J
MND95TSC<,(?MR2+6]-[0%8@8/BV#95U*8&G1R*6"#*P$19B( \1' B 9&Z!N
M:8 *6F;M@&!'S3\*X+ O/H)(?UK_^Y_TR\RAIO6']6]>KSL*&525TSH?+U8M
MO 5.T'?J[^N[= "KD?1YFSY*?^?#*_ Q;.<VF5G%#I $=L1R>TB]E&IUH?*P
MRD&GRP7L#D<YP+^!JUV;YD2 Y&8L77O!"J=3$WC@$%T5=N1PV9E4T!/<"D:!
MY7["VYZ11:*C^VN*+8LL!RPG+:R%QW=;9%Z@]MLE*G+,0RW"MTE)N.O,M;@]
MEN8DOE&8 7L49MH) "+>:LZ,.( C:JE]OFOU3/WL>1A^J$K_<M'IC^"G>HMM
MY&?GZX:5O9N.-L:>T&^'AW^76PAS'_ER^"_]F5SX]X*597<LLL6QF>CI;E^Z
MY_JV?<.<P2ON!UE88@U?+J^W+PNN3V<WB]NT+4%FM[!?/20PS#R/!ZL<M39%
M2*V5!'\U %.2YB>AI.H&RT'+CQ;&9H$6BS Q8VX&RJCNZH!='>,<2,*?]G20
MXG#9VF52&*ZRM3*?6O[8BKI$<I))C462$H()NY+H3CGI/-,C?KQK%"+W8E4J
MWZ@[1C0/YHQCSM*'QLT<.7O[^M?U?[ZYZZ4]YX[?UT_1ISU\?,:85<=JN ^6
MC&.'ZZU+_P__65_USW?>0I/>1YU_V0=[G5R^4S__T<+=)-Z[6]O73(3MC64%
M&?GRV/@>\KW)R^35MF7)W'9^B_PT_XSM=[;#Z3P(U#H<2FHMIWAK%>'I# @R
MJL,(GD,727"'J[I*W:F^JS)AM0USJ:"F,DG5)>(X<::X6%PO[A1/BD(*OFP3
M&1&+BU9O/AD^MBIK*K%=V>[[B1J;VX#H,N)]\/LL3R35 )%S9K0C=J'1>U[=
M<;0):G]:LK7UX @W''9[M/I9QQ#^_BDC)L]"G?L?6OU[")Z%V7!YW9S7>+ZI
M5VFC_GENY^7UTX:.'$<P<[#]S.*Q9X(CL8=R@]'@!'$!FB.N1MN1L->]-_6(
M^T@J*P=#H3+#.2>%Y"#K,>'VJ@C&7GHMHX2=Q<Z=3H9@PGF$7#[;'^5[^%G:
MUI\"JC62DV>MWN"'?C_OK':Y4JIM? H?YDNP"#W'8P$ZDU^/)2K1QVKB?.^2
M <[G); 7AKU-S6VC8)>A:)-I\J(TBF-6#,W81E[(,<#W>#:.P8NF+B[1W]W6
M-*NT=?#ME4-O'Y:S8LR_-STW5W]L4/C>46.GPD&*OO^)AZJ?"@WUEA7TOOVF
M,@MT-3Q473\C;]"-?4>-PGNC .^-A7AON/"P[X[U7V]YV($\206.J6B""T^8
MBP?NVJ[.#4[D=/+!6JO"U?(,Q_F2076I/$L^)?\HL[+LJR[1QFDSM<7:>FVG
MQFL$<) P>(._&^%>K?G&N SW <7R2%1)O*I(XL]KCXX.3G__S3;PY:Y7H??$
MD[M6-=54+3]6RZPH>NT0NT/_&9N'773NTCLP!!?7Z6<_7?8$['5^Z>-Q?"^Z
M\P=0[]<AS!%).%$![!4[XV"SN>STKNS4%&Z!=8%W>?K^;'86"S5;9C=J;(>Z
M%Q0$B<5=9EK<)&; L+B[=>TZ/2?;E9.3G9*:6I:6[DK#3#P0* L68"N\(#W%
MXV2#6J8_- Z&NQ=W/]?]8G<VI3OLWKW Y4Y+#01%4,#+XWB^T[@NO-OI89YW
M01?NG7%Q7<4J<8EX3OP!<^)  1!9XK9Y*\@$<[IF=V-=>25Y2,N#>:GI*7E!
M;ES:S+3%:>O3V+1V!_I5:K[A,3,/B<G^HYZS#L@AO^HLN\ZF%VB)1)(J@)=L
M=B4YA,]WQ,MYJ@B;2QT\9132J4<AJ7I%_6L$-S3B1-^56$KVS!C;Y<;49&=:
MN&K$D)X]DV9N+\^X]9:1&T=V'5Y^Y/"W$V9WZQY*]5D*Y(R\D3=G.OIU&L9F
MZ;U@WP?MTRUY;\_+2AH]6G\>JC43K;H*_X4&K]2_A.,?R\Z9?CY/K947O737
M#?!ULLH_M7V#+N"]G@%FQ/H\[86-EJ<]398C0=:>5@NAQ3/+OX2<205K/9(H
M<K46(2-#LC/)U;.<2S!EX]W-5-N(8ND3JR7)7^V+JRBTCO(E6B ZH:88CK&H
M>=R7;^"LY)B@C +E;:E,8?OA)RS,^G;K+<-35^4_MF19_>YI)W;H7Q2L37^N
M;%+53-F%IJ*7UA;?Y:Q_<--]1\>4KJW_/;Q5?6UFV9TE*(ZP0&.Y1E*[_WK$
MA3=_'7$!\S\O%@"W8\KW@S.Q!_H+4]U/.A@?-KG]1!GC7$Z'H\SMPC::2[79
MIG."B^,$/$5FR*/#[2,@M(QDTWSU809B==3I G[14B])"/(NMX.YZ/P!\P15
MX&Q.KD0^)R/9CS54G\S/!(O!>L#8\,M)P!# V_#LFFN,42VN)&!F&#7#Y:X%
MMTE0)";$RKC:$*%^V\*;82]((L50W&>;P7A?WCAL0$ETY,2)?8,9O?,>GE;5
M<^*V83?</GPDH2D4F7UP]J8N^O==.AW53T!Y^7B=P.2VG6[[%XWSMH/*6!3/
M1)EQKH>MJ3+CL%.J9_$DB'90KUIYFUUELK7IVB/:LUJ3QFD\3W A.'J^:0Z-
M',X47[K.GW0U.@\YIH,K[DFJ*N\T)J!UZ9V5-!=M.%:WFZEK7;9[J;J5&;X+
M[;CR*5-GK",[@T:B_Q0[$(2:Y%>8+)3*94D%TFO<&?E3>(%]5\)&*5<F"MAV
M%8A_=+K!M62"2ZO(>!PR; ]A9TC$#["(HD)C>EALQK+KA4;AKU@%$J" [4!&
M89*8<<QBY@!SCODS\W<LUID2?,&DX$^QQL/ 8@9BBY[AUH%&<!2\!;X%G T;
MONNQGG@2G,-VL-!AX8URN2;#HA8DC6TGOZ\.!+K6[PHKR8([(;$AB27C/?'I
M,%CWR>\VUNN3EI8_SF:U'&*&X'D:V;*/F=^RPJ3Z%33B:5ML@L1RG$CF0,'V
M?)G(X=GAVL-Z);F>/4=)6U" J!!M'_(D7U;B1 5!;-[S)< @YIUT6$(8E- Q
M&C[D-B!V&&/<8Z&9='TU3![YI;UF'D9$#$N?GO!XC]>5PJVW;VS>/$*?0;C?
M -A\Y5.LZV:!:Z,439S%>?1Z*,V@^D&?PBREU\/IWRG&)[WN3Z][8!MZ!+TN
MI=<4#8'RDPJ:#]A-GTRQ& T<X]_'5J5FAKMVS2SN.MY7=</,KL)LM%"9E?F8
MPJ[)VYK2(.Y-V9_''68/I_PN[ZV45_/^F/=5GH#%$K18K< 6" 958+66J4&7
MJ@8;O5"UJA9;>JVD=*JU*S 0JF6ZU#)>(0A $]_L0EG5O#4(>-:C3E?1:K5>
M/:$RJMJM>K%KO0NY# 6BW<HE17WSB29-H0C;(TVT(@-%%Y*T$=-X-)5K9(3/
M&DXAC0(-!#L&4UZE<#>.O&O9_!WZ[H$/!N^NJ[CKH?D[VIX<L"A4]<N<O1-N
MNZ=Q3*OKP6WT#;;!+J_]XF7]:WWBV.&M[R!IY5]>A@&XO:(4Y;;^J.^X,&LU
M'/+=W)4M9^ #+\U<HQ_Z;MX*O%*ME"[)S(^AWK]!^AEF%:;3-/!BK*?=X70"
M/'_30TFN4"@)L^4R)\!J")!DN8P773PO\C)PLZ(:J$K&&FNRR\E+(J]6)3?#
M^EAGI 0#24PHE.%TN9G;\%)/!(_@;=D$W@4_ I'4FQ/Q?F<[\9=YQ!-#)5V[
M7$EU=&^$^DE!\5=4:\!B#G/FN";*==07N$3,,@D[R(I#)44,#.*;H?FV%SE_
M%O#?T/@]CXV?YYBS\5[;G#MW]_*-V++"55A=NN@FL=?0@V^LJ.T]!3W>>D_Y
M;?/7GEH.S[=J<VW=L#V7@48,)+,S%L\6W@Q8)YT?&S#5\9@#J7@JK(2%6667
MU2J3V#VL0KE<4)6$6DW#)"@J,MZ_%EEAUEJ?L*)Q5FAE(;*RVUW'7$C"C0UU
M:?;_-]\B-* !*# 4W:K&B!_V;TP)-8VM&+GU^-8!M14KMS#;UQQL'+ F#^IX
MUS[:=?VR6VF6:MLWW%C\_-E@9ZP0IJ5GL)D@*SN[#&1BQI/IQWJCQX<53!^!
M[33R&F$:;]$\WH"8C;E*%>.J8LC29HM*5J;?Y[.I?'9F%@-XGS\ .(^FVCQL
MKF6@992%*2&!6357.1L)"\(K2F2L-_^ZR-($>BE>YFY=TXPH\VO6LX?YSA-?
M6E9-6;A[Z%QA54/%O%!-W0+[^+N>R:ZJ6Z1VOV'PYGZ!T1M?/G2F9O1;#U0/
MV(EJ6T>/S9EW]%T4;+U]6#B_]^(#J^'W5SZE\Z*?H?/2#9R-]:<XIIAUF.EG
M1.2&N[G"X6Z=<G/+LG)<65DY>%],-])TG"Y7*"LW)0Q%R6^5.MNKW I?%>I<
M%<+3="1-L2C V8S&QV[LE,,[L7+B\F-B<7%2UQ38#4C8'GDWC,*Y.9W";&[6
MP*Q164Q)%LQJUY_C4W<I,7.7[-2U4W1MP>7KWQC12ATGJWT?]*9');\VO<SX
M]KG;*!:.'[*HI[ANX(-WW3[OFCEFLUIO'Q U9['ETZP\8Y\\EK%PP/433GP=
MF/,S)_ <JP!KC;'"I^7C,K(1F U,:U85;Q[55H]EGE9O%=5ZA(U6M]A5/(@M
M=Z"I"(A<H_5#*[+2:?DM)RG!S4AC(E>%9)$H[HS^ =@XZ,6Y*TON?FRIOG#/
M@-BYR\.F,76;](GA=>.FOWH+4Z=/TNO?&#K4Q$+(9+-!#S27^D?/,[745T,D
M> K5=UQ@0JROZ1@U9;:5/+I:3QRCO)T^.5HBPKAO=#V -BJB9U(A3=20CB*Z
MA@SG5QRFM/)U!W<I'8KW1-W 0W.7CYCX^(/;B]_Y>=AT+)LG=JZKF/;JK? 7
M.@;<L=KV-2-BNR, 'HJ-FJI,"2P$"Y2U"G=#H&>@KYUY&NRQ[K'O\;''P'&L
M7-2;[A2+P^,YXH?^6H="(18$;) 0Z!*FFB3,HG'8$I&J99OLJ2YQSR2'(E@6
M8CE(/"O7'-(;T/Y43ZIL=YF:;@)# %*/*1JK_^2#TEV#MY34+6C;_(S^YM)G
M^$U\U:"7X:>;[IBV]@L7''GQ3?U]?='![9;*"605VKYF3^"1$:_ X['I69Z!
MTKV>A2%VF6=98$UH32H+L;K$)3(@"^6;-+3?O3=XW(VM+EC/\RP*UFH*@T1W
MK2QP+#_!-S49"<!7G>(,$U\"MK["UH.8TDBH.&_EB;:YGMG)L(QA)QCIH!'C
M#.^2"0P:;JU,I-V_5F1$)F30D+=(#T<'C]I58O[@X=(M)^I*GLKYU^-;7]2O
MO++N!'QEX<%)975;I\ W]"A>U\A%R'_^NOZ9/NMOAYPH63_V[?WKX*)3]ZZD
M<9&8'FLQ/3I!"*R(C6"QR<30U$\W'KB;2&CC-,(BR2I;_QR12D"1R<#KR3$B
M9 "C,3.9)YA&YA1SD1$8?[4#6V"R1=(8SJ:4*$BA)]+$?]K1?4H7^S?<IY "
M2Z?'36]:[@@ZS<P9>!DN>JEN2'[9K4-O;#S<.&S\\7&;8&[1V:UCQXTE":&P
MV=IG,#:DU>4%1>_?]<RM>A8<..K."=T3Z.B/FNCH'K#N/HK#Q6!*8MI1UVD$
M*?&PZ2,I*G4..!2;O$?9&SJL,"S$VUJ0\7QD9>?D\'9L928ENY*2DOF<G#)
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MG,C#8I\KQQ\T^V$D:';ZPSXQ*/"A;%6R" +E_BH@,59PNOT>+I1I'L_!7*?
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M'IX#@8)\G<#71])N\PU;&X0B!/JZE#IS*9=,)398H7.*5W13MMEH'"*/E_G
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MU82.>!DU*2HD>G[(4R63)-M3#21](G/0Q3C7L%YI?3V,"++_Z!P/^%V*#S_
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M&%VI<@JKG*9)S5S6:*=1B><"T WGO%Y.-]'-BYQFO%O0<9Z F].Y>(_(&?A
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>_\  $0@
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M<D<J'HRLL1!!]17I'[<?_)M'B7_KK9_^E45=9^S;_P D#\#_ /8%MO\ T 4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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M_P"-4?\ #1'QS_Z-VU__ , ;W_XU0!]645\I_P##1'QS_P"C=M?_ / &]_\
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MK\"_#'QG%XKT#5?$=S>QPR0B.]N(7BVN,'A(E.?QH ]JHHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ==07VGZCI]] ES97]A>VTDMM>65Y;2Q7%K=6\LD%Q!(DL4CQNK&Y0 4444
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MPZT/QGX<U'Q+?_&O6(Q87NE6^G>&_#%F'\/3^(HQHLOB[7/"Z:E;7]B;NPG
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MXETC5/!OB+7=0$NJ:W#X*USPY876@ZOK6HZEJTFG^+)-%>>/3/#^EPK\T_\
M!T9_P6V_:'^''QQT?_@E_P#L+>-_%/@;QL^E^%I_V@/'?PNNYX/BCJGB7XD6
MMO=>!?@=X&UC19'\0>&KN[T'5M"\1^([OP\;'Q/J\WB7PWH.G:C:6,>O66L
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M6:]+ C,5C>\N60*9'+?H;_P6/_93\6_MA?\ ! SQU\,_A[IUSK'Q"\*_L]_
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MHOC+H_QI\0:-I=Z()[BW%_#+XHL[&58+B>(W8*Q32J5=@#]P_P#@^:_X^?\
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M1\8^(/#$MO;W&D#4/$EIX8&IJVJ7GA:ZN(M-73?ZOZ* /PN_8-_X-]_V-/\
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M(:EJVJ:;-X?B\!?"/X:7%K=SW&LW27TFHW6JPRPQP+;V]LZR22\?_P %B/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!17B7[2?Q_\ AW^RK\ ?C!^T?\6=3_LCX=?!7X?^)?B'XKND!>ZET[PYILUZ
MNF:; JO)=ZSK=VEOHVB6$*//J&KW]E901O-<(A_''_@W[_X*8?MC?\%6?@-\
M<?VF/VE?AI\$/A=\-]-^+[?#7X#:-\)_#'Q#TK6-5M/#^DQZUXUU7Q9XB\;_
M !(\8V/BR"R?Q)X6\-Z;J/ASPYX/M3KFB>+WN+60RV^G:. ?OW17\4O[(?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4_&I^)>@_&'5?B4T'C*/P_XR2+6V\''6M;_MY%UO3=/74-0^R_JA_P %6?\
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M<N=4\"_$LVGF3R6T-CJJV/PXN/LMO!;^7?VU]=NUQ)?R&+\B/VUO^5N'0O\
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M<?&CXL:7I!GFC&\[!\.-'CD="9(X1&!T45_IMZ-J<.M:/I6LVXQ;ZMIMCJ<
MW;L0W]K%=1#=@;ODE7YL#/7 Z4 :5%%% !1110 4444 %%%% !1110 4444
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MHFJVC_)=:?J=E:W<#_++"AXK^'S_ (*"?L(_MP>-/^#G1/CYX._8U_:L\6?
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M%/OV@_VR?VD]7\'?L^?M/?LT>.OAM=?%O]H?]GGXI_$[X)?%+X2^"/&/Q3\
M_%W0=;\#>$?#GQ7\7^'_  YX;T+Q/XFTZ_U+7? 6MPZO(G]LZ+I]VQBT@7^I
MV6U^W3_P42_X+\?MZ^%M%_X)O_M)_"KXO2ZS8ZWH-EXO^%/@C]FGQ'X+^)/Q
M=\0>$]0A_L;4OB+;:+H[#7].M=<M[3Q B^'-/T'P)<ZK:Z;XC^PRBPTR\M@#
M](_^#(OP?J5[^U[^VGX^B$W]D>&OV;O"'@^^*N1;C4O''Q.T[6M*$J=&F-K\
M/=9^SN>4C%R!Q(:^*?VUO^5N'0O^TI?[$O\ ZFOP!K^U/_@W&_X)/>)O^"6W
M[%>H6OQFL;&R_:=_:-\0:9\2?C-IMI<:;J/_  @NGZ7I;Z=X ^%+:SIJR6^J
M7'@ZPOM9U379K6^U'38O%WBKQ):Z1?WVEVUG?7/\K'[7?["'[</B7_@Z%T;]
MH#PY^QI^U9K_ ,!XO^"D7[('CF7XV:)^SO\ %W5?A''X)\,^+O@C<^)/&,GQ
M(L/!\_@U/"WA^VTG5;C6_$+:R-)TJ#3-0EO[NWCL[EHP#]L_^#UC_E%W^S[_
M -G\?#3_ -9Y_:@KZB_X-(_^4+WPD_[+)\?O_5@WM>??\'=O[//Q^_:4_P""
M<?P-\#_LY_ WXP_'[QKI'[;/P^\5ZKX/^"GPS\:?%3Q3IGA:R^!/[1FD7GB7
M4/#_ (%T37M6LM M-6US1=+N=8N;2+3H-1UC2[*6Y2YU"TBF^C?^#7[X*_&3
MX ?\$DOAA\-_CQ\)?B9\$_B)I_Q8^-VHW_@+XN> _%/PW\:66GZMXYN[O2K^
M[\+>,M*T;7+:RU.T9;K3[J:Q2"\MV6:VDDC(:@#^-_\ X-N_^5B_5/\ K^_;
M3_\ 37XTK]#?^#Y#_D>_^";W_8I?M2?^GCX"UXS_ ,$!/V&/VVO@U_P7IU+X
MP_%_]CO]J?X5?"22\_:X9/BE\2?V?/BUX&^'+KXET[Q<GAUD\;^)_".E^&67
M7WN;9-%(U,C57N(%L3.98PWW7_P>/?LC?M7?M/>,_P!@*Z_9J_9B_:%_:&M?
M!OAC]I"W\7W/P-^"WQ(^+4'A2?7-5^"LFB0>))O /AKQ!'H<VL1Z5JDFE1ZH
MUJ^H)IM^UHLRV=P8P#ZV_:=^'6M_%#_@SF\+^'?#\DT=_I'_  3Q_9)^(L_D
MLZE]$^$FO_!OXI^)HY A!:%_#7@[5A(K?)M^9@54U\*?\&/OQ:\+OX1_;Z^!
M4TEG:^-+;Q'\%?BSIT3O"M_KOA>^TSQKX/UF2VC#F>:T\*:MIVA+>NT:Q6\W
MC.P".[W3JG]3_P#P31^"%S/_ ,$B?V./V=_C[\.M<T.;4/V)/AC\)OB]\*_B
M'X=U/PYX@T^'5/A;8^%_&7@SQ?X7U^SLM6T;44MKF_TK5M)U6QMKVTE,L%S;
MQRHRC_.S_:K_ ."9O_!5W_@W\_;6U'X_?L;VGQ@UKX7:9J&OK\(OVDOA;X.D
M^(F@ZI\-=<N$ED^'?QY\+VNBZ]HNGZC!:QZ?9>(M&\<Z!%X5\0ZQI=GXH\'S
M275C93:, ?VE?\'7?Q)\*^!O^"*'[1GAK7]1TBUUKXN^./@#\/O ^GZD\?VG
M6O$=A\:_!'Q+O[71X'(>?4;'P=\/?%.M$Q@FWL],NKDG$>#^<W_!DKX&UG2O
MV*_VO?B'>6E_;Z-XS_:8T3PUHMQ<1RQV-]+X%^&6A7FJ3Z>7"I/Y4OC6VM;N
MXAW1F:!;9G\VVD1/YE?%]Q_P75_X..?C/\+O!OCGPI\0?&'@SPU=;M U-_AI
M>?!_]EKX16FJRVNG:[XZU_6K;1+70K[6&MQ)(US>ZAXM\?ZA8PWVC>$;&XM$
MDTI?]-S_ ()P?L,?#K_@G%^QO\&?V1_AM<R:O8?#C0II_%7BRX2:.[\=?$7Q
M)>3:]X^\9W$$\]S)91:[XEOKZ;2M*$\L6AZ''I>AV[M;:;$2 ?YU/_!L^BO_
M ,'"^J,R@F.S_;%="0"58V?B.,L,]#LD=<C!PQ'0D'^RW_@Z9 /_  0P_;1S
MVO\ ]FHCV/\ PUA\#A_(D?C7\OG_  ;T_L,?MM?!7_@NGJGQ=^,G['?[4_PE
M^%$EG^U6L?Q.^)G[/GQ:\!_#QV\16^N+X?5/&GBGPCI7AMFUTS1#1@NI$ZF9
M8Q9"<NN?ZQ?^#D;X2?%;XY_\$:?VN/A?\$OAE\0OC%\3/$EY^SXWAWX=_"SP
M7XD^(/CK7UT7]IOX.:_K#:+X1\):;J^OZJNDZ%I>IZUJ9L=/G%AI.G7VHW1B
ML[2XFC /QO\ ^#)22.']B3]L::61(HHOVHM*DEED94CCC3X2>$V>21V(5$10
M69F(55!)( )KU7_@J/\ \&]W_!.'_@J!^T;X[\6?LN_M9_"[X _MV^)-(U'X
ME?$WX<^#_$W@KXG>'_'EK9ZGH^CZW\1_&WP<T7Q1I_C;P7J%[JVK:3IVO>//
M#]S;Z+?:YJT6H:WX9UKQ)J=S?7=K_@T2_97^/?P"_8O_ &O/ '[4W[.OQC^!
M]]XY_:"MKFS\'_'GX3^./A=J/BOPG=_"GPYHNHWEAHGC[0=!O-8T*:9;S2[F
M\M+>>R,Z7%H\HE21!_.-^T3_ ,$X?^"J7_!O-_P4$U/]J+]AKX=^./BA\#[?
M6?$EK\)_B=X2\":Y\5?"&L?"WQCYM_=?!KX]^#_#]UJ/B32YM%M;6TTO4M3U
M>;1[/7]2T'2/&?A'Q#9:TL5OH@!^>W_!1+_@A=_P4<_X)%:=X?\ CK\4[/PM
MJ?PRL/'.E:/X9_:#^ 7Q OK^Q\,^-'FN=0\)/>0WUAX.^(W@S6+LZ7)=Z1K+
M^'HM*MM4MXK&#Q!_:DMA%<_Z)/\ P;8_M[_$_P#X*#?\$P_!7Q!^-WB)_&/Q
MB^#OQ&\9?L^>/_&ET9#JWC&Z\%Z9X6\4>&/$?B!G&+CQ'>>!/'7A6WU[4D>3
M^V=6L[S69C%=:A<6\/\ $K^U%_P4B_X+D?\ !P%X;\)?L8:9^RIIA\(3>.])
MUK6_#?[/_P %_B1X-\/:IXJ\,V]_#:7?Q7^(_P 4O'/C'0_"F@>'[YM1U'R=
M3\1>$M'M=3BM4U%[^_LK #^_K_@BA_P3HNO^"7O_  3[^%?[,WB74]'USXJ7
M.HZ]\4?C;K/AYFFT*[^*GCIK)]7L-&O);6SN-3TOPIH>E^'?!6GZQ<VUO/K%
MKX:BU1K6R2\2RM@#^(C_ (/7=>L;O_@I#^S9X;AM0NH:)^Q/X5U2]O\ Y?W\
M&O\ QR^.D%E8G#%LV)T*[N<%%7&IC:S$L$_TH_ACIT^C_#7X>Z1<N\ESI7@?
MPGIUQ)(<R//8Z#I]K*\A[NTD3,Q[L37^;Q_P6]T6']O'_@Z-^ O[+FC:8?%N
MG^%O$O['7P \8:;Y:369\*F_MOC;\4'E67$4^G>'O!OQ(\27FM(N_8-,U.VV
M//$T1_TO@ H"J %       &  !P !P . * %HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?&O_(F^+?\
ML6=>_P#35=UTU<SXU_Y$WQ;_ -BSKW_IJNZ /R-HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH [/X<?\E#\!_]CGX7_P#3Y8U^LM?DU\./^2A^ _\ L<_"
M_P#Z?+&OUEH **** "BBB@ HHHH **** "BBB@ HHHH *\"_:N_Y-<_:3_[(
M%\8O_5=^(Z]]KP+]J[_DUS]I/_L@7QB_]5WXCH _B4HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ^G/V+?^3M/V=/^RO>"/\ T]VM?VF5_%G^Q;_R=I^S
MI_V5[P1_Z>[6O[3* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@#L_AQ_P E#\!_]CGX7_\ 3Y8U^LM?DU\./^2A^ _^QS\+_P#I\L:_66@
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MBV>DW?@?Q!H6N:_8ZU8/H-^EE#HL&H65S;W=YY&I)_0G_P $=_VM?&W[:7[
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M: /IG_AXW_P3T_Z/P_8S_P#$H/@C_P#-Q1_P\;_X)Z?]'X?L9_\ B4'P1_\
MFXKYF_X@J?\ @EE_T7S]O_\ \.G^SK_]"K1_Q!4_\$LO^B^?M_\ _AT_V=?_
M *%6@#Z9_P"'C?\ P3T_Z/P_8S_\2@^"/_S<4?\ #QO_ ()Z?]'X?L9_^)0?
M!'_YN*^9O^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\
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MZ_\ T*M'_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6@#]_O^'L7_  2R_P"DEG[
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M ?\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M9]_\/-\.?_FDH_X:T_95_P"CF?V??_#S?#G_ .:2OUM_X@J?^"67_1?/V_\
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MKZ[JVG>&_$5A>:1XV\&VNL:OJ6JP^%/$ND6VJ7USJEM?./OOX0?&KX0?M!>
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MT72_$>I:OK.KZG>R0V>G:7I>GVUQ?:A?7<T5M:6D$UQ/(D4;L/V1_P"'O_\
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MM?C/9)XT\6V=Q96+I+-K>MVDGA73I+*.X/A1O%6L6HT*Z_;C_@H-^WU\'/\
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MZ=?77AK6]0LK6\U2R\)^++G1-!N+V\TZVN[C1_$/A[PQXB_LW6(-'N-$U/\
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M  8 'C_X2@ #H /^'AW %?I__P %-/V#_P!I[_@HI_P3G_9QU*V_X17X0?\
M!2C]G74/@!^UQ\/[:UO;'_A"?"_[6/@'PSI^I>.?AU!JD&N^*M(3PU<>(=0\
M0Z-X?U-O$/B?1+;5]*\+ZI=ZUJ^DVL^H7 !^D_[>GC+2OAW^PY^V3X]URX6U
MT?P9^RO^T#XGU*=^B6FB?"?Q9J$P5<$O(ZV_EQ1J&:65DC169@I_.K_@VU\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'AX>'A[_P  1" !5 $,# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M-4 ?5E%?*?\ PT1\<_\ HW;7_P#P!O?_ (U1_P -$?'/_HW;7_\ P!O?_C5
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M+T1#5$1E8V]D90HO3&5N9W1H(#,Y.3 Y/CX*<W1R96%M"O_8_^  $$I&248
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MY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _OXHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_L>:%^S=^U3^TA^SYH?B?X&^.-7\2:-\$/CC\3OA1I7B'5;3Q\EG::GKFG>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +5LNMW]O!NCM99_"?PB\=V.EQS*FU"L*>*;YX(6!7<ID50T*E?P6_X)4_\
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M$'B;0_&7B+Q9I6H>%_[1:^GTQ="U:P6[?4+^WTX _D3_ ."CW_!574/V\_\
M@H;X4_X*%^%O@9I7[/OC;PO'\&M0_P"$/LO'<GQ!@U3Q?\%]3BO=#\4WOB4>
M#? EPTUY9:=X?TJ2U;1Y);6VT2 IJ$RO'#;?VG?\'K%U'>_\$Z_V3[V+_57?
M[8.AW4?_ %SN/@;\7I4_\=<4SPI_P=9>,?C5_P %3[3]B+]DS]EKP)^TU\"_
MB'\<?!WP?^#GQ5L/B!XL^&OBO5](ELM&M/B+\3M36_\ "GC/2]0\'>'=1@\;
M>+M*E@T'0);GX>Z+97ETPNYIKBKG_![+_P H]_V6?^SRM*_]4E\8* /NC_@T
MV\.Z9HG_  11^ >I6%I!;77B_P")G[0GB+6IH8DCDO\ 4[7XP>*?"<5W=.BA
MIYTT?PQI-BLLA9UMK*WA#".&-5_CD_X.[$/A_P#X+-:SK>D-]AU2?]G_ . F
MO&\@55F&JV%OKUC:7A8J0\\$&D6"1NX;"6\2'*H /[.O^#4[_E"!^RQ_V-O[
M1O\ ZT3\3:_C)_X/!O\ E,)J/_9LWP0_]&^,J /[&/\ @[ 8O_P1)^/SM]Y_
MB'^SLQQP,M\9/!Y/'U-?%O\ P90D?\.V?VE!W'[</C _@?@+^S\!_(U^A'_!
MT/X#\0>//^"(G[5L?AO3+C5KSPC<_ _QY?VMKM,T/A_PQ\:OA_<^)-3*,R[K
M?1M"EO\ 5[W:2T=C8W,P5O*VG^=[_@T9_P""HO[%W[*7[/O[3O[-/[47QY^'
MW[/WB/5?C-;_ !P\%ZY\5O$-AX.\(^+-&UKP%X5\$Z[I6F>)M6EM]'3Q#H5W
MX'T^ZDT:\N[:_P!2L];@FT>&_P#L6I"T /,O^#WB1#^U=^Q'$"-Z?L]>/)&7
M(R$E^)!5"1UP3#( >AVG'0U^I'_!?KQ=J7AO_@V"_96T:Q:86OQ \'?\$^_"
M.LB-"R-IME\,M'\>Q+<$<)"-7\$:4RNW!G6!/O.M?RY_\'-G_!1CX3?\%'?V
M]M"\8_LZZIJ'BS]G_P"!GPOMO@5X0^([Z1?:;X>^(_C/2/$VN^,_B'XD\)3:
MA%;W5YH5O)XT\.:#9S7%M:2WMMI%MK]M;OHVO:1>WO\ 9E_P52_9>\7_ +5?
M_!LEX&\*_#[2+C7_ !Q\,?V1/V0?CUX?T2SMKR\O]3M?A-\/_ 6N^,[73;.P
M@N;N]U0_#I_&$FF64%O+)>ZA';6BA&G$B '\@7_!&7_@XP_X<_\ [-'CC]GW
M0OV+M)^.>I>/_C+KGQ=USXB7OQWN?AS>2-J?A#P5X0TWPR-"@^$'C<-9:);>
M#Y+VWNCK8$MUK=^18V[%Y)_B7_@M)_P5ELO^"P'Q[^&'Q_F_9KTS]G7Q/X ^
M%$?PGU>WT[XFR_$UO&.E:?XL\0^*]"OKN_E^'W@!]/ET>?Q3K=I' UKJ1FAN
MD/VF%85A/]%7_!I/_P %>_V4/V6_@O\ '/\ 8J_:R^,WA+X$-J'Q7N?CK\)/
M'OQ3\16WAGX>:M;^)O"GA+P?XT\$2^*]8EM] \+:GI-YX,T?Q)IEIJU[8V^O
M#Q'KTMG(;O3;B.X^[_VJ/^#M23P;_P %";#]EC]A?X ?#7]N/X2:S>_#;X8^
M%?%VC?$+Q!X"UCX@?''QAKD^F:GI_@/QI;Z-XU\-:SX'6XUCPMX<TC5?^$,5
M+C7;'Q'JEMJ^L>'[O2+A #^M+]D_QO=?$S]EG]FKXCWLWVB]^('P ^#?C>[N
M/F_?W7BOX=>'->N)OF);][+?N_S$M\W))YKW^JMC)>2V5G+J-M!9ZA):V\E]
M9VMT]];6MX\2-<VUO?26MB]Y!!.7BANGLK-[B-5F:UMRYB2U0 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?Q=_P#!Z+^U_/\ #3]CCX"_L<>'[V2#6/VG?B9=
M^.O&\4<3/'-\,?@7_9.IP:7<R[U6!M5^)7B7P1J]D0LC2CP;?)^[49;]]O\
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MI&T35-<N=4\"_$LVGF3R6T-CJJV/PXN/LMO!;^7?VU]=NUQ)?R&+\B/VUO\
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M - ;7AH6MG1AJIM#J@T?538B<:?=^2 ?T7?\$,45/^"0'_!.P*  ?V7/ALY
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MI/J^L:59^'K1;<M<SWFL06L<;K.XK_2/_P""HGQ(\/\ PC_X)O?MW_$/Q/)
MND^'_P!DKX^_N+F2*./4M4U;X9^)-#\/Z(C3,L1N->U_4],T6TC9OWMU?PQ
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M-+LI;E+G4+2*;Z-_X-?O@K\9/@!_P22^&'PW^/'PE^)GP3^(FG_%CXW:C?\
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MD_;&FED2**+]J+2I)99&5(XXT^$GA-GDD=B%1$4%F9B%5022 ":]5_X*C_\
M!O=_P3A_X*@?M&^._%G[+O[6?PN^ /[=OB32-1^)7Q-^'/@_Q-X*^)WA_P >
M6MGJ>CZ/K?Q'\;?!S1?%&G^-O!>H7NK:MI.G:]X\\/W-OHM]KFK1:AK?AG6O
M$FIW-]=VO^#1+]E?X]_ +]B_]KSP!^U-^SK\8_@??>.?V@K:YL_!_P >?A/X
MX^%VH^*_"=W\*?#FBZC>6&B>/M!T&\UC0IIEO-+N;RTMY[(SI<6CRB5)$'\X
MW[1/_!.'_@JE_P &\W_!034_VHOV&OAWXX^*'P/M]9\26OPG^)WA+P)KGQ5\
M(:Q\+?&/FW]U\&OCWX/\/W6H^)-+FT6UM;32]2U/5YM'L]?U+0=(\9^$?$-E
MK2Q6^B 'Y[?\%$O^"%W_  4<_P""16G>'_CK\4[/PMJ?PRL/'.E:/X9_:#^
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M"IO[;XV_%!Y5EQ%/IWA[P;\2/$EYK2+OV#3-3MMCSQ-$?]+X * J@!0
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MD\22PRZQK.J>)_'WB'Q7XNUF]N5MK.TBEU;7KW[#IMCI^E6 M=,L+.T@^HJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!OQ>_P#".T3_ .:^@#]6**_*?_A\5^R7_P! WXO?^$=HG_S7T?\ #XK]DO\
MZ!OQ>_\ ".T3_P":^@#]6**_*?\ X?%?LE_] WXO?^$=HG_S7T?\/BOV2_\
MH&_%[_PCM$_^:^@#]6**_*?_ (?%?LE_] WXO?\ A':)_P#-?1_P^*_9+_Z!
MOQ>_\([1/_FOH _5BBORG_X?%?LE_P#0-^+W_A':)_\ -?1_P^*_9+_Z!OQ>
M_P#".T3_ .:^@#]6**_-WX;_ /!4W]F?XI^/O!_PX\,V'Q/C\0>-_$&F>&M&
M?5/"ND6NG)J.K7*6EJU[<P^)[J6"V$LB^;+';3NBY(C8C%?I%0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#P?ZK_ /)= 'ZXT5^1W_";>,_^AN\3_P#@_P!5_P#DNC_A-O&?_0W>)_\
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M0!^1M%%% !1110 4444 %%%% !1110 4444 %%%% '9_#C_DH?@/_L<_"_\
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MZA::5I6GVRD!KB^U&^F@M+2!2P#2W$T<8) + D4 :E%?.?[,_P"U=\#/VNO
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MUS3[35]%U*PUC2M0A6YL-3TN\M]0T^]MWSLGM+VTDFMKF%\';+#*Z-@X8XH
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M?P-\.?!#7O%7Q(^*$_B#P_X<7PG!XLNOB'KVH>3JOBBTOM"L;VYL_A9X7L;
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M_P#3Y8U^LM !1110 4444 %%%% !1110 4444 %%%% !7@7[5W_)KG[2?_9
MOC%_ZKOQ'7OM>!?M7?\ )KG[2?\ V0+XQ?\ JN_$= '\2E%%% !7Y._\%$_V
M2?C'\1O%OP\_:8_9JU5+#XQ_"O1KO1;O3DO;73M2UCP[!-J>I:=<:'=ZH_\
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MGJ(HHH(HX((XX888TBAAB18XHHHU"1QQQH B1HH"HB@*J@!0  *DHH ****
M/IS]BW_D[3]G3_LKW@C_ -/=K7]IE?Q9_L6_\G:?LZ?]E>\$?^GNUK^TR@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?&O_(F^+?\ L6=>_P#35=UT
MU<SXU_Y$WQ;_ -BSKW_IJNZ /R-HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH [/X<?\E#\!_]CGX7_P#3Y8U^LM?DU\./^2A^ _\ L<_"_P#Z?+&OUEH
M**** "BBB@ HHHH **** "BBB@ HHHH *\"_:N_Y-<_:3_[(%\8O_5=^(Z]]
MKP+]J[_DUS]I/_L@7QB_]5WXCH _B4HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ^G/V+?^3M/V=/^RO>"/\ T]VM?VF5_%G^Q;_R=I^SI_V5[P1_Z>[6
MO[3* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_\B;XM_P"Q9U[_
M --5W735S/C7_D3?%O\ V+.O?^FJ[H _(VBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#L_AQ_R4/P'_V.?A?_ -/EC7ZRU^37PX_Y*'X#_P"QS\+_ /I\
ML:_66@ HHHH **** "BBB@ HHHH **** "BBB@ KP+]J[_DUS]I/_L@7QB_]
M5WXCKWVO OVKO^37/VD_^R!?&+_U7?B.@#^)2BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#Z<_8M_Y.T_9T_[*]X(_P#3W:U_:97\6?[%O_)VG[.G_97O
M!'_I[M:_M,H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-<_:3_[(%\8O_5=^(Z]]KP+]J[_DUS]I/_L@7QB_]5WXCH _B4HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^G/V+?^3M/V=/^RO>"/\ T]VM?VF5_%G^
MQ;_R=I^SI_V5[P1_Z>[6O[3* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BOXP_V_/\ @O9_
MP67_ &:?VR?VA/@/\ _^"71^,?P<^&'C^[\,_#[XG_\ #/W[5'B?_A-- @L+
M"YAUG^W_  9J\'A;5?-GN9X?M6B0QV3>3M5=ZOGY _XB7?\ @OI_TAO/_B,'
M[9__ ,O* /[^Z*_@$_XB7?\ @OI_TAO/_B,'[9__ ,O*/^(EW_@OI_TAO/\
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M']K3_P",T?\ #[/_ (+9?](B/&G_ (CC^UI_\9H _K\HK^0/_A]G_P %LO\
MI$1XT_\ $<?VM/\ XS1_P^S_ ."V7_2(CQI_XCC^UI_\9H _K\HK^0/_ (?9
M_P#!;+_I$1XT_P#$<?VM/_C-'_#[/_@ME_TB(\:?^(X_M:?_ !F@#^ORBOY
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MEW_@OI_TAO/_ (C!^V?_ /+RC_B)=_X+Z?\ 2&\_^(P?MG__ "\H _O[HK^
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MD74=W;0ZC!8^%=-O)K-Y8U6>.VO[.9D)$=Q$V&'Z>_\ $2[_ ,%]/^D-Y_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYG\BV@EE\FWAFGDV[(8I)&5#^"?_ !%'?\$*/^CYO_-9OVP__H?:_;7XR_\
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MM>A:W)H.B:>^J:1<D SZ;>M/9RL SPD@$?S?_P#!+*ZU3_@D_P#\%-OVC_\
M@C1XXNKVU_9K^/G_  DG[8W_  3;U_6+F0Z99Z%JDMS=_%GX":?J%_,BSZGX
M7&G:EJ5CHU@DTL-OX'\1^+=7>*Y\>:>LX!^__P"TY^VQ^S)^QS-\&[3]HGXE
M/X&U3]H/XHZ/\%_@SH.F^"OB'\0_$OQ ^)6O+G3/#NB^&/AEX3\9>(%21V@@
MN=<OM-L_#NG7=_I=EJ6K6EWJVF0W?U.S*BL[L%5069F(5551DLQ.   "220
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M2QSP3QI-#-"ZR1312*'CEBD0LDD<B,'1T8JZD,I((-?G+\4/^"0W_!,WXM_
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M_4M*O-"\3P^'=(TW^V-.DT_6-5M4M[XS)#'J%YY(C-Q*6_G>_P""+/CO7O\
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MM= \/:6L.F:'9V(2U4"]>WM/Z-Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K^8SQ[*?@__P '77P8\4^.3#I?AK]J+_@EKXI^$_PCUO59$AL-
M;^(?@3XJW_C?Q/X.T*>4JK^(=.\-^%EU>YL5(D:Q\1VIB,DMZL1_ISK\L/\
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M;RX35+[4[G[<8[E+>#\@/^#LCX5:*/\ @F_I_P"U[X<U37O _P"T-^R%\7/
M.L_!GXG^#=0?0O%FAV/Q=\3Z+\+O'_AD:W:!=1C\/>(=)UJPU/4+*TN;?[3J
MGAK1?.>2S%Y:W7]1-?BI_P '!W[)'[0G[</_  2V^-W[.7[+OP__ .%G_&7Q
M?XM^#&I^'?!W_"5^"/!7]HV/A/XL>$O$OB"?_A(?B'XD\)>%;3[!HFF7U[Y5
M]KEM-=>1]FLH[F[EAMY #]$_V-OV</A?^R-^RU\"_P!G+X-Z,NA_#SX5?#GP
M[X=T2 K%]MU*X-FE_KGB36IH8XDO/$/BK7KS4_$GB&_\M#?:UJE]=%4\T*OT
ML_W&_P!UOY&LKP_:SV.@Z)974?E7-GI&FVMQ%N1_+GM[*&*:/?&SQOLD1EW1
MNR-C*LRD$ZS E6 ZE2!]2* /YQ/^#4'_ )0D_LW_ /8_?M$?^KR\<UA_&?\
MX)Y_\%2OV/OVT?VB?VJO^".OQ$_93U/X<?MH:]9_$']HS]EO]K>U\<VG@KPW
M\<42.WU7XO?#N^^'LEEJ,E[XU>ZU;7O%L<FO>'[IM5O+H7=EXSM?^$=M_"GU
M7_P;X?LD?M"?L/?\$M_@G^SG^U%\/_\ A6'QE\(^+_C-JGB'P=_PE?@CQK_9
M]CXL^*WBOQ+X?G_X2'X>>)?%OA6[^WZ+J5E>^58ZY<S6OG?9KV.VNXYH(_GW
MQU^S3_P5'_8%_;,_:Q^/O_!.?X3? W]KC]GK]N?Q;X?^+OQ#^ GQ6^*EK\$_
M%WP7_:%M=(L/"WBKX@>%?%5WIPTCQ%X,\;:?;V^M>)=(N+B\UU[G3;>UTJVL
M)K$7'B( ^,/V(/V=/CW\.?\ @Y+UGQ)^TA\5+/X\?M&ZW_P2JU7XN_M,_$#P
M7I^IZ#\(O!7CCQ]^T)H_@7P#\&_A3X7U*26Y\.?#[P3\,_!_AJT\.+J4O]O^
M,K]/$OCK7((=5U74(X?Z_J_('_@E_P#L)_';X$^+_P!I?]LS]MWQ?X*\=?MV
M_MJ>(/"FH_%-?AI+K$WPL^#GPS^'>FSZ/\+O@9\,7UPK>S:+X6TZZFGU[6&@
MBEUW5C:BZN=;DTF/Q#JWZ_4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7\ROP:OG^#G_!U%^V'X;\;*;2+]K__ ()X_"3Q[\'-6U5O)34)/@]>^ O!
M?B/P7X7DG2,7DTZ^%?&?B_5+"R>XD@C\/W5]<B-"NW^FJOQ]_P""LO\ P3+\
M7_MT:/\ !+XT_LU?&9OV9_V[_P!D/Q5J_CG]F+XZ#3TO](@FU^QAL?%GPX\?
MVJ66H75UX&\9VMK:P7LL=AJZZ;+'-]J\/^(M#U/7_#NL 'ZX3:UH]MJMAH-Q
MJVF0:YJMIJ&H:9HTU_:Q:KJ-AI+V46J7MAISRK>7EIILFI:='J%S;PR0V;W]
MDEP\;74 D_FA_P""8LZ?%'_@X!_X+X?&WPBPO?AWX>A_9 ^!4^NZ>K/HFH_$
M7P/\*=.\+>,='COX@]E?:[X5UOX<ZW8:Y:PSM=Z.UY:17T,#7T'F?#/[7/[$
MW_!PE_P46\1_L\Z;\7_V=_V)_P!F?X[_ +-/B^WU3X=?\%&?A'^T9\3]#\3>
M#;#4KJT7QK>?#CX?^#_&^JZM"_BVQT>P3Q#I/C#P1=V&J6S)IVGQ>&Q<2WFD
M_I?_ ,$%O@9\>?V"M%^-G_!/O]H']EGQ3X;\<>%?&/C#X]ZI^W=HGB:/QU\(
MOVU+KQ]XCL+*+QCJ'B/6[JW\;:#\7+;339:3JW@35]/U*33=&\,MK.IZG:7>
MKV;Z\ +_ ,'5O_*#W]J[_L:/V<?_ %H_X65_0CH7_(#T;_L%:=_Z20U^/'_!
MP%^R?\?_ -MS_@E=^T'^S?\ LP^ ?^%F_&CQQKWP4O?"_@S_ (2GP5X+_M2V
M\(_&OP#XN\0R_P#"1?$+Q'X3\*67]G^'M$U/4-FHZ[:27?V;[)8I<WTUO;2_
ML9I,$MMI6F6TZ[)K?3[."9-RMLEBMXXY%W(61MKJ1N5F4XRI(P: /C__ (*0
M_P#*._\ ;U_[,O\ VI/_ %1WCJOY0?\ @EU_P;9_LL_M4_\ !/?]DG]HKQA^
MV/\ \%)/ WB?XO\ P=\/>,];\(?"O]H7X=>&?AWX?O\ 47NEET[PAH&J? KQ
M%J&E:-#Y2FVL[O6]3FC+/NNI,C']>7[;'P\\8?%S]C/]K?X4?#S2/^$A\?\
MQ._9C^/?P\\#:!_:&EZ3_;GC#QI\*_%?AOPSI']J:Y>Z;HNF_P!I:UJ5E9?V
MAJ^HZ?I=GY_VG4+VUM(YIX_"O^"2OP*^*G[,O_!-G]C7X _&_P +?\(3\6_A
M3\$?#7A#Q]X3_MOPYXD_L'Q%I[WC7>G_ -O>$=7U_P ,ZIY(EC/VO1=9U&QD
MW?NKE\-@ [;]@#]A+X<_\$[/@$/V>?A?\3/CC\6?#7_":^(_'4GC#]H7QGH7
MCSXBS:GXFATNWNK";Q!X>\(>"+"31[&+2+9-+M3HGVBV5IEDO+A6C6+\'?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '__V0IE;F1S=')E86T*96YD;V)J
M"C$R,R P(&]B:@H\/"]4>7!E("]83V)J96-T"B]3=6)T>7!E("]);6%G90HO
M5VED=&@@-C<*+TAE:6=H=" X-0HO0V]L;W)3<&%C92 O1&5V:6-E4D=""B]"
M:71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],96YG=&@@
M,C X.#X^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $, !0,$! 0#
M!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:'1T?
M'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$( %4
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /LNBN#^/GCRY^&GPLU3QE::?%J$UD\"BWED**_F2I&>0"1C=G\*
M\&TW]I;XS:G80:AIOP"U>]L[A!)!<6]K=R1RH>C*RQ$$'U% 'UK17RG_ ,-$
M?'/_ *-VU_\ \ ;W_P"-4?\ #1'QS_Z-VU__ , ;W_XU0!]645\I_P##1'QS
M_P"C=M?_ / &]_\ C5'_  T1\<_^C=M?_P# &]_^-4 ?5E%?*?\ PT1\<_\
MHW;7_P#P!O?_ (U71_ G]H#Q5X\^+$_@+Q+X$'AFZM[*2YF29Y5G0KL*JT;J
M",AP>>V/6@#Z)HHHH \2_;C_ .3:/$O_ %UL_P#TJBKK/V;?^2!^!_\ L"VW
M_H KD_VX_P#DVCQ+_P!=;/\ ]*HJZS]FW_D@?@?_ + MM_Z * /0:*** "O'
M?VEOCII'P@T:&&*"+5/$=Z,VE@9-JHF<&60CD+U '5CP. 2.O^,_Q"TGX9>
M+_Q3JI#F(>7:6V[#7,[?<C'UZD]@">U?"?P5\#^)/VC?C'>^(/%EQ/)ID<HN
M-7NURHQ_!;1?W<@8 'W5!/7&0#Z1_9B\>?&KXJW_ /PD_B$:1HWA"%F5$MK
MJ]\XXVH79B$4]6]1@=R.?\#_ /*1;QE_V"A_Z36M?4FD:=8Z1I=KI>F6D-I9
M6D2PV\$2[4C11@*!V %?+?@?_E(MXR_[!0_])K6@#ZNHHHH \2_;C_Y-H\2_
M]=;/_P!*HJZS]FW_ )('X'_[ MM_Z *Y/]N/_DVCQ+_UUL__ $JBJQ\-O&_A
MSX>_LL^#O$OBB]-K8PZ-:H-JEGE<I\J(HZL<'\B3@ F@#V6BO'O@Q^T7\/\
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M&1@/F<^[,2Q]S6_61_PE/AG_ *&+2/\ P-C_ ,:/^$I\,_\ 0Q:1_P"!L?\
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUCJ6G_!71O%/BW0[*W@TR3[1I-IJ&EV?A3X?V<T%WX>TO6X[O3[W3;7]2_\
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M:)_ZLSP)7[1U^+G_  <1_P#*%G]O_P#[))HG_JS/ E '^/S\*_&7C#X+^/\
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MEE!=S+X=O+#7]7\?_"2?5A%%):VMCK;^)OB1IB:E</;JNHV.E:8[S3ZCI\0
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MGKVG>%;:2YOC86\X!_8Y_P ')/\ P3B_:#_X*>_\$Z_V<_B+^S[X3'CKX\?
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M^GVUQ!X@T^;2-$FATO4I=,EL& /Z1_\ @]I\*>';O]@W]DWQS<V=@_BWP_\
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MO"GCCP=8V%[?>.? /Q&TB309=,\?ZS/=VL&A6^H27]MIDL.J06\-U:WO<?\
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MMIUM\/[OQ3>:,_AQ/ /PF^&<MG/<R^+M274VU.;6(YHX+$6L5DT<[7/[)T4
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M: OP07QI_P (PKS.$LO^%@?VJ%"AM:8@L?WTHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **\2_:3^/_P ._P!E7X _&#]H_P"+.I_V1\.O@K\/_$OQ#\5W2 O=2Z=X
M<TV:]73--@57DN]9UN[2WT;1+"%'GU#5[^RLH(WFN$0_CC_P;]_\%,/VQO\
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M>2PN\GC$[O%^GZY:ZYX@?4/$5MJ>D)Y6K+;:AJD%X ?UL_LI_M3?!/\ ;4^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P -!? 3_HM_PA_\.5X,_P#EU1_PT%\!/^BW_"'_ ,.5X,_^75 'KU%>0_\
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M_P"RO>"/_3W:U_:90 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/C7_
M )$WQ;_V+.O?^FJ[KIJYGQK_ ,B;XM_[%G7O_35=T ?D;1110 4444 %%%%
M!1110 4444 %%%% !1110!V?PX_Y*'X#_P"QS\+_ /I\L:_66OR:^''_ "4/
MP'_V.?A?_P!/EC7ZRT %%%% !1110 4444 %%%% !1110 4444 %>!?M7?\
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MOQ'0!_$I1110 4444 %%%% !1110 4444 %%%% !1110!].?L6_\G:?LZ?\
M97O!'_I[M:_M,K^+/]BW_D[3]G3_ +*]X(_]/=K7]IE !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?@/_ +'/PO\ ^GRQK]9:_)KX<?\ )0_ ?_8Y^%__ $^6-?K+0 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N9\:_\B;XM_P"Q9U[_ --5W735S/C7_D3?%O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7,^-?^1-\6_\ 8LZ]_P"FJ[KIJYGQK_R)
MOBW_ +%G7O\ TU7= 'Y&T444 %%%% !1110 4444 %%%% !1110 4444 =G\
M./\ DH?@/_L<_"__ *?+&OUEK\FOAQ_R4/P'_P!CGX7_ /3Y8U^LM !1110
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M6_\ 8LZ]_P"FJ[KIJYGQK_R)OBW_ +%G7O\ TU7= 'Y&T444 %%%% !1110
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ME%%% !1110 4444 %%%% !1110 4444 %%%% 'TY^Q;_ ,G:?LZ?]E>\$?\
MI[M:_M,K^+/]BW_D[3]G3_LKW@C_ -/=K7]IE !1110 4444 %%%% !1110
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M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\
MT*M 'TS_ ,/&_P#@GI_T?A^QG_XE!\$?_FXH_P"'C?\ P3T_Z/P_8S_\2@^"
M/_S<5\S?\05/_!++_HOG[?\ _P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I
M_LZ__0JT ?3/_#QO_@GI_P!'X?L9_P#B4'P1_P#FXH_X>-_\$]/^C\/V,_\
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M?!'_ .;BC_AXW_P3T_Z/P_8S_P#$H/@C_P#-Q7S-_P 05/\ P2R_Z+Y^W_\
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M4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT
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M?/V__P#PZ?[.O_T*M 'Y)?\ #6G[*O\ T<S^S[_X>;X<_P#S24?\-:?LJ_\
M1S/[/O\ X>;X<_\ S25^MO\ Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)
M9?\ 1?/V_P#_ ,.G^SK_ /0JT ?DE_PUI^RK_P!',_L^_P#AYOAS_P#-)1_P
MUI^RK_T<S^S[_P"'F^'/_P TE?K;_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:
M/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M 'Y)?\-:?LJ_]',_L^_\ AYOAS_\
M-)1_PUI^RK_T<S^S[_X>;X<__-)7ZV_\05/_  2R_P"B^?M__P#AT_V=?_H5
M:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M 'Y)?\-:?LJ_]',_L^_^'F^'/_S2
M4?\ #6G[*O\ T<S^S[_X>;X<_P#S25^MO_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/ LVL:M?0Q[[U([[0AX\U#3I4A\B8^"M6BDFC>-67^KJO\^__@G9\-?VP?\
M@EI_P4(^ 7[4O_!<CX4_'KXL^*/C1\$OAO\ LL?LN?M,:+XD3]HG1OV9/$NO
M:I)X,TOX2_%Z+P@FMZI9^-O$5EK%EX5TG7]*U+Q&9[GQ;XGEL[KQU?\ B7Q9
MK'A;_00H _F3_P""9G_*PE_P<"_]@W]AC_U31K^FROPN_89_8X_:/^#O_!8[
M_@L'^U5\1_AS_P (Y\!?VIK']E*'X$>//^$O\":O_P )U)\-?AH?#_C5?^$7
MT+Q1JGC/PQ_8NK_Z)GQCX=\/+J/_ !\:2;^U_?5^Z- '\I__  >)0QW'_!*#
MP;!,N^*;]LSX(0RIEEW1R>#_ (MHZ[E*LNY6(RI##.00>:^LO^(7'_@A1_T8
MS_YLS^V'_P#1!4S_ (.2?V)/VGOV^O\ @GYX6^"'[)?PR_X6Q\4--_:<^%/Q
M#O?#'_"9_#WP)Y/@_P ->'?B)8:UJ_\ ;7Q+\6>#?#TGV*[UW2HO[/BU:35+
MG[5OM+*>."Y>'^@&@#YS_92_9,_9^_8A^"'A?]G#]E_P!_PK'X,>"[SQ'J'A
MKP;_ ,)5XV\:?V;=^+?$.I>*O$$W_"0_$+Q)XL\5WG]H:]J^HW_EZAKEU%:?
M:/LMDEM9106\7X@?\'8_P^\%^+_^"*WQ^\5>)?#NF:QXB^%/Q!^ 'C'X>:Q>
M6ZR7_A3Q)K/QJ\$?#C5=5TBXXDMY]0\%>./%/A^["MY<UCJ\ZR(SK$\?])=?
MC9_P7Z_93^/G[;'_  2I_:0_9M_9C\!_\+,^-/C[5/@E<^$_!G_"4>#/!G]K
M0^$/CQ\-?&?B)_\ A(OB#XB\*>$['^S_  UX?U?4MNI:[9O=_9/L=BMS?SVU
MK, ?:/\ P3X^%_@3X,?L+_LB?#3X:>';/PMX+\,_L[?"./2=&L?,:..74_!.
MCZSJ]]<SS/)<7NIZSK6HZCK.KZC=2RW>I:K?WE_=RRW%Q+(WV%7CG[.WA77_
M  )^S]\"_!'BJP_LKQ1X-^#GPQ\*^)-,^U65]_9NO^'O!.B:1K%A]MTVXO-.
MO/L>HV=Q;_:K"[NK*X\OS;6XG@>.5O8Z /YD[[_E;6T;_M#?+_ZT)JM?L'_P
M4=_8*^"O_!2?]DWX@_LI_'.YO]%\.>+Y=(UCPUXVT06/_"2?#SQ_X?O!=^%/
M&/AXZBDEI+>6=T\VFZAITWEQZYX?U76= DGMXM4>>/X7N_V./VCY?^#B#3/V
MZ4^'.[]E>W_X)IR?L_S?%+_A+_ @V?%QOC'J'BH>$O\ A"#XH'Q&;.@3Q7_]
MO+X1;PS\WV4ZU]M5K<>L?\%L/V#/B=^WQ^QQ9>&/V?=;TOPY^U!^S[\9/AO^
MU'^S1JNM30VFD2_%OX37>H2:=H6I7URZV=G;Z]HNLZU8V5UJ2RZ3::__ &)?
M:I%]BM)98@#\J_"?_!(C_@J_>> 9_@W_ ,%)O^"MUO\ &O\ X)S_  CT@:YX
MJ^%/P_\  EGH'Q0^/?PU^'&GVFM6WP^^-7Q8U+PCI'CNQ\#ZC%X>6#QS8W/Q
M!^)>H^*= FU;2;_6?/U"VU;2?HG_ (-//"]YX=_X(I?L_P"H7=I+:CQE\1OV
M@/%%H98VC:ZLT^+WBCPQ%=J&52T4C^&I$BD&5DCC5T8H5-?*GQZ_:L_X+>?\
M%+O@3?\ _!/SPO\ \$L?B%^Q!XS^-VAI\*OVI?VL_BWXYTVY^#GP_P#AWKEO
M#IWQ+U/X400Z?I=UXS/BOP]-J>FV]IH&N^(M5TNWU2?1K#^T+O/BG2_Z<_V6
M/V=? ?[(_P"SC\$_V9?AC#+%X%^!_P ./"_P[T":X4+>ZG%X>TV&TO->U/:S
MJVK^(M2%[KVL2*S"75-1NY0</0![Y1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HKR[XE?''X*_!FS_M'XP?&#X7?"G3_LSWOV[XE?$#PGX%L_L<199+O[3X
MHU;2X/LT;(X>??Y2%&#."IPSX9?'3X)?&NRDU/X-?&/X5_%O384$DVH?#+XA
M>$O'ME%&VP+))=^%=7U6!$)D0!FD"G>F#\PR >J4444 %%%% !1110 4444
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M$,K$$&IZ "BBB@ HHHZ]* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWB?PA<_8/$.FWDAL[73@#_4XHK^3O_@[V_:,_:$_9I_8._9T\8?LY?'?XR_
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MJ+>=1T3X3:1#9^"?AUX?\(:-=K+JWA[P3XBG\0^'=-;4+WQ#IG]HP^(KF/\
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MPA<IN)4FN^H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%[X*MW\'^!M1T?XG>(/$EOKEUI$%WX7^)7AV^TN 3&T\4V%MIRW#0@'ZW_\
M!'[_ (+'?L__ /!7WX+>(O'7PST35/AG\6/AC<:)I?QI^"7B/5++6=7\%WWB
M"WO)M$UO0]=LX+%/%?@7Q#)I>L0:%XC;2=%O'NM)U&QU71-+N[=8YOX&O^"]
MG_!-K]N+_@G#_P %(?C7^WO\#]$^)V@_!/XG_&KQ1^T9\,/VE_@[=:\C?"CQ
MI\2=:OO$_C#PMXPUSP^_]I_#C5],\6:YKMEI4FL/:>&_%'A;4M/MM)U&^D?7
M=!TC[,_X,D?!'Q(N_P!L;]L'XCZ>D\?PBT']FK1_!/BV5K68VMU\1/%?Q0\+
M:[\/X8KS:(!<V7AOP;\2))8 [2B&]B=HPDBN/T?N?^#JSXE?#C_@J3J/[$_[
M;?[-OPB_9T_9J\#_ !?^)7P-^.'C:XU#QYX^\8:2UDFM:)X$^("W-S::%HA^
M'&N:LGAW6M;5_ VI/<> _$!\0:?J9M[)8=3 /Q)_8V_X/ _^"D/P*O-!T+]I
MS1/AK^V1\/K*41ZG=>)=%L?A?\8/LGVA&B;3/'G@/3K;PI-<V-N98TE\1_#;
M7;_4"(C=ZO'/YMV_^B;_ ,$\_P!O_P" O_!2W]F+P?\ M1_L]WVJCPKX@NK_
M $#Q)X4\2PVEIXQ^'?CK0Q;CQ!X(\765E=WUG#JNFB[L[VVNK*\NM/UC1-1T
MK6]-N);'48&K^/G_ (.)= _X-W?%_P"Q#\3?B_\ LV^*_P!BZ]_;7U75O"%_
M\'[C]C?QU\/+[Q5XHUK5O'6A1>,[CXC>"?A%K_\ PC%UH,OA!?%-UK7B#QWH
ML>J66H6RMI%[)XAEBL+[Z9_X,FO!OCK1_P!B3]K+QEK-A?V?@+QG^TII-IX'
MFN[.XMK;5=5\+?#K1K;QGJ6E3S(D>H62OJ?A[2)KJT,MO'J6DW]BTOVJSN88
M0#^TROX7O^#X/_DA'[ 7_96_C=_ZAW@6O[H:_A>_X/@_^2$?L!?]E;^-W_J'
M>!: /RW_ ."P/P(@\1?\&X__  0M_:1MM-NI]3^%6EW7PBU"_M8YY(;3P_\
M&?POK7BA9-4$0:&*VCUOX,Z=:65W=!4@O-6-G%(LVIB.;\YO^"G_ .V=J?\
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MF&>\N#YWAS0=.TK1M&TNT26^UKQ%XAUB\L-#\/Z+812WNJZO?V=G FZ7<O\
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MJV\-YIGB#_@J)^R%HFHVEQ&LMO=6&K>.O@?87EO/$X*20SV]Q)%+&X*NC,K
M@D5_0_\ \&1O_)FG[9?_ &<WX<_]57H%?S]?M??\K<WAO_M*]^Q=_P"K(^!%
M '^E1_P4(T/3_$_[!'[;OAS5K>*[TO7OV1/VDM'U"UF4/%/9ZC\&_&=I<1.I
M!!5HI6'3(ZCD U_!G_P9%3RK^US^VK;!R(9OV<?!D\D?9I;?XFV<<+GW1+J=
M1[2&O[Y/VYO^3)OVP_\ LUG]H/\ ]5+XNK^!;_@R+_Y/ _;1_P"S;/"?_JT-
M+H _TCZ_ W_@Z _Y07?MT_\ 7G^SM_ZUI\!J_?*OP-_X.@/^4%W[=/\ UY_L
M[?\ K6GP&H _@2_X(A_\$%+G_@LQX,_:-\56G[5$'[.US\ M>^'F@PZ9<_!.
M3XK0>+Y/'VE^+M12XEU&+XL_#F3PXFEMX6$#1IINOM>"_,H:U-IY5S\8?M??
ML ^(/^"3W[?>C_L^_MW^!-8^+'PK\/:WH'C.XN/A/XK;P&/CO\#]4O;F*V\0
M> /%FKZ#KDOAN_N6LK_2M:TJ_P!*DO='\1:/K'AY=3BA-AXJ?^O7_@QU_P"2
M3_\ !1#_ +*'^SK_ .HW\6Z_5[_@Z!_X)>G]OS]@S5/BW\-/#G]J_M*_L?V^
MN_%'P%'I]J9=9\:_#0VL,_Q<^&L*VUG=WVH7-WH6FP>,O"VF6\;7-YXK\)6&
MBV;0+XBOG< _2[_@DCX/_P""?OA_]AKX/>)/^":?A'PYX6_9E^(VE2>,-(DT
MM[V]\5:IXEDFDTOQ0GQ0UO6[[5O$^J_$;P]K.G7?A;Q*GB/5M0O=&O-&;0[.
M2+2M/L((_GO_ (+#_P#!;']D#_@D_P"$?#.@?&SPWK'QL^,/Q.TR]UGP'^S]
MX3BT9[[4]"TZY>T/BSQOK6OK/H_@WP:VKPOI=EJ<]AK>M:IJ,%ZN@>&]7CT?
M6IM-_D;_ .#.O_@IA-\)?C[XT_X)Q_$_Q"\?P\_:&:_^(/P'_M*Z<VGA[XW>
M'-(\[Q1X5L?,S%:V_P 2_!&E-?QQF2*#_A)/!%C:6<$FI^*)C+\>_P#!T[YV
MA?\ !=Z^UCXY6M_XE^#[^ _V7-:TSP]8&ZM;ZY^"MCI5E:^-O#^FW#7<&+K4
M_%VF?$][:YLKBRCBN]2P)(KJ*>X8 ^P?C)_P<-_\%JO^"IOPM^./P_\ V)_V
M)]!^&_P&N/A=\0K'XO\ C3PAX-U_XM:CX8^'Z^&-1D\?P>(?C;\0$\/?"'0#
M+X.GO81:GP3IOB:59I9=!E;4'LQ;]+_P9![O^&F?VZ""=G_"BOAAN7L6/Q U
M7:3[@!P/]XU_0;_P4D_X+"?\$N/@+_P25^,&B?LQ?M#?LY:[<?%O]F/Q[\(/
MV9?@G\#/$'A'5=8M-3\?>!M4\!Z$MU\-?"%VFH^ =!\"S:L;SQ4/$VG^'ET>
M31KS0YP?$+P:9/\ SQ?\&0^L6,'[5W[;F@27$2ZGJ?[/7@+6+2U9@)IK'0_B
M1]BU&>-,Y:*VN/$.EQS, 0CW4 )&\9 /BG_@\._Y2_R?]FN?!/\ ].7CZO\
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M;R12MH7B'QE#KOC._GM;T));W][X<TSPMJ1MIB-.NM-ND2\']@WP'^ OP?\
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MPGUOPEKWAW2I=!O?@9J'C)O"=[>>#=+CUJQ7Q\FL7-M/?I8Z[ITLMO-:_P!
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MG/\ X*'_ +/OAC]I+]F/QF/%G@'Q!-<:5J=A?VZZ9XM\#^+-.CMY-9\$^.=
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MVWVW5;G3M!LGN4TO1[,O$MYK6M7?V;2-&M'F@CN=4OK2&6>"-VE3_/M^(O\
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M4M4NYO$UYJ^I:Y?Z5J6AP+8:79_E!_P>5?M>>._BG^W/\)?V(M!U#4Y?AU\
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MT7[?/QWU=X(C$+B#XJ^+OV?-?\(32%L/+,/AY_PAT$LK<,T)6+,*QFO]#?\
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M>"=;N+18FU'1IKV-+C1/$^C^>K0IKGA/7[72_$VAR3*\46K:39R2H\:LI_S
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M10 J^$/#2J!T"KHUD ![ #%?Y8W_  1,X_X.G/!>/^CG_P#@H3_ZI;]JBO\
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M8?8/_!U-_P $/_C1^VE=^!_V[OV/_!EW\1OC%\./ J_#CXU_"#0(S-XP\?\
MP^T74=0UOPCXR\!Z:98TU_Q5X.EUG7]*UWPU:QS>(/$WA^ZT)?#\5W>^&DTK
M5/YPO%'_  6J_P""]?Q4_99UG_@F;JGPS\>:W>ZMX#3X0^*-?TW]FKXGS?M:
M:S\/[F,^'KSPAK5Y TT);7-%2;P?JNN)\.[;QCJ6GR7:2>(#K=Q<:E( ?U>?
M\$-/^#>GP'_P3;_:=O\ ]LCX:?\ !1'P=^U]X;\0?!GQ=\*$T'P1\%M$\*Z+
M-;>,M=\&>(8=?A\=Z#^T/\5[&XCLW\'Q)'IT>BA;X7@F74K<6WEW'\LW_!9M
M%D_X.I?%2, 5?]K'_@GRC \@JWPF_9;!!!X(()'-?U6?\&N__!&/XG?\$X?A
M!\3?VB?VH= 7PK^TO^TCI^@:#:_#FZ-A=:Q\'_A/X;O[[4[;1-<O[">Z@C\5
M^/=9N+'7_$VCV]U/#HUCX?\ "6GW1AUN#6;2V_ '_@K+^PA^W#\1_P#@Y2\1
M?';X>?L:?M6>//@A/^T[^PQK\/QD\&?L[_%WQ1\*IM"\(_#+]F^P\5ZU%\0]
M#\'WWA&32?#%]H6MV7B'4DU<V>BW>CZK;:E-;3:?=I" ?Z0/Q,&?AQ\0 >A\
M$^*P?_!%?U_F'?\ !F9_REE\?_\ 9EGQ?_\ 5H_ FO\ 3X^(5M<WO@'QQ9V=
MO/=WEWX0\2VUK:VT4D]S<W,^BWL4%O;P1*\LT\TKI'%%&K222,J(K,P!_P Z
MS_@TR_8:_;7_ &<?^"G'C?Q]^T-^Q[^U+\!_ MW^R-\4_#5KXU^,W[/OQ9^%
MWA*Y\1ZC\1_@O?:?H%OXC\;^$=#T>;6KZRTK4[RSTJ.\:^N;73K^XA@>&SN'
MC ,[_@]S!_X;%_8Q../^&:/% SVR/BEK.1^&1GZBO[[_ -APAOV*?V/F4@JW
M[+?[/Q!!R"#\)O"1!![@CD&OX]/^#S']A+]H;XTK^R?^U=\&/A;XN^*/@WX7
M>&/B'\+OBX/ NAZKXHUSP5#K&M:%XF\$^(=4T+1K2]U!/"U[,?%>GZAX@2 V
M&CZA%I=MJ<T!U>P,G8?\&I?[=W_!2W]H7XC:_P#L]?M5P_%K7?V7?@;^R-HW
MAWX%>*O$/P3B\*>#-'U?P!XT\!>$]"\-:O\ %2S\%Z/+XN\:7/@'5FM-'MO$
M?B35=7OM \&ZIJ8BN+^'7-4O #^W^O\ ,,_X/2_ 7B+1/^"E_P #/B%>6DH\
M+>._V//!NCZ#J32;H9M:\#_%;XN#Q)ID:$[HI-.M/$OAN^E4 1L-:B=27:4+
M_IYU_/K_ ,'$'_!'O4/^"L'[*7A]?A,^CV'[5'[.^IZ]XO\ @I-K$]IING>-
M=+\06-G!XX^$VJZU<Q[-(B\7IHV@ZCH.J7,\&GV'BKP]I":G<6>CW^JWD !^
MN'[%OQ3\(_&[]D+]F'XN> K^SU+PA\0_@+\*/%.AW-@KQVZVNI^"=%F>S\F5
M(YK6?3;@S:==V4\<5Q97=I/:7$4<\,B+_FA_\';?C#2OC5_P6>7X>?#4Q^*_
M%O@3X#_ KX*ZMH^@1M=ZA+\1M9UCQAXVL?#6R-<76MRZ;\3/#%LMO"TC))<V
M]C(4N89H8O /@'_P41_X+[_\$C_".O\ [$_A'0_C=\+-(;5-<TGP?\./BO\
ML[KXZOO OB*^O+N75=2^"NH>*O"6KQW5EJ5W#>ZG96>D7?BKX=ZC/)>>(](T
M:>XU&\U2[_6/_@@/_P $*/VN_P!IC]L;P]_P4T_X*3>%OB'X9\'^#_'R?&SP
MSHWQNAU;3_BW^T%\:(K_ /MWPQXQU_0->AB\0:7X%\,^(5M/%DE]K\&F/XHU
M#3=$TK1M/OO#$NISQ@']%G_!RKX?N/"7_!O=^T9X5NV=[OPSX?\ V0O#]T\C
MB21KC1OVC?@-ITS/("PD=I+9BSAF#,2P)!S7Y]_\&2G_ "8M^US_ -G96_\
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M/%F@7^HKJN^.ZTWP#)XKTWQ59:A%;ZO_ ,)+XNDO=#O/#NFR:7;/_:&K!O\
M3EK\P_VB_P#@B]_P2R_:P\6ZYX^^._[$?P4\6>._%%Q+>>)O&VC:5JWPZ\7>
M)+^:.*&74_$'B7X9:QX.UK6M5>*&)#JNIWMUJ.V-0+D8H _SAO\ @MK_ ,%8
M?$'_  7Q_:;_ &6_AO\ LR?L\_$#0]$^'">*? ?P:\"ZO-INN_%3XB^/OC)J
MOA ^(;N^TSPY<7N@Z);-'X(\+6&GV%OK&J0V5O8:GK6K:W%:W!@TW_4(_84_
M9[NOV3?V+_V5OV9]1O;?4]7^!?P"^%?PQU_4[08M-3\2^$O!NDZ5XEU*T&6Q
M:W^O6^HWEL-S$0S("S$$GSK]EG_@E[_P3X_8HUM_%7[+G[)'P:^$7C)[*73/
M^$ZT;PT-7\?Q:;<1"&ZTZW\>^*;C7?&%K87L:JM_9VVMQ6]^0&O(YW :OO*@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#P[XX?M.?LV?LR:9H6M_M)?M"_ []GS1
MO%%_=:5X9U?XX?%GP%\)],\1:G8VZ7=[IVA7_CS7] M=7O[.UD2YNK/3Y;BX
MM[=TFEC2-@Q^<?\ A[%_P2R_Z26?L ?^)D?LZ_\ SQJ_EX_X/?/^39?V%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?!WX4^.-3NV#0N]_XHT/6?$=Q=74F-^J:P]S+%)N:%P#^-KQG^T!_P %>/\
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M ()>+M/MU-]/XE_8.\9RK:(OVFZU#1/$WAO2K<R; 'DNC;^&;*"(OF3R8[=
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M%]Y\-]7ET=]%\1:O="2^UV7PEXI\/:5K>J75_K>HZ1/KVI:CJMW>_P"";?\
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MQ"?$X\??"GXFF]:S/PZT0:,=*;11;BZU7[<-1,]H;'] _P!E/]F_P/\ L?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5\/\ _!2B#]IS4?V$OVH?#O[&G@34?B+^TWXT^%'B
M'X?_  BT#2O%'@'P9>V7B/Q_''X.F\80^)/B;XD\)^#-/?P#I&MZEXV1=4UF
M.2]ET".PT^TU'4+JVL;C[@HH _GT_P"#<3_@E5XO_P""7G[#MWH_QT\*:;X8
M_:L^//C._P#'WQQTZSUOPYXJD\*Z?HLMYH'PT^':>*O"MWJ6A:O;>'?#:W'B
M.\_LG5]8TRU\4^-O$]O8:I?6D<%P_P#07110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1152_O;?3;&]U&[<QVEA:7%[=2*C2,EO:PO/,X1 SN5CC9@B*68C"@D@
M4 6Z*\-_X:,^$_\ T';S_P $FK__ "'1_P -&?"?_H.WG_@DU?\ ^0Z /<J*
M\-_X:,^$_P#T';S_ ,$FK_\ R'1_PT9\)_\ H.WG_@DU?_Y#H ]RHKPW_AHS
MX3_]!V\_\$FK_P#R'1_PT9\)_P#H.WG_ ()-7_\ D.@#W*BO#?\ AHSX3_\
M0=O/_!)J_P#\AT?\-&?"?_H.WG_@DU?_ .0Z /<J*\-_X:,^$_\ T';S_P $
MFK__ "'1_P -&?"?_H.WG_@DU?\ ^0Z /<J*\-_X:,^$_P#T';S_ ,$FK_\
MR'1_PT9\)_\ H.WG_@DU?_Y#H ]RHKPW_AHSX3_]!V\_\$FK_P#R'1_PT9\)
M_P#H.WG_ ()-7_\ D.@#W*BO&]+^/?PRUC4].TBPUJ[EOM5OK33;*)M'U6)9
M+N^N([6VC:62U6.-7FE12\C*B [F8*":]DH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"W_!7[_A;_Q:^'7PM_X9Y_X1[_A/_%^A^%/[=_X6U_:W]D_VS?16?V_^S/\
MA6>F?;_LWF^9]E_M"R\[;L^TQ9WC]IJ_BS_8M_Y.T_9T_P"RO>"/_3W:U_:9
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5S/C7_ )$WQ;_V+.O?^FJ[
MKIJYGQK_ ,B;XM_[%G7O_35=T ?D;1110 4444 %%%% !1110 4444 %%%%
M!1110!V?PX_Y*'X#_P"QS\+_ /I\L:_66OR:^''_ "4/P'_V.?A?_P!/EC7Z
MRT %%%% !1110 4444 %%%% !1110 4444 %>!?M7?\ )KG[2?\ V0+XQ?\
MJN_$=>^UX%^U=_R:Y^TG_P!D"^,7_JN_$= '\2E%%% !1110 4444 %%%% !
M1110 4444 %%%% 'TY^Q;_R=I^SI_P!E>\$?^GNUK^TROXL_V+?^3M/V=/\
MLKW@C_T]VM?VF4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<SXU_P"1
M-\6_]BSKW_IJNZZ:N9\:_P#(F^+?^Q9U[_TU7= 'Y&T444 %%?D#_P %C_\
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M^3M/V=/^RO>"/_3W:U_:90 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!/EC7ZRT %%%% !1110 4444 %%%% !1110 4444 %>!?M7?\ )KG[2?\
MV0+XQ?\ JN_$=>^UX%^U=_R:Y^TG_P!D"^,7_JN_$= '\2E%%?$7[?W[3\'[
M+O[/VO>(],NXX_B'XP,W@[X;VWWY8]?U"UE:ZU]HPC@6OA?3EGU9I)E%M+J"
M:7ITKJ^HPA@#\1?^"L/[2>H_'#XN7_PK\$M=ZC\,?V?YI(/$>H:>C7.E7GC^
M_N(='U?4[RYMWE@2VT.YN8O!VF-=""1=7/B!(?-AOH6/[8?\$U/^3'O@%_V
MO$W_ *GWBROR!\=?LQW'P(_X);>)O&OB^TE7XJ?&KQQ\-?&?BF:_$CZIIFA2
MZTT_A7P_=2W,4=VEU'9WDVN:Q%< SQZUK5Y:3O,+"!Q^OW_!-3_DQ[X!?]@+
MQ-_ZGWBR@#[GK^<?_@JOIFJ_'#]MK]GK]GW1[E;234/#?A+0H=0\E[T:5J?Q
M(\<:E9:EJ5Q9++;F6WTK1],TK4YXEN(7F@BE4RQ *X_HXK^;?]K7]G/]LCXM
M?\%"/$GBOX3^#_&7AR"9]$L_AY\5)XKO0O"/A_2?#_@C2=*U+4%\96MM<QZ7
M*VJ2ZU-9QIOUV>YO'ETFUE\N-H0#I/\ AQ?XE_Z./T/_ ,-C?_\ S;U]7?\
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M'4AD=2592""00: /I_\ 8M_Y.T_9T_[*]X(_]/=K7]IE?Q9_L6_\G:?LZ?\
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M_"/?\)1Y']A7XO?LW]D_VYX=\W[5CRO._M./R/O^5-]RNI_9I^"W_#._P/\
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M7Q!!_8MO&P\J73_".C2A$!(/V)^W;\&/C+^T+\$)?A#\'M6\*:"_BSQ%H_\
MPG.J^*=5U?3%7P?I<QU*73],71])U2:[N[[5[?2S<07'V6UFTZVO+264B[&W
MZ3^'OPY\-_#?X;>$OA;H5HH\+^$?"FF>$;.VF!<W.GZ=IT>GR279=F::>_"R
M7%[+(S//<7$TDC,[LQ /YK/@I\%_AOXZ_P""8G[47QE\7:%HNO?%2U^(VKZG
MI_C_ %"PM[GQ?HTFC1_#J_33;?7KB.;4(8]9N]6U>;5(H9HXM2CUPK=*\L44
MJ?N=^P#XCUGQ7^QM^S]K&O->2:E_P@T>DM+?R>==3V7AS5M3\.Z5<R2[W:1+
MG2M*LIX7D<RM!)&TV)2X'YMZ]_P2W_:7T9?''P0^$WQ\\):#^R7\2?&%IXL\
M0>&]9M]0F\66?V2ZL+BVM6M%\-WTNK7&F1Z5H]O#+!XXT2TU\:7:3ZU;6\D*
M*_[4_"[X=Z#\)/ASX)^&7A=91H'@;PUI7AK3'N"&N;B#2[2.W:]NV&%>\OIE
MDO+MU 5KF>5E55(  /MG]BW_ ).T_9T_[*]X(_\ 3W:U_:97\6?[%O\ R=I^
MSI_V5[P1_P"GNUK^TR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?&
MO_(F^+?^Q9U[_P!-5W735S/C7_D3?%O_ &+.O?\ IJNZ /R-HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH [/X<?\ )0_ ?_8Y^%__ $^6-?K+7Y-?#C_D
MH?@/_L<_"_\ Z?+&OUEH **** "BBB@ HHHH **** "BBB@ HHHH *\"_:N_
MY-<_:3_[(%\8O_5=^(Z]]KP+]J[_ )-<_:3_ .R!?&+_ -5WXCH _B4HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^G/V+?\ D[3]G3_LKW@C_P!/=K7]
MIE?Q9_L6_P#)VG[.G_97O!'_ *>[6O[3* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N9\:_\B;XM_[%G7O_ $U7==-7,^-?^1-\6_\ 8LZ]_P"FJ[H
M_(VBBB@ HHHH **** "BBB@ HHHH **** "BBB@#L_AQ_P E#\!_]CGX7_\
M3Y8U^LM?DU\./^2A^ _^QS\+_P#I\L:_66@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KP+]J[_DUS]I/_L@7QB_]5WXCKWVO OVKO\ DUS]I/\ [(%\8O\
MU7?B.@#^)2BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z<_8M_P"3M/V=
M/^RO>"/_ $]VM?VF5_%G^Q;_ ,G:?LZ?]E>\$?\ I[M:_M,H **** "BBB@
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M*RB9(M2\1:M<B1I"UVRE53YO_P"(*G_@EE_T7S]O_P#\.G^SK_\ 0JT ?O\
M?\/8O^"67_22S]@#_P 3(_9U_P#GC4?\/8O^"67_ $DL_8 _\3(_9U_^>-7X
M _\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K0!^_W_#V+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/
MV=?_ )XU?@#_ ,05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\
M_P##I_LZ_P#T*M '[_?\/8O^"67_ $DL_8 _\3(_9U_^>-7/>+O^"K?_  2X
MN?"?B>VMO^"DW[ MQ<7'A[6H(((/VQ?V>)9IYI=-N8XH88H_B*SR2R.RI'&B
ML[NP5020*_"+_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^
M'3_9U_\ H5: /IG_ (>-_P#!/3_H_#]C/_Q*#X(__-Q1_P /&_\ @GI_T?A^
MQG_XE!\$?_FXKYF_X@J?^"67_1?/V_\ _P .G^SK_P#0JT?\05/_  2R_P"B
M^?M__P#AT_V=?_H5: /IG_AXW_P3T_Z/P_8S_P#$H/@C_P#-Q1_P\;_X)Z?]
M'X?L9_\ B4'P1_\ FXKYF_X@J?\ @EE_T7S]O_\ \.G^SK_]"K1_Q!4_\$LO
M^B^?M_\ _AT_V=?_ *%6@#Z9_P"'C?\ P3T_Z/P_8S_\2@^"/_S<4?\ #QO_
M ()Z?]'X?L9_^)0?!'_YN*^9O^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3
M_P $LO\ HOG[?_\ X=/]G7_Z%6@#Z9_X>-_\$]/^C\/V,_\ Q*#X(_\ S<4?
M\/&_^">G_1^'[&?_ (E!\$?_ )N*^9O^(*G_ ()9?]%\_;__ /#I_LZ__0JT
M?\05/_!++_HOG[?_ /X=/]G7_P"A5H ^F?\ AXW_ ,$]/^C\/V,__$H/@C_\
MW%'_  \;_P"">G_1^'[&?_B4'P1_^;BOF;_B"I_X)9?]%\_;_P#_  Z?[.O_
M -"K1_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H ^F?^'C?_!/3_H_#]C/_ ,2@
M^"/_ ,W%'_#QO_@GI_T?A^QG_P")0?!'_P";BOF;_B"I_P""67_1?/V__P#P
MZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5: /IG_ (>-_P#!/3_H_#]C
M/_Q*#X(__-Q1_P /&_\ @GI_T?A^QG_XE!\$?_FXKYF_X@J?^"67_1?/V_\
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M;O\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\
MZ%6@#\DO^&M/V5?^CF?V??\ P\WPY_\ FDH_X:T_95_Z.9_9]_\ #S?#G_YI
M*_6W_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5: /R2_X:T_95_Z.9_9]_\ #S?#G_YI*/\ AK3]E7_HYG]GW_P\WPY_^:2O
MUM_X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_HOG[?_P#X=/\
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M  \WPY_^:2OUM_X@J?\ @EE_T7S]O_\ \.G^SK_]"K1_Q!4_\$LO^B^?M_\
M_AT_V=?_ *%6@#\DO^&M/V5?^CF?V??_  \WPY_^:2C_ (:T_95_Z.9_9]_\
M/-\.?_FDK];?^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K1_P 05/\ P2R_Z+Y^
MW_\ ^'3_ &=?_H5: /R2_P"&M/V5?^CF?V??_#S?#G_YI*/^&M/V5?\ HYG]
MGW_P\WPY_P#FDK];?^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\
MHOG[?_\ X=/]G7_Z%6@#X;_9'_;/_8\\-_M/? ;7_$7[6'[-.@:%H_Q2\'ZA
MJ^MZU\=OA=I6D:786NL6TMS?:CJ5]XI@L[&SMXE:2>YN9HH8D4O(ZJ":_KB_
MX>Q?\$LO^DEG[ '_ (F1^SK_ //&K\ ?^(*G_@EE_P!%\_;_ /\ PZ?[.O\
M]"K1_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5: /W^_P"'L7_!++_I)9^P!_XF
M1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ_ '_B"I_P""67_1?/V__P#P
MZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5: /W^_X>Q?\$LO^DEG[ '_
M (F1^SK_ //&H_X>Q?\ !++_ *26?L ?^)D?LZ__ #QJ_ '_ (@J?^"67_1?
M/V__ /PZ?[.O_P!"K1_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H _?[_A[%_P2
MR_Z26?L ?^)D?LZ__/&H_P"'L7_!++_I)9^P!_XF1^SK_P#/&K\ ?^(*G_@E
ME_T7S]O_ /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6@#^F;X
M)?MI?L<_M+Z_JWA3]G']K+]FC]H#Q3H.CGQ#KOAKX)?'?X6_%;7]%T 7MKII
MUS5M&\">*M>U'3M'&HWUE8'4[RVALA>WEK:F?S[B&-_I>OPY_P""7'_! 3]C
MG_@DE\7OB%\:?V<?B5^TOXU\4_$GX;O\+]=L/C;XQ^%OB/0+30'\3Z#XK-YI
M-KX$^#7PVU&#6!J/AVRA%Q>:K?V7V*6ZC.GF=X;F#]QJ "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:=HFEZ9IMG]&_P#!S1%I5YJ?_!&;3OB FE-\$K[_ (*U?L\1?%;^V_L[:/\
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M>UD\07.L:Y\'7N;FXBNGN'\*7LP5=0UZ]O)/U?\ ^"G?_!+B]_X*@^(_V?/
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M?$.D>)O$5]X>NO#-UKDGBZ;3?$5S96VKV'BC3X(;:TL8GT^4Q2O, ?B!K/\
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MVG?;V,J0SM%^WM '\H7_  =9^!_"_P 3OAK_ ,$M/AMXXTO^V_!7Q"_X*?\
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M$O\  ?@?S]#\,:[<7FN7W]O_ !(\4>#_  Q%]AMI$D^S3:U'>7.=EG;W$@*
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MC/)<7+RS2.\DC,0#U2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\
M^RZ*** "BBB@ HHHH **** "BBB@#B_CCXTN/AW\+-:\96MC%?S:<L3+;R.4
M5]\R1G)'(X?/X5\^Z5^TQ\9-6TZ#4=+^ FK7]E<+OAN+:VNY(I%]598B"/<5
MZO\ MF_\FT>,/^N5M_Z50UJ?LL_\F]>"O^P8O_H1H \>_P"&B/CG_P!&[:__
M . -[_\ &J/^&B/CG_T;MK__ ( WO_QJOJRB@#Y3_P"&B/CG_P!&[:__ . -
M[_\ &J/^&B/CG_T;MK__ ( WO_QJOJRB@#Y3_P"&B/CG_P!&[:__ . -[_\
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MOI__ "D:U'_L##_TDCH ^J**** /(/VS?^3:/&'_ %RMO_2J&E_9B\0Z!:_
M'P;;W.N:9!-'IJAXY+M%93D\$$Y%=U\3?!NE_$#P-J7A#69[RWL-15%FDM'5
M95V2+(-I96 Y0=0>,UX5_P ,5?"S_H/^,_\ P,MO_D>@#Z"_X2GPS_T,6D?^
M!L?^-'_"4^&?^ABTC_P-C_QKY]_X8J^%G_0?\9_^!EM_\CT?\,5?"S_H/^,_
M_ RV_P#D>@#Z"_X2GPS_ -#%I'_@;'_C1_PE/AG_ *&+2/\ P-C_ ,:^??\
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M \2_;C_Y-H\2_P#76S_]*HJZS]FW_D@?@?\ [ MM_P"@"N3_ &X_^3:/$O\
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ML_Z#_C/_ ,#+;_Y'H_X8J^%G_0?\9_\ @9;?_(]?3-% 'S-_PQ5\+/\ H/\
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>_\  $0@
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M?PKP;3?VEOC-J=A!J&F_ +5[VSN$$D%Q;VMW)'*AZ,K+$00?44 ?6M%?*?\
MPT1\<_\ HW;7_P#P!O?_ (U1_P -$?'/_HW;7_\ P!O?_C5 'U917RG_ ,-$
M?'/_ *-VU_\ \ ;W_P"-4?\ #1'QS_Z-VU__ , ;W_XU0!]645\I_P##1'QS
M_P"C=M?_ / &]_\ C5='\"?V@/%7CSXL3^ O$O@0>&;JWLI+F9)GE6="NPJK
M1NH(R'!Y[8]: /HFBBB@#Q+]N/\ Y-H\2_\ 76S_ /2J*NL_9M_Y('X'_P"P
M+;?^@"N3_;C_ .3:/$O_ %UL_P#TJBKK/V;?^2!^!_\ L"VW_H H ]!HHHH
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MN2*1?566(@CW%>K_ +9O_)M'C#_KE;?^E4-:G[+/_)O7@K_L&+_Z$: /'O\
MAHCXY_\ 1NVO_P#@#>__ !JC_AHCXY_]&[:__P" -[_\:KZLHH ^4_\ AHCX
MY_\ 1NVO_P#@#>__ !JC_AHCXY_]&[:__P" -[_\:KZLKR;]H_XVZ+\(/#\;
MM%'J.OW@/V'3]^W('620CE4'YD\#N0 >6?\ #1'QS_Z-VU__ , ;W_XU6_\
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M_&OGW_ABKX6?]!_QG_X&6W_R/1_PQ5\+/^@_XS_\#+;_ .1Z /H+_A*?#/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA\4?M:_M,_"3Q7^S+\*+QX;&ZNO ]UXX\1>#/%OB#X@Z79ZPA\/R:EX7\,>
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MGA;4-*U_1Y+_ $?4M1TF]DT_4+=KK3+^]L)S):W4\4@!^T%?Y_\ _P %>_\
M@L?^V-XF_P""XGP3_P"":/@OQ6GPD_9E^%/[9O[&'AOQEIG@2YO;'Q3\<I/%
MWBCX,^.]1C^)'B021WC>$(%\5_V+#X"T<6.A:E!9S77B@^(FN;2WTKZ)_P"#
M:#]H?]M+]K'_ ()>_P#!4>[\:?M"_M&?'WX[:=+XU\*_ [Q#\1/C5\0?'GQ
M\-^*]5_9YU.7PGIW@#Q9XT\4W^J>$[V3QC/I]]ILVE:KI4=IK1@U(307$8N4
M_A?^-?PZ_;Z\/?MX'X:_'?4/C9<?\%"O^%J?"O13J/C3XHWWB?XY_P#"W=:M
MO!C_  BF/Q7G\7:M?_\ "40VNH>!QX7U[_A,?-T&./1TBU'3AIJ+:@'^UI^T
M3X$UOXH_L_?'7X9>&6L4\2?$7X.?$[P)X?;4[A[335UOQ=X)UOP_I+:A=10W
M,EM8K?ZA;F[N([>=X8!)(D,K*$;^5W_@W#_X(4_MI_\ !*']HWX__%3]IS6_
M@9JWACXG_!.Q^'_AU/A1XY\3>*M4AUZT\=Z#XCD;5+37O ?A&*VL'T_3[D1W
M%O<W<AN D3P(KB2O=O\ @CWX(_X*@? +_@D;^WTW_!2#Q3^TG:_M(Z?JO[17
MC+X6^)/CE\;M;^*GQ)T+P#8_LS>"CX7U#PCXYD\=^--3\.Z;IGCS2?%E_I%C
M8:YI\VF:\FH:Q;VEO<7HO+C\@O\ @S^_;-_;!_:8_:\_:K\-?M(?M7?M*?M
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MVN6UEJ=JS6VH6L-\D%Y;L8;F.2,E: /Z%Z*_RYOV(OVE/^"ZG_!8S]EO0_\
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M^-OQ#_:Y_P"%7?$V^\">$]3^ .L_#KP7JUHGQ;T.R\6>'K7XA>$Y-'/B1O\
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M_P#LL?MP?#AYMUEX4_: ^'OC>WM_F_=77Q ^'4V@W<W7;^_B^&=DG #?Z/\
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M\FA_MI_]G(>#_P#U6.GU^!W_  4^_P"5LB3_ +/Y_8&_],W[--?OC_P9%?\
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M3_X+Q-XC_P""EMYX(.DZ#\9OVC-,\3>./BI'9Q?#GPC^T6FK^*X-)\>>.?\
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MAX*\(:;X9&A0?"#QN&LM$MO!\E[;W1UL"6ZUN_(L;=B\D_\ 5=^W-^R]XO\
MVJ_^#3#]G+PK\/M(N-?\<?#']@']A#X]:!HEG;7EY?ZG:_";X/\ PRUWQG:Z
M;9V$%S=WNJ'X=/XPDTRR@MY9+V_CMK10C3B1/RA_X-)_^"O?[*'[+?P7^.?[
M%7[67QF\)? AM0^*]S\=?A)X]^*?B*V\,_#S5K?Q-X4\)>#_ !IX(E\5ZQ+;
MZ!X6U/2;SP9H_B33+35KVQM]>'B/7I;.0W>FW$=P ?SJ_P#!:3_@K+9?\%@/
MCW\,/C_-^S7IG[.OB?P!\*(_A/J]OIWQ-E^)K>,=*T_Q9XA\5Z%?7=_+\/O
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M$OQ,\)_#OQ1XD\(>*=0UKX2:SX6T'QI#J'@K6H==TJ&SU'QCX,\>Z''9W%W
MD>H1S>'+B>6V+);7%I*1,."_X)??\$O/@#_P29^ OC#]G?\ 9S\7_&#QIX*\
M;?%W7/C1JNJ?&O7_  7XC\4V_BGQ!X,\!>![RPT^]\"_#_X<:3%H$6D_#O1;
MBUM;G1+O44U&ZU2:759K:>TM+'](:* /Y1O^"B/_  :6?L8_MM_'OQK^T;\-
M/C!\0?V5?'/Q0UV;Q7\2?#OA3PMH'C[X:^(?%^JZK<:IXK\7Z9X7U74?#>J^
M&O$'BV:[GN=733O%#^'/[78ZQ;^'8KBYU*/4/2OAU_P:@?\ !,?P7^R%X^_9
M:UB7XO>)/%/Q3UKP;KOC7]I^+5O UA\=K2;P1KZ:_I>A_#VZUGP)XK\$^ ?"
M-VWVG2]:T:R\(ZC?:[IEY)_;>M:EJ5EH^I:9_3?10!^9W_!/W_@EC\#O^"<?
M[*7CW]CGX-_$WX]^//A+X]\1^.?$CW/QE\3^ ?$7BOPG-\0_#&D^&/$>E^#]
M0\&_#+P#H^GZ+(-*.O6MEJ6@ZN\/B+4]7OY+B:"]-G'\F_\ !,/_ (-X_P!B
MS_@D]^T!XG_:/_9U^)_[4/C/QQXL^$OB'X-:CI7QI\:?"CQ%X4A\,>)/%O@7
MQE?7]E8^!O@I\.=7CUZ+5/A_HT%I=3ZY<Z?'87.IQ3:7/<36MU9?O'10!QOQ
M&\#Z3\3OA[X[^&VO7&HVFA?$+P;XH\#ZU=Z1-;6^K6ND^+-$OM!U&XTN>]M-
M0LX=1AL]0FDLIKNPO;:.Y6)Y[2YB5X7_ !M_X)<?\$!OV.O^"27Q;^(?QF_9
MP^)/[2_C7Q1\2_AR?ACKMA\;?&/PM\2:#::"?$VA^*OM>DVO@3X-_#;4(-7_
M +1T"SA^T7FJ7]E]BEN8_P"S_/>*XA_<2B@#\G/^"J?_  1S_9D_X*]^&_@W
MX7_:4\=?';P1I_P/UOQCK_A.;X'>)_A_X:O-0O/&]AH&G:K%XAD\>_##XEP7
M=M;P>'+%M/33;?298I9;IKF:[1X4@^T/V/OV6_A_^Q1^S-\'?V5?A7K'C'7_
M (>_!'PE'X-\*:S\0-0T35?&>H:9%?WVHK/XAU'PYX>\*:'=WYGOYE:73?#N
MDVYB6)1:AU=W^DZ* /Y^OA=_P;??L/?"7_@HI=_\%-/#GQ4_:LO?CQ>?'OXI
M?M%2^$M;\<?"*Y^$:^-OBYJ?B_5?$FEQZ#8? S3?&0\+65QXUU5-$LF\>MJU
MM#;Z>M_K>I217,EW]7_\%5O^"/\ ^RM_P5P^%OA;P+\?X_$WA/QK\-[[4=1^
M%/QE^'UQI]IX[\"/KDFEGQ)I$<>KV.I:+K_A;Q/%HVFQ:YH&L6$R&2RM-1TF
M[TC5[6#4(_U6HH _D8_8D_X,^?V&OV9/C'HOQ@^.7Q;^('[71\'ZTNN>#OAM
MXO\ "7A[P'\,%OK.^CO-%N/'7A_3-2\2ZEX];2C#"7TRYUS2/"NL3"7^V_#-
M_I\HTV/[M_9(_P"#<O\ 8E_8F_;F?]OCX#?%7]JK0_B3)XE^*NNO\,K[QK\(
M)/@@=*^+=KXBM=:\"GPOI7P,T?Q:?!.@CQ D_A/33X[.HZ9=^'_#ES>:OJ<F
MGS&[_?JB@#XU_;J_8(_9D_X*-_ ;5_V>/VIO @\8>";V^AUS0-6TV\;1?&G@
M#Q=9P7-MIOC/P'XEABFN-"\0V$%W=6Q9X;S2M5T^ZO-&U_2]7T6^O=.N/Y2X
MO^#(7]EH>,[F^F_;B^/TGP]8M]D\+Q?#KX=P^,X%,S,HN?';W,^B71%N4B9H
MOAS9AIE:<*J,+=/[?J* /BS]@S_@G]^S%_P3<^ VF?L\_LL>!V\*>#H-1N/$
M/B77-7O3K?CCXA^,+Z"VMM0\9>/?$LD,$VMZ[=6UG:64"Q6]CI&C:79V6B^'
M]*TG1[*TL(?E'_@JE_P1)_8R_P""M6@^'I_CKIGB7P)\7_!%@^E>!_CQ\+[G
M2],\?Z3H<EY]OE\+:Y%J^F:MH?C'PD]VUQ<0Z/KNGRW.CSWNI7/AG5-!NM3U
M&>Z_8&B@#^*WX(_\&4/['/@OQ[8>(OCC^U;\;/CAX*T[5EOO^%=:'X2\.?"*
MWUO3HXALT3Q)XHT[7/%^OS6TUP"U[>>&)/"6HR6Q%O97.GSC[:?[&_AK\-O
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M^,G_  4$\:+!+_9VC?#/X#>%Y;GRV\D7OB7Q3\1M5@@$N-IE,'A.XD,8)8(
MS  KGXXOO^#<'_@XV_:/33/A;^T!\1KV?X:Z-JEC'I;?'K]M>_\ B9\.M*BM
M81';ZSI'A/0?$GQ.U2TBT^%WM[9(O"5GJ,95HX+58&$I_NB_X(U?\$G_ (<_
M\$C?V4Q\#_#?B3_A8GQ-\=>(5\?_ !Q^*3:?)I<7B_QL^EVFE6VG:!IDT]S/
MI7@OPIIUJ--\-:?/.]S*\^JZ[?"+4M<O8HP#YI_:"_X-P/V'_P!I+_@H/-_P
M4F\<_%3]JS2OCG-\5?@_\7V\*>%/''PBL?A./$OP4T[P+IGA6Q70M8^!NN^,
M!H>H6_P^T9_$%L?'1O[J:ZU-M.U/2DFM([+]C/VH/V>O!?[6?[.OQJ_9E^(V
MI^*-%\!_';X;^*_A=XNU;P5>Z3IWB[3O#_C#2KC1]3O/#E_KNB^)-&L]8@MK
MF22QN-3T#6+**<(UQI]U&&B;W>B@#\<_^"5'_!$3]E+_ () :E\;]4_9J^('
M[0GCBX^/EC\/M/\ &"?'+Q7\-_$L.FP_#:X\97&AMX:7P#\)_AF]G+=OXXU8
M:LVJ2:RDZ6^G"S2P,5RUWC?\%4/^"%/[)'_!7?QE\(_''[27Q$_:,\$:M\&?
M#/B3PIX7M_@?XN^&?AO3K_3O%.JZ?J^H3:_%X]^$7Q+N;J]AN=-@2SDTZ[TN
M".!Y5GMKB1DEC_:6B@#QK]GSX&^$/V;OV??@G^S9X*O-=UOP%\!_@]\.O@EX
M3U#QE<:9J7B;5_"7PR\&:/X&T.[\4W6DZ1H6C7^N7^CZ+:S:W<:;H6CZ9=7\
MMS)9Z386KQVD7\P/[</_  9]?L+?M.?%'Q/\6_@+\5_B#^R!J_C/4+K6=?\
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MO\6Y?"^H?V[JGQRUGP=_PD-^W@+1QK]W_P ('_9MTMSJ0T[2=+,UJ;/^UJ@
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M5>MI.N:=?0Q79N()RT7EN >ST5_/[_P;[?\ !9G6?^"O'[/7Q,U7XQ:!\./
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MOEW_ (/6/^47?[/O_9_'PT_]9Y_:@KZB_P"#2/\ Y0O?"3_LLGQ^_P#5@WM
M'\E?_!MW_P K%^J?]?W[:?\ Z:_&E?V"_P#!>#]N/_@DG^QYX@_9GL_^"F_[
M%6N_M;ZKX_T?XK7/P=O-'^"?P5^+J^!=/\-WO@"+QQ;3R_%SXE^ )=!;Q#<Z
MWX6ECCT&+5(]2&C,VI26C6-BMQ_'U_P;=_\ *Q?JG_7]^VG_ .FOQI7Z&_\
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M2K\V!GK@=* -*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_,4_X.)+=_#'_!RG\#
M/$&JR-/IM]JW["OB:"*8@11:5IOB[1M)NH$( (A>[T#49GR2?,GFY P!_IUU
M_G"_\'J7P7U7X>?MB_L7_M:>&4U;3+KQ]\'-:^',NOV44BV>G>+_ ($^/6\8
M:#>K>K$8[;7)]/\ BM";9)9A)<6OAU)+:(K8W3C_ $+/@G\2-)^,?P:^$OQ=
MT&]M-2T/XI?#/P)\1='U"QECGLK[3/&WA?2_$EC=VDT1:*6VN+;4HI87C8HT
M;*5)!% '^7A_P33_ .5LU_\ M(/^WK_Z1_M)5^J?_!\S_P A+_@F+_UX_MD_
M^E'[+5?+'_!/C]A']N#P7_P<YM\?/&/[&O[5GA/X%']N;]M;Q</C3XF_9X^+
MN@_"7_A%/%5I^T OA?Q/_P +&U3PA:^#O^$>\2-K.CKH&M?VS_9NL-JVFC3K
MFY-]:^;^E'_!Y-^R9^U3^U!J'_!.U_V:?V9_V@?VAT\$V?[6"^,W^!GP9^(W
MQ:7PBWB.?]F\^'E\3MX!\-^(!H#:\-"ULZ,-5-H=4&CZJ;$3C3[OR0#^B[_@
MABBI_P $@/\ @G8%  /[+GPV<@?WI--9V/U+,2?4G)YK_/\ ?^"E(Q_P=FQX
M_P"DA/[!9_.U_9M)_6O]"_\ X(V^ _''PO\ ^"6/[!WP]^)?@SQ7\._'W@_]
MF_X>Z%XM\#^.O#NK^$O&'A?6[+3?+O-'\1>&=?L]/UK1-5M'^2ZT_4[*UNX'
M^66%#Q7\/G_!03]A']N#QI_P<Z)\?/!W[&O[5GBSX%#]NC]BGQ<?C5X:_9X^
M+NN_"4>%/"MM^S^OBCQ.?B/I?A"Z\'?\(]X;;1M877]:_MG^S='.E:D-1N;<
MV-UY0!_I8T444 ?Y07_!OG\2M ^&_P#P<8>#X_$4D%M:_$+XE_M:_#73[ZX:
MV2*TU_Q)X8^)ESX?C$EQ)&4GU?6-*L_#UHMN6N9[S6(+6.-UG<5_I'_\%1/B
M1X?^$?\ P3>_;O\ B'XGD@72?#_[)7Q]_<7,D4<>I:IJWPS\2:'X?T1&F98C
M<:]K^IZ9HMI&S?O;J_AB +. ?\R/X%?\$0O^"GW[0?[9/[2>K^#OV?/VGOV:
M/'7PVNOBW^T/^SS\4_B=\$OBE\)?!'C'XI^ ?B[H.M^!O"/ASXK^+_#_ (<\
M-Z%XG\3:=?ZEKO@+6X=7D3^V=%T^[8Q:0+_4[+:_;I_X*)?\%^/V]?"VB_\
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M\2WU]-I6E">6+0]#CTO0[=VMM-B) /\ .I_X-GT5_P#@X7U1F4$QV?[8KH2
M2K&S\1QEAGH=DCKD8.&(Z$@_V6_\'3(!_P""&'[:.>U_^S41['_AK#X'#^1(
M_&OY?/\ @WI_88_;:^"O_!=/5/B[\9/V._VI_A+\*)+/]JM8_B=\3/V?/BUX
M#^'CMXBM]<7P^J>-/%/A'2O#;-KIFB&C!=2)U,RQBR$Y=<_UB_\ !R-\)/BM
M\<_^"-/[7'PO^"7PR^(7QB^)GB2\_9\;P[\._A9X+\2?$'QUKZZ+^TW\'-?U
MAM%\(^$M-U?7]572="TO4]:U,V.GSBPTG3K[4;HQ6=I<31@'XW_\&2DD</[$
MG[8TTLB111?M1:5)++(RI''&GPD\)L\DCL0J(B@LS,0JJ"20 37JO_!4?_@W
MN_X)P_\ !4#]HWQWXL_9=_:S^%WP!_;M\2:1J/Q*^)OPY\'^)O!7Q.\/^/+6
MSU/1]'UOXC^-O@YHOBC3_&W@O4+W5M6TG3M>\>>'[FWT6^US5HM0UOPSK7B3
M4[F^N[7_  :)?LK_ ![^ 7[%_P"UYX _:F_9U^,?P/OO'/[05M<V?@_X\_"?
MQQ\+M1\5^$[OX4^'-%U&\L-$\?:#H-YK&A33+>:7<WEI;SV1G2XM'E$J2(/Y
MQOVB?^"</_!5+_@WF_X*":G^U%^PU\._''Q0^!]OK/B2U^$_Q.\)>!-<^*OA
M#6/A;XQ\V_NO@U\>_!_A^ZU'Q)I<VBVMK::7J6IZO-H]GK^I:#I'C/PCXALM
M:6*WT0 _/;_@HE_P0N_X*.?\$BM.\/\ QU^*=GX6U/X96'CG2M'\,_M!_ +X
M@7U_8^&?&CS7.H>$GO(;ZP\'?$;P9K%V=+DN](UE_#T6E6VJ6\5C!X@_M26P
MBN?]$G_@VQ_;W^)__!0;_@F'X*^(/QN\1/XQ^,7P=^(WC+]GSQ_XTNC(=6\8
MW7@O3/"WBCPQXC\0,XQ<>([SP)XZ\*V^O:DCR?VSJUG>:S,8KK4+BWA_B5_:
MB_X*1?\ !<C_ (. O#?A+]C#3/V5-,/A";QWI.M:WX;_ &?_ (+_ !(\&^'M
M4\5>&;>_AM+OXK_$?XI>.?&.A^%- \/WS:CJ/DZGXB\):/:ZG%:IJ+W]_96
M']_7_!%#_@G1=?\ !+W_ ()]_"O]F;Q+J>CZY\5+G4=>^*/QMUGP\S3:%=_%
M3QTUD^KV&C7DMK9W&IZ7X4T/2_#O@K3]8N;:WGUBU\-1:HUK9)>)96P!_$1_
MP>NZ]8W?_!2']FSPW#:A=0T3]B?PKJE[?_+^_@U_XY?'2"RL3ABV;$Z%=W."
MBKC4QM9B6"?Z4?PQTZ?1_AK\/=(N7>2YTKP/X3TZXDD.9'GL=!T^UE>0]W:2
M)F8]V)K_ #>/^"WNBP_MX_\ !T;\!?V7-&TP^+=/\+>)?V.O@!XPTWRTFLSX
M5-_;?&WXH/*LN(I].\/>#?B1XDO-:1=^P:9J=ML>>)HC_I? !0%4 *
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_"HT/_Y.H [.BN,_X6/\//\ H?/!G_A4:'_\G4?\+'^'G_0^>#/_  J-#_\
MDZ@#LZ*XS_A8_P //^A\\&?^%1H?_P G4?\ "Q_AY_T/G@S_ ,*C0_\ Y.H
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M%Q_\QI\'_P#YW]'_  ] _;G_ .BX_P#F-/@__P#._KX%HH ^^O\ AZ!^W/\
M]%Q_\QI\'_\ YW]'_#T#]N?_ *+C_P"8T^#_ /\ ._KX%HH _6_]F+_@H=^V
M'\0_VA_@OX%\8_%_^V/"OBSXC^%M!\0:7_P@'PNT_P#M#2=2U6WMKVT^W:7X
M)LM1M?.A=D\^RO+:YCSNBFC<!A_3S7\6?[%O_)VG[.G_ &5[P1_Z>[6O[3*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_\ (F^+?^Q9U[_TU7==
M-7,^-?\ D3?%O_8LZ]_Z:KN@#\C:*** "BBB@ HHHH **** "BBB@ HHHH *
M*** .S^''_)0_ ?_ &.?A?\ ]/EC7ZRU^37PX_Y*'X#_ .QS\+_^GRQK]9:
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_@C1\ /VP/V4O^";?[64_C+Q=\&/B=\-?AW8:MJ>I?"W2/"MK?\ C[Q#X/\
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M-T =G\./^2A^ _\ L<_"_P#Z?+&OUEK\FOAQ_P E#\!_]CGX7_\ 3Y8U^LM
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M2?$GBOX'>(Y%O)=#UKPEJ/VN]N_"FDWRZ1/>W!MO$7AVVN=>T[6(/TW^(?\
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M]V5>W?MB?\%BOAQ^Q[^VG\'?V+/$?P:\;>,O%/QCM_A5<:3XTT3Q!H6GZ!I
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MWKO]@?VA_P )QXN_X2S/_"?_ &7^U/L/AK']D^?_ &<?M_DV7[IT =G\./\
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M_P#!$?X+Z7XMAU3Q)\6?'OBGPC;SPSCPDNEZ1H5[>K$^Z2TU/Q-93SRR6EP
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M;_R=I^SI_P!E>\$?^GNUK^TROXL_V+?^3M/V=/\ LKW@C_T]VM?VF4 %%%%
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MY$C2%KME*JGS?_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H _?[_A[%_P $LO\
MI)9^P!_XF1^SK_\ /&H_X>Q?\$LO^DEG[ '_ (F1^SK_ //&K\ ?^(*G_@EE
M_P!%\_;_ /\ PZ?[.O\ ]"K1_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5: /W^
M_P"'L7_!++_I)9^P!_XF1^SK_P#/&H_X>Q?\$LO^DEG[ '_B9'[.O_SQJ_ '
M_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:
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MW_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M 'V-X!_X*2?\
M!.RS\=>"KR\_;W_8MM;2U\6^'+FZNKG]J7X&P6]M;P:Q9RSW%Q/+XZ2*&&&)
M6DEED98XT5G=@H)'Z<?\/8O^"67_ $DL_8 _\3(_9U_^>-7X _\ $%3_ ,$L
MO^B^?M__ /AT_P!G7_Z%6C_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K0!^_W_#V
M+_@EE_TDL_8 _P#$R/V=?_GC4?\ #V+_ ()9?])+/V /_$R/V=?_ )XU?@#_
M ,05/_!++_HOG[?_ /X=/]G7_P"A5H_X@J?^"67_ $7S]O\ _P##I_LZ_P#T
M*M '[_?\/8O^"67_ $DL_8 _\3(_9U_^>-1_P]B_X)9?])+/V /_ !,C]G7_
M .>-7X _\05/_!++_HOG[?\ _P"'3_9U_P#H5:/^(*G_ ()9?]%\_;__ /#I
M_LZ__0JT ?O]_P /8O\ @EE_TDL_8 _\3(_9U_\ GC4?\/8O^"67_22S]@#_
M ,3(_9U_^>-7X _\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M '[_ '_#V+_@EE_TDL_8 _\ $R/V=?\ YXU'_#V+_@EE
M_P!)+/V /_$R/V=?_GC5^ /_ !!4_P#!++_HOG[?_P#X=/\ 9U_^A5H_X@J?
M^"67_1?/V_\ _P .G^SK_P#0JT ?O]_P]B_X)9?])+/V /\ Q,C]G7_YXU'_
M  ]B_P""67_22S]@#_Q,C]G7_P">-7X _P#$%3_P2R_Z+Y^W_P#^'3_9U_\
MH5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K0!^_W_#V+_@EE_P!)+/V /_$R
M/V=?_GC4?\/8O^"67_22S]@#_P 3(_9U_P#GC5^ /_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M '[_?\ #V+_ ()9?])+
M/V /_$R/V=?_ )XU>)?M,?\ !4S_ ()C:]^SA^T#H>A_\%&OV$-:UO6O@E\5
MM)T?1])_:\_9]U'5-6U34? FO6>GZ;INGV?Q"FN[_4+^[FAM;.SM89;FZN98
MX((WE=5/XW?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M 'Y)?\-:?LJ_]',_L^_^'F^'/_S24?\ #6G[*O\ T<S^S[_X
M>;X<_P#S25^MO_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V_
M_P#PZ?[.O_T*M 'Y)?\ #6G[*O\ T<S^S[_X>;X<_P#S24?\-:?LJ_\ 1S/[
M/O\ X>;X<_\ S25^MO\ Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JT ?DE_PUI^RK_P!',_L^_P#AYOAS_P#-)1_PUI^R
MK_T<S^S[_P"'F^'/_P TE?K;_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*
MG_@EE_T7S]O_ /\ #I_LZ_\ T*M 'Y)?\-:?LJ_]',_L^_\ AYOAS_\ -)1_
MPUI^RK_T<S^S[_X>;X<__-)7ZV_\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M 'Y)?\-:?LJ_]',_L^_^'F^'/_S24?\
M#6G[*O\ T<S^S[_X>;X<_P#S25^MO_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y)?\ #6G[*O\ T<S^S[_X>;X<_P#S
M24?\-:?LJ_\ 1S/[/O\ X>;X<_\ S25^MO\ Q!4_\$LO^B^?M_\ _AT_V=?_
M *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JT ?DE_PUI^RK_P!',_L^_P#A
MYOAS_P#-)1_PUI^RK_T<S^S[_P"'F^'/_P TE?K;_P 05/\ P2R_Z+Y^W_\
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MO#IU]#X=USPA\.&B?4AJ"W>B>(O&.BR6<>GZK>+?_P!8H 4!5 "@      #
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M^%?[9OP'\5_\)A\//@E!H?C#Q_X(^*/[._AKPQHVL_$&^L]/^&/[57CO7_\
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MQ-XBOO#UUX9NM<D\73:;XBN;*VU>P\4:?!#;6EC$^GRF*5Y@#\0-9_X+._\
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M$9:.>TO;.>&YMIHR4EAE1U)5@:^*/^"GWPJT[XW_ /!.7]N?X6:G%!+'XO\
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M;=-N+S3KS['J-G<6_P!JL+NZLKCR_-M;B>!XY6]CH _F3OO^5M;1O^T-\O\
MZT)JM?L'_P %'?V"O@K_ ,%)_P!DWX@_LI_'.YO]%\.>+Y=(UCPUXVT06/\
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M()_D'_X+[?LE?\%C_P!J+]OW]DGXB_L?_L=> ?VF_P!F#]D+0M*^)/A+P?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /_9"F5N9'-T<F5A;0IE;F1O8FH*,3,Q(# @;V)J"CP\+U1Y<&4@
M+UA/8FIE8W0*+U-U8G1Y<&4@+TEM86=E"B]7:61T:" V-PHO2&5I9VAT(#DT
M"B]#;VQO<E-P86-E("]$979I8V521T(*+T)I='-097)#;VUP;VYE;G0@. HO
M1FEL=&5R("]$0U1$96-O9&4*+TQE;F=T:" Q-3,P/CX*<W1R96%M"O_8_^
M$$I&248  0$   $  0  _]L 0P % P0$! ,%! 0$!04%!@<," <'!P</"PL)
M#!$/$A(1#Q$1$Q8<%Q,4&A41$1@A&!H='1\?'Q,7(B0B'B0<'A\>_]L 0P$%
M!04'!@<." @.'A01%!X>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>_\  $0@ 7@!# P$B  (1 0,1 ?_$ !\   $%
M 0$! 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !
M?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:
M)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M'QS_ .C=M?\ _ &]_P#C5?5E% 'RG_PT1\<_^C=M?_\  &]_^-4?\-$?'/\
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M;V1E"B],96YG=&@@,34S,#X^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $
M /_; $, !0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3
M%!H5$1$8(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'O_  !$( %X 0P,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M5[VSN$$D%Q;VMW)'*AZ,K+$00?45Z1^W'_R;1XE_ZZV?_I5%76?LV_\ ) _
M_P#V!;;_ - % 'BG_#1'QS_Z-VU__P  ;W_XU1_PT1\<_P#HW;7_ /P!O?\
MXU7U910!\I_\-$?'/_HW;7__  !O?_C5'_#1'QS_ .C=M?\ _ &]_P#C5?5E
M% 'RG_PT1\<_^C=M?_\  &]_^-5T?P)_: \5>//BQ/X"\2^!!X9NK>RDN9DF
M>59T*["JM&Z@C(<'GMCUKZ)KY1\#_P#*1;QE_P!@H?\ I-:T ?5U%%% 'B7[
M<?\ R;1XE_ZZV?\ Z515UG[-O_) _ __ &!;;_T 5R?[<?\ R;1XE_ZZV?\
MZ515UG[-O_) _ __ &!;;_T 4 >@T444 %%%% !7RCX'_P"4BWC+_L%#_P!)
MK6OJZOE'P/\ \I%O&7_8*'_I-:T ?5U%%% 'B7[<?_)M'B7_ *ZV?_I5%76?
MLV_\D#\#_P#8%MO_ $ 5R?[<?_)M'B7_ *ZV?_I5%76?LV_\D#\#_P#8%MO_
M $ 4 >@T444 %%%% !7RCX'_ .4BWC+_ +!0_P#2:UKZNKY1\#_\I%O&7_8*
M'_I-:T ?5U%%% 'B7[<?_)M'B7_KK9_^E45;'[.WB+P_;? KP5!<:[I<,T>C
M6ZO')=QJRG8.""<@UUGQ5\#:3\1_ U]X0URXOK>PO6B:22S=4E'ER+(,%E8=
M5&>#Q7A__#%7PL_Z#_C/_P #+;_Y'H ^@O\ A*?#/_0Q:1_X&Q_XT?\ "4^&
M?^ABTC_P-C_QKY]_X8J^%G_0?\9_^!EM_P#(]'_#%7PL_P"@_P",_P#P,MO_
M )'H ^@O^$I\,_\ 0Q:1_P"!L?\ C1_PE/AG_H8M(_\  V/_ !KY]_X8J^%G
M_0?\9_\ @9;?_(]'_#%7PL_Z#_C/_P #+;_Y'H ^@O\ A*?#/_0Q:1_X&Q_X
MU\Q?#NZMKS_@H;XON;.XAN('TKY)(G#JV+>U!P1P>16W_P ,5?"S_H/^,_\
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M_P"C=M?_ / &]_\ C5'_  T1\<_^C=M?_P# &]_^-4 ?5E%?*?\ PT1\<_\
MHW;7_P#P!O?_ (U1_P -$?'/_HW;7_\ P!O?_C5 'U917RG_ ,-$?'/_ *-V
MU_\ \ ;W_P"-5T?P)_: \5>//BQ/X"\2^!!X9NK>RDN9DF>59T*["JM&Z@C(
M<'GMCUH ^B:*** /$OVX_P#DVCQ+_P!=;/\ ]*HJZS]FW_D@?@?_ + MM_Z
M*Y/]N/\ Y-H\2_\ 76S_ /2J*NL_9M_Y('X'_P"P+;?^@"@#T&BBB@ HHHH
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M_C/_ ,#+;_Y'H_X8J^%G_0?\9_\ @9;?_(]?3-% 'S-_PQ5\+/\ H/\ C/\
M\#+;_P"1Z/\ ABKX6?\ 0?\ &?\ X&6W_P CU],T4 ?,W_#%7PL_Z#_C/_P,
MMO\ Y'KM/@Y^SCX(^%GB\^)_#^J^(KJ\-L]MLOKB%X]KE23A(E.?E'>O9:*
M"BBB@ HHHH **** "BBB@ HHHH **** /__9"F5N9'-T<F5A;0IE;F1O8FH*
M,3,T(# @;V)J"CP\+U1Y<&4@+UA/8FIE8W0*+U-U8G1Y<&4@+TEM86=E"B]7
M:61T:" V-PHO2&5I9VAT(#@U"B]#;VQO<E-P86-E("]$979I8V521T(*+T)I
M='-097)#;VUP;VYE;G0@. HO1FEL=&5R("]$0U1$96-O9&4*+TQE;F=T:" Q
M-30U/CX*<W1R96%M"O_8_^  $$I&248  0$   $  0  _]L 0P % P0$! ,%
M! 0$!04%!@<," <'!P</"PL)#!$/$A(1#Q$1$Q8<%Q,4&A41$1@A&!H='1\?
M'Q,7(B0B'B0<'A\>_]L 0P$%!04'!@<." @.'A01%!X>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>_\  $0@ 50!#
M P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$
M +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"
ML<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JR
ML[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY
M^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$
M P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)R
MT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BY
MNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "
M$0,1 #\ ^RZ*X/X^>/+GX:?"S5/&5II\6H363P*+>60HK^9*D9Y )&-V?PKP
M;3?VEOC-J=A!J&F_ +5[VSN$$D%Q;VMW)'*AZ,K+$00?44 ?6M%?*?\ PT1\
M<_\ HW;7_P#P!O?_ (U1_P -$?'/_HW;7_\ P!O?_C5 'U917RG_ ,-$?'/_
M *-VU_\ \ ;W_P"-4?\ #1'QS_Z-VU__ , ;W_XU0!]645\I_P##1'QS_P"C
M=M?_ / &]_\ C5='\"?V@/%7CSXL3^ O$O@0>&;JWLI+F9)GE6="NPJK1NH(
MR'!Y[8]: /HFBBB@#Q+]N/\ Y-H\2_\ 76S_ /2J*NL_9M_Y('X'_P"P+;?^
M@"N3_;C_ .3:/$O_ %UL_P#TJBKK/V;?^2!^!_\ L"VW_H H ]!HHHH ****
M "OE'P/_ ,I%O&7_ &"A_P"DUK7U=7RCX'_Y2+>,O^P4/_2:UH ^KJ*** /$
MOVX_^3:/$O\ UUL__2J*NL_9M_Y('X'_ .P+;?\ H KD_P!N/_DVCQ+_ -=;
M/_TJBKK/V;?^2!^!_P#L"VW_ * * /0:*** "BBB@ KY1\#_ /*1;QE_V"A_
MZ36M?5U?*/@?_E(MXR_[!0_])K6@#ZNHHHH \2_;C_Y-H\2_]=;/_P!*HJZS
M]FW_ )('X'_[ MM_Z *Y/]N/_DVCQ+_UUL__ $JBK8_9V\1>'[;X%>"H+C7=
M+AFCT:W5XY+N-64[!P03D&@#U6BLC_A*?#/_ $,6D?\ @;'_ (T?\)3X9_Z&
M+2/_  -C_P : ->BLC_A*?#/_0Q:1_X&Q_XT?\)3X9_Z&+2/_ V/_&@#7KY1
M\#_\I%O&7_8*'_I-:U]+_P#"4^&?^ABTC_P-C_QKYB^'=U;7G_!0WQ?<V=Q#
M<0/I7R21.'5L6]J#@C@\B@#ZTHHHH Y;XJ^!M)^(_@:^\(:Y<7UO87K1-))9
MNJ2CRY%D&"RL.JC/!XKP_P#X8J^%G_0?\9_^!EM_\CU],T4 ?,W_  Q5\+/^
M@_XS_P# RV_^1Z/^&*OA9_T'_&?_ (&6W_R/7TS10!\S?\,5?"S_ *#_ (S_
M / RV_\ D>C_ (8J^%G_ $'_ !G_ .!EM_\ (]?3-% 'S-_PQ5\+/^@_XS_\
M#+;_ .1Z[3X.?LX^"/A9XO/B?P_JOB*ZO#;/;;+ZXA>/:Y4DX2)3GY1WKV6B
M@ HHHH **** "BBB@ HHHH **** "BBB@#__V0IE;F1S=')E86T*96YD;V)J
M"C$S-2 P(&]B:@H\/"]4>7!E("]83V)J96-T"B]3=6)T>7!E("]);6%G90HO
M5VED=&@@-C<*+TAE:6=H=" Y- HO0V]L;W)3<&%C92 O1&5V:6-E4D=""B]"
M:71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],96YG=&@@
M,C S-CX^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $, !0,$! 0#
M!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:'1T?
M'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$( %X
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /LNBBB@ HHHH **** "BBB@ HHHH XOXX^-+CX=_"S6O&5K8Q7\
MVG+$RV\CE%??,D9R1R.'S^%?/NE?M,?&35M.@U'2_@)JU_97"[X;BVMKN2*1
M?566(@CW%>K_ +9O_)M'C#_KE;?^E4-:G[+/_)O7@K_L&+_Z$: /'O\ AHCX
MY_\ 1NVO_P#@#>__ !JC_AHCXY_]&[:__P" -[_\:KZLHH ^4_\ AHCXY_\
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MCZ19Q6=A9Q+#;P1+A8T48 %?,FG_ /*1K4?^P,/_ $DCKZHKY7T__E(UJ/\
MV!A_Z21T ?5%%%% 'D'[9O\ R;1XP_ZY6W_I5#53X,^,- \"?LH>%/$OB6]%
MIIUMID89@I9G8L0J*HY+$]!5O]LW_DVCQA_URMO_ $JAK+^%?@C1OB)^R%X:
M\)ZZC?9;S24VRI]^"0,2DB^ZGGT/(/!H N?!W]I+X>?$SQ ?#^GG4-(U1\FU
MM]2C1/M( R0C(S#<!SM)!],X-2?M>?$H_#CX1W<EC<>5K>KDV.G8/S(6'SRC
M_<7.#_>*U^?7Q(\'^)?A3\1)M#U%WMM1T^59[2[A)42)G,<T9ZC./P((ZBN@
M^*_Q'\5?'+Q;X:MKFU4WL5M!IMM;Q'Y9;AR \@'\)=R..P44 >S?\$]_A@-2
MUR[^)FK6^;73F:UTH.O#SD?O)!GJ%4[0?5CW6ON*N8^%?@^R\!?#W1?"5@%,
M>GVRQNX&/-E/,CGW9RQ_&NGH *^5]/\ ^4C6H_\ 8&'_ *21U]45\KZ?_P I
M&M1_[ P_])(Z /JBBBB@#R#]LW_DVCQA_P!<K;_TJAI?V8O$.@6OP!\&V]SK
MFF031Z:H>.2[164Y/!!.17=?$WP;I?Q \#:EX0UF>\M[#4519I+1U65=DBR#
M:65@.4'4'C->%?\ #%7PL_Z#_C/_ ,#+;_Y'H Z7]ICX>>"?C#X<M8H_%NA:
M9KFGONL[Y[F-QL/WXG ;)4\'V(]R#YW^SS^S]X=^'OQ MO%_B/XA^'-6EL$8
MV5O;3JJK*P*^8Q9N< G QU(/:M__ (8J^%G_ $'_ !G_ .!EM_\ (]'_  Q5
M\+/^@_XS_P# RV_^1Z /H+_A*?#/_0Q:1_X&Q_XT?\)3X9_Z&+2/_ V/_&OG
MW_ABKX6?]!_QG_X&6W_R/1_PQ5\+/^@_XS_\#+;_ .1Z /H+_A*?#/\ T,6D
M?^!L?^-?,^@W=I??\%$K^YLKJ"Y@;1@%DAD#J<6L8.".*UO^&*OA9_T'_&?_
M (&6W_R/77_"+]FOP+\,?&<7BO0-5\1W-['#)"([VXA>+:XP>$B4Y_&@#VJB
MBB@ HHHH **** "BBB@ HHHH **** /_V0IE;F1S=')E86T*96YD;V)J"C(@
M,"!O8FH*/#P*+U!R;V-3970@6R]01$8@+U1E>'0@+TEM86=E0B O26UA9V5#
M("]);6%G94E="B]&;VYT(#P\"B]&,2 Y-R P(%(*+T8R(#$P,2 P(%(*+T8S
M(#$P-2 P(%(*+T8T(#$P.2 P(%(*+T8U(# @,"!2"B]&-B Q,30@,"!2"CX^
M"B]83V)J96-T(#P\"B])-" Q,3<@,"!2"B]),3$@,3$X(# @4@HO23$T(#$Q
M.2 P(%(*+TDQ-R Q,C @,"!2"B])-R Q,C$@,"!2"B]),34@,3(R(# @4@HO
M23$@,3(S(# @4@HO23$X(#$R-" P(%(*+TDQ.2 Q,C4@,"!2"B])-B Q,C8@
M,"!2"B]),B Q,C<@,"!2"B])." Q,C@@,"!2"B]),R Q,CD@,"!2"B]),38@
M,3,P(# @4@HO23$S(#$S,2 P(%(*+TDQ,B Q,S(@,"!2"B]),3 @,3,S(# @
M4@HO23D@,3,T(# @4@HO234@,3,U(# @4@H^/@HO17AT1U-T871E(#P\"B]'
M4S @.34@,"!2"CX^"B]#;VQO<E-P86-E(#P\"CX^"B]0<F]P97)T:65S(#P\
M+T]#,2 Y,R P(%(@+T]#,B Y-" P(%(^/@HO4VAA9&EN9R \/ H^/@H^/@IE
M;F1O8FH*,3,V(# @;V)J"CP\+U1I=&QE("A#;W9E<BD*+U!A<F5N=" Q.#$@
M,"!2"B].97AT(#$S-R P(%(*+T,@6S @," P70HO1&5S="!;,R P(%(@+UA9
M6B P(#<Y,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ,S<@,"!O8FH*
M/#PO5&ET;&4@*%1A8FQE(&]F($-O;G1E;G1S*0HO4&%R96YT(#$X,2 P(%(*
M+U!R978@,3,V(# @4@HO3F5X=" Q,S@@,"!2"B]#(%LP(# @,%T*+T1E<W0@
M6S4@,"!2("]865H@," W.3(N,# @;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*
M,3,X(# @;V)J"CP\+U1I=&QE("A-1"9!*0HO4&%R96YT(#$X,2 P(%(*+U!R
M978@,3,W(# @4@HO3F5X=" Q-#4@,"!2"B]&:7)S=" Q,SD@,"!2"B],87-T
M(#$T-" P(%(*+T,@6S @," P70HO1&5S="!;-R P(%(@+UA96B P(#<Y,BXP
M,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ,SD@,"!O8FH*/#PO5&ET;&4@
M*$EN=')O*0HO4&%R96YT(#$S." P(%(*+TYE>'0@,30P(# @4@HO0R!;," P
M(#!="B]$97-T(%LW(# @4B O6%E:(# @-S$P+C W(&YU;&Q="B]#;W5N=" P
M/CX*96YD;V)J"C$T," P(&]B:@H\/"]4:71L92 H3W9E<G9I97<I"B]087)E
M;G0@,3,X(# @4@HO4')E=B Q,SD@,"!2"B].97AT(#$T,2 P(%(*+T,@6S @
M," P70HO1&5S="!;.2 P(%(@+UA96B P(#<Y,BXP,"!N=6QL70HO0V]U;G0@
M,#X^"F5N9&]B:@HQ-#$@,"!O8FH*/#PO5&ET;&4@*%)E<W5L=',@;V8@3W!E
M<F%T:6]N<RD*+U!A<F5N=" Q,S@@,"!2"B]0<F5V(#$T," P(%(*+TYE>'0@
M,30R(# @4@HO0R!;," P(#!="B]$97-T(%LQ-2 P(%(@+UA96B P(#<Y,BXP
M,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-#(@,"!O8FH*/#PO5&ET;&4@
M*$QI<75I9&ET>2!A;F0@0V%P:71A;"!297-O=7)C97,I"B]087)E;G0@,3,X
M(# @4@HO4')E=B Q-#$@,"!2"B].97AT(#$T,R P(%(*+T,@6S @," P70HO
M1&5S="!;,C,@,"!2("]865H@," W.3(N,# @;G5L;%T*+T-O=6YT(# ^/@IE
M;F1O8FH*,30S(# @;V)J"CP\+U1I=&QE("A/=&AE<BD*+U!A<F5N=" Q,S@@
M,"!2"B]0<F5V(#$T,B P(%(*+TYE>'0@,30T(# @4@HO0R!;," P(#!="B]$
M97-T(%LR-R P(%(@+UA96B P(#<Y,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N
M9&]B:@HQ-#0@,"!O8FH*/#PO5&ET;&4@*$-R:71I8V%L($%C8V]U;G1I;F<@
M4&]L:6-I97,@86YD(%-E;G-I=&EV92!!8V-O=6YT:6YG($5S=&EM871E<RD*
M+U!A<F5N=" Q,S@@,"!2"B]0<F5V(#$T,R P(%(*+T,@6S @," P70HO1&5S
M="!;,C<@,"!2("]865H@," V-#$N-C(@;G5L;%T*+T-O=6YT(# ^/@IE;F1O
M8FH*,30U(# @;V)J"CP\+U1I=&QE("A%>'!L86YA=&EO;B!A;F0@4F5C;VYC
M:6QI871I;VX@;V8@3F]N+4=!05 @1FEN86YC:6%L($UE87-U<F5S*0HO4&%R
M96YT(#$X,2 P(%(*+U!R978@,3,X(# @4@HO3F5X=" Q-#<@,"!2"B]&:7)S
M=" Q-#8@,"!2"B],87-T(#$T-B P(%(*+T,@6S @," P70HO1&5S="!;,S$@
M,"!2("]865H@," W.3(N,# @;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,30V
M(# @;V)J"CP\+U1I=&QE("A'04%0('1O(&YO;BU'04%0(%)E8V]N8VEL:6%T
M:6]N<RD*+U!A<F5N=" Q-#4@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S,U(# @
M4B O6%E:(# @-SDR+C P(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$T-R P
M(&]B:@H\/"]4:71L92 H3W1H97(@271E;7,I"B]087)E;G0@,3@Q(# @4@HO
M4')E=B Q-#4@,"!2"B].97AT(#$U,R P(%(*+T9I<G-T(#$T." P(%(*+TQA
M<W0@,34R(# @4@HO0R!;," P(#!="B]$97-T(%LS-R P(%(@+UA96B P(#<Y
M,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-#@@,"!O8FH*/#PO5&ET
M;&4@*%%U86YT:71A=&EV92!A;F0@475A;&ET871I=F4@1&ES8VQO<W5R97,@
M06)O=70@36%R:V5T(%)I<VLI"B]087)E;G0@,30W(# @4@HO3F5X=" Q-#D@
M,"!2"B]#(%LP(# @,%T*+T1E<W0@6S,W(# @4B O6%E:(# @-S$S+C W(&YU
M;&Q="B]#;W5N=" P/CX*96YD;V)J"C$T.2 P(&]B:@H\/"]4:71L92 H0V]N
M=')O;',@86YD(%!R;V-E9'5R97,I"B]087)E;G0@,30W(# @4@HO4')E=B Q
M-#@@,"!2"B].97AT(#$U," P(%(*+T,@6S @," P70HO1&5S="!;,S<@,"!2
M("]865H@," V-38N,#<@;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,34P(# @
M;V)J"CP\+U1I=&QE("A,96=A;"!0<F]C965D:6YG<R I"B]087)E;G0@,30W
M(# @4@HO4')E=B Q-#D@,"!2"B].97AT(#$U,2 P(%(*+T,@6S @," P70HO
M1&5S="!;,S<@,"!2("]865H@," T.#DN.#<@;G5L;%T*+T-O=6YT(# ^/@IE
M;F1O8FH*,34Q(# @;V)J"CP\+U1I=&QE("A2:7-K($9A8W1O<G,I"B]087)E
M;G0@,30W(# @4@HO4')E=B Q-3 @,"!2"B].97AT(#$U,B P(%(*+T,@6S @
M," P70HO1&5S="!;,SD@,"!2("]865H@," W.3(N,# @;G5L;%T*+T-O=6YT
M(# ^/@IE;F1O8FH*,34R(# @;V)J"CP\+U1I=&QE("A5;G)E9VES=&5R960@
M4V%L97,@;V8@17%U:71Y(%-E8W5R:71I97,I"B]087)E;G0@,30W(# @4@HO
M4')E=B Q-3$@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S0Q(# @4B O6%E:(# @
M-CDQ+C<R(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$U,R P(&]B:@H\/"]4
M:71L92 H1FEN86YC:6%L(%-T871E;65N=',@86YD(%-U<'!L96UE;G1A<GD@
M1&%T82D*+U!A<F5N=" Q.#$@,"!2"B]0<F5V(#$T-R P(%(*+TYE>'0@,3<T
M(# @4@HO1FER<W0@,34T(# @4@HO3&%S=" Q-3D@,"!2"B]#(%LP(# @,%T*
M+T1E<W0@6S0Q(# @4B O6%E:(# @-#,V+CDR(&YU;&Q="B]#;W5N=" P/CX*
M96YD;V)J"C$U-" P(&]B:@H\/"]4:71L92 H0V]N9&5N<V5D($-O;G-O;&ED
M871E9"!3=&%T96UE;G1S(&]F($5A<FYI;F=S*0HO4&%R96YT(#$U,R P(%(*
M+TYE>'0@,34U(# @4@HO0R!;," P(#!="B]$97-T(%LT,R P(%(@+UA96B P
M(#<Y,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-34@,"!O8FH*/#PO
M5&ET;&4@*$-O;F1E;G-E9"!#;VYS;VQI9&%T960@4W1A=&5M96YT<R!O9B!#
M;VUP<F5H96YS:79E($EN8V]M92D*+U!A<F5N=" Q-3,@,"!2"B]0<F5V(#$U
M-" P(%(*+TYE>'0@,34V(# @4@HO0R!;," P(#!="B]$97-T(%LT-2 P(%(@
M+UA96B P(#<Y,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-38@,"!O
M8FH*/#PO5&ET;&4@*$-O;F1E;G-E9"!#;VYS;VQI9&%T960@0F%L86YC92!3
M:&5E=',I"B]087)E;G0@,34S(# @4@HO4')E=B Q-34@,"!2"B].97AT(#$U
M-R P(%(*+T,@6S @," P70HO1&5S="!;-#<@,"!2("]865H@," W.3(N,# @
M;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,34W(# @;V)J"CP\+U1I=&QE("A#
M;VYD96YS960@0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@4VAA<F5H;VQD
M97)S)R!%<75I='DI"B]087)E;G0@,34S(# @4@HO4')E=B Q-38@,"!2"B].
M97AT(#$U." P(%(*+T,@6S @," P70HO1&5S="!;-#D@,"!2("]865H@," W
M.3(N,# @;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,34X(# @;V)J"CP\+U1I
M=&QE("A#;VYD96YS960@0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@0V%S
M:"!&;&]W<RD*+U!A<F5N=" Q-3,@,"!2"B]0<F5V(#$U-R P(%(*+TYE>'0@
M,34Y(# @4@HO0R!;," P(#!="B]$97-T(%LU,2 P(%(@+UA96B P(#<Y,BXP
M,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-3D@,"!O8FH*/#PO5&ET;&4@
M*$YO=&5S('1O($-O;F1E;G-E9"!#;VYS;VQI9&%T960@1FEN86YC:6%L(%-T
M871E;65N=',I"B]087)E;G0@,34S(# @4@HO4')E=B Q-3@@,"!2"B]&:7)S
M=" Q-C @,"!2"B],87-T(#$W,R P(%(*+T,@6S @," P70HO1&5S="!;-3,@
M,"!2("]865H@," W.3(N,# @;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,38P
M(# @;V)J"CP\+U1I=&QE("A.;W1E(#$N($)A<VES(&]F(%!R97-E;G1A=&EO
M;B!A;F0@4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC
M:65S*0HO4&%R96YT(#$U.2 P(%(*+TYE>'0@,38Q(# @4@HO0R!;," P(#!=
M"B]$97-T(%LU,R P(%(@+UA96B P(#8X.2XT-"!N=6QL70HO0V]U;G0@,#X^
M"F5N9&]B:@HQ-C$@,"!O8FH*/#PO5&ET;&4@*$YO=&4@,BX@4F5S=')U8W1U
M<FEN9R!A;F0@16UP;&]Y964@4V5V97)A;F-E*0HO4&%R96YT(#$U.2 P(%(*
M+U!R978@,38P(# @4@HO3F5X=" Q-C(@,"!2"B]#(%LP(# @,%T*+T1E<W0@
M6S4U(# @4B O6%E:(# @-SDR+C P(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J
M"C$V,B P(&]B:@H\/"]4:71L92 H3F]T92 S+B!';V]D=VEL;"!A;F0@3W1H
M97(@26YT86YG:6)L92!!<W-E=',I"B]087)E;G0@,34Y(# @4@HO4')E=B Q
M-C$@,"!2"B].97AT(#$V,R P(%(*+T,@6S @," P70HO1&5S="!;-34@,"!2
M("]865H@," R.3(N-S0@;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,38S(# @
M;V)J"CP\+U1I=&QE("A.;W1E(#0N($EN=F5S=&UE;G1S*0HO4&%R96YT(#$U
M.2 P(%(*+U!R978@,38R(# @4@HO3F5X=" Q-C0@,"!2"B]#(%LP(# @,%T*
M+T1E<W0@6S4W(# @4B O6%E:(# @-SDR+C P(&YU;&Q="B]#;W5N=" P/CX*
M96YD;V)J"C$V-" P(&]B:@H\/"]4:71L92 H3F]T92 U+B!,96%S97,I"B]0
M87)E;G0@,34Y(# @4@HO4')E=B Q-C,@,"!2"B].97AT(#$V-2 P(%(*+T,@
M6S @," P70HO1&5S="!;-3<@,"!2("]865H@," T-SDN-30@;G5L;%T*+T-O
M=6YT(# ^/@IE;F1O8FH*,38U(# @;V)J"CP\+U1I=&QE("A.;W1E(#8N($QO
M;F<M5&5R;2!/8FQI9V%T:6]N<R!A;F0@3W1H97(@4VAO<G0M5&5R;2!";W)R
M;W=I;F=S*0HO4&%R96YT(#$U.2 P(%(*+U!R978@,38T(# @4@HO3F5X=" Q
M-C8@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S4Y(# @4B O6%E:(# @-S(P+C P
M(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$V-B P(&]B:@H\/"]4:71L92 H
M3F]T92 W+B!#;VUM:71M96YT<RP@0V]N=&EN9V5N="!,:6%B:6QI=&EE<R!A
M;F0@3&ET:6=A=&EO;BD*+U!A<F5N=" Q-3D@,"!2"B]0<F5V(#$V-2 P(%(*
M+TYE>'0@,38W(# @4@HO0R!;," P(#!="B]$97-T(%LU.2 P(%(@+UA96B P
M(#(S-"XQ-"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-C<@,"!O8FH*/#PO
M5&ET;&4@*$YO=&4@."X@26YC;VUE(%1A>&5S*0HO4&%R96YT(#$U.2 P(%(*
M+U!R978@,38V(# @4@HO3F5X=" Q-C@@,"!2"B]#(%LP(# @,%T*+T1E<W0@
M6S8S(# @4B O6%E:(# @-#@T+C<R(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J
M"C$V." P(&]B:@H\/"]4:71L92 H3F]T92 Y+B!&86ER(%9A;'5E($UE87-U
M<F5M96YT<RD*+U!A<F5N=" Q-3D@,"!2"B]0<F5V(#$V-R P(%(*+TYE>'0@
M,38Y(# @4@HO0R!;," P(#!="B]$97-T(%LV-2 P(%(@+UA96B P(#<R,"XP
M,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-CD@,"!O8FH*/#PO5&ET;&4@
M*$YO=&4@,3 N($9I;F%N8VEA;"!);G-T<G5M96YT<RD*+U!A<F5N=" Q-3D@
M,"!2"B]0<F5V(#$V." P(%(*+TYE>'0@,3<P(# @4@HO0R!;," P(#!="B]$
M97-T(%LV-2 P(%(@+UA96B P(#,V."XU-"!N=6QL70HO0V]U;G0@,#X^"F5N
M9&]B:@HQ-S @,"!O8FH*/#PO5&ET;&4@*$YO=&4@,3$N(%-H87)E:&]L9&5R
M<R<@17%U:71Y*0HO4&%R96YT(#$U.2 P(%(*+U!R978@,38Y(# @4@HO3F5X
M=" Q-S$@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S8Y(# @4B O6%E:(# @-3<X
M+C<R(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$W,2 P(&]B:@H\/"]4:71L
M92 H3F]T92 Q,BX@16%R;FEN9W,@4&5R(%-H87)E*0HO4&%R96YT(#$U.2 P
M(%(*+U!R978@,3<P(# @4@HO3F5X=" Q-S(@,"!2"B]#(%LP(# @,%T*+T1E
M<W0@6S8Y(# @4B O6%E:(# @-S(P+C P(&YU;&Q="B]#;W5N=" P/CX*96YD
M;V)J"C$W,B P(&]B:@H\/"]4:71L92 H3F]T92 Q,RX@4V5G;65N="!);F9O
M<FUA=&EO;BD*+U!A<F5N=" Q-3D@,"!2"B]0<F5V(#$W,2 P(%(*+TYE>'0@
M,3<S(# @4@HO0R!;," P(#!="B]$97-T(%LV.2 P(%(@+UA96B P(#0S-"XY
M-"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-S,@,"!O8FH*/#PO5&ET;&4@
M*$YO=&4@,30N(%-H87)E+4)A<V5D($-O;7!E;G-A=&EO;BD*+U!A<F5N=" Q
M-3D@,"!2"B]0<F5V(#$W,B P(%(*+T,@6S @," P70HO1&5S="!;-S$@,"!2
M("]865H@," Q.#DN-S(@;G5L;%T*+T-O=6YT(# ^/@IE;F1O8FH*,3<T(# @
M;V)J"CP\+U1I=&QE("A%>&AI8FET<RD*+U!A<F5N=" Q.#$@,"!2"B]0<F5V
M(#$U,R P(%(*+TYE>'0@,3<U(# @4@HO0R!;," P(#!="B]$97-T(%LW-2 P
M(%(@+UA96B P(#<Y,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ-S4@
M,"!O8FH*/#PO5&ET;&4@*$9O<FT@,3 M42!#<F]S<R!2969E<F5N8V4@26YD
M97@I"B]087)E;G0@,3@Q(# @4@HO4')E=B Q-S0@,"!2"B].97AT(#$W-B P
M(%(*+T,@6S @," P70HO1&5S="!;-S<@,"!2("]865H@," W.3(N,# @;G5L
M;%T*+T-O=6YT(# ^/@IE;F1O8FH*,3<V(# @;V)J"CP\+U1I=&QE("A3:6=N
M871U<F5S*0HO4&%R96YT(#$X,2 P(%(*+U!R978@,3<U(# @4@HO3F5X=" Q
M-S<@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S<Y(# @4B O6%E:(# @-SDR+C P
M(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$W-R P(&]B:@H\/"]4:71L92 H
M17AH:6)I=" S,2XQ*0HO4&%R96YT(#$X,2 P(%(*+U!R978@,3<V(# @4@HO
M3F5X=" Q-S@@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S@Q(# @4B O6%E:(# @
M-SDR+C P(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$W." P(&]B:@H\/"]4
M:71L92 H17AH:6)I=" S,2XR*0HO4&%R96YT(#$X,2 P(%(*+U!R978@,3<W
M(# @4@HO3F5X=" Q-SD@,"!2"B]#(%LP(# @,%T*+T1E<W0@6S@S(# @4B O
M6%E:(# @-SDR+C P(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$W.2 P(&]B
M:@H\/"]4:71L92 H17AH:6)I=" S,BXQ*0HO4&%R96YT(#$X,2 P(%(*+U!R
M978@,3<X(# @4@HO3F5X=" Q.# @,"!2"B]#(%LP(# @,%T*+T1E<W0@6S@U
M(# @4B O6%E:(# @-SDR+C P(&YU;&Q="B]#;W5N=" P/CX*96YD;V)J"C$X
M," P(&]B:@H\/"]4:71L92 H17AH:6)I=" Y.2XQ*0HO4&%R96YT(#$X,2 P
M(%(*+U!R978@,3<Y(# @4@HO0R!;," P(#!="B]$97-T(%LX-R P(%(@+UA9
M6B P(#<Y,BXP,"!N=6QL70HO0V]U;G0@,#X^"F5N9&]B:@HQ.#$@,"!O8FH*
M/#PO5'EP92 O3W5T;&EN97,@+T9I<G-T(#$S-B P(%(*+TQA<W0@,3@P(# @
M4CX^"F5N9&]B:@HQ.#(@,"!O8FH*/#P*+U!R;V1U8V5R("A796)&:6QI;F=S
M*0HO5&ET;&4@*#(P43%?,3!17SDN,S N,3E?1F]R;2 Q,"U1*0HO0W)E871I
M;VY$871E("A$.C(P,3DQ,3<Q-3(S*0H^/@IE;F1O8FH*,3@S(# @;V)J"CP\
M"B]4>7!E("]#871A;&]G"B]086=E<R Q(# @4@HO4&%G94QA>6]U=" O3VYE
M0V]L=6UN"B]6:65W97)0<F5F97)E;F-E<R \/" O2&ED951O;VQB87(@9F%L
M<V4@+TAI9&5-96YU8F%R(&9A;'-E("](:61E5VEN9&]W54D@9F%L<V4@+T9I
M=%=I;F1O=R!F86QS92 O0V5N=&5R5VEN9&]W(&9A;'-E("]$:7-P;&%Y1&]C
M5&ET;&4@=')U92 ^/@HO3W5T;&EN97,@,3@Q(# @4@HO4&%G94UO9&4@+U5S
M94]U=&QI;F5S"B]/0U!R;W!E<G1I97,@/#PO3T-'<R!;.3,@,"!2(#DT(# @
M4ET@+T0@/#PO3TX@6SDS(# @4ET@+T]&1B!;.30@,"!272 O05,@6SP\+T5V
M96YT("]0<FEN=" O3T-'<R!;.3,@,"!2(#DT(# @4ET@+T-A=&5G;W)Y(%LO
M4')I;G1=/CX@/#PO179E;G0@+U9I97<@+T]#1W,@6SDS(# @4B Y-" P(%)=
M("]#871E9V]R>2!;+U9I97==/CY=/CX^/@H^/@IE;F1O8FH*>')E9@HP(#$X
M- HP,# P,# P,# P(#8U-3,U(&8@"C P,# P,# P,#D@,# P,# @;B *,# P
M,C$S,C4Y,R P,# P,"!N( HP,# P,# P,S<P(# P,# P(&X@"C P,# P,# V
M,C0@,# P,# @;B *,# P,# Q.3<X.2 P,# P,"!N( HP,# P,#(R.3,U(# P
M,# P(&X@"C P,# P-30U-#0@,# P,# @;B *,# P,# U-#8V,B P,# P,"!N
M( HP,# P,#8Q-#4V(# P,# P(&X@"C P,# P-C$W-#0@,# P,# @;B *,# P
M,# X,S<R,R P,# P,"!N( HP,# P,#@S.#0S(# P,# P(&X@"C P,# Q,30T
M-3,@,# P,# @;B *,# P,#$Q-#@X-B P,# P,"!N( HP,# P,34U,S8R(# P
M,# P(&X@"C P,# Q-34T.#(@,# P,# @;B *,# P,#$W,#,S,R P,# P,"!N
M( HP,# P,3<P-#4S(# P,# P(&X@"C P,# Q.#4W.3,@,# P,# @;B *,# P
M,#$X-C W." P,# P,"!N( HP,# P,C R.#,R(# P,# P(&X@"C P,# R,#(Y
M-3(@,# P,# @;B *,# P,#(S,#0Y.2 P,# P,"!N( HP,# P,C,P-C$Y(# P
M,# P(&X@"C P,# R-C(R-#8@,# P,# @;B *,# P,#(V,C4S," P,# P,"!N
M( HP,# P,C@P,S(Q(# P,# P(&X@"C P,# R.# V,#<@,# P,# @;B *,# P
M,#,R,#DY,B P,# P,"!N( HP,# P,S(Q,C<U(# P,# P(&X@"C P,# S-#$X
M.#8@,# P,# @;B *,# P,#,T,C P-B P,# P,"!N( HP,# P,S@X-3@R(# P
M,# P(&X@"C P,# S.#@W,#(@,# P,# @;B *,# P,#0Q,3@R,2 P,# P,"!N
M( HP,# P-#$Q.30Q(# P,# P(&X@"C P,# T-3,T.38@,# P,# @;B *,# P
M,#0U,S<X,B P,# P,"!N( HP,# P-#<R.38U(# P,# P(&X@"C P,# T-S,T
M,C(@,# P,# @;B *,# P,#4R-38V.2 P,# P,"!N( HP,# P-3(U.3,V(# P
M,# P(&X@"C P,# U-#4Q-C(@,# P,# @;B *,# P,#4T-3(X,B P,# P,"!N
M( HP,# P-38U-3$P(# P,# P(&X@"C P,# U-C4V,S @,# P,# @;B *,# P
M,#4W-3$S,R P,# P,"!N( HP,# P-3<U,C4S(# P,# P(&X@"C P,# U.30Q
M.#$@,# P,# @;B *,# P,#4Y-#,P,2 P,# P,"!N( HP,# P-C(V,#$S(# P
M,# P(&X@"C P,# V,C8Q,S,@,# P,# @;B *,# P,#8T-3 V,2 P,# P,"!N
M( HP,# P-C0U-3 S(# P,# P(&X@"C P,# V.#8Q,C @,# P,# @;B *,# P
M,#8X-C(T," P,# P,"!N( HP,# P-S,W,# R(# P,# P(&X@"C P,# W,S<Q
M,C(@,# P,# @;B *,# P,#<W-S@T-2 P,# P,"!N( HP,# P-S<W.38U(# P
M,# P(&X@"C P,# X,C,P-C8@,# P,# @;B *,# P,#@R,S$X-B P,# P,"!N
M( HP,# P.#<S-S,T(# P,# P(&X@"C P,# X-S0P,C$@,# P,# @;B *,# P
M,#DR-C(S." P,# P,"!N( HP,# P.3(V,S4X(# P,# P(&X@"C P,# Y.#4P
M,S,@,# P,# @;B *,# P,#DX-3$U,R P,# P,"!N( HP,# Q,#,Q,S@P(# P
M,# P(&X@"C P,#$P,S$U,# @,# P,# @;B *,# P,3 W.30S-" P,# P,"!N
M( HP,# Q,#<Y.#8S(# P,# P(&X@"C P,#$Q,C<W-SD@,# P,# @;B *,# P
M,3$R-S@Y.2 P,# P,"!N( HP,# Q,38X-30Y(# P,# P(&X@"C P,#$Q-C@V
M-CD@,# P,# @;B *,# P,3$Y,CDX,B P,# P,"!N( HP,# Q,3DU-3(W(# P
M,# P(&X@"C P,#$R,#0U-S4@,# P,# @;B *,# P,3(P-#8Y-2 P,# P,"!N
M( HP,# Q,C$P,3<P(# P,# P(&X@"C P,#$R,3 R.3 @,# P,# @;B *,# P
M,3(S-38R." P,# P,"!N( HP,# Q,C,U-S0X(# P,# P(&X@"C P,#$R-C$S
M,3(@,# P,# @;B *,# P,3(V,30S,B P,# P,"!N( HP,# Q,C8X.3,T(# P
M,# P(&X@"C P,#$R-CDP-30@,# P,# @;B *,# P,3,Q-#8T-R P,# P,"!N
M( HP,# Q,S$T-S8W(# P,# P(&X@"C P,#$S-38U.# @,# P,# @;B *,# P
M,3,U-C<P," P,# P,"!N( HP,# Q,S<P.34T(# P,# P(&X@"C P,#$S-S$P
M-C,@,# P,# @;B *,# P,3,W,3$W,2 P,# P,"!N( HP,# Q,S<Q,C0X(# P
M,# P(&X@"C P,#$T-34R-C,@,# P,# @;B *,# P,30U-30S,2 P,# P,"!N
M( HP,# Q-#4V,S0W(# P,# P(&X@"C P,#$T-38U.3(@,# P,# @;B *,# P
M,34Y-S U," P,# P,"!N( HP,# Q-3DW,C(S(# P,# P(&X@"C P,#$U.3@Q
M-#,@,# P,# @;B *,# P,34Y.#,Y,B P,# P,"!N( HP,# Q-C8U-S(Q(# P
M,# P(&X@"C P,#$V-C4X.3<@,# P,# @;B *,# P,38V-C@Q-" P,# P,"!N
M( HP,# Q-C8W,#8S(# P,# P(&X@"C P,#$W-3(R,30@,# P,# @;B *,# P
M,3<U,C,Y-B P,# P,"!N( HP,# Q-S4S,S$S(# P,# P(&X@"C P,#$W-3,U
M-CD@,# P,# @;B *,# P,3<U,S8W,B P,# P,"!N( HP,# Q.#0P.#8T(# P
M,# P(&X@"C P,#$X-#$P-#(@,# P,# @;B *,# P,3@T,3DU.2 P,# P,"!N
M( HP,# Q.#0R,C$S(# P,# P(&X@"C P,#$X-#,Y,#D@,# P,# @;B *,# P
M,3@T-38R," P,# P,"!N( HP,# Q.#0W.#(R(# P,# P(&X@"C P,#$X.34X
M-C0@,# P,# @;B *,# P,3@Y.#$Q." P,# P,"!N( HP,# Q.3,X,3DV(# P
M,# P(&X@"C P,#$Y-# T-3 @,# P,# @;B *,# P,3DX-C(T,B P,# P,"!N
M( HP,# R,#4Y.34Y(# P,# P(&X@"C P,#(P-C$V,S(@,# P,# @;B *,# P
M,C V,S,T,R P,# P,"!N( HP,# R,#8U,#4T(# P,# P(&X@"C P,#(P-C<R
M-38@,# P,# @;B *,# P,C$R,S4W-R P,# P,"!N( HP,# R,3(U,C<S(# P
M,# P(&X@"C P,#(Q,C8Y-CD@,# P,# @;B *,# P,C$R.#8X," P,# P,"!N
M( HP,# R,3,P,SDQ(# P,# P(&X@"C P,#(Q,S,P.38@,# P,# @;B *,# P
M,C$S,S(Q-2 P,# P,"!N( HP,# R,3,S,S8P(# P,# P(&X@"C P,#(Q,S,U
M,C$@,# P,# @;B *,# P,C$S,S8T," P,# P,"!N( HP,# R,3,S-S<V(# P
M,# P(&X@"C P,#(Q,S,Y,C8@,# P,# @;B *,# P,C$S-# X-B P,# P,"!N
M( HP,# R,3,T,C(P(# P,# P(&X@"C P,#(Q,S0S.3@@,# P,# @;B *,# P
M,C$S-#8Q-R P,# P,"!N( HP,# R,3,T-S4P(# P,# P(&X@"C P,#(Q,S0Y
M,3D@,# P,# @;B *,# P,C$S-3 Y,B P,# P,"!N( HP,# R,3,U,C0T(# P
M,# P(&X@"C P,#(Q,S4S.3$@,# P,# @;B *,# P,C$S-34S,B P,# P,"!N
M( HP,# R,3,U-C@V(# P,# P(&X@"C P,#(Q,S4X.#<@,# P,# @;B *,# P
M,C$S-C T-R P,# P,"!N( HP,# R,3,V,C,S(# P,# P(&X@"C P,#(Q,S8S
M.3D@,# P,# @;B *,# P,C$S-C4X-2 P,# P,"!N( HP,# R,3,V-S8Q(# P
M,# P(&X@"C P,#(Q,S8Y-3<@,# P,# @;B *,# P,C$S-S$T." P,# P,"!N
M( HP,# R,3,W,S(Q(# P,# P(&X@"C P,#(Q,S<T.30@,# P,# @;B *,# P
M,C$S-S8T,B P,# P,"!N( HP,# R,3,W-S@U(# P,# P(&X@"C P,#(Q,S<Y
M-S4@,# P,# @;B *,# P,C$S.#$V,B P,# P,"!N( HP,# R,3,X,S$Q(# P
M,# P(&X@"C P,#(Q,S@T-S$@,# P,# @;B *,# P,C$S.#8S," P,# P,"!N
M( HP,# R,3,X-S@X(# P,# P(&X@"C P,#(Q,S@Y-#0@,# P,# @;B *,# P
M,C$S.3$P,2 P,# P,"!N( HP,# R,3,Y,C0Y(# P,# P(&X@"C P,#(Q,SDS
M.#8@,# P,# @;B *,# P,C$S.34T-B P,# P,"!N( HP,# R,3,Y-C@U(# P
M,# P(&X@"C P,#(Q,SDX,C8@,# P,# @;B *,# P,C$S.3DV-R P,# P,"!N
M( HP,# R,30P,3 X(# P,# P(&X@"C P,#(Q-# R,S4@,# P,# @;B *,# P
M,C$T,#,P,2 P,# P,"!N( HP,# R,30P-#$S(# P,# P(&X@"G1R86EL97(*
M/#P*+U-I>F4@,3@T"B]2;V]T(#$X,R P(%(*+TEN9F\@,3@R(# @4@H^/@IS
7=&%R='AR968*,C$T,#@V-@HE)45/1@H!

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>chart-0e7efb26c0365e6cb47.jpg
<TEXT>
begin 644 chart-0e7efb26c0365e6cb47.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O@_P#X*._MKW/[ 7[,>K?M"Z?\(-4^.NKV_P 0OA)\-=!^
M&6C>,]&\ 7_B+Q#\7_B%H?PZT"*+Q3X@TW5='TP1:OK]F[O?VJVSJ=L]W90^
M9=1?>%?AK_P<->&/$GC+_@G5+X;\):EK^A>(-5_:K_8GMM,\1>&-(CUW7/#-
MS)^T]\.%C\3Z=I<]K>6=U<^''9=:ACOX'T]I;)$OP;5I00#@=?\ ^"YWB3X0
M^ ?VRX?VI_V#/BS^S;^TI^R#^SIX2_:IN/V?/$GQ?^%?CS3/BM\&/%_CT_#:
MT\3>!_C)\-QXB\+1C2_%J-I>MVU_HSS6MRRVUL+RYMM4@TW]N/!/QE^&OC[1
M=<UCP]XY\%:E_P (='''\0+72?&/AW67^'NJKI2:O?Z+XTDT_4)5\-:GIEHT
MDU[:ZXNG7$%O$]U-#%"K,O\ ,U_P4G_X)HW7[/O_  3?_P""I/[1_P 1_P!H
MGX^_MK?M8_%_]DSP]\&+CXH_%K3?!.GWGA_X5>"OB3H_B72OAW\._A]\*?">
M@:)HFDWWB;4;CQ)KC^1J=WJ&J6\5^KV3R:G)??*_[5OP@^$'[#7CC_@IC9?
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MBF=TBDE6)B461T=4)X9E8#D5TM?#?[)G_(>\9_\ 8'T7_P!.%_7W)0 4444
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MX*O?\GJ>./\ L2OAG_ZCCU_637\FW_!5[_D]3QQ_V)7PS_\ 4<>@#\X**/\
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M,_\ U''H _."BBB@ J*?_43_ /7";_T4]2U%/_J)_P#KA-_Z*>@#^XC]G/\
MY-]^!?\ V1SX8?\ J#Z%7LM>-?LY_P#)OOP+_P"R.?##_P!0?0J]EH ****
M"BBB@ HHHH **** "OS\_:8_X*I?\$]OV.?B-%\(_P!IO]JWX5_!KXD3>'-*
M\71>$/&-_K%MJ[^&];N-0M=*UA8K'1;^'['>W&E:A%"WG[R]K*&11M+?H'5>
M6TM9VWS6\$KX"[I(8I&P,D#<Z,<#)P,X&3QS0!^0'_#_ ._X(X?])!/@!_X-
MO$O_ ,S%>1_&_P#X+M_\$A/%7P]U/2-&_;]^ 5U?RWVC316Z:GXKD>1+;5+>
M6;:L'A.9ODB#2L2H4(C?-NVJW[K?V=8?\^5I_P" MO\ _&J/[-T__GRM/_ 6
MW_\ C5 '\IG_  ^+_P""7'_1\OP+_P# SQG_ /,;1_P^+_X)<?\ 1\OP+_\
M SQG_P#,;7]67]F:=_SXV?\ X"6__P :H_LS3O\ GQL__ 2W_P#C5 '\IO\
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MWB7_ .9BOUZ_LZP_Y\K3_P !;?\ ^-4?V=8?\^5I_P" MO\ _&J /R%_X?\
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MQ%A)<3V?]KB")9B@!E:Q^W7K'P2M? &H?MD?"?0?@#H7COP7\9?$$?C/P?\
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,4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>chart-5f32bf9b0ca256e99b2.jpg
<TEXT>
begin 644 chart-5f32bf9b0ca256e99b2.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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MR\0ZE8ZE!%X@N)/@/\2+N_N([S4;>$7=V9+V.34$WO<6UQ.8[U(I]Z#\CO\
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MX-^)/Q4_9INO$VEM&/LMQ-XT^&'A_P"&]C>ZK'B34M/\">'MQD6U0J ?LR%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 445Y/\:?%.M^#? 6H:[X?N
M8K34[>^T>&*::UANT6.[U&&WG!@N%:-BT3LH8C*$[EP10!ZQ17YL?\-&?%K_
M *#]A_X3^E?_ !JC_AHSXM?]!^P_\)_2O_C5 'Z3T5^;'_#1GQ:_Z#]A_P"$
M_I7_ ,:H_P"&C/BU_P!!^P_\)_2O_C5 'Z3T5\M?L_?$[QEX]U;Q+:^)]1MK
MZ#3M-TRXM%@TVSL3'+<W=W%*S-;(K2!DB0!7)"D$J,DU]2T %%%% !2%E'!8
M ^A(%+7\V_\ P4?_ &K/VC_A5^U=XN\&?#GXR>-/!WA6R\*> ;VTT'1;C2X]
M/M[O4M":XO[B-;K2[J827<X$LQ:9E+_=51Q0!_2-O3^\O_?0_P :-Z?WE_[Z
M'^-?QG?\-X_MD?\ 1QOQ)_\  O0__E'1_P -X_MD?]'&_$G_ ,"]#_\ E'0!
M_9CO3^\O_?0_QHWI_>7_ +Z'^-?QG?\ #>/[9'_1QOQ)_P# O0__ )1U'-^W
ME^V2L,S+^T;\2@RPRLI%WH>0RQL01_Q(NH(!H _LWZ]**\L^!NL:IXB^"GP@
MU_7+ZXU36M<^%WP^UC5]3NBC76HZIJ?A+1[[4+ZY:-(XVN+N[GFN)BD:(9)&
M*HJX4>IT %%%% !1110 4444 %%%% !1110 5X-^TC_R2K5_^PGX?_\ 3O;5
M[S7@W[2/_)*M7_["?A__ -.]M0!^4_Q/^(7A[X1_#3XC?%CQ=]O_ .$4^%W@
M'QG\1_$_]E6HOM4/AWP+X:U3Q5K2:99&2%;O49--TFYCL;9YH8YKIHHY)H8V
M>5/@+X6?MY?'+XE_L\R?%RS_ &!?C;)\0-7^)UAX'^'GPRTOQ[\,YO"7C?PQ
MX@N/$]UIOQ-G^.\^I/\ #WP?X'\&Z5X9O-%^+6NZ\GV#PQX_%AH&E/JMGXCT
MJ[MOT!^)5CXIU/X<_$#3? VF^"=9\:ZCX'\6Z?X0T;XE6][=?#G6?$U[X?U"
MUT31O']MIK)J$_@G6-1EM],\5163?:6T.[OO*60CRG_!']D7]GG]KKX1_L\_
MM 65I^Q?X3OO@I\6/BOI/AOQ#_P3G\9_M#1:C;S_  L^W?&CPW^TS<? CQSJ
M>JVO@GX9Z;XWU+7/AUI'@'P/XDU<^&_$O@?P#KWBY&T?5/&7AZ:8 _3Z]_;Q
M^'4?[!^B_M[Z9X*\<ZIX'\3> /!WC#P_\.\Z)IGCB]UOQWXWT?X9>'_!EUJ5
M_>)X6TQV\?ZW::/?^,+F_;PK::*DWBU;B?2/*67UC]E_]H-_VC? /B;Q)JGP
M[UOX3>-OAW\6OB5\"_BC\.=;\2>&_&Q\)?$[X4:M:Z5XLTS2/'G@V6;PIXYT
M#=?V%QI?B?0&6SNA-/9306]_I]W"OYH7G[-7[<DO_!-RP_8GU'P7X5\1^([/
M]G_PU+K&OS_&[3K>R\1V]E^TK#K6K?L(+JTFD?VK;Z./V3[>'X3V_P"T!/<K
MH=Y=0+I++#%,VO+]@_\ !.7X)^/_ (#_  2\=>%O&'PVLO@1X5\2?M!?%[XC
M?!#]FNQ\:Z9\1D_9M^"OC6^T>^\-?"6X\:Z)/>Z-K%Y#XAA\7>,[JUT?4]6T
MK0)O&+:)9:I=I9L(0#]K_P!DS_D/>,_^P/HO_IPOZ^Y*^&_V3/\ D/>,_P#L
M#Z+_ .G"_K[DH **** "OY-O^"KW_)ZGCC_L2OAG_P"HX]?UDU_)M_P5>_Y/
M4\<?]B5\,_\ U''H _$?XU?'SQ)\-_'_ ,-?AOX&^%>H?%;Q3XUL]4\4:EI&
MG^+/#GA;4;?P5H>HVVC:F?"MMX@FB7Q7XQEO[Z.YL]#26QL(--T^\GU75+,W
MMA(NG/\ ''6].^.NA?"/6_A9KFC^&_&5WXKT;P-\1KCQ)H<\OB;6O!7@^W\;
M:[??\(!;1R>(-)\ 2:=-/H^C^.[R]>TOO%-C/I$^GV2W%E<3>+_MK?"'XF_%
MZ+P#HW@;X?\ @;Q5$MQJEIHWCF^\5:OX"^(OP3^(5_:7JZ#\2-"\4Z3!=7EQ
MX)LHHK:[\2^'=+2UU'4=:T'0K6XEOK'5%M[3H-9^'GQUUO\ :!\!^+[OPU\/
MH-'^%MYXENM/^,FC^*+C2/%_Q)^&^K?#V^TZV^!OB_P.UG=3V[:E\4;T>,O$
M/B%]5?PG:Q:=I.KZ!I-KKL4ML0#J_&_[2X\%_%*;P4_P\U?4_ _AWQ1\'O W
MQ'^*$?B+1K*U\$^+_CT95^&=E%X1N86UCQ'HT[G3$\5:[9WME'X>;7-/\FSU
M06^H&#Z>N 1!< C#+#.K ]0RQN&!]P00?<5^>?Q7_9T\=?&KXE?##Q+XC^$?
M@;PO=7$WP'\5_$;XBZ'\8?%$EYX>O/A;XA;Q5XB\#7?P]M5M/#WQ-U<3J/"7
MPT^(DUHG]@>&-<\3-?M!(-/@3]#KIC)'=2-C=)'<R-CIND61VQTXW$X]J /[
MAOV<_P#DWWX%_P#9'/AA_P"H/H5>RUXU^SG_ ,F^_ O_ +(Y\,/_ %!]"KV6
M@ HHHH **** "BBB@ HHHH *_/S]IC_@JE_P3V_8Y^(T7PC_ &F_VK?A7\&O
MB1-X<TKQ=%X0\8W^L6VKOX;UNXU"UTK6%BL=%OX?L=[<:5J$4+>?O+VLH9%&
MTM^@=5Y;2UG;?-;P2O@+NDABD; R0-SHQP,G S@9/'- 'Y ?\/\ [_@CA_TD
M$^ '_@V\2_\ S,5Y'\;_ /@NW_P2$\5?#W4](T;]OWX!75_+?:--%;IJ?BN1
MY$MM4MY9MJP>$YF^2(-*Q*A0B-\V[:K?NM_9UA_SY6G_ ("V_P#\:H_LW3_^
M?*T_\!;?_P"-4 ?RF?\ #XO_ ()<?]'R_ O_ ,#/&?\ \QM!_P""Q?\ P2X/
M7]N;X&'@#F\\:'@# '/@WH   .@  ' K^K+^S-._Y\;/_P !+?\ ^-4?V9IW
M_/C9_P#@);__ !J@#^4W_A\7_P $N/\ H^7X%_\ @9XS_P#F-H_X?%?\$M_^
MCY?@7_X&>,__ )C:_JR_LS3O^?&S_P# 2W_^-4?V9IW_ #XV?_@);_\ QJ@#
M^=G]G7_@MY_P27\&ZMXHNO$'[>OP$L8[W3M)M[7S=0\7Q&9X;N^EFV&;P?%&
M1$K1[P'W?O4*JPWE/JW_ (?_ '_!'#_I()\ /_!MXE_^9BOUZ_LW3QTLK,?]
MNMO_ /&J/[.L/^?*T_\  6W_ /C5 'Y"_P##_P"_X(X?])!/@!_X-O$O_P S
M%'_#_P"_X(X?])!/@!_X-O$O_P S%?KU_9UA_P ^5I_X"V__ ,:H_LZP_P"?
M*T_\!;?_ .-4 ?D+_P /_O\ @CA_TD$^ '_@V\2__,Q7\Y?_  46_P""H'_!
M/SXN_M4>+/''PY_:P^%7BSPK?^%/ =C:ZUI,_BBXLI;O2]$>UO[=9?\ A&5S
M);3860 $*649W;E7^Z[^SK#_ )\K3_P%M_\ XU2'2].)R;"R)]3:6Q/_ **H
M _S;O^&]/V-O^CC/AY_Y<_\ \S='_#>G[&W_ $<7\//_ "Y__F;K_20_LO3?
M^?"R_P# 2V_^-4?V7IO_ #X67_@);?\ QJ@#_-O_ .&]/V-O^CB_AY_Y<_\
M\S=1S?MY_L;M#,J_M%_#PLT,JJ!_PD^2S1L !_Q3?4D@5_I*?V7IO_/A9?\
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MTK4O&EY/JGCZQU>;XEP_V++=Z1I>G>%'\"P:GHFH>-/&WHGQ=_8Q'QD_9-^
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>chart-986746bac297519d8c3.jpg
<TEXT>
begin 644 chart-986746bac297519d8c3.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M_&[Q+^WW_P $6-#_ &</'7@+X7?&S7/BK^W%I'@_XE?$GP-/\2?"W@&VU/\
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MI:?X$\/;C(MJA4 _9JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBT^RTF+:D^CZ@8XV7]9:* /QC^)/_!#+]DGX@>$O@GX2TCXD_M7_  @3X/\
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MN-%U37?"Q\$ZOJNF:EJFGSW26EX8T^@OV>/V8?&7A_\ ;X_:]_:D\:>$M/\
M"7A"?X3?LT?L@?LNZ7!?Z9=W<GP0^"^C>)?B7XU\6?9-,O\ 4CH6E^)_C!\6
M-5\)Z+H6JR66M+IGPIM]<O+"&TU[37E_2>B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHKR3XV^)M;\(_#_4=;\/7OV#4X+[1X
M8KG[/;76R.ZU*&"=?)NX9X6\R)V3+1EESN0JP!H ];HK\S/^&@?BY_T-8_\
M!)H'_P K*/\ AH'XN?\ 0UC_ ,$F@?\ RLH _3.BOS,_X:!^+G_0UC_P2:!_
M\K*/^&@?BY_T-8_\$F@?_*R@#],Z*^5/V>?B1XS\<ZOXFM?%&L#4X-/TW3+B
MT06&G6?E2W%Y=Q3-NLK6W9]\<2+B0LJ[<J 237U70 4444 %?+WQ/_;0_9A^
M#'C"]\ _$[XN:%X2\7Z?9Z=J%YHE]IWB2YN8+/5K<W6G3M+INB7MH5NK<&1
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M[2/_ "2K5_\ L)^'_P#T[VU>\UX-^TC_ ,DJU?\ ["?A_P#].]M0!^<%%%%
M!1110!]:?LF?\A[QG_V!]%_].%_7W)7PW^R9_P A[QG_ -@?1?\ TX7]?<E
M!1110 5_)M_P5>_Y/4\<?]B5\,__ %''K^LFOY-O^"KW_)ZGCC_L2OAG_P"H
MX] 'YP4444 %13_ZB?\ ZX3?^BGJ6HI_]1/_ -<)O_13T ?W$?LY_P#)OOP+
M_P"R.?##_P!0?0J]EKQK]G/_ )-]^!?_ &1SX8?^H/H5>RT %%%% !1110 4
M444 %%%% !1110 5X-^TC_R2K5_^PGX?_P#3O;5[S7@W[2/_ "2K5_\ L)^'
M_P#T[VU 'Y.?%SXH^$O@C\+?B%\8?'L^H6W@OX9>$M8\:>)Y=)T]]6U7^R=&
MM_.FATO3(Y8#?ZE>2M!96%JUQ:P2WES"+J[L[03W<'R=I7_!0#P5+X?_ &=M
M?\4_ C]J#P!#^T-XBT'PI#_PE'PMLX].^%^N^+_'VD_##P-%X^UZU\3R:9J]
MA\0/&&N:9_PA5[\+C\0)]6\(2W?Q$NM/TOP3I6IZO:_67Q;\(:[\0/A;\1/
MOACQ!HOA3Q#XQ\&>(/#6C>(_$O@K1OB1X9TB_P!8T^:RBN/$WP]\0C^Q/&_A
MJ997LO$7A;4VCM]:T6ZO[)9H)Y89X_RC^&7_  3=^/?ASX'_ +.'P<U;XU?"
M+P]X9^'/QAT3XZ>)- \-_#/Q?J&M_ SQ9X>^(WA/QQH^G?L5_$C4OB!>Z[\-
M(?\ A&-!\3_"G6QXM_M_PZWASXH>/]0\-Z+IMC?VWA0@'W9^SQ^U]X,_:3U;
MXW6_@KP-X_TOPQ\$/&'B?P3?^/=9NOAMJV@>.-:\'>)_%OA7Q#'X-T+P%\0/
M&/Q!LS:WO@W4KS3K/Q[X-\%ZIXCTJZTN_P##5AJ\5Z-G0_LZ_M.>&/VC8O'D
M&E_#[XP_"CQ1\-]1\&VWBGP!\<?!5MX$\<V6D?$GP=;>/_AQXG;1++7?$45O
MI/C3PC=#4[.PU"]L?%&A7-M?:+XL\/Z%K-G)9GY^^#W[)?QG^$'QI^*'QMT_
MQ/\ LN2:[XWTO2OAM8:1X%^ >K?!?0M5^%FF?$GXL?%L>)_B?IW@;Q#/9>*_
MCVOB/QYX=\(VOB:PM;/PK%X(T/Q1>SV5QXB\8LNF=O\ L._ +XY? 'P9\1['
M]H3QG\(OBA\3/B/\2;[XF^+/BQ\-]*^(VG>)/B1XFURT^QZKK7Q)_P"$_P!0
MNK2"XT32[#PWX,^'GAGP)8:#X*\$_#_PYIOAW2]'B:*2XN0#]D/V3/\ D/>,
M_P#L#Z+_ .G"_K[DKX;_ &3/^0]XS_[ ^B_^G"_K[DH **** "OY-O\ @J]_
MR>IXX_[$KX9_^HX]?UDU_)M_P5>_Y/4\<?\ 8E?#/_U''H _$SXC?&3Q9X,^
M._P>^&T6E^$=,\$^/X+D7OBGQE=>)--E\3ZX9]2MCX(^'VL:;IE[X6M/'&BV
M]KIFMQ^'_%ES;77C.+7[+3M!^SK9ZA?Q^4ZQ\??CY%X#^-6H6N@_!30_'_P5
M\=:)X>U+1]3'Q/UW1O$T?BCPYIESH7A/P[8J?"GBF?Q1<>-]>T?P1I/C>6VB
M^'7C=_[0UKPNILK*Z%K]">.O@;X1^(7COP7X[U_4/%8E\(/9M<>%[#Q+J=EX
M,\7?V)J<GB'PF?%?AR*466H3>%/$\C:[IMW +2ZN9!'8:G->:=!;6\&5H/[.
M/@'0(+B-=3\?:_=W?C'X9^+[W6O&7C;4/%OB&\3X-WC7WPR\)76M:Q!->S^"
M_"4[N]CI,C/J%S++/=ZGK5]?7-Q=2 &;\;/B7\4?A%\//#'C&+PYX URZTZ[
M\-6/Q26ZU3Q58Z5!J.JW>A:-<Z=X-N;*POH=)L;G5]0UFZ7QU\0=2L/!_A'0
MM$BN_%$L_P#:J2VGT7>*$2\C5MRQK=(KXV[U19%5\'.-X ;&3C.,GK7CGQ$^
M!_AGXI6MSIOB_P 2?$B?1[[4-8?4M#TCQUJ.@Z+J_ACQ#IF@Z7K_ ,.=:TW3
M;>*WU7X?:POAZUO;K2+Q9-5M[^_UR33=>L+;6;VT?V"< 6\X"JH\B8!44(B*
M(F"HB* J(@ 5$4!40*J@* * /[B/V<_^3??@7_V1SX8?^H/H5>RUXU^SG_R;
M[\"_^R.?##_U!]"KV6@ HHHH **** "BBB@ HHHH **** "O!OVD?^25:O\
M]A/P_P#^G>VKWFO!OVD?^25:O_V$_#__ *=[:@#\X**** "BBB@#ZT_9,_Y#
MWC/_ + ^B_\ IPOZ^Y*^&_V3/^0]XS_[ ^B_^G"_K[DH **** "OY-O^"KW_
M ">IXX_[$KX9_P#J./7]9-?R;?\ !5[_ )/4\<?]B5\,_P#U''H _."BBB@
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MOX ?^"GQ)_\ -/0!C_:K7_GZM/\ P,M?_CU'VJU_Y^K3_P #+7_X]6S_ ,.
MO^".'_2/K]G_ /\ !1XC_P#FFH_X<!?\$</^D?7[/_\ X*/$?_S34 8WVJU_
MY^K3_P #+7_X]1]JM?\ GZM/_ RU_P#CU;/_  X"_P"".'_2/K]G_P#\%'B/
M_P"::C_AP%_P1P_Z1]?L_P#_ (*/$?\ \TU 'TS^R?>V::]XR+7=F ='T4#_
M $NU)_X_]0/03$]OY#J1G[@_M&P_Y_;3_P "K?\ ^.U^0W_#@+_@C@?^<?7[
M/_\ X*/$@_EXFI/^' /_  1P_P"D??P _P#!3XE_^:>@#]>O[1L/^?VT_P#
MJW_^.T?VC8?\_MI_X%6__P =K\A?^' /_!'#_I'W\ /_  4^)?\ YIZ/^' /
M_!'#_I'W\ /_  4^)?\ YIZ /UZ_M&P_Y_;3_P "K?\ ^.U_)]_P5;G@D_;2
M\;O'/ ZGP5\- &2X@89'AUP>1(1P1_7I7ZC_ /#@'_@CA_TC[^ '_@I\2_\
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MZ$ CMP1D<4M( 0 "<D  G&,D#KCMGTI: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>chart-f4d60677c0e25c84939.jpg
<TEXT>
begin 644 chart-f4d60677c0e25c84939.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M"GPZ^,?PRT#X!ZCX9T;XA? 3QU_P<O?LC>(9O#OA?]E+Q'^RI\)O&'P2\?\
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M$7B2;QU=^+M:N?&]Y\4]/\5?VAXCT8Z)H'AKPI?WESHOAFREL]'L]:UKL/\
M@MI_P4(_:J_9/\7Z]9?LO?M%_#GPAJGP;_9;\0_M+ZU\!?#O['OQ5_:V^+GQ
M%.AZUXGBN+_XV>)=!DT'X8_LK_LQIH_AEH$^+FO>+;?Q9<Z[;>*&LM'O]-TJ
M%H@#[2_:M_X(U_!/]KCXK_%/X@^,_P!H[]M+P+X&_: M?AO9?M%?LX?"[XY6
M6@?L]_'.S^&$&G6.B6OB_P ':UX+\2:YX>@UC1])T_1?%T?PT\4^!E\2V,,L
M]^&U.^U"_NOUUM[:"U@AMK>-8;>WBC@@AB&R*&&%%CBBB1<+'''&JHB*  J@
M<U_*3^V;_P %4/VXO@W^TC\-_$7B+XE^ OV+?V4M;^$7[*OQ#^&'C'XN_L>?
M%3XV?LT?M%^)/BMIUIK'QO\ !GQ=_:J^'.KZGKG[+][\.9]0M?#_ (3AA\$:
MHNH++9^(O%6JZ+HMVNIM^R?_  5'_:-\<?L\_LRZ-XE^%GQ\^%?[/GC'XA_%
MOX<?"_P]\1_'GPB^(O[1GB"9/&$^IW,^C? G]GSX5Z;JOB3XZ?'/6K'2G'@+
MX?L+#P_?VT>M:SKFL:=IVE&X4 _2G@9.<9P.2<9Z  $X&2<<=3ZFO ? _P"U
M;^R[\3?%S_#_ .&_[2'P%^(/CM9+R.3P7X(^,?PZ\6>+8Y=/$[:A&_AO0?$N
MH:TCV(M;DW:?8@UJ+><S",0R%?@?_@C-^U[\<_VPOV7OB5KW[1-U_:_Q.^"/
M[6'QZ_9JU+Q5>_"._P#@#XG\::9\)/$6C0:)XI\=?!#4-8UV;X3>/+_3];CM
MO%O@'^TKC_A&]6LI=/E/VN*Y9OY4_P!@+]F#Q3^T_P# #]C3PW^SQ_P3&U3P
MA\</AY_P4GUWXS>-/^"L-]I'P9^'VAP?"GX8?MF?%;Q#XQM="^(&EZ];?&_X
MG7NG^%M/3X00_#[4M&DT>;5-)\B*2.QTK2;J( _T(=BD@\Y P#N.<<=#G/.
M3@_,0"V2!@*@]1V(SW&<=#U'0'@CD ]0"/Y-?V<_^"QO[8WQI_;N\/#1-$\5
M^.?V:/'7[<?Q,_9!U']G[PK^PQ\=/L/P9^#OA'Q)XQ^'/A/]JG6OVX+6&^^&
M>L^)+GX@^'-!?XI_#2XA;P[X.\-^)+FWM;^TU#1-2N],S?A!_P %'?\ @J3X
MC_8.^%7[4/BKXJ_LYW7C7]NW]L/X:_L#_LG:+%\#+W2O#WP/\1^(?VI?B_\
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M]E;]@>V_:8TO5?!G[07[*OPL_;3\&V'@;X;>.M/U'P%X*T+]NKQ_XJ\5>-_
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MPQ>SH\NC:AK/AB^O_#VH7MD8KJ?1;^_TQI19WUW#-VU !1110 4444 %%%%
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M %%%% !7@O[21Q\*=7."<:EX?.!U.-7M^![FO>J\&_:1_P"25:O_ -A/P_\
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M[_GQL_\ P$M__C5']F:=_P ^-G_X"6__ ,:H _E-_P"'Q?\ P2X_Z/E^!?\
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M #;_ /AO3]C;_HXOX>?^7/\ _,W4<W[>?[&[0S*O[1?P\+-#*J@?\)/DLT;
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>chart-ff3385a010ad5ef68c1.jpg
<TEXT>
begin 644 chart-ff3385a010ad5ef68c1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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MB@ HHHH **** "BBB@ HHHH *0D $DX !)/H!R32TC9*M@ G:< ]"<< ^QH
M_#K]I'_@K]\6/!7QS^//P?\ V-_^">7QI_;MT?\ 9#BTN/\ :S^)G@7XF?#S
MX7>%_AIX@U'PP/&MSX ^']IXS@O]5^-GQ+\/^%)[/5?$7@[P?!#>:;=7=OH8
M:?5)1&OZ0?"/]L[]G?XO_ OX2?M!Z?\ $7P[X)\#?&7X<>'?B=X7M?BCKF@_
M#_Q+9:!XAN]'T?[-K^B^(-5M9-.U/1_%6NZ=X,UA(Y;JQ@\5W-MH]K?W<M]I
M[7?\P_Q"_:'\'?\ !.#QC_P5?_9,_:D^*O[7'[(6O?M8?MQ>*/VX?V2OVG_V
M8?@OXA^(WB3XR>&/C#I'PYU/4?A1\,]>M? WCSPC:^.O#&O?#^]^''BK0?',
M/A^+^R]9,UIJ>FVKP:LK?V1OV??B%^V!^T3_ ,$7+S_@IY\+O%'Q7^*.B_\
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M+EU[7K7PKHM[>0:EXDGT+18Y]9U:#2+:^DTK2HY=0NTM[-'F'\N'P9_X*/\
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M[NY\/Z9?>.O%?@GX<:-8:L+#6+I/A-J&J2V3Z->Z!>W7Z4T4 %%%% !1110
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M]^ 5U?RWVC316Z:GXKD>1+;5+>6;:L'A.9ODB#2L2H4(C?-NVJW[K?V=8?\
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MX(X?])!/@!_X-O$O_P S%?KU_9NGCI96G_@+;_\ QJC^SK#_ )\K3_P%M_\
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MPM\*[C]K[XP_M:?$[X9?!CX@>.=?U'X.7?P6\:ZYX%TO7?B;\*H?AO\ #_\
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< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895570096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Disaggregated Revenue Within Reportable Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 37,341<span></span>
</td>
<td class="nump">$ 35,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">37,345<span></span>
</td>
<td class="nump">35,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">33,428<span></span>
</td>
<td class="nump">31,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Nuclear Precision Health Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical | Pharmaceutical Distribution and Specialty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">33,212<span></span>
</td>
<td class="nump">31,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">3,917<span></span>
</td>
<td class="nump">3,801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Cardinal Health At Home [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">471<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical | Medical distribution and products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">3,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904149328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">$ (4,921)<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments and other</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net unrealized gain/(loss) on derivative instruments, net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income/(loss)</a></td>
<td class="num">(4,943)<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Cardinal Health, Inc.</a></td>
<td class="num">$ (4,944)<span></span>
</td>
<td class="nump">$ 589<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904248560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">$ (4,921)<span></span>
</td>
<td class="nump">$ 594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings/(loss) to net cash provided by/(used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Impairments and (gain)/loss on sale of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">(Increase)/decrease in trade receivables</a></td>
<td class="nump">229<span></span>
</td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">(Increase)/decrease in inventories</a></td>
<td class="nump">356<span></span>
</td>
<td class="num">(178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="num">(1,812)<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other accrued liabilities and operating items, net</a></td>
<td class="nump">5,211<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by/(used in) operating activities</a></td>
<td class="num">(653)<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments', window );">Purchase of available-for-sale securities and other investments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments', window );">Proceeds from sale of available-for-sale securities and other investments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from Sale of Property, Plant, and Equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">740<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in short-term borrowings</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Reduction of long-term obligations</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net tax proceeds/(withholdings) from share-based compensation</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common shares</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury shares</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(585)<span></span>
</td>
<td class="num">(764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and equivalents</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase/(decrease) in cash and equivalents</a></td>
<td class="num">(1,319)<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at beginning of period</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at end of period</a></td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">$ 2,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from purchases of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Purchaseofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895924928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>segment </div>
<div>Reportable_Segments</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments | Reportable_Segments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ProjectCostsOnInvestmentAndOtherSpending', window );">Project Costs On Investment And Other Spending</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ProjectCostsOnInvestmentAndOtherSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ProjectCostsOnInvestmentAndOtherSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895701712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Oct. 25, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FinalSharesReceivedfromASRProgram', window );">Final Shares Received from ASR Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (using cost method), shares</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share)</a></td>
<td class="nump">$ 43.76<span></span>
</td>
<td class="nump">$ 50.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FinalSharesReceivedfromASRProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Final Shares Received from ASR Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FinalSharesReceivedfromASRProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6805839664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>36,310</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>34,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,035</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>972</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,345</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,217</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,341</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,213</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Revenue by Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33,212</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>31,209</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>216</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>207</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33,428</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>31,416</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,446</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,380</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>471</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>421</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,917</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,801</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,345</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,217</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,341</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,213</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Segment Profit by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>398</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>409</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>135</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>568</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>544</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5,832</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>272</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>816</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Assets by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>21,755</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22,446</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,462</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,962</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,179</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40,963</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:13pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895108288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee- Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890184336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Three</a></td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">$ 328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897527120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Currency Exchange Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce volatility in earnings, cash flow and net investments in certain subsidiaries to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the condensed consolidated statements of earnings. For the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>no</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Flow Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into a forward interest rate swap with a total notional amount of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$50 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;to hedge probable, but not firmly committed, future transactions associated with our debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gains and losses recognized in accumulated other comprehensive loss and reclassified into earnings were immaterial for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. All gains and losses currently included within accumulated other comprehensive loss associated with our foreign exchange forward contracts to be reclassified into net earnings within the next 12 months are immaterial. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Net Investment Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#165;64.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> cross-currency swap maturing in 2022.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During three months ended September&#160;30, 2018, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#8364;200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> cross-currency swap maturing in 2023.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cross-currency swaps designated as net investment hedges are marked to market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive income/(loss) until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in our net investment hedges during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Economic (Non-Designated) Hedges</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The gain and losses recognized in the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were immaterial. The principal currencies managed through foreign currency contracts are the euro, Canadian dollar, British pound, Japanese yen, and Chinese renminbi.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, accounts payable, and other accrued liabilities at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,001</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,991</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890206416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Obligations and Other Short-Term Borrowings</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;">6. Long-Term Obligations and Other Short-Term Borrowings</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had total long-term obligations, including the current portion and other short-term borrowings, of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$8.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at both </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$19.7 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$21.5 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, we repurchased a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$74 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of notes due in 2022 and 2047 with available cash.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;commercial paper program backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> committed receivables sales facility.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our revolving credit facility and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter from  </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> through December 2020, a consolidated net leverage ratio of&#160;no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every fiscal quarter thereafter. </span><span style="font-family:Arial Narrow;">As of September 30, 2019, we were in compliance with our financial covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6900984368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>305</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>296</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904193152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization of right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock', window );">Leases Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>394</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>103</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>312</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>415</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasePaymentsTableTextBlock', window );">Schedule of Lease Payments</a></td>
<td class="text">upplemental cash flow information related to leases:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance lease</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Lease Payments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Years Ending September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>107</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>83</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>62</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>519</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>538</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>61</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>415</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of September 30, 2019, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As previously disclosed in our fiscal 2019 Form 10-K under the prior accounting guidance, the future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$126 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$100 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$76 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$54 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$33 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$94 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Lease Payments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesSupplementalBalanceSheetInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897392464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Share-Based Compensation</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The total tax benefit related to share-based compensation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$4 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:52%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>60.92</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45.29</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$125 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>two years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>ten years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.58847736625515%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:53%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>63.75</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>63.67</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$3 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>one year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:58%;"/><td style="width:21%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units vest over a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>zero</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>240 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43.68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>48.40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.59</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>50.84</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$25 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> if the performance goals are achieved.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895985424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares) | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares) | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">63.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895078944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Narative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Operating Leases, Future Minimum Payments, Due in Three Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">Operating Leases, Future Minimum Payments, Due in Four Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">Operating Leases, Future Minimum Payments, Due in Five Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Operating Leases, Future Minimum Payments, Due Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>32
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_RNPJ%S?N__L?%%T-3PZR[,%U!+ P04    " "3@F=/F5R<(Q &  "<)P
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MTZ"21]._+NV['MJY86!4.[:JR=0O;W\#4$L#!!0    ( )."9T\7I*! IP,
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M^M@/E\I>MU/#.MWTYC(WX]']/P+;_P!02P,$%     @ DX)G3]MGB]UB @
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M+T$M;CJWR/79GA4YO0C2=+!G#K^T+69_=T#HL'5]]W;PVIQKH0Y0D??X##]
M_.SW3$9H=CDU+72\H9W#H-JZG_U-F2F]%OQJ8.!W>T=U<J#T305?3UO74T!
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M@QF^P53/)TJFXN_@#!+#@Q+,41KIXDK*WGFC)A:4HOC+N L=]V&\N;R>8.N
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MNVV3E6TIFZIJI59:I6KZS-IC&P48%_ Z_?L"=ERKL?H"S'#.F0M#/J)]=AV
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M:&5E=#$W+GAM;'U386_;(!#]*X@?4&*2M5ED6VHZ3:O42E&G;9^)?;91P7B
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MR\;^U\9X0"G)%8Y0BQ]L,134/AP_X=E.8S89WO3S#V++-RY^ U!+ P04
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MH_,W&^=?(3KPI6SN_ HU_H'-CH+*!?/!VV9<L]%QV$TOB,W/./\+4$L#!!0
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M(6[_X-Z-UST:P?;32V;S[U3]!U!+ P04    " "3@F=/B9REG00"  !M!0
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M)+'#LW"<IC!! .88&()@0A#X/DRP @E6AF#UC@#=%3E@(H-I#2;&L$8(:H2
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M&2<U/4D]C-68#V?Z,)&LL_<5;[PTY7\!4$L#!!0    ( )."9T^]Q J((P(
M %,&   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;(U5[8Z;,!!\%<0#
MG D$$B) NN14M5(K15?U^MLAFX#.QM1VPO7MZP_"$7!/]R?8R^S,[!IOLH[Q
M5U$!2.^-DD;D?B5ENT%(E!50+!Y8"XUZ<V*<8JFV_(Q$RP$?31(E* R"!%%<
M-WZ1F=B>%QF[2%(WL.>>N%"*^=\M$-;E_L*_!9[K<R5U !59B\_P$^2O=L_5
M#@TLQYI"(VK6>!Q.N?^XV.Q2C3> EQHZ,5I[NI(#8Z]Z\^V8^X$V! 1*J1FP
M>EQA!X1H(F7C3\_I#Y(Z<;R^L7\QM:M:#EC CI'?]5%6N;_VO2.<\(7(9]9]
MA;Z>V/?ZXK_#%8B":R=*HV1$F%^OO C):,^BK%#\9I]U8YY=SW]+<R>$?4(X
M)"CMCQ*B/B%Z3UB:XJTS4^H3EKC(..L\;@^KQ?J;6&PBU<Q2!TWOS#M5K5#1
M:Q$%28:NFJC';"TF'&$6 P(I]D$B=$ELPUEZ>"^PFR/BE5LA<A81F?SHKHC_
M$"R=!$M#L+PC6$^Z8#&)P32VC-BM$3LU8H=&.M&PF'BL$4QZ%<]MI&X;B=-&
M,K,1IM,#3V8V%E,;<TCD=K%RNEC-FS&2N"-8.PG6GS_RU$F0?N+(TWFOIWUP
M0)*)#32ZBQ3XV8PMX97LTDC]U8^BPV1\#/5=GL2W:F+: ?=.8\?M#\S/=2.\
M Y-J4IC[?&),@G(8/*A#JM2$'S8$3E(O5VK-[9RS&\G:?H2CX7^D^ =02P,$
M%     @ DX)G3Y[?&JJ= @  $ H  !D   !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&ULE59=CYLP$/PKB/<>V(2/1 0IN:IJI5:*KKKVV4F<@ XPM9UP_?>U
MC<.1L$CT)=AF/+-K[X1-6\;?1$ZI=-ZKLA9K-Y>R67F>..2T(N*)-;16;TZ,
M5T2J*3][HN&4',VFJO2P[T=>18K:S5*SMN-9RBZR+&JZXXZX5!7A?[>T9.W:
M1>YMX:4XYU(O>%G:D#/]2>5KL^-JYO4LQZ*BM2A8[7!Z6KL;M-IBK#<8Q*^"
MMF(P=G0J>\;>].3;<>WZ.B):TH/4%$0]KO29EJ5F4G'\L:1NKZDW#L<W]B\F
M>97,G@CZS,K?Q5'F:S=QG2,]D4LI7UC[E=J$0M>QV7^G5UHJN(Y$:1Q8*<RO
M<[@(R2K+HD*IR'OW+&KS;"W_;1N\ =L-N-^ NUPZ(1/Y9R))EG+6.KP[_(;H
M.T8KK,[FH!?-49AW*GBA5J]9@%#J7361Q6P[#!Y@/A">8N\E,"2QQ:/M>+F$
M"0(PQL 0!'<Q8IA@ 1(L#,'BCB!X2++#1 93&\RG$-8(08T0"'(!$T0@000$
M&3X$V6'"09!)$">P2@RJQ".59/$@$H]$!H=U)Y& $@F02/2@D0")1#ZLL@15
MEH!*#!,@'RY]?WY=H0GWH!F594'AC-)"H(,V",\O+@1[" 4SRLN"AI'B*)JX
M? 1[#8W--JHPBQGJ3-P]@LV&PADU9D'WV803;D&P*1'DRBD*V'$H_H\R@QV%
M($N-RFSLJ:E#A1V%EO.K#,.6POZ,*K.@8:!AC"8<@6'CX;'Q1E6&Q[Z;^B/#
ML.\PGE%F%A3=I>,_7K W^"!7E)]-*R*< [O4I@\:K/;MSL9T.]X'O.N5?A!^
M+FKA[)E4;8'Y>)\8DU0%XS^I;'/5GO63DIZD'L9JS+L>I9M(UMC^R^N;P.P?
M4$L#!!0    ( )."9T\S0%/7D ,  (80   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;)68[VZ;,!3%7P7Q  /;F#]5$JG)-&W2)E6=MGVFB9.@ LZ
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MG"NJ'09/^C.H]%T^31@]*S/,]%@,%]HP4;P;+VLT_6,H_P%02P,$%     @
MDX)G3\D-FSOY 0  8 4  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
MC93;CILP$(9?Q>(!U@GAE B0-EM5K=1*T59MKQT8 EH;4]L)V[>O#RREQ"OU
M)K;'__S?C(F=CUR\R!9 H5=&>UD$K5+# 6-9M<"(?. #]'JGX8(1I9?B@N4@
M@-0VB5$<;C8)9J3K@S*WL9,H<WY5M.OA))"\,D;$[R-0/A;!-G@+/'>75ID
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M,4-"A@2,PF%,9=(;AH@7&)) 2,(A1>Q $@;))6:DD)$"AG 8*6-DA!D99&2
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MB[ 7^<RY JWG/>F$*]VJ)X/!69EIJN=BZ%>#H7@W]F(R_1#*?U!+ P04
M" "3@F=/=_.8+F("   $"   &0   'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6R55>V.FS 0?!7$ QRV^4@XD4A)JJJ56BFZJM??#G$".H.I[83KV]<VA*-A
MD=(_P3:S,SM+UINU0KZI@C'MO5>\5BN_T+IY#@*5%ZRBZDDTK#9O3D)65)NM
M/ >JD8P>75#% X)0$E2TK/UUYL[V<IV)B^9ES?;24Y>JHO+/EG'1KGSLWPY>
MRG.A[4&PSAIZ9C^8_MGLI=D% \NQK%BM2E%[DIU6_@8_[W!L QSBM62M&JT]
M:^4@Q)O=?#VN?&0S8ISEVE)0\[BR'>/<,ID\?O>D_J!I \?K&_MG9]Z8.5#%
M=H+_*H^Z6/E+WSNR$[UP_2+:+ZPW%/M>[_X;NS)NX#83HY$+KMROEU^4%E7/
M8E*IZ'OW+&OW;'O^6Q@<0/H ,@1TQ9D-"/N \",@<N:[S)S53U33=29%Z\GN
M:S74_BGP<VB*F=M#5SOWSKA5YO2ZCE":!5=+U&.V'8:,,'A !(9]D""0Q)9,
MPLF_ KLI(IU1"$$3H8L/QPHH@0DBD"!R!-&X"AC=5:'#) Y3.\PB':79.9F"
MEBB<\1*#J<235#"ZJ]>VP\0C%9PN2'27RQ1%<!S&<#()F$P"U.7.\C:9UB6"
M-1:@Q@+0(##!$B183KY^A$.8( 4)4B"#^V*FTV(BA& 5C.!60X#.S.? ,]V*
M'_>*P6[<8/* VQ[TH%VX*7$(",UT)8;;$D?_81=N)SSM)\!N//D/XZG=8'2G
M5DR>W?A17BXNM9M]H]-AQ&V(NY,_X-U\_$[EN:R5=Q#:W.SN_CT)H9E)!CV9
M9 HSDH<-9R=MEPNSEMU<ZC9:-/W,#8;!O_X+4$L#!!0    ( )."9T\.B[F)
MA@,  -(1   9    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;)68;6^;,!#'
MOPKB Q3L,T]5$FEM-6W2)E6=MKVFB9.@ L[ :;IO/_/0C,#?57@3'G+W/]_A
MG\^P.*GJI=Y+J9VW(B_KI;O7^G#K>?5Z+XNTOE$'69I_MJHJ4FTNJYU7'RJ9
M;EJG(O>X[X=>D6:ENUJT]QZKU4(==9Z5\K%RZF-1I-7?.YFKT])E[ON-IVRW
MU\T-;[4XI#OY0^J?A\?*7'EGE4U6R++.5.E4<KMT/[';!Q$V#JW%KTR>ZL&Y
MTZ3RK-1+<_%ULW3]9D0REVO=2*3F\"KO99XW2F8<?WI1]QRS<1R>OZM_;I,W
MR3RGM;Q7^>]LH_=+-W:=C=RFQUP_J=,7V2<4N$Z?_3?Y*G-CWHS$Q%BKO&Y_
MG?6QUJKH5<Q0BO2M.V9E>SSU^N]NV('W#OSL0-&'#M0[T-F!LP\=1.\@1@Y>
METI;FX=4IZM%I4Y.U3W>0]K,(G8K3/77S<VVV.U_ICRUN?NZ$BQ:>*^-4&]S
MU]GP"YOXTN9^:L.3Y-+F >G\M_',.,^#Y7"PO!400P'N8P&" M0*T(4 PP("
M"@@P CY*L[,)6YNR*P4+<)  !@E $,("(10(KT\S@@(1&($8/?%HDF80A):G
M$<,H,8@2C*(@FQ '26"0! A$6(#Y&!'_^G(R"V7LBH+V1L.*AI94&>:#(4!B
MBP0FA,U A&%&&((D&:\IG5$PI$3XENG#,"<,@$+^.% P#63+!]/$0A"&C<.$
MDS#"PBS#S#$ '7&+! :*Q3,>'L:% 5Z(QC,5&0G+2HZAXCZ0&,/?&R7#H@8W
M%B8X1H]/T:/0UG4L;8=?7U:.L>($T@W'Z=)T#C%;63%[?,H>199)Q#%5/)B1
M+2:&(V(FV4Z)B<GV;#$R'"%C6=PY1H;/0(9C9#BB8;0_NNN-+I:AV+9WP<@0
M0F:\KO9&PS@D0LM*1!@9 MU*V,:*D:$9R)!EKP:0$>-EEZ;(< LQA(DAT*VF
M507=RM)7"5-%H%<)"YB$J:(9VSK"P- U&[O>:)AL$)+M^6.L".S;;/V0,%:4
MS-BL8V($(&:2;F]TL9%EMNDN,#$"$6.9AP(3(V80(S Q C69\4(DIL00M[R>
M",M+$$!&V"0P#F)&DQ$8!X&:S"3;:9-)Q@W"&[PK-U\[OJ?5+BMKYUEI\]K=
MOAQOE=+2Z/DW1FDOT\WY(I=;W9Q&YKSJOC)T%UH=^B\HWODSSNH?4$L#!!0
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MBK[\1TH%R"*])WFV2OG'&18$CD)-4SEG?=OM%X*VYI>"AO]:_@=02P,$%
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MSSWGBND<PSN]8T?]/=(-"K97YG:F[T73E#<#Q>OV@R/HOGI6_P%02P,$%
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MLY!/ZL"Y]I[+HE(+_Z!U?1L$:G/@)5,WHN:5^6<G9,FT6<I]H&K)V=8%E44
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M+=JYT&X4K[N9A_K!F_T#4$L#!!0    ( )."9T^5;W^$8P(  '8(   9
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M)LF),0D*9?&D_D"5^K8,"P(GJ6]3=<_MA+4+R=K^XX&&+UCQ#U!+ P04
M" "3@F=/ !RD-G$"  !<"   &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6R-5MN.FS 0_17$>P&;>T20DJVJ5FJEU59MGQWB!+2 J>V$[=_7-H1%,$C[
M$E\X<\X9XV&2]8R_BI)2:;TU=2OV=BEEMW-=492T(<)A'6W5DPOC#9%JR:^N
MZ#@E9Q/4U"[VO,AM2-7:>6;VGGF>L9NLJY8^<TO<FH;P?T=:LWYO(_NQ\5)=
M2ZDWW#SKR)7^I/)7]\S5RIU8SE5#6U&QUN+TLK</:'=$D0XPB-\5[<5L;NE4
M3HR]ZL6W\][VM"-:TT)J"J*&.WVB=:V9E(^_(ZD]:>K ^?S!_L4DKY(Y$4&?
M6/VG.LMR;R>V=:87<JOE"^N_TC&AT+;&[+_3.ZT57#M1&@6KA?FUBIN0K!E9
ME)6&O UCU9JQ'_D?87  '@/P%."; '<0,LX_$TGRC+/>XL/A=T2_8[3#ZFP*
MO6F.PCQ3YH7:O>=A@C+WKHE&S'' X!GF'>$J]DD"0Q)'O H/(P\F\$&/OB'P
MYP1^#!,$($%@"((Y0> ODH0P$2P2@B+AVF40P@012!"M'21XX7+ A ;3&@R&
M)6)0(EY+1$N)^*,2"2B1 %DLSSI927S:N%$IJ)$":00+C72EL7'GD <7A@<D
MLA0907,5?T-EH_S0^M8D&[<&@>5U0!@P&BV-#J!X9C1$3K2E!-<A\H%S3Y=*
M PCY,ZD .UZZ(057+ +*,8F74L%:*O*<=..^(KAN4;B6BE>?P/##UPDN;@15
M=[)4B59O*0@=O#PZ=_9Q;RB_FK8FK(+=6M-39[M3ZSQ@TQS>X4/?_4'XM6J%
M=6)2M1C3""Z,2:K<>([*ME2M?EK4]"+U-%9S/O2[82%9-_9R=_I#D?\'4$L#
M!!0    ( )."9T_11-JB>P(  )0(   9    >&PO=V]R:W-H965T<R]S:&5E
M=#8V+GAM;)66W8Z;,!"%7P5Q7\#F/R)(R595*[72:JMMKQWB!+2 J>V$[=O7
M-H12&"YZ$VPS/M^,G:,AZQE_$R6ETGIOZE;L[5+*;N>ZHBAI0X3#.MJJ-Q?&
M&R+5E%]=T7%*SF934[O8\R*W(55KYYE9>^9YQFZRKEKZS"UQ:QK"?Q]IS?J]
MC>S'PDMU+:5></.L(U?ZG<K7[IFKF3NIG*N&MJ)BK<7I96\?T.Z((KW!1/RH
M:"]F8TN7<F+L34^^G/>VIS.B-2VDEB#J<:=/M*ZUDLKCURAJ3TR]<3Y^J'\R
MQ:MB3D30)U;_K,ZRW-N);9WIA=QJ^<+ZSW0L*+2ML?JO]$YK%:XS48R"U<+\
M6L5-2-:,*BJ5AKP/SZHUSW[4?VR#-^!Q YXV^+&I90"9S#\22?*,L][BP^%W
M1-\QVF%U-H5>-$=AWJGDA5J]YV&29NY="XTQQR$&SV+0%.$J]0F!(<01K[:'
MJ0<+^&".OA'PYP)!# L$H$!@!()_BL2+(H<8-*39FB#/26%*"%+"-25:4D*(
M$L*4"*1$0"W^@A*M*1\\9^/28A 3 \4$"TS\/Y@$Q"1 -4M,LL8@!\.4%*2D
MZS]0LG'HR(-MX@&)1DN?#$'Q+-$0.<$6:<.0"#CYE2-'V_HS5. [4;*! HUY
M0!@H*EZB,(!*G&"#!#L8^6M2C)8D?TT*E3LV3(A@KR/([,D2%:QORG.2K:)@
MOR/ \.FJJ"$HFI'PUA\"-CP"'!\L'0\&+9WHSII"0_G5M$-A%>S6FEX\6YU:
M[@&;IO(W?.C7WPB_5JVP3DRJUF0:R(4Q254NZL9LJU2?"-.DIA>IA[$:\Z%/
M#A/)NO$;P)T^1/(_4$L#!!0    ( )."9T^P"X I)EX  +:- 0 4    >&PO
M<VAA<F5D4W1R:6YG<RYX;6SM?6ESW,B5X.?=7X'@<&TR BS53;+E<01%2FUY
MU!)-JMWAG=C8 *M0)"P44,9!BA/[X_==>0&)*A2EGO'&]DR;(JN /%Z^?/?Q
MA[*L@CI+_E''EWF=5?]Z,#L?'P1?UVE6_NO!0U5M?GCUJEP\Q.NH'.2;.(-O
M5GFQCBKXL[A_56Z*.%J6#W%<K=-7X^%P_FH=)=G!'_]0)G_\0_7'R_PQ+H+K
MZ#X.3H+R(2KB\@^OJC_^X15^S8],@I_RK'HH@[?9,EXVO[V--X-@,@R#\7!T
MWOSRTZ*"+T?^+WGJ#4P]:'YUE2_J=9Q5P>?G3=S\<C0\^4OG"W^IHZ**B_0Y
MN(DW>5$U'ZR*NC6@?ODZ+I)\B?L,KJ*J]9S:ZG__;__-MQ^SZ"+*RJ1*\JQC
M$:LH+5NCO\VJI'H.WB5I''RLUW=QT=KXR6@T.9UTO'@3WR=E!5-7P<=HW1K^
M,BJ621:EP9_B**T>PN!]MFC!78:ZA%T4\.A[./"OP;_%S\WGAO!_IV-8S*@U
M35T4"(-W2;F $?X61T4G/$].AO.3R; 3CO88[^##%F:.A^.=;\N9>M__2VOY
M%_#JDE]/H_L.\ #D\@+.-<(C#H/;"O86Y$5 %[0 \.7+UEX__:ECL,_1U^#]
M$F9,5LF"1NPX_<GH9'@^.YO/YQTC72R7<'O+4/T2?$BR./B4M=9R"J<7:'RX
M3J-%%S+J(2_Q+]CBY_PI:T&\ODN3UJ?-$324KHO\,<EV3WF=EQ4L[W\F&R]
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MW,4@B\8!CQ]4T=?VR1 [*'%[\&AP= =GNTJJ8%7DZ^.M+WZ,JUW;^P!4[8?
M?C"(*L:HZ XH494'60Y3 -?.";=@0MYEG]E:8_43L1J#P%$!^AB"UV_4UE5Y
M$Y7) D]22$8+%E=)6B.J;GGDESBY?X!G3B*\$4 4,^*(B* +AR3GAM"U%G(9
ME0^ VX\)T#L@$<MXD<([R]8^7T0AD:\4\0,\AY==R)FAEMLIHZ9Z70-U4T.^
M)POG)<9-.<86&-X!WB?W6; @9KYX#E R+U,A)LN_UV5E* ,1%A_&U1G(,FGR
M'P ()!X*9Y!Z !EX9)J79$C;:#2ZE+@_N#$M)IFC.)7OVLGN(;:\[+^ OA=>
M?!&[U_"R^]B!=V^B%'D"RC- F?OBV)_KK%L95J(B$WO_Q2'.!/P%Y!P\3Y^@
M$P? !F)X G;I)__O,^#=58Y\POO]=1$#9UIJ9MF-@P)L9^$> @YW&V0BM?8-
MHJ)W8I0:G@!T%C>%<P;Y*^G<"]^\"^_,O#K_JD $1FVL#*ZC9X14V"56JU-)
MD^@N28'9>N00]0R)^'#YX':D>79_ BBZ#G+0?IA!6X $&@?/\@-W>0&2,])\
M_^:BQ:*H >6L%6P_ART/?O M*PQ25 <7[BY:#")>Q052:IOI6CO:,BL@E+S+
M#"(,6C)["Z87-3Q1(&G[W;^<C4?CUZ!D!?A2B5.J<=Z79:V? !+A81L68WK1
MO*>S6;#F^^R?=C(^;3P E ;DW@VP$V2/ZKX3K( "Q/J3$*YJN8E)MTM;:LY-
M7 %-!Z IN6*['@1DIP)N4-;%<X@+0)GSAV R;:T-5C$^^U56#)>J7M<L\OH8
M"?( /^IZ23&O[0'TAK@H?T^THZT,?MR++_09D9^TT#G0&"=OTL&?ONYXOQ_'
M.+J.\+8]Q%6RB-)CKT[W6=!]IU)GBR[O ([9(D&S12Y6QF[!A114#8^WM!\"
M?EJ3QGPM%.VBP3H;4%?"?_?%OY6;$^GKM?O9A&Y9!];O'K#Q8(_1".9RA_:5
M/Q'TMPYV,32_Z6 )%;N6C$?723/>=M ,M3W9<>L&?[I\WSILQM0=%Z\+!13:
M X&YBT'-QU4AK#9L=[74#7S$%I!:YHD=0^UZ_;.FCG??;TV]!]TUD(M(GFOI
MD_^-LOC!)U[C(Z*[\ /?\6JS;.+5D]1<'UE1^!Q]#3MG\^/66VU\04 $&X L
M4&'D.D2?1 .1^X0\_2%.EV0@T&8;KTW 8+]MF N#"[39%!Z:%#VS%H9#W\2;
MNE@\1&4L&F+G+;Q2ZFT_<OO))UI;R!ZCC-6%G5L->IV#['K1B]8O7T>/X?;8
MRIYWMJ5H[4='6J]_#SKR\D'WV%SO\^H_R*X7OPUO7C+<KB'ZV8U0MWZ7YD^]
M-7EZ8T5OH"DRR+5)5<B43T^\L.PZ0/O07 N2&A#"S&,]1)L'?+S B39H!%W"
MLN^>7QW5)2EAQ_WFO(J!0(,XJ*W4D66VWM,D74;LGDFRQUCVT:)P>+(G=U%)
M5N\U&A"\,[EFW;MH&2SCN_9PE^Q]@8.P-DL*/:W/$M(U5XA7*]!/Y%@L8SR_
ML4QPZ4E5%QY8'0$#0XR+CU\M8_Z-U:J&5:7G>XFQLW@\+?38JR/U AJS4=5G
MJ\2&K1*]#0*LAVL0)8#;?GO)Q_U1:A?J,S;L1/VEG +@]<9K$FJAB,5MH\<H
M21$B)X N)X2')?OH$L<(L04S >,6<;R412M4_NX#W\K RNP5H@,=[5TXUMNN
MO>XX%A^(=QW+BO7 [<="\^H[ULLH=1,OZ\56,Y=O$A#'<&\$J%?DLD4Q",<_
ME@/I23BT;(4$R7$[;,,?91GI>%2#7R#N!5Y+2"5"0R1'>8G1I2[PY/7UL-GB
MW(F?'/1YW6<6[I =^K[J,%B?(ZED!(]+>,,PEMMZO8X Q*B_)/<9Q:N .B.6
M5E8YTF3A@:3GD2TVB]$@^!Z+Z!CD4XU6*R4S+&R98:4M*Z61'A)2J$#?>(@-
M^4;"DJ;!.OI[CF$$)_D3ZN0YC4R:%9I"Z[LR6281F^&),\,KI;5HLF4M.%2"
M_4/1PG RX.,TUT,$FM=='&=!G"9K6"(L=1"\-_0*,>E.8C@"#"0BT@8?/CTD
MBX?@*0Z6Z%ZI>"19(4A<M7Q".R-&\XS$._X*BTK@6KE+7:5UC (:!>U9;"2S
MX;81V,-^"PVNF#4W7.$]3<9FM6 =5P\Y;.4&[4*LF<+MFM+#J[H0LLS!C$2.
MX#\X/.=MFV[+2+A*XD('3W%X$!S ._ /F?@ ?&E4()W*8&%L4GT '&D&#>)4
M[V#> $,-:3VX['_P4WA]4,!L6U./:+ #_>;!<5"HO?D-H+BJI"K[(U)09V3+
MQ_7@(_'7"N8@Y;9D3O8$1S<@+%]Q -PSAL\I@BK&WB:HY%&,IV/[,6Z'H ,W
M9Z_K@N<. ^+ZK/D1+\DHD2OP659GF=.Q0P>N(7JP][4UMV:#WB[V:Q!&%DM2
M-)!%T3)_'MP.5"B2D@ET6!!: 9*2Y-BC@]NWEP?'XFY=:&&GB3REBSUTQ!8-
ML3&:!=9R ?(WRJOJ)%$X4)<'@;8I8(!D P>O0E]2^AXQ<"G'%/R<)5KO*6&Q
M/UY<7,-J$7F)SB1K"U"%BE8;!)_A7091I)A^!QU$J./:\?81]' *@WTU06,=
M?8$+#K+,FM9!A*PLZ_5&X/4 _"=BQJH('"_&[&0O=,/Q%T)#$59 YV*@!!>+
MJD;?H$RQCIX!T"N\BR2,,%ZK96I:BV25:$R^23**.4*2;7OK,U 2RA(9$ (V
M"E:@3B'X#']!863/31A<%40!H@@8",<+L%,(@GZBM(R?X(K'FG!I-..5EC70
M>R>XH& A&, ".,=^UP)1G<*@@)4 V@$*Y.IHU=55KD*B'?;VPF !0B\HC8B4
M  %ZH,VI"HSZ@&NS2IA7P:)8/0@=)"SK%'4A'E_8!.W+ID<*>Y4] +:$S$R=
M1 )W(0'BLN!@" &_&IOP#4__CF/#%F8:(% UP*Q!)1$N+FVB*_("*EAG4;VD
M.PE0#X7TP/ IJ P@B-?I$A>%T?ERM_Y>9RQW:]*D!NAW#U0P&ET!X@[L*D@8
MIR^R#*]$F\/]FP&("XNX292/\*$#_EV_?7",W&0!RT@Q>C??<-2I6J0EF=UB
MS!#PP3*XTM$KO/0_Q<M[-D8'GQ95CEP5;80AK6K'6&]R^ <(WKN+VS=(GLD-
M!#C)&[#(Z'V=,.E7@ )D7S86\B +8=$)4&Z=5,QMZU(C%S$+>/\3B$(9ADRI
M)<*+-Z@A *OX].X&%F.>X%#ZVZ=H ]]^>G\+7\+=CH(WP(,?0*+]H@WQ/ 0>
M"4(E=D3;NM@ )2@1)>&6Z W![VP52>@"*L6 C[2 (97H0L3=9?5K(!:(B-%F
MDR8H>\!E10E),=_@#L5HYA,1GFY"L8M+(U%& 1+1 @\H 3J\J)2DMA-M!\$'
MU(5*//=W\5U1(V&%@Y_+P<.)]CE/NN2:#Z%\%,?:  <R['_$P1KC5E.>+&<V
MHRR.E!O#AT$/:+,+FR_@UJ(DDC-I*/ P3_+5":(#&:H8,GHM45KF9BTV<V=2
MA'/A[/G=WP6^J%]FT1TY8SQ 0L0K:#<XG8A^3'$!2J@0L! .Q(,I<T7*T<)8
M"X!&DNA-G(]A, A^D=/$:^#@TI)#9'OA3IPR0<6'*Y/T(DC"=PCX$BZ"I0-$
MLF=Z7,]GH1K*>0Z:,14WDH&<IS9..,<E2H\!#SYR.!V/=2@$BUM],%>Q#QA!
M5!T.HTG@7)>2"H'VS #C<3-4D% $@97@CFI U((O@+!1>C2Z+V*%]KA+)?/3
M)/ P[P9@H4DY@4SQ6PP$1(D%B8-F$$6,R5QX7O;;P)K7S!@M2O<8PW&D0N:T
M3:X%<!% U:S*U@$#X!K+YQ(MCS0&67M*0J;;((Y9>YNQ7"3<'N%JB;M%?$]:
MT+W&0LTW..!F%ZF'*8*_P05J<YGW)@8R. DN80M)%:";DHD+L;$7$A8*6!/
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M5\6+ARQ/\WM425=%I-Y#E)$L*1(IA;DR("V/I8LX@^"*I_19YT*TZP)%28E
M6!P;_RK@6,KXY EPB88"BOO(P9, -Z7M,(V#3Q_A ',@<BO1/\5.@+X7M 3C
MG\@32!'/!#N1?JU1L!:[*F#>ZEE,)\HTS+R(AP+$T, @2JG1[Q V90MHA^.Y
M_EOII=4NLJ"#68D8N+;#$*FW#G6W)")EW,2U$7Q*&T"ADE\+Y$ KD71)$.M!
M&+:;LDHG.$$%!@QV45(5(&5OPO$1;T5<_TI_:)!43<. ]O,DEW0I-!EXJ\B
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MP)O.E/@KC%7M%>4Q'P0OFM%ZBR;[A:]'Q9?-+TPDNM23G;*EI(J=5@KD)&=
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M364!-QOV=HQ*G@ *AY7RPKJIN/44JP,82(\.+9*/\ZX!V5^J1^6C>*#>X)$
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M+J!K9^V%.&M_1' '5TBSK(C2C?:]?\Q)4&'&Y49/H+%N-AK,9SP(>G>#Z7@
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M?FW^;:]][^CR"QV\"7(=:# 8,63%B9OCU5>S4AM ;H@5W_C'UH'LN^P?"$:
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MC6KA2(\#+LT):TE2CR*QOU@P"<U]_?KW_4A=H^VU6+6.+NPD&:XUK9_3KN9
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MJWUKZ,$ST4_#'^&'S\,_P5X#CW: ?SYL.>C&L?&DSW=@?WW_L87;>C:"+[:
MVXUOWNC(-8%.762A'PO>UEH?6H,F(X;!#-$ 7B%*)I*8J!@Q0N?6W#.&J:!"
M J6+7&?VC"6_MV[/SDS]UQQ&N)!5;IO!_D[JY6N.Q<P())0V GO0&D(_0TIA
MR:_UI%I<&1^Y0#T>SS.M,)%H[O4&L VH'CK)1,@(RR:-!Q>FT*<X-G(D25+S
M5")SC%,IP?0@(B@1'%4:%A'U0&.GF-);<SE\B5?890SL&O-*7 B,BL50[[H>
MMF_-OK-EFF4O8\_VXH*,S(1Z7^CM\&IN*@[?2!R3LIJ7<2- TU&6T?D[2A+.
ML-W,SH3>G@E#'RWR@%1(<J]YIE2FVH E!#,L%9DN6[Y)E(UQJ1;E5,;[:NYU
M4/.ASSG!'$M$ET7KVO^?3_D?*^Z/_EYR=:NL"SZ@1O-7WP&1@RZ(''9!9"=J
M\KP+(B\Z(')T@%OSI47V7_H@G;H36FJW5IJMQ@HF!:&*\%IM2J((6SVFVPW@
M9]-&TY66I^VY-%ZAB?[,6^'KV C'J*#JQFRQ<@:P'7\TPKUALVK<( +8CC_A
MB!2LZNB=]ELR_ U02P,$%     @ DX)G3R@H*T((!0  \BL   \   !X;"]W
M;W)K8F]O:RYX;6S%FM]OVS80@/\5PB_K@'6V]:MM$ =(D[0+D#9&'.1UH"7:
M)DJ1'DDY3?_Z'>4XH1;EL)>+GFQ1E/29LNX['G5\;^R/I3$_V,]::3<;;;S?
M'HW'KMR(FKL_S59HV+,RMN8>-NUZ[+96\,IMA/"U&B>323&NN=2CD^/#N>9V
M'&\8+THOC8;&T' GQ;U[WA\V&8<..W'+E[/19,1XX\T7J;RPY]R+K]8T6ZG7
ML]%TQ%;2.K\(UVY[UE++6OX25;OE-N;^+V/E+Z,]5XO2&J7:H\*.]B"X@GMJ
MN1/6R[+3T?/E#0?6V:B8P EWTLFE5-(_S$;M=R5&\"O&T<]HQ^'PN1_$(_M_
MAM&L5K(4YZ9L:J']?ARM4.'JVFWDUHV8YK68C<[,3E@VYVL1L.$JE]7^)W@8
MG&<N9H\D[+"7U30P4O+H2F@G*@;?G%&R HZ*+0(.'!I!)@AD,B#DWTD$F2*0
MZ2"0G[GBNA0L@LP0R&Q R,Y(Y@AD/N3M3B/( H$LAH3,(L@/".0'6LC/W$G'
MS(K-K7#0M>W!N ;.IJYY!/D1@?Q("WDCG+=-Z1L+7FCA+NJM,@]"L(78Q7'R
M$P+YB1;RJS'5O52JY;OV&PCBES">>ATPV&D<S"=8-)_08E[J'8QFZ.1B)%0P
MQ(:Y$MR)#@UFDBFQ2JZ,7K^_%;9FUTLEU_L.SS<UQL1<,B6725W+_7W\(P08
M#X\&;+ KR4,*$V-B-ID2Z^12EZ86[);_[-YA3!Y38GM\X=*R.ZX:P;[!7Z^Q
MXL7C@&EC2NR-+U*#:B57$#]"W'L!A^EB2NR+Q89;L3&J$M;]QB[^:2!9CMDP
M2TR)-7'!K8:GP+$YQ-X6E)UZ;^6R@3Q?==)IS!-38E$LQ#KT@+N[/QSVQTDT
M)H>$6 [MH+V'G*!-6FHXDWO!AYDB(38%FJUTDM,$G8P0*P3-5[J8F$(28H6@
M&4L7$U-(0JR0?7K WMV&A]C]'F-A%DF&L<B!,\;$;)(,89/>P<2TD@R@E5Y(
MS"_)D'[I/B^87Y*W]TO?4*:8:-*!1/,(&F-BODD']4U<9T@QWZ2#^J:#B9:_
MB'V#8\8%D13S34KL&QPSCS$Q_Z3$_L'MW;GIF']28O_@F)V;C@DH)180CMFY
MZ9B"4F(%1=4;]IU;R\,Z"GMW+CR7JAO>,06EQ IZ3-F \'7 #/-/1NR?1\"V
MQFD?0H1O6\!%+F1',2;FG^Q-*F,O,>?\(1P98V+^R:A+9B\POX6%NJ;>X\:8
MF'\R8O\\86ZWJDW6(2D^++XL-AU,= &&>KZ#%2 [:6:&^2<C7X-!"I!=3,P_
M&;%_X@)D3\B,,3'_9,3^>6TV^4@<8V+^R8C]TS^;?!K6&!/S3T;LGU<FO8<
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MHOH.EW#07G)5SBT+'_N79+(\K&.O&J7.H.U:7QD>VMMS'%ZW/?D74$L#!!0
M   ( )."9T]LZ:\^,P(  ,LG   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'/%VCMNVT 4A>&M"%R 1W,?8SNP7*5QFV0#A#1ZP!))<!C$WGT8-6$
MFR>%<-A($"C<^U<?B"&?ON5S/9S:IAQ/75F]7<Y-V53'8>B^A%"VQWRIRUW;
MY6:\LF_[2SV,/_M#Z.KM:WW(0=;K%/KIC.KY:3IS];+;5/W++E:K'W5_R,.F
M"F_G\*OM7\LQYZ&$ZU>\&Q>,?WGO\O^L;_?[TS9_;;<_+[D9/JCXNZ *'P?)
M?)#0@W0^2.E!-A]D]""?#W)Z4)H/2O2@^_F@>WK0PWS0 SWH<3[HD1X4UT#&
M-3\)8<W7.@*N(]_K",".?+$C(#ORS8X [<A7.P*V(]_M".".?+DCH#OR[8X
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M96QS+RYR96QS4$L! A0#%     @ DX)G3R?HAPZ"    L0   !
M     ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "3@F=/1 AT
MA.X    K @  $0              @ &9 0  9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " "3@F=/F5R<(Q &  "<)P  $P              @ &V @
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )."9T\[&[OF.0,  #L/
M   8              "  ?<(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " "3@F=/%Z2@0*<#   =$   &               @ %F#
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ DX)G3]MGB]UB
M @  V <  !@              ( !0Q   'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( )."9T]>E11+N0,  %(1   8              "
M =L2  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "3@F=/
M$]2_ZQ8"  "*!@  &               @ '*%@  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ DX)G3TC/'KB(!   \A8  !@
M     ( !%AD  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M )."9T\M=[=\!00  !X3   8              "  =0=  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " "3@F=/*8;FS+0!  #2 P  &
M            @ $/(@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ DX)G3_?Q_K.U 0  T@,  !@              ( !^2,  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( )."9T^L&14(M0$  -(#
M   9              "  >0E  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ DX)G3\:A?D^T 0  T@,  !D              ( !T"<
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "3@F=/#:NC
MQ+,!  #2 P  &0              @ &[*0  >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( )."9T^S4L2XM0$  -(#   9
M  "  :4K  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
MDX)G3W?!48&V 0  T@,  !D              ( !D2T  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " "3@F=/A&,6YK,!  #2 P  &0
M            @ %^+P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( )."9T_0%L?HM0$  -(#   9              "  6@Q  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ DX)G3]8C[HNU 0
MT@,  !D              ( !5#,  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " "3@F=/7AG@@;,!  #2 P  &0              @ %
M-0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( )."9T\]
ML_B&M0$  -(#   9              "  2HW  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ DX)G3^*,P &U 0  T@,  !D
M     ( !%CD  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )."9T] D@BMX@$   $%   9              "
M =E"  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ DX)G
M3]9Z*G:W 0  T@,  !D              ( !\D0  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " "3@F=/8?C=S+,!  #2 P  &0
M        @ '@1@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( )."9T\PF(M#LP$  -(#   9              "  <I(  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ DX)G3X*C0CBS 0  T@,
M !D              ( !M$H  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " "3@F=/XU4X7ND!  !"!0  &0              @ &>3
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( )."9T^FBQ!\
M[ $  &8%   9              "  ;Y.  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ DX)G3P]3C=*9 0  6@,  !D
M ( !X5   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "3
M@F=/B9REG00"  !M!0  &0              @ &Q4@  >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( )."9T\=O_8_?P(  $ )   9
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M970S."YX;6Q02P$"% ,4    " "3@F=//!6IU4<"  !E!P  &0
M    @ 'X8@  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M )."9T]*U<F:60(  #T(   9              "  79E  !X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ DX)G3\D-FSOY 0  8 4  !D
M             ( !!F@  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " "3@F=/EIHLZ>,!   \!0  &0              @ $V:@  >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )."9T^J5T[(10,
M  00   9              "  5!L  !X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ DX)G3U][UVD* @  ' 8  !D              ( !
MS&\  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "3@F=/
M=_.8+F("   $"   &0              @ $-<@  >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( )."9T\.B[F)A@,  -(1   9
M      "  :9T  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ DX)G3[%;C7@F P  A T  !D              ( !8W@  'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " "3@F=/+*.O06X"   F"@
M&0              @ ' >P  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( )."9T]VN!0<-@(  .,&   9              "  65^  !X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ DX)G3Z=9M4':
M 0  WP0  !D              ( !TH   'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " "3@F=/BB;6.V,"  #/!P  &0
M@ 'C@@  >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( )."
M9T\)@9I5/P,  + .   9              "  7V%  !X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ DX)G3[,L0\@0 @  L04  !D
M         ( !\X@  'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
M    " "3@F=/$YPHP.T!   "!0  &0              @ $ZBP  >&PO=V]R
M:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( )."9T^:?1P8(@(  #,&
M   9              "  5Z-  !X;"]W;W)K<VAE971S+W-H965T-34N>&UL
M4$L! A0#%     @ DX)G3\9JQMG_ @   0T  !D              ( !MX\
M 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "3@F=/!TE
MWW0"  "G"   &0              @ 'MD@  >&PO=V]R:W-H965T<R]S:&5E
M=#4W+GAM;%!+ 0(4 Q0    ( )."9T_U\Z)$*@(   @'   9
M  "  9B5  !X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
MDX)G3U$1D[(" P  ^ P  !D              ( !^9<  'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " "3@F=/=(&HXW<"  "I"   &0
M            @ $RFP  >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( )."9T\_XC'"R@(  ,X+   9              "  >"=  !X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ DX)G3PH9+>)$ @
MA <  !D              ( !X:   'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q02P$"% ,4    " "3@F=/E6]_A&,"  !V"   &0              @ %<
MHP  >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( )."9T_]
M[YG9,0(  ,T&   9              "  ?:E  !X;"]W;W)K<VAE971S+W-H
M965T-C0N>&UL4$L! A0#%     @ DX)G3P <I#9Q @  7 @  !D
M     ( !7J@  'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
M" "3@F=/T43:HGL"  "4"   &0              @ $&JP  >&PO=V]R:W-H
M965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( )."9T^P"X I)EX  +:- 0 4
M              "  ;BM  !X;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0
M   ( )."9T^]6>>^A (  %@.   -              "  1 , 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ DX)G3R@H*T((!0  \BL   \
M ( !OPX! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( )."9T]LZ:\^,P(
M ,LG   :              "  ?03 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( )."9T^!IOXX^0$  !@G   3              "
M 5\6 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !+ $L ?Q0  (D8 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812235360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Supplemental Balance Sheet Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Net property, plant and equipment</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6905026816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements Narrative (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895191616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,663</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,715</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,658</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,702</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,360</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Definite and Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,555</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,592</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,963</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>673</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>307</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>366</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,603</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>656</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>947</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,555</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,276</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,853</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,555</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,298</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Definite and Indefinite-Lived Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897530560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Segment Information</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33,212</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>31,209</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>216</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>207</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33,428</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>31,416</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (2)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,446</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,380</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>471</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>421</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,917</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,801</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,345</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,217</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (3)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,341</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,213</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services".</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>36,310</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>34,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,035</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>972</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,345</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,217</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37,341</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>35,213</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; state opioid assessment related to prior fiscal years; other (income)/expense, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$3 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$7 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as discussed further in </span><a href="#s3E77F52A990B55D8984E21DCB5CC440C" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the naviHealth divestiture, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three months ended September 30, 2018, which was retained at Corporate.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>398</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>409</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>170</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>135</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>568</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>544</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5,832</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>272</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5,264</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>816</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, <br/>2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>21,755</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22,446</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,462</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,962</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,179</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40,963</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:13pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6810168768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(112</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(101</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>The sum of components may not equal the total due to rounding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6896776448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details) - Performance Share Units<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 51.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">43.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">48.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">50.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 50.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $</a></td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6896288304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895903136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Narrative (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109977999&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904189456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Summary of Lease Costs (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalFinanceLeaseCost', window );">Total Finance Lease Cost</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable Lease, Cost</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalFinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalFinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904974720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Lease Obligation</a></td>
<td class="nump">$ 7,991<span></span>
</td>
<td class="nump">$ 8,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">19,724<span></span>
</td>
<td class="nump">21,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities Member | Committed Receivables Sales Facility Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>44
<FILENAME>0000721371-19-000127-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-19-000127-xbrl.zip
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M'$I+J 8NYB_SCI#Y$N"SRTPNYGW1G%P%><>,'V37\JB4FHY)'%,KXJ?I]3S
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M,6=V5?:K04C\$.W##]QM@*[HY/'%M<P#E)N3\>T=9OPM7\DL(/U>\H<8,GF
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M>,?TJ3T_92Q(8R;%^SY75!B C>UX<VI]I^;4]1SO[NG&OIN>-%-('MJR]U-
MB32RU(O [J)!D(P*2 7"9VK9)G'J==P;M\6Y_M*^ZGB4.3Z%[:?Y;4K\&3%I
M%)[DH>9M[RR,Q-WI6F#"Z5*YX-DG1-?YK0G$V=<M!K#[40H67<N#%696+<VL
M(\?[!%;4!"LJ+/V%9[]FGOVJB1GAV'TUQVY54$$$>5XIR%,A_4+@P(OA0(6T
MB9*44B%#7E"&5 =]>)6=XI)[.Z./8DW1PM0G#F;CWDXIQ42_KF79""CB#.S
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MPD2NT)/@#A;E4=2+\1M4;S#+M&N&[RKL?"L?:MOH_[L=\HX,E)A3R71($-1
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MWVV\N03!S=H=PZIQ/VR;02INT[.XC >'S,@3=FVV<<OVQ.;@?_"P@)QU0R8
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M2CGYUI,>J&0M[Y@D.UXXL<<4N ?F/:)KE/K8^YMYHY-HK<3]P"SRN/"^FDM
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MS]>GC][/UF_KHL8V/K"NXI(WMST , D"&@0SWM_38>D>H<>KDY9:L.]K'!T
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M=Y7!H*7M;8=]\6"?F?'2I*0B*A! Z-1MX/L#]*SW/60-"#OXB2$J08?R"(Q
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M>@,Z6X&PVK2F4RB@$9*-+L."NR#151#YH(XV9SG;0TCA,H=]OZD_T<GA4C/
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MJ#QY?NE^N9_(/">S1U* 3I5'4M<[6/><5[2O.YKLRLBF_PUPX&';U'555;T
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MO/5SUK81UX9<^U9/:#U-N%R 8>&CGK#4Z//8 $^[%4 +_"0N1OI)Y9@_-J8
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MT1XLJSR3Q16 5_VPW$9V5$Q0AL' 2Z'K<B;]EA!:S[I-M\L(/BT:GK$)TU$
MN>T^Y1?''(8H6P<ZMNRBH<'_70VS@N3,+R1>D#.1RU: 7;C7X 8FTE'SP65\
MN*Y*DO_@ (B^@>(?I.&8I6F"/V^"D(J0J2"-**:*WW_]XWU ?WZO^(Z"D>%9
MCN%BW0U,1_-5WS9E;)J^K2AW4AS.Z)H6V?OG,)Q_7V!?=@=I3["MWR$?*?#
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MJ0IYSV%@_$2R[/N-!H84-L04--:-EP05O8I+JBUMC_8/>IZS"T,OK!"K,00
M>8%O^28U0F3L8&1YV'*Q:F'+"7P5ZZM:!E4I:B_F6>R,<\4\]\2"GH4^N\I^
MN  _Z:N!<:7\8&_R5U!-_K8B8]]R/.09JN-;NA%@K:SD1@%&)R#_[LP(0?Y'
MAS8.GP6P0>EJ[]Z\"'_<Z=)<4SQ6V@R/H&W<@W0TEJW#NY5OHZ?%Y1L@?Z99
M)5=3C=Y>A5.T.BZMZZJN^XIC:ZH?! @I2%&KE%9-68M+O^$H.IM3N-/:]6,Q
MY :]R=TP_@&ZH07[/JXWR("Y];Y.?$5OI FZEAQ8KN;KGJ=ZLH$#5:Y&?SMH
M+=?X(-[<H4/>M/K D'OLR;^1\5/]V,_F)OY=CL;JZ< !T4!9S,[J_:PD 0<!
MARMHPW&<"#I^D-(&2TU!%T.CK5"[ZHE<1SW^[D<QC.MJ C@[YIBTFG 56(%I
M!IZ);1=A63=MVW1EI#F!H1@FTERX1TRXZKFZ*29<B0E71X'RVCGCK>]?3+B2
MG'!**85(GUX(6:61 _8KQE@)+\Q)QEB]X6EY:[+4&T+U:L98730[9%@#B?8W
M83L-KU9CK+@$4N61=-$Q1/U(HKL=E+C[\;\6,=EY^'WQ@IV6&.PL6],P>MFX
M_/H=O]=!Y]>^UWZ6:9TI<XBW/\VED%&UZ#)_C;5:?6$$@P5"7P1[AYE=;IB]
ML [RY%^+Z$LX;>E9:[/AJ\D[/F8O9\@0WIJ$IJBRCHAB&GH]KB^P?<7UD&FJ
M&L8ZLDQLRK8KZY:B&BA83T*CZ&''$_B/7R.(G;MTA=#?\K_#Z8*LI*-]X*G"
M751UC!3498^ZB^6-W8":>(7LX9JYP=[$;S7:S+@!\F3%<U4'8ULV'4=W?*0A
MWW5\7]/DCH@?6;]I'1"_,L)JEV5=ETT:O0F[XN['SVDX(5)*QH2BR^.4\"[U
M-]:*NK6DMI!<$2N6/1.IOJ\BV<:&Y]B.K.E:$'B*[6D6,E:)]?<:YK^0O##G
M3B:9S1'JMG'+MB/NK<@>K)$S9,K<FQ 5JR)$1[-\0S=<6S411I9M68Z"#:1@
MQ<.RX@0M";$C*6F.-,T<-"$.T.C^$'^A.)&D43?RL:?$UEX,:C7U^8[C*+*!
MH'0*:YIEZ=C3'-.V7=U MF:N4E\)VE=*>Z>S2Y61AKNDNMY*N5L29CTEH[VI
M1C=KY5'Q*(78KD%-.ZR:BN5I6N#9KJMCQZ;_?QC5="2J*-68G8X<Z+](&H!%
M]S$E\S":2.3;'-+-NALW>FVZ8WMQ9M:$:<B>%?B68Q@VQJXJ6Y;I!,C!'OW#
M,'UOX^  'FD_M4F'1B8^R_"PW@H[8=)=(5GN286J+->MKER;?N\X,.PKP+9B
MF(JK.C8V?$OSD8_6Q.,^5-B5D!Q9FCYH*KS5OOE+"18WV/BZK?Q49:6F7 U9
MMFRY@1U@!0>6XE@:DFU;=5WZE[T^QOL\HE-11P;J5';VLON%Z$L_8/+<FQJU
M.IM U1R0G)JGR!K59JEJ"\UC7=FP;<73Y;6.L><1H0H>&9HQ>&KLIQ$J^H?W
M!R "" (KAA],^9@F<[J%URJ+<0[EP2*NLBZZ4<,$EE79PX;JV;J#L*_;IN4Y
M@6=ZOH8\0_/7<H%**'^<AG%NQQ._!/0IXRS*2%6Z; \Z<,UYN,IQC_1?I-3Z
M+S:1[[J^9JC8Q[YO6?0*QS9E&RN::RM'$E%G>70J[M*C)!3>,PBUOR7)Y&LT
MG=;1%IAQ$L;/D4BJ.U3J-0Q66?5-W]60A0,+*[YLV2:R?5_WK<"P3=5=CXN6
M,.>F*Y]YP >HE4=TNH ,&NF=9AGTSQ?<*TKNJ\"\-DK=FS!UW$A8,$S#=AV3
MJI]8=CW304K@0>J"H@2:XW=#F%W%:-#(E(=-F#<X?8P%^;H)SUSIV*#V(M:L
M12RR7&1;*D:R:F#%-6P;N3Z6=<>U?<M?]PDW8JLP-NCD20Z:V64*TJZ3[J]D
M%5.^KIU<]Z5.1:[EK.THV/=,9-B&ACW#<&39H4IP@)%GF%0);DF=G24_R/@F
MJ%-,Y7I+Z/"$B;<D\5$P:Q6=/59#NW@1^RG'L?19-Z'_J7431[<M1S$,-\#8
M"!1'LP/3,BT/Z99MJUOBU2=31E1KA(Q>3%NY$C6E+?^[3OWEEIC<3?*TO5E8
MHQY*P;9I>Z[C6=C&OAO8MH--U?1,S_4-0UOS8&YC81UI;)H\LG3UIEG814/J
MUY!8,;!]W])>;_*,>Q]G/&U?SY^B\#&:1GE4U'I]>@E3\D)_(VGV?_^/J2#C
M!PD"U_GK-2=<W6SJ75\XQF"!,+@4NPT\HNP6.JUYQ;$M0Z_]V/N@&?2%MJ]]
MK[W7 #JTN^WQF*X_SZ1Y^ I-:\Z$V@-PJ/;;N=#:8:I:2ITOA2U#U6W7<UP-
MZPA;)G0A4VT3FX:AH[6TC!*9/G)<.GG)NC4R.DT0[I]WH5<<Z-KEZ?4Y./O-
M8_9E*1I"-4O175U'GNZ;JH61CDT7R\AP5-_ @66MMU/;EZ5TE2V-1E@==AN,
MP1DHM3TR3U*&@,F3-$U@H22=2<DC?1V;>M1H7B-E+_1:?L%C @^EJ[Y$67Z?
M50&M4>M@><@R/$]&/C20,AW;=4U#,0,UT)"N*FB5;G^B\/],H>N1QYPU$9Y'
M>3C]B809^;4^D%-K"/HP6@C?DG%YI42V-TUI=3:68LNJHABNHVD.]@/;-%V$
MJ3RT%(WJV^OJ]9$TU57,K],<K?Z+P0$8^45N\WB<+LBDZ;6[L=*$]I*P4:N
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M'[9W-@.OJ:RUK6N+VBUJMZC=HG8-J,UDI9>EQ4[%/#:<4!E+A S+4)LP',<
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M+8-D1;[V"Z6Q1A>;UIFBW5!I;)WL:BN5:6CA/QL_U*-5SZT\8P]U3'DY(,4
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MJF?M)/YK-D@C#.8XLF"V^:5UDBP8(;6R0"!HO2]8,X]F\N@U_(LT9H!^3X#
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MBJZFEQO.#@B&*\XU#DJNUS+ 91E\4$ [Y,4+$DTHT%@8!+!B&H.84+SL'>U
M,G_MX4BV(@A[0)*]7?;6P\)ZWDJ<QT'ROW?G,X +%[_\_9@._4L"#X=XK\H]
M'T4Q07&#8.<,\M^K#QT$>O<?A?L@R!/_LX!+U$G[_?FG_W$%KK+?_6(ZQ>\K
M]N)S+S3W^#7]%GT<WB=+0=]OO>[TSO_H5SN/-WG2]Y/1)/VQ^.&GI]&EJT6V
M1*61XOI<BOP1F/SIIZNEV-C\,[S=9T<NWUP=@$M3Q!'9$%J?$Y2-SJ&K<[L/
MI[(/C6K;?_H$7QMD7YIGOT^(^>IGDXS]D_T%_YDF_>E=':;1G"M79'+][SYW
M+TCR&SSH.SZF^VXOF@<10DP&1,XKU@B"-[\UCY6>'L'MPTDK=A*Q[<YP#F<,
MU7(ZE/U[-RZMJB_IFYMQFOS^)KGUDOACTO^6/$R"G7 WGAN<26;^3QQB6#!M
M*$*..L@%@]H:S:RRCEI&PW>2FBS5 YZ]U?Y2K8VZ;&LBMMX.I6C]9PCM8*.N
M3:).";S%=$42]?R#X_8FJ>'P]#;[WRIT^G4X]82?#B/O72>#3KC3IVDR3>_7
M=R'<:T_/W>PY]_6?J.):$1"9W_C/W=YDU$_"3;/WOND/.[__%%40[\^/+O<;
MG4QS$9U?1&1VS:/TB?5']4\3:KZFDVD0MO_T\NCW:/*I<Y=V9_TT'#$7GTT^
M^UOI\&)7F4H-OWY*^VD6='HCE.,6:RD0Q\H21RC/L@P4 )1!'+\!E0;70$!*
M#$#"4/]_DB!6)"08 O!5E'J3;13@:#Q+KUY$5?&$F<5&*N/=< VOME^S.Q3*
M<0GILC?IIIWA. N7!5*E_N'D;539YEW-W3K?*#I\<*R.<.2[0:1F7_PCPIF]
MN(Z^I0'HNM%P-M[?=5@=7%X;6R9$2NSW'>/*\0V(58R9E4P)A@Q5(O:BH#2%
M DJT5-CPUYXG4V_Z\"YXE9X=WG\;I./0JOE#.@ZNIK=V]<.'9.Q_?!Q0#NEM
MXC<X2+[V*E/".\/[=*%&==+WFC7]=)>F4S7H*D^T\/Y)WWK_J#^<S/P#]8/_
M932<)/V_>(-C-/&WR+/JPC5YF#?MOA^E.:^4O>A^]<_-7=:E3AJ#6?Z',K2-
M%I'M-VA#,XWER/8HWX@#1+9S?AD6.QY2'#(:^!^BP6)]40&0U]$OOYCHNZOR
MHZOO@P'3R^1X.([\6_H-]E9-V+BQ-T_3;G3S$!D/\M/AX#JRLYM>OY>.HW]/
M[D<_11][G=!9(DK_Z-PE@R]IEE#1229WT6@\[*1I=Q(-;P_%T^L/3!9,79X@
M<Q![D.::<$ -E%8XR3U3.V*@]<[5TH')A_G[N_'PWO;"[O2FGMG>W^K9Q&/)
M9)(^25N:9RW]VCQFWO60QF_?,0]I<C;Y+O.(HZ2;0?#@2\Y1WEQ,/)O=IO-.
MWVE^3C7Y/OLM>374)+"2#FPU@MIQ@3UN6A9S(0OS@$**=T+-7X>#0A#]7N27
M7 "&$G)\#$W_.?/4> 2@231*QM,"6J=WR33R2#MY/6XKC^R]D6J!XTQQ:01A
M@' &"VZ+H5F4;GL:_?BA7,2[0;<W]J;O@MDN@)F\'_(*&ODVRRM\RE3^SZ7J
M?1O]3QKYM0RCN^1KN@ YOZA^E+FK66QAG"8=?Y=QNO1-_Z>DTQG.!@N<G-[U
M)G-='F@5!57UI?HB]^GT;M@-KU'Y9M9N-7"[-Z+?9!FK_J&CD!3@/^PG7]Z>
MB%EM9^-BN2NR;Q<9L]$\638WO+TT#+\,_#V[0=S'Z9MI\D?T)=#A-0T76J9:
M R,,4L*(V#NDT $%@S7N8&R@T$KJ1Y(^3C\G?_S%O_UP4#%:5N=7>X^Z84*^
M<VGS<?.U<K;(YO2%OL7#7.RZY7X'W=&['R6]<>899P+V7>"I[W_PFS<)PM:=
M[UTFBGDN<F"YV3B0JAMLFQ#Z'63QK^PQDX(VX1MI,AX$<_[MJE!34\7SLY?+
MCK_R(0CIUZ0_2Z,,)1]#UK$K3Q825^96 <>$(A@Y[_Y"ZZTY0H133/G_@X[Q
MI5&#<8:M?\V@M1(069T\=28BA\^\YJ5@"U8)BWBVP-(J8I2@FEEAE#44"8XQ
M\F;_4I;DUFSQJ$/HB;,%7F&Y'Y(M0GSAX@MK_FLV2 _WND_+;-S95#A=9PIW
M-!YFQJZ7JFD:3>Z"7?W(3O_W_R,0Y#]-HD$ZC8("]X;C7:]SE^FJ8#^.P]J]
M^GZ?]1?ZKI>)\/<_S(,4U]GW_,=ATUZBW:^S!_3N0TU36-6*+-8G-:>+M %X
M0VZAY(C>4$QX(F2:X!O6Q1U&4\AO;QZE#;SH\"68F;^DR21]_ER%062,!,BK
M3TYC&>;T&J>PMMP9JV-4.5=A1OGK!!=*2("A!5!I?ZE3G$(&!<\!,P,Q-7WQ
M<^"^QS*-/X:A;Z.<(*=A!GK/=33VVF+LOY@[OL-<-05G,UM''O(;CD=AH4$6
M;WN=U$N#MYFGX][-+-/4MTFGU\]"U=?1U]2+8S_\E,4&O=X=!5G*O.1NZH7G
MWF] U/.6MO=RQ^,0J,YD+=2GY<^,DB"A'0\YX=XW#U$:#-3\I;[=I9E<!_&M
M?MMSY=?T89+7#X:]#:[ +-PKV!$AD'[;"UYEL.ZS%RMNY+W.X4WFZD]F-U[R
M_97>Y7^(@M]?Q W\S8?W7AIOTD%ZVPN5BN/A?7:7;,NR=PF1>._3^Z?F09WL
MK^$%YC?)GOPV>N\Q;K[(+QZQ<Y?DB[_O.'MJ=Q@-AMEJLE=*!@]1 3@!^'O=
M4$F9F^M?9HE?_C0$83V%JE=YNF3ZP=_F:SKPUTQ.)6B@TR^]08#;Z+]F?C=@
MKF6NEYDRR?RZ8%GE8)\WD\M]M^OBMT['8TPWZO=RXO0*GNRFM^EXG'TQZ(9H
MFOPQCV3G7ZQ\88,?>),;A%Y/I1EQ'[]FSHAOAK=O,D;,'<OP&"].08O[>X9K
MGRSNT>/#.JM!D< :]YYI.CG7A[?P+Q'>:YBKM)&_<?ADX=+E]QPE#SFKA0R+
M[,+\[T$<E]][KBLST7_Z=H5_/*F^5Q:P\GR79 L.+!7>JK?F<6KB#94\_C8L
MQ&%2L+XW +YZ@<WD]G[4[W5ZTR@@3Q8?RN0I(T<_^/M>9K+'>SJ.LPWQC'8S
M#(P6WG>\M#F]06XM!UA)OB:]?I9DMG)3/=T+L"K"6!NV-@.X\(+9DZJO'L"N
M-\VW+.D&I"UN'9Y_*K*9IU6EZR0P&&[I>/KP&/4S<^LZZLS&X< YFIMVV>8-
M0W:%WP4/O_[M<V^H(H23.W]M?L&"I'/Y7?G5:_]BD\G2DUXDOZ=!B)4J9$Z*
M@CK9\4BA1?*+/8][Q%F$P+R]\N;I![D[$31?KB<[8?Q%0$TO>IFFRRR]/,PV
M#UEG&.%WX6ZNYX) ! F>Y.0,.CV$O?OIT[=X&Q4!]^M<G4Y[ 8J'V7^O@S*>
MBU=.R$F!%EZ$^MZ(#";Z@N<RIVC6SU J5^3Y=W-\?QM]>OR';/UYHX$\:EB%
MYG!<'E+0<@X/B+10K5EPL>HU/.\"+.5GS1,\__135$F]^O,B0^WIY?E%>4[W
M4H)6M6)N%XL?[F?(HY>9[D>5CT<2?KM(!EUX=9. ^)YKSZ<YR-O3 *Y'!VQ5
M*!F-@L'MQ3D$J4*A13! NKUT#B\553"'-V^\CU/O&'A<FIL-"V-DX4049E2N
MD99-L>S6Q?UZ'L"2*-<IM[DF\1 ZB"":,X8'D2=OL;"2*G;0/*YP^AR5!3NJ
MX!>R"Z-D'O#,%,*"@,$T2CJ_)U_FODY8^PI23L(Q[WUO&KXSR[J[9%OE?9A)
M=E/OT'B9]=JX".@4*FU:'%4$BGU+QMTGAF,@WG 66"#35MDI*_Q^X> %'RI+
MV_!OE(/Z_'N97UO1D%[/H>\+-14TGW<9.W-CT7,0_CX*9=MA#^<>7L<;L2?C
M6KTO-RR3O[S)3FG7!\:>.[8E^Q\LK:*(;RU"_ Q12L/)#ZST'&-6&JV 41A@
MJ67,$&%& P@IT6[IY.>7D >6+GR9+ SSV:_J_:V9DW_-(=!D//W[QQ!)R(+Q
MX;>_^IVYG]T7D?A*C/W-).W\V)V-'T)#F9_A4Z4?A;\?(K8^&\V1<CS\(^NK
MY!'S%:A3YKPH#4G,K+8Q$R8FS%GD/'4X%U9C!=@AJ9/\L15U$%Y)GLD!Z%,-
M[.22=)\\+!!L.,I-6$]!O[PT^#CC:.X!3M.*?^PQ:U"ZBI-A<! ?%KDH<[,U
M.%ZY7>VU3H HKR87(:H0-QMDP9_L8>FXT\M<TF#R9&_Q%*]V2O;/J&<\_'T.
M'NRSL6>))64,"PXQ$$89!3$#&&B"# &"NDKLF2)N"2>4*,"M!ER+&/A+8\]?
MCB <[Q,\/BC6YL?I>6NM+%J0Q14FL_L06/U7.IF[#0O_:Q$["!KDQX(>EU=%
M1S96T7&XOE+NF8\0W^IKEU3B7BE=W+'N:PYVQRZ'KW?T2&:=_C6WS./E5+2F
M]4$X1&?IIR=7F3$> ,7?[SNO9N89 I/O3X*1=NML?%@NJWICAQN)VF 6\^[&
MDV.#H.F.U##AL!.C:F64G5J\;V*.!G=V7[$%&[+MYYZ'P)6!%Y  J T%P$C)
MM85 >C,1"JD1CSE:&GCQV.<(5NLA^T]C6&=C]S,=?G8Z./;HU.L9%#N#8>T[
M#B=I/K<=>L+X,?A0/>F>O2*U8$_&K-7H:+0NJ0S=)(1;0)&+D:-<0:F@U5Z7
M>%5"C;-@U=#-  >9)OD8'OW^]K\G>>O.9R8FU:I@EG-Z#Z!?FB_4K^D]U"C7
M^0R0VR9HF=,U#D5EBBX+;4.HT40Z2Z73PG(OT"9F,8* \&KF;+;W58D^M&U8
MJ^B>M@5X!B[N_TO\IS?]&J7V8E2P!*7$QI)+P8&+A9(NCC$@&(?,<X&E$!+1
MIRJXV/:C2.Q1G+D3D-;' \8N;53U7B&L%^W=:<PFK"N2M>7.G*/-(JNS"YUF
M#!I%H  8X]@8$0<$M$A9!LS2A([CQ+'8X084MN,)ZQE/6&-[S95'V)/J&?9D
M-AKU%UGVU<3I1WGUE4K\/-UH<;Z]8V7;I\ISJP6X[\J';LY",)08 ZV$ $%&
M)--:(&B,H4JKT*OE336\3#%UADB@L,#(A)E4_E*K8B*AT\\GSFY\SK,5<.VQ
M__D?^[<GN@U-#=B057N13NZ*;2H/=E?5N;Z<I0Z[10V=:'YV"+1\X/_<F<3Q
M#LB:YO*<=MPF-%U>V$D00&6%Y%9R1XQ %D(#C45.> ,(PZ4.+(^/X9\<GAQN
MMIFL,^AZ I&:8ZJ<-9.)(!\=?$134Q1,,S;D#/5)OM;JOV:YB/B9TOGS3-/8
M';E)&7$7,7/4 6D$%%)YO]8R[)&;8BLPEW:IL.8Q<O]2U-7-Z7$PZ(9@>5A\
M"]TG)K1/S<+Z)/12#LLPJ.2K"&!L3"454%,: \6(E5YTB2!!=AW<4G1#)^L#
M2R^&RV.V+_+L[*P259JE<$_U] >#2L8*H@)+:A!EEEE)(+"6!)&.)2?*P*73
MGS4B?;CYZY"V:2L7Y4VT[M6YNU<K@*M(=*\EJGL,XC>"X&=@LW]8W[CK:8.C
MUD1?H\\A867#<F^+>PU..(%>!U,>2ZB\/F>0<J>H6LIG>R:E_'"N]7*+_M8V
M/W$EU31\;IQR/@.L7A$"7=D,L<7M+7%;E.=96#NMG%20:*,X84!EH17& 8@1
MP$MEI57</EI,M%97K,7MPTOL+]OW*FU/+![))JJ<-3, @<32*1*FO@BDE--!
M-@T'R OJ4MASI6P>(>A9:\RS^6*X,:VW,<D]QRO>VQ@1/7ZQP)GWP]B7"<\Q
MP(PJ$Z0E!@QIP#E5V@&).(R=!T\.L#$$P*5ANRO!\W"0N3S6]H!U!B?83V.[
M H3G<_L?/V!EG^K-/:6WR&U_\3R7J@QNGN^R5WW#FDJ,ZJ)7_B6_LCOO[5K<
MIOQ]]_*-I7SF.AGH *]U0I4*]\GX2V^0OUXRFPZ+/^3&0_:7FHH9\,9B!DS6
M5R5@O-UGC3AMG@]'VBKLPPX?[6KWH=V'IH<.]E-9^X\\7F% (OYJ;+1]9<]^
M^V:2L7^ROR ?&5A'H^SJ8+C'^_F_>]W^ZN??X$%?;W\>"F?#P92/@LT?)L3<
M1Q"\^:TA7'3T8^'']GCUW[MQ:1Y]2=_<C-/D]S?)K>?L'Y/^M^1A$K3YW7AO
MN_& ;D?M+W5"-N/1#$+$UAM]%#U3WHIV, C7UFRF!-YBNL(EGG]P.HIR_MZW
MV?]68>"OPVF:==]WBVE BYG.^T?IEO?TU''NTM>_%N=WA\>71S->%"U:%YZ8
MW_C/W=YDU$_"3;/WO@E]$HJA8AGB_7G%Z+%,1&N?/+;?Z+#CMKS8L6?%A_E(
MR,U]*:S6"J+8QC$ L0+$0(<!!@IA89D0U>D8RA(N&8!,&B<)YL(I S"A',0Q
MYV$ZQC-]*38^9ZDO1;7;QV(HWL9.'T]#BXM@]0:NV>+]+M&6N.A.&>V C'9
MQJMD;9Q7.Y5V0$8#62S$J+Q.'26>%F$.97(?ANE.'DU4#D.C[KUBG>6SK<NI
M4944@Q\WL."Y9?JM/RN]E&RW9K>I+\M]*X.4%US^I'JP[0YS7MUA,"ZK&J7!
M%O%86: LAX1" 1W U IM31QOZ@Y3.% G,ZBE^2!R#D,PYN&[->CR* _OPO3B
M[C)+RCZTL8.QD!3'G%OAA-$8(B^SCB@$D47/#L/X,/:F2V^4](\ANFUG@9/R
MIT( ?O F$]D58VNBX4V8;IO;O.D?G;LPZ[<<SE[-F]]D[;Y&V=-A-JR%^\ U
MZ;<M3<86UY=P792XCI6 $ANH':>:F]BRT%^< 0&0C#673W']217J^[E\OAO$
M<^ETP_%V72CJG<70%C^=FCL8)/B16=:V97LLI@248FIT;!3E#CL'G$!,*L>#
MF%HMO3<EEH:P;R.FV^3RURND=:;S-U\6ZZF :K80*V_/AY!D;HY-ILF@FXR[
M4=(=CG*>OA]Y2GMK+D0H_VO6?XA@WCI[U\2XXF5GHS6;[[?HIZ5SX_+[=#2]
M^OD[&,+SL]'/>[W$5@=&&XV.8Y;)-1KM*E5)@DMH& $""D-B@@%6U*,=9)HS
M .%22:=7):K3"5%RO^ /X^' _]C) N/OQR:#NW>#Z@69.]I/X]O;M.-14LVY
M];=9XB^X]41:GM,X!\)/]N_SA_Y==4/>1N;/>C!=_PH3]4=O\O=.<O=W]<D(
M@OZ:G9=M"Z<33Q[_M^>[< '0A#JI4RB%VO+>:RI]7I01L")7Y;DD@6CYE5;F
M!Y)<CN>DW%HG>538D%OS6(Z7DBAVU1 YUF[-A &^-[SHLYE3^RBS=_D!VR0[
M74LS< AJ:T]-%;[[;QO1CY;H!X5&4)$8(:0A- 0Y#WH62,<X4=B):DK1Q[33
M3R:3!6@-;[OI;3H>I]U0R^X-/(])XVXP\[[UIG<Y *T!MCIB;\O!M^) _ D>
M[;27T>UX>!^-BR4_!,^_6&Z4=4OP=D82.I_<3K+)0U&Y_"BL/R/L=)P,)KV,
M"E]FO>S#MZN:63U"E::6+LX1>'%B_WZV?)(6W27>(HMRI9QVWR1>Y)(OJ=^Q
M>^\4+*Z+\DX4._/[RO=YI/N+5+DEYF=E)IMFA!&A,;0:(8P=PL@ Y#325C,A
MEN(1CV,-_S-?H\J7^+%88?;A9[\^N*Y6N<+5;R9IY\?N;/R0)N.KG]E;M"YU
MK<9]BL+#)EF;M164ZO8FF6D1^:6F!R71>H"J-!K&3%AF.1/4,2A0#+6C@48Q
MCSU@(?(B&MGYVC[ZI7U(QYUM6G!XV,E,J!*B\ *AWJ#G3_;>+MM*T2A_[@'H
M^A197I0S6NS?I\Y=VIWUT_>W;C:=C=._>IZ^G]U_S!(PBS.5I;C;%AFF&A.$
M%&-6(>LDYU!A!;#Q.H<'_0,J&:88"""0@)Q9:: &F&IODALOI\ 9S/ESH\M>
M,XTWW[$YPHWF>Q5E65O1(#MY& 3[K9S5.YD[J_M516T8&+7;33TPC,/)R#PO
MN3SRJ 6!UOZO>,KEI=A"M#''ENZ68PN?J>U^+C7W;!YV=@>9YY48^DJYG]L-
MD&NSS2^!%[9I.MURPB5P0M9*[<)3PO^6^8?Q(#QZ8]5%8YOT'X9E#I#X?5'8
MT7) RP'GRP%GYVE<_9S'-4,(8WB;=5XYFV*)4ZZ-V#:4RBHGW9!8 AW7!L4:
M(LXH41!@(RU&$NAX:<#3+^EDDJ9K$NR*4.""/=[?YMUY@O&P.JBZ.,W.[J3&
MXW!8'F[R^6&4+@ZN'S_O90?8S\1BY5E465R &]("23.!A*+*F8R+#5#"QLH*
M0 5A!,R!Q FFMVOD>S  J3ZM-O@XB^'=+7HT$3U6!"%.%TYV3LEC');U7XI:
M8V',,4/8"J-(3'-\P3R6F#WN<Q.,E+VAI0X+H\ZR@!/(.#[].)<G/=S@S9Y;
M'<_6XBCX0AR)41K&B& 6"^*D@,PX+XX:4$F]J(J=_ 8[2X,T?OXV;*"S $&=
MWD+SDE@;)=NO%:BZ5-'FH)P1B9U &,+8.@X=%X:C,&(LB+9P,2';S3.J5Z0/
M8KZS5IQ;<3XM<=[9DN:(EMU/)!;(*J@A%Q(Q&!-5J&YM:2RVM:0WB78M.K?6
M 3R-$](S/!KPM$?G64>[M:Q5YBU#8I64A '!@)5.$.ALD#7"M:$N7LHF?Y&9
M'+HA-M!0YO(<?-X+B(M=C$"R4OD10K71''"J%);2R3CDD@>!C+'7@V@GXW9?
M06RCTZT4GJP4[FZ3BK*B1PMAF(ECRP!&(C;84IR+I8H%D.2E-NEZB:Q!L@0^
M!]&ZL* NOC!7<5LI%*!4CA8*@2 @E@"'O=6J* W)(%I(PRUG2Y&?EUBK;CAK
M8@H(%6?M8#9*MINJ6,]6M%&EY2T.G3(U# ,YJ,4QB)6>B[9U#BZ5?&YC]^XK
MTHTW>UMY;N6YR1:T(+C21Q$*8%VLH8&(8XLLG0NXI3(&_(46]'K9KN/DI>V1
M>WI177*>[NO6LE;I/Z$=P4Q3  #G#CB)B<CL9$/\Y?Y_>]G)O:]-#.J2-E7Z
MS+3DJ<NC*'5?;"EA#E!D%>+($*:-R.61,:[=4A'#5L;MGG)X$..V%<)6"!MM
MD4I05@0PQ0%&4(:^/0@C+KBW0W,M&2MIX4LMTK4"68=ZJ],B;;[AN:E:_PQ"
MOI_]WJ79?/-:&^0>>*\:I& EJCB76", N68:2",YCJ4,!J_Q?_=*5RP-7]G6
MX%6!/@VV>B&I,Y=A9TYJK*IN%(XT5<=?+("0TA8@,=:6."61!8PJB(%1<P !
M&( 7IUW4!ASUF.G_2L?#;C*Y"QPC$$0_M:C1%(%H4:,9J+&[2\'*(D!CN12*
M"R,P#V=8' N7PXC26#GZ I=B"P1I#8C7\DC0L?N'U>EXA&9AT>VJMJ\''M71
M4,G?6M!%:2]HHJCTG\3.((,T8%*8(.A:,Z>AYKLZ' WT,2@\'$0L\\B)& 7'
M 8#3T/WG)N@$@%*C"\0Q=SIV! ,NK9),DKF@2[6B0&*38_#ZOL!3"Z"5[E:Z
MST&Z=S7@B9? 2OF%=,(B[F)J-4:<(YOK=<.!T>R1 9\94B\4]#KT,:XU);2I
M$MO,].]ZU%"P!G\LIBD,AM/H(9UZ=KGWO--)N^WDO]-,D]L:;TB9T4YA;!'6
M6EIO= BC$3+,XXVS1G#.Z8JN06M\B%^'T[^E4U/PD+H/(V/^/WMOWMRXD>0-
M?Q6$GIW'W1&2!JC"Z=[7$3AG>A[;W>[N6<?^-0&1H B;)#@ *+4V]L._F56%
MDZ=(D"(E>'?L;N*J(ROO_.496A-Z#U+2NPY?Z\&NI> 1@Y@&\17#46S'5-3
M55Q^L'57=DRZ?+!76@Z='^L+B"?TA[H_U.=L+M02^V27ZJIIZ6 R*)KE$+ =
MQ"EW"'8@WV(N/.-T]Z+W9,E%E^/*YW9$/)TO<C ;8L2*C[+\R(&],SW/NQY?
M1:Z$M&WJ6N $CN9C88HM>[J'Z">>2AU=MC6Y?GR;^O!'ON8?Q9*?H:*M=ED$
MOHTFSE<TO\!9/UL)_<H/=BT?T)<]S[1DT]%=/5!U6_&IS@^VJ_F*UX 0JVO$
M'1[KHSCK.ZU+Z\]T?Z8O3?E6:CE[H'5;GA?8ID$MZNO$]%2;'W+?MFW3WZ)\
M_W-6=(V.AO[W :A21]:_U2ZQML_V]':64?,:<OQ9J@W/L9D(NHOW:M5XC)C<
MP2;<J9N/'$PQ%Z+(Z%85'U"5P/0-,] =7S-<WPHP_<"3B4(I&"]+><EKH@/G
M:)\HQV.'SR"-"]%R7I@]GE-#E)X5OB%6:)H55&V@N)IB.;HNV[)+#$MV"U9H
M$E?=+1/K["PZI5, Z9X+]ESP(KG@"H/P#;+%O<UB(ALU2&\K4*AJ63+UE<"Q
M/=4A@D_Z@2;;6\SBXYF_]'C>JTM@=<PP_FL>WDVB\G?V;_:3-(@F$T%U_]^5
M?,7^#N\8%'\70V@1I@J$61_5MW@:9=*OT:/T)9F&LP_2\O":MOEC/,S'/Q*5
M$[A8^IU->3@NS?7<D%Z&!-[@2C+_YE[J T]3VYEH,/-MRT!KE/#'(LOCT5-'
MFHZ=81/B1D=ZB<B*=2T]1M(X',).IWD8SXI\P'P<YG IC:3H>S1@D;V[12X-
M@;@Q57 </D3LB*;)!%^<CR,XFW 6)D^PLE*895&>?<"?TPA.8W3-[ECR04CA
M;"@QSG63C&X6<)$_*87P8?Q.&@WPB&%8D;T!/@DR+XO0.3EC9RUD0PLGJ!1)
MV3B"IV^E;82_:0M6T/;&7=EV1-=LBW@,]F6>1@]QLL@F3Q+Z B=)QN>;+%)I
MQ)KOL9V2 N!JDB+?_#^^TFP]YFF<I%(X8!Y$7/G[!2P)+ 5?<%%?-8UG\70Q
MA=6<H2NH*+1"/BDEA6$M=I[K K"_^!,\E^/HX;Z4=03$'X%UW@SP&Q/&,OBF
MYE$ZS7#4$7-B(DTDLTAZBD(87KYO,JE8I'\L9A$?5T&VA[V/35PL[6%OJG?U
MWG,L^1@$Q/WX\(&H!PX$SV)>XH'PPQ\BD4Q V\Q^/'" 7(7XCZTZ!*W:@MB*
MZKF6:]@N:!/4UZ@9.#10'1F3X*U WNQVR@)&_+]PVJ_EQ+N+% _"LHJA6+^I
M71A39+EG%AS!R03^T%(U]EO*ZQ-MA2K7/(".X1ENH,%>6"2P?#?0BZV ^^B>
M6_%Q]NTQP?+B['B[(<NO9#>J?&W0I@D)X!?7-#S?LV23F,5N.(:^U$5Z]]W
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MIT&M<V5X09O'L3B7X/=XV*(R42F:SB?)4\0+)&&CT"<3+H887$.0.D9H!?O
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M] J,Q( G54M75,VDFND$H.E2ZBI$\15=5=5]]PV=2J?<MQ/'A7I_^BE#U4+
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MOU23E,5N1F$Z@Y?"O3G7I5&H@,P-05 "6<3)D.T OHG1%7\14P>B=!ZFJ-2
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M@'0:$:->INBKMJPZIFT9GN'Z'O7-H$B$U#Q[J:>XR\[-Q]D_9VF$2?31\&]
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ML1AV0TQ?[O-*[F"T83M>5G.*U=!76+@MK4"-:XU#EARG0(=[JP+;>R2\66W
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MT&PQF$1A6MP9"W)*PV&<K!T!DAG\*9XP,OE0C5\\\50G[/J<QDDVCW.8,Y[
MQV@RP?].V>EBO X1.,-YXW%F6,!5_#/8^0C(F:U^Y[64,#3YE>O"7_,$?_S
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MWEW]_#'X=/4>Z1?X3)ZD3]( 3L=]E/WUW0 .29QG[S\@A>0I\)E%BE] ^HJ
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M6< )UZ.M ><.0SZU/]3104TISP6 5'!<_-PU[D1L.;9\KK 7H0UPY]*3W93
M2TP7G.Q.WMAO,E4->\_+_,\BB_/S<)SO.B/G7=J@%^XT2^3;_MQT?DY/'<J<
M^OB/U!DM"'),;OS=13^[NTG"3?/G_APB77^+*COM[QY=[B<Z&1<J.KF(R/R:
M)]'Z3:+?<+N@-GJUSE.L$TG;)A"'M@J]+<7J1^0Z.S:,TV/#Z%J"[YSWHFL)
M?FHMP0_>$GJ!E'4L*IUP=/W"9Y_ZF&;C4;\W]L8V/W3,DX&FQXPM)PJH*V'V
MB)D#-LB415C2% E6=L>5UBI(&.:0<X"8%83I:2J/8&X^6ZU(44@O%N<GQ(5P
M+J4LGE49J' R_NO#7?JH]J"4^$\A%>0W+^_9QT^_U=BNLKU< 8TRF$T*"YV2
M66R?%5S;Z%4YI200WMAQBAD!F@-@))IF.\76S+4$W]3H39MI'-CH=5VV3F<3
M^NIM/$E6G&1+#N^JR6>G2<&P,=*1H.RPR1U%@' '88R<TYQZH#-5>LK87">&
M;9#.:J6?KF*N\N_S-:Q/X4^!=J%-F_XC5<NUM;!"7B21$U!2@ W7,<=<0\AF
MW/L2POVZWEUJ84=^<F+D)Q^\<0C+/>BE:\=C6LMTL+G+)J6Q(!I@""P6E#AB
MA 1.@:FQP%K-4Q_L-#A16?_\_O4UPNV84AJC&L<*$4[-?JQM+BH$2HZR.)@,
MI9VP'EEPH=T4X3.']KRMWYVYJ!/?'Y^YV V#RHZ01S7[)2=IV=7Y_+.E::WA
M(JCK5.@HR DVAUB"SFRF5A0CX[QY= P0_Y<$DU)N1RVN_?RG#K $VD!FT$3C
MUJ1#F^.T3Z=LCM:T/AA4>)J8UE(Z[9 !6E)BB*8SQ":(FZ>\W ZQU8&]]DGC
M=%B,M9LNBW.L*7O+3'\)#T =N=HAV7INQ(%@H. 1&"??9E05HX*V)=1Z+*47
M^)ID=90SED/,;_4O*]6U2FW$G+70 $ECQ:R"#OGQY^IJ&69\+G@["Z^FHR_]
MR39H3FE_3;[I8AI"I\P]@XGY(.TTC?.)5M<QXSG7R$&6L#SZCKW%10I@ 2P$
M,0-^ >-B"34GL9AKI[2K):S/(L^W1-KE$DY)9L9Y0O3M,$^(3O.$Z#J_9T&?
MP6IR;".EL9JQ6<?]SKQ9S.ZFQ#]/J7E>X#G $_@'5GH2M)DG07.C*-X,=W@I
M)U0E^3-7NBC/"SD.3J>%B:M9=#5*!N&U/'$^UZ*<P"FZ\K9CE-S</$1?_ >C
M_B!*_[P/!+&#0?BK/\B\O[S)JQZCL ?9@0U]PO0T9T$)K;1;IA91HJ 6FB)O
M3ZW3EA/*B=$,HCENT<4FLT+[I!_F2:%"1#'_\;N?$;^,'_QC#2_@CO(J*];U
M=9;V?KBX'WWUT#1+!Z_>%H;N(4U&V3Q54>WV]3Q:(CM)KS>Z3Z->DEU'7NS[
M?O]Y$<2D_\6[B+Q;]'4RCL+U=\E#7CMV?^==X9=B^@(74Y"WG(\I.Z^5Y&OQ
M^BZ:\6)5@SWKCQ]6TW?%$CGK$+'$ J.!XE+C60MPP'B%OBLF_DKB+Z#,:$0T
M E9/@5D<D^>K!E=^SW'3=V7WM[?)R'_$"]&-A]U>[[("*&15W#U:+'=/;-4/
M&QO@U42$QU=,65.E)-^N4E+NLQSR&>ZMII1#'K+V[2Q*O_4\=HWNO-84>I3<
M#N^]@5Y5%;?M >>.9W*WA6_K@+W69<4UHQ3N0!+QS_RW].*U\H-/KM*E?F=O
M3_3W@-XCZ_UEY)+^Z/ /]'MRXQ%A,#2YSK2\6/#GX2" 76]!/ X._>FCIT&#
M0]4"'4F%"(:H3!8G#,688X6MUE0((2U%!&F! 16&B+ECT8TW>;'?PHP?WODM
M[N@^W^&^]UAS].MU,BC24;/9NOH-2KY96]C7IYX*D]QA9X=/83NN&I-&&9<F
MG=%VA74M**S#L)*P*YV*@2/$QA)2CK$V',:4&0(-UMS.-2;?@]F< JD)CLI1
M3  Q </D"&*G%O4^N_B0%J3O5;.*9E85/'^V <_9_/E&:RSKR6VC)R@ZO=B3
M-6V2F:"L-!.Q5!HR$W,24R5BP?U?'&'CO.4@5N[/3.3+D;T;%/'U7=,6- 1?
M-18IG0 @:DE-'X:\/'W@C##()=90,6HQD! XQS! !'+BB#N4.K_4]>^"IF0;
M[T_0.:@SW:SY?OP$XC"_YZCST-O$/5J*[U>:"EDIT9$4$2*X09!3K9B&QF@I
MM(,,:NKB_9F*8IV.P//76NVS2L9*76E(OO228Z/F6)&FXHMC-2>KK D"92J.
M@3A6UB+"(:, (0F5QQX$00 $X((?RIH<._!@X%SN):#;?$1R/,##A$K3FW#^
M,[@(BWN9]EL9:$"H-! HMGX+P@S@DE(;8T4L $I3PAW DLT1".S.0+CI@C01
M<?R_=#2\2++KX'H$@NAOI[#IZ((-IZ/26)8GLS%72%ENF1842JUB[)P#@G&N
MC9XO8-BY2M][-3LZAW^2&E\;,\".-Q!;'+;LBT_@43;)(Z;_C5-*]CGGASX[
M73"C:UHZ6EHZ135RC!'(%*4,<HU#JW5E*(VI$S%M4 Y*,&:'CY3@/9;F'ME)
M:J.T<RN+V*0$EUV0$&R]5VX\>\HV23&-MMV\0JL/!8P)AU3[C2=Q1G.#M84.
M^&VG86J.BJJ9B3 UFO5MC\+H.=HG\T)#(U:+FOL]+<IK:FW6&I0*:U2BO9VG
M5%#C8RN]/BM*R',:B+M1^CI003SB>N@-L_%9-$C'H7 QE##>YF5JE^6.\ZQ:
MNS:8H?4E56R#X3AZ2 //1&]X-?#/=7$H.@DD6:62UC#A%$!0,VICOY_7$"D$
M !-"<ST7G5N+BV!F[W)[E>7$:-7WC9_:GX?C_TR]79I.QJXMWV;G?FBOS 9G
MT=?K?N\ZZF<YHVUO(EJ?TZK0Y-772?1U6IR2%+XD%&'TAQ=!6/=>FHU!>;HL
M ;&,(L0@BFF,8LF A,82#5Q,O7O>FT 5(5XW'$U>"M<=I'C[ZW!_I=OMXF?(
MUR*:@*SCH&58V#GBF&D9,"Q3SQ4V@DE'((..6F=%C&,N$5;$<6M<?4<]:],R
M;$4_WQQ*AOP\,4")]%LZZO6SO)8\T. <8+G+DSUN() 2.$EB18W"VE%E"870
M24V5F/$U])+K'^+RP8L%>W^92_B[P7^&.=SWZJ6#_:W=Y6AXFZMTKN31A4>,
MYY&ZN7EB IXN;Z#2\,C4^\2)SGLD$.YRFXS^\##R2UYY.>'4\,#UU@.](FY7
M&)&;AYQ^P;\YZ4[C_WOR$'N@X*BL2_8"U@U-O-F !J-8Q(Q"Y3":[D$,M+C"
MNF$YDL+JF M*-&? &QPPHT.3 )P2;<:C9D./.#1J8\A8>\A'QY AY3D5@G".
M&4.40KISO@S\#$V%Z/@R.KZ,XV9'R$W[X1D(%J+_UB6?=#P=C>+IF*!=[XYS
M_.8-R^&?R108L>/I\#;C?NSWS8/PS1U3QX;Y8*32UI&Q&$L-(&-84"VY8$)9
MI#4@F@%58RWIQ-A7UN\Y1HYZ,AI8>VN_&V4*FI1TT+%JM(%5@U1Z9HI8D=AB
MY2C55+M8.H&D0+$S3,5(U)=,,&_BGB0-3+%%#BU6&KYMJU#P.1?M-8 GMR=N
M,?D%P>6IMW%(Q4!PZ*RCD!@%&((*,\TQ%037QY&SL";^[Z-AMB3B_;BC0E<_
MTJ(M_(G7CQ!:!NT95S%3D%DD.748"NHD4X#XUPVGX.7.-'N1_KW H2YK=-(5
M>K0I7C"5D#912JS4YPKYC#,.$JH!0$)2 YD2 L>.:.JO]'_F]_\A=/PNR^[3
M"WL_FIWA%RU:JT>&LXD_)F_9O+S51JEH4_WKR2JJ*'O]<<VI=8(;YB35ADJD
M$&$ ,>H<-.CE"3JK'.]4@4_2]S9/T4]PO]I1*A1J3"LM.QU!5!H>8Z!"OC83
MBD"DN '8&!*3^NJOYZNLU> B_G;7+X[45Y,V-M ]-]8+M\G9'KLRPDJ9&888
M(DF9,IC2V&D*&(> (FT%0FC_RGA*+K;YGO1)9L4Y;7#=[J&8#)Z<M^^ RV#G
M\W[H,ZL%L[JFJ<*EJ3(6 Z YB"EFE#@G$:8$4V0L )#9^>S>W9_3!_/3P'/Z
MS86KF0=9;8X [.\D_WCH 4ZT_)_2LLLV1B;$'K5A"M,XIH)+S9SS)I!8XFA]
MU"W;GM@_,8$UG-COI5W%L4&S>JA!7AH$V1?$BA]7#NV%+FI;'+7 K3;:N/ R
MX]%P#Y@(1<!R0[6VVFBLG0%:840UJJ\WV>,X:EC>8T92"T@^-I2'@P.FO=B6
M%\U.DV!5DTQ'X\#7FG-SHE94EDF5F$/!@-),(.BAF]02$&BH0=Z88E4C-?"\
M%3TP1&.\L[&+Z)1JN?>1D#%UG$DE9]+C4OCF4"6Q2J#?L1@[ 92UTF,\'@N"
M-8,8&JX-0F8.\S6+*ND9IH2M:9+F23\[DJ1Y4:JT-H:.8HXA4#(6U& F26PE
M1=K$.K;.[H]UZP4D23LCXQ@."B*5?? C1?.NXA&/W5Q]YG>SROO(8^MD7#C%
M[V;(^.GEQ44%SHJ*SQ+Y?_P'UJ#>8T)R2OR&D@CLG,%  #*EO> D9J_1JQ?2
M= 3F%>4]7+A]<E-9ET 389-QLIJ+ \<X=@81:HR,I0 ,@!D7!Z965;@X$,5,
M4(X%-(X3&4.E5,'%X?\"FAPS%T?F'=[P2_\BC9+9?'I3.4[Z-U6/]LB/=30<
M\S0<$(#MB#?$,WP5$^*-S<@UH-PC)P?D'2?'<YP<JY@W6LUWL +IMS3EJ#TB
M\>IM8"Q8N?B-K]"8=VO;S(FZNAJE5]X11_W!>-0?9!X>S4C2AI4,E!GAVGBZ
M'4@'^THH;6H1> /.E8\VPX97NB%J)[&)B8 QPU0 H!RU4JF<I8[%K/;"TLJA
M\[NIU&].)+_+& $$[2TC;Y0!;M(QT2F9T/99S+4-)"I+%P 'Q@'H,+"((J&E
M0X9CAZS$&G,%#V@@ W-&9R"[E)YF(-8J%? +$.N&W)3US&2C45JE?R5G4 B@
M8FRUI,Y9#13$###*!#6:X(5&Z/-J(_1Y];GS8R/T--1^:C!MA8PU%Y =P,PT
MM53K2 W%VG:!EB>\H912.Q%K( 3%1"F"G880*(]:))6+>4GV9!=."ITTU2XL
M;?#5G=W4<79#MCJ[01N>PL@6GZ?D32Z6'*:T)%K>':#4EL=[S&+0'9HLFI-_
M/DV0&J6W27\0CDD"  FN/K2>N>E?+CM&:5ZX\]!AL55;U&4)8@*6J32**T>$
M5B:6E&(*%(/$,:9B1P!"N/8=ZO+BM8]3@3"E//R:CF[1?K+$@@-[]9:NR UK
MCO UV)2?MM:MJV2H5#).& -88$Z4I0@;*;%4P"#!%33*Q8U4LK /7-VO<L=*
MULYX[0N=Y8(([I&$HIKE%G%9,!1#+2EWR.C07%8)01 "T@')-!>$+R:PJ"=
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M+R%=;4VW9!>E\)SLA0"^F3;UY+;O[6W93@ KSR\UTK$B+G:!8XXA("&*I=-
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M8X%4#,+%)8 [L0UNNB(M AHGA2?:!!L:;@)66@!2[C.(AD03@JE4CL:QU0@
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MS#]4_&-DSJ/_4+^YG]3//S=-"4[=79_Z^'8FQ@M",C_U_;XKO<G%.;F_]+N
M1?&83IR[\1V%.)OK?GH9Q=_2WGU.!/;^\K+?6\ATWBB1GF(ST2(<VHWU1##W
MJ=NO)HWO]%!U9-7O[VS '_'OZN=/G7!WX]M%JM7LN.)0R,0F7_QS!#'_D@RR
M3LR[\1V%C5Z*L4O*ZQ48>\N<>;'M66;7P[[K8=^EGS<MW;B;AVX>.O33)8J_
M*%&\ZV'?)%':=0][<3(][/_7O[WY/+QX>/N__^W-]?CVYNW_!U!+ P04
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M/\&GD]9#^'1 7^\.H:Z8!K6 *YO2W _Z.F9; <WUYETP[1DR ' QDDND9*Y
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MG#-/<#KB@IL9IG?;AD4O8"EBT>\(O"):**!L.'[()Y1F*@7V:9N.^KY4@37
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M:O^E-\??]#S\EY[+MSW[OT:7_P-02P,$%     @ DX)G3W=L7,]2!0  'B(
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MX1R0GAI)N! C<)/\4E@AY\#<L4V=P%TCGL)<Q%0:X<OQ5GP(G]]37,T%T<W
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M"(6>,0-HCA<"75 R3(,]HEB?P\@YYU'CU3W/#\AF-UB2)4-6$N@[2R?7Z!U
MX,J8BM-GQ,0+>F=P'.[BR>DK46+6TM 6B"Z-!);,?X_69%$X&+\=R#BZ*S"S
MIZ0DH(&X75>KJ*01^>UK>A+7H A9.BB\B+V ^E;3'XW<D7;)(X!H+.<W2C6]
M0\]Q@6TFU$RHOYE0QS;47CTXR;E@4Z4F5&(N[5?(ABH%)-3.%2MND8!WZ/6B
M<_BK73G;+5?DJ</K^KZ-(3D-XT*[64^UF!%VG =\B' /6<D@&Y5' M%^)11\
M!QVLIRJ=+9%A[&,W8BPA87T@Y#$C2 @_DVDFTP\4IQ,FT1,RKE?',AW78,@R
MYD8&O,7,KWC?2,PD?3Q[4PW#G]0^CRJ!UIB(P!U"!_Q.CI6(+.S7$#(R,=TU
MCKQ&+I-.D[,OM4^FFDD@D\"1V%$(Y8!RU15]V7N4'-0ZE36U0!DSJG9SRJ@M
M6CY*8J]<&&.M33"5."JJ#16U]6'22E)ATKAA2<A^&%5]9*1FI$YGS0R%UY%+
MQR9^ #_R@*5 XHQX-G5"BP8 ]THW'*%,&'U_QUKG*J*,OGMK] ."R"&:U&^T
M\I:E.3=8'@$WY,#&5"^\%$2Y'KRKP?;D!N%4)QVZ?@PW9Y1FE'XXLS D??2*
MXE!YE%IR3J'?<=RR&2N$T9),<L7[4C)RWSBU((]GTFQL-CP(C%/%=B/\5<NB
M[S^PEC\'GU,?L/B!';=)A1<1P4L,N96$XFM\ZLN"4[P.)S;JKC/R+;6XWQ,\
MK&_K2HV$XR1E:?OZC=Y+]M:Z^<NZSO25Z6M2"@Q*,O5 6NO>XC+CPKXJ-(,)
M'9S8\6$'QVJ-J8N4>AABRXM=2I1#Y2%7(FD6&%SJUPL(=)1,9BQF_&;\/J!%
MI?]SY)E8SAE<X-@/QF"JX&RO\X.+A12-Q>Y';. U,<2<H9>A]R%?FUIJ7_<>
MM<3=%7BH#OM%3(KU6<HG^^P?:MYK2IG6-&0H9BA^ (HKZQN-\GK1[1!U2V>[
MAM"T?R8SN(RJ^Z+J0%[&^I.U+54=]+;C<3[2Y#JW' 7]1I$ @S\<[@O&C\/=
MN3C;,&3*IS/(@,V O0NP_0X[^P)W'(-%+P'(Z5'F:Y\Z,<J*('P?V:4G! !B
MJDC&9L;F=&:Z 5AUG)-M/!@:)>N+(2X[,I5+>#B:*9R)P 6J2QTJ78><=L5!
M4HTY"DO:L=L)3%"-&81VB^D$E%>X&_AKW+<,+7S:#(+AC:[;2=-[W#:'>L%:
M3]ZN'.'*H/] L6NLW)O%D@7T,LGB)NDQTUH*7X5T CC!^Y8&2-[5#@>L_(FZ
M"KZ]P!Y4J&X,A77[S1#Z-LNU76*U;.$%[V8\BP\?J3U&M5OK;C+8,]CO"*B%
M(%C,'@N-B,?IVJ&JP/>50(&OTC:OG$?6WP]8)RH)C65"8&*O(PUJX<[H7X=D
MF;3% DP)L[3OI"02 1ALCE,*'7**(0/.V';4W DW9J7YJ*ST9)*8G/"@KN".
M6EB*-NN[W^->UV'OE$J$?FF@2U"A O#=IFN18R<1OIABP\EFFF()86]C3&]N
M:1-EH L=XG>A9FW6=^+XF'?@GWC/)?I.= %O!7:!:.7ZMPR+W_+B_"IT\AR]
MYKAK^2QMWCVT-^^+$'$K@)H)52'*LG3*I'BDXW:($J/ROK=MZ&&YYZB/?E]+
M&[OR]V8""HU^/YE"&A01W"AD8LPA LAY)>'.4"H4SZ&I@L,L,)X-)CC5&6&"
MZ4:Q3L;SW^\*=,<K;!6)KZ'1/NV74[*-/RP";:N!M:^Q=HJJ;JFE[D1[KH[;
M-5Y;6!&4WY5R&EX)!+B$A=C@A@'8VJ%?JDR6F2P?LIMJCWU,A*9JP8[Y/-=[
M-WUN24961M91W2NH7*,63YS =Z1_9JP06+J^'H#V3,3>-M-=!2/#G=J*>FA)
M0'4&?=NGOD(TJ;%IB'_RC=JE.S7.CDTY/.F.OH;#EBIEOY$$=YX=AL\$E GH
M?JPY]#(NV0!1+>Z+1[IZ2V4PO4Y.G>O54A>#%0]W+$(Y 2?Q]9K_T?Z<E39(
M<[M0UKH_M+K%%ND-1BLZHWO*/MY0E!7 ,/RH]2&V/ 1%![6OZ$4&I6;N=T:Y
MI>9&)&9$2W$^5&$7VR!&PL/W&.9IJ6P.URG36::SJ0G'P$09F]7PE@-K6PZP
M9O3'TAZ/ZG<9O69[;7'W6R4.!!:W6: N/88=:;%C#_;_3_K $<EAO&^YZTO"
MK:[GO#TW4+M&VFVZNL$A '$@I5"(WB:S3=XA0S]#?VK"0[=!+-H9\#)[*$:)
M'A:[O4+L%/PAPS'II4C[Q\A26^TM+,,]4+K78RVW9<LXO[\M$H+&LZ1XDFKR
M >6\MXI3'(#HFWD,/J+8)A-#X,/YQ%4$T"LU[J&X 64$,98Y;D;BU(07TMP@
M \1-E32F86QXQ_:H8'-+EB08+>1T_26IT':K4!?!GJ^\'Q-O:;@&;MUF!&8$
MWG_+A["Y[7031XH-AYU?*V"DJ.VJPAJ+VSDKL]'.FB$P7(>J=:<P>,N;MY'O
M&W"^H>YZ9 .BHAJ>B@J&:G7<MEW@QV%3U1XQ*),0'/WN^^=1WX8AL0(K1E-?
MS<%K9BK)5/+P'25B=?(8;=RC,=;PS$0+]EY58<CYM@A;2RUX\SW>(C844&H7
M-Y\-VRHG3AC*<U:C/D6#^AV]*$:Q\Q0HDF)0J1*>\9WQ?7\I@,@)D<60E,P\
M-NQ;'-FUY#H.<D6ROL);0-R]W0^E$87KR4L1MF6A3$XZ'!-.:9-OWI<9=>H@
M>0ZV>4,RHX JEH9RSM[(X4^)T:V\47VK,/0TFI+]I9DR,F7<P^VN,54.V*I*
MMCJA34Y&N<I[-V%G0P$@"=H)8!G)B//L5+$RMK;+709@!N"D4PX&U<#<I&GC
M)E#$\'B_6 !1)9;6EEM=UT$'D6;)#1B\5UCX#KKYFG>TQ\!IW@HJ ^V^NUA&
M,RGL5HVZ+,UWUBN4LZ0\)-W\9F".J(:&R#8>SN#+X)L2L]P56>+NZ%Z45"FW
M&()J]#ZG5^]PS[NW?!$=.KL2/C2U">UNSD_/GF%__K4X.YW_[?$]8@A'7S=%
MU]DY?([?\?W?P]2W%ENKAE?EC?]F\2W#T2'JO7\&;4]3[A]M:FGVCRU C5>;
M@P%0@.P?\RN,R.\?+:8.;J<.@E+T\\1;A.*S@RG4^@8T_/XH57V%'11@.1R[
MCWQD1YCSS\WH=W& RKJM=.6\MO:&HDS8%89=47'0D.79*'D#=@S:$WVGI#(V
MD1]N WL:ZQG D.>T'["S;3!J1I<Y5846^F!]4 U$S._!2LU.EZCPS=([J$UQ
MBQ.E@<D4H<WH"M?!4QZ+GU1BL1@K[*(.6=A40=&4H>&-4QOM>5/K.UX?G0ZJ
M:6,J%  98].AJ)1B=>,^J7N$\Z]")H=;,OU+SRR)-7[R_&1AR]V+3Y^?K-IU
M_>)_ 5!+ P04    " "3@F=/.T=;=%\3  #0V@  $    &-A:"TR,#$Y,#DS
M,"YX<V3M75MSVSBR?I]?@:.7DZE:Q9;M))/49+;D6]9;3JQC.3.[3UL0"4DX
MH0@M -K6^?6G 5Y$BB!XD3RBEZI*I62RN]&-KP%T-T#RU[\^+SST2+B@S/_<
M&[P][B'B.\RE_NQS[_NX/QQ?W-ST_OK;3[_^5[__C_/[6W3)G&!!?(DN.,&2
MN.B)RCGZPR7B!YIRMD!_,/Z#/N)^/V1"^L>S<#\)9TX6&&$I.9T$DEPSOK@D
M4QQX\G,O\/\=8(].*7%!!8^H)C($J=L2\QF1W_""B"5VR.?>7,KEIZ.CIZ>G
MMP[FH#SVWCIL<71R//AX_/$4C (S??')P?/JQ![U?V2HGR?<>\OX#"B/3X_4
M[0D6)";WF>\'"S.#*_F17"W)$1#U@8IPZB1\Y4Q9!D7@RH0GK=6[H_!FFI1:
M;*"^D-AW$AN><S8_G6KJP<>/'X_TW814N"9"$#LX^L?7V['&NO?;3PAI[.EB
MR;A$?@ZS*183S2FX["MSA0:B?SSHGPYZ*/296^9@J3TT;72:53,=$4^*M:#^
M6M!;T*&'CNJILPM%ME$A$/T9QLOZ:J090U6B*]NJPYG7!!^C/EK6M@HU=!BC
M0HU]QC:N"M3)LZB_^C%?7UWJ#TZVTV(]0]73(N;;A18?CS!W%-0 FR/[Y'GI
M81]+QE?7\'<US3S.,U*NUD*4BA^5BH/W6ZBH)?MDII:SZBJEN7:J1XUNB3FV
M;M^\0E51(\WY+63<H3;--&FNAGDUK3A^8@;5\+MZ30KBO)VQQR.'!;[D*S4S
M?;!-:<+&&/_17TMIJ$W .82#J](9-J].FC/YJ\GLFA'K$EI?EYA)_=A: _+L
MS.NKD'#I7ULK0?U'(G2H<5IEW3.P1;_[:Q'--/$Q=42IMQ9SA3^W=E1!'25N
M4$>)F$?]Z*^9&RH@EUQ)^Z666R1<^E=_S;^I!/9])K4D=2F^N%Q2?\K"*W!-
MK=N?XL7[GDR1#M@_14NG/:P_6G*V)%Q2"*=2F8T6,.=D^KD'N5,_3I'^Y4#.
M!'E 3)&3GXTJ]"H%+$[@:1MNUSK&$M2\_;DGH+,]$AG^9]ODDFE=FX"%^K2]
M)GEX4M<D8"%>.ZU9<E+7&F 1Q)>-O$X)>  "1"'3/<>"BKOI*"5OZ+OC8+'
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ML@^0+'85S15I([+S@O%.Z^:ZF]']Y0/'+H'(](? T4C)6E)"L_=Y[<8'U<*
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M,P8L W2^9Z1:6[LP(9PL.E!;]1T)IT]E P;(RD+OOH:/L*A_ E* JR_0^#
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M*W$0$: I@=Y1[K2WU,J]G%I#0^,TI\8DM%9GA@#OY2I+5';;A>C(D+D73?)
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M&)'( 2XP9%@J0<G!V6.4=!_*\D(X'!*>[VR.=)_3J^77L$25&4?C7J=T^,K
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M&"]A)*77F;Y[EQ9;0_7H7-.BE41 :*P$' JAN'6 65;9-J0<1/&HS8 >QOA
M3:4P[XI\EF57*Q]@LO,2F?DZ3*=O/U<G6[,Z-Z!![80C+!T,X@)ON0^V+V&V
MDEL:U#W5</"$B1$49'B HII)WN3+<JH-X"[*K?QMD;[SRG-M)M *::AS'%JI
M#';!C6(51A;W>%=K\'2*<\TR \#6^8*!8KWOT*OEU;S(9M][>,3XJ*N22"B
M8,9#0K6"V!$BZ+[3E#'0?449/$UB0*X'1J4KE46YK_E+D#E?WINNCK'X?.E$
M6V,<<!23L-R!8&S=ZZI%/9X6&3Q186@"!P%DLI2X_]J$2>77;'V37SVS,_!<
M_MOS-1($, Q+EH;E51J(>\^QK.1380Z*)V-@A-EY&%!&W_MY76XTC[GML_O
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MNV\RCG<%2R]L\T%PF&J8'M?/MX6Y*1W@5\O[!>;+V?S+(MN=V?X.TO_=I*%
M=;"J9IR/\KU$&@L08HIKCZ34WEIJ*I-.,191/&@$NS0&2*=V3/<AL;U_>GL[
M7Z]?A*,()6>8A"D&">TE F&R$  ; 4GY]@6XP-U,*(WST!FNK$8DB*(@VDN$
M65CB(G84&Y-1[RBV0R!J1W$[WE11E)/*5L#0Y1,^X;$J":3ETF<-+O,V*&>6
M.P.P!3JLI@'<*16CC_O7F-TGL<%!<)DN3ORTNR>/PAROE%CH-0?!Y,4&,8NM
M#@O-3DJ#I+8J;J^O/WD-M*$74B]5+Z)T^6)2AT%\O(=;%K6^WG-%$T"<E)Y@
MIP$T7&OOPZ1($/$V=)L:&Y\]/@3B^:"H=*3.![LYF/^GB7M:,*%,*Z6LI-X'
M-=6.4Z]"!RD32 05CN@$R$BT]<;DG-NVK^?II_EBOKZK=LW>9R40@8"WG_U\
M-4L7)^[\Z=YH(CP7T DG,(60$82(8,$*DA9#30&;<CNHNP/>U=Z?#+>IM.O^
M,.BM5>T;2RS!/MC3Y77A!*HP\)SS #L.J#)A&8WH%NX1M&ETO#HN+#LM[Z<3
MG=I)J'< "\*!0%8#HH6A/(CG-:".X1Z3RVA7] Z@#E- %=5J93=9*<+'/_*^
M2]3WEI(PE08D!-<2$D8]I!Z$D6$"'-PZ[[NKSF@W^4Z]+G4&*XK%J)'2-&PA
M\1QC8QR'1FC!(1!,T3!X!$ 880JZ^YZCW=L[U;+3&:01UII:RIM73J"25.C@
MABD+? "-4!CFSO(P&3&"HNX^ZFBWYTZPJG3&)\JE)'RX]KF0MFTE@)ORG7 !
MA4,&0\PPY.4,&7Y%E)/=9XC1+L0]UW+2 :ZH%I03JM.XC00 IFP9/R#&V_*V
M4DAU.5\R1CG!K+LO,]KEN5,O*AU@&G%9.4)\F^H))C:H.+78:8R9+17?E%.G
M$F$T,-T];VFTRW8G7%HZ(!3CXN+S3>]8VKVF$L>8Y3:H?,"# <")LB7<6D@=
M_'C>(X4%1*PT$\$5T])R0G&:-I$X@@ED2DL9#'!CRN$DRAG3^#!=(MKCOL!+
MB+F.!--X"\L1VEO43H#ER@,A"'3*(.^1ET$4CPC! &C:XY+=F..BXR$4Y;(R
MKW_AL&53B16,>J*DIQ8Z@P$1!I;SI"' 2(UZ;,S$'#R="*ZHEI5ZQ6G:1 ()
MD]9C;3GPBI5/ :)RF940 ,0,[Y%S?PDATY%@&G%9>9[V%K43IH B FO#-8<(
M4VWI=M*TC!"(>(]E)>:XYW@(Q;:LJ,_KK!AP;7G07H)+3]T )3C0 D/KJ J.
MNS$82T28Z/% ><QQU"DQBV65::I'K=I)-+2 "@2L=) %+)AFY7Z"5  %$X[T
M6&\N(:8Z)E;C+#JGM*!M$XF1P)8.O,&4(0&X0Q* ,F$2*<0TZ!'XB#E".C),
ML:U! RP["154 5K>G$*XTIHIO@WY&*TIT 3W2"J-.:PZ,DRQ+"X]UI.$ ,<\
M((P[:Y6$DC@8IL7@PAGG*>?=;]%#EQ Z'1B>CJO&QWR=+MJP>[I2PJ!3G)4[
M0]@":[ 4X;^AX\ H0J3LD8X<<X1S<&!ZV0%')IPW^?H_LG5Y\C(+NG>E;LO3
MI;760)N&DN!A68P-M1S28"P'+PN481AO33!Z%.D>VT:7$>D<$:Q>VO#L7-->
M%YHWDR@%F9000H*"=  JHU@P>0T2EI@^,6\4<_QR JB&F^?;\-^T>B+";$:
MQP$W;X238&O%>*8%HM;Y[FXABCD,.2)$@YP$>W7[9;/.#F^H'R&YMDX")('E
M&[O!(#%.E$>?N AR0!)4U!#ANC,;>[AQ2%P&.!W6C,R:&HF'W)97[SL'A(0<
M6!2,DM!E#Y@@AO0PT&*._0V+RG#S\&_+J_)!M3 U9%?NVRPL'VVGXF,M)(!
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MNHU;I:M-<>(RGF:5P[++G&7>E0?:)()$,BDK08SKD7LY30R@"R7YR"!=2B3
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MXIQ:DZH)IV'ELDX9*+Q6%E.,W%X([7E,EU>-P?<($$V;U-<^H[>T43 E#EG
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M8=@I@[!B2E9":2J[S]7M(Y23,CXB2&<PLAHG*32NFRBJPKJ$RLLWF NJ;C#
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M>;"/%;>(,!ZZL!>".-?]<N$)[[CKPO0(X'1D>,B[1A%"7 AIM'0 .@8)].Z
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MNF_KK%BF"[-9K?/;K%C=?S56%5FZVL[$'[-O:QTZ\WOMGECG5A/$H$3. X"
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M@W]3##$),:*IGR$8PQ3MDZK0#3,IO&A%LHR9_A7V093:]$K/3$'LC.:CTBX
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M9ZX79%$2>;[P(5V&XEE.([E,9Z^3C\;.0:FSEWKE<+$2IUB9<OMR8CF%T7*
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M7^H_WO#[HD(G&8'5F]4??1#6<&:T<5BW]J8?BI^O?H,X!CY+&1(_<],L@!Z
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MBX>\9/.D[WQ;1__VM>(RY<B@8IP8'RQ[)D>)W4:$9TLUX\+BI1]GD*%AWCS
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M.N:(8#_(WEV[]:E8=VO/;?64^4/=B;]5-5H)EU]"3^6_'*F/['YB;S??Z"I
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M]X)=7>71]OKQD9K)3G5ZQ9$S?4_'OWET+*T25.9:DUB7*+L(1X&Z<]06+B$
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M*7;_/'I?@?.'LLW7^Y<5-*4>2K,@0QZ@*<;0Q0,P:8!I($,O@V%M[UV\X[F
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M0<K;ZPV+ZP6,0B;G<&'"&!:") DEA^2(4B L[AWR@$)+J0;?0W3 ,R##>(B
M9@*9B/7)\T/OSTF*&#DW&#-_2?K]A7$FRN[1P>?"[9O+L>8*HMK>%.5N+V&K
MA_Z^/Y3;]L[Z/JDLHCRA,(Y8G.41)GF.$@)[W#+5$!L9GQST.*K/U)+_NKO8
M]J8%/>4DPT&PQYERC!3@R1/,B9_M*ZQ'3R=+.;Y#YW%RXJ[9S"2AS8</QQ,7
MUY&:;@4(Y 0Q1E2Y#R<@@RE%J,>9Y(*:GBX?'Z'Y^H_Q2?1GJS]/#J!KI<-9
M2MVTJP"Z8?UC2-D _[VO IA%8BRIZF8>RZ_KHL-)TSAC*2,BBT$&>)3$X4%2
M,P2-KE$<'YWG%8 30'82-9<@CC-"]QN_R4L^RJ\?<VGZ16 \)B7[1O#'2$H#
M_'><E(9&8H+Q<W]2OCLHWQ?*/F[+5:&V@MUT6\$$A8S%($UHG'&><H+$P1&>
M$:-C*3.$[SFM]3!_Z>\CZ($&#5*5X [OD2C/)]MYY:PYC+XU:XJ6,).]6R]N
MNWC6NJ9ZO7W\Z(XS]7/=U/X8:=@G0?XFCWYB.;-$OL!Y")(H!RD4..)Y!N,\
M[-'C,.23;I >A'Q.VZ;W=7/*M)VC3K=[>EA+F%7B=AK^'R-;_R%3]/1Y6;LE
M_:]*QOJL3).!#:/F+.W61CO^+GI HYB1D & . HC&K/X>(8*DTSK<J(YXAYQ
M*[C7O#IFJ!WEUIE&V7U^K>VWD/]86=9=1(=DV@G:U0^2;:=@QC3C3A:]T;+N
M82.PEA,Y9FE(DU#P-,J2E$.$DL-.3T3@J(G7+?1Q%F'GD'T=AWRD!#Q=M"?,
MP:]LT_^CI6&CN/K,Q'X:V!\D&7LBQW4^]AG#V9Q;N.A3BD@<@2B!C%).8(1C
M=CB+D4*:C[FF[-<3SPG[P@F'*6O2GEO'3 Y!C-8P9GY XD=+]C[C/N7I"B?M
M\0<9"LR#J[%/93B,\-P6JD5,!&,@B3(0,X##% )VJ#RP7$QXCF,0[CF<[M <
M"LQ2C7^<=4;=EO#'4%CGK$RTSF@6M0D.CUQ&GZ$88,X0XI +%,9A=$!/<C+5
MD9)!F*<^:#+EQ,E9W$<_A3):R&=R-N4/->71C.,X1UF<M*0_1I)USHJ_8R\.
MHZ:;9#\5*@SENFQ0?[CY5'PK-OM"7<;_N;AM*K%?*B9A5NORNKE"1 %=<")2
ME& $<VD^X33$C B!48P2.4VBQ"1G>H+@.04^1:W27X>[?52C1Q[LJN 4>_!;
M@_[\68)1HZ27X680(+.$Y2LV7O*.';L7THCG<,TC*_AVLAJU"^B_[OBWXKI<
M+=>=4?*]K!<<"DQXQK(,22(Y(PR@WH@0"=)]P-'BTYXUMD/4=]C@-P5*4SIM
MR;HLB2/P9"9U4U"D_PRB9ZKL7CHTI$SG&<.7?KZBSP,)F?XQPB'@*R>-PE8G
M>76_+#<+1!/$TBC/>(Y EA N1].=F2S.]2X/L?[XV%K9PK*6 EW*3/72 UL#
M%7,DHFQ5TP-A=KK9$Z7V2 3>1;0UIB6CA@S-34A-X9^54BL>#,3TNE3/@W[=
MJU:SW%P_;*OK_6I7_ZUH;Y#*<AZ%22A'N!3RE&&IX[U9(8-M**[#C(TDMJ<@
MVV=2.YC!;RU0<U492+*V'(_'KYT\SX]:8P$?C^)A ^$!5!OH^D4V+NN\&R)G
MH_N.W'F9!USRI),7V')[76Z6Z[\6R_7NCNS^6MT7G3%!TA3E5+",0X@S%L9<
M],:(_ /=;## A/=MHRVRH(46D%V@P%G(TQ :W];[D1@T4_EYD*>OZ".1:*?C
MUF3JJ/=YS\]HM@.JIE=J%TY43IN/OBI_O%MN[Y>K0J:!9V667&0HC4,!0DIE
M DA#D='.%A%QKO6 VC +GC7Y*3#KHN@ !M_6XW'(,Y/CZ7G3E^)Q^+-38CL>
M=63XK-=G5'@X2].+L ,?*I?M9J $=^49:0,3EL.<89AR"'(&#M9@%&L7H8?8
MF$B&C2NM@WBTE&(/%+H1XW'9&RC('EAT4+4>69\OUK!=T#93C3;UXBV5MF+%
M7*?YT_+)YX=B5<KQ^F,W4L<T9R'AB(=1B!@3(,=9;YXPH76)LW.CXRHY?UXI
M/,"UF+F[)=]4[4?D?9#\SYARVQ0Q(O5.AO%#0F">.RZSHY5,'!$\M^SBRJVS
MZ<8I;SKYY]?]:ETLMQ^WTE MC;;UH<_%]ENY*OJZ/4Y@SGE.&$P%)3Q*HC#O
MS%*!PTPW[S@QYCG?=!B# \B^IMG#M! ]-R2_G5]&Y]<LK\R76OT\,CK%=OG#
M =4Z>4.'C3/YPBF1T^<)M^Y4GAJ<X?'7_=>ZVUK>5*E"&$$&8!("04.<P1P1
MWEI!89H(;'1,U?#;GE7_!(Y1S=F:JLMB/@9+9MIM0)"?LY%/F7A%5(9R-H]3
M)=;HGY\)',2"A4)T%9(XA'&:Y)QR@AB(H^:9]LY.!*G947;CKX^I$D;%T &$
M&2N%!ZX&:,5;-/E6B[,5T.',S4XQ3/&?UPPK)BQ4XWA@30YMWNV*^U:M2$+D
M1#<DE&4HAQEE$8@ZNW'&(ZV]6^ZLC:@J3Q &#<2AXQ%;BHUU9P1V[77(@EC?
MRO0Z7WI*-9#KV2G74'_.*YD3IIPH6Z>I&4_3+$188$%1RC"2H['>,L_BR)FV
M:=J;6MV&CJ/LB7:@<!XX=JQQ4X^_SG%FJW.&C/\ 2F?JD8G66;&EK7:MV4_%
M0[7=E9O;[DJ"PTT%FUN%X7VY*1HL"QQ"B.(HCDC*$QBR5(XG>Q0P,AS5.;;M
M6P6[?1X'O%>'"T%.(#=]-OA-H6Z[KZDJN@Z(ID).& M#M70=!C_J:<;G)27U
M%)F9J*HO[YXKK%<6]>_):JS6"_FE+"0D#),\D4-5Q$B<=)]/8LB,'L;1_JAG
M?>QPF-Y)I<N(GHYY(<-,H'H(8U\ U5J]H"3&W,Q#(LQAO[AVR<IOW4[];K.J
M[HLOR^^\K%?KJMYOB_ZQ]T4$,0ISPCGA>0Q@R&$8-=?M95DH941W_C+$A+^&
MWJ(*)*S@B&NRE^XO<'2A3[A@=A[=Q(DGE?MV-[@S?2F^[ZCT])^+7,0LXQFD
M4<CC$*:A_%UODK$P-<F:@PQYSJ3'CG4ABWB@SUJ,_##G1(T4M*#!-KT>'6@R
M$R1S=F>K2!:NO"U)MOQHUTAVRUUS!^^'F\\[:>:N6DOFZOQ?^W+W>-!#!*,\
M91S!G+%<\!0#PF-$4YCF( 3LK;U_;HUYG'[W^-2%J*<(_R-H,4XV -!B[M)$
MVRGS\^B"CGUZ/JGVP-A;G;+>[A:?5W?%]7Y=?+AAU>:ZV-3%M2@WRXW:9WW
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ML/_=+E9S1FDDU2J-PSPD40IH(@[6,0I-1,653<]*T\'L>T^#])?JYA>)-6C
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MBN>!:0^:-X,ZT>O$6>N>(>\_@O*9NF2D?59\V:G?^W+3OI"PX(1PM>*/!((
M"\)3=CPM@6.CK3ZV-L9>)5/(@@;:($TS(-%&QOSP-W#53(>Z$93JP(VV.)FS
M.4<]LO#BH@39LJ*] TA^_\/-LV-:R^_E_?Z>5MMM];LZQ+5\D'^R>US0* %9
MQF"DG@Z4_P[3+&LAI)& &3':%^32L._=0MWYDV?'%J^"#G!P0!STD WW$#F-
M@IZ6318 ,X%SR;V?74@&/%[:F^0C'/-02#^N/=_'Y(\_72WM;YO[</.7JKK^
MO5ROOQ3?=U12\<]%QI((PS1C,0T%AY0 'D<,,@A0GB6)4=%_B!W/2GEZX5X/
M3AV7^%0\5-OVM?C/Q:U*;&8".8A:/3T<BU4S^7N5T/:^PD#A"QJ (P_U+E!U
M0>%<$#P/07/B2>6^^1D<F.^L53>\N"DWY:Y8;J[?;:Z[W[POOQ7RMSO9$DO9
MTDA=%[NZ:70GH' ,XS2+" \3'J<BC_(\8F&8A0@(I'?7T$A01A2]WH?F$//1
MBU\:-X*C'T'KB,$A\A$B=EDH9Q@L>RTUC).)Y$X2.H,K N850KMSG2.%4NM&
M@<%\OI(S1P[4]*<YQW2VFJ0SF,TE\ON'=?58%,TS5A^:&G1WRA1Q&J7J>E+(
M,TXR$N60P#SEN2 XQL#H[BU[*[Y3J@(4M(@TDZ0#YO0F"N.09IC:U.-FOWQM
MGDCXN'QL2L%DNY4_4K0+6BW.B2[:.LO8A=G"<);G,5=PX$?ENOV92=''8GM3
M;>^7TMWV!='^&B\A35&!\BCB.2.<0BIZ:Y!0K5M5AMKP+$,GL-HG)(._R[1@
M*$C6_.G)T1C4F8G1"];JB73G##475&<HF?/0G,%>5&Z;F'Y=XA]%O2LWM^UR
M>[E13_S4TG1K=4$AC)$0.(58Y(!F889B94]$$,4QT%I_&F[%L^9TX/IM)^6F
M>>BH#B3 KC?ISSP'TOEV/6 \)LTD:$8DZL_,QR/3;M(]@%2=B?1%]\_,D=U0
M-OWTUY$?E>O&9#EI+;;?RBY74#4G8=7]0[&IF^;V9?F=%ALYP=X)2<'IG^3?
MU2^+!:-4Y#F% ' (:1RG"4_ZM(*YV>5&(T'RG!,DP.!KBS#8%NNENM!L5[4/
MQG>SOM4):LL)L^>H&<ZNYQ,PQU/Q#N)5H*+:N3'1?'P0QSJ3]W&".(]1]]A.
MGRL+C,FY]M:(5]&<= OZ>/R1KM>0WY?;Z^8?3W(97,0IXH*D&891' N1DSP[
ME#GRF&G=YCT),,]9HH$4?.M&:0_M*.VG?ICVL^&.BU$CIKE%8Z[!LL\0IXZ<
MI@FU:>;53*(\N6K_%3P=D(^\!\1A+"YM&IDBY//()].X_GQ;RG3\.YUU_%IM
ME# 6+:[Z2[5;KD__G%7U[M=J]]_%[E.QJFXWY;^+ZP4+$T9BBBFA,,&0B22,
M>[P4A)'SB8@7E+Z7ZMX:[QZ<ZL5+>:&>^)9Y:1<<';GJ'@#W,'OQ$WV'$YK)
M ^]XCN,LYM/-?VQ",G1*Y+49S".KS8 'FXG3")'161_)OZL'X&JU Z5-JA]N
M/LJ>6;_;_+<:XR]"GF84PI!1A EF($PBVEL$49[HKI ,M>,YYYS Z^<YU4WP
MH! :3WB<T/KV2LF8C)J)^04RKPY%_A&YU%\P&9-3NR63+W>%I+ _S/<?=2!5
M<K==KG;[Y3I0U^X.>R'B#0+.+)JXHFWZ91-GGE3N&Y5%@>SKV_.LKY?F69_*
MV[M=+5&O5$.]+184)3E,&.41#V-"(X)CT&/E+--*!],B]+ZPLKV5 ]*'DQTK
MMY7LFC\MZV"I_K/":5,Y&S^4!B6T64=QXEI:ZUMSZT?GW01U-=<!>JO -EF#
MF,><9&(.7BNY31P1W;3UKID5*01_K=;7TFY]/,=V_+/ZN%L^9"&#!*50@ R'
M(LU Q'$,4YZ%,4XI,,E(SHU[3C8GF,PRBGN6]9+%I 2;Y8$CG*#'>A6<GA(Z
MP1O\-MG)65-&+PBWM^#,0Y/]N5>-U,CUJSKO"RGE)Q:2D$=Y&C,D>)P!'@N*
MHAAQC 1!>4:T;A2W^:YG_6OAZ%<2C&EYNPKCDQ$SP6J1Z$G1<&;T:RH^&;*K
MH9@PI5,T>>;AF2*)+0_3%T6LD5?#6X'MA2G=I2#M-2%2@]]MFOFX:B=RM-O^
M87/N<I' 6$19DK)02J[((P90U*AOFJ8Q968E#0_V?:^VG@QI.ES! 75P ONJ
MF?5V/]$>>3:\2\]+=#2K%!,'QK &X24FGF]NT2;V4NW 8YCF,0KUZN'9&V!\
ML:FMR^?MOS_>1\CB+.6)' (SA)(LSR$(>],1,KL,T(E!W\I[J6</N++4#=F:
MNCHVSX9".IQB/ZJI0=LEF73)^DQTT:E+SX70/5^ZRM?>\+&($\19SE,.>1J%
MD9SMQZS_N)S]&^TPU_RD[X4NM6$E6%Z^=,I+YVG]O] ]# F:1P<P!5T-:A2#
M[Z%L!@N$QC@"<<@IPR$"$4]B#B/ TB3%/(5&Y^IL;7ANYL^N2+2>\1@29SJK
M\<>9_<Q%F[JQKI34GGS8L3D/'1GLQ=O72%JPHJTTN^6N79+<US(SUW67NNOF
ME9B()DG&>"P_CU(& <BCK+<9)X NOA7;KY6VX@RR9=*'3F%I=Z4/#\5VV8Q9
MU35T!O?=^NE.E\BZU*F<D#R3KN7&E^<=S"%#NMVL[\K'T2\+22*'"6$&&459
M+$</@G9VLD1V;9-4;O[UT9*X]:3:@C&]'.Z7++/L;<:3%YUY0<<%;;&G;AYZ
M,@!_Y:H1V>G&E^UR4]_(CK@@&2$IB2@'@,3J(NDH;O4I"S'FPF@*8/[UD73C
M*CA LE,- [[,5,,/57:JH<.25\TXF-?0#'/BYJ49%OC/:(8M$Z::\:E:KT6U
M55L*%Q0AEJ<D3Q"">1;'%))^5)/!+#6ZZ='F^Z.--Q2HH$-E.>(PXLU,/7Q1
M9COJT&/+JX:<4**A(C8$SDM'K#PXHR3V;)AJR8(F(<X%R+)$$$@8RU@FNL^3
M-,OR17ON3,ZMMCLS&7GSTR8=X3D*[3Y!B]MRLU&3_Z_+M3I%8J<=;_-D)AA.
MR;%3B6ED04,+M+F9EP#HPS[3ZPW]-NWJ4E"*\G;#]MMML5D]-J.5=;-T]Y=E
MN7E?U?6"8T1)%@HJ;6*818B&_5R',"RBQ::X53?<?3$?5#BPKM4ELK9+O "J
MW3TZH,&J0QKLCE"#Y?7_[/NMZJJ86.WNBJV=HK@(AYGFC!6"@7.?/@ ]SN $
M:*"0!C\IK.>/_GG5K[=)U% XAY&8EP:Z=.R,2CKGSGC(%,=$6HA8KB9Y".$H
MCV#W>9J').Z&3/GFVG# ]-:'S0=,/0;M;BC_@LY8:?(A@BY5\^H>^K#/#1',
M_)[VB'N,$YX)0!$7&8(TBG*UU**V4"193)CI(N,D&+TO3O[?*>E9GI+6;1?S
MT)>).1CEE+191+S??IO_:U_N'H^OP=<?U%3@R]URTSV-=;B6ZK28([($ICA)
MPV;1F>8PR9/>"2GKB84DS@>\=ZTT??-G7K>K6I'^EO#-+_HS4L09DN/J#M<Q
M8C@C#?VO0J6#XII(W9#)X"_RTSN^W!5B66[_L5SOBU,O 8TI#.,< H@($S$5
MB/=>ACFV&7?^0-YY5^$>[2\=W*#!&RC @4(<-)#5#4VM2/_AY-DD7-/JMY>&
M];]&X/VP-WX&\-@*=%.$].V^;.OF9",]W:@A?K%9E47-RWJUKNK]]N3AWA#C
MC,,$\QB(E$'.F( M")&@#!K=[NW8M.<-#R=HU<W,'=A=\+Y<?BW7Y4ZB;A8>
MWLM?WEJ\*.0Z$'HK$!/&P&P5X@1H0_,3J,$1ZX3W%)EQ>2'_> K*/-*#+^>J
M41JV_OU$AP.9WXK-OOCZ^)>BNMTN'^[*57NX1*"09U"0&#/!.,[2"& A<)*1
M/$K#5$M)7=CQ+)O'X\D-/E4P/2(T.W'FA-7+LC@VH68:.#<N]2](&I-3NPN3
MAG&K<X72&QR\D@]<,C?]%4O./*G<MRO3,?/VH=K*<;H<R'<(NL>=4XA9E/$D
M0X1C0<,$$]K92U@*,[,"A[T=[Z6& [2QAUAG&+DXFAK*XEP&3H/]>#%&<L/,
MF\,A]5K-]G'Q]\\+PD.:RX['6"9B%H89P6'_X3B*J-:H1_]SG@<W?__UW9><
M!Y^_D"_Y9\W$:\#%&V,5/S28#4GT&'A%"^I>#.IB]:?;ZMN?.W>4%N#^-TH&
M\(D,'%U^+5N:\S%Q4K0 7%G'WBS%247X>]V) :<XC '-8"C"* 8PC;*HLX#4
MV7B3FH_)=SUW7@E%_COXK45C>'+%B!^]4HPO:LPZM"XK7M+["047$KH-4?-(
MX5;(J^'-Q$75XOWAW&W,(<I!AA,"8\(!@#Q%O55 <[T<[LC6M-6+]Z9'[9U1
M/*2,X8==IZ6,Z8AU4=/P0[!=7>.4RN"FV@93%CK>7[CQP#6E<RYX6'BC5?2P
M94DK,^SO[Y?;Q^KF;^6FO-_?-[===\N>-?E:-R^T+:1!P%/ $(LX#D,0QS "
M$4MEDHHYC70>_7-CR*-TM?C4]5\=PJ"!V&_^K8/?>I0FXN6&7@/Y&IUFR\*L
M"[JU9$N'D'/"Y93,&4B76W\J7\W.;%+;V#K9P/%%_NWF!BJ8R,%RR%DD(A0E
M&'&<,Q!Q0 G-"8B,=C58&_$\E&T[S9,'IQ4TV7LD.,/9KSV1>E/A43@T4WU+
M^KQ,D\_1<V'./)C1>4R@A[M1.6YIPQ6(5_?+<K/@4% ,0(@C%B(><:J>NVX,
MLC"CW.AJ^ %FIE*A%IX#'=*ETUZ)/##I2(O>(G$T-6J!&.J1(:_S52131S0T
MR8H;G6G=X0K6QFI75P1QGF4BCG(*(,.4"@'E&"R,!9>&$Z9U4Z;UQSTKT/'.
MV;8;F=7_[2E[>^+KG2TSE9F**/TIK'?"[&:LSX@;-"E]S<4S<]!!;$P_Y1P&
MOW+4*O2%4Y0;==SQU$B"*"&$9XD0<JQ(<YP((HTD2&TU$I'6"QB6G_8LFATB
M:R6P(>MMP?3,DYE<3D&1OE1ZILI.*)]0-D@F7[IW1B0'\#"]1 X!7SEI"Z:S
MW;HNBJ=ZW!^7>>QK?I\*-;*5K'VX$66]6J[_NUAN%ZG *<S3/(T2"%$<AG&*
M0,0R'D&: (3-9L/>8'B6W0,H5?T.00A,I\?^^->=/L^">M/IM0)]%3P;QUT=
MCGH]7AT6'ZZ")S%J\0?*@;$GX;9$7YRD>X_>7";Q_AU],<D?B5M=L3[-"II
M>!P)++,&2I(8$IDZ\ER *,<@(2Q*<&8BTA[,SUN<??"M)\H34SU@6#UK"3:G
M]8+T>HS1/"37IX/5:.U=OUS0ZKT)AD3D($IC#-*04Q#3E"588A 4)#F*](;
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MUIB=,C\/+77LT_/U9P^,V0YO#[M^/VZKFW+WOJIK'?FF)$I RA,F. DI03'
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MI0O*.)37>6C<8"]>>3I@."LFNB/UCBT?RO[QE)-W/18ARQ*:)(""+.( ($%
MTAO% !D>Y1AHS/MF0K;<;A^;P8K1:YWN^L]Y<M[H1@Y8G4]O<N',*YW*&4=F
M#Q"6R_6Q.]>O/0I"DY2&',8TA$!$!&*>M=8SF, <&5T6Y<JF[]EB#_,DBQF^
MX.&,7<T)W 3$&D[-7N-T'L\*:9)W:1;EF/YYJ)USKUY]1-(U:\:5MZ/)FGR5
M0):KW0(EG$MC+(]BGJ<XXR"%:F!#&8M30HRW,-C8&&5Y[@18\%L/;:I:QRLL
MZ90NAI [DY[FQ)5SA87A_%ALQ3I9W!/;XE_[8K-Z;#9", PR#A%B* %1EG-
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MUB6#@;@E7R,7;G.<ICG*!,BR4((B$4W[JC(#3,1=X3;?7(]:MGT+EGG9MO?
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MH)0N:C9M6!P'M&TEVFU /Z#N.\[(B:5NZL44<T;6Y63SA/ ?J%Z&=LJ1>4%
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M<9HMG6%<NU#[_'@NYZ(Z5?%Z(+"'6IQ2.CU"_R6Y^Q_B+Y\)BUYZO# D@-"
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MZ ?JK,I/R4.Y2O)T!/ U+58>@#NA%7C)N0L$M,9U$$K<H.?1'A8KO[I.\G0
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M8B^TZ0K4P?)F44-E&J6]WRY7Y79;T?U,1=O)]^(D3534!-8,T4"0-ES4LNK
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M/7GP<A$X!\.I# )A)X.*RRG%_N$,B1=,H8NV@%]/'I0%4,,]5R(8+K"*<$)
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M0"*RB.M@I>.8I7L*O*S=!N1SLG/S+/^:P(+6DW*G43MS=_<H\?XAHK.-$B4
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MDRZU3F)R.-62W%U*<_9KIKA,C6=ED];KC*QL0H<&%95@$;$"2W!&86X(JW1
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M4D$[1<QM/QVB%-HN,31P22'(EURL*F_!\JH_0!R+&/*P==]I-Q,Q<CF8M1_
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M5Q,'BG^/FH?_V.>:=^#I03M:]K0HRVY->E@O;<;V^P&K@L.UO/SH&9OD3K^
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M68TMQ//K,Q_1T0+I-#.\H+ZC<JE#S?2QB/^FWB>,OWS"+<JCK[N]G;":^80
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M:G!GU7@+5!-9MV8A+Q4Q @H*0K15T$9,VXHH0B+:@H@8%24(0MHG F+:%DR
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M(D;1>F&.NAOLU: W&J#=%:,W@:D3%)@JIZ>K8&8*N$:[<WB3_3<U0VY% ^*
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M5,G(9#W[?8QL'NNKZ%2\%J1%'LD_)+C2HVZL):]L1Y]J[<&MB'D#(Y5K3%Z
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MV$S@#[%G\&" ]$,9*)O_YJ<N"7D%?2L<K"+1K%M'#:!#Q6X+.6FSGHDOPW9
MT=:&*_65QI=W\)\3DY<H7GEKLY_/RLM^&.9E$RU+:3EM#',Q_8@TVUI40GPR
M&$LTEM:$47KKQDQHOTX)%@Y,C:ZJ!\LS+UW2*Y.MKSMJML2]^/28;WUSDF=
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MAQ7M&]*C6XM[ZXH<V^!M!AM?N3[R?W68^^V_OZ_T_],@Z@;^&U!+ P04
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MF'Q;=' LB,S'IX[HPV>*Q\RN>!J^5>:+N8813//*QOJ4U_KT\K5EU8\^VV4
MRRX%ABRW#BJ+M_WG<\G_/X.E&?IO4$L! A0#%     @ DX)G3YK%[O0FM@$
MK>X6 !H              ( !     &$R,'$Q,3!Q,#DS,#$Y9F]R;3$P+7$N
M:'1M4$L! A0#%     @ DX)G3X[X!WM?"   6S0  !L              ( !
M7K8! &$R,'$Q,3!Q.3,P,3EE>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    ( )."
M9T]3W\LQ6 @  ,8T   ;              "  ?:^ 0!A,C!Q,3$P<3DS,#$Y
M97AH:6)I=#,Q,BYH=&U02P$"% ,4    " "3@F=/=VQ<SU(%   >(@  &P
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M,#$Y,#DS,%]L86(N>&UL4$L! A0#%     @ DX)G3XIJ"J'-B@   C$' !0
M             ( !ET4# &-A:"TR,#$Y,#DS,%]P<F4N>&UL4$L! A0#%
M  @ DX)G3XLI/_5/+0  ^#$  !T              ( !EM # &-H87)T+3!E
M-V5F8C(V8S S-C5E-F-B-#<N:G!G4$L! A0#%     @ DX)G3^T((QW3)@
M "L  !T              ( !(/X# &-H87)T+35F,S)B9CEB,&-A,C4V93DY
M8C(N:G!G4$L! A0#%     @ DX)G3_]^+%.'(0  KB4  !T
M ( !+B4$ &-H87)T+3DX-C<T-F)A8S(Y-S4Q.60X8S,N:G!G4$L! A0#%
M  @ DX)G3^22D. H.P  TS\  !T              ( !\$8$ &-H87)T+68T
M9#8P-C<W8S!E,C5C.#0Y,SDN:G!G4$L! A0#%     @ DX)G3PD]>< F)0
MQ2D  !T              ( !4X($ &-H87)T+69F,S,X-6$P,3!A9#5E9C8X
<8S$N:G!G4$L%!@     /  \ *00  +2G!     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6893070944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Numberofsharesexcludedfromcalculationofdilutedshares', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss', window );">shares that would be antidilutive as a result of net loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Numberofsharesexcludedfromcalculationofdilutedshares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares excluded from calculation of diluted shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Numberofsharesexcludedfromcalculationofdilutedshares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares that would be antidilutive as a result of net loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Sharesthatwouldbeantidilutiveasaresultofnetloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890153072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Carrying amount</a></td>
<td class="nump">$ 7,991<span></span>
</td>
<td class="nump">$ 8,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 8,001<span></span>
</td>
<td class="nump">$ 8,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6896447872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Assets by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 39,179<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">21,755<span></span>
</td>
<td class="nump">22,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,462<span></span>
</td>
<td class="nump">15,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,962<span></span>
</td>
<td class="nump">$ 3,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6900806576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 37,341<span></span>
</td>
<td class="nump">$ 35,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="nump">35,662<span></span>
</td>
<td class="nump">33,546<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and employee severance</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Amortizationandotheracquisitionrelatedcosts', window );">Amortization and other acquisition-related costs</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(511)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation (recoveries)/charges, net</a></td>
<td class="nump">5,673<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings/(loss)</a></td>
<td class="num">(5,264)<span></span>
</td>
<td class="nump">816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings/(loss) before income taxes</a></td>
<td class="num">(5,344)<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="num">(423)<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">(4,921)<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings/(loss) attributable to Cardinal Health, Inc.</a></td>
<td class="num">$ (4,922)<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings/(loss) per common share attributable to Cardinal Health, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in shares)</a></td>
<td class="num">$ (16.65)<span></span>
</td>
<td class="nump">$ 1.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in shares)</a></td>
<td class="num">$ (16.65)<span></span>
</td>
<td class="nump">$ 1.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share</a></td>
<td class="nump">$ 0.4811<span></span>
</td>
<td class="nump">$ 0.4763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Amortizationandotheracquisitionrelatedcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Amortizationandotheracquisitionrelatedcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6905034192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Shareholders' Equity - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Shares</div></th>
<th class="th"><div>AOCI Attributable to Parent</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2018</a></td>
<td class="num">$ (6,059)<span></span>
</td>
<td class="num">$ (2,730)<span></span>
</td>
<td class="num">$ (4,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Statement of Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings/(Loss)</a></td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee stock plans activity, net of shares withheld for employee taxes</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Stockholders' Equity, Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2018</a></td>
<td class="num">$ (5,913)<span></span>
</td>
<td class="num">$ (2,590)<span></span>
</td>
<td class="num">(5,097)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Sep. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,678)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2019</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2019</a></td>
<td class="num">$ (6,330)<span></span>
</td>
<td class="num">$ (2,763)<span></span>
</td>
<td class="num">(5,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2019</a></td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2019</a></td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Statement of Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings/(Loss)</a></td>
<td class="num">(4,922)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="num">(4,921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee stock plans activity, net of shares withheld for employee taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">350<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Sep. 30, 2019</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Sep. 30, 2019</a></td>
<td class="num">$ (903)<span></span>
</td>
<td class="num">$ (2,669)<span></span>
</td>
<td class="num">$ (371)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Sep. 30, 2019</a></td>
<td class="num">(34,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Sep. 30, 2019</a></td>
<td class="num">$ (2,039)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,039)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895584880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments Narrative (Details) - naviHealth [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Aug. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentLineItems', window );"><strong>Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PartnershipIndirectOwnership', window );">Partnership Indirect Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PartnershipIndirectOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Indirect Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PartnershipIndirectOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812203856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Total Share-based Compensation Expense by Type of Award</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>20</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.58847736625515%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:53%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>63.75</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>63.67</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalStockOptionPlanDataTableTextBlock', window );">Schedule of Additional Data Related to Stock Option Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:58%;"/><td style="width:21%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Transactions Related to Restricted Share Units Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:52%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.09</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>60.92</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45.29</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Transactions Related to Performance Share Units Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43.68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>48.40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.59</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>50.84</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A disclosure of additional data related to all stock option activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904544000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=cah_EnterpriseWideCostSavingMeasuresMember', window );">Enterprise Wide Cost Saving Measures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cah_EnterpriseWideCostSavingMeasuresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cah_EnterpriseWideCostSavingMeasuresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890111360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table>(2)    The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897561664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We primarily have operating leases for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Beginning July 1, 2019, operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our condensed consolidated balance sheet. Operating lease right-of-use assets and corresponding operating lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our condensed consolidated balance sheet. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our lease agreements include leases that contain lease components and non-lease components. For all asset classes, we have elected to account for both of these provisions as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the condensed </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">consolidated financial statements at or for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was not material. In addition, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our leases have remaining lease terms from less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> up to approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>23 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization of right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>36</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental balance sheet information related to leases:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>394</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>103</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>312</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>415</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance lease</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> from reclassifying deferred rent as an offset in accordance with the transition guidance. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6.2</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> years and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>3.0 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Years Ending September 30,</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>107</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>83</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>62</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>519</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>538</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>61</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>61</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>415</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of September 30, 2019, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As previously disclosed in our fiscal 2019 Form 10-K under the prior accounting guidance, the future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$126 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$100 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$76 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$54 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$33 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$94 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6898108800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)    The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6706388576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. Refer to </span><a href="#sF26386BC522F5F17861BDCB6DADF5D65" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 4</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for further information on our equity method investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Derivatives and Hedging</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a Benchmark </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Interest Rate for Hedge Accounting Purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$422 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. </span><span style="font-family:Arial Narrow;font-size:10pt;">S</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">ee&#160;</span><a href="#s1b4f19725b5347a89ea3b6d3c65e17fb" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of adoption on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904976688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Summary of Minimum Lease Committments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">$ 95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=cah_OperatingLeaseMember', window );">Operating Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OperatingLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=cah_FinanceLeaseMember', window );">Finance Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FinanceLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FinanceLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FinanceLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Finance Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OperatingLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OperatingLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total undiscounted Lease Liability Payments Due for both operating and financing leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease, due in remainder of fiscal year following latest fiscal year ended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=cah_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=cah_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=cah_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=cah_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895821792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 423<span></span>
</td>
<td class="num">$ (142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">7.90%<span></span>
</td>
<td class="nump">19.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, interest and penalties accrued</a></td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="nump">$ 5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Indemnification receivable</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_CareFusionMember', window );">CareFusion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Indemnification receivable</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IndemnificationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IndemnificationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_CareFusionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_CareFusionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6812058192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details) - Stock Options - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of outstanding options at period end</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of exercisable options at period end</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904921536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Revenue by Geographical Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuebyGeographicLineItems', window );"><strong>Segment Revenue by Geographic [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 37,341<span></span>
</td>
<td class="nump">$ 35,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuebyGeographicLineItems', window );"><strong>Segment Revenue by Geographic [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">36,310<span></span>
</td>
<td class="nump">34,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuebyGeographicLineItems', window );"><strong>Segment Revenue by Geographic [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">1,035<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuebyGeographicLineItems', window );"><strong>Segment Revenue by Geographic [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">37,345<span></span>
</td>
<td class="nump">35,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuebyGeographicLineItems', window );"><strong>Segment Revenue by Geographic [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SegmentRevenuebyGeographicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Segment Revenue by Geographic [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SegmentRevenuebyGeographicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6905070624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenue by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 37,341<span></span>
</td>
<td class="nump">$ 35,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">37,345<span></span>
</td>
<td class="nump">35,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">33,428<span></span>
</td>
<td class="nump">31,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">3,917<span></span>
</td>
<td class="nump">3,801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember', window );">Nuclear Precision Health Services [Member] | Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember', window );">Pharmaceutical Distribution and Specialty [Member] | Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">33,212<span></span>
</td>
<td class="nump">31,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember', window );">Medical distribution and products [Member] | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">3,446<span></span>
</td>
<td class="nump">3,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember', window );">Cardinal Health At Home [Member] | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 471<span></span>
</td>
<td class="nump">$ 421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6895734464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 6,330<span></span>
</td>
<td class="nump">$ 6,059<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">5,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), before reclassifications</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gain/(Loss) on Derivatives, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), before reclassifications</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (101)<span></span>
</td>
<td class="num">$ (96)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897530560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. Refer to </span><a href="#sF26386BC522F5F17861BDCB6DADF5D65" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 4</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for further information on our equity method investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;">Derivatives and Hedging</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a Benchmark </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Interest Rate for Hedge Accounting Purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements. </span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$422 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. </span><span style="font-family:Arial Narrow;font-size:10pt;">S</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">ee&#160;</span><a href="#s1b4f19725b5347a89ea3b6d3c65e17fb" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of adoption on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6893594560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">$ 2,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">8,190<span></span>
</td>
<td class="nump">8,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">12,458<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,855<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">23,715<span></span>
</td>
<td class="nump">25,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,324<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangibles, net</a></td>
<td class="nump">11,658<span></span>
</td>
<td class="nump">11,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">1,482<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">39,179<span></span>
</td>
<td class="nump">40,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable, Current</a></td>
<td class="nump">19,724<span></span>
</td>
<td class="nump">21,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">631<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">22,549<span></span>
</td>
<td class="nump">24,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">7,360<span></span>
</td>
<td class="nump">7,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">8,367<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Authorized&#8212;500 thousand shares, Issued&#8212;none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Authorized&#8212;755 million shares, Issued&#8212;327 million shares at September 30, 2019 and June 30, 2019, respectively</a></td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common shares in treasury, at cost: 34 million shares and 28 million shares at September 30, 2019 and June 30, 2019, respectively</a></td>
<td class="num">(2,039)<span></span>
</td>
<td class="num">(1,790)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cardinal Health, Inc. shareholders' equity</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">6,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">6,330<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 39,179<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>160</ContextCount>
  <ElementCount>368</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Condensed Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings</Role>
      <ShortName>Condensed Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003000 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1014000 - Statement - Condensed Consolidated Statement of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statement of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1015000 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Restructuring and Employee Severance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</Role>
      <ShortName>Restructuring and Employee Severance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Commitments, Contingent Liabilities and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</Role>
      <ShortName>Restructuring and Employee Severance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstruments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2316301 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails</Role>
      <ShortName>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails</Role>
      <ShortName>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails</Role>
      <ShortName>Restructuring and Employee Severance Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Goodwill and Other Intangible Assets Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - Investments Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Leases Narative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesNarativeDetails</Role>
      <ShortName>Leases Narative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Leases Summary of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails</Role>
      <ShortName>Leases Summary of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Leases Summary of Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails</Role>
      <ShortName>Leases Summary of Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2407405 - Disclosure - Leases Summary of Minimum Lease Committments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails</Role>
      <ShortName>Leases Summary of Minimum Lease Committments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2407406 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408401 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2409401 - Disclosure - Commitments, Contingent Liabilities and Litigation Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2410401 - Disclosure - Income Taxes Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Fair Value Measurements Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Financial Instruments Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails</Role>
      <ShortName>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Shareholders' Equity Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Segment Information Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2415403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Revenue by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2415404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Segment Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2415405 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Assets by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Segment Information Disaggregated Revenue Within Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails</Role>
      <ShortName>Segment Information Disaggregated Revenue Within Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Segment Information Revenue by Geographical Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails</Role>
      <ShortName>Segment Information Revenue by Geographical Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2416402 - Disclosure - Share-Based Compensation Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2416403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2416404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2416405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2416406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="a20q110q093019form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="a20q110q093019form10-q.htm">a20q110q093019form10-q.htm</File>
    <File>a20q110q93019exhibit311.htm</File>
    <File>a20q110q93019exhibit312.htm</File>
    <File>a20q110q93019exhibit321.htm</File>
    <File>a20q110q93019exhibit991.htm</File>
    <File>cah-20190930.xsd</File>
    <File>cah-20190930_cal.xml</File>
    <File>cah-20190930_def.xml</File>
    <File>cah-20190930_lab.xml</File>
    <File>cah-20190930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>chart-0e7efb26c0365e6cb47.jpg</File>
    <File>chart-5f32bf9b0ca256e99b2.jpg</File>
    <File>chart-986746bac297519d8c3.jpg</File>
    <File>chart-f4d60677c0e25c84939.jpg</File>
    <File>chart-ff3385a010ad5ef68c1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/invest/2013-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>a20q110q093019form10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cah="http://www.cardinal.com/20190930"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cah-20190930.xsd" xlink:type="simple"/>
    <context id="FD2020Q1YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="I2020Q1Oct31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2018Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="I2020Q1ASC842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cah:EnterpriseWideCostSavingMeasuresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cah:EnterpriseWideCostSavingMeasuresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-01</instant>
        </period>
    </context>
    <context id="FD2019Q1YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="D2020Q1SD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="FI2020Q1_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="I2020Q1lawsuits_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="I2020Q1lawsuits_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_MajorCustomersAxis_cah_CVSHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-01</endDate>
        </period>
    </context>
    <context id="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-01</instant>
        </period>
    </context>
    <context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationnetoftaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="I2020Q1opioid_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-21</instant>
        </period>
    </context>
    <context id="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-01</endDate>
        </period>
    </context>
    <context id="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_cah_TaxMatterAxis_cah_CareFusionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="I2019Q1ASR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-10-25</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="FD2020Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="StateAG">
        <measure>cah:StateAG</measure>
    </unit>
    <unit id="segment">
        <measure>cah:segment</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Number_of_Reportable_Segments">
        <measure>cah:Reportable_Segments</measure>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="plaintiff">
        <measure>cah:plaintiff</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="lawsuit">
        <measure>cah:lawsuit</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="FD2020Q1YTD"
      id="Fact-03851B3F47D6B214760693192986D604-wk-Fact-03851B3F47D6B214760693192986D604">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="FD2020Q1YTD"
      id="Fact-66D653005BACA5530824931926EBCC16-wk-Fact-66D653005BACA5530824931926EBCC16">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="FD2020Q1YTD"
      id="Fact-E5F679FA624C68C1CD18931928B4956A-wk-Fact-E5F679FA624C68C1CD18931928B4956A">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="FD2020Q1YTD"
      id="Fact-F9E6C55E8F4229D4699E931927C94862-wk-Fact-F9E6C55E8F4229D4699E931927C94862">2020</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="FD2020Q1YTD"
      id="Fact-DBBEF5F96FE2F1EBE22393192631E974-wk-Fact-DBBEF5F96FE2F1EBE22393192631E974">0000721371</dei:EntityCentralIndexKey>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-BF7BA5939DBD23296D9874189FB72F03-wk-Fact-BF7BA5939DBD23296D9874189FB72F03"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2020Q1"
      decimals="-3"
      id="Fact-B0C8BC96263F2C9EE91D74189FA7DFF4-wk-Fact-B0C8BC96263F2C9EE91D74189FA7DFF4"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-C9C1D3565F006568F66E74189FB7F8A1-wk-Fact-C9C1D3565F006568F66E74189FB7F8A1"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q1"
      decimals="-3"
      id="Fact-7961B8F1C9301A4E89AC74189FB73511-wk-Fact-7961B8F1C9301A4E89AC74189FB73511"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-8"
      id="Fact-CC971F9D740B2F025CB3126E9B603DCD-wk-Fact-CC971F9D740B2F025CB3126E9B603DCD"
      unitRef="usd">8000000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:NumberOfReportableSegments
      contextRef="FD2020Q1YTD"
      decimals="INF"
      id="Fact-CA070B4FA21B18EE514D1CFCC3BB9BD0-wk-Fact-CA070B4FA21B18EE514D1CFCC3BB9BD0"
      unitRef="Number_of_Reportable_Segments">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-3D9379467961DD3497E874189FB72DE9-wk-Fact-3D9379467961DD3497E874189FB72DE9"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2020Q1"
      decimals="-3"
      id="Fact-353001115F5F8BAD85D574189FA76840-wk-Fact-353001115F5F8BAD85D574189FA76840"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-93CA4D17D50927846EDE74189FA70D73-wk-Fact-93CA4D17D50927846EDE74189FA70D73"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2020Q1"
      decimals="-3"
      id="Fact-8203F7A161711566F30574189FB7BCF5-wk-Fact-8203F7A161711566F30574189FB7BCF5"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-124727C0A519C25933E874189FB7AFDF-wk-Fact-124727C0A519C25933E874189FB7AFDF"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q1"
      decimals="-3"
      id="Fact-F618A0412A91D0D7663674189FA78817-wk-Fact-F618A0412A91D0D7663674189FA78817"
      unitRef="shares">34000000</us-gaap:TreasuryStockShares>
    <dei:DocumentType
      contextRef="FD2020Q1YTD"
      id="d113070679e2744-wk-Fact-1D1B7C2164515E709578A38E11AD66B4">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="FD2020Q1YTD"
      id="d113070679e2762-wk-Fact-CCCC036B50F42C3EBCE292C2DCF2436D">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="FD2020Q1YTD"
      id="d113070679e2772-wk-Fact-808AE6486E405B709EACACA22950E5F0">2019-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="FD2020Q1YTD"
      id="d113070679e2792-wk-Fact-30DDD43F776BEDFE503B92C3499AC80C">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="FD2020Q1YTD"
      id="d113070679e2805-wk-Fact-77F0B507F87532B0F19092C423D3E39C">1-11373</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="FD2020Q1YTD"
      id="d113070679e2812-wk-Fact-EA306DE4D52F3A5652E592C48788F861">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="FD2020Q1YTD"
      id="d113070679e2838-wk-Fact-2C0A3CC8A2CDFB3028F192C948D79BB1">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="FD2020Q1YTD"
      id="d113070679e2868-wk-Fact-388B10B98E730D2AC58A92CCFFA3276C">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="FD2020Q1YTD"
      id="d113070679e2952-wk-Fact-5E7C98E3D3635AF41E7792CD237CC7C0">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="FD2020Q1YTD"
      id="d113070679e2962-wk-Fact-EE8D27460BE52439C4E192CD4989B32D">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="FD2020Q1YTD"
      id="d113070679e2972-wk-Fact-EB50E24701CEE249262C92CD742A1238">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="FD2020Q1YTD"
      id="d113070679e2982-wk-Fact-74D6BB81F7B4D875939792CD9D10E2DB">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="FD2020Q1YTD"
      id="d113070679e3023-wk-Fact-8371BAFDD4A6F71AAA9C92CF16C97A94">614</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="FD2020Q1YTD"
      id="d113070679e3028-wk-Fact-6FC9DF892B7EBC23BCEA92CF3FC08FB3">757-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="FD2020Q1YTD"
      id="d113070679e3081-wk-Fact-4E3AB3224F3C893755C792D222C3035D">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="FD2020Q1YTD"
      id="d113070679e3086-wk-Fact-5CA866ACCC37B77E982292D223770DF3">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="FD2020Q1YTD"
      id="d113070679e3091-wk-Fact-3E2392A0AA607612B07A92D223F16B70">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="FD2020Q1YTD"
      id="d113070679e3096-wk-Fact-7A88D5CC7AE5B743FC2992CF8BB85906">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="FD2020Q1YTD"
      id="d113070679e3110-wk-Fact-768A8AB834F000EE0F2E92D00BADAF3D">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="FD2020Q1YTD"
      id="d113070679e3143-wk-Fact-084C0A803CEB800CF27A92D0A5FEFF19">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="FD2020Q1YTD"
      id="d113070679e3194-wk-Fact-2BC1A2F7C0A844824D1392D0D8665D36">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="FD2020Q1YTD"
      id="d113070679e3225-wk-Fact-467FDDD8970EA3AD8BEF92D0D929442A">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="FD2020Q1YTD"
      id="d113070679e3240-wk-Fact-64C2B25BA9E62D09E22D92D185DA7E57">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I2020Q1Oct31"
      decimals="0"
      id="d113070679e3259-wk-Fact-EE0BCB3884065ACEA80A216FCDA1DFB3"
      unitRef="shares">292488354</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e2835-wk-Fact-2EB2517D9B7C56CF8B4E3EA80588EA22"
      unitRef="usd">37341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e2854-wk-Fact-0A6172E3579B0878A1BA74189FE5023E"
      unitRef="usd">35213000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e2869-wk-Fact-4EDDEE0C6D378D155DF174189FE5D1A9"
      unitRef="usd">35662000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e2888-wk-Fact-F423499D4BB3CE30FDB574189FE55EA8"
      unitRef="usd">33546000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e2908-wk-Fact-0629FA7509FB597CAFF79BD1A7BFFC67"
      unitRef="usd">1679000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e2927-wk-Fact-5709F3B2E27A9618E5C474189FE548C5"
      unitRef="usd">1667000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3029-wk-Fact-C4D0FDF407C45245B9023ED2CCC6D99A"
      unitRef="usd">1107000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3048-wk-Fact-9E016B61E89C362C33FA74189FD6D792"
      unitRef="usd">1155000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3068-wk-Fact-FC6357DD0856F8E6785674189FD65150"
      unitRef="usd">30000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3087-wk-Fact-76D8C8D0F3F3A19A1A7E74189FD61527"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3107-wk-Fact-341B2F11B418954B6E4474189FE56D5A"
      unitRef="usd">132000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3126-wk-Fact-003ECA458AD9D3DA508574189FE5D00A"
      unitRef="usd">156000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3146-wk-Fact-26E35CF3BB3A12B0A6CB74189FD68C16"
      unitRef="usd">-1000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3165-wk-Fact-E50D33B0DE70FEF2421474189FE54D37"
      unitRef="usd">511000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3187-wk-Fact-339651A9460C4BA8E66274189FD67937"
      unitRef="usd">-5673000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3206-wk-Fact-B8AD5079716E08F8615B74189FE5726D"
      unitRef="usd">-19000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3226-wk-Fact-C69CC6A1EB30AC79AEA374189FE51E22"
      unitRef="usd">-5264000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3246-wk-Fact-9E7250608ACD7C0949BA74189FE59C2A"
      unitRef="usd">816000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3307-wk-Fact-EB895B0DBC7B5642900E74189FD6FF92"
      unitRef="usd">-14000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3326-wk-Fact-A4EAD856191F08E67F7574189FC6FDD9"
      unitRef="usd">-3000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3346-wk-Fact-F700C2D94B2C80AA1EA574189FE56260"
      unitRef="usd">66000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3365-wk-Fact-F01596FBD407DC00E70874189FE595D8"
      unitRef="usd">77000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3385-wk-Fact-8672D8BC1DB49E74979F74189FE5D37D"
      unitRef="usd">-5344000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3405-wk-Fact-B42BF90E4B0662E8F0B874189FE56096"
      unitRef="usd">736000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3466-wk-Fact-9083B5C4BBFBE29B5DBD74189FE549A7"
      unitRef="usd">-423000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3486-wk-Fact-CC66B2605549CED11BB974189FD685EB"
      unitRef="usd">142000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3506-wk-Fact-20615342158EE0B1641174189FE583ED"
      unitRef="usd">-4921000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3526-wk-Fact-D5D3196327F48E77BF2FB5FE576F0E7B"
      unitRef="usd">594000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3587-wk-Fact-11DFE9E87DC05B519D59C53959BFE356"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3607-wk-Fact-A205E9BD1D73BE967F5474189FE51F51"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3634-wk-Fact-1A54C3173FDE51E0A09F56C9BE18161A"
      unitRef="usd">-4922000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3654-wk-Fact-B9E1AF545110BC886F6D74189FE5100D"
      unitRef="usd">593000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2020Q1YTD"
      decimals="2"
      id="d113118214e3756-wk-Fact-D24DE77832DDB090C67174189FD6E9F0"
      unitRef="usdPerShare">-16.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d113118214e3776-wk-Fact-4377CD3164F70A0F3C4274189FE5B2E3"
      unitRef="usdPerShare">1.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2020Q1YTD"
      decimals="2"
      id="d113118214e3791-wk-Fact-4C4398D2C5F97F558F0374189FC65D14"
      unitRef="usdPerShare">-16.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="FD2019Q1QTD"
      decimals="2"
      id="d113118214e3811-wk-Fact-EC923336F5FA80B9DE9974189FE5E98F"
      unitRef="usdPerShare">1.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3913-wk-Fact-D6C8D60818B189B0168C74189FD6136D"
      unitRef="shares">296000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3932-wk-Fact-6E64E45E52945A2BB3CD74189FA7EE57"
      unitRef="shares">305000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113118214e3952-wk-Fact-46FD7D10EEDAFA15016374189FE5F0CD"
      unitRef="shares">296000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113118214e3971-wk-Fact-DD255080D24812C9B08874189FE5673E"
      unitRef="shares">306000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2020Q1YTD"
      decimals="INF"
      id="d113118214e4037-wk-Fact-1B8A5101527F59160CFC74189FD674FD"
      unitRef="usdPerShare">0.4811</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2019Q1QTD"
      decimals="INF"
      id="d113118214e4056-wk-Fact-E666A9A9123E8BDB616074189FF522F8"
      unitRef="usdPerShare">0.4763</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e2834-wk-Fact-20615342158EE0B1641174189FE583ED"
      unitRef="usd">-4921000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e2854-wk-Fact-D5D3196327F48E77BF2FB5FE576F0E7B"
      unitRef="usd">594000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e2951-wk-Fact-37C681EAB28FEEDEF0CF74189FD6F059"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e2971-wk-Fact-8BCB1610D232C4492CE474189FD6780E"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e2992-wk-Fact-15CECAF243773555C29A74189FD6AD24"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e3012-wk-Fact-F8D25D4616385DFCAFA774189FD66324"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e3033-wk-Fact-787E9E0F660FBFCE017774189FD66FFA"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e3053-wk-Fact-8922AB9156A1C19E7B0D74189FD61069"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e3115-wk-Fact-62A95E0557DCAF3D8F3974189FD6749B"
      unitRef="usd">-4943000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e3135-wk-Fact-95BDD1AFDAB59DBDC30F74189FD686DB"
      unitRef="usd">590000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e3197-wk-Fact-11DFE9E87DC05B519D59C53959BFE356"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e3217-wk-Fact-A205E9BD1D73BE967F5474189FE51F51"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113117897e3243-wk-Fact-66366E2BA43EFF11212374189FD6A429"
      unitRef="usd">-4944000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113117897e3263-wk-Fact-7C90F9C4E6DD3D075F3074189FE5FB14"
      unitRef="usd">589000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e2876-wk-Fact-2FAE2CD18834556198580AC0692371F4"
      unitRef="usd">1212000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e2895-wk-Fact-6CF1D02DC3B55A08BB6BE141ECBEE440"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e2910-wk-Fact-50D813EE310A57DBAB0464FFD2AD4917"
      unitRef="usd">8190000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e2929-wk-Fact-B49E767CA381519A99B2571252D502BF"
      unitRef="usd">8448000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e2949-wk-Fact-EBBB20710F9C5449965D4B8AAC671A48"
      unitRef="usd">12458000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e2968-wk-Fact-52DAACAC7ECB53829D44FDACC65BA65B"
      unitRef="usd">12822000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e2988-wk-Fact-70D9FE9B77A55C30998BF1B5D99878ED"
      unitRef="usd">1855000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3007-wk-Fact-CA131BBFA77F5A2782C3BA57E94E1E1B"
      unitRef="usd">1946000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3027-wk-Fact-419A09CFAF525F92B9410AA3CCB94A59"
      unitRef="usd">23715000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3046-wk-Fact-34B2C3B4D2045C3D9F87DCC07AA2D606"
      unitRef="usd">25747000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3107-wk-Fact-030D573DA6B15E6A89DBFD8DE41D74E0"
      unitRef="usd">2324000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3126-wk-Fact-581ECCE4735E5EE99061BA80A524CA20"
      unitRef="usd">2356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3146-wk-Fact-03E8EC4195F952E09A81AEE6E9F7A83C"
      unitRef="usd">11658000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3165-wk-Fact-52787ACB841D50CD8B12FD538222F4BE"
      unitRef="usd">11808000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3186-wk-Fact-19C1A935103752C7AA1CE506BCAE9E06"
      unitRef="usd">1482000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3205-wk-Fact-AB25ED817A745D77B00B9A8F51D789F7"
      unitRef="usd">1052000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3230-wk-Fact-1B6A9B277CF557F2B4AF8989D169AA36"
      unitRef="usd">39179000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3249-wk-Fact-25A8ADCBD95A5ECFAAB5838D8DCE774C"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3392-wk-Fact-059736ACDBC4561598B0463A8587761E"
      unitRef="usd">19724000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3411-wk-Fact-06C661D6E83951658C5017B3E75F99BF"
      unitRef="usd">21535000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3426-wk-Fact-9D197DD01EA65B8BACC8728F3F416321"
      unitRef="usd">631000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3445-wk-Fact-2A03227CB44B5EFA88C15C50924C451E"
      unitRef="usd">452000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3465-wk-Fact-149E758871B95AB39078D701D0EA286A"
      unitRef="usd">2194000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3484-wk-Fact-B5731062608B522683EC117D51DEED16"
      unitRef="usd">2122000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3504-wk-Fact-F510E29A95DA5EF7BFE9A859413E2CC8"
      unitRef="usd">22549000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3523-wk-Fact-90FBB01E2FEF5D0186C1A61F0A87F768"
      unitRef="usd">24109000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3584-wk-Fact-76A797952E225384BAC3F840B1B60AA0"
      unitRef="usd">7360000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3603-wk-Fact-8BECC219FEB35575BF2390A3AD6E683A"
      unitRef="usd">7579000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3624-wk-Fact-54A0262E6A035D4C92E6DF2EAB0FB8C6"
      unitRef="usd">8367000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3643-wk-Fact-A68C3ECA11B3536CBD950A939258EC4D"
      unitRef="usd">2945000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockValue
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3792-wk-Fact-C39D37D4B17C52598B80035C5241ED90"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3811-wk-Fact-794183FF51A85C0AA028F78C56690B81"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3884-wk-Fact-33E5132C4AA5539B8F579FC21C26DF5D"
      unitRef="usd">2669000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3903-wk-Fact-281BDEB7DBF957E4B36578656309849C"
      unitRef="usd">2763000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3923-wk-Fact-7C67F838B9C65A089AFBF5136F8072D8"
      unitRef="usd">371000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3942-wk-Fact-FE6C51E8BC0F582FB769EB10F9DBCD94"
      unitRef="usd">5434000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e3970-wk-Fact-7D76E032ACF15352B83B3AD9653BF739"
      unitRef="usd">2039000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e3990-wk-Fact-925D7327DA9F5B608CADD3D8CA88BCCE"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e4011-wk-Fact-342B257EA09C565EABB78E213A2500B6"
      unitRef="usd">-101000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e4031-wk-Fact-2447D06E11965163A0E019E15F78C658"
      unitRef="usd">-79000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e4052-wk-Fact-2944B823E8D35CD08E719A9A0E22C9E9"
      unitRef="usd">900000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e4071-wk-Fact-6B319AB31643582CB6DEE82BEB949299"
      unitRef="usd">6328000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e4092-wk-Fact-05197C5E29B558C69B2036BD1779DEB6"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e4111-wk-Fact-5C84B37A23435AE28F8B03F2BD63FF2A"
      unitRef="usd">2000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e4131-wk-Fact-B6C4A36010E956AF9BB5F5160629B01E"
      unitRef="usd">903000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e4150-wk-Fact-4A7519D276995847851ABD77F30E521C"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113123061e4175-wk-Fact-9623F1FC8A345D7AAD0CD6D008A95464"
      unitRef="usd">39179000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113123061e4194-wk-Fact-8139A144E4215B56B551F13EDC30D701"
      unitRef="usd">40963000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e3230-wk-Fact-BFCB88004E1122D268B5FA0C3CFB7A10"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e3249-wk-Fact-4DC1D2C6DB57E62312D5FA0C41BAE946"
      unitRef="usd">2763000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e3268-wk-Fact-3944F89BE4C010D29ECAFA0C44F9C283"
      unitRef="usd">5434000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e3283-wk-Fact-3EABC0CD34A748C07D94FA0C48005196"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e3303-wk-Fact-348D10A02C50743EEF9FFA0C4AF50DD5"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113132713e3323-wk-Fact-071601D8D69897438770FA0C4E1F18C9"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d113132713e3344-wk-Fact-151B8FBD5F0A4DCA5B43FA0C4FC90DB1"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113132713e3363-wk-Fact-4A7519D276995847851ABD77F30E521C"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113132713e3413-wk-Fact-1A54C3173FDE51E0A09F56C9BE18161A"
      unitRef="usd">-4922000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d113132713e3490-wk-Fact-23C9265606CA7B930FE846F120F78FA6"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113132713e3509-wk-Fact-20615342158EE0B1641174189FE583ED"
      unitRef="usd">-4921000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113132713e3621-wk-Fact-8406AAE597DB0C4AC93FFA16BC55D48F"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113132713e3662-wk-Fact-2AA592A00B66DD1C572DFA16C13F5FF2"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e3696-wk-Fact-B64B7FF6977EC37FAD82FA17B91780EF"
      unitRef="usd">24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e3750-wk-Fact-A269E5FBD3B3AB81BAF6FA17BF1EC2C1"
      unitRef="usd">31000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113132713e3810-wk-Fact-B3327C1C8C0BA4167D32FA17C349CE61"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e3845-wk-Fact-8EBEC36E75DCE61F9F58136D3D8B4FDB"
      unitRef="usd">70000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e3884-wk-Fact-3351D8DA1A9D2AC1C3F9FA187C43B99A"
      unitRef="shares">6000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e3899-wk-Fact-937860E42DB2830910A8FA19E0799EE4"
      unitRef="usd">280000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113132713e3960-wk-Fact-EC09646B09BD5464E583FA1A70E1E761"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:Dividends
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e4016-wk-Fact-052A555F8C753111AF71FA1ACD031A74"
      unitRef="usd">141000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113132713e4113-wk-Fact-D9F457536EDB23EA7068FA1A72E5F522"
      unitRef="usd">141000000</us-gaap:Dividends>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e4134-wk-Fact-56F9B47CDEF9772FC270FA1B6FC3EFD2"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e4153-wk-Fact-C08440E7E6A897150863FA1B71B6EFF2"
      unitRef="usd">2669000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e4172-wk-Fact-BDF4D1FCABC66EBE61FFFA1B73AAB5F9"
      unitRef="usd">371000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e4187-wk-Fact-209D89320781DA949CFBFA1B75A065AA"
      unitRef="shares">34000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e4207-wk-Fact-9A49F47ED60EC247A8C9FA1B77950ED4"
      unitRef="usd">2039000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113132713e4227-wk-Fact-E34511C10C32EDD553A3FA1B79871F1E"
      unitRef="usd">-101000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d113132713e4248-wk-Fact-3028A39BFFADE8E166F1FA1B7BA00308"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113132713e4267-wk-Fact-B6C4A36010E956AF9BB5F5160629B01E"
      unitRef="usd">903000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e4475-wk-Fact-C6709446863CFD9FB5CEFA20DC2E243B"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e4494-wk-Fact-AC44E26B84EFA8A8AEA1FA20DEC83A6E"
      unitRef="usd">2730000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e4513-wk-Fact-B2E351A726A27368F778FA20E163A401"
      unitRef="usd">4645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e4528-wk-Fact-BFBDF3AB260697F28ED3FA20E41FB559"
      unitRef="shares">18000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e4548-wk-Fact-ACBEAB4305D5645D6D0EFA20E6EC0461"
      unitRef="usd">1224000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113132713e4568-wk-Fact-F0FC2671DB2AEA78A1F5FA20E9DAF16A"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d113132713e4589-wk-Fact-0DA31E4C31E063DBA100FA20ECEE4DB0"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4"
      decimals="-6"
      id="d113132713e4608-wk-Fact-1E9B49341796FA83C340FA20EF8BAFED"
      unitRef="usd">6059000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e4658-wk-Fact-DDBB3102BE6323DA2AC3FA21F8576512"
      unitRef="usd">593000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113132713e4754-wk-Fact-B9E1AF545110BC886F6D74189FE5100D"
      unitRef="usd">593000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113132713e4865-wk-Fact-BA9945E841400C48BC35FA220594CB52"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113132713e4906-wk-Fact-F81D2D52F39BCAD840FFFA220ACAF793"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e4940-wk-Fact-4AAC038CD2492E49B4AFFA22143D5356"
      unitRef="usd">20000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e4994-wk-Fact-CFAA6B6BA2664C46E50EFA221B965798"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113132713e5054-wk-Fact-00E38CAF69231A238822FA22223A5927"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e5089-wk-Fact-85FFA6C83B393F9128C2136CBEEF88C5"
      unitRef="usd">120000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e5130-wk-Fact-D6F75E692A0EB1BE55BDFA2225CD3303"
      unitRef="shares">9000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e5145-wk-Fact-F6B407ACB2D57F8A4B6CFA2228561F54"
      unitRef="usd">480000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113132713e5206-wk-Fact-67722AE26562B60A14DBFA2230E25D8B"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:Dividends
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e5262-wk-Fact-ACB39F35E28E1CB9B568FA2235F7B0E3"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113132713e5359-wk-Fact-9EF486632D7F387EEFE0FA224593A285"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e5415-wk-Fact-59E515CC2734A8DD81D5FA224A27FDA9"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113132713e5511-wk-Fact-0F876415DDCAAB46DA50FA225A157F2C"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e5531-wk-Fact-761FACB4F38E6F630971FA214DDC7AD0"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d113132713e5550-wk-Fact-3795A419A6B903EF3318FA21511A089A"
      unitRef="usd">2590000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d113132713e5569-wk-Fact-CFD3FAE7EC7459E922C6FA215463EE01"
      unitRef="usd">5097000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e5584-wk-Fact-DBDFA9A68CB5AAF4AE05FA21576C3E81"
      unitRef="shares">27000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113132713e5604-wk-Fact-F8362EF85A05A4EED475FA2159E9EFD4"
      unitRef="usd">1678000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113132713e5624-wk-Fact-7FD60141CC612AE36F65FA215CF9F794"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d113132713e5645-wk-Fact-4A36FB68F5C2CB88CBCDFA215F8FFD1B"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q1"
      decimals="-6"
      id="d113132713e5664-wk-Fact-CA6679447FA78401D251FA21625DEC3D"
      unitRef="usd">5913000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e2874-wk-Fact-20615342158EE0B1641174189FE583ED"
      unitRef="usd">-4921000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e2894-wk-Fact-D5D3196327F48E77BF2FB5FE576F0E7B"
      unitRef="usd">594000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e2991-wk-Fact-795E6807B52763EFA3FD74189FD69B01"
      unitRef="usd">234000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3010-wk-Fact-B76E84F3D1630CD8DD8A74189FD6A00D"
      unitRef="usd">245000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3030-wk-Fact-4C3E96593FFC54DD050B74189FC6C897"
      unitRef="usd">0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3049-wk-Fact-72003EB7EE52294C028874189FC6CEFB"
      unitRef="usd">2000000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3069-wk-Fact-26E35CF3BB3A12B0A6CB74189FD68C16"
      unitRef="usd">-1000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3088-wk-Fact-E50D33B0DE70FEF2421474189FE54D37"
      unitRef="usd">511000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3109-wk-Fact-BF2D43D3FCC2502D97E374189FD688F6"
      unitRef="usd">20000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3128-wk-Fact-FC8D0668E0CCB0A419BB74189FD626CC"
      unitRef="usd">19000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3148-wk-Fact-FFD5904F32EFE6D6CDEE74189FC6D7B3"
      unitRef="usd">29000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3167-wk-Fact-0DB3FB57D01D911004AB74189FD68CE3"
      unitRef="usd">21000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3229-wk-Fact-61346CE076B40CA0031A74189FC6C6D2"
      unitRef="usd">-229000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3248-wk-Fact-CF2A59C421A79AD0BFE474189FD6A5F4"
      unitRef="usd">302000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3269-wk-Fact-71CACDFCFDCF760C6B8F74189FD6A2B0"
      unitRef="usd">-356000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3288-wk-Fact-27804DCFA6F15E82662774189FC6C7B8"
      unitRef="usd">178000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3309-wk-Fact-1F8F92DF618F95F4A95B74189FC6B2FC"
      unitRef="usd">-1812000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3329-wk-Fact-6273CDA26BC4E758B45C74189FD6A3FF"
      unitRef="usd">559000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3349-wk-Fact-E6D11EF678D4B017A43174189FD67DC5"
      unitRef="usd">-5211000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3368-wk-Fact-B22640171ED41FB87DD774189FD64789"
      unitRef="usd">84000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3389-wk-Fact-5709DFB42A034681EF0F74189FD68A3C"
      unitRef="usd">-653000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3409-wk-Fact-19981D5E1F8567F9899574189FC676B5"
      unitRef="usd">365000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3511-wk-Fact-D8AD73904D0CD5B23F1974189FD6F81B"
      unitRef="usd">72000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3531-wk-Fact-81ADF8B28F1562A9C00F74189FD6010F"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3552-wk-Fact-FC2E7CD6EB9337EFD94974189FD696E6"
      unitRef="usd">3000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3572-wk-Fact-AB7117E6D84FAC4E4FF374189FD68021"
      unitRef="usd">4000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3593-wk-Fact-B036D5DD257FBC65AA7D74189FD67F57"
      unitRef="usd">2000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3612-wk-Fact-8F0D4B2144FE48E7FDDB74189FD67A3C"
      unitRef="usd">1000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3633-wk-Fact-F7F2DE1C4FFFE6BA84F074189FD60A59"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3652-wk-Fact-DEDE4FBC41F15576E51374189FC6BA0A"
      unitRef="usd">740000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3672-wk-Fact-D8CD4A06DEB42291EA3D74189FD66E25"
      unitRef="usd">-73000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3692-wk-Fact-34BA50F7A75BD28A79E074189FD67E70"
      unitRef="usd">679000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3794-wk-Fact-7C076D5A7E7F985981C0F9FBD4D1B11E"
      unitRef="usd">-2000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3814-wk-Fact-7158B6C76244C918F1C5F9FBD4D132ED"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3834-wk-Fact-84266507C37F7D0D7FBB74189FD682C8"
      unitRef="usd">74000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3854-wk-Fact-174646EFB17FB2E816B274189FD63A3B"
      unitRef="usd">1000000</us-gaap:RepaymentsOfLongTermDebt>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3875-wk-Fact-AB14BA91ABC6628EDFA774189FD69EE2"
      unitRef="usd">-13000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3895-wk-Fact-FE76F6582218E7AD586474189FD6D3BD"
      unitRef="usd">-13000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3916-wk-Fact-CBF425A2EEEA821C4A5E74189FE5B72A"
      unitRef="usd">146000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3936-wk-Fact-65DBD271AE0265EB451A74189FD6140A"
      unitRef="usd">150000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3957-wk-Fact-EC09646B09BD5464E583FA1A70E1E761"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e3977-wk-Fact-67722AE26562B60A14DBFA2230E25D8B"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e3998-wk-Fact-390E6013804C373E5C0974189FD6459F"
      unitRef="usd">-585000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e4018-wk-Fact-3D0E8AD2FA4F2D35F82674189FD61E01"
      unitRef="usd">-764000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e4081-wk-Fact-444EF4868703817C983E74189FD68D52"
      unitRef="usd">-8000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e4101-wk-Fact-D5D2831A64B17AE5D06774189FC628DB"
      unitRef="usd">2000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113137623e4162-wk-Fact-F09C05CC0288F3092B2074189FD6FFDF"
      unitRef="usd">-1319000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113137623e4182-wk-Fact-CA4233AA332ADF0B93C174189FD63D05"
      unitRef="usd">282000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113137623e4202-wk-Fact-6CF1D02DC3B55A08BB6BE141ECBEE440"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-6"
      id="d113137623e4221-wk-Fact-609B85E7AD9052962BC974189FC62CFD"
      unitRef="usd">1763000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113137623e4246-wk-Fact-2FAE2CD18834556198580AC0692371F4"
      unitRef="usd">1212000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q1"
      decimals="-6"
      id="d113137623e4265-wk-Fact-96D972D046548AF93F8574189FD6A572"
      unitRef="usd">2045000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-04C33DC208A221B4B6D77418A0058754-0-wk-Fact-CCC48DD14087CAA4E21474189FB7FCDF">&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;1. Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. Refer to &lt;/span&gt;&lt;a href="#sF26386BC522F5F17861BDCB6DADF5D65" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 4&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for further information on our equity method investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our fiscal year ends on June 30. References to fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and June 30, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (the "&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Form 10-K"). &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;"&gt;Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2018, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a Benchmark &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Interest Rate for Hedge Accounting Purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$422 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;S&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;ee&#160;&lt;/span&gt;&lt;a href="#s1b4f19725b5347a89ea3b6d3c65e17fb" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 5&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of adoption on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-AEA6674A9F146FABF9757418A005FA86-0-wk-Fact-FA3B5F79C171AC78D79674189FC6742F">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. Investments in business entities in which we do not have control, but have the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. Refer to &lt;/span&gt;&lt;a href="#sF26386BC522F5F17861BDCB6DADF5D65" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 4&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for further information on our equity method investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our fiscal year ends on June 30. References to fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and June 30, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (the "&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Form 10-K"). &lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-60B296B6B2C10CEDC6627418A0057F98-0-wk-Fact-6AF5367D58A86600805974189FE5ABB2">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-style:italic;"&gt;Derivatives and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2018, the Financial Accounting Standards Board ("FASB") issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a Benchmark &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Interest Rate for Hedge Accounting Purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$422 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;S&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;ee&#160;&lt;/span&gt;&lt;a href="#s1b4f19725b5347a89ea3b6d3c65e17fb" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 5&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of adoption on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842
      contextRef="I2020Q1ASC842"
      decimals="-6"
      id="d113143499e2820-wk-Fact-5A723703A1031B5BE55728F1290E7CC6"
      unitRef="usd">422000000</cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-500D7889F1E75F73158A7418A00555EB-0-wk-Fact-E9CE402CAC19FF34F69574189FB75A1E">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;2. Restructuring and Employee Severance&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three months ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During fiscal 2020 and 2019, we implemented certain enterprise-wide cost-saving initiatives affecting various functional and commercial areas intended to optimize and simplify our operating model and cost structure. We incurred &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$20 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$26 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, in expenses related to these cost savings initiatives, which are reflected in restructuring and employee severance in the condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-5C164C39B02F20E9E7CD74189FF5FA65-0-wk-Fact-8EE9EAB035E72B2E0DB574189FB77425">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes restructuring and employee severance costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three months ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;32&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113151149e2884-wk-Fact-966D2BF5DB025D303C0174189FC6533E"
      unitRef="usd">20000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113151149e2903-wk-Fact-0D6306C6E12DAD6D57FE74189FC62533"
      unitRef="usd">29000000</us-gaap:SeveranceCosts1>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113151149e2918-wk-Fact-B003EEA4667288CC473474189FC6A85E"
      unitRef="usd">10000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113151149e2937-wk-Fact-E99D833FB4C191549E3174189FC6BAA8"
      unitRef="usd">3000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113151149e2962-wk-Fact-FC6357DD0856F8E6785674189FD65150"
      unitRef="usd">30000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113151149e2981-wk-Fact-76D8C8D0F3F3A19A1A7E74189FD61527"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember"
      decimals="-6"
      id="d113151149e3043-wk-Fact-F8FE406895A64FD94D6EA7B533DD8805"
      unitRef="usd">20000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2019Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember"
      decimals="-6"
      id="d113151149e3047-wk-Fact-179F2B2AD55BB5EB6EFFA7B4371470E7"
      unitRef="usd">26000000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-F3C4E3BC5FE590F1013C74189FF548CD-0-wk-Fact-A3309D2521691953F63674189FB77E94">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:8%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d113151149e3175-wk-Fact-FDA4F247F9C857BBAF82C1F81AEDC56E"
      unitRef="usd">64000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d113151149e3194-wk-Fact-C88E416445C7559BB8A01C7712F6679F"
      unitRef="usd">8000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113151149e3213-wk-Fact-B78BE175D46C5924A4D7F229B7B8CC4B"
      unitRef="usd">72000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d113151149e3229-wk-Fact-F9A36EF9A02555269B8AA6FA5702226C"
      unitRef="usd">19000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d113151149e3248-wk-Fact-EC7DA0A9C6AB5AAF98194750FC3DC10B"
      unitRef="usd">6000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113151149e3267-wk-Fact-54E791A337AF5DC398A650DDB0451B88"
      unitRef="usd">25000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d113151149e3288-wk-Fact-40336673F13355D495CEFA980929019A"
      unitRef="usd">10000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q1YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d113151149e3308-wk-Fact-B41A098CBB5255BD94F27564E3085911"
      unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113151149e3328-wk-Fact-5AD776B51F8A53CCA82A2FAB1AC86209"
      unitRef="usd">12000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d113151149e3355-wk-Fact-02A01DBA7EE35D2CB8371BE6ED5F00E1"
      unitRef="usd">73000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d113151149e3374-wk-Fact-FC60B0C0E3CC52A8B11C897A8B3F85E1"
      unitRef="usd">12000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113151149e3393-wk-Fact-13C7D7C846115E939A0059692AB6366E"
      unitRef="usd">85000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-7B102BFA2515469A6A1A7418A0051D00-0-wk-Fact-2FD6889C03328C2FF74C74189FC6AC1D">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;3. Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,360&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,592&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;307&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,603&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;947&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,276&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,853&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,298&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Total amortization of intangible assets was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$129 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$133 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; through&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; 2024&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; is as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$382 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$442 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$408 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$358 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$328 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-325FE466B5D46D7F69A27418A0051D02-0-wk-Fact-87B4564CA1E7C930492474189FC6C82A">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,702&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,360&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113172190e2848-wk-Fact-6C6BD431632551CBB618CAB1485E3438"
      unitRef="usd">2663000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113172190e2867-wk-Fact-6412ABB0FAA55EEFAF07C2C0C62C0CD3"
      unitRef="usd">5715000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e2886-wk-Fact-7D554EE9405958328C0F245EFE162DBF"
      unitRef="usd">8378000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113172190e2902-wk-Fact-5C416E9498ED5A70A7DF8B57E8DCCD9D"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113172190e2922-wk-Fact-F230856634C953E8A5F777D301CBCB7B"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113172190e2941-wk-Fact-DEFB2BBB956D566FA07F7A7CA02E99AC"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113172190e2963-wk-Fact-1C8E0CF9B7B154009C69DF7AEE8F761C"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q1YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113172190e2982-wk-Fact-DE1CB6801D57557FB2FB1DD692FDA51C"
      unitRef="usd">-13000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113172190e3002-wk-Fact-41BCF94B321B588A8A1908B208FDF79F"
      unitRef="usd">-13000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113172190e3029-wk-Fact-B3ECBF6B3FBE508BA820BB94B732207A"
      unitRef="usd">2658000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q1_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113172190e3048-wk-Fact-22049C37AC1F5DBBACAC430A48F38F4E"
      unitRef="usd">5702000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3067-wk-Fact-209E5B2652B95EB69D4622AB1BE59262"
      unitRef="usd">8360000000</us-gaap:Goodwill>
    <cah:ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-6148D2052A6C5B9EE9087418A00564AD-0-wk-Fact-C389B90C3A3D5C220AA374189FD6D28A">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,592&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;673&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;307&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,603&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;656&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;947&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,276&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,853&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,555&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,298&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d113172190e3370-wk-Fact-16D413E79DD75E7F916DFE5BC244DA53"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d113172190e3408-wk-Fact-16D413E79DD75E7F916DFE5BC244DA53"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3434-wk-Fact-2359C9C3F3765D96A11B474A22992278"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3472-wk-Fact-2359C9C3F3765D96A11B474A22992278"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d113172190e3647-wk-Fact-156C2596C0315ECE8DBD1441269446A9"
      unitRef="usd">3555000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d113172190e3666-wk-Fact-D00338625A06532E8171FFA615637414"
      unitRef="usd">1592000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d113172190e3685-wk-Fact-E57357C306C65D13B080FC5713B57F09"
      unitRef="usd">1963000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      id="d113172190e3705-wk-Fact-737A88EAE5805BE686892E1728EFCAA9">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d113172190e3716-wk-Fact-DAE688AF8FC2551BAF7E026FF9B9E8FE"
      unitRef="usd">673000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d113172190e3735-wk-Fact-95C64061BB865A4C935228BF36A5A3FD"
      unitRef="usd">307000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d113172190e3754-wk-Fact-D9B07CF65EFA57DABAA05176FC257D89"
      unitRef="usd">366000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      id="d113172190e3774-wk-Fact-936DE9E2EA165E47B24EC8EE8BEFD062">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d113172190e3785-wk-Fact-5516F54F85EB5E309EEC507FC80441E8"
      unitRef="usd">1603000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d113172190e3804-wk-Fact-877968D977FE5D0C8C4901761FDA57E7"
      unitRef="usd">656000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d113172190e3823-wk-Fact-AA452D6D1C2F5D0A80D03066A536788D"
      unitRef="usd">947000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      id="d113172190e3843-wk-Fact-CDE853B63CB256C590487FEF5C9BC739">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3854-wk-Fact-B4AFD79CF13E5D4E910A55BD6F34B259"
      unitRef="usd">5831000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3873-wk-Fact-C3598D28424B57ADB11A14FE3B76705A"
      unitRef="usd">2555000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3892-wk-Fact-BECA546C78CF5B1498F4A6F7DBE5F212"
      unitRef="usd">3276000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q1YTD"
      id="d113172190e3912-wk-Fact-3340978409705A179D45BD8AC7340D5B">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3929-wk-Fact-5874C2CDD69D5F64ABDF3D304CD0D909"
      unitRef="usd">5853000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3948-wk-Fact-C3598D28424B57ADB11A14FE3B76705A"
      unitRef="usd">2555000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e3967-wk-Fact-29A516CC38325059A67D4CF9E61BB3D8"
      unitRef="usd">3298000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d113172190e4212-wk-Fact-CD737963CE5F53F19BDF66AACB22E1DF"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d113172190e4250-wk-Fact-CD737963CE5F53F19BDF66AACB22E1DF"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4266-wk-Fact-1296F6644DFB52BAA144453F964872B7"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4304-wk-Fact-1296F6644DFB52BAA144453F964872B7"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d113172190e4449-wk-Fact-E53CB576AF67509DA8ED2B9DA79116F0"
      unitRef="usd">3562000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d113172190e4468-wk-Fact-30EFC104B10558838B8E8EDE0A874191"
      unitRef="usd">1517000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d113172190e4487-wk-Fact-9B3CC7BC21A858C6813A2FF8BC952EEB"
      unitRef="usd">2045000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d113172190e4508-wk-Fact-31BCBAD6DA9E50EAB68D88639E74F588"
      unitRef="usd">672000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d113172190e4527-wk-Fact-647667D06E965580931F8774EA99518E"
      unitRef="usd">295000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d113172190e4546-wk-Fact-FF9B8D99B31355EEA2F77352B5BECBCB"
      unitRef="usd">377000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d113172190e4567-wk-Fact-851B5392424E551EB3CD7993988833D9"
      unitRef="usd">1602000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d113172190e4586-wk-Fact-1BA88DCA6E7C53ADB878CD90E4145E0F"
      unitRef="usd">616000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d113172190e4605-wk-Fact-800027ABA6135BCD90059E78A59A3395"
      unitRef="usd">986000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4626-wk-Fact-CBD6B020708451E3B93ACE9F3C6CA20D"
      unitRef="usd">5836000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4645-wk-Fact-F850A66737FB55138C14CDD0E72F0537"
      unitRef="usd">2428000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4664-wk-Fact-6EEA529E17D159DD935C7C67DC86B8BA"
      unitRef="usd">3408000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4691-wk-Fact-FEDEBF2E866452218405ED2DDEADB998"
      unitRef="usd">5858000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4710-wk-Fact-F850A66737FB55138C14CDD0E72F0537"
      unitRef="usd">2428000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113172190e4729-wk-Fact-24BBBD95FB5B523E950EE9F428DC3559"
      unitRef="usd">3430000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113172190e4758-wk-Fact-9B9293F2F10881ED393E74189FC6F41C"
      unitRef="usd">129000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113172190e4762-wk-Fact-F6176CF0D7010A68527EB6148FE0759D"
      unitRef="usd">133000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e4783-wk-Fact-327E95A019CA5B109BC6BBA0F8DA1149"
      unitRef="usd">382000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e4787-wk-Fact-DD1F19B131FD589684317A35382C38AC"
      unitRef="usd">442000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e4791-wk-Fact-A2932E075D2A5798ACB44D19796A4FBB"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e4795-wk-Fact-4DE89FFA0681585B927AAEA8999AD39E"
      unitRef="usd">358000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113172190e4799-wk-Fact-A0BF2D2A14B450B38C203A6B30E4531C"
      unitRef="usd">328000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-8AF7D3B98273AD4F457E7418A005613E-0-wk-Fact-3008154C028C58C5942674189FC6C403">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;4. Investments&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In August 2018, we sold our&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;98 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;ownership interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp;amp; Rice in exchange for cash proceeds of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$737 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;(after adjusting for certain fees and expenses) and a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;44 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;equity interest in a partnership that owns&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;100 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We are accounting for this investment using the equity method of accounting and on a one-month reporting lag. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended September 30, 2018, we recognized a pre-tax gain of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;related to this divestiture in impairments and (gain)/loss on disposal of assets in our condensed consolidated statement of earnings.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The carrying value of this investment was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$329 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$334 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. For the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, our proportionate share of naviHealth&#x2019;s net loss, which was recorded in Other (income)/expense, net in the condensed consolidated statement of earnings, was immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="d113144993e2733-wk-Fact-A20EAE36D96A862C5A8E13EAB5181928"
      unitRef="number">0.98</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d113144993e2737-wk-Fact-70EC407B4705C19D8F9713EF4C1D522C"
      unitRef="usd">737000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="d113144993e2741-wk-Fact-24DB21BF78396AD6E78974189FC65153"
      unitRef="number">0.44</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <cah:PartnershipIndirectOwnership
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="d113144993e2745-wk-Fact-E74D0F76A79C8460476174189FC6E1CA"
      unitRef="number">1</cah:PartnershipIndirectOwnership>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2019Q1YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d113144993e2752-wk-Fact-0C8C2A8C8E5611F0A18E13F1EC18BA9B"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2020Q1_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d113144993e2759-wk-Fact-0F68A432F6A81D396448FA6AA6A1F670"
      unitRef="usd">329000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d113144993e2763-wk-Fact-AF6839DA4CA85B6D8CADC5287332BF7E"
      unitRef="usd">334000000</us-gaap:EquityMethodInvestments>
    <cah:LeasesTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-612CC902D3975E99DA7CFA3BD7FCDBE2-0-wk-Fact-6CA02D878A89031D01ABFA3FA7516187">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;5. Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We primarily have operating leases for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Beginning July 1, 2019, operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our condensed consolidated balance sheet. Operating lease right-of-use assets and corresponding operating lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our lease agreements include leases that contain lease components and non-lease components. For all asset classes, we have elected to account for both of these provisions as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the condensed &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;consolidated financial statements at or for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; was not material. In addition, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our leases have remaining lease terms from less than &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; up to approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;23 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of lease cost:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Variable lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarizes supplemental balance sheet information related to leases:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;312&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Property and equipment, net &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Current portion of long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Long-term obligations, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Financing cash flows paid for finance lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes the effect of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; from reclassifying deferred rent as an offset in accordance with the transition guidance. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operating leases had a weighted-average remaining lease term of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; years and a weighted-average discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;3.0 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Future lease payments under non-cancellable leases as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;                          &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Years Ending September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Remainder of 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;519&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;538&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;432&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;As of September 30, 2019, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;As previously disclosed in our fiscal 2019 Form 10-K under the prior accounting guidance, the future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and thereafter were as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$126 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$76 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$54 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$33 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$94 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</cah:LeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2020Q1_srt_RangeAxis_srt_MinimumMember"
      id="d113162555e2751-wk-Fact-9B6D9CBA0CA3039B9E6246CB01154BF0">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2020Q1_srt_RangeAxis_srt_MaximumMember"
      id="d113162555e2755-wk-Fact-AB14E6DBDE68CE46FD2F46C778DB3A06">P23Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-9395663871308CACA136030B42C4085F-0-wk-Fact-527D47454A07DB07B8E0030E8CEF423E">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of lease cost:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Variable lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e2830-wk-Fact-F1401BC500C997BD109003189B27E727"
      unitRef="usd">31000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e2864-wk-Fact-447D052FE2F57A19A1DB0319B25CFD0A"
      unitRef="usd">4000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <cah:TotalFinanceLeaseCost
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e2884-wk-Fact-664F455CB49FD59FB8D7031CE6E21047"
      unitRef="usd">4000000</cah:TotalFinanceLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e2904-wk-Fact-E979870FE8A9FEE30433031D83988925"
      unitRef="usd">1000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e2929-wk-Fact-2FB661CA4180333ECC8E031DD2AD60CB"
      unitRef="usd">36000000</us-gaap:LeaseCost>
    <cah:LeasesSupplementalBalanceSheetInformationTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-C54CC1D910216496BB821CCC5ABA6174-0-wk-Fact-F1535FC490A3832CA0F81CCDAE491FB1">&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;312&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Property and equipment, net &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;18&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Current portion of long-term obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Long-term obligations, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:LeasesSupplementalBalanceSheetInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3008-wk-Fact-101AD897D97F4C82D11C1CD2F8C1D31E"
      unitRef="usd">394000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3044-wk-Fact-8E6F5F09C8189AAE4D631CD53D8379D0"
      unitRef="usd">103000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3064-wk-Fact-80CDE59581B55E0A64D91CD484D837F1"
      unitRef="usd">312000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3084-wk-Fact-258395C256D6D9410DD41CD4E974AC1B"
      unitRef="usd">415000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3146-wk-Fact-084DD41474120257E91A1CD6157FA5A5"
      unitRef="usd">18000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3188-wk-Fact-3BFBAF9A14BCA7460AD91CD6700E2037"
      unitRef="usd">5000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3208-wk-Fact-6010939FA46A1F82AAFB1CD6C70260A1"
      unitRef="usd">12000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3233-wk-Fact-93062B0775ABF09271EF1CD703CC401C"
      unitRef="usd">17000000</us-gaap:FinanceLeaseLiability>
    <cah:LeasePaymentsTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-DBBA12EDEE00EA04C1F3030A238D688F-0-wk-Fact-AD47960169CF94378FAC034570EE773E">upplemental cash flow information related to leases:&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Financing cash flows paid for finance lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;</cah:LeasePaymentsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e3334-wk-Fact-9C3D27EAD0AD7145181F035D8BDCEE1E"
      unitRef="usd">31000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e3349-wk-Fact-EF1E8953E77D8F8CB312035F4A212D2A"
      unitRef="usd">2000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e3389-wk-Fact-3A8193C1BF75B7CED68E03608029EB79"
      unitRef="usd">15000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113162555e3409-wk-Fact-CBECA57F3FF0F8269AF70360DB99C38D"
      unitRef="usd">17000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
      contextRef="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member"
      decimals="-6"
      id="d113162555e3433-wk-Fact-8791C640818C4E4303A503616B760111"
      unitRef="usd">-400000000</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification>
    <cah:ReclassificationofdeferredrentinaccordancewithASC842
      contextRef="D2020Q1SD"
      decimals="-6"
      id="d113162555e3453-wk-Fact-18B21A4E222B11C42F601D09F674A3F8"
      unitRef="usd">22000000</cah:ReclassificationofdeferredrentinaccordancewithASC842>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2020Q1"
      id="d113162555e3460-wk-Fact-B64648B31DB2233F232C02FB2BDB6889">P6Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2020Q1"
      decimals="3"
      id="d113162555e3464-wk-Fact-368D6D7685F6182E1BF502FBE7EB1124"
      unitRef="number">0.030</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-B3422A66DA2DF9771A3A03C1C47A4E20-0-wk-Fact-3080828176D9C1B035B503C31D0FC377">&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Future lease payments under non-cancellable leases as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;                          &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Years Ending September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Remainder of 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;83&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;41&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;42&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;149&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;519&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;538&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;432&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;As of September 30, 2019, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;As previously disclosed in our fiscal 2019 Form 10-K under the prior accounting guidance, the future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and thereafter were as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$126 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$76 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$54 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$33 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$94 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3633-wk-Fact-14D41F7BC2EB127654A103C9D3290BEB"
      unitRef="usd">91000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e3652-wk-Fact-36FEC0A8DEAD8058464003C9D32F86BC"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3671-wk-Fact-EA5DCD1E73623D8CA4E503C9D337E936"
      unitRef="usd">95000000</cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3687-wk-Fact-4CAB1E2436E84F9816CF03CB0595EA58"
      unitRef="usd">101000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e3706-wk-Fact-3F82311EDF71F78C72E203CB058FE441"
      unitRef="usd">6000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <cah:LesseeLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3725-wk-Fact-99382DA1B1789261E4AF03CB059BD5E8"
      unitRef="usd">107000000</cah:LesseeLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3746-wk-Fact-14DA99460860D9F841FD03CB47BC5FE9"
      unitRef="usd">79000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e3765-wk-Fact-445BCB7075AA399F9E1B03CB47E34AF2"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <cah:LesseeLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3784-wk-Fact-B88C6CEED60328EC3D5303CB47AE8094"
      unitRef="usd">83000000</cah:LesseeLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3805-wk-Fact-D1882104D40F3946A55103CB89C7D761"
      unitRef="usd">58000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e3824-wk-Fact-93F4A2B170EE5D3E0EAB03CB89CDFF1D"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3843-wk-Fact-3A180DFEB1C1273D2D5B03CB89D59E07"
      unitRef="usd">62000000</cah:LesseeLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3864-wk-Fact-BF436B500077F0F9348103CBC4316666"
      unitRef="usd">41000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e3883-wk-Fact-ED546F052DA272C46BC803CBC4667BFB"
      unitRef="usd">1000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3902-wk-Fact-6A70321980822327879E03CBC43EA9D1"
      unitRef="usd">42000000</cah:LesseeLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3923-wk-Fact-33B2017B6B09C973E99103CC33B52D8A"
      unitRef="usd">149000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e3942-wk-Fact-4E3BD4FA92D065A130CA03CC33B03002"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e3961-wk-Fact-CD798A78C8373E0E738F03CC33AB3AF5"
      unitRef="usd">149000000</cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e3982-wk-Fact-B4A59316EFC2C2B0698C03CCBB6FB1B7"
      unitRef="usd">519000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e4001-wk-Fact-82737FBEF43079DA969403CCBB69AFE9"
      unitRef="usd">19000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <cah:TotalLeaseLiabilityPaymentsDue
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e4020-wk-Fact-449F8D27FE5DB32772DC03CCBC70CB65"
      unitRef="usd">538000000</cah:TotalLeaseLiabilityPaymentsDue>
    <cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e4045-wk-Fact-51ED23BB9D0018CB22C603CFDC877756"
      unitRef="usd">61000000</cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount>
    <cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e4064-wk-Fact-272872E17B1AB814FC1C03CFDC6C0B83"
      unitRef="usd">0</cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount>
    <cah:TotalLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e4083-wk-Fact-0C3648968D2159B2F8DC03CFDCB29AF7"
      unitRef="usd">61000000</cah:TotalLeaseLiabilityNotYetCommencedAmount>
    <cah:OperatingLeaseImputedInterest
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e4104-wk-Fact-A865FBFB5EDFEBA0D6DD03CD43B60A50"
      unitRef="usd">43000000</cah:OperatingLeaseImputedInterest>
    <cah:FinanceLeaseImputedInterest
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e4123-wk-Fact-E0DD8908B6C6F46A1E3603CD43C5E1D8"
      unitRef="usd">2000000</cah:FinanceLeaseImputedInterest>
    <cah:TotalLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e4142-wk-Fact-68D9DDFA87393E628D4A03CD43EAAA8E"
      unitRef="usd">45000000</cah:TotalLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d113162555e4169-wk-Fact-541F8E78F6BE57CE9F9403D021338652"
      unitRef="usd">415000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q1_us-gaap_LeaseArrangementTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d113162555e4188-wk-Fact-1F1C519B660A0C2790C403D021382C49"
      unitRef="usd">17000000</us-gaap:FinanceLeaseLiability>
    <cah:TotalLeaseLiability
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113162555e4207-wk-Fact-149F1349903E1FBAD4B203D0213EF50A"
      unitRef="usd">432000000</cah:TotalLeaseLiability>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113162555e4236-wk-Fact-A14DC9C7AC1493E538FB3F4B00CB69F0"
      unitRef="usd">126000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113162555e4240-wk-Fact-54B7D7CF5AC192F9ECF63F4B00CB2403"
      unitRef="usd">100000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113162555e4245-wk-Fact-AD422F245C87DED908283F4B00CBB76C"
      unitRef="usd">76000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113162555e4249-wk-Fact-5C3EEB444A0E7A7ED8203F4B00CB2321"
      unitRef="usd">54000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113162555e4253-wk-Fact-28E7D49D7E1D195BE26A3F4B00BC2396"
      unitRef="usd">33000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113162555e4257-wk-Fact-1071D27B5AC1D20991703F4B00CB57A6"
      unitRef="usd">94000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-A61F28039C602432AF2A7418A005F57B-0-wk-Fact-56BB80D4E0251C78095574189FB7F87B">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;"&gt;6. Long-Term Obligations and Other Short-Term Borrowings&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We had total long-term obligations, including the current portion and other short-term borrowings, of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$8.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at both &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$19.7 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$21.5 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;During the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we repurchased a total of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$74 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of notes due in 2022 and 2047 with available cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;commercial paper program backed by a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;revolving credit facility. We also have a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; committed receivables sales facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#x201c;CHF&#x201d;) through September 30, 2022. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Our revolving credit facility and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter from  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; through December 2020, a consolidated net leverage ratio of&#160;no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every fiscal quarter thereafter. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;As of September 30, 2019, we were in compliance with our financial covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="FI2020Q1"
      decimals="-8"
      id="d113151154e2733-wk-Fact-2F18C7B499CBFF2E8F4674189FE5732B"
      unitRef="usd">8000000000.0</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q1"
      decimals="-8"
      id="d113151154e2747-wk-Fact-3F7132AB85A7403B103512A919493FF2"
      unitRef="usd">19700000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-8"
      id="d113151154e2751-wk-Fact-186042CE13C61A97F8F612FD0D40C27A"
      unitRef="usd">21500000000</us-gaap:AccountsPayableCurrent>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113151154e2771-wk-Fact-E44D3ED299C567440432FA87DB0C7F13"
      unitRef="usd">74000000</cah:NotesPayableRepurchased>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember"
      decimals="-6"
      id="d113151154e2781-wk-Fact-2841F996BBEF5DD8A27851A6BFF29356"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember"
      decimals="-6"
      id="d113151154e2785-wk-Fact-7A2479D365CD5D5F9B2FA032AC0814AC"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2019Q4_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d113151154e2789-wk-Fact-79327C1227FA5FC4B072457F82C2F0C7"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-64BB0CF7B5B34E03BF857418A005D0C4-0-wk-Fact-2EA8B0B18151C780AE1B74189FE5900B">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;7. Commitments, Contingent Liabilities and Litigation&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Generic Sourcing Venture with CVS Health Corporation ("CVS Health")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$45.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to CVS Health for the remainder of the initial term.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We become involved from time to time in disputes, litigation and regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We are named from time to time in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information have led, and may in the future lead, to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Opioid Lawsuits &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Pharmaceutical wholesale distributors, including us, have been named as defendants in approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;2,400&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits relating to the distribution of prescription opioid pain medications. These lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as negligence, public nuisance and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#x201c;MDL&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;21&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; state attorneys general have filed lawsuits against distributors, including us, in various state courts. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Additionally, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; state attorneys general have formed a multi-state task force to investigate the manufacturing, distribution, dispensing and prescribing practices of opioid medications. We have received requests related to the multi-state investigation, as well as separate civil investigative demands, subpoenas or requests for information from these and other state attorneys general offices. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In October 2019, we agreed in principle to a global settlement framework with a leadership group of four state attorneys general from the multi-state task force that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The Settlement Framework includes (1) a cash component, pursuant to which we would pay up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.56 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;eighteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, (2) development and participation in a program for free or rebated distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. The Settlement Framework is in its early phases, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We have included a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.56 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; accrual related to the Settlement Framework in deferred income taxes and other liabilities in the condensed consolidated balance sheets and litigation (recoveries)/charges, net, in the condensed consolidated statements of earnings.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;On October 21, 2019, we and two other national distributors agreed to a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$215 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; settlement with two Ohio counties, Cuyahoga and &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Summit, to resolve all claims in the first bellwether trial in the MDL that had been scheduled for trial in October 2019. In connection with this settlement, we have accrued &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$66 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, which is included in other accrued liabilities in the condensed consolidated balance sheets and litigation (recoveries)/charges, net, in the condensed consolidated statements of earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with these matters, we recorded a total pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; after tax) during the three-months ended September 30, 2019 for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. Moreover, the global Settlement Framework is in early stages and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. We are unable to reasonably estimate the liability associated with any potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to under the Settlement Framework. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.    &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The Settlement Framework does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals. Private parties had brought approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;325&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits as of November 1, 2019. Of these, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;97&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. We will continue to vigorously defend ourselves in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Product Liability Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;As of November 1, 2019, we are named as a defendant in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;280&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3,463&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits involving similar claims by approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At September 30, 2019, we had a total of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$414 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, net of estimated insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits which are presented on a gross basis in the condensed consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;to be approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$836 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, net of estimated insurance recoveries.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Shareholder Securities Litigation&lt;/span&gt;&lt;/div&gt;In August 2019, the Louisiana Sheriffs' Pension &amp;amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. Due to the early stage of this proceeding, it is not possible to reasonably estimate the amount of any possible loss or range of loss in this matter.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LongtermPurchaseCommitmentPeriod
      contextRef="FD2020Q1QTD_srt_MajorCustomersAxis_cah_CVSHealthMember"
      id="d113156494e2745-wk-Fact-955E82571B1C382AEBA33C72C8825BFB">P10Y</us-gaap:LongtermPurchaseCommitmentPeriod>
    <cah:MaximumQuarterlyPayment
      contextRef="FD2020Q1QTD_srt_MajorCustomersAxis_cah_CVSHealthMember"
      decimals="-5"
      id="d113156494e2749-wk-Fact-13E89AE26351F5888D9474189FD6C188"
      unitRef="usd">45600000</cah:MaximumQuarterlyPayment>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2797-wk-Fact-CC310D8A0ED8E87B86883BFAEAED921E"
      unitRef="number">2400</cah:LossContingencyLawsuitsNumber>
    <cah:NumberofStateAttorneysGeneralfilinglawsuits
      contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2807-wk-Fact-33AC43B6921B23E94BBC3BFD2B7FC38D"
      unitRef="StateAG">21</cah:NumberofStateAttorneysGeneralfilinglawsuits>
    <cah:InvestigationbyMultitateTaskForce
      contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2814-wk-Fact-EF149905CA93A22E38C83BFD81A77DCB"
      unitRef="StateAG">43</cah:InvestigationbyMultitateTaskForce>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      decimals="-7"
      id="d113156494e2824-wk-Fact-A13CDA568F748FE405853C4F19A8D598"
      unitRef="usd">5560000000</us-gaap:LitigationReserve>
    <cah:CashComponentForSettlementFrameworkTerm
      contextRef="FD2020Q1YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      id="d113156494e2828-wk-Fact-D1034B4348C61FD6A3C446E025361324">P18Y</cah:CashComponentForSettlementFrameworkTerm>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      decimals="-7"
      id="d113156494e2832-wk-Fact-A13CDA568F748FE405853C4F19A8D598"
      unitRef="usd">5560000000</us-gaap:LitigationReserve>
    <cah:OpioidTotalSettlementCuyahogaandSummitCounties
      contextRef="I2020Q1opioid_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="-6"
      id="d113156494e2839-wk-Fact-D1F7A855E0AFBC74FA073C52050132AE"
      unitRef="usd">215000000</cah:OpioidTotalSettlementCuyahogaandSummitCounties>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember"
      decimals="-6"
      id="d113156494e2846-wk-Fact-225F3F55569943BABA8B3C5BFCACC04B"
      unitRef="usd">66000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-7"
      id="d113156494e2853-wk-Fact-B506B163336CA2A537D23C2E6E5AC74F"
      unitRef="usd">5630000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember"
      decimals="-7"
      id="d113156494e2857-wk-Fact-44379A8082792262DF663C56556A2302"
      unitRef="usd">5140000000</us-gaap:LitigationReserve>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q1lawsuits_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2865-wk-Fact-49EE1DEAA7E1E8918D243C60B4076F69"
      unitRef="lawsuit">325</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q1lawsuits_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2869-wk-Fact-B9F441FF943F8ABFF1FE3C64787C95CE"
      unitRef="lawsuit">97</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2879-wk-Fact-43C92510F2F23F189DE63BFEDE4815D7"
      unitRef="lawsuit">280</cah:LossContingencyLawsuitsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="d113156494e2883-wk-Fact-3C08D5E119447B7DE0B83BFF2805F9BB"
      unitRef="plaintiff">3463</us-gaap:LossContingencyNumberOfPlaintiffs>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q1lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d113156494e2887-wk-Fact-F3F476F70FB25E8E14F73BFFFFA1A1ED"
      unitRef="plaintiff">24</cah:LossContingencyLawsuitsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="D2020Q1Lawsuits_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="d113156494e2891-wk-Fact-20DEAEBEC0427631015F3C0047E0FEDB"
      unitRef="plaintiff">28</us-gaap:LossContingencyNumberOfPlaintiffs>
    <cah:LossContingencyAccrualNetofInsuranceRecoveries
      contextRef="FI2020Q1_srt_RangeAxis_srt_MinimumMember"
      decimals="-6"
      id="d113156494e2898-wk-Fact-EF269163684A80383ACF3C0121F0FCAE"
      unitRef="usd">414000000</cah:LossContingencyAccrualNetofInsuranceRecoveries>
    <cah:LossContingencyAccrualNetofInsuranceRecoveries
      contextRef="FI2020Q1_srt_RangeAxis_srt_MaximumMember"
      decimals="-6"
      id="d113156494e2905-wk-Fact-913E310B1B2A2BE6A38A3C01719635A4"
      unitRef="usd">836000000</cah:LossContingencyAccrualNetofInsuranceRecoveries>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-F314BED7E6BE01B007AB7418A00555B1-0-wk-Fact-F9C9792EE55091E6839874189FA72D4C">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;8. Income Taxes&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Fluctuations in our provision for income taxes as a percentage of pre-tax earnings (&#x201c;effective tax rate&#x201d;) are due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:174%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Opioid Settlement Framework&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; pre-tax charge for the opioid litigation, we recorded a tax benefit of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$487 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is net of unrecognized tax benefits of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$468 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See &lt;/span&gt;&lt;a href="#s3E77F52A990B55D8984E21DCB5CC440C" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for more information regarding these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Effective Tax Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the effective tax rate was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; percent and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;19.4&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; percent, respectively. The change in the effective tax rate from fiscal 2019 to fiscal 2020 is primarily due to the net effects of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;the Settlement Framework, partially offset by the prior-year benefit of discrete tax items&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$943 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$456 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of unrecognized tax benefits at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. The &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; balances include &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$795 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$303 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$126 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$122 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for/(benefit from) income taxes in the condensed consolidated statements of earnings. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and a net decrease of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$10 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, exclusive of penalties and interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Other Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2008&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$168 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$165 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and is included in other assets in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition. The indemnification receivable was&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$23 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and is included in other assets in the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Future adjustments to the financial statements may be necessary as final tax regulations related to U.S. Tax Reform are issued. We will assess any impact as additional guidance is issued.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-7"
      id="d113161720e2737-wk-Fact-B506B163336CA2A537D23C2E6E5AC74F"
      unitRef="usd">5630000000</us-gaap:LitigationReserve>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q1QTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d113161720e2741-wk-Fact-C9CD6B08A7031FD26DD0277587D815EF"
      unitRef="usd">-487000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d113161720e2745-wk-Fact-0923D5404A13C6277704277F1B2B5A9D"
      unitRef="usd">468000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q1YTD"
      decimals="3"
      id="d113161720e2768-wk-Fact-1DE819693BC927BB339374189FB790E7"
      unitRef="number">0.079</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q1QTD"
      decimals="3"
      id="d113161720e2772-wk-Fact-66171FF81F70CC79485374189FA758B6"
      unitRef="number">0.194</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113161720e2786-wk-Fact-8D65B2A0A4A4A27E073213F812267D05"
      unitRef="usd">943000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113161720e2790-wk-Fact-A143F72D6DA157EEADC0BAC1A6DA1431"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113161720e2811-wk-Fact-858485D87A6C2A3DDDE713F8940A70EC"
      unitRef="usd">795000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113161720e2815-wk-Fact-E998AA6838165229AAB4072F6DE9915A"
      unitRef="usd">303000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113161720e2830-wk-Fact-BB7F588F375A507F89EBE18E9A576D83"
      unitRef="usd">126000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113161720e2834-wk-Fact-BA004D72295B52C1B0C856FF6530A700"
      unitRef="usd">122000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="FI2020Q1_srt_RangeAxis_srt_MinimumMember"
      decimals="-6"
      id="d113161720e2841-wk-Fact-3936A8FA1F7F57848E2E45CEE8802D16"
      unitRef="usd">0</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="FI2020Q1_srt_RangeAxis_srt_MaximumMember"
      decimals="-6"
      id="d113161720e2845-wk-Fact-A53029DBA34F503EAC8DD49ECBC6E98F"
      unitRef="usd">10000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:OpenTaxYear
      contextRef="FD2020Q1QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember"
      id="d113161720e2856-wk-Fact-E3A4CAC8D2383422A9A992FD3604BB1C">2008</us-gaap:OpenTaxYear>
    <cah:IndemnificationReceivable
      contextRef="FI2020Q1_cah_TaxMatterAxis_cah_CareFusionMember"
      decimals="-6"
      id="d113161720e2863-wk-Fact-6379AB05FF925289B1F968A18B73849F"
      unitRef="usd">168000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember"
      decimals="-6"
      id="d113161720e2867-wk-Fact-70004961458358BF8DD33C121E16444F"
      unitRef="usd">165000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2020Q1_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d113161720e2882-wk-Fact-3815843869A45388B082BE8FB895877A"
      unitRef="usd">23000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d113161720e2886-wk-Fact-265955F65B015870B68DD112C9BF40EA"
      unitRef="usd">22000000</cah:IndemnificationReceivable>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-061CAC08006F27343D647418A005D3E9-0-wk-Fact-F05A7A31B8FF69A2316D74189FB726C9">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;9. Fair Value Measurements&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;(2)    The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-B50C28896AD44EDBEFAA7418A005F93F-0-wk-Fact-821DE10FFE69B2E6D05474189FB731F6">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)    The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3031-wk-Fact-3A266D0C483C5F069F82CE57DCC13E47"
      unitRef="usd">109000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3050-wk-Fact-17CEF2CD47D35B9C9D2EB7C372D2FA2F"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3069-wk-Fact-7D4387CB8FB7576DAAD4FDE8FE2D2066"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3089-wk-Fact-8DC2356E39E856C0B7A41CE12D46F5BE"
      unitRef="usd">109000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3104-wk-Fact-B56668CF1D2C58091A3174189FC63402"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3123-wk-Fact-B93B0DC0D202594CABB36C1C0C6800E6"
      unitRef="usd">95000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3142-wk-Fact-B9EA90193CA74A39E2C074189FD60F46"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3162-wk-Fact-49BF938C03CB5BBBB519A5C4233973CA"
      unitRef="usd">95000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3456-wk-Fact-E60F2E9A330258028EF28F301B5EDE8B"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3475-wk-Fact-C75FA6BE84DE5EF88F4328F64FF2C59F"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3494-wk-Fact-D95FDA1C90395F42A14F88125FC84DA4"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3514-wk-Fact-64E48318DBA9503C9DC3BEE135AD0834"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3529-wk-Fact-639547B086125E6BAA90BD889B173266"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3548-wk-Fact-FC2991C23DA55E8985AFFC229A09627A"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3567-wk-Fact-19DBFC31CF135B5B903A50123475A587"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d113175573e3587-wk-Fact-2CC33737A18F5363963036CE1A52CE25"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-4D239D8E4356A16EF7AA7418A005167D-0-wk-Fact-B7D4A0C237C9334FA8B974189FC63FB2">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;10. Financial Instruments&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Currency Exchange Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce volatility in earnings, cash flow and net investments in certain subsidiaries to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense, net in the condensed consolidated statements of earnings. For the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, there was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered into a forward interest rate swap with a total notional amount of&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$50 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;to hedge probable, but not firmly committed, future transactions associated with our debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Gains and losses recognized in accumulated other comprehensive loss and reclassified into earnings were immaterial for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. All gains and losses currently included within accumulated other comprehensive loss associated with our foreign exchange forward contracts to be reclassified into net earnings within the next 12 months are immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;&#xa5;64.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; cross-currency swap maturing in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During three months ended September&#160;30, 2018, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;&#x20ac;200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; cross-currency swap maturing in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Cross-currency swaps designated as net investment hedges are marked to market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive income/(loss) until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in our net investment hedges during the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Economic (Non-Designated) Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. The gain and losses recognized in the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; were immaterial. The principal currencies managed through foreign currency contracts are the euro, Canadian dollar, British pound, Japanese yen, and Chinese renminbi.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The carrying amounts of cash and equivalents, trade receivables, accounts payable, and other accrued liabilities at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; approximate fair value due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,001&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,065&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,991&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113175563e2767-wk-Fact-1E4A04B8A97D7CED3E8F74189FC65DA2"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d113175563e2785-wk-Fact-175D87DF859D77410CDD1CE850154095"
      unitRef="usd">50000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d113175563e2813-wk-Fact-B27A36CFDDB2CE1ABF4BFF6CC35510AE"
      unitRef="jpy">64000000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d113175563e2820-wk-Fact-D52D656C3D6C567CBF685661AA68CFA2"
      unitRef="eur">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-CB6C795BD80C52C50A517418A00507B8-0-wk-Fact-9FF961D7A25CBF0717FD74189FC6C13D">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,001&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,065&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,991&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-6"
      id="d113175563e2938-wk-Fact-2B8AC88CD1AC537FB80130D609C18B3B"
      unitRef="usd">8001000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-6"
      id="d113175563e2957-wk-Fact-BDDCA688E57E5E8398C556AB1D295E3B"
      unitRef="usd">8065000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113175563e2972-wk-Fact-E11E3F8B9488DEE2DBD374189FD60998"
      unitRef="usd">7991000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113175563e2991-wk-Fact-2413CA5A499E549187148F86D7E18BA1"
      unitRef="usd">8031000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-D6AF146B3664B947C07F7418A0055005-0-wk-Fact-251EAC5711D1C4AC71F074189FC69592">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;11. Shareholders' Equity&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered in an accelerated share repurchase ("ASR") program to purchase common shares for an aggregate purchase price of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$350 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and received an initial delivery of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6.4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$280 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$43.76&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The ASR program began on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;August&#160;20, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and is expected to conclude in the second quarter of fiscal 2020. We funded the repurchases with available cash and short-term borrowings. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered in an ASR program to purchase common shares for an aggregate purchase price of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and received an initial delivery of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;9.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$480 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$50.45&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The ASR program began on August 16, 2018 and was completed on October 25, 2018 when we received the final delivery of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.0 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares. We funded the repurchases with available cash and short-term borrowings. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The common shares repurchased are held in treasury to be used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Comprehensive&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;The sum of components may not equal the total due to rounding.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113179283e2746-wk-Fact-EC09646B09BD5464E583FA1A70E1E761"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d113179283e2750-wk-Fact-B1F4212AA19353809BFAA920A9BF9713"
      unitRef="shares">6400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113179283e2754-wk-Fact-0BEF0FDC145C175897D774189FC69BBD"
      unitRef="usd">280000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d113179283e2758-wk-Fact-DACE87CF131E58799A0B8CC8D7566010"
      unitRef="usdPerShare">43.76</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113179283e2774-wk-Fact-67722AE26562B60A14DBFA2230E25D8B"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d113179283e2778-wk-Fact-CD4E24E70A0554468C2596F8DAF82F83"
      unitRef="shares">9500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d113179283e2782-wk-Fact-D66144D7A52552FCB96CBD2A33C36946"
      unitRef="usd">480000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2019Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d113179283e2786-wk-Fact-4C3A6BDF41E05266B947C85900182087"
      unitRef="usdPerShare">50.45</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <cah:FinalSharesReceivedfromASRProgram
      contextRef="I2019Q1ASR"
      decimals="-5"
      id="d113179283e2791-wk-Fact-C9EF386A862C5EBB0274272157B948FE"
      unitRef="shares">2000000.0</cah:FinalSharesReceivedfromASRProgram>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-AE48D64FD4F988DB97377418A005C018-0-wk-Fact-4205D718CE895E94079E74189FC6BF81">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Comprehensive&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;The sum of components may not equal the total due to rounding.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e2930-wk-Fact-8D96C37DC9B950F996CA01E91A5A3D19"
      unitRef="usd">-95000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e2950-wk-Fact-FAD122199E3A55E192DCAD8BBBDEF534"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e2969-wk-Fact-96A3B6F01252589BA0D9D0F1A616B0BE"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e2986-wk-Fact-3349BF97A5A657DFAE532DFEB6834C48"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3006-wk-Fact-07EE5CE4B4745CA48E6CB983281F1B3D"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113179283e3025-wk-Fact-B7F54CF26E995C1CACEEC48937E12358"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3047-wk-Fact-603D029C90795BD5A3C7CF49A3FE3725"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3066-wk-Fact-DD397E0DEB245C2B91268430938CD503"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d113179283e3086-wk-Fact-5EC81D68C0275594A064669E0C2A81B6"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3108-wk-Fact-8CDBEEB3339A1F0605D574189FB748CE"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3128-wk-Fact-0D28DD3FF2EC43B154FF74189FB707FA"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3148-wk-Fact-89EA8B078D7F467D306374189FC624E5"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3175-wk-Fact-82BFA8437E115682A3A11DFE9009A1E3"
      unitRef="usd">-112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3195-wk-Fact-710CDB9CF7A05D918CCA52BB02E68FDD"
      unitRef="usd">11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d113179283e3214-wk-Fact-DAE58CA1ECA75C63B0F57F47D704B2E2"
      unitRef="usd">-101000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-E4145B6DBEC45BF408167418A00519B7-0-wk-Fact-791EFD8CB2DFE02326FB74189FB7E370">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;12. Earnings Per Share Attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;305&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;For the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; employee stock options, restricted share units and performance share units were excluded from the calculation of diluted shares outstanding, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of which would be anti-dilutive as a result of the net loss for the period. &lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for the three months ended September 30, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6 million&lt;/span&gt;&lt;/span&gt;.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-6F49B8D1C4C6F93177717418A005CCA5-0-wk-Fact-F50D8FD1DF65D7339DC674189FB78F9E">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;305&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units, and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;306&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113182751e2820-wk-Fact-D6C8D60818B189B0168C74189FD6136D"
      unitRef="shares">296000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113182751e2834-wk-Fact-6E64E45E52945A2BB3CD74189FA7EE57"
      unitRef="shares">305000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113182751e2880-wk-Fact-BD26C7762CF58010A02B74189FB7F8FE"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113182751e2894-wk-Fact-14BF7E222BDC99D7DEB6FF6FC9C0499E"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113182751e2909-wk-Fact-46FD7D10EEDAFA15016374189FE5F0CD"
      unitRef="shares">296000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113182751e2923-wk-Fact-DD255080D24812C9B08874189FE5673E"
      unitRef="shares">306000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <cah:Numberofsharesexcludedfromcalculationofdilutedshares
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113182751e2942-wk-Fact-2078264059D7BFAC99241405983B9CF9"
      unitRef="shares">6000000</cah:Numberofsharesexcludedfromcalculationofdilutedshares>
    <cah:Sharesthatwouldbeantidilutiveasaresultofnetloss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113182751e2946-wk-Fact-2816668B82065370EBBC14080A884F40"
      unitRef="shares">1000000</cah:Sharesthatwouldbeantidilutiveasaresultofnetloss>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113182751e2957-wk-Fact-2F73427B9D18400BDE8374189FB72FCB"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-D5EB916ACEF74B4A02217418A0059F5C-0-wk-Fact-01509553240AC9483BA074189FF5DDBB">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;13. Segment Information&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operations are principally managed on a products and services basis and are comprised of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33,212&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;31,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;207&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;31,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;471&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;421&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,801&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,217&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services".&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;36,310&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;34,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,035&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;972&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,217&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Segment Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;amp;A") expenses. Segment SG&amp;amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; state opioid assessment related to prior fiscal years; other (income)/expense, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the opioid litigation as discussed further in &lt;/span&gt;&lt;a href="#s3E77F52A990B55D8984E21DCB5CC440C" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which was retained at Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the naviHealth divestiture, we recognized a pre-tax gain of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during the three months ended September 30, 2018, which was retained at Corporate.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;398&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5,264&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;816&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;21,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,462&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,962&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="FD2020Q1YTD"
      decimals="0"
      id="d113200062e2731-wk-Fact-2C5AB69C8E09576C8B2672107B337B38"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-57E629E0F1ACF36757417418A0052FB1-0-wk-Fact-9E68A53EA695D57ADF3474189FE560E0"/>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-54C7A415717EA0BC0E237418A005427D-0-wk-Fact-D61815FED296CFCC0BC874189FE5CF0C">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33,212&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;31,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;207&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;31,416&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,380&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;471&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;421&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,917&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,801&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,217&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services".&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d113200062e2873-wk-Fact-75FDAFF094B04FFB1E5774189FB7002D"
      unitRef="usd">33212000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d113200062e2892-wk-Fact-5FEB709CCE0D5B4C3F51FF7640C9E51C"
      unitRef="usd">31209000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d113200062e2907-wk-Fact-D365D56F6B32B633066574189FA70B58"
      unitRef="usd">216000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d113200062e2926-wk-Fact-7BC0EDE7EB35EEEEB3A7FF764439A6D7"
      unitRef="usd">207000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113200062e2946-wk-Fact-9322960E35296FF7D7F674189FE57A1B"
      unitRef="usd">33428000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113200062e2965-wk-Fact-94F07C1C2F0CC190213774189FE50D2F"
      unitRef="usd">31416000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d113200062e2985-wk-Fact-9F21207EA9E0E1B6F67674189FB75D32"
      unitRef="usd">3446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d113200062e3004-wk-Fact-669367ADA2E4542C9E14FF76486F7804"
      unitRef="usd">3380000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember"
      decimals="-6"
      id="d113200062e3024-wk-Fact-479A3B1717A0429191AB74189FB7AF26"
      unitRef="usd">471000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember"
      decimals="-6"
      id="d113200062e3043-wk-Fact-0E65F4EC6D2AD3010A61FF764C0B2ABF"
      unitRef="usd">421000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113200062e3063-wk-Fact-A065FAB12FD6E82CF19974189FE527D8"
      unitRef="usd">3917000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113200062e3082-wk-Fact-CAD7425759D4623AF43174189FE52902"
      unitRef="usd">3801000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d113200062e3102-wk-Fact-BCA91130B4F39530B77074189FB7C48D"
      unitRef="usd">37345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d113200062e3121-wk-Fact-7AFA75CD4358E29E425BFF7599AB94EF"
      unitRef="usd">35217000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e3141-wk-Fact-338EAA0C70B476F7739C74189FC6B624"
      unitRef="usd">-4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e3161-wk-Fact-B3E8683DA707418FA0C1FF759B900A48"
      unitRef="usd">-4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113200062e3187-wk-Fact-2EB2517D9B7C56CF8B4E3EA80588EA22"
      unitRef="usd">37341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113200062e3206-wk-Fact-0A6172E3579B0878A1BA74189FE5023E"
      unitRef="usd">35213000000</us-gaap:Revenues>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-EAC1B5CA9BD5B60D9CCC7418A0054105-0-wk-Fact-AE802BF7FC901646BAD574189FE58FD5">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;36,310&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;34,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,035&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;972&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,217&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;35,213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d113200062e3355-wk-Fact-8786B7C52D2C2F0FA85774189FC6D1DA"
      unitRef="usd">36310000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d113200062e3374-wk-Fact-265570CA61F1A09C006AFF7595EBC9C1"
      unitRef="usd">34245000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d113200062e3389-wk-Fact-83CD6193BA6DD56857A374189FC6E0A4"
      unitRef="usd">1035000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d113200062e3408-wk-Fact-50978C0BD74341B189ACFF7597DBC9FE"
      unitRef="usd">972000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d113200062e3428-wk-Fact-BCA91130B4F39530B77074189FB7C48D"
      unitRef="usd">37345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d113200062e3447-wk-Fact-7AFA75CD4358E29E425BFF7599AB94EF"
      unitRef="usd">35217000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e3467-wk-Fact-338EAA0C70B476F7739C74189FC6B624"
      unitRef="usd">-4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e3487-wk-Fact-B3E8683DA707418FA0C1FF759B900A48"
      unitRef="usd">-4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113200062e3513-wk-Fact-2EB2517D9B7C56CF8B4E3EA80588EA22"
      unitRef="usd">37341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113200062e3532-wk-Fact-0A6172E3579B0878A1BA74189FE5023E"
      unitRef="usd">35213000000</us-gaap:Revenues>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113200062e3562-wk-Fact-3B1AC78018485D7EAF62AC566422A1FB"
      unitRef="usd">3000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113200062e3566-wk-Fact-52F39D2D1D9C5D9F9671F64FC84B7E14"
      unitRef="usd">7000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-7"
      id="d113200062e3586-wk-Fact-B506B163336CA2A537D23C2E6E5AC74F"
      unitRef="usd">5630000000</us-gaap:LitigationReserve>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2019Q1YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d113200062e3597-wk-Fact-0C8C2A8C8E5611F0A18E13F1EC18BA9B"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-0216633A22A564BF7B327418A0056D5B-0-wk-Fact-C6155509D66E4250D14B74189FE51FFE">&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;398&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;568&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5,832&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5,264&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;816&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113200062e3719-wk-Fact-996C21E56BB37654870674189FC6CBD0"
      unitRef="usd">398000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113200062e3738-wk-Fact-D4244625ADDFDF9A1FF374189FE50F74"
      unitRef="usd">409000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113200062e3753-wk-Fact-88AE264E40BA5BDEE89A74189FE5091A"
      unitRef="usd">170000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113200062e3772-wk-Fact-964881E02799EAF0874D74189FB79DF3"
      unitRef="usd">135000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d113200062e3792-wk-Fact-8DAF8C6B204EC904BBA174189FA7F95E"
      unitRef="usd">568000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d113200062e3811-wk-Fact-8B0105944ACF05AFD4F274189FF5E468"
      unitRef="usd">544000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e3831-wk-Fact-97167790AD19ABCB886A74189FC67807"
      unitRef="usd">-5832000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q1QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e3851-wk-Fact-82FC50683B80D8DBB86E74189FC6A82D"
      unitRef="usd">272000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113200062e3876-wk-Fact-C69CC6A1EB30AC79AEA374189FE51E22"
      unitRef="usd">-5264000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113200062e3896-wk-Fact-9E7250608ACD7C0949BA74189FE59C2A"
      unitRef="usd">816000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-698C2AB6DE2F324ADC257418A005B778-0-wk-Fact-413949A6C5D4756AF09574189FE55D26">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;21,755&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,462&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,962&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,179&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113200062e3987-wk-Fact-62245C0C3BC0518DBC1B03CED7CC47DA"
      unitRef="usd">21755000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d113200062e4006-wk-Fact-D6DA3EDBFE0E59978CCC85FED7013410"
      unitRef="usd">22446000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113200062e4021-wk-Fact-745BE35D38F558AB8E670C55EBEAB51F"
      unitRef="usd">15462000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d113200062e4040-wk-Fact-2A6DCB6AD27D535DB17BAFDFE9C85D0E"
      unitRef="usd">15284000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e4060-wk-Fact-DDC1D5A12ADF5E1CAB78869146632E78"
      unitRef="usd">1962000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d113200062e4079-wk-Fact-F0FF2A69CB115530B166E4DC9050D6BB"
      unitRef="usd">3233000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113200062e4104-wk-Fact-1B6A9B277CF557F2B4AF8989D169AA36"
      unitRef="usd">39179000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113200062e4123-wk-Fact-25A8ADCBD95A5ECFAAB5838D8DCE774C"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-6897547C5483FFC308047418A00574E6-0-wk-Fact-40972DED5A3250EA9B5A74189FE5A485">&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;14. Share-Based Compensation&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We maintain stock incentive plans (collectively, the &#x201c;Plans&#x201d;) for the benefit of certain of our officers, directors and employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The total tax benefit related to share-based compensation was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Restricted share units granted under the Plans generally vest in equal annual installments over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.09&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;60.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$125 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Employee stock options granted under the Plans generally vest in equal annual installments over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and are exercisable for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.58847736625515%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;63.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;63.67&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables provide additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Performance share units vest over a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;240 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;50.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$25 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; if the performance goals are achieved.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-F9E9329767B3B84477147418A005738E-0-wk-Fact-5B121AE9FC189C202E9174189FA7DCA4">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;19&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e2868-wk-Fact-9DDA14637177026D846B74189FE586FC"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e2887-wk-Fact-6908026753640B700C9274189FA7EDC4"
      unitRef="usd">14000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e2902-wk-Fact-7F52047F11E2FFB756B774189FA75662"
      unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e2921-wk-Fact-92F819503C7BE737B11674189FE59911"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d113202395e2941-wk-Fact-4B0310D3854F4C890FA074189FE53BAB"
      unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d113202395e2960-wk-Fact-F56E4B03ABF8D7B178BF74189FA76F24"
      unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113202395e2985-wk-Fact-BA532CF6F2F6046F290A74189FF5D3FC"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113202395e3004-wk-Fact-6BB99FBF2C0B954C4B5F74189FA784F8"
      unitRef="usd">19000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113202395e3023-wk-Fact-26FDD1C095EA6DA1F22974189FD63671"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2019Q1QTD"
      decimals="-6"
      id="d113202395e3027-wk-Fact-EBB92A0380D10E60297E74189FB74E8A"
      unitRef="usd">5000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d113202395e3045-wk-Fact-415D254A1B8B52EBBDFBD74574CB6126">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-E92FDF24D4D0CB0A79B37418A005B067-0-wk-Fact-E4FDF479B56CB24B20DB74189FD6EE41">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.09&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;60.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45.29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e3122-wk-Fact-462E373A3DBB58889D5242B83058C48C"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d113202395e3141-wk-Fact-9FAE0F44DE915733BC71E56C41C3B7D0"
      unitRef="usdPerShare">51.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e3156-wk-Fact-9E9AB16CE74E5A8E87E5A723CF4DE4D9"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d113202395e3170-wk-Fact-76461793B1A65D30910FF63024174F4F"
      unitRef="usdPerShare">42.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e3190-wk-Fact-F9524487C2175BA6B1CCB98BF161B5FE"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d113202395e3205-wk-Fact-C13EADD24716502291A9104210080787"
      unitRef="usdPerShare">60.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e3225-wk-Fact-2ED1746C07955DE3A4D00AB547F0396B"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d113202395e3239-wk-Fact-4E7A2AD7D6B8519BAE3FFF08677BCB8A"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e3259-wk-Fact-A5B2F66416A55617B30EA9AC55E5F8E5"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d113202395e3278-wk-Fact-9181E4715B9554FCB7C3BD1F0039C6A4"
      unitRef="usdPerShare">45.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d113202395e3296-wk-Fact-41C68FA021B65DEB85B12A200688B7BB"
      unitRef="usd">125000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d113202395e3300-wk-Fact-904D6522612E5E2E96091CD4B0FE5278">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3311-wk-Fact-A3C869F4161F5DFD8E3E7923A4F7DCFB">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cah:ExercisablePeriodOfPlansInYears
      contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3315-wk-Fact-7C10990F94EA5CA3BF5AD4511F9B5A8D">P10Y</cah:ExercisablePeriodOfPlansInYears>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-EB47921C32E8E651AF327418A005C1D3-0-wk-Fact-D7298DBE7854B7603E7074189FD63900">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.58847736625515%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;63.75&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;63.67&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1.5px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2019Q4"
      decimals="-6"
      id="d113202395e3402-wk-Fact-66E39B0166385B97868AD2BB04B60AD9"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2019Q4"
      decimals="2"
      id="d113202395e3421-wk-Fact-8EA4ED3AF55B5BFE9F82982EFC6AE284"
      unitRef="usdPerShare">63.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113202395e3436-wk-Fact-CF2AE0871FDF514CA0621A36B7358430"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q1YTD"
      decimals="2"
      id="d113202395e3450-wk-Fact-67AE6A16D2975F3185F96A0467AC7504"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113202395e3470-wk-Fact-FCF145B002895C16A883EF4B53955559"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q1YTD"
      decimals="2"
      id="d113202395e3484-wk-Fact-7B75DF87C6F95BC592A2460265FF1C2B"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="FD2020Q1YTD"
      decimals="-6"
      id="d113202395e3504-wk-Fact-F4259C7E30A85B168A412A7C03CC4E4A"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q1YTD"
      decimals="2"
      id="d113202395e3518-wk-Fact-931312956AC355EFB50671052BD8222A"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113202395e3538-wk-Fact-CD300B70E53654FF92354352CD0016DD"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2020Q1"
      decimals="2"
      id="d113202395e3557-wk-Fact-32C5559BC6A35EE5879B6FFD304D4F55"
      unitRef="usdPerShare">63.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="FI2020Q1"
      decimals="-6"
      id="d113202395e3572-wk-Fact-C70164520D7C5BBDBCB3BFC0BA325B2C"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="FI2020Q1"
      decimals="2"
      id="d113202395e3591-wk-Fact-371860AB68215579B9041C5C2B3B3A6B"
      unitRef="usdPerShare">63.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e3618-wk-Fact-F6E3F80ADD925B7E843B6131C7BC22CC"
      unitRef="usd">3000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3622-wk-Fact-1F537310A9E85C3694ED952BCEBEDFDB">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cah:AdditionalStockOptionPlanDataTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-3E3EFC245CC9E98060027418A00535DA-0-wk-Fact-2536857381CF749E1AAA74189FA740B4">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables provide additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:AdditionalStockOptionPlanDataTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e3705-wk-Fact-BF93CE481E635800AF5D9AAD72986E60"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e3724-wk-Fact-070CF01F30D2528B9F2C73F2D93B37A1"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e3739-wk-Fact-761880AE3DB95FFDB0A136065685CB43"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d113202395e3758-wk-Fact-B168BF8EB088534AA43FB110A0709594"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3810-wk-Fact-A7AF48BACE955350A614F66AEF402233">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3820-wk-Fact-7466038374AD523C9939A0C287A1CAFE">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3831-wk-Fact-E1B957F2CB2E5EA8842209F096B7847D">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d113202395e3841-wk-Fact-BD784B81F6F158498165D903AA48B860">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <cah:VestingPeriodinyearsforShares
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="INF"
      id="d113202395e3914-wk-Fact-1A88A95399165914B95EA36880B94D8B"
      unitRef="number">3</cah:VestingPeriodinyearsforShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="FD2020Q1YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e3918-wk-Fact-10FA6F24C98455C7B0E119424524B632"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="FD2020Q1YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e3922-wk-Fact-54F2F948FC025604BB0D1742EF4FD46B"
      unitRef="number">2.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="FD2020Q1YTD"
      id="TextSelection-669A6F411C9A84E61E5A7418A005E071-0-wk-Fact-05A9C0AA18B24BDCF0E174189FD68D43">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;50.84&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d113202395e4030-wk-Fact-210D8645A43E5D299E5346E97C01C98B"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e4049-wk-Fact-D5BA21AE8D8F5DBFB98B9263AFB34152"
      unitRef="usdPerShare">51.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d113202395e4064-wk-Fact-B2BEA4FEF3685620912E9FB092B76EA6"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e4078-wk-Fact-2571FBB6784059B69C3021A5C765644A"
      unitRef="usdPerShare">43.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d113202395e4098-wk-Fact-193C646341585048AD0A35B2B98F8363"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e4113-wk-Fact-DF0E6B82F4F3553D9E4E44D41B1A578F"
      unitRef="usdPerShare">48.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d113202395e4133-wk-Fact-09571AD138775C8BA6C874CCD09A611E"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e4148-wk-Fact-4B14B44359AF5EEDB2009F1A0A44258E"
      unitRef="usdPerShare">50.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d113202395e4168-wk-Fact-115B1BBB51E85F95B5706004CB3BA709"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d113202395e4187-wk-Fact-63A682CC66D05D4DBADF13630172414F"
      unitRef="usdPerShare">50.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d113202395e4227-wk-Fact-8EDC7E7D9FCF50A0B44013BD15AB007F"
      unitRef="usd">25000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="d113202395e4231-wk-Fact-57CA0B42B4325FB3A9A4CF133B1D8FD1">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890151728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Shareholders' Equity</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered in an accelerated share repurchase ("ASR") program to purchase common shares for an aggregate purchase price of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$350 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and received an initial delivery of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6.4 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$280 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$43.76</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The ASR program began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;20, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and is expected to conclude in the second quarter of fiscal 2020. We funded the repurchases with available cash and short-term borrowings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered in an ASR program to purchase common shares for an aggregate purchase price of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and received an initial delivery of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>9.5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$480 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$50.45</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The ASR program began on August 16, 2018 and was completed on October 25, 2018 when we received the final delivery of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2.0 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares. We funded the repurchases with available cash and short-term borrowings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(112</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(101</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>The sum of components may not equal the total due to rounding.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6805525424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingent Liabilities and Litigation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Commitments, Contingent Liabilities and Litigation</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>10 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$45.6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the remainder of the initial term.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are named from time to time in </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information have led, and may in the future lead, to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our condensed consolidated statements of earnings.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Opioid Lawsuits </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical wholesale distributors, including us, have been named as defendants in approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>2,400</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits relating to the distribution of prescription opioid pain medications. These lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as negligence, public nuisance and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;). </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>21</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have filed lawsuits against distributors, including us, in various state courts. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>43</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have formed a multi-state task force to investigate the manufacturing, distribution, dispensing and prescribing practices of opioid medications. We have received requests related to the multi-state investigation, as well as separate civil investigative demands, subpoenas or requests for information from these and other state attorneys general offices. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of four state attorneys general from the multi-state task force that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions, but not private plaintiffs (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework includes (1) a cash component, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.56 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>eighteen years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, (2) development and participation in a program for free or rebated distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. The Settlement Framework is in its early phases, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We have included a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.56 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrual related to the Settlement Framework in deferred income taxes and other liabilities in the condensed consolidated balance sheets and litigation (recoveries)/charges, net, in the condensed consolidated statements of earnings.  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On October 21, 2019, we and two other national distributors agreed to a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$215 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> settlement with two Ohio counties, Cuyahoga and </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Summit, to resolve all claims in the first bellwether trial in the MDL that had been scheduled for trial in October 2019. In connection with this settlement, we have accrued </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$66 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, which is included in other accrued liabilities in the condensed consolidated balance sheets and litigation (recoveries)/charges, net, in the condensed consolidated statements of earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these matters, we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> after tax) during the three-months ended September 30, 2019 for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. Moreover, the global Settlement Framework is in early stages and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. We are unable to reasonably estimate the liability associated with any potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to under the Settlement Framework. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.    </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework does not address claims by private parties, which includes unions and other health and welfare funds, hospital systems and other healthcare providers, businesses and individuals. Private parties had brought approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>325</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits as of November 1, 2019. Of these, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>97</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. We will continue to vigorously defend ourselves in these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Product Liability Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As of November 1, 2019, we are named as a defendant in </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>280</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3,463</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>24</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits involving similar claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>28</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At September 30, 2019, we had a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$414 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, net of estimated insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits which are presented on a gross basis in the condensed consolidated balance sheets. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$836 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, net of estimated insurance recoveries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Shareholder Securities Litigation</span></div>In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. Due to the early stage of this proceeding, it is not possible to reasonably estimate the amount of any possible loss or range of loss in this matter.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897426848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Goodwill and Other Intangible Assets</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,663</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,715</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,658</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,702</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,360</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,555</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,592</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,963</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>673</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>307</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>366</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,603</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>656</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>947</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,831</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,555</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,276</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,853</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,555</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,298</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Total amortization of intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$129 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$133 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> 2024</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$382 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$442 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$408 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$358 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$328 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6703699840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring and employee severance</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904868592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">5,831<span></span>
</td>
<td class="nump">5,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 3,276<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Intangible, Total other intangible assets</a></td>
<td class="nump">$ 5,853<span></span>
</td>
<td class="nump">5,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Intangible, Total other intangible assets</a></td>
<td class="nump">3,298<span></span>
</td>
<td class="nump">3,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember', window );">IPR&amp;D, trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">3,555<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,963<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember', window );">Trademarks, trade names and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 1,603<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">656<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 947<span></span>
</td>
<td class="nump">$ 986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6893408416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,488,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6893435504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 903<span></span>
</td>
<td class="nump">$ 6,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Shares, authorized</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Shares, authorized</a></td>
<td class="nump">755,000<span></span>
</td>
<td class="nump">755,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Shares, issued</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common Shares in Treasury</a></td>
<td class="nump">34,000<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6905089024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (5,264)<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (5,832)<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6814217536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8211;basic (in shares)</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8211;diluted (in shares)</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890113520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Restructuring and Employee Severance</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance costs:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During fiscal 2020 and 2019, we implemented certain enterprise-wide cost-saving initiatives affecting various functional and commercial areas intended to optimize and simplify our operating model and cost structure. We incurred </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$20 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$26 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, in expenses related to these cost savings initiatives, which are reflected in restructuring and employee severance in the condensed consolidated statements of earnings.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>73</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897502480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Income Taxes</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fluctuations in our provision for income taxes as a percentage of pre-tax earnings (&#8220;effective tax rate&#8221;) are due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items.</span></div><div style="line-height:174%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$487 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$468 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a href="#s3E77F52A990B55D8984E21DCB5CC440C" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Effective Tax Rate</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>7.9</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>19.4</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent, respectively. The change in the effective tax rate from fiscal 2019 to fiscal 2020 is primarily due to the net effects of </span><span style="font-family:Arial Narrow;font-size:10pt;">the Settlement Framework, partially offset by the prior-year benefit of discrete tax items</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Unrecognized Tax Benefits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$943 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$456 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> balances include </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$795 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$303 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$126 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$122 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for/(benefit from) income taxes in the condensed consolidated statements of earnings. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>zero</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a net decrease of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$10 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, exclusive of penalties and interest.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Tax Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2008</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$168 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$165 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition. The indemnification receivable was&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$23 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheet.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Future adjustments to the financial statements may be necessary as final tax regulations related to U.S. Tax Reform are issued. We will assess any impact as additional guidance is issued.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6890189808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock', window );">Investments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Investments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2018, we sold our&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>98 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;ownership interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp; Rice in exchange for cash proceeds of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$737 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;(after adjusting for certain fees and expenses) and a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>44 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;equity interest in a partnership that owns&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>100 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We are accounting for this investment using the equity method of accounting and on a one-month reporting lag. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended September 30, 2018, we recognized a pre-tax gain of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;related to this divestiture in impairments and (gain)/loss on disposal of assets in our condensed consolidated statement of earnings.&#160;</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying value of this investment was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$329 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$334 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. For the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our proportionate share of naviHealth&#8217;s net loss, which was recorded in Other (income)/expense, net in the condensed consolidated statement of earnings, was immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings.  This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897392464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc.<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share Attributable to Cardinal Health, Inc.</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Earnings Per Share Attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>296</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>305</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>296</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">For the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> employee stock options, restricted share units and performance share units were excluded from the calculation of diluted shares outstanding, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>1 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of which would be anti-dilutive as a result of the net loss for the period. </span></div><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for the three months ended September 30, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6 million</span></span>.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904006224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract', window );"><strong>Basis of Presentation and Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842', window );">Lease Liabilities established as a Result of the adoption of ASC 842</a></td>
<td class="nump">$ 422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation and Summary of Significant Accounting Policies [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities established as a Result of the adoption of ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6905641888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">8,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">8,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">5,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 5,702<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a20q110q093019form10-q.htm": {
   "axisCustom": 4,
   "axisStandard": 23,
   "contextCount": 160,
   "dts": {
    "calculationLink": {
     "local": [
      "cah-20190930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cah-20190930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "a20q110q093019form10-q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20190930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20190930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cah-20190930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 523,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 12,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 17
   },
   "keyCustom": 44,
   "keyStandard": 324,
   "memberCustom": 28,
   "memberStandard": 31,
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20190930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.cardinal.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105100 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106100 - Disclosure - Investments",
     "role": "http://www.cardinal.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107100 - Disclosure - Leases",
     "role": "http://www.cardinal.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109100 - Disclosure - Commitments, Contingent Liabilities and Litigation",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation",
     "shortName": "Commitments, Contingent Liabilities and Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110100 - Disclosure - Income Taxes",
     "role": "http://www.cardinal.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111100 - Disclosure - Fair Value Measurements",
     "role": "http://www.cardinal.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112100 - Disclosure - Financial Instruments",
     "role": "http://www.cardinal.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113100 - Disclosure - Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001000 - Statement - Condensed Consolidated Statements of Earnings",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
     "shortName": "Condensed Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115100 - Disclosure - Segment Information",
     "role": "http://www.cardinal.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116100 - Disclosure - Share-Based Compensation",
     "role": "http://www.cardinal.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Restructuring and Employee Severance (Tables)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables",
     "shortName": "Restructuring and Employee Severance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Leases (Tables)",
     "role": "http://www.cardinal.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311301 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312301 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313301 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315301 - Disclosure - Segment Information (Tables)",
     "role": "http://www.cardinal.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316301 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2020Q1ASC842",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Narrative (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2020Q1ASC842",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
     "shortName": "Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
     "shortName": "Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails",
     "shortName": "Restructuring and Employee Severance Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1QTD_us-gaap_RestructuringPlanAxis_cah_EnterpriseWideCostSavingMeasuresMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405404 - Disclosure - Goodwill and Other Intangible Assets Narrative (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - Investments Narrative (Details)",
     "role": "http://www.cardinal.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003000 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Leases Narative (Details)",
     "role": "http://www.cardinal.com/role/LeasesNarativeDetails",
     "shortName": "Leases Narative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Leases Summary of Lease Costs (Details)",
     "role": "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails",
     "shortName": "Leases Summary of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Leases Summary of Lease Payments (Details)",
     "role": "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails",
     "shortName": "Leases Summary of Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407405 - Disclosure - Leases Summary of Minimum Lease Committments (Details)",
     "role": "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails",
     "shortName": "Leases Summary of Minimum Lease Committments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "cah:LeasesSupplementalBalanceSheetInformationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407406 - Disclosure - Leases Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "cah:LeasesSupplementalBalanceSheetInformationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408401 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "lang": null,
      "name": "cah:NotesPayableRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2020Q1opioid_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:OpioidTotalSettlementCuyahogaandSummitCounties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409401 - Disclosure - Commitments, Contingent Liabilities and Litigation Narrative (Details)",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
     "shortName": "Commitments, Contingent Liabilities and Litigation Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2020Q1opioid_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:OpioidTotalSettlementCuyahogaandSummitCounties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410401 - Disclosure - Income Taxes Narrative (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411402 - Disclosure - Fair Value Measurements Narrative (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412402 - Disclosure - Financial Instruments Narrative (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412403 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
     "shortName": "Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413402 - Disclosure - Shareholders' Equity Narrative (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "I2019Q1ASR",
      "decimals": "-5",
      "lang": null,
      "name": "cah:FinalSharesReceivedfromASRProgram",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:Numberofsharesexcludedfromcalculationofdilutedshares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. Narrative (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:Numberofsharesexcludedfromcalculationofdilutedshares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415402 - Disclosure - Segment Information Narrative (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
     "shortName": "Segment Information (Revenue by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
     "shortName": "Segment Information (Segment Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415405 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
     "shortName": "Segment Information (Assets by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Segment Information Disaggregated Revenue Within Reportable Segments (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
     "shortName": "Segment Information Disaggregated Revenue Within Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1014000 - Statement - Condensed Consolidated Statement of Shareholders' Equity",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
     "shortName": "Condensed Consolidated Statement of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Segment Information Revenue by Geographical Segments (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails",
     "shortName": "Segment Information Revenue by Geographical Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1QTD_srt_StatementGeographicalAxis_country_US",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416402 - Disclosure - Share-Based Compensation Narrative (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails",
     "shortName": "Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
     "shortName": "Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:AdditionalStockOptionPlanDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2020Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1015000 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103100 - Disclosure - Restructuring and Employee Severance",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeverance",
     "shortName": "Restructuring and Employee Severance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q110q093019form10-q.htm",
      "contextRef": "FD2020Q1YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 59,
   "tag": {
    "cah_ASC842Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC 842",
        "label": "ASC 842 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "ASC842Member",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AdditionalStockOptionPlanDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A disclosure of additional data related to all stock option activity",
        "label": "Additional Stock Option Plan Data [Table Text Block]",
        "terseLabel": "Schedule of Additional Data Related to Stock Option Activity"
       }
      }
     },
     "localname": "AdditionalStockOptionPlanDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AlamedaCountyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Alameda County [Member]",
        "label": "Alameda County [Member]",
        "terseLabel": "Alameda County [Member]"
       }
      }
     },
     "localname": "AlamedaCountyMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Amortizationandotheracquisitionrelatedcosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Amortization and other acquisition-related costs",
        "terseLabel": "Amortization and other acquisition-related costs"
       }
      }
     },
     "localname": "Amortizationandotheracquisitionrelatedcosts",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Basis of Presentation and Summary of Significant Accounting Policies [Abstract]",
        "label": "Basis of Presentation and Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "BasisofPresentationandSummaryofSignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.cardinal.com/20190930",
     "xbrltype": "stringItemType"
    },
    "cah_CVSHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CVS Health [Member]",
        "label": "CVS Health [Member]",
        "terseLabel": "CVS Health"
       }
      }
     },
     "localname": "CVSHealthMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CardinalHealthAtHomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardinal Health At Home [Member]",
        "label": "Cardinal Health At Home [Member]",
        "terseLabel": "Cardinal Health At Home [Member]"
       }
      }
     },
     "localname": "CardinalHealthAtHomeMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CareFusionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CareFusion [Member]",
        "label": "CareFusion [Member]",
        "terseLabel": "CareFusion [Member]"
       }
      }
     },
     "localname": "CareFusionMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CashComponentForSettlementFrameworkTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Component For Settlement Framework, Term",
        "label": "Cash Component For Settlement Framework, Term",
        "terseLabel": "Cash Component For Settlement Framework, Term"
       }
      }
     },
     "localname": "CashComponentForSettlementFrameworkTerm",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_ClassActionLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Action Lawsuits [Member]",
        "label": "Class Action Lawsuits [Member]",
        "terseLabel": "Class Action Lawsuits [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommittedReceivablesSalesFacilityProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.",
        "label": "Committed Receivables Sales Facility Program [Member]",
        "terseLabel": "Committed Receivables Sales Facility Program [Member]"
       }
      }
     },
     "localname": "CommittedReceivablesSalesFacilityProgramMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_EnterpriseWideCostSavingMeasuresMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Enterprise Wide Cost Saving Measures",
        "label": "Enterprise Wide Cost Saving Measures [Member]",
        "terseLabel": "Enterprise Wide Cost Saving Measures [Member]"
       }
      }
     },
     "localname": "EnterpriseWideCostSavingMeasuresMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ExercisablePeriodOfPlansInYears": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The instrument's contractual term.",
        "label": "Exercisable period of plans, in years",
        "terseLabel": "Exercisable period of plans (in years)"
       }
      }
     },
     "localname": "ExercisablePeriodOfPlansInYears",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_FacilityExitAndOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.",
        "label": "Facility Exit and Other Costs",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityExitAndOtherCosts",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinalSharesReceivedfromASRProgram": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Final Shares Received from ASR Program",
        "label": "Final Shares Received from ASR Program",
        "terseLabel": "Final Shares Received from ASR Program"
       }
      }
     },
     "localname": "FinalSharesReceivedfromASRProgram",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_FinanceLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease Imputed Interest",
        "label": "Finance Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease",
        "label": "Finance Lease [Member]",
        "terseLabel": "Finance Lease [Member]"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_IPRDTrademarksandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "IPR&amp;D,TrademarksandOther [Member]",
        "terseLabel": "IPR&amp;D, trademarks and other"
       }
      }
     },
     "localname": "IPRDTrademarksandOtherMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_IndemnificationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.",
        "label": "Indemnification Receivable",
        "terseLabel": "Indemnification receivable"
       }
      }
     },
     "localname": "IndemnificationReceivable",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_InvestigationbyMultitateTaskForce": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investigation by Multitate Task Force",
        "label": "InvestigationbyMultitateTaskForce",
        "terseLabel": "InvestigationbyMultitateTaskForce"
       }
      }
     },
     "localname": "InvestigationbyMultitateTaskForce",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_LawsuitTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Axis]",
        "terseLabel": "Lawsuit Type [Axis]"
       }
      }
     },
     "localname": "LawsuitTypeAxis",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Liabilities established as a Result of the adoption of ASC 842",
        "label": "Lease Liabilities established as a Result of the adoption of ASC 842",
        "terseLabel": "Lease Liabilities established as a Result of the adoption of ASC 842"
       }
      }
     },
     "localname": "LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for Lease Payments [Table]",
        "label": "Lease Payments [Table Text Block]",
        "terseLabel": "Schedule of Lease Payments"
       }
      }
     },
     "localname": "LeasePaymentsTableTextBlock",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesSupplementalBalanceSheetInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]",
        "label": "LeasesSupplementalBalanceSheetInformation [Table Text Block]",
        "terseLabel": "Leases Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "LeasesSupplementalBalanceSheetInformationTableTextBlock",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leases [Text Block]",
        "label": "Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesTextBlock",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due After Year Five",
        "label": "Lessee Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Five",
        "label": "Lessee Lease Liability Payments Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Four",
        "label": "Lessee Lease Liability Payments Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Three",
        "label": "Lessee Lease Liability Payments Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Two",
        "label": "Lessee Lease Liability Payments Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Remainder Of Fiscal Year",
        "label": "Lessee Lease Liability Payments Remainder Of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LitigationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Litigation Type [Axis]",
        "label": "Litigation Type [Domain]",
        "terseLabel": "Litigation Type [Domain]"
       }
      }
     },
     "localname": "LitigationTypeDomain",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LossContingencyAccrualNetofInsuranceRecoveries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency Accrual, Net of Insurance Recoveries",
        "label": "Loss Contingency Accrual, Net of Insurance Recoveries",
        "terseLabel": "Loss Contingency Accrual, Net of Insurance Recoveries"
       }
      }
     },
     "localname": "LossContingencyAccrualNetofInsuranceRecoveries",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LossContingencyLawsuitsNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Lawsuits, Number",
        "label": "Loss Contingency, Lawsuits, Number",
        "terseLabel": "Loss Contingency, Lawsuits, Number"
       }
      }
     },
     "localname": "LossContingencyLawsuitsNumber",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_MaximumQuarterlyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.",
        "label": "Maximum Quarterly Payment",
        "terseLabel": "Maximum quarterly payment"
       }
      }
     },
     "localname": "MaximumQuarterlyPayment",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical Member",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicalSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Segment [Axis]",
        "label": "Medical Segment [Axis]",
        "terseLabel": "Medical Segment [Axis]"
       }
      }
     },
     "localname": "MedicalSegmentAxis",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_MedicalSegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Medical Segment [Axis]",
        "label": "Medical Segment [Domain]",
        "terseLabel": "Medical Segment [Domain]"
       }
      }
     },
     "localname": "MedicalSegmentDomain",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicaldistributionandproductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical distribution and products [Member]",
        "label": "Medical distribution and products [Member]",
        "terseLabel": "Medical distribution and products [Member]"
       }
      }
     },
     "localname": "MedicaldistributionandproductsMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "naviHealth [Member]",
        "label": "naviHealth [Member]",
        "terseLabel": "naviHealth [Member]"
       }
      }
     },
     "localname": "NaviHealthMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Netproceedstaxwithholdingsfromsharebasedcompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.",
        "label": "Net proceeds/(tax withholdings) from share-based compensation",
        "terseLabel": "Net tax proceeds/(withholdings) from share-based compensation"
       }
      }
     },
     "localname": "Netproceedstaxwithholdingsfromsharebasedcompensation",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NotesPayableRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Principal Amount of Notes Payable Repurchased during the year",
        "label": "Notes Payable Repurchased",
        "terseLabel": "Notes Payable Repurchased"
       }
      }
     },
     "localname": "NotesPayableRepurchased",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NuclearPrecisionHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nuclear Precision Health Services [Member]",
        "label": "Nuclear Precision Health Services [Member]",
        "terseLabel": "Nuclear Precision Health Services [Member]"
       }
      }
     },
     "localname": "NuclearPrecisionHealthServicesMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NumberofStateAttorneysGeneralfilinglawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of State Attorneys General filing lawsuits",
        "label": "Number of State Attorneys General filing lawsuits",
        "terseLabel": "Lawsuits Against Distributors"
       }
      }
     },
     "localname": "NumberofStateAttorneysGeneralfilinglawsuits",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_Numberofsharesexcludedfromcalculationofdilutedshares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares excluded from calculation of diluted shares",
        "label": "Number of shares excluded from calculation of diluted shares",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "Numberofsharesexcludedfromcalculationofdilutedshares",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_OperatingLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease Imputed Interest",
        "label": "Operating Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "OperatingLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease",
        "label": "Operating Lease [Member]",
        "terseLabel": "Operating Lease [Member]"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Lawsuits [Member]",
        "label": "Opioid Lawsuits [Member]",
        "terseLabel": "Opioid Lawsuits [Member]"
       }
      }
     },
     "localname": "OpioidLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation",
        "label": "Opioid Litigation [Axis]",
        "terseLabel": "Tax Matters Agreement [Axis]"
       }
      }
     },
     "localname": "OpioidLitigationAxis",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_OpioidLitigationCuyahogaandSummitCountiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation, Cuyahoga and Summit Counties",
        "label": "Opioid Litigation, Cuyahoga and Summit Counties [Member]",
        "terseLabel": "Cuyahoga and Summit County [Member]"
       }
      }
     },
     "localname": "OpioidLitigationCuyahogaandSummitCountiesMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationlessCuyahogaandSummitCountiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation, less Cuyahoga and Summit Counties",
        "label": "Opioid Litigation, less Cuyahoga and Summit Counties [Member]",
        "terseLabel": "Opioid Litigation, less Cuyahoga and Summit Counties [Member]"
       }
      }
     },
     "localname": "OpioidLitigationlessCuyahogaandSummitCountiesMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidSettlementFrameworkMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Settlement Framework [Member]",
        "label": "Opioid Settlement Framework [Member]",
        "terseLabel": "Opioid Settlement Framework [Member]"
       }
      }
     },
     "localname": "OpioidSettlementFrameworkMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidTotalSettlementCuyahogaandSummitCounties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Total Settlement, Cuyahoga and Summit Counties",
        "label": "Opioid Total Settlement, Cuyahoga and Summit Counties",
        "terseLabel": "Opioid Total Settlement, Cuyahoga and Summit Counties"
       }
      }
     },
     "localname": "OpioidTotalSettlementCuyahogaandSummitCounties",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OtherJurisdictionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Jurisdictions [Member]",
        "label": "Other Jurisdictions [Member]",
        "terseLabel": "Other Jurisdictions [Member]"
       }
      }
     },
     "localname": "OtherJurisdictionsMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PartnershipIndirectOwnership": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Partnership Indirect Ownership",
        "label": "Partnership Indirect Ownership",
        "terseLabel": "Partnership Indirect Ownership"
       }
      }
     },
     "localname": "PartnershipIndirectOwnership",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_PatientRecoveryBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patient Recovery Business [Member]",
        "label": "Patient Recovery Business [Member]",
        "terseLabel": "Patient Recovery Business [Member]"
       }
      }
     },
     "localname": "PatientRecoveryBusinessMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalDistributionandSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical Distribution and Specialty [Member]",
        "label": "Pharmaceutical Distribution and Specialty [Member]",
        "terseLabel": "Pharmaceutical Distribution and Specialty [Member]"
       }
      }
     },
     "localname": "PharmaceuticalDistributionandSpecialtyMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical [Member]",
        "label": "Pharmaceutical Member",
        "terseLabel": "Pharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical Segment [Axis]",
        "label": "Pharmaceutical Segment [Axis]",
        "terseLabel": "Pharmaceutical Segment [Axis]"
       }
      }
     },
     "localname": "PharmaceuticalSegmentAxis",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_PharmaceuticalSegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Pharmaceutical Segment [Axis]",
        "label": "Pharmaceutical Segment [Domain]",
        "terseLabel": "Pharmaceutical Segment [Domain]"
       }
      }
     },
     "localname": "PharmaceuticalSegmentDomain",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PlaintiffTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Axis]",
        "terseLabel": "Plaintiff Type [Axis]"
       }
      }
     },
     "localname": "PlaintiffTypeAxis",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_PlaintiffTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Domain]",
        "terseLabel": "Plaintiff Type [Domain]"
       }
      }
     },
     "localname": "PlaintiffTypeDomain",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PreTaxGainonDivestiture": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre-Tax Gain on Divestiture",
        "label": "Pre-Tax Gain on Divestiture",
        "terseLabel": "Pre-Tax Gain on Divestiture"
       }
      }
     },
     "localname": "PreTaxGainonDivestiture",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_PrivatePartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Private Parties [Member]",
        "label": "Private Parties [Member]",
        "terseLabel": "Private Parties [Member]"
       }
      }
     },
     "localname": "PrivatePartiesMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from sales of available-for-sale securities and other investments.",
        "label": "Proceeds from sale of available-for-sale securities and other investments",
        "terseLabel": "Proceeds from sale of available-for-sale securities and other investments"
       }
      }
     },
     "localname": "Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ProductLiabilityLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Liability Lawsuits [Member]",
        "label": "Product Liability Lawsuits [Member]",
        "terseLabel": "Product Liability Lawsuits [Member]"
       }
      }
     },
     "localname": "ProductLiabilityLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ProjectCostsOnInvestmentAndOtherSpending": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.",
        "label": "Project Costs On Investment And Other Spending",
        "terseLabel": "Project Costs On Investment And Other Spending"
       }
      }
     },
     "localname": "ProjectCostsOnInvestmentAndOtherSpending",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Purchaseofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow from purchases of available-for-sale securities and other investments.",
        "label": "Purchase of available-for-sale securities and other investments",
        "negatedLabel": "Purchase of available-for-sale securities and other investments"
       }
      }
     },
     "localname": "Purchaseofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ReclassificationofdeferredrentinaccordancewithASC842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reclassification of deferred rent in accordance with ASC 842",
        "label": "Reclassification of deferred rent in accordance with ASC 842",
        "terseLabel": "Reclassification of deferred rent in accordance with ASC 842"
       }
      }
     },
     "localname": "ReclassificationofdeferredrentinaccordancewithASC842",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Definite and Indefinite-Lived Intangible Assets [Table Text Block]",
        "label": "Schedule of Definite and Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Definite and Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofDefiniteandIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_SegmentRevenuebyGeographicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Segment Revenue by Geographic [Table]",
        "label": "Segment Revenue by Geographic [Line Items]",
        "terseLabel": "Segment Revenue by Geographic [Line Items]"
       }
      }
     },
     "localname": "SegmentRevenuebyGeographicLineItems",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_SegmentRevenuebyGeographicTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Segment Revenue by Geographic [Table]",
        "label": "Segment Revenue by Geographic [Table]",
        "terseLabel": "Segment Revenue by Geographic [Table]"
       }
      }
     },
     "localname": "SegmentRevenuebyGeographicTable",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_Sharesthatwouldbeantidilutiveasaresultofnetloss": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "shares that would be antidilutive as a result of net loss",
        "label": "shares that would be antidilutive as a result of net loss",
        "terseLabel": "shares that would be antidilutive as a result of net loss"
       }
      }
     },
     "localname": "Sharesthatwouldbeantidilutiveasaresultofnetloss",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_ShortTermCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other short-term credit facilities and an unsecured line of credit",
        "label": "Short Term Credit Facilities Member",
        "terseLabel": "Short Term Credit Facilities Member"
       }
      }
     },
     "localname": "ShortTermCreditFacilitiesMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SummaryofMinimumLeasePaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summary of Minimum Lease Payments [Abstract]",
        "label": "Summary of Minimum Lease Payments [Abstract]"
       }
      }
     },
     "localname": "SummaryofMinimumLeasePaymentsAbstract",
     "nsuri": "http://www.cardinal.com/20190930",
     "xbrltype": "stringItemType"
    },
    "cah_TaxMatterAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Matter [Axis]",
        "label": "Tax Matter [Axis]",
        "terseLabel": "Tax Matter [Axis]"
       }
      }
     },
     "localname": "TaxMatterAxis",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_TaxMatterDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Tax Matter [Axis]",
        "label": "Tax Matter [Domain]",
        "terseLabel": "Tax Matter [Domain]"
       }
      }
     },
     "localname": "TaxMatterDomain",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TaxMattersAgreementDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Tax Matters Agreement [Axis]",
        "label": "Tax Matters Agreement [Domain]",
        "terseLabel": "Tax Matters Agreement [Domain]"
       }
      }
     },
     "localname": "TaxMattersAgreementDomain",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TotalFinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Finance Lease Cost",
        "label": "Total Finance Lease Cost",
        "totalLabel": "Total Finance Lease Cost"
       }
      }
     },
     "localname": "TotalFinanceLeaseCost",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability",
        "label": "Total Lease Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "TotalLeaseLiability",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability Not Yet Commenced, Amount",
        "label": "Total Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "TotalLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total undiscounted Lease Liability Payments Due for both operating and financing leases",
        "label": "Total Lease Liability Payments Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDue",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability Undiscounted Excess Amount",
        "label": "Total Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "TotalLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalOpioidLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Opioid Litigation",
        "label": "Total Opioid Litigation [Member]",
        "terseLabel": "Total Opioid Litigation [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TotalOpioidLitigationnetoftaxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Opioid Litigation, net of tax",
        "label": "Total Opioid Litigation, net of tax [Member]",
        "terseLabel": "Opioid Settlement Framework [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationnetoftaxMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TrademarksAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Trademarks And Patents Member",
        "terseLabel": "Trademarks, trade names and patents"
       }
      }
     },
     "localname": "TrademarksAndPatentsMember",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_VestingPeriodinyearsforShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting Period in years for Shares",
        "label": "Vesting Period in years for Shares",
        "terseLabel": "Vesting Period in years for Shares"
       }
      }
     },
     "localname": "VestingPeriodinyearsforShares",
     "nsuri": "http://www.cardinal.com/20190930",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "invest_InvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment [Line Items]",
        "terseLabel": "Investment [Line Items]"
       }
      }
     },
     "localname": "InvestmentLineItems",
     "nsuri": "http://xbrl.sec.gov/invest/2013-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "invest_InvestmentTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment [Table]",
        "terseLabel": "Investment [Table]"
       }
      }
     },
     "localname": "InvestmentTable",
     "nsuri": "http://xbrl.sec.gov/invest/2013-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Statement of Stockholders' Equity"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r98",
      "r111"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r116",
      "r186",
      "r188",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesNarativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesNarativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesNarativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesNarativeDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r82",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Consolidated Statement of Shareholders' Equity"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r115",
      "r186",
      "r187",
      "r335",
      "r339",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts Payable, Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r38",
      "r43",
      "r44",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r39",
      "r43",
      "r44",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gain/(Loss) on Derivatives, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r41",
      "r42",
      "r43"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r40",
      "r43",
      "r44",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by new accounting pronouncement.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings/(loss) to net cash provided by/(used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r193",
      "r216",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r73",
      "r130",
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r40",
      "r43",
      "r44",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r102",
      "r310",
      "r324"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r36"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r195",
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r232",
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r21",
      "r75"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and equivalents at end of period",
        "periodStartLabel": "Cash and equivalents at beginning of period",
        "terseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.",
        "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
        "totalLabel": "Net increase/(decrease) in cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "terseLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r158",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments, Contingent Liabilities and Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common shares, without par value:"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common Shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Authorized\u2014755 million shares, Issued\u2014327 million shares at September 30, 2019 and June 30, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r47",
      "r49",
      "r50"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r47",
      "r49",
      "r239",
      "r248"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income/(loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate",
        "verboseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r315",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Debt and Lease Obligation",
        "verboseLabel": "Carrying amount"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Obligations and Other Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r311",
      "r312",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r28",
      "r78",
      "r176",
      "r179",
      "r180",
      "r181",
      "r281",
      "r282",
      "r284",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Estimated range of decrease in unrecognized tax benefits within the next 12 months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes and other liabilities"
       }
      }
     },
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r73",
      "r100"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "terseLabel": "Derivative Assets (Liabilities), at Fair Value, Net"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r258",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r256",
      "r258",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r251",
      "r252",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r81",
      "r250",
      "r253",
      "r254",
      "r256",
      "r257",
      "r260",
      "r261",
      "r264",
      "r265",
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "verboseLabel": "Developed technology and other"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r182",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r55",
      "r85",
      "r88",
      "r89",
      "r90",
      "r91",
      "r94",
      "r318",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings/(loss) per common share attributable to Cardinal Health, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r55",
      "r85",
      "r88",
      "r89",
      "r90",
      "r91",
      "r94",
      "r318",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share Attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r278"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r80",
      "r222",
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit related to share-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee- Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r22",
      "r103",
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r274"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r269",
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r268",
      "r269",
      "r271",
      "r272",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r269",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r269",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r269",
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r273",
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r289",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "verboseLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.",
        "label": "Finance Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in remainder of fiscal year following latest fiscal year ended.",
        "label": "Finance Lease, Liability, Payments, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r291",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows paid for finance lease"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under finance lease.",
        "label": "Finance Lease, Right-of-Use Asset",
        "terseLabel": "Net property, plant and equipment"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r290",
      "r294",
      "r303"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "cah_TotalFinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r131",
      "r133",
      "r136",
      "r140",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r136",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r131",
      "r135"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Impairments and (gain)/loss on disposal of assets, net"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation (recoveries)/charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r123",
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r256",
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings/(loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r76",
      "r101",
      "r230"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income Tax Expense (Benefit)",
        "verboseLabel": "Provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "(Increase)/decrease in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other accrued liabilities and operating items, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "(Increase)/decrease in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r132",
      "r139"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r132",
      "r139"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r129",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r52",
      "r99",
      "r280",
      "r283",
      "r319"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r2",
      "r34",
      "r122"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for investment holdings.  This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseArrangementTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by group of related lease arrangements. For example, but not limited to, leases grouped by facility or contractual terms.",
        "label": "Lease Arrangement, Type [Axis]",
        "terseLabel": "Lease Arrangement, Type [Axis]"
       }
      }
     },
     "localname": "LeaseArrangementTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseArrangementTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Group of related lease arrangements. For example, but not limited to, leases grouped by facility or contractual terms.",
        "label": "Lease Arrangement, Type [Domain]",
        "terseLabel": "Lease Arrangement, Type [Domain]"
       }
      }
     },
     "localname": "LeaseArrangementTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r301",
      "r303"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r19",
      "r314",
      "r327"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r29",
      "r159"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability",
        "verboseLabel": "litigation settlement liability recorded"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term obligations and other short-term borrowings"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r28",
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermPurchaseCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Purchase Commitment, Period",
        "terseLabel": "Long-term Purchase Commitment, Period"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r57",
      "r58",
      "r73",
      "r316",
      "r333"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss on Sale of Investments",
        "terseLabel": "Impairments and (gain)/loss on sale of investments"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r33",
      "r313",
      "r326"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r70",
      "r71",
      "r74"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by/(used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r45",
      "r48",
      "r54",
      "r74",
      "r93",
      "r317",
      "r331"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Earnings/(Loss)",
        "totalLabel": "Net earnings/(loss) attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r45",
      "r48",
      "r242",
      "r247"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: comprehensive income attributable to noncontrolling interests",
        "negatedTerseLabel": "Less: Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.",
        "label": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification",
        "negatedTerseLabel": "Amended lease standard adoption impact as of July 1, 2019"
       }
      }
     },
     "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in CCYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Open Tax Year"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating earnings",
        "totalLabel": "Operating earnings/(loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r295",
      "r303"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "verboseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r292",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows paid for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r300",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r299",
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "Operating Leases, Future Minimum Payments Due, Next Twelve Months"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Five Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Four Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Three Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Two Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r98",
      "r111"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r26"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r43",
      "r51"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive income/(loss), before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Net unrealized gain/(loss) on derivative instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r37",
      "r279"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r46",
      "r49",
      "r51",
      "r175"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income/(loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income/(loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r46",
      "r49",
      "r239",
      "r240",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury shares",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r68",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments and other adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends on common shares"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units",
        "verboseLabel": "Performance Share Unit"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred shares, without par value:"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred Shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred Shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Authorized\u2014500 thousand shares, Issued\u2014none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net change in short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from Sale of Property, Plant, and Equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r45",
      "r48",
      "r69",
      "r102",
      "r112",
      "r239",
      "r241",
      "r243",
      "r247",
      "r248"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings/(loss)",
        "totalLabel": "Net earnings/(loss)",
        "verboseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r8",
      "r9",
      "r143",
      "r329"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r56",
      "r120"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r15",
      "r20",
      "r328",
      "r337"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Loss [Rollforward]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r43",
      "r44",
      "r51"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r107",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r106",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r106",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Segment Profit by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r105",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "verboseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r105",
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Revenue by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Reduction of long-term obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Restricted Share Unit"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeverance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r73",
      "r146",
      "r151",
      "r155"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "totalLabel": "Total restructuring and employee severance",
        "verboseLabel": "Restructuring and employee severance"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Additions",
        "verboseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r147",
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r182",
      "r325"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r53",
      "r97",
      "r98",
      "r110"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByGeographicalSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r298",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "New financing leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r298",
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "New Operating Leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Total Share-based Compensation Expense by Type of Award"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r268",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r131",
      "r135"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r139",
      "r141"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Performance Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r149",
      "r150",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r149",
      "r150",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r147",
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r96",
      "r102",
      "r104",
      "r108",
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r195",
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Restricted Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r198",
      "r210",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Transactions Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r30",
      "r77",
      "r172",
      "r173",
      "r174",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r61",
      "r121"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Distribution, selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r73",
      "r146",
      "r151",
      "r155"
     ],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance Costs",
        "verboseLabel": "Employee-related costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "negatedLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in usd per share)",
        "periodStartLabel": "Nonvested at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share",
        "verboseLabel": "Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of outstanding options at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r200",
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r192",
      "r197"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Target performance goal (as a percent)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercisable options at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r102",
      "r127",
      "r145",
      "r148",
      "r156",
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Operating and Reportable Segment"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r32",
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails",
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesNarativeDetails",
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSummaryOfMinimumLeaseCommittmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r13",
      "r14",
      "r175",
      "r182",
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r13",
      "r14",
      "r182",
      "r194",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "negatedTerseLabel": "Employee stock plans activity, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r14",
      "r17",
      "r18",
      "r118"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Cardinal Health, Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r237",
      "r238",
      "r246"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "negatedPeriodEndLabel": "Balance at end of period",
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders' equity",
        "verboseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Stockholders' Equity, Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items [Axis]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items [Domain]"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationDisaggregatedRevenueWithinReportableSegmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationNarrativeDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury shares acquired, average price per share (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r31",
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r31",
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Treasury, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period (in shares)",
        "terseLabel": "Common Shares in Treasury"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r14",
      "r175",
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury shares acquired (using cost method), shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r31",
      "r183",
      "r184"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common shares in treasury, at cost: 34 million shares and 28 million shares at September 30, 2019 and June 30, 2019, respectively",
        "negatedPeriodEndLabel": "Treasury, balance at end of period",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r175",
      "r182",
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.",
        "label": "Type of Adoption [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r221",
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, interest and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r296",
      "r303"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable Lease, Cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r87",
      "r91"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average common shares\u2013diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r86",
      "r91"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares\u2013basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b,c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e604059-122996"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r341": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r342": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r343": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r344": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r345": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r346": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(d),(e))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6600054256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,001</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,991</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6897392464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance costs:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:44%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>19</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>73</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6816004016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Summary of Lease Payments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows paid for operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows paid for finance lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">New Operating Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">New financing leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification', window );">Amended lease standard adoption impact as of July 1, 2019</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6893769600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2019 </div>
<div>StateAG </div>
<div>plaintiff </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 21, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidTotalSettlementCuyahogaandSummitCounties', window );">Opioid Total Settlement, Cuyahoga and Summit Counties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember', window );">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">litigation settlement liability recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,560.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashComponentForSettlementFrameworkTerm', window );">Cash Component For Settlement Framework, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember', window );">Cuyahoga and Summit County [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">litigation settlement liability recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NumberofStateAttorneysGeneralfilinglawsuits', window );">Lawsuits Against Distributors | StateAG</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_InvestigationbyMultitateTaskForce', window );">InvestigationbyMultitateTaskForce | StateAG</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cah_CVSHealthMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermPurchaseCommitmentPeriod', window );">Long-term Purchase Commitment, Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_MaximumQuarterlyPayment', window );">Maximum quarterly payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyAccrualNetofInsuranceRecoveries', window );">Loss Contingency Accrual, Net of Insurance Recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyAccrualNetofInsuranceRecoveries', window );">Loss Contingency Accrual, Net of Insurance Recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">836.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember', window );">Alameda County [Member] | Product Liability Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">3,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember', window );">Other Jurisdictions [Member] | Product Liability Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | plaintiff</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">litigation settlement liability recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember', window );">Opioid Settlement Framework [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">litigation settlement liability recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,140.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember', window );">Private Parties [Member] | Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember', window );">Class Action Lawsuits [Member] | Private Parties [Member] | Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashComponentForSettlementFrameworkTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Component For Settlement Framework, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashComponentForSettlementFrameworkTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_InvestigationbyMultitateTaskForce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investigation by Multitate Task Force</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_InvestigationbyMultitateTaskForce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyAccrualNetofInsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Net of Insurance Recoveries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyAccrualNetofInsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyLawsuitsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Lawsuits, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyLawsuitsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_MaximumQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_MaximumQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NumberofStateAttorneysGeneralfilinglawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of State Attorneys General filing lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NumberofStateAttorneysGeneralfilinglawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidTotalSettlementCuyahogaandSummitCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Total Settlement, Cuyahoga and Summit Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidTotalSettlementCuyahogaandSummitCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermPurchaseCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermPurchaseCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_CVSHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_CVSHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_AlamedaCountyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PlaintiffTypeAxis=cah_PrivatePartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6904509680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details) - Restricted Share Units<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 51.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">42.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">60.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 45.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6896340736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to share-based compensation</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VestingPeriodinyearsforShares', window );">Vesting Period in years for Shares</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">240.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ExercisablePeriodOfPlansInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The instrument's contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ExercisablePeriodOfPlansInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VestingPeriodinyearsforShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting Period in years for Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VestingPeriodinyearsforShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
